data_1sou_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sou _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.987 0.422 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 163' ' ' ASP . 16.6 ptmt -52.44 -50.38 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.681 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -70.93 -40.08 72.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.8 -37.43 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.115 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD21 HD21 ' A' ' 129' ' ' LEU . 38.0 tp -67.01 -37.23 83.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 96.6 mtt180 -60.72 -44.96 95.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.245 0.545 . . . . 0.0 109.843 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.38 -50.92 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.121 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -62.63 -34.8 77.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.57 0.224 . . . . 0.0 111.576 -174.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.12 -40.4 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.366 . . . . 0.0 110.189 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.684 HD11 ' HD3' ' A' ' 14' ' ' ARG . 31.0 tp -62.21 -34.78 77.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -59.65 -43.92 93.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -81.97 -28.78 32.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.096 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.684 ' HD3' HD11 ' A' ' 11' ' ' LEU . 32.1 ttt85 -56.69 -43.96 81.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.293 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 pt -88.41 0.89 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.408 . . . . 0.0 111.115 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -89.57 -20.78 23.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.28 137.56 47.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.44 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.7 t -90.65 145.35 24.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.483 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 40.7 mm-40 -59.8 -25.14 64.71 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.284 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -53.25 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.379 0.609 . . . . 0.0 110.379 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.86 -40.62 65.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 66.9 ttt180 -56.34 -50.67 70.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.686 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -64.15 -33.73 76.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -70.97 -38.83 72.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.3 -37.5 71.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.437 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.483 ' HA ' HG12 ' A' ' 55' ' ' VAL . 70.7 m -59.32 -39.98 84.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.704 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.72 -44.19 85.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -62.35 -43.8 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -44.95 99.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.479 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 56' ' ' ASP . 67.1 mt -56.93 -53.87 37.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.0 m -59.28 -44.55 92.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.993 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 2.7 t-20 -61.1 -52.51 64.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD12 ' HZ ' ' A' ' 114' ' ' PHE . 20.0 tp -60.75 -38.35 84.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.078 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -79.4 -21.19 45.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.315 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -85.83 -18.93 31.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.208 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 32' ' ' ASN . 92.5 mt -55.94 119.61 27.53 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.728 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.21 -22.76 75.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.015 2.476 . . . . 0.0 112.764 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.95 -23.88 48.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.606 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.53 -23.04 59.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -71.43 -29.12 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.41 -37.35 11.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.272 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m -58.19 122.54 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -90.94 -41.9 10.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.553 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 18.7 mmtp -95.23 109.02 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.17 101.45 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -100.64 136.27 40.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.49 151.06 39.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.484 ' HD1' ' HA ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.84 -90.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.647 ' HG ' HG23 ' A' ' 51' ' ' ILE . 35.6 t 176.05 127.23 0.15 Allowed Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.254 0.346 . . . . 0.0 110.344 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.39 112.29 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.169 2.579 . . . . 0.0 110.932 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.647 HG23 ' HG ' ' A' ' 49' ' ' CYS . 10.7 pt -127.98 -47.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 51' ' ' ILE . 74.4 mmtt -96.7 -69.24 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -171.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.543 ' HA3' ' HG2' ' A' ' 14' ' ' ARG . . . -149.58 46.79 0.64 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.303 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HG3' HH21 ' A' ' 14' ' ' ARG . 3.9 mp0 -97.87 -156.18 0.53 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 26' ' ' SER . 91.6 t -101.41 138.35 25.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.608 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' O ' HD12 ' A' ' 30' ' ' ILE . 27.1 m-20 -72.35 75.18 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.16 0.505 . . . . 0.0 111.08 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD13 HG11 ' A' ' 150' ' ' VAL . 93.2 mt -90.72 -5.02 56.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.768 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -47.54 98.85 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.452 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.3 -7.66 20.72 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.252 1.968 . . . . 0.0 113.205 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 64' ' ' VAL . 40.9 tp -87.17 -7.08 58.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.794 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 13.0 m-30 -53.31 -50.65 81.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.943 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.8 Cg_exo -52.17 -42.05 61.74 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.239 1.96 . . . . 0.0 112.977 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -65.41 -43.82 89.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.647 0.261 . . . . 0.0 110.848 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 60' ' ' LEU . 56.0 t -64.66 -48.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.635 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.36 -33.87 66.09 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.435 0.459 . . . . 0.0 111.382 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -64.32 -45.87 86.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.705 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -101.81 -60.55 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -108.55 -171.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.021 0.439 . . . . 0.0 111.272 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.587 ' HG2' ' HD2' ' A' ' 84' ' ' ARG . 1.8 mp0 -96.35 116.8 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.253 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.79 116.06 18.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.642 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 58.0 mt -111.12 126.02 68.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.896 0.379 . . . . 0.0 110.623 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.3 mt -120.69 150.08 51.78 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HA ' HD23 ' A' ' 82' ' ' LEU . 58.8 Cg_endo -73.27 125.7 10.46 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.577 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 8.9 tmtm? -116.63 124.37 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.72 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG23 HG12 ' A' ' 80' ' ' ILE . 41.6 t -90.7 105.98 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.13 -24.97 18.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.753 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.44 80.63 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.83 -56.96 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 0.0 111.118 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.96 141.48 34.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 75' ' ' VAL . 67.5 mt -105.08 127.87 59.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -102.89 163.28 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.642 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 66.3 mt -115.8 124.54 50.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.04 0.448 . . . . 0.0 110.855 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -108.36 134.69 50.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.238 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.587 ' HD2' ' HG2' ' A' ' 69' ' ' GLU . 13.7 ptt180 -93.8 140.66 29.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.07 140.99 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.485 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.61 2.71 15.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.796 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 25.4 p -149.86 151.9 33.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.739 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.7 Cg_exo -76.6 44.37 1.39 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.997 2.465 . . . . 0.0 111.742 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 -74.31 0.42 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.848 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.4 t -95.2 92.81 6.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.116 0.484 . . . . 0.0 111.496 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt -138.21 98.82 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.388 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.28 152.65 17.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.218 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.54 107.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.458 . . . . 0.0 110.341 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.78 -40.88 1.39 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 98' ' ' ILE . . . -87.67 -152.48 0.2 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -78.37 58.35 2.11 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.453 0.644 . . . . 0.0 111.405 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.2 -13.67 60.08 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.979 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.411 ' CG1' ' HB1' ' A' ' 95' ' ' ALA . 41.0 pt -90.08 148.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.75 0.31 . . . . 0.0 110.89 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 ptp -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 16.8 pt-20 -138.01 147.52 56.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.79 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 3.7 Cg_exo -81.1 106.66 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.492 2.128 . . . . 0.0 111.418 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.63 -21.16 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.26 127.15 43.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.856 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.59 -143.4 8.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.12 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -106.85 116.79 32.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.966 0.413 . . . . 0.0 110.377 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -79.11 116.52 19.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.333 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 142.04 25.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.855 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.8 p30 -80.2 137.73 52.72 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.515 ' HA ' HD12 ' A' ' 82' ' ' LEU . 34.6 Cg_exo -58.88 -24.33 71.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.97 2.447 . . . . 0.0 113.847 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.99 -9.75 59.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.82 -10.86 54.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.349 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 66.7 t -77.21 121.98 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.343 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 11.5 m-20 -74.7 -52.98 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.468 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.527 ' CZ ' HG23 ' A' ' 148' ' ' VAL . 34.6 t80 -124.31 123.99 41.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.253 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 15.2 tt -130.38 139.83 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 110.741 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.61 109.48 20.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.259 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.513 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 11.6 m -119.74 120.05 30.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.289 0.566 . . . . 0.0 111.135 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 1.4 Cg_endo -84.1 163.96 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.025 2.483 . . . . 0.0 111.95 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.41 154.15 25.47 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.6 t -55.97 -47.28 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.982 0.391 . . . . 0.0 110.894 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.5 147.84 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -129.78 167.19 18.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.979 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.508 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 1.3 p-10 -127.23 -169.62 2.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.699 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.1 mt -92.3 4.03 54.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.05 -25.82 10.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.649 0.261 . . . . 0.0 110.781 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.45 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . 117.86 26.07 2.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 174.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -102.23 158.07 16.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.782 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' OD2' ' A' ' 166' ' ' ASP . 33.0 mtm180 -124.35 -176.97 3.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.479 HD21 HD21 ' A' ' 6' ' ' LEU . 20.6 tp . . . . . 0 C--N 1.319 -0.725 0 CA-C-O 121.28 0.562 . . . . 0.0 109.726 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' HA ' HD13 ' A' ' 140' ' ' LEU . 6.5 p-10 -67.92 -23.85 65.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.008 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.99 -35.99 74.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.902 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.22 -36.76 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 137' ' ' ASP . 79.8 mt -67.66 -26.36 66.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.108 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 34.3 mmtp -76.72 -21.66 54.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 109' ' ' PRO . 27.5 mmt180 -77.52 -53.11 8.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.172 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.84 103.21 4.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.84 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -113.99 24.4 12.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.25 -139.75 5.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.808 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.93 101.36 13.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.62 ' HE2' HD12 ' A' ' 167' ' ' ILE . 18.9 mttp -88.54 106.67 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' A' ' 114' ' ' PHE . 67.7 t -101.0 116.98 45.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.801 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -78.94 121.57 5.6 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.432 HG11 HD13 ' A' ' 57' ' ' LEU . 61.9 t -113.65 115.86 50.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.552 0.215 . . . . 0.0 110.463 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.95 -179.81 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.084 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.407 ' O ' HG22 ' A' ' 156' ' ' VAL . 95.1 m-85 -97.56 156.1 16.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.86 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.3 p -61.23 -25.9 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.589 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.526 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 70.7 m-85 -61.78 -36.4 80.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -90.62 8.31 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 152' ' ' TYR . 61.5 t -109.66 133.79 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.892 0.377 . . . . 0.0 110.424 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.93 -169.52 1.85 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 48.2 mt-10 -84.74 -50.15 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.281 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.1 ptm180 -141.11 146.65 37.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 176.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 92.5 mt -116.6 149.16 43.35 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.995 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.35 104.57 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.274 1.983 . . . . 0.0 111.007 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -73.55 111.41 8.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.0 110.768 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' A' ' 3' ' ' LYS . 24.7 t70 -62.71 -78.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.963 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.6 -96.26 0.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.781 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -128.54 61.66 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.358 0.599 . . . . 0.0 111.25 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 128' ' ' ARG . 38.7 t70 -74.36 141.82 45.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.62 HD12 ' HE2' ' A' ' 147' ' ' LYS . 14.1 tt -79.11 120.26 80.08 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.941 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.5 Cg_exo -74.15 148.65 39.76 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.023 2.482 . . . . 0.0 111.807 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.94 169.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.011 0.434 . . . . 0.0 111.607 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -93.3 -40.08 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.297 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 148' ' ' VAL . 17.0 t -133.07 155.12 40.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 55.5 tp -135.43 118.31 16.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.97 126.45 73.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 0.0 110.799 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 71.7 p -114.56 -172.49 2.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.266 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 176' ' ' LYS . 2.5 pm0 -85.73 -15.05 43.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.031 0.443 . . . . 0.0 110.125 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.414 ' HG3' ' HG2' ' A' ' 175' ' ' GLU . 29.4 mtpp -112.31 -47.82 3.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.197 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -131.43 163.1 28.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 112.102 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.53 122.56 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.73 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 3.0 mmp_? -108.93 131.73 54.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.993 0.425 . . . . 0.0 110.186 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -121.74 128.39 51.72 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.45 HD11 ' HA3' ' A' ' 126' ' ' GLY . 23.4 mt . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 121.672 0.748 . . . . 0.0 110.247 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -53.21 -57.83 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -60.66 -39.18 87.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.54 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.71 -52.34 21.61 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.091 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -61.88 -35.23 77.72 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.321 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -56.11 -59.42 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.451 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -74.25 -37.54 63.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.764 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.54 -39.79 92.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.494 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.1 t -86.19 -41.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.7 tp -60.34 -37.59 81.14 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.173 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 75.9 t60 -59.69 -31.04 69.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.741 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -82.71 -42.74 17.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.916 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.565 ' NH2' ' HA ' ' A' ' 151' ' ' ALA . 52.2 ttt180 -61.19 -38.75 87.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 0.0 111.103 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.1 pt -88.18 -4.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.368 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 66.1 t30 -98.4 -13.69 20.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.888 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.78 143.83 15.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -61.98 144.59 54.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -59.27 -49.33 78.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.548 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.81 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.786 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.09 -44.61 91.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.409 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -59.13 -42.57 90.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -25.5 66.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.688 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -83.86 -18.48 37.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.903 0.382 . . . . 0.0 110.785 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.7 mt -86.56 -53.52 4.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.094 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 m -57.17 -34.49 68.52 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.09 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -48.27 -50.44 29.83 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.086 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -80.59 -26.59 37.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.323 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 25' ' ' LEU . 58.0 t -65.07 -49.51 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.82 -46.42 96.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.619 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -62.09 -40.94 97.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.456 ' OD1' HG23 ' A' ' 178' ' ' VAL . 21.8 t-20 -66.51 -51.14 59.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.008 0.433 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.793 HD12 ' HZ ' ' A' ' 114' ' ' PHE . 36.9 tp -57.64 -38.61 75.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.4 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -72.85 -33.38 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.917 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -75.35 -16.87 60.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.346 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD11 HD11 ' A' ' 33' ' ' LEU . 79.7 mt -56.46 126.3 69.03 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.852 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -32.74 96.04 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.571 2.181 . . . . 0.0 111.593 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.27 -35.08 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -62.22 -30.31 71.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.078 0.466 . . . . 0.0 110.433 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -64.52 -40.08 94.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.73 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -80.79 -33.2 35.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.159 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.484 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 46.4 m -55.53 105.81 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.046 0.45 . . . . 0.0 111.1 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 84.4 tttt -98.47 -30.67 12.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.653 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -102.91 98.21 8.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.383 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.16 109.01 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 111.066 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.29 139.64 34.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.551 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.27 145.96 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.888 0.375 . . . . 0.0 110.831 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.29 -4.11 59.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.911 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 70.9 m 65.17 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 123.727 0.642 . . . . 0.0 111.465 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 95.92 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.502 2.135 . . . . 0.0 112.743 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 35.7 pt -90.65 161.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 67.4 mttm 70.91 -55.25 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.725 0.64 . . . . 0.0 110.805 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.22 -83.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 4.4 mm-40 45.53 39.55 4.87 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.801 0.84 . . . . 0.0 112.862 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG23 ' CZ ' ' A' ' 152' ' ' TYR . 53.3 t 68.26 101.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.084 -174.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.07 92.71 1.34 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.826 0.822 . . . . 0.0 111.183 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 150' ' ' VAL . 93.8 mt -88.49 15.19 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.792 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 8.8 p -62.35 -38.47 46.93 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 30.5 Cg_exo -64.38 -11.48 28.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.925 1.75 . . . . 0.0 112.717 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.426 ' O ' HG21 ' A' ' 64' ' ' VAL . 36.9 tp -89.24 -16.2 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.59 0.233 . . . . 0.0 110.741 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 23.9 m-85 -56.51 -50.65 86.54 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 50.4 Cg_exo -55.74 -35.19 92.97 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.13 1.887 . . . . 0.0 112.509 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.46 -43.73 76.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.485 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 60' ' ' LEU . 59.2 t -64.49 -44.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.26 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.51 -18.83 65.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.704 0.288 . . . . 0.0 111.549 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -75.99 -36.52 59.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.393 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -124.11 -46.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 31.1 mmtp -101.93 -175.04 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.017 0.437 . . . . 0.0 111.52 -168.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.492 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 38.6 mm-40 -98.3 120.0 37.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.595 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.05 102.44 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.2 mt -91.52 116.89 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.085 0.469 . . . . 0.0 110.494 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.8 mt -117.11 137.09 23.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.205 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.6 119.4 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -105.74 117.45 34.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.08 95.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -96.72 71.29 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 109.71 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.37 -111.18 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.429 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.55 -22.97 14.8 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -77.43 89.05 3.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.719 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.84 119.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -111.85 132.29 54.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.452 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -81.85 103.93 11.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.054 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 3.7 m-85 -95.97 120.19 35.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.197 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 24.2 ptt85 -83.42 131.3 35.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.68 133.19 68.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.998 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.23 12.83 7.69 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.5 m -112.05 109.68 54.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.536 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.2 Cg_exo -74.42 31.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.463 2.775 . . . . 0.0 112.915 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 -28.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.951 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 58.2 m -84.75 38.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -172.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.22 152.22 21.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -132.89 176.31 19.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.99 98.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.114 0.457 . . . . 0.0 110.031 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.19 -32.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.058 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.485 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -76.18 94.84 3.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.855 0.327 . . . . 0.0 111.072 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.1 t80 72.49 -52.13 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.199 0.599 . . . . 0.0 111.809 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.32 33.92 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 95' ' ' ALA . 41.5 pt -122.86 172.72 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 66.1 mtt -94.24 86.94 5.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 2.3 pm0 -87.93 148.36 43.17 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.983 0.421 . . . . 0.0 110.263 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 8.1 Cg_exo -72.17 106.09 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 103' ' ' GLU . 31.2 m -76.72 -25.01 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.499 0.666 . . . . 0.0 109.421 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 59.7 mm-40 -122.28 129.11 51.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.938 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.11 -159.2 28.37 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 34.3 tt0 -138.71 131.16 28.76 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -79.74 113.62 18.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.44 154.23 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.138 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -81.99 142.11 47.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.294 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HB2' HG23 ' A' ' 143' ' ' VAL . 24.2 Cg_endo -61.22 -23.21 76.67 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.299 2.666 . . . . 0.0 113.69 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.82 -19.67 63.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.88 0.371 . . . . 0.0 110.975 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.51 -12.56 53.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.391 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.98 114.22 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 110.847 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 42' ' ' SER . 38.8 t70 -90.47 -51.61 5.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.258 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.793 ' HZ ' HD12 ' A' ' 33' ' ' LEU . 38.3 t80 -130.43 139.39 50.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.471 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.6 tt -146.29 139.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 110.74 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.64 20.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.463 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 59.4 t -122.33 110.89 32.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.01 165.9 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.922 2.415 . . . . 0.0 112.081 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.78 163.89 30.57 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.01 -38.46 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.571 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.63 159.06 44.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.173 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.28 165.84 25.7 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.517 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 16.1 p30 -126.46 -172.09 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.69 -2.2 58.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.029 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -105.79 -28.7 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.809 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.17 30.64 0.85 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.869 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -108.99 151.83 25.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.318 0.559 . . . . 0.0 110.414 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -122.89 149.6 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.067 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.442 0.639 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.38 -41.91 99.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.13 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.82 -25.6 65.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.851 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.07 -56.57 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.192 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.2 -12.85 61.69 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.769 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -76.47 -32.52 58.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -94.43 -40.81 9.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.083 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 109' ' ' PRO . 49.7 t -71.82 91.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.268 0.556 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 144' ' ' LYS . 5.6 tmtm? -103.89 68.21 0.91 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.554 0.692 . . . . 0.0 109.837 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.69 -150.29 19.01 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 113' ' ' ASP . 11.0 mp -83.29 89.03 6.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.979 0.889 . . . . 0.0 109.227 171.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -81.98 102.47 10.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.458 HG22 ' CE2' ' A' ' 114' ' ' PHE . 89.8 t -98.82 114.72 37.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.622 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -79.03 119.95 5.17 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.539 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.512 HG12 HD11 ' A' ' 57' ' ' LEU . 47.5 t -98.05 110.73 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.371 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.565 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . . . -154.05 176.5 12.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.248 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.446 ' CZ ' HG23 ' A' ' 55' ' ' VAL . 71.6 m-85 -96.69 151.96 19.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.0 t -62.28 -17.78 59.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.45 0.166 . . . . 0.0 111.071 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -62.73 -33.44 75.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.263 0.554 . . . . 0.0 110.389 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.52 -3.8 58.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.429 -174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 38.8 t -91.19 110.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -105.62 -179.17 3.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.523 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.31 -58.6 4.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.079 0.466 . . . . 0.0 110.039 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -144.77 138.54 27.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.848 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 90.5 mt -93.45 152.65 41.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.87 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 101.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.074 1.849 . . . . 0.0 109.653 167.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -73.63 150.09 41.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.263 0.554 . . . . 0.0 111.114 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -103.85 -172.91 2.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.087 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.58 35.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -96.82 64.19 2.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -74.98 108.36 7.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.863 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.2 103.98 55.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.867 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.49 159.75 10.93 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.839 2.359 . . . . 0.0 112.416 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.35 173.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.02 -52.52 3.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.038 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.2 130.97 68.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.24 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 57.0 tp -104.97 108.63 20.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.033 0.444 . . . . 0.0 110.218 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.01 130.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.434 ' HB ' ' OE2' ' A' ' 175' ' ' GLU . 40.2 p -126.55 -173.89 2.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.275 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.434 ' OE2' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -79.34 -9.0 59.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.097 0.475 . . . . 0.0 110.862 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -120.31 -62.01 1.52 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -110.01 151.75 26.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.316 0.579 . . . . 0.0 112.548 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.456 HG23 ' OD1' ' A' ' 32' ' ' ASN . 16.6 t -103.81 99.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.102 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 79.2 mtt85 -94.5 85.23 4.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.292 0.568 . . . . 0.0 110.782 -176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -76.27 99.42 4.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.511 -170.087 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 121.169 0.509 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.634 ' HD2' ' HG ' ' A' ' 129' ' ' LEU . 65.3 pttt -72.72 -11.09 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -60.7 -47.57 85.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.546 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -34.18 71.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.814 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.25 -44.11 80.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.166 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 120' ' ' VAL . 4.9 tmt_? -58.39 -43.97 88.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.18 -41.37 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.52 -44.09 89.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 37.2 t -71.78 -46.12 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.322 . . . . 0.0 110.348 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.24 -39.61 83.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.782 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -53.16 -39.38 63.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.072 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -90.75 -1.24 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.653 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 62.6 mtp180 -97.34 -48.74 5.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.127 0.489 . . . . 0.0 111.435 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.59 -21.99 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.687 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -76.82 -16.1 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.35 153.62 26.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.628 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -63.1 144.89 56.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.79 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.66 -48.88 78.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 110.011 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 2.5 mp0 -54.33 -49.14 70.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.963 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.76 -53.04 62.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.631 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 22' ' ' ARG . 33.1 ttp180 -64.49 -38.87 92.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -69.67 -36.13 75.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.863 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -65.98 -30.16 70.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 109.88 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.94 -46.08 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.145 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 t -57.45 -35.31 69.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.289 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.64 -51.32 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.405 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -74.28 -28.11 61.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.974 -174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.17 -47.94 80.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.1 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.454 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 m -62.19 -40.42 95.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.32 -46.05 74.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.403 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.586 HD12 HD11 ' A' ' 36' ' ' LEU . 46.6 tp -61.49 -41.89 97.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.569 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -64.58 -33.16 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -70.15 -26.17 63.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.739 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.586 HD11 HD12 ' A' ' 33' ' ' LEU . 92.6 mt -61.91 120.12 54.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.169 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.44 -33.58 78.91 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.241 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -22.08 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' CZ ' ' HE2' ' A' ' 68' ' ' LYS . 50.4 t80 -68.84 -29.94 68.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.83 -31.08 15.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.18 -49.87 74.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 113' ' ' ASP . 70.1 m -86.82 122.1 30.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.37 -21.54 18.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -173.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.58 97.8 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.157 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.98 118.04 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.307 0.575 . . . . 0.0 110.858 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -98.75 137.12 37.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.46 139.28 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.72 0.295 . . . . 0.0 110.262 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -85.57 -6.12 59.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.8 t 67.11 102.08 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.306 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.1 124.41 9.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.429 2.086 . . . . 0.0 112.243 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.4 pp -111.57 152.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.296 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 63.08 20.19 12.13 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.098 0.475 . . . . 0.0 110.982 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.17 -88.19 0.63 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.83 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 70.8 mm-40 64.08 -85.01 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 122.925 0.49 . . . . 0.0 109.769 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 150' ' ' VAL . 88.1 t -148.95 116.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.51 101.41 2.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.78 9.54 24.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.501 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.482 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 68.5 p -65.21 -38.81 30.57 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 58' ' ' THR . 68.6 Cg_endo -74.14 4.56 4.19 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.62 1.547 . . . . 0.0 112.543 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 64' ' ' VAL . 27.9 tp -99.33 -17.28 18.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.594 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 30.9 m-85 -52.07 -46.25 93.26 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 87.4 Cg_exo -49.86 -45.39 32.47 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.083 1.856 . . . . 0.0 112.589 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.92 -32.96 65.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.692 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 60' ' ' LEU . 76.9 t -61.61 -45.2 99.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.93 -12.71 61.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.427 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 62' ' ' PRO . 31.4 mmmt -92.46 -58.45 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.087 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.24 -38.99 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.372 0.606 . . . . 0.0 110.684 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 22.6 mttp -125.63 -171.6 2.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.769 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 86' ' ' HIS . 42.8 tt0 -120.17 135.08 55.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.168 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.412 HD12 HG13 ' A' ' 64' ' ' VAL . 62.3 tp -92.47 132.48 36.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 111.391 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -119.83 127.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 97.4 mt -126.29 144.14 48.24 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.48 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.47 146.45 12.21 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.962 2.442 . . . . 0.0 112.593 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -135.0 135.1 41.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.93 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -99.23 124.51 52.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -119.13 44.21 2.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.03 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.64 -93.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.861 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -109.7 -27.47 9.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -92.75 134.75 34.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 tt -116.82 127.82 74.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.114 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -124.55 178.89 5.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.47 138.77 50.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 27.0 m-85 -121.5 146.68 46.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 0.0 111.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.802 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 21.6 ttm180 -91.2 118.43 30.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.962 -172.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 HD23 ' A' ' 91' ' ' LEU . 46.4 t -119.04 111.67 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.419 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.1 p-80 -139.06 30.31 2.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.514 0.674 . . . . 0.0 109.222 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.8 p -154.27 143.91 15.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.819 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.6 Cg_exo -73.18 171.77 16.93 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.934 2.422 . . . . 0.0 112.386 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.8 18.83 11.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.793 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 53.4 m -113.93 3.34 15.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.501 HD23 HG11 ' A' ' 85' ' ' VAL . 91.7 mt -108.3 126.05 52.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.211 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.92 -163.56 9.79 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.8 t -123.04 119.4 57.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.926 0.363 . . . . 0.0 110.09 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.37 -98.61 1.36 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 132.81 46.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.6 t80 72.12 -53.47 0.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.904 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.33 34.26 0.37 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.006 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.9 pt -108.35 172.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 91' ' ' LEU . 48.6 tpp -70.72 102.76 2.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 29.4 tt0 -114.31 134.59 22.23 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -172.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 11.3 Cg_exo -70.27 119.65 6.52 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.357 2.038 . . . . 0.0 109.812 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG11 ' HG2' ' A' ' 103' ' ' GLU . 13.6 t -54.04 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.678 0.611 . . . . 0.0 111.031 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG2' HG11 ' A' ' 102' ' ' VAL . 54.4 mm-40 -136.64 145.69 45.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.7 -148.61 13.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.622 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.802 ' HG3' ' HB3' ' A' ' 84' ' ' ARG . 6.3 pt-20 -91.2 151.24 21.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 111.433 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -100.41 162.33 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.751 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 50.5 t -125.57 136.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.073 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -82.77 139.04 43.4 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.555 ' HB3' HG22 ' A' ' 143' ' ' VAL . 52.2 Cg_exo -56.42 -23.82 49.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.642 2.228 . . . . 0.0 111.265 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.11 -32.59 71.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.158 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.86 -11.51 36.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.893 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -77.46 126.39 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.445 ' CB ' ' HB3' ' A' ' 42' ' ' SER . 15.0 m-20 -96.0 -51.94 4.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.522 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -123.23 148.35 45.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.895 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.56 138.9 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.012 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.46 112.3 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.09 126.42 28.04 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.503 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.2 -168.05 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.735 2.29 . . . . 0.0 111.768 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.7 150.51 6.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.935 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 7' ' ' ARG . 98.9 t -74.22 -38.69 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 0.0 110.943 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.53 166.08 25.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -140.7 148.7 41.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 111.389 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 159' ' ' ARG . 11.5 t70 -101.97 156.85 17.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.871 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 49.4 mt -71.9 -26.76 62.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 111.226 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -85.81 -7.17 58.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.104 0.478 . . . . 0.0 110.029 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 111.27 -0.88 28.14 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.98 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.485 ' N ' ' HB3' ' A' ' 123' ' ' ASP . 95.1 m-85 -64.47 156.89 28.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.31 0.555 . . . . 0.0 110.689 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 37.0 mtm180 -103.99 -71.98 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 160' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.472 0.632 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.019 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.655 0.74 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.75 -24.54 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.07 -25.42 67.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.176 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 45.1 tp -83.84 -39.93 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.513 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.71 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.538 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.513 ' HG2' ' HB ' ' A' ' 167' ' ' ILE . 22.2 mtmm -86.37 -0.07 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.171 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -100.45 -36.32 9.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.93 0.395 . . . . 0.0 110.477 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.1 t -84.91 91.14 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 110.052 177.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.51 62.28 3.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.748 0.785 . . . . 0.0 110.193 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.81 -152.95 23.17 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.68 94.39 8.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.427 0.614 . . . . 0.0 109.827 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.474 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 9.5 mtmp? -77.49 104.91 8.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 76.3 t -95.12 113.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.484 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.404 ' O ' HD13 ' A' ' 172' ' ' LEU . . . -84.75 117.19 4.44 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 55' ' ' VAL . 22.6 t -105.8 109.15 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -159.01 -177.83 6.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.109 0.48 . . . . 0.0 111.362 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -100.06 166.92 10.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.176 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.5 m -77.02 -22.09 53.59 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -78.79 2.78 18.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.795 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -101.43 -10.78 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.041 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 t -91.63 115.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.503 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 96.3 m-85 -112.08 178.96 4.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.13 -76.72 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 110.837 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.654 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 43.2 mtm180 -141.18 132.91 27.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.774 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.756 ' HB3' HD13 ' A' ' 129' ' ' LEU . 52.4 mt -103.5 153.44 38.56 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.577 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.8 101.62 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.131 1.887 . . . . 0.0 111.57 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.765 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -90.57 147.33 23.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.564 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.7 -67.1 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.514 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.69 -85.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.612 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 14.9 m-90 -103.72 66.87 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.894 0.378 . . . . 0.0 111.21 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.05 110.17 18.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.513 ' HB ' ' HG2' ' A' ' 141' ' ' LYS . 19.4 tt -74.06 122.89 88.63 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.472 0.653 . . . . 0.0 111.661 -171.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 21.5 Cg_exo -67.2 154.66 73.56 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.154 2.569 . . . . 0.0 112.851 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -82.75 171.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.975 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -108.82 -46.59 3.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.586 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 46.5 t -123.06 113.51 38.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.686 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.844 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 62.3 tp -100.01 102.65 14.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 110.283 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.1 t -89.91 112.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.217 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.0 p -105.06 -175.93 2.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 12.4 pt-20 -72.69 -15.6 61.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.385 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.53 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 66.1 mttt -119.31 -48.71 2.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.48 168.82 18.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.625 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.426 HG23 HD21 ' A' ' 36' ' ' LEU . 23.3 t -91.81 105.03 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.844 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 11.7 mmt180 -80.25 86.21 5.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -78.34 103.49 8.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 121.366 0.603 . . . . 0.0 111.164 -173.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -61.51 -33.66 74.19 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.61 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -80.45 -31.36 37.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 111.184 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.76 -29.66 32.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.86 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' HE2' ' A' ' 9' ' ' LYS . 54.5 tp -58.3 -42.26 86.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 109.563 173.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 129' ' ' LEU . 39.6 ttp180 -58.33 -34.96 71.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.624 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -64.68 -49.18 71.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HE2' HD13 ' A' ' 6' ' ' LEU . 55.6 pttt -72.2 -31.95 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.543 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.544 HG13 ' HB1' ' A' ' 121' ' ' ALA . 86.6 t -69.54 -35.19 65.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.45 ' O ' HG12 ' A' ' 15' ' ' ILE . 54.1 tp -64.97 -51.17 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.802 174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 11.6 t-160 -59.47 -32.58 70.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -77.74 -40.0 42.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 15.8 ttm180 -66.1 -38.07 87.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.673 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.588 HG21 ' HA3' ' A' ' 53' ' ' GLY . 36.9 pt -91.41 7.87 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.784 0.325 . . . . 0.0 111.217 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 9.2 t30 -85.47 -18.43 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 109.612 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.434 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.99 144.7 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 48.6 mt-10 -71.42 -38.55 71.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.04 -39.47 93.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.0 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 24' ' ' ARG . 10.7 tp10 -62.47 -40.77 97.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.717 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -60.68 -41.62 95.49 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 17.1 mmt180 -56.7 -41.64 77.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.433 0.635 . . . . 0.0 110.184 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 21' ' ' GLU . 39.2 ttp180 -71.51 -43.34 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.253 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.73 -38.18 83.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.906 0.384 . . . . 0.0 110.756 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.464 ' HA ' HG12 ' A' ' 55' ' ' VAL . 68.6 m -58.38 -42.14 86.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.598 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.34 -37.83 73.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mtpt -60.97 -52.59 64.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 110.348 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG12 HG11 ' A' ' 150' ' ' VAL . 48.9 t -61.35 -43.88 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.836 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 81.7 mt -61.11 -45.72 98.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -64.68 -33.46 76.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.61 0.243 . . . . 0.0 110.942 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -66.41 -55.17 17.05 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.291 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.48 -31.53 71.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.069 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 23.3 tttp -68.26 -35.26 77.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.0 p -83.69 -14.56 51.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.275 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 38' ' ' GLU . 7.3 tt -58.51 123.34 66.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.847 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -55.63 -44.7 45.56 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.429 2.753 . . . . 0.0 113.452 -172.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 7.6 mp0 -60.95 -25.25 66.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.855 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.74 -36.4 73.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -82.22 -0.54 45.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -106.16 -52.45 2.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -70.08 158.72 35.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.867 -172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -113.31 -34.09 5.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.202 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.03 98.45 11.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.404 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 106.52 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.22 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -97.62 136.76 37.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.49 152.77 42.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' HB2' HG12 ' A' ' 117' ' ' VAL . 7.1 t80 -80.47 -98.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.189 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.67 ' HG ' HG21 ' A' ' 51' ' ' ILE . 49.1 t 177.89 116.46 0.18 Allowed Pre-proline 0 N--CA 1.462 0.154 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -88.46 103.12 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.177 2.585 . . . . 0.0 112.058 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.67 HG21 ' HG ' ' A' ' 49' ' ' CYS . 2.8 pp -118.09 140.99 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.361 177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 71.85 -51.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.267 0.627 . . . . 0.0 111.483 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.588 ' HA3' HG21 ' A' ' 15' ' ' ILE . . . -139.64 -158.68 7.71 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 14' ' ' ARG . 4.2 mm-40 77.34 150.75 0.12 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.974 0.892 . . . . 0.0 112.101 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 26' ' ' SER . 57.1 t -36.85 126.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 112.631 -2.077 . . . . 0.0 112.24 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 30' ' ' ILE . 3.5 m-20 -68.08 76.96 0.23 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.59 -10.3 54.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.838 0.351 . . . . 0.0 110.708 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.463 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -53.87 -49.89 86.91 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 58' ' ' THR . 36.7 Cg_endo -66.0 -8.02 18.72 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.087 1.858 . . . . 0.0 113.526 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.34 -14.09 29.25 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.137 -0.352 . . . . 0.0 110.803 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.3 m-85 -53.75 -52.35 68.28 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.985 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 53.8 Cg_exo -54.34 -37.11 88.74 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.321 2.014 . . . . 0.0 113.183 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.05 -52.35 36.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.623 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.69 -34.59 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.275 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 88' ' ' PRO . 38.1 tp -66.24 -26.23 67.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.297 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.69 -48.99 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.532 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.39 -45.58 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 111.815 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -123.29 -171.68 2.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.626 -163.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.61 100.93 11.4 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.4 tp -80.52 120.56 24.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.593 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.8 mt -102.42 119.81 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.848 0.356 . . . . 0.0 110.371 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.39 142.59 28.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.536 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HA ' HD21 ' A' ' 82' ' ' LEU . 74.3 Cg_endo -92.24 121.61 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.203 2.602 . . . . 0.0 113.279 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.788 ' HD2' ' HE2' ' A' ' 83' ' ' TYR . 55.9 tttm -105.97 133.97 49.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 102.4 8.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -86.69 -19.49 29.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.952 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 156.91 80.47 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 7.0 t30 70.44 -50.8 0.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.216 0.607 . . . . 0.0 111.103 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.38 156.53 25.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -104.63 131.94 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.055 0.455 . . . . 0.0 111.513 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -111.0 115.65 29.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 73' ' ' PRO . 80.6 mt -82.52 141.15 32.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.266 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.788 ' HE2' ' HD2' ' A' ' 74' ' ' LYS . 18.9 m-85 -112.59 141.62 46.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.187 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.548 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . 27.0 ttt180 -88.15 91.72 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.118 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.17 114.51 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.368 0.604 . . . . 0.0 111.936 -171.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -140.62 14.44 2.34 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 23.3 t -99.99 104.79 31.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.333 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' A' ' 65' ' ' LEU . 24.4 Cg_exo -63.64 -29.58 69.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.154 2.569 . . . . 0.0 113.524 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.55 -16.12 40.46 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.521 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 47.0 t -89.89 76.01 7.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.357 0.599 . . . . 0.0 110.485 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.9 mt -135.82 117.54 15.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.899 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.59 178.6 25.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.713 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.96 134.46 66.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.87 -74.58 0.93 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.842 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.42 153.74 40.01 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.896 -0.179 . . . . 0.0 111.3 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.4 t80 73.7 -47.55 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.656 0.782 . . . . 0.0 111.995 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.96 11.8 1.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.309 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -93.17 166.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.4 mtp -92.23 120.79 33.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.037 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.7 120.89 28.47 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.971 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.01 124.92 14.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.856 2.37 . . . . 0.0 111.575 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.25 -53.22 42.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.15 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.11 136.93 52.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.461 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.05 175.26 40.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.14 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HG2' ' HB3' ' A' ' 84' ' ' ARG . 1.1 pm0 -93.72 141.55 28.37 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 4.1 ptp85 -93.12 139.57 30.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.318 0.58 . . . . 0.0 111.229 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.65 143.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.629 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -92.98 152.92 41.83 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.12 -27.0 27.81 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.224 2.616 . . . . 0.0 113.307 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.17 -38.21 82.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.734 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.31 -13.35 57.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.23 110.84 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.261 0.553 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -80.0 -53.07 7.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.52 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.66 136.6 48.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.526 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.53 139.12 45.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.36 119.97 24.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 48' ' ' TYR . 35.7 m -125.46 139.56 34.23 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.849 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 95.3 Cg_endo -80.84 -174.94 2.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 111.506 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.78 -164.32 23.24 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.359 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.95 -50.0 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 10' ' ' VAL . . . -139.72 140.09 36.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.626 ' CE2' ' HB3' ' A' ' 128' ' ' ARG . 49.3 m-85 -134.67 168.79 18.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.736 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 24.2 p30 -135.27 -170.07 2.51 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.476 HD21 ' NH1' ' A' ' 179' ' ' ARG . 90.0 mt -82.23 -20.69 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.978 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.424 ' CD ' HH12 ' A' ' 162' ' ' ARG . 41.5 mt-10 -92.12 -12.12 33.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.692 0.282 . . . . 0.0 111.353 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.38 12.66 22.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.369 171.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -88.29 146.8 25.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -131.63 132.59 44.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 160' ' ' LEU . 11.1 mp . . . . . 0 C--N 1.318 -0.788 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.346 0.594 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -56.34 -42.89 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.776 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -11.6 59.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.269 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 143' ' ' VAL . 61.8 tp -93.19 -73.17 0.57 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.33 -29.14 69.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -83.52 -14.62 51.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 111.292 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -102.06 -15.54 16.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.111 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 139' ' ' LEU . 93.0 t -71.26 123.42 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.44 1.07 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 110.051 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.67 -155.76 10.55 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.754 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.72 120.79 28.4 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.662 -0.316 . . . . 0.0 111.022 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.633 ' HG2' ' OD2' ' A' ' 170' ' ' ASP . 20.3 mmtm -87.04 106.51 17.9 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.44 114.63 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.909 0.385 . . . . 0.0 110.34 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.53 125.35 8.51 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.423 HG11 HG12 ' A' ' 29' ' ' VAL . 39.4 t -102.49 123.43 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.59 155.95 27.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 111.804 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.529 ' O ' HG22 ' A' ' 156' ' ' VAL . 69.0 m-85 -91.27 141.98 28.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.181 174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.3 m -57.3 -26.03 60.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.877 0.736 . . . . 0.0 111.829 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -59.28 -38.7 80.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' A' ' 14' ' ' ARG . 10.4 mm100 -108.28 24.03 13.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.601 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 152' ' ' TYR . 50.2 t -116.75 105.92 19.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.322 0.582 . . . . 0.0 109.454 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 82.2 m-85 -92.65 -178.41 4.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.761 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.95 -61.82 2.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.736 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 3.1 ptm180 -153.08 135.62 15.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.609 HD13 HD12 ' A' ' 129' ' ' LEU . 95.9 mt -98.57 155.26 36.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.748 -174.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.9 117.71 4.56 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.819 2.346 . . . . 0.0 111.199 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 162' ' ' ARG . 6.2 ptp180 -126.24 -179.65 4.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.122 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -105.51 -91.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.45 97.55 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.69 0.281 . . . . 0.0 111.576 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 53.16 78.81 0.13 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.599 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.572 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.6 t0 -83.84 -169.46 2.58 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.74 102.78 6.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.643 0.259 . . . . 0.0 110.387 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 0.9 OUTLIER -83.07 167.11 14.31 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.194 2.596 . . . . 0.0 112.345 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 147' ' ' LYS . 27.3 m -90.39 166.86 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.794 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 147' ' ' LYS . 24.8 m-20 -100.54 -38.04 8.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 110.388 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.47 112.85 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.871 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 35.6 tp -99.71 110.7 23.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.4 120.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.073 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 52.6 p -109.35 179.62 4.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.036 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.435 ' CD ' ' HZ2' ' A' ' 176' ' ' LYS . 1.0 OUTLIER -87.77 9.68 20.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.414 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.435 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 62.4 mttp -133.23 -44.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -128.31 167.87 16.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.057 0.456 . . . . 0.0 111.056 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.35 113.38 41.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 92.6 mtt180 -94.01 99.04 11.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -88.64 108.46 19.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.367 0.603 . . . . 0.0 109.977 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 -174.26 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 93.1 mt . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.87 -30.67 71.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.766 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -83.14 -30.09 28.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 tm-20 -70.35 -42.32 72.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 10' ' ' VAL . 61.9 tp -61.48 -39.9 92.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.753 174.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.11 77.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.54 -38.32 89.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -62.96 -43.8 97.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 6' ' ' LEU . 21.3 t -67.54 -48.76 75.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.001 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.11 -47.75 68.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.352 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -58.55 -51.39 70.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.033 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.35 -38.65 88.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.119 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.516 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 20.0 ttm180 -58.02 -49.74 75.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.931 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 pt -86.94 -0.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.637 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.35 -10.12 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.143 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.17 136.24 56.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -67.09 156.99 34.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.488 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.1 -55.15 31.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.647 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.88 -45.8 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.163 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.82 -45.51 85.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.582 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -62.62 -46.09 89.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.736 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 21.0 tpt180 -60.06 -36.8 78.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.908 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -38.4 90.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.046 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.58 -51.19 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.799 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -62.54 -34.91 77.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.26 -39.56 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.97 -38.14 87.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.305 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 175' ' ' GLU . 56.2 t -63.75 -47.42 91.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.422 . . . . 0.0 110.487 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.43 -48.13 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.72 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -60.86 -39.11 87.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.09 0.471 . . . . 0.0 110.359 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.19 -53.53 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.03 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.4 -40.61 97.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.87 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -62.61 -32.74 73.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.3 m -83.49 -19.87 35.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.351 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.425 HD21 ' HD2' ' A' ' 37' ' ' PRO . 2.0 tt -52.32 115.53 7.07 Favored Pre-proline 0 CA--C 1.533 0.295 0 O-C-N 123.26 0.35 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HD2' HD21 ' A' ' 36' ' ' LEU . 50.4 Cg_exo -54.78 -32.56 77.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.223 2.615 . . . . 0.0 113.45 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.54 -26.16 30.36 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.025 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -76.04 -14.82 60.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.149 0.976 . . . . 0.0 109.015 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.47 -22.82 40.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.742 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 54.4 mttp -104.69 -12.37 16.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.451 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -64.29 149.36 48.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 111.76 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -109.84 -65.83 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.731 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -91.28 95.29 9.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.703 -176.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.6 t -102.35 108.28 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.692 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -94.65 119.86 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.433 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.4 129.47 52.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' HB3' ' HD3' ' A' ' 118' ' ' PRO . 23.2 t80 -77.79 -2.02 34.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.373 -173.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.9 m 66.12 96.58 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.349 0.595 . . . . 0.0 111.548 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.61 128.06 7.57 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.762 2.308 . . . . 0.0 113.084 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.424 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 38.7 pt -129.51 158.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.437 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 68.5 -66.02 0.25 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.37 0.668 . . . . 0.0 112.481 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.89 21.15 0.37 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.494 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 51' ' ' ILE . 23.2 mm-40 -82.4 36.36 0.47 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.478 ' HA ' ' OH ' ' A' ' 152' ' ' TYR . 47.2 t 68.85 114.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 122.977 0.511 . . . . 0.0 110.528 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -71.53 80.66 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.957 0.884 . . . . 0.0 111.476 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 HG12 ' A' ' 150' ' ' VAL . 86.7 mt -86.08 3.82 40.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -53.92 -46.98 98.36 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 58' ' ' THR . 27.0 Cg_endo -62.99 -11.48 24.88 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.104 1.87 . . . . 0.0 113.332 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.6 tp -92.7 -14.28 28.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 14.9 m-85 -56.75 -48.38 97.37 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.878 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.29 -33.58 56.13 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.331 2.021 . . . . 0.0 113.322 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -71.48 -50.75 28.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.405 . . . . 0.0 110.837 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.63 -37.3 79.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.63 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 86' ' ' HIS . 23.7 tp -67.06 -24.39 65.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -93.81 -53.73 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.18 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -50.63 11.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -100.76 -171.78 2.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.183 0.516 . . . . 0.0 111.123 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -105.21 102.81 12.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.025 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -78.76 114.95 18.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.956 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 61.4 mt -101.39 117.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.059 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.617 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 98.0 mt -113.25 139.99 23.8 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.629 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.0 Cg_exo -74.99 120.04 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.873 2.382 . . . . 0.0 112.093 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 45.0 tttm -116.91 152.78 33.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.13 114.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.493 . . . . 0.0 110.413 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -111.56 107.1 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.147 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.75 39.21 97.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.8 t30 65.91 16.43 10.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.127 0.571 . . . . 0.0 111.114 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.16 136.39 54.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.433 ' HB ' ' CD1' ' A' ' 136' ' ' TYR . 20.4 tt -79.08 135.88 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.422 0.63 . . . . 0.0 111.244 -173.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.3 m -139.93 167.49 21.99 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.3 mt -109.89 131.56 54.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.93 0.395 . . . . 0.0 110.951 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.513 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 26.3 m-85 -117.66 124.12 47.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.193 0.521 . . . . 0.0 110.444 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -93.45 118.54 31.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.861 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.37 154.7 40.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.982 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.61 ' HA ' HD12 ' A' ' 65' ' ' LEU . 1.8 p80 -162.44 47.87 0.16 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.986 0.898 . . . . 0.0 109.119 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 43.9 m -156.05 160.41 30.81 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.259 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 87' ' ' SER . 41.7 Cg_endo -67.44 166.78 22.54 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.275 1.983 . . . . 0.0 112.601 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' O ' ' SG ' ' A' ' 90' ' ' CYS . . . 65.14 -155.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.788 0.68 . . . . 0.0 111.065 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 89' ' ' ALA . 15.2 p 60.53 6.33 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.717 1.207 . . . . 0.0 112.828 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.6 mt -97.51 149.34 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.36 -172.41 34.48 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.5 t -134.43 119.53 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.41 -33.28 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.238 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.52 -146.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.223 0.209 . . . . 0.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -39.5 -53.21 2.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.0 0.92 . . . . 0.0 112.971 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.56 47.99 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.17 148.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.2 mtt -72.26 93.43 1.47 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.073 0.463 . . . . 0.0 110.234 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.599 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 11.6 pt-20 -102.06 143.64 27.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.229 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.617 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 43.3 Cg_endo -72.27 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.928 1.752 . . . . 0.0 111.171 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.64 -44.19 69.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.11 171.67 7.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.623 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -148.03 19.19 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.909 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 124.32 40.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -75.8 126.8 31.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.178 0.513 . . . . 0.0 111.21 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 91.4 t -122.11 139.24 49.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.594 ' OD1' ' HD2' ' A' ' 109' ' ' PRO . 64.8 t30 -84.42 135.9 40.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.594 ' HD2' ' OD1' ' A' ' 108' ' ' ASN . 5.1 Cg_endo -47.52 -23.67 3.7 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.744 2.962 . . . . 0.0 113.856 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.67 -34.15 72.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 111.234 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.75 -15.67 53.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.584 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.52 116.15 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -93.85 -25.17 17.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.369 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -134.79 122.68 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.413 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.08 139.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.89 0.376 . . . . 0.0 110.692 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.45 108.74 15.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 51.6 t -116.24 120.68 34.7 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.493 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 7.0 Cg_exo -74.57 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.917 2.411 . . . . 0.0 111.94 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.64 128.64 1.2 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 39.7 t -58.01 -40.88 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 111.81 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 129' ' ' LEU . . . -132.42 127.76 36.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.774 0.321 . . . . 0.0 111.091 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -121.62 161.72 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.58 174.41 6.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.02 3.84 47.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 37.6 mt-10 -101.31 -33.96 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.584 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 134.31 16.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.179 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.99 158.64 16.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.526 0.663 . . . . 0.0 111.119 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -115.65 157.68 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.693 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 25.2 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' CD1' ' HB ' ' A' ' 80' ' ' ILE . 69.6 m-85 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.68 -31.19 72.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.527 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -57.94 -23.66 54.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 143' ' ' VAL . 13.8 tp -93.58 -59.89 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.231 0.539 . . . . 0.0 109.945 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -33.32 72.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.679 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -75.55 -22.58 56.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.748 0.309 . . . . 0.0 111.307 -175.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -102.85 -15.05 16.33 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.696 -0.402 . . . . 0.0 112.053 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 139' ' ' LEU . 62.0 t -67.92 95.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.193 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -86.44 -4.04 59.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.611 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.57 166.75 15.49 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.109 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 46.8 tp -53.0 111.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.095 0.474 . . . . 0.0 110.778 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -82.88 99.6 9.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.123 -176.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.42 123.99 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -101.25 138.19 13.72 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.566 HG12 HD12 ' A' ' 57' ' ' LEU . 67.3 t -120.89 124.81 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.081 0.441 . . . . 0.0 110.515 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -164.17 167.47 20.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.505 ' O ' HG23 ' A' ' 156' ' ' VAL . 50.5 m-85 -84.34 149.95 25.7 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.305 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 85.0 p -67.55 -25.03 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.368 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -58.64 -26.53 63.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.025 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.516 ' OE1' ' HB2' ' A' ' 14' ' ' ARG . 21.3 mm-40 -115.42 11.98 16.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.881 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 152' ' ' TYR . 88.1 t -108.46 114.3 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.191 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 91.4 m-85 -94.84 157.09 16.08 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.836 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -54.75 -54.55 40.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -147.22 150.73 35.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.027 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.08 158.54 72.49 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.889 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.47 112.66 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.955 1.77 . . . . 0.0 110.586 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 162' ' ' ARG . 16.6 ttp180 -73.52 131.73 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.642 -170.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.38 -166.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.913 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.97 107.29 15.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.201 0.524 . . . . 0.0 110.857 -174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 79.62 13.07 1.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.076 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.85 123.35 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.0 tt -76.2 116.83 59.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.382 0.611 . . . . 0.0 111.27 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 8.2 Cg_exo -72.15 150.37 53.66 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.996 2.464 . . . . 0.0 112.547 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 147' ' ' LYS . 34.3 m -86.02 148.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.57 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -87.35 -40.77 14.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.411 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.701 HG23 ' HG2' ' A' ' 180' ' ' ARG . 61.0 t -120.08 130.44 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.437 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 53.7 tp -111.51 115.92 30.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.054 0.454 . . . . 0.0 110.082 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.1 111.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.352 0.596 . . . . 0.0 109.766 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -109.01 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.264 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 29' ' ' VAL . 9.9 pt-20 -54.9 -34.26 62.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.892 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.419 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 47.2 mttm -87.49 -58.64 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.306 -171.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -155.53 174.72 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.85 121.59 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.802 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -126.33 119.15 26.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' HG23 ' A' ' 171' ' ' VAL . 57.1 mtt180 -81.87 139.5 34.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--N 1.318 -0.769 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 10.7 mp . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -70.33 -35.72 73.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.875 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 t -72.63 -29.87 63.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.247 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 2' ' ' LEU . 1.8 mp0 -89.24 -25.33 21.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.823 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.69 -44.95 93.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.62 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -66.55 -24.06 66.3 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.865 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 5' ' ' GLU . 98.6 mttt -73.16 -43.19 61.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.311 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.6 -29.56 70.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.6 HG12 ' NE2' ' A' ' 155' ' ' GLN . 77.1 t -75.63 -55.24 12.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.749 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -46.05 91.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.504 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -66.54 -21.23 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.111 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -76.56 -46.71 25.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.47 . . . . 0.0 110.496 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 36.7 mtm180 -73.2 -29.7 63.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.861 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -80.81 3.0 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.929 0.395 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -117.16 -98.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.4 mt 58.38 173.06 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.513 0.673 . . . . 0.0 111.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 m -76.37 123.34 25.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.06 -29.1 60.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.401 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.8 mp0 -63.53 -45.04 92.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.12 -50.13 74.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.445 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -52.55 -44.67 65.98 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.774 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.85 -47.16 69.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 2.6 ptt85 -73.53 -19.72 60.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.449 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 48.8 mt -78.0 -40.67 38.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 172.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -60.91 -35.19 76.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.403 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 28' ' ' LYS . 1.1 tm-20 -57.66 -41.15 80.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 46.6 mmtm -69.61 -42.65 74.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.572 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.0 t -62.33 -45.92 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.08 -44.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.673 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.5 m -60.37 -38.51 84.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -71.19 -47.24 58.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD13 ' HZ ' ' A' ' 114' ' ' PHE . 49.6 tp -62.61 -38.93 92.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.013 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.21 -16.71 54.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.162 0.506 . . . . 0.0 110.513 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.5 t -75.89 -25.76 56.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.705 HD21 HG23 ' A' ' 178' ' ' VAL . 58.4 mt -55.66 130.78 71.65 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.083 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.6 Cg_exo -64.87 -21.37 64.31 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.63 2.22 . . . . 0.0 111.456 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 2.5 mp0 -69.45 -24.72 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.856 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -68.18 -29.25 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 109.51 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.18 -29.33 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.039 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . 62.4 mttp -63.86 -38.92 92.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.965 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 t -90.78 136.43 33.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.645 0.736 . . . . 0.0 112.038 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -92.31 -17.57 24.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.361 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HB3' HD11 ' A' ' 71' ' ' ILE . 78.9 mttt -121.2 97.29 5.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.764 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.02 107.51 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HB ' ' A' ' 71' ' ' ILE . . . -98.41 130.2 45.04 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.996 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.91 130.14 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.06 4.5 14.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.269 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 18.6 t 71.32 125.62 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.29 0.636 . . . . 0.0 111.181 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 4.4 Cg_exo -77.84 45.32 1.75 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.221 2.614 . . . . 0.0 112.929 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 52' ' ' LYS . 2.1 pp -61.28 -32.08 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' N ' HD11 ' A' ' 51' ' ' ILE . 72.5 mmtt -136.33 33.63 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.44 146.71 18.33 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.683 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 7.2 pt-20 -83.71 -15.57 48.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.088 0.47 . . . . 0.0 111.241 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.87 132.23 54.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.735 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.87 86.76 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.98 0.419 . . . . 0.0 110.273 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -88.92 -1.17 57.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.274 0.559 . . . . 0.0 110.25 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -61.08 -47.09 96.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.02 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 58' ' ' THR . 51.0 Cg_endo -69.68 -5.32 15.87 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.592 1.528 . . . . 0.0 113.236 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.7 tp -88.73 -20.61 24.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.82 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.0 m-30 -49.73 -52.22 53.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 83.4 Cg_exo -50.28 -40.36 52.37 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.551 2.167 . . . . 0.0 113.362 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 17.0 tt0 -78.27 -37.44 45.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.349 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 70' ' ' LEU . 61.1 t -60.16 -44.83 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.4 -27.02 68.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.988 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 63' ' ' GLU . 31.9 ttpt -74.16 -36.01 64.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.783 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -95.9 -67.32 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.194 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -124.98 -171.79 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.43 . . . . 0.0 111.981 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.01 118.31 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.153 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.495 HD13 HG12 ' A' ' 64' ' ' VAL . 58.6 tp -94.36 107.96 19.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 44' ' ' LYS . 61.8 mt -89.0 116.93 31.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.439 HD12 HG21 ' A' ' 85' ' ' VAL . 91.4 mt -115.2 151.31 45.63 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 80' ' ' ILE . 5.2 Cg_exo -80.51 127.43 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 112.916 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 101' ' ' PRO . 25.6 tptp -105.8 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -85.61 103.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.876 0.37 . . . . 0.0 110.678 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.83 78.06 1.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.688 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.26 -80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.007 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.464 ' ND2' ' HG3' ' A' ' 79' ' ' GLU . 3.2 p-10 -123.72 -16.26 6.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.464 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 21.0 mt-10 -126.53 167.42 15.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.493 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.511 ' HB ' HD23 ' A' ' 139' ' ' LEU . 65.3 mt -118.43 126.9 75.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 -175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.7 m -96.65 134.46 39.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.289 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 109' ' ' PRO . 98.1 mt -90.43 131.83 35.97 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.57 147.81 44.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.313 0.578 . . . . 0.0 111.939 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 105' ' ' GLU . 39.6 ttt180 -81.6 108.59 15.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.121 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 90' ' ' CYS . 47.3 t -110.07 118.08 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.108 0.48 . . . . 0.0 110.486 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -124.65 -29.19 3.47 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 15.9 m -89.85 126.3 58.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.25 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.1 Cg_exo -61.29 -12.56 24.17 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.196 2.597 . . . . 0.0 113.011 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 4.22 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.853 0.359 . . . . 0.0 111.417 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.478 ' HB3' HG13 ' A' ' 85' ' ' VAL . 49.0 t -88.67 -0.51 57.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 111.073 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.95 113.32 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.021 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.56 158.71 22.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.966 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 61.5 t -79.71 127.99 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 0.0 110.244 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.582 ' HA3' ' OE2' ' A' ' 100' ' ' GLU . . . -81.98 -131.1 1.36 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.655 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.72 2.83 22.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.06 30.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.453 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.28 76.96 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.457 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 24.1 pt -114.1 163.92 10.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.53 119.02 38.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 110.504 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.582 ' OE2' ' HA3' ' A' ' 94' ' ' GLY . 8.5 pt-20 -138.87 155.06 73.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.529 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.614 ' O ' ' HD3' ' A' ' 74' ' ' LYS . 33.5 Cg_endo -64.65 120.45 7.73 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.308 2.672 . . . . 0.0 113.398 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.36 -37.39 7.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 11.6 mm-40 -136.37 109.63 7.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.058 0.456 . . . . 0.0 111.78 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.17 43.68 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.544 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 21.1 mp0 -81.49 121.44 26.29 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -70.25 132.52 45.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 109.956 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.87 133.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.624 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.87 132.97 95.05 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . 50.2 Cg_exo -55.2 -33.03 82.96 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.573 2.182 . . . . 0.0 112.674 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -71.75 -19.72 61.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.718 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' A' ' 44' ' ' LYS . 23.9 t70 -80.95 -17.5 50.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.394 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.45 ' HB ' HG12 ' A' ' 143' ' ' VAL . 93.9 t -60.88 131.76 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.265 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.74 -41.59 7.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.522 ' HZ ' HD13 ' A' ' 33' ' ' LEU . 54.0 t80 -132.9 130.45 39.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.276 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.52 138.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 110.894 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.92 115.95 28.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.82 118.6 36.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.37 90.69 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.301 175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.1 156.54 53.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.004 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.485 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 48.8 t -63.76 -47.72 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.44 157.93 34.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.97 156.34 46.36 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.11 0.257 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -109.67 -171.71 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 94.1 mt -79.37 6.03 11.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -119.85 -36.71 3.24 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.63 11.95 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.576 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -95.52 167.18 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.57 -162.49 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.776 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.456 HD11 ' HD2' ' A' ' 161' ' ' PRO . 35.8 tp . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.651 0.739 . . . . 0.0 109.748 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.18 -33.73 70.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.985 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -66.3 -30.8 71.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.772 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.511 HD23 ' HB ' ' A' ' 80' ' ' ILE . 48.2 tp -67.42 -45.29 76.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.29 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.82 -38.52 75.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.877 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 167' ' ' ILE . 55.7 tttm -81.14 -21.67 39.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.247 0.546 . . . . 0.0 110.465 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 109' ' ' PRO . 30.0 ttp180 -77.35 -24.61 50.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.951 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.45 HG12 ' HB ' ' A' ' 112' ' ' VAL . 75.6 t -78.66 118.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.724 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.487 ' HZ1' ' HB2' ' A' ' 144' ' ' LYS . 3.6 ttmp? -97.16 -2.02 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 110.785 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.58 -179.23 41.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.03 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.37 122.52 17.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.364 . . . . 0.0 110.57 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.72 109.64 21.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 171' ' ' VAL . 80.9 t -107.68 128.95 62.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.562 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -100.54 122.31 7.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.37 114.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.538 0.169 . . . . 0.0 110.629 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.16 164.63 32.75 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.501 0.501 . . . . 0.0 110.13 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 75.6 m-85 -86.76 158.44 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.511 . . . . 0.0 111.051 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.7 p -61.79 -25.95 67.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.792 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -77.1 -9.23 58.6 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.635 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.6 ' NE2' HG12 ' A' ' 10' ' ' VAL . 8.5 mm100 -108.54 9.4 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.27 116.69 44.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -111.18 179.7 3.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.799 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 30.4 mt-10 -70.8 -68.71 0.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 0.0 111.273 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.75 117.2 13.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.314 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.83 154.05 37.99 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.456 ' HD2' HD11 ' A' ' 129' ' ' LEU . 49.9 Cg_exo -56.14 111.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.259 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -88.31 151.07 22.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.675 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.24 143.15 50.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.18 -15.9 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -110.98 13.12 22.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -89.93 115.3 27.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 141' ' ' LYS . 40.3 mt -74.77 112.09 16.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.666 -172.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.94 163.75 28.16 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.547 2.165 . . . . 0.0 112.209 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.45 HG22 HD13 ' A' ' 181' ' ' LEU . 28.6 m -103.6 166.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.637 177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.33 -41.02 6.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.258 0.551 . . . . 0.0 110.588 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 148' ' ' VAL . 61.8 t -116.84 120.67 65.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.405 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.8 tp -101.05 114.08 27.68 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 122.36 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.654 ' HB ' ' OE1' ' A' ' 175' ' ' GLU . 46.6 p -111.37 -168.3 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.654 ' OE1' ' HB ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -72.29 -25.17 61.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.113 0.482 . . . . 0.0 110.215 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -115.11 -47.56 2.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.401 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.42 172.99 11.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.309 0.576 . . . . 0.0 112.053 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.705 HG23 HD21 ' A' ' 36' ' ' LEU . 98.9 t -126.06 115.03 41.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.632 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -100.03 116.38 31.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -73.71 95.03 2.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.866 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.45 HD13 HG22 ' A' ' 169' ' ' VAL . 69.6 mt . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 88.6 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -70.86 -52.04 22.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.807 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -66.5 -24.63 66.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.469 . . . . 0.0 110.036 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 42.4 tt0 -58.37 -54.66 44.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.424 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.68 -35.77 75.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.168 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.15 -42.7 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.962 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.13 -42.76 99.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.108 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 26.8 mtpp -63.94 -51.89 62.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.61 -44.78 97.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.99 -35.79 77.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.426 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 24.8 t-80 -67.04 -37.8 84.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.371 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 7.4 mtpm? -66.27 -31.68 72.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 110.44 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 50.8 mtt180 -63.34 -54.45 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.176 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.673 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 27.0 pt -88.03 5.88 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.161 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -84.28 -30.83 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.28 144.99 55.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.863 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.5 m -71.79 151.21 43.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.703 0.287 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 22' ' ' ARG . 5.1 tp10 -59.44 -36.61 76.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.589 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 50.7 mt-10 -55.23 -52.55 63.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.088 0.471 . . . . 0.0 110.623 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.11 -39.81 95.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.379 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.673 ' NH1' ' HA ' ' A' ' 15' ' ' ILE . 23.6 mtm180 -65.76 -39.13 90.74 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.37 -37.5 87.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.0 110.841 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 49.5 mtt85 -69.56 -48.27 60.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -67.79 -43.36 79.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.451 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.478 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.6 t -62.03 -43.75 98.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.896 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.75 -35.44 81.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.848 0.356 . . . . 0.0 110.124 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.697 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 33.2 ttmt -59.02 -44.5 91.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.441 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 25' ' ' LEU . 42.9 t -67.76 -39.48 82.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 26' ' ' SER . 80.8 mt -61.41 -49.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -64.72 -37.19 86.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.13 -39.44 94.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.242 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD12 ' HZ ' ' A' ' 114' ' ' PHE . 46.8 tp -65.79 -34.18 77.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.475 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 45.9 mtpt -72.76 -25.52 61.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -78.89 -21.3 47.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.902 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 38' ' ' GLU . 2.4 tt -58.28 121.46 52.01 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.134 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD2' HD21 ' A' ' 36' ' ' LEU . 69.4 Cg_exo -52.89 -37.71 77.84 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.309 2.672 . . . . 0.0 114.058 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.504 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -18.57 58.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.11 -15.65 63.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.967 0.413 . . . . 0.0 111.2 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -76.41 -45.34 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.748 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -74.69 -35.8 62.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.1 p -73.39 95.99 2.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.293 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HE2' ' HG3' ' A' ' 69' ' ' GLU . 79.1 tttt -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 111' ' ' ASP . 40.5 mttm -99.23 101.55 12.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.458 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.95 114.98 48.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -96.66 134.49 39.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.509 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -120.17 136.03 54.76 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.871 ' HB2' HG13 ' A' ' 117' ' ' VAL . 26.0 t80 -74.67 -10.67 59.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.019 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.2 t 67.84 106.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.406 0 CA-C-O 121.3 0.572 . . . . 0.0 110.824 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.65 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 76.1 Cg_endo -78.08 151.14 26.89 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.616 2.211 . . . . 0.0 113.437 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -134.85 166.66 27.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.257 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 34.4 mtpt 64.59 8.63 4.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.327 0.392 . . . . 0.0 111.556 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.24 -106.58 2.41 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.583 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 70.4 mt-10 61.66 -83.44 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.616 0.767 . . . . 0.0 110.764 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 150' ' ' VAL . 51.2 t -132.8 96.18 2.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 104.71 15.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.65 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 91.6 mt -95.91 3.73 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.671 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.3 m -59.17 -39.5 73.75 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 58' ' ' THR . 50.2 Cg_exo -57.78 -9.71 6.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.175 1.916 . . . . 0.0 114.136 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.8 tp -84.92 -12.93 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.622 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m-30 -54.99 -53.85 56.74 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.644 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 84.4 Cg_exo -52.59 -31.39 49.3 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.73 2.286 . . . . 0.0 113.476 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.0 -43.78 51.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 68' ' ' LYS . 84.0 t -72.98 -42.43 59.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.606 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt -65.93 -5.78 10.38 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 62' ' ' PRO . 63.4 mttp -66.1 -57.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.588 0.233 . . . . 0.0 110.903 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.45 -17.83 1.3 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HB2' HG12 ' A' ' 64' ' ' VAL . 68.0 mttm -91.69 173.64 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.003 0.43 . . . . 0.0 110.888 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG3' ' HE2' ' A' ' 43' ' ' LYS . 42.7 mt-10 -100.93 118.7 37.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.453 175.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.54 111.01 21.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 59.5 mt -97.89 112.37 29.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 98.1 mt -114.78 145.07 33.17 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.199 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.39 132.24 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.009 2.473 . . . . 0.0 112.544 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.868 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 5.5 mtpp -105.76 125.89 51.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.985 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.85 89.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.19 17.59 19.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.991 175.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.4 -121.22 2.13 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.78 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -91.14 -10.09 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 0.0 111.185 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -105.18 109.34 21.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.306 0.574 . . . . 0.0 110.285 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.572 HD13 ' HD1' ' A' ' 136' ' ' TYR . 57.1 mt -87.38 110.86 21.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.868 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 19.3 m -82.98 106.8 15.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.879 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 139' ' ' LEU . 94.4 mt -74.65 100.54 3.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 1.2 m-85 -96.11 116.22 28.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.617 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 3.0 ptp180 -83.89 124.29 30.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 101' ' ' PRO . 58.0 t -135.82 133.16 51.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -118.43 -9.98 10.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.5 m -91.4 136.58 26.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.483 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.6 Cg_exo -77.86 165.6 26.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.932 2.422 . . . . 0.0 112.105 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.72 4.76 3.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.1 m -95.94 28.25 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.786 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -113.62 138.39 50.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.03 143.37 15.04 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -91.3 128.15 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.92 -163.12 26.87 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 96' ' ' PHE . . . 47.63 78.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 77.7 t80 72.71 -50.83 0.7 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.879 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.94 36.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.061 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.39 172.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.2 ptm -123.75 99.34 6.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.396 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 5.3 pt-20 -96.67 159.0 32.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.343 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.14 116.3 4.34 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.48 2.12 . . . . 0.0 111.429 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.23 -22.14 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 110.55 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.38 152.78 51.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.005 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.66 -153.17 25.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -141.44 135.64 30.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.024 0.412 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -77.23 127.16 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.14 160.97 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.322 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.03 145.93 78.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.543 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.01 -17.15 10.41 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.391 2.727 . . . . 0.0 113.456 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.37 -29.73 70.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.061 0.458 . . . . 0.0 110.686 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 21.3 t70 -83.49 -10.35 58.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.83 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.57 95.55 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.401 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.33 -32.41 33.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.093 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.58 ' HZ ' HD12 ' A' ' 33' ' ' LEU . 42.7 t80 -137.51 138.82 40.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.427 HG12 HG12 ' A' ' 117' ' ' VAL . 16.0 tt -146.88 140.54 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.751 0.31 . . . . 0.0 110.401 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.13 112.34 18.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.871 HG13 ' HB2' ' A' ' 48' ' ' TYR . 27.3 m -126.33 128.63 24.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.429 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.33 108.81 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.429 2.086 . . . . 0.0 111.485 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.58 157.04 18.28 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.452 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.81 109.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.18 134.52 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.135 0.897 . . . . 0.0 112.512 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.14 146.09 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.886 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -103.27 -172.38 2.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.422 . . . . 0.0 111.219 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.939 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 70.5 mt -79.45 -3.97 49.03 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -105.56 -38.11 6.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.853 0.358 . . . . 0.0 110.284 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.6 11.65 1.67 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.682 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.58 168.4 11.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.304 0.552 . . . . 0.0 110.233 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -153.63 135.18 14.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.571 -166.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.956 178.231 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.572 ' HD1' HD13 ' A' ' 80' ' ' ILE . 31.9 m-85 . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -22.63 65.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -69.93 -13.77 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 110.583 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 82' ' ' LEU . 48.5 tp -89.81 -42.89 11.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.423 ' O ' ' HD3' ' A' ' 147' ' ' LYS . 94.2 mt -57.05 -38.68 73.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.667 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -64.72 -26.97 68.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.94 -18.25 29.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.051 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.07 114.72 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -90.45 -6.06 55.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.382 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.72 43.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.39 109.58 11.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.963 0.411 . . . . 0.0 110.261 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 140' ' ' LEU . 32.6 mtmm -82.71 103.12 11.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.829 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.483 HG21 ' HB ' ' A' ' 171' ' ' VAL . 84.9 t -99.05 122.37 50.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.677 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -94.7 133.32 11.52 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.681 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.463 ' CG1' HG11 ' A' ' 55' ' ' VAL . 43.5 t -107.64 120.07 58.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.95 154.73 40.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.042 0.449 . . . . 0.0 111.898 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.96 160.9 21.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.836 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 m -55.37 -27.58 48.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.599 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.0 -15.76 63.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.664 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -99.43 -6.22 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.414 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 45.0 t -91.64 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.8 -176.63 2.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.151 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.939 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 33.8 mt-10 -90.79 -66.98 0.88 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -125.4 115.04 19.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.18 143.57 26.86 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.94 101.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.776 1.651 . . . . 0.0 110.165 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -109.74 177.14 4.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.196 -172.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.71 168.3 10.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.454 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.69 64.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -102.39 66.19 0.97 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.571 0.701 . . . . 0.0 109.339 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.66 162.82 12.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.633 HD11 ' HD2' ' A' ' 168' ' ' PRO . 3.9 tp -138.99 111.52 8.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.139 0.495 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.633 ' HD2' HD11 ' A' ' 167' ' ' ILE . 72.5 Cg_endo -77.27 173.56 14.15 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.667 2.245 . . . . 0.0 112.572 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 181' ' ' LEU . 21.1 m -112.17 151.98 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.211 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.03 -30.16 34.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.179 0.514 . . . . 0.0 110.083 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.484 HG12 HD11 ' A' ' 36' ' ' LEU . 49.0 t -142.22 135.03 27.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.648 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 179' ' ' ARG . 61.0 tp -114.33 118.34 33.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.519 HG23 HG12 ' A' ' 178' ' ' VAL . 63.2 t -109.22 123.22 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.185 0.517 . . . . 0.0 110.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 75.1 p -108.46 -164.86 0.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.601 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.697 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 5.7 pt-20 -73.16 -22.33 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.654 0.264 . . . . 0.0 110.98 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.499 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 64.8 mttp -122.26 -61.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.758 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.98 141.03 30.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.216 0.531 . . . . 0.0 112.037 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 173' ' ' VAL . 57.6 t -109.47 102.32 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.658 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.743 HH22 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mtp-105 -85.69 99.82 11.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.423 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -76.34 92.39 3.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 169' ' ' VAL . 88.0 mt . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.782 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.681 0.277 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -95.42 -45.48 7.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 0.0 109.719 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -58.85 -55.08 39.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.065 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.406 ' HG2' ' HD2' ' A' ' 9' ' ' LYS . 37.9 tt0 -59.04 -52.54 65.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.49 -46.31 90.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.4 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 8.0 tmm_? -58.67 -45.68 88.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.038 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.01 -45.11 71.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.437 -175.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 13.4 ptmm? -70.36 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.583 HG11 ' HB1' ' A' ' 121' ' ' ALA . 84.0 t -70.14 -35.19 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.004 0.431 . . . . 0.0 110.467 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.74 -46.57 87.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.269 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' HA ' HG12 ' A' ' 15' ' ' ILE . 33.8 t-80 -66.76 -34.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.682 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 68.8 mmtt -51.88 -41.48 61.94 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.455 0.472 . . . . 0.0 111.144 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' NH2' ' HB3' ' A' ' 54' ' ' GLU . 36.7 ttp180 -72.85 -38.36 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 12' ' ' HIS . 34.0 pt -90.71 -9.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.554 ' C ' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -93.09 -6.51 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.536 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 13' ' ' LYS . 98.7 mt -67.4 161.02 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.602 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.7 m -62.74 127.27 30.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.335 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.9 -42.49 90.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.648 0.261 . . . . 0.0 111.356 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -67.99 -32.18 72.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.954 0.407 . . . . 0.0 110.089 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' HB2' ' A' ' 18' ' ' SER . 9.7 tp10 -63.13 -50.57 69.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.259 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 18' ' ' SER . 72.3 mtp180 -60.41 -37.45 80.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.94 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -56.74 -50.68 71.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.532 . . . . 0.0 110.527 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.95 -33.19 73.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.022 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.7 mt -69.58 -47.15 64.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.657 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.6 m -63.34 -31.71 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -56.76 -42.45 79.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.145 0.498 . . . . 0.0 110.255 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.56 -34.3 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 175' ' ' GLU . 66.0 t -62.19 -47.96 90.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.517 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 72.0 mt -57.48 -46.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.144 0.497 . . . . 0.0 110.097 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -61.76 -38.47 88.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.87 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.33 -43.66 81.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 0.0 110.324 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.535 HD12 HD13 ' A' ' 36' ' ' LEU . 40.2 tp -61.26 -36.68 80.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.365 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.39 -13.77 59.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.004 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.7 m -82.61 -23.43 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.535 HD13 HD12 ' A' ' 33' ' ' LEU . 74.3 mt -61.8 118.61 40.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.093 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.21 -23.0 53.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.417 2.078 . . . . 0.0 110.774 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.08 -31.26 70.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.312 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.22 -24.96 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -70.49 -49.62 46.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -72.34 -26.28 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.707 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 114' ' ' PHE . 31.1 m -71.26 98.04 1.66 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 30.9 mtmm -86.35 -25.16 25.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.23 -171.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -110.48 108.58 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 t -109.02 113.05 43.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 71' ' ' ILE . . . -96.5 124.58 40.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.483 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.75 130.99 55.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.25 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -72.62 -27.57 62.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.8 t 72.24 133.73 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.855 0.722 . . . . 0.0 111.226 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 14.4 Cg_exo -69.36 140.59 44.55 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.677 2.251 . . . . 0.0 111.824 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 pt -124.15 -27.58 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 18.6 tptt -124.38 -35.73 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.628 . . . . 0.0 110.41 -175.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.51 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 138.53 88.13 0.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -121.07 -87.15 0.65 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG22 HG11 ' A' ' 150' ' ' VAL . 58.6 t -135.09 131.58 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.3 96.57 4.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.294 0.569 . . . . 0.0 110.688 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.57 13.67 20.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.496 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -66.34 -44.8 58.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.536 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 58' ' ' THR . 42.5 Cg_endo -68.81 -0.96 6.84 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.769 1.646 . . . . 0.0 112.773 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 63' ' ' GLU . 60.0 tp -92.07 -17.26 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 30.9 m-85 -50.93 -51.27 68.76 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.8 Cg_endo -56.64 -41.6 74.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.192 1.928 . . . . 0.0 112.471 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HB2' HD13 ' A' ' 60' ' ' LEU . 6.1 mt-10 -66.5 -36.34 82.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.52 -41.79 91.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.434 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 86' ' ' HIS . 65.1 mt -66.3 -14.19 61.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -82.15 -61.9 1.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.99 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -93.04 -29.66 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 27.1 mmtp -124.45 -174.47 3.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.536 0.684 . . . . 0.0 112.234 -166.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.06 128.24 48.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.975 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 112.63 24.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 44' ' ' LYS . 61.5 mt -98.41 117.64 43.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.923 0.392 . . . . 0.0 110.101 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.8 mt -118.96 133.97 23.64 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -84.25 123.17 2.99 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.722 2.281 . . . . 0.0 112.621 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 57.0 tttm -105.42 101.48 11.01 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -82.15 92.72 2.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.313 0.578 . . . . 0.0 109.846 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -101.21 107.15 18.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.236 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.28 -90.97 0.92 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.59 11.61 1.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 109.828 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.22 120.51 40.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.27 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.649 HD12 ' HD1' ' A' ' 136' ' ' TYR . 56.7 mt -85.07 99.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.331 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -95.97 112.11 23.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.68 131.14 35.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.07 144.93 48.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.421 0.629 . . . . 0.0 111.697 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -90.65 96.81 10.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.693 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.0 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' HA ' HD21 ' A' ' 65' ' ' LEU . 1.7 t60 -136.39 16.28 3.18 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -121.31 120.0 29.23 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.023 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.96 -8.62 22.55 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.622 2.215 . . . . 0.0 112.307 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.32 12.46 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.4 t -95.69 -144.93 0.27 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.6 mt 64.57 113.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.799 0.687 . . . . 0.0 112.616 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.95 127.08 4.28 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.18 110.2 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.934 0.367 . . . . 0.0 110.279 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.91 -98.94 0.65 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.014 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . -60.03 127.23 30.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.322 0.249 . . . . 0.0 111.638 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.7 t80 70.47 -38.55 0.42 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.021 0.826 . . . . 0.0 112.061 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ALA . . . 130.07 10.02 2.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.926 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 pt -91.34 172.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.725 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtm -93.42 100.71 12.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.651 ' HB3' ' HE2' ' A' ' 74' ' ' LYS . 43.2 mt-10 -84.86 132.34 46.38 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.438 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 24.5 Cg_exo -64.15 114.26 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.388 2.059 . . . . 0.0 111.426 174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.79 -17.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.317 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -148.1 150.27 33.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.3 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.06 -158.45 27.74 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.811 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -112.44 161.65 16.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -89.26 126.14 35.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.36 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.58 130.66 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 110.738 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.69 152.23 38.99 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.58 -23.71 41.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.66 -22.07 66.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 44' ' ' LYS . 4.7 t70 -94.7 -3.41 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.229 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.92 112.63 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.239 0.543 . . . . 0.0 111.527 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -60.18 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.187 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.686 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 21.3 t80 -134.84 139.61 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.9 139.2 41.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.5 111.65 21.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.497 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 46.1 t -117.89 108.62 42.35 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.18 62.74 8.12 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.206 2.604 . . . . 0.0 111.299 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.06 169.13 22.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.436 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.29 107.35 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB1' HG11 ' A' ' 10' ' ' VAL . . . 71.99 133.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.275 0.984 . . . . 0.0 112.335 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.36 165.24 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.244 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.517 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -135.12 -178.72 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.443 HD11 ' HG2' ' A' ' 158' ' ' GLU . 90.6 mt -74.46 -12.72 60.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.496 ' HB2' ' NH1' ' A' ' 159' ' ' ARG . 7.0 tp10 -81.97 -42.16 19.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.08 24.9 2.88 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.192 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -101.31 -176.41 3.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.126 0.489 . . . . 0.0 111.381 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -122.2 -171.84 2.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.556 -173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 40.6 tp . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.484 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.649 ' HD1' HD12 ' A' ' 80' ' ' ILE . 66.1 m-85 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.683 0.754 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.77 -34.73 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.068 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -55.91 -34.42 65.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.116 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.584 ' O ' HG21 ' A' ' 143' ' ' VAL . 56.9 tp -84.75 -54.14 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.64 ' HB3' HG23 ' A' ' 167' ' ' ILE . 96.9 mt -57.37 -38.55 74.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.8 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.626 ' HD3' HG13 ' A' ' 167' ' ' ILE . 25.9 tptp -74.24 -15.88 60.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 -176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 142' ' ' ARG . 19.7 mtp180 -109.36 -4.5 16.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.417 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 139' ' ' LEU . 96.2 t -69.15 104.63 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.078 0.466 . . . . 0.0 109.889 174.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.843 ' HB3' ' HZ2' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -92.55 12.88 21.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.603 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.29 -174.28 46.25 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 103.1 8.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.511 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 9.8 mtmp? -87.12 102.86 14.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.766 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.7 t -104.97 119.25 53.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -90.87 136.5 13.4 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 174.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.489 HG11 HG22 ' A' ' 55' ' ' VAL . 13.7 t -122.67 124.45 70.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.24 164.13 35.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.529 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.403 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 94.3 m-85 -75.61 169.4 18.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.016 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.6 t -69.12 -26.08 64.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.335 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -74.88 -5.68 44.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.055 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -106.47 4.67 28.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.666 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.19 114.9 44.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.615 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -103.0 179.62 4.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.142 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 124' ' ' LEU . 4.8 tm-20 -89.12 -50.9 5.88 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 125' ' ' GLU . 4.9 tpp180 -149.06 123.62 9.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.335 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.5 mt -101.26 159.09 30.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.162 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.75 103.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.419 2.079 . . . . 0.0 111.223 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -92.6 159.49 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -123.61 179.88 4.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.75 -49.19 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.594 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -93.14 9.27 36.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.341 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.62 159.43 33.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.455 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 140' ' ' LEU . 3.9 mp -105.12 111.86 65.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.338 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.87 148.79 7.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.79 2.327 . . . . 0.0 112.871 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.64 174.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.172 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 25.1 m-20 -108.62 -49.44 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.93 145.59 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.593 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.1 tp -124.34 103.37 8.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.824 0.345 . . . . 0.0 110.616 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 178' ' ' VAL . 49.1 t -87.05 120.1 35.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 p -105.97 -177.4 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 10.0 pt-20 -71.03 -7.23 44.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.634 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.512 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 30.0 mmtp -119.95 -62.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.142 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.86 161.98 30.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.359 . . . . 0.0 111.14 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 173' ' ' VAL . 70.7 t -87.39 101.46 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -88.39 91.91 8.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.671 -175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -74.41 108.71 7.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -174.184 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.732 0.301 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -60.23 -45.75 92.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.453 0.644 . . . . 0.0 110.026 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -71.75 -40.27 69.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.641 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.95 -45.79 76.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.901 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 tp -53.65 -40.82 66.19 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.33 0.394 . . . . 0.0 111.391 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -61.01 -54.74 41.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.264 0.554 . . . . 0.0 110.807 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -25.51 64.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.766 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.48 -55.05 11.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.185 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' A' ' 155' ' ' GLN . 61.1 t -70.99 -33.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.013 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.563 HD11 ' HG2' ' A' ' 52' ' ' LYS . 54.9 tp -62.19 -29.98 70.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.411 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 10.8 t60 -67.72 -36.7 81.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.992 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -68.32 -32.27 72.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 17.6 mmt180 -52.78 -57.82 8.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.342 0.591 . . . . 0.0 110.602 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.3 9.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.445 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -88.1 -25.63 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.121 -0.362 . . . . 0.0 110.334 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.2 142.73 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.067 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 t -64.96 148.26 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.45 -42.36 70.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.88 -51.07 64.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.891 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.21 -44.55 95.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.455 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.588 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 5.3 tmm_? -57.77 -47.23 83.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.731 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -62.07 -46.22 90.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.097 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -60.11 -47.96 83.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.667 0.27 . . . . 0.0 111.035 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.8 mt -66.69 -37.54 84.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 31.1 t -58.96 -49.53 77.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.918 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -59.79 -34.94 73.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -42.02 91.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.579 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 25' ' ' LEU . 45.5 t -62.19 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.073 0.463 . . . . 0.0 109.994 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' SER . 69.8 mt -58.39 -40.12 77.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.505 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.0 m -61.15 -40.28 93.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -42.41 84.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD13 HD12 ' A' ' 36' ' ' LEU . 39.9 tp -62.32 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.205 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HE3' ' CE2' ' A' ' 39' ' ' PHE . 2.5 mmpt? -66.94 -30.97 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.26 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.1 m -71.58 -24.59 61.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 178' ' ' VAL . 46.4 mt -61.18 116.79 21.04 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.348 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.1 -35.89 84.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.036 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.69 -37.32 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.798 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 69.7 t80 -74.08 -17.15 60.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.207 0.527 . . . . 0.0 110.776 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.88 -41.91 10.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -81.54 -33.23 31.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.761 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 t -84.9 122.04 28.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 92.7 mttt -93.28 -3.93 52.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.714 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 8.7 mmpt? -89.31 86.13 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 68' ' ' LYS . 45.8 t -121.61 118.15 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 111.475 -173.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -111.62 138.96 47.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.161 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 57' ' ' LEU . 7.4 mp -120.2 144.17 47.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.784 ' HB2' HG12 ' A' ' 117' ' ' VAL . 37.8 t80 -77.33 -6.63 53.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.152 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.1 t 70.8 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.825 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.732 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 2.7 Cg_exo -75.1 98.18 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.864 2.376 . . . . 0.0 112.436 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.798 HG13 ' HD3' ' A' ' 52' ' ' LYS . 40.7 pt -89.4 -5.45 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.227 0.537 . . . . 0.0 110.144 173.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HD3' HG13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -107.19 144.85 33.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.78 72.63 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.708 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' HG3' ' H ' ' A' ' 55' ' ' VAL . 5.2 pt-20 -129.52 -79.62 0.56 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.595 0.358 . . . . 0.0 110.203 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.712 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 38.3 t -100.17 123.74 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' CG ' HH12 ' A' ' 22' ' ' ARG . 20.6 m-20 -79.14 71.88 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.898 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.732 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 88.2 mt -85.51 -10.46 56.0 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.232 0.539 . . . . 0.0 109.581 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.721 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m -62.49 -53.3 58.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.177 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 21.9 Cg_exo -67.31 -6.55 16.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.175 1.917 . . . . 0.0 112.217 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -89.32 -15.25 33.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.389 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.637 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.0 m-85 -55.74 -52.38 72.65 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.319 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 61.1 Cg_exo -54.93 -34.37 85.95 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.396 2.064 . . . . 0.0 112.898 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 1.3 tm-20 -65.38 -50.62 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 109.925 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.618 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 84.9 t -64.87 -41.51 92.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.586 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 88' ' ' PRO . 50.8 tp -67.48 -16.77 64.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.509 . . . . 0.0 111.198 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 13.7 tppt? -71.16 -52.22 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.467 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.4 pt-20 -121.81 -30.01 4.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.074 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 64' ' ' VAL . 30.2 mtmm -103.4 -173.03 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.239 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE2' ' HD3' ' A' ' 84' ' ' ARG . 49.2 mt-10 -106.63 119.34 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -89.81 106.06 18.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.047 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 46' ' ' ALA . 59.3 mt -93.69 123.83 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.2 mt -120.12 141.68 32.08 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.094 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -76.81 110.86 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.962 2.441 . . . . 0.0 111.724 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.82 114.82 29.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.26 101.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.418 . . . . 0.0 109.874 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -90.74 85.25 6.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.556 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.74 0.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.16 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -112.13 -9.08 13.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -115.33 109.42 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.669 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.74 135.82 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 m -140.33 149.45 42.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.353 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 3.3 mm? -84.64 114.25 21.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.415 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.8 124.67 39.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.513 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 17.5 ttm180 -84.31 102.72 12.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 110.21 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 90' ' ' CYS . 55.2 t -89.65 111.81 23.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.253 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -114.85 -4.87 12.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.637 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -117.69 126.65 27.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.609 -178.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.656 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.3 Cg_exo -60.95 -22.2 73.69 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.812 2.342 . . . . 0.0 113.293 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.15 -5.03 58.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.863 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 87' ' ' SER . 61.3 m -84.44 1.76 43.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 111.495 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.9 129.64 48.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.279 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.5 161.17 29.09 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 t -88.15 86.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.307 0.575 . . . . 0.0 110.374 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.5 -155.91 10.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.58 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.518 ' HB2' HG12 ' A' ' 98' ' ' ILE . . . 55.79 -129.56 1.98 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.564 0.346 . . . . 0.0 110.616 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -97.07 24.05 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.032 0.444 . . . . 0.0 110.783 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.45 51.11 1.0 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.379 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 95' ' ' ALA . 40.1 pt -131.41 163.78 36.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.621 0.248 . . . . 0.0 110.369 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 tpp -81.03 90.97 6.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.79 158.0 36.08 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.991 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 43.9 Cg_endo -72.64 107.92 2.42 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.138 1.892 . . . . 0.0 111.166 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -77.22 -22.97 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.3 0.572 . . . . 0.0 110.224 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.05 -175.52 4.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.527 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.35 -138.38 11.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.418 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -141.69 128.17 20.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -78.16 101.94 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.538 0.685 . . . . 0.0 110.453 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.42 153.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.741 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.569 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 28.5 p-10 -70.93 146.33 92.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.18 -8.45 12.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.238 2.625 . . . . 0.0 112.714 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.569 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 42.0 tt0 -69.29 -23.84 63.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.481 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.64 -19.45 57.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.585 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.31 110.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 25.7 t70 -91.06 -36.36 14.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.122 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CZ ' HG23 ' A' ' 148' ' ' VAL . 31.2 t80 -133.53 127.74 33.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.619 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 147' ' ' LYS . 12.9 tt -135.46 139.74 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.78 118.92 30.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 48' ' ' TYR . 19.9 m -118.25 127.35 26.64 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.131 0.491 . . . . 0.0 111.332 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 6.1 Cg_exo -79.91 84.1 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.983 2.456 . . . . 0.0 111.178 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.33 162.25 19.86 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.886 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 50.8 t -99.08 128.06 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . . . 67.75 114.72 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.2 0.938 . . . . 0.0 112.684 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -137.6 166.81 23.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.587 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 16.2 p30 -137.83 -165.14 1.73 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.748 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.93 -5.66 59.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -104.51 -31.48 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.231 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 121.64 17.75 3.8 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.954 172.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.429 ' OH ' ' HD2' ' A' ' 162' ' ' ARG . 22.7 m-30 -69.72 144.43 52.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 117.371 0.585 . . . . 0.0 110.142 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 2.0 tmm_? -122.62 106.04 10.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 110.731 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 28.7 tp . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.145 0.498 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -67.03 -28.19 68.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 109.654 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 138' ' ' ARG . 59.7 mtt85 -76.62 -27.18 55.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.272 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 tp -66.34 -35.56 80.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.74 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.93 -30.71 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 167' ' ' ILE . 23.9 ttmm -72.44 -27.24 62.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -78.37 -23.05 47.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.497 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.25 96.2 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.172 0.51 . . . . 0.0 109.81 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -90.09 16.49 8.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.055 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.9 -162.86 34.87 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.33 99.39 9.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.761 0.315 . . . . 0.0 110.169 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 36.9 mtmm -78.87 102.93 8.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.786 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 171' ' ' VAL . 62.1 t -98.41 124.39 51.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.402 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.11 121.43 6.69 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 111.95 33.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.831 0.348 . . . . 0.0 110.088 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -145.65 151.76 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.193 0.521 . . . . 0.0 112.094 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.34 151.92 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.124 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -60.38 -23.74 64.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.759 0.314 . . . . 0.0 111.425 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -66.48 -25.06 66.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.67 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 2.8 mp0 -98.37 2.42 47.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.831 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.96 124.82 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.08 -169.4 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.434 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.19 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 11.2 ttp180 -155.78 141.5 17.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.17 158.94 69.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.768 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.57 107.79 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 111.157 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.429 ' HD2' ' OH ' ' A' ' 127' ' ' TYR . 25.5 ttt180 -73.67 121.96 21.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.52 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.64 -67.76 0.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.981 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.02 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.499 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -117.61 72.52 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.336 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 33.3 t70 -88.92 145.96 25.21 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.177 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 141' ' ' LYS . 65.2 mt -89.93 107.87 22.03 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.6 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 6.9 Cg_exo -73.36 157.04 50.13 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.143 2.562 . . . . 0.0 112.317 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 30.6 m -86.61 176.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.593 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 -44.76 7.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.003 0.43 . . . . 0.0 110.95 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.7 t -132.4 134.94 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.475 HD23 HH11 ' A' ' 179' ' ' ARG . 60.5 tp -115.14 112.52 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.885 0.374 . . . . 0.0 110.199 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.4 t -99.21 118.01 45.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 0.0 110.349 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.22 169.76 8.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -84.45 65.7 9.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -175.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 175' ' ' GLU . 10.3 mmtp 179.02 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.262 0.976 . . . . 0.0 110.89 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -144.17 156.92 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 0.0 111.271 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 36' ' ' LEU . 48.0 t -102.54 106.55 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.257 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.475 HH11 HD23 ' A' ' 172' ' ' LEU . 40.8 ttm105 -93.58 95.43 9.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.747 -173.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -78.45 123.89 27.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 169' ' ' VAL . 73.7 mt . . . . . 0 C--N 1.319 -0.754 0 CA-C-O 121.037 0.446 . . . . 0.0 111.109 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.21 0.528 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 161' ' ' PRO . 29.2 pttt -68.87 -28.28 66.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.921 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.2 t -78.82 -36.08 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.945 0.402 . . . . 0.0 110.01 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 17.7 tp10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.07 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.67 -48.95 78.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.383 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -56.04 -44.7 79.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.729 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -60.8 -46.91 88.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.923 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HG3' ' A' ' 5' ' ' GLU . 61.7 mttm -58.97 -43.97 91.47 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.189 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG13 ' HG3' ' A' ' 155' ' ' GLN . 43.8 t -67.76 -46.5 82.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.476 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.37 -40.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.121 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.62 -48.11 82.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -78.87 -30.36 45.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.553 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' NH1' ' HG2' ' A' ' 54' ' ' GLU . 30.5 ttp180 -57.18 -46.91 82.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 52' ' ' LYS . 33.2 pt -90.82 3.27 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.699 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -101.92 2.1 37.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 154' ' ' PHE . 89.1 mt -67.43 138.12 56.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 p -70.95 155.9 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.59 -58.72 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.562 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.08 -48.93 79.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.582 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.21 -44.24 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -61.62 -46.39 90.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.445 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -69.16 -34.69 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -66.21 -31.03 71.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 0.0 110.923 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.55 -41.77 21.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.253 0.549 . . . . 0.0 110.007 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -61.5 -36.3 80.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.006 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.62 -42.24 82.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.591 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.49 -34.92 75.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 55' ' ' VAL . 42.0 t -66.36 -42.95 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.925 0.393 . . . . 0.0 110.361 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.64 -44.22 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.271 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.8 m -64.52 -32.71 74.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.711 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -63.96 -54.37 35.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.88 -33.33 74.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.703 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -67.83 -30.58 70.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -87.61 -14.25 40.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tt -64.11 113.69 11.17 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.4 -48.34 13.85 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.869 2.38 . . . . 0.0 112.861 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.79 -20.1 65.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.501 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.1 -46.7 41.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 57.3 tttm -73.47 -29.75 62.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.719 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -68.76 -37.3 79.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -82.7 148.29 27.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 110.753 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 35.7 mtmt -101.35 -37.04 8.65 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.069 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -89.28 96.52 10.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.14 122.88 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.927 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.02 124.02 44.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.968 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.88 122.27 45.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.741 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.677 ' HD2' ' HD2' ' A' ' 118' ' ' PRO . 6.4 t80 -83.42 98.85 9.72 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.6 m -51.9 114.85 5.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.895 0.747 . . . . 0.0 112.673 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.88 131.67 23.01 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.816 2.344 . . . . 0.0 111.108 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.416 HG23 HG23 ' A' ' 98' ' ' ILE . 2.4 pp -120.01 -8.93 10.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 41.0 mttp -145.72 70.37 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.379 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -114.76 3.88 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HG2' ' NH1' ' A' ' 14' ' ' ARG . 29.7 mt-10 61.32 25.48 15.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 169.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG21 HG11 ' A' ' 29' ' ' VAL . 98.0 t 69.69 106.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.431 0.634 . . . . 0.0 110.485 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.28 96.52 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.677 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.7 mt -88.12 9.63 22.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.674 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.444 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -62.62 -47.39 88.29 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.3 Cg_endo -70.95 1.13 5.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.694 1.596 . . . . 0.0 112.905 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 tp -88.77 -16.91 30.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.794 0.33 . . . . 0.0 110.599 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.414 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 21.2 m-85 -56.7 -48.02 97.98 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 93.9 Cg_exo -48.1 -31.84 17.32 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 122.53 2.153 . . . . 0.0 113.546 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.59 -48.28 12.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 68' ' ' LYS . 98.9 t -61.89 -39.33 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.512 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 96.2 mt -64.18 -14.77 57.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -88.73 -48.46 7.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.043 0.449 . . . . 0.0 111.34 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 28.3 mt-10 -93.69 -38.0 11.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.45 . . . . 0.0 112.057 -171.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HZ1' ' HA ' ' A' ' 40' ' ' LYS . 33.9 mttp -119.66 167.31 12.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -161.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -93.24 121.44 34.6 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.646 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HG ' ' HG ' ' A' ' 72' ' ' LEU . 58.6 tp -84.02 112.69 20.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.243 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.22 115.87 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.897 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -121.26 136.01 25.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.666 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.5 132.78 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 0.0 111.86 176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 53.2 tttm -105.95 128.81 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.0 104.02 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.48 12.18 30.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.0 -105.02 1.26 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.7 -15.26 22.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.279 0.561 . . . . 0.0 109.805 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -89.52 143.45 26.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.123 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.689 HD13 ' HD1' ' A' ' 136' ' ' TYR . 62.0 mt -113.64 111.64 36.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.212 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 20.1 m -94.95 108.53 20.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.135 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.2 104.13 6.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.98 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.21 140.2 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.853 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.37 151.35 37.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.0 176.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.886 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -139.27 11.05 2.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.365 0.602 . . . . 0.0 109.872 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 p -162.7 150.51 11.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.711 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.8 Cg_exo -76.07 49.76 2.64 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.012 2.475 . . . . 0.0 111.496 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.82 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 38.4 t -124.6 94.41 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.269 0.557 . . . . 0.0 110.834 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 101' ' ' PRO . 95.3 mt -123.07 120.82 34.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.64 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.06 -171.33 27.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.6 t -136.82 116.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.67 -59.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.995 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.403 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -107.92 139.1 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.799 -0.236 . . . . 0.0 111.326 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 65.2 10.88 6.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 0.0 111.935 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.66 16.26 67.55 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.782 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.416 HG23 HG23 ' A' ' 51' ' ' ILE . 39.1 pt -105.58 172.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.833 0.349 . . . . 0.0 110.953 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -73.4 131.26 41.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.281 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -117.04 121.42 32.56 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.237 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 74' ' ' LYS . 24.8 Cg_endo -62.54 118.15 5.04 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.607 2.205 . . . . 0.0 112.398 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 58.5 t -93.18 -55.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.792 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -105.05 154.59 19.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.746 0.308 . . . . 0.0 110.601 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.54 162.77 10.63 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.37 135.8 35.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 106' ' ' ARG . 17.8 ptt85 -87.48 145.28 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.74 153.09 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -82.71 161.88 57.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.53 -14.83 5.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.284 2.656 . . . . 0.0 113.476 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.3 -37.14 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.313 0.578 . . . . 0.0 110.763 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.76 -23.68 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.9 107.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.974 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.87 -49.7 5.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.573 ' CZ ' HG23 ' A' ' 148' ' ' VAL . 20.7 t80 -118.75 129.82 55.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.5 tt -139.19 139.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.993 0.425 . . . . 0.0 110.574 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.27 116.05 23.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.066 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 48' ' ' TYR . 33.7 m -124.86 127.35 25.15 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 0.0 111.274 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.677 ' HD2' ' HD2' ' A' ' 48' ' ' TYR . 2.2 Cg_endo -83.35 -164.46 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.001 2.468 . . . . 0.0 111.166 171.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.51 175.55 32.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.782 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -99.98 121.33 50.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 72.58 126.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.32 1.012 . . . . 0.0 112.654 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.501 ' HA ' HD13 ' A' ' 160' ' ' LEU . 63.0 m-85 -138.09 168.41 19.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 45.3 p30 -126.3 -164.55 1.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.268 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.75 -13.8 37.15 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 181' ' ' LEU . 44.7 mt-10 -110.51 -62.49 1.52 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.97 62.32 0.13 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.924 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -82.91 134.03 35.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.2 82.82 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.7 tp . . . . . 0 C--O 1.232 0.16 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.616 175.366 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.689 ' HD1' HD13 ' A' ' 80' ' ' ILE . 95.3 m-85 . . . . . 0 C--O 1.238 0.45 0 CA-C-O 121.786 0.803 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.32 -16.95 63.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.55 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -54.74 -34.52 62.62 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 143' ' ' VAL . 51.6 tp -87.22 -51.22 6.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.142 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.64 -26.93 62.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.11 -28.55 63.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.74 -2.57 15.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.784 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 139' ' ' LEU . 98.4 t -70.19 102.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -97.19 10.98 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.92 -176.42 43.56 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.683 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.0 100.71 1.26 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.986 0.393 . . . . 0.0 110.283 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.43 100.06 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.091 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 114' ' ' PHE . 92.3 t -96.29 114.93 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.025 0.441 . . . . 0.0 110.014 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.35 124.26 7.72 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.723 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.27 116.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.23 161.51 40.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.672 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -96.61 156.31 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -62.43 -31.44 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.43 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 26.8 p90 -78.18 -6.2 54.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.421 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.505 ' HG3' HG13 ' A' ' 10' ' ' VAL . 28.5 tt0 -100.95 -6.23 24.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 0.0 109.816 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.5 115.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.64 -166.39 1.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 33.6 tt0 -69.69 -67.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.92 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -145.43 132.62 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.462 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 122' ' ' PHE . 80.9 mt -96.52 138.87 21.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.616 0.246 . . . . 0.0 110.75 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.508 ' HG2' ' HB3' ' A' ' 3' ' ' LYS . 3.1 Cg_exo -76.36 101.87 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.789 2.326 . . . . 0.0 111.25 174.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.72 148.66 29.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.102 -177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -114.81 -135.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.328 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.69 -23.79 66.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.42 0.628 . . . . 0.0 110.312 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -87.58 67.68 9.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.278 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 168' ' ' PRO . 31.5 t70 -59.38 -74.18 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.367 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 41.2 mt 41.04 81.38 0.25 Allowed Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 124.285 0.991 . . . . 0.0 113.246 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.4 ' HD3' ' OD2' ' A' ' 166' ' ' ASP . 90.8 Cg_endo -89.04 165.49 5.75 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.44 2.093 . . . . 0.0 111.798 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.58 177.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.75 -43.26 3.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.473 0.654 . . . . 0.0 109.369 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.41 122.33 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 42.5 tp -101.95 109.93 21.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.12 123.68 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.85 3.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.403 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -26.29 28.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.134 0.492 . . . . 0.0 110.479 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.597 ' HB3' ' HZ1' ' A' ' 176' ' ' LYS . 9.9 mtpm? -91.2 -34.2 15.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.34 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.5 171.66 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.946 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 t -113.58 111.49 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 42.0 ttm180 -89.56 96.3 10.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.284 0.564 . . . . 0.0 111.132 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.87 115.26 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.391 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 125' ' ' GLU . 75.6 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 111.042 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -48.77 70.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 m -63.88 -35.59 81.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.946 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.99 -53.95 52.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.654 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.54 -48.37 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.512 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.04 -49.45 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -65.08 -43.07 93.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.612 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.51 -46.77 68.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.863 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.17 -37.15 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.0 tp -57.24 -37.49 72.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.285 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.573 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 15.0 t-80 -67.13 -25.93 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.963 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 45.9 mmtt -95.67 -16.22 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 110.968 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 155' ' ' GLN . 25.0 ttt85 -75.66 -42.98 49.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.3 pt -90.78 6.84 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.256 0.551 . . . . 0.0 110.68 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -77.25 -26.09 52.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.896 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.09 135.35 57.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.639 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -65.3 142.53 58.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.122 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -52.69 -43.15 65.4 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.3 -59.44 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.152 0.501 . . . . 0.0 110.957 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.4 -44.85 81.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.143 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -62.21 -41.83 98.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.967 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -71.07 -35.38 71.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.661 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -65.66 -35.53 81.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.025 0.44 . . . . 0.0 110.469 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.83 -37.49 70.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.444 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 30' ' ' ILE . 38.0 m -65.67 -30.75 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.53 -42.88 79.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.217 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -60.99 -46.52 90.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.127 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 175' ' ' GLU . 37.0 t -61.49 -42.07 92.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.128 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 26' ' ' SER . 80.6 mt -61.18 -50.27 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 110.634 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -60.69 -41.78 95.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.6 -51.25 66.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.79 -36.37 83.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.032 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -76.31 -17.45 59.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.833 0.349 . . . . 0.0 110.706 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -88.52 -18.95 27.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.543 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.448 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.1 tt -55.38 117.3 14.31 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD2' HD23 ' A' ' 36' ' ' LEU . 44.6 Cg_exo -56.48 -42.66 63.23 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.169 2.579 . . . . 0.0 113.273 -176.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.4 -27.81 67.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.84 -34.96 74.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.267 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -64.81 -42.09 95.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.29 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -73.55 -24.0 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.466 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -66.59 124.84 23.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.375 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 61.8 mttm -103.85 -37.1 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.501 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.637 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 26.5 mmtp -96.43 108.76 21.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.12 110.51 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.968 0.414 . . . . 0.0 111.152 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -91.64 114.05 26.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.35 121.71 45.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.291 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -79.03 105.88 10.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.523 ' HB3' HG22 ' A' ' 98' ' ' ILE . 43.3 t -58.42 115.28 10.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.503 0.502 . . . . 0.0 110.996 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.872 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 Cg_exo -73.14 108.23 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.977 2.452 . . . . 0.0 111.899 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.668 HG13 ' HG2' ' A' ' 52' ' ' LYS . 44.7 pt -78.37 -22.55 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.268 -175.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.668 ' HG2' HG13 ' A' ' 51' ' ' ILE . 71.7 mmtt -117.31 25.24 10.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 110.884 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.07 -71.42 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.872 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 6.1 mm-40 39.74 53.05 2.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.146 0.978 . . . . 0.0 113.029 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HA ' ' HH ' ' A' ' 152' ' ' TYR . 47.7 t 68.03 100.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.34 0.591 . . . . 0.0 109.778 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.71 111.97 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.203 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.07 14.91 15.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.643 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 59' ' ' PRO . 42.6 p -63.02 -41.37 70.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 23.4 Cg_exo -66.27 -10.94 29.29 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.879 1.719 . . . . 0.0 112.594 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.97 -21.84 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.291 . . . . 0.0 110.669 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.5 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.5 m-85 -57.94 -52.7 72.54 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.015 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.0 Cg_exo -54.52 -34.1 80.85 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.363 2.042 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -66.47 -53.0 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.4 -36.12 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.204 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.11 -26.24 67.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 66' ' ' LYS . 70.9 mmtt -114.17 -7.87 13.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.93 -31.14 9.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.225 0.536 . . . . 0.0 110.702 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 47.7 mttm -142.1 -171.86 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.085 -169.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -105.69 126.48 52.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 54.6 tp -82.58 144.69 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 69.6 mt -126.86 114.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.459 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 62.8 mt -109.65 138.89 20.75 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.61 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.0 126.54 5.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.846 2.364 . . . . 0.0 112.936 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.579 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 9.3 tmtm? -105.5 97.71 7.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 77' ' ' GLY . 11.5 t -92.86 117.81 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.658 -170.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -87.96 5.18 41.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.648 ' H ' HG13 ' A' ' 75' ' ' VAL . . . 106.52 -51.87 0.71 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -104.11 -48.49 3.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.5 -0.35 . . . . 0.0 110.456 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -91.49 149.44 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.051 0.453 . . . . 0.0 111.118 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.712 HD13 ' HD1' ' A' ' 136' ' ' TYR . 65.1 mt -124.26 101.38 8.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.524 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 m -85.6 112.67 21.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.023 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.5 mt -84.47 136.15 33.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CE1' ' HG2' ' A' ' 106' ' ' ARG . 88.8 m-85 -128.55 144.1 51.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 0.0 111.248 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.536 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 45.2 mtp180 -79.26 106.99 11.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.649 175.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 51.0 t -89.56 111.43 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -107.02 -28.47 10.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.504 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -141.1 158.21 65.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.292 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.86 -155.48 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 74.45 -46.06 0.6 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.561 0.745 . . . . 0.0 112.199 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 5.7 t -81.68 34.96 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.222 0.535 . . . . 0.0 110.903 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -117.25 131.18 56.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.417 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.12 -169.9 12.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.987 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -136.0 123.36 34.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.463 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -132.52 -85.13 0.28 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.502 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.4 155.48 18.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.558 0.218 . . . . 0.0 111.397 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 72.49 -46.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.926 0.891 . . . . 0.0 111.975 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 20.79 5.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.92 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.523 HG22 ' HB3' ' A' ' 49' ' ' CYS . 2.1 pp -101.62 172.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.618 0.247 . . . . 0.0 111.205 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.09 105.03 6.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.862 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.579 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 2.3 mt-10 -83.6 115.46 59.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.976 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 2.8 Cg_exo -74.39 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 110.56 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 27.9 t -73.34 -58.74 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.415 -173.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.95 178.62 6.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 111.067 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.66 -139.06 10.12 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.6 138.05 51.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' HG2' ' CE1' ' A' ' 83' ' ' TYR . 83.4 mtt180 -83.35 140.75 32.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.948 0.404 . . . . 0.0 110.394 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 84' ' ' ARG . 21.9 t -117.99 137.3 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.577 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -104.69 150.58 38.76 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.33 -35.63 16.12 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.008 3.139 . . . . 0.0 114.998 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.699 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 43.3 tt0 -65.05 -26.98 68.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 14.0 t70 -80.83 -13.69 58.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 0.0 111.148 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.83 131.37 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.618 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.637 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 13.0 m-20 -83.94 -52.42 6.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.629 0.728 . . . . 0.0 110.017 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.5 ' CE2' HG22 ' A' ' 148' ' ' VAL . 46.2 t80 -129.85 131.03 45.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.528 -170.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.2 tt -125.79 137.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.968 0.413 . . . . 0.0 109.943 173.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.481 ' HB3' ' HE1' ' A' ' 114' ' ' PHE . . . -121.23 115.72 23.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.631 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.22 118.95 33.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.82 110.12 2.28 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.336 2.024 . . . . 0.0 111.258 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 122' ' ' PHE . . . -100.0 131.68 10.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.43 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.73 -30.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 122.476 0.31 . . . . 0.0 111.205 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.91 142.13 19.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.635 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 28.7 m-85 -137.77 168.65 19.26 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.505 0.503 . . . . 0.0 110.254 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.54 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 34.0 p-10 -137.96 -167.82 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.76 -0.29 57.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.274 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -97.32 -36.81 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.413 ' CA ' ' HG ' ' A' ' 181' ' ' LEU . . . 113.98 39.99 1.02 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.734 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -108.29 169.27 8.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.485 . . . . 0.0 111.433 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 157.65 32.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.433 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.672 -179.704 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.712 ' HD1' HD13 ' A' ' 80' ' ' ILE . 18.2 m-85 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -70.86 -33.84 71.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.149 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.36 -34.48 77.38 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 143' ' ' VAL . 52.6 tp -70.5 -59.24 2.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.416 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.67 -38.55 78.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.187 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -78.71 -11.16 59.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 111.098 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -107.55 -5.82 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.661 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 139' ' ' LEU . 93.9 t -57.62 118.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.699 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 52.8 tttm -87.69 -2.61 58.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 110.509 -175.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -96.2 -161.91 32.96 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.11 131.49 38.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.94 0.37 . . . . 0.0 110.75 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -93.03 110.6 22.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.5 HG22 ' CE2' ' A' ' 114' ' ' PHE . 89.3 t -109.84 128.16 66.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 0.0 110.973 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 122' ' ' PHE . . . -98.92 132.95 11.11 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.635 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.63 122.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.661 0.267 . . . . 0.0 110.659 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -158.44 168.29 27.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.876 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.401 ' HH ' ' HA ' ' A' ' 55' ' ' VAL . 89.0 m-85 -88.74 170.91 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.5 p -63.74 -27.3 69.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.242 0.544 . . . . 0.0 110.938 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -68.05 -25.59 65.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.089 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.447 ' HG2' HH11 ' A' ' 14' ' ' ARG . 2.3 mp0 -92.67 4.54 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.531 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.03 113.22 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.402 . . . . 0.0 110.631 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -106.98 178.67 4.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.807 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.47 -54.57 6.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.582 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 71.7 ttp85 -149.28 139.46 22.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.025 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 67.9 mt -98.98 158.39 32.4 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.743 174.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.71 105.79 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.38 2.053 . . . . 0.0 112.539 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.74 100.9 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.96 -77.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.186 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.77 -69.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -80.78 -3.92 52.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -165.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.41 -175.49 5.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.311 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.782 HD13 ' HD2' ' A' ' 168' ' ' PRO . 4.1 tp -135.19 129.38 18.85 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.594 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.782 ' HD2' HD13 ' A' ' 167' ' ' ILE . 56.5 Cg_endo -72.2 159.74 48.98 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.514 2.143 . . . . 0.0 112.701 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.34 -177.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -100.42 -56.08 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.451 ' HB ' HG21 ' A' ' 148' ' ' VAL . 45.8 t -128.13 140.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.62 116.01 30.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.671 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.7 t -106.83 125.28 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 0.0 110.247 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 50.3 p -119.54 -169.67 1.8 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.679 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 9.6 pt-20 -68.75 -27.52 65.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.868 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 56.9 mtpt -125.89 -21.47 4.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.76 143.6 50.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -172.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.409 HG11 ' HG ' ' A' ' 36' ' ' LEU . 63.5 t -111.52 102.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -122.25 112.41 18.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.166 0.507 . . . . 0.0 112.082 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.6 ttm105 -70.3 152.44 44.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' A' ' 181' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 122.103 0.954 . . . . 0.0 112.214 -166.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 129' ' ' LEU . 15.7 ptpt -66.41 -22.89 66.24 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.94 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.8 t -59.16 -29.5 67.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.184 0.516 . . . . 0.0 110.684 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.32 -45.27 18.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.067 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.17 -35.72 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.628 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -55.38 -45.98 76.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.848 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.37 -39.08 88.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -60.35 -49.69 76.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.6 -42.33 80.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 15' ' ' ILE . 62.1 tp -61.43 -42.51 98.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.667 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 5.0 t60 -58.35 -44.57 88.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.243 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 26.3 mtpp -67.65 -35.48 78.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.314 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 44.2 ttm-85 -60.77 -50.77 72.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.259 0.552 . . . . 0.0 110.652 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 11' ' ' LEU . 18.5 pt -83.67 9.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.0 111.369 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -101.37 -11.62 19.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 152.4 24.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.279 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -75.09 156.53 35.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.544 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 37.8 tt0 -68.28 -39.42 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.261 . . . . 0.0 110.906 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.56 -44.07 97.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 109.742 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.92 -34.47 76.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.401 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 7.5 mmt85 -55.18 -61.49 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.01 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 66.6 ttt180 -62.81 -37.01 85.03 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.035 0.445 . . . . 0.0 110.708 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 52.7 ttt180 -60.56 -44.87 95.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.952 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -86.57 -37.85 17.73 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.267 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.4 t -66.09 -31.86 72.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.528 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 8.7 tt0 -69.77 -26.1 64.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 74.1 mmtt -74.84 -43.94 51.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.901 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.78 -48.26 89.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.742 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 79.0 mt -60.13 -47.35 92.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -61.82 -39.41 91.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.505 HD22 ' HA ' ' A' ' 177' ' ' ASN . 8.3 t-20 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.244 0.545 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.56 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.464 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.691 ' HE2' ' HG2' ' A' ' 63' ' ' GLU . 2.8 mmmp? -71.43 -31.12 66.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.602 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -84.38 -9.26 58.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.129 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -71.51 111.45 10.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.67 -33.11 96.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.999 2.466 . . . . 0.0 113.529 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.63 -34.67 77.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.784 0.326 . . . . 0.0 110.334 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.79 -25.3 63.72 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.89 -34.87 74.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.262 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -100.44 -21.64 15.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.084 -171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -58.93 123.87 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 110.916 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 1.1 mmpp? -74.71 -63.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.644 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 113.48 25.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.149 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' O ' HD11 ' A' ' 70' ' ' LEU . 46.0 t -116.41 115.14 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -99.34 143.69 29.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -136.93 148.26 46.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.794 0.33 . . . . 0.0 110.551 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.484 ' CE1' HG12 ' A' ' 117' ' ' VAL . 64.6 m-85 -97.06 141.6 30.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.898 171.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.536 ' HB2' HG23 ' A' ' 98' ' ' ILE . 67.5 m -73.75 146.8 86.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.569 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.69 106.52 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.049 2.499 . . . . 0.0 113.042 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.852 HG13 ' H ' ' A' ' 52' ' ' LYS . 8.9 pt -99.96 -85.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.472 174.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.852 ' H ' HG13 ' A' ' 51' ' ' ILE . 45.8 mttp -91.62 -6.82 51.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.24 0.543 . . . . 0.0 109.761 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 14' ' ' ARG . . . -98.07 120.89 6.94 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 174.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.49 7.43 38.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.746 0.308 . . . . 0.0 111.249 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG23 ' CZ ' ' A' ' 152' ' ' TYR . 21.5 t -70.51 100.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.418 ' OD1' ' HD3' ' A' ' 59' ' ' PRO . 6.6 t70 -86.19 102.76 14.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.237 0.541 . . . . 0.0 111.047 -171.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.1 15.77 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.365 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.488 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 m -62.71 -50.62 77.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 22.0 Cg_exo -67.07 -0.65 5.05 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -85.87 -19.04 31.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.691 0.282 . . . . 0.0 110.516 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.517 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.2 m-85 -59.63 -49.58 91.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 76.1 Cg_exo -53.11 -32.77 60.68 Favored 'Trans proline' 0 C--N 1.359 1.132 0 C-N-CA 122.296 1.997 . . . . 0.0 112.687 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.691 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 18.3 tp10 -71.69 -52.57 17.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.17 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.9 t -57.27 -45.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.221 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -65.17 -12.6 52.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -97.05 -14.22 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.936 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.64 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 43.1 mt-10 -110.56 -56.67 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 0.0 110.94 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.64 ' HD2' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -129.43 -171.53 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 -171.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.07 138.29 32.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 41.6 tp -98.94 157.38 16.36 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.661 ' HB ' ' HB3' ' A' ' 46' ' ' ALA . 67.2 mt -138.52 131.28 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 96.1 mt -129.32 132.6 24.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.37 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.84 2.36 . . . . 0.0 111.77 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.701 ' HG2' ' HB2' ' A' ' 100' ' ' GLU . 2.8 tmtp? -105.89 113.63 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.92 106.71 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.091 0.472 . . . . 0.0 111.1 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -104.45 88.92 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.373 174.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 -98.73 1.04 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -123.18 -4.18 8.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 109.87 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.23 106.71 18.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.435 HD13 ' HD1' ' A' ' 136' ' ' TYR . 55.5 mt -82.72 102.37 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.089 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -84.74 122.72 29.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.495 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.91 100.17 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.521 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 40.8 m-85 -103.21 130.36 50.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -79.04 153.26 30.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.134 176.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 98.5 t -130.68 124.08 56.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.469 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -148.85 25.12 0.94 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.2 m -146.37 149.52 37.98 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.741 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.4 Cg_exo -78.23 160.5 29.52 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.742 2.295 . . . . 0.0 111.958 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.27 19.39 11.68 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 85' ' ' VAL . 30.7 p -103.61 5.78 36.75 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.023 -0.423 . . . . 0.0 110.63 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -100.94 129.48 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.43 171.08 25.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.144 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.34 102.06 13.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.967 0.413 . . . . 0.0 110.374 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.31 -34.6 1.92 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' HG12 ' A' ' 98' ' ' ILE . . . -82.24 -163.34 0.66 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.905 0.383 . . . . 0.0 111.209 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -54.85 -43.28 72.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 58.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.628 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 49' ' ' CYS . 43.0 pt -131.3 166.66 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -106.41 96.35 6.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.701 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 3.3 pt-20 -105.25 154.38 38.94 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.639 -173.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.521 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 11.0 Cg_exo -71.15 112.45 3.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.62 2.213 . . . . 0.0 111.985 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.43 -48.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -121.1 99.08 6.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.842 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.42 -162.42 9.1 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.908 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 36.9 mt-10 -127.02 142.34 51.57 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -77.27 128.33 34.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.097 0.475 . . . . 0.0 111.613 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 84' ' ' ARG . 84.1 t -124.18 145.13 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.949 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 110' ' ' GLU . 9.5 p30 -97.9 157.46 34.56 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.83 -25.22 42.12 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.503 2.802 . . . . 0.0 114.645 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.461 ' HB3' ' OD1' ' A' ' 108' ' ' ASN . 20.6 tt0 -68.92 -23.59 64.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.846 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -93.42 0.03 56.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.939 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.76 103.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.12 -58.04 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.791 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 23.4 t80 -124.06 144.72 49.69 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.337 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 17.3 tt -149.66 141.01 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.662 0.267 . . . . 0.0 110.494 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.61 120.43 38.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.484 HG12 ' CE1' ' A' ' 48' ' ' TYR . 27.5 m -116.82 120.78 33.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.216 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 4.1 Cg_exo -77.37 104.69 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.787 2.325 . . . . 0.0 111.217 174.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.57 156.5 15.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.852 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 125.65 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.1 106.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.164 0.915 . . . . 0.0 112.491 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -127.84 157.43 40.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.596 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -103.94 -173.98 2.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.895 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 46.1 mt -87.06 15.74 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.56 -15.59 6.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.861 0.362 . . . . 0.0 110.571 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.433 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 118.05 5.46 13.39 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.71 169.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -85.92 132.35 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.542 0.671 . . . . 0.0 111.213 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -94.25 128.6 40.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.357 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 160' ' ' LEU . 30.6 tp . . . . . 0 C--N 1.33 -0.281 0 O-C-N 123.535 0.522 . . . . 0.0 110.56 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HD1' HD13 ' A' ' 80' ' ' ILE . 66.2 m-85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 9.6 p-10 -65.89 -29.37 69.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -49.94 -39.72 41.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.035 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.408 HD23 ' HH ' ' A' ' 48' ' ' TYR . 50.5 tp -81.85 -40.64 22.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.148 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.01 -16.64 64.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.454 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 32.1 mmtp -73.2 -29.22 62.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -95.75 -27.83 15.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.194 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.43 98.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.076 0.465 . . . . 0.0 110.118 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -134.46 56.62 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.096 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.43 9.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 114' ' ' PHE . 23.7 tp -83.39 89.2 7.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HB3' ' OD1' ' A' ' 170' ' ' ASP . 25.1 ttpt -91.07 105.38 17.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.688 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' A' ' 114' ' ' PHE . 45.6 t -104.49 124.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.143 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.2 10.61 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.53 115.99 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.44 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -158.59 175.03 14.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.713 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.603 ' HD1' ' HG3' ' A' ' 175' ' ' GLU . 46.4 m-85 -102.09 153.37 19.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 176' ' ' LYS . 29.6 t -61.08 -13.14 15.01 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.717 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -71.66 -23.55 61.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.585 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 16.4 mp0 -107.58 13.86 26.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.921 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.1 t -117.92 120.92 66.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.181 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.73 -175.16 2.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.391 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.895 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -89.94 -36.74 14.83 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.274 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -138.11 145.34 41.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 129' ' ' LEU . 95.3 mt -132.77 161.84 61.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.95 101.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.572 1.515 . . . . 0.0 110.892 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -104.67 141.0 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 11.3 t70 -128.08 -163.49 1.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.145 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.48 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . -81.6 -40.91 22.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 0.0 110.674 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -85.0 43.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.404 0.621 . . . . 0.0 110.241 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.55 110.77 22.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.303 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.98 114.06 53.61 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.579 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.07 160.02 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.172 2.582 . . . . 0.0 113.08 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.401 ' HA ' ' HE3' ' A' ' 147' ' ' LYS . 31.1 m -103.25 -179.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.698 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 8.1 m-20 -107.8 -32.79 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.815 0.34 . . . . 0.0 110.903 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 148' ' ' VAL . 43.8 t -136.05 153.13 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.552 ' HB2' HD12 ' A' ' 181' ' ' LEU . 44.1 tp -128.94 122.15 29.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.604 HG23 HG11 ' A' ' 178' ' ' VAL . 86.2 t -109.14 126.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.166 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.2 p -127.19 -174.6 3.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.322 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.603 ' HG3' ' HD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -85.79 -1.48 57.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 110.113 175.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.444 ' HZ2' ' HB3' ' A' ' 153' ' ' SER . 40.5 mmtm -93.56 -64.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.141 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.505 ' HA ' HD22 ' A' ' 32' ' ' ASN . 8.3 t-20 -155.62 174.87 14.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.022 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 173' ' ' VAL . 4.4 m -108.04 99.6 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.64 . . . . 0.0 110.26 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 179' ' ' ARG . 33.1 ttt180 -103.7 116.57 32.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -74.7 132.74 41.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.521 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 172' ' ' LEU . 61.6 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.184 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -54.18 -40.66 67.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.542 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -62.12 -36.09 80.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.425 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 6.0 mm-40 -77.9 -43.43 30.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.482 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.07 -38.22 85.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -54.54 -53.86 48.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -68.42 -24.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.332 -173.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -74.18 -47.08 38.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 110.394 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.29 -44.63 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.297 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 tp -59.73 -45.57 91.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.558 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 13.7 t-80 -62.05 -43.02 99.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.66 -41.49 99.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.447 HH21 ' N ' ' A' ' 54' ' ' GLU . 10.8 tpt180 -63.95 -53.59 47.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.339 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.2 pt -80.97 4.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 111.599 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 6.5 t30 -78.67 -28.69 45.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.15 142.56 46.86 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.619 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.61 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 38.9 p -76.91 160.49 29.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.079 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.16 -30.06 71.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.9 -52.28 64.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.57 -30.78 36.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.386 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 18' ' ' SER . 83.7 mtt180 -56.9 -59.19 5.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.3 -40.35 77.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.38 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.63 -45.8 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.082 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -70.68 -44.65 66.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -61.23 -33.56 73.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.08 -39.28 78.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.427 0.632 . . . . 0.0 110.179 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -74.27 -34.23 63.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 175' ' ' GLU . 44.9 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.415 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 HG22 HD13 ' A' ' 60' ' ' LEU . 77.5 mt -58.21 -44.27 87.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.114 0.483 . . . . 0.0 110.325 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.1 m -65.25 -36.56 84.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -67.98 -42.35 80.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.888 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.804 HD12 HD12 ' A' ' 36' ' ' LEU . 26.3 tp -62.68 -46.61 87.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.652 ' HD3' ' HE2' ' A' ' 39' ' ' PHE . 23.4 mmtp -60.38 -28.94 68.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 176.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -82.97 -17.82 42.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.519 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.804 HD12 HD12 ' A' ' 33' ' ' LEU . 44.6 mt -61.43 120.52 56.31 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.1 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.03 -35.6 81.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.756 2.304 . . . . 0.0 111.388 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -60.01 -52.67 64.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.652 ' HE2' ' HD3' ' A' ' 34' ' ' LYS . 88.2 t80 -73.34 -30.22 63.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -58.04 -41.39 83.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.04 -23.28 33.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.5 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 39' ' ' PHE . 49.9 m -50.8 123.19 8.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.248 0.546 . . . . 0.0 111.696 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -102.99 -34.57 8.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -113.52 97.96 6.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.075 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.47 122.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.145 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 116' ' ' ALA . 54.1 mt -111.78 136.52 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.065 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -85.64 -0.52 55.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.158 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.5 t 65.89 98.76 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.119 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 41.9 Cg_endo -68.35 97.76 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.467 2.111 . . . . 0.0 112.398 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' GLY . 24.5 pt -87.18 154.82 3.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 tptp 71.63 -15.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.807 0.692 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 133.28 -77.89 0.37 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' HH21 ' A' ' 14' ' ' ARG . 3.3 mm-40 22.93 77.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 113.708 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 150' ' ' VAL . 58.4 t 62.56 94.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.402 -174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.76 88.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.793 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 97.5 mt -100.2 9.45 42.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.005 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.48 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -60.09 -44.52 96.72 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 58' ' ' THR . 52.8 Cg_endo -70.19 -5.78 17.26 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.691 1.594 . . . . 0.0 112.488 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 63' ' ' GLU . 60.6 tp -87.81 -18.38 29.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.781 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.521 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 14.2 m-85 -54.31 -54.92 42.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 47.7 Cg_exo -58.84 -34.74 99.19 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.939 1.759 . . . . 0.0 112.278 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HB3' HD11 ' A' ' 60' ' ' LEU . 49.6 tp10 -64.91 -45.7 84.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.441 HG21 ' HG ' ' A' ' 60' ' ' LEU . 93.2 t -66.85 -41.88 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.92 -27.13 67.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.332 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -74.01 -55.5 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.447 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -81.26 -51.72 8.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.75 -174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -118.83 -171.92 2.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.353 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 40.5 mt-10 -104.16 130.71 51.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.696 175.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.1 tp -102.36 121.23 41.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.2 mp -99.14 118.84 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.429 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.68 142.44 28.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.94 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.44 ' HA ' HD21 ' A' ' 82' ' ' LEU . 56.3 Cg_endo -71.69 128.82 14.73 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.752 2.301 . . . . 0.0 112.198 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -119.64 117.49 28.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.916 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.07 106.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -92.43 21.7 5.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 81.15 1.46 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.91 -59.05 0.52 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.322 0.649 . . . . 0.0 110.324 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -58.23 118.26 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.995 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.532 HD11 ' HD1' ' A' ' 136' ' ' TYR . 14.4 tt -110.76 136.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 t -130.81 176.75 7.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.4 mt -119.45 122.51 41.87 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m-85 -110.91 127.27 55.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.097 0.475 . . . . 0.0 111.223 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.488 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 23.7 ttp85 -86.75 119.55 27.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.482 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -118.66 145.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.638 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -139.23 22.88 2.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 t -141.06 122.93 9.27 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.805 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.92 -31.2 93.37 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.155 2.57 . . . . 0.0 113.315 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.73 1.31 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.3 t -109.11 4.14 22.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.255 0.55 . . . . 0.0 110.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.41 136.61 33.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.651 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.91 159.92 30.33 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.986 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.35 113.95 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.758 0.279 . . . . 0.0 110.54 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.18 -58.15 0.41 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.689 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.68 142.55 47.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.882 0.372 . . . . 0.0 111.702 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 73.22 -54.4 0.69 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.021 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.61 44.35 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.916 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.79 168.94 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 72.8 mtm -91.77 100.01 12.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.151 0.501 . . . . 0.0 110.155 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.74 157.34 37.07 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.828 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.18 115.56 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.963 1.776 . . . . 0.0 110.273 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.04 -45.71 70.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.262 0.553 . . . . 0.0 109.545 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -129.82 -157.04 0.79 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.793 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.77 -161.61 14.21 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.358 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 84' ' ' ARG . 35.9 mt-10 -124.03 111.11 15.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 26.2 ptt180 -74.28 148.11 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.908 0.861 . . . . 0.0 112.754 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.32 136.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.473 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.69 142.82 91.78 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.73 -18.42 12.18 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.389 2.726 . . . . 0.0 112.879 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.65 ' HG3' ' HE3' ' A' ' 144' ' ' LYS . 43.2 tt0 -64.33 -31.12 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -94.06 4.55 53.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.911 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.9 t -82.74 120.34 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.22 -46.48 6.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.258 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.609 ' HZ ' HD13 ' A' ' 33' ' ' LEU . 35.7 t80 -125.14 129.93 51.16 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.61 139.17 45.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.596 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HB3' HD23 ' A' ' 47' ' ' LEU . . . -110.84 113.47 26.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -118.56 113.74 36.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.43 ' HG2' ' HA ' ' A' ' 50' ' ' PRO . 11.6 Cg_exo -71.98 118.66 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.595 2.197 . . . . 0.0 110.579 171.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -121.16 142.24 15.34 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.689 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.5 106.07 14.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.53 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.266 0.979 . . . . 0.0 112.932 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 161.75 25.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -175.87 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.761 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 79.3 mt -68.47 -29.45 68.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.47 -39.19 19.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.121 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.5 31.46 0.46 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.468 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -99.93 156.87 16.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.193 0.521 . . . . 0.0 111.057 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -99.63 157.45 16.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.499 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.089 0.471 . . . . 0.0 109.978 175.281 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.532 ' HD1' HD11 ' A' ' 80' ' ' ILE . 2.1 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.657 0.742 . . . . 0.0 109.264 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.01 -51.96 48.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.571 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -57.71 -37.5 73.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.039 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 82' ' ' LEU . 26.5 tp -58.41 -48.23 81.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.949 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.4 mt -59.18 -37.22 76.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.24 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -89.67 0.4 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.977 0.418 . . . . 0.0 110.7 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.554 ' HE ' ' HA ' ' A' ' 142' ' ' ARG . 1.9 tpm_? -95.3 -29.04 14.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.147 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.96 107.56 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.079 0.466 . . . . 0.0 110.478 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.65 ' HE3' ' HG3' ' A' ' 110' ' ' GLU . 19.7 pttp -85.66 9.32 16.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.19 -154.66 30.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.201 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.428 HD12 HG23 ' A' ' 171' ' ' VAL . 31.8 tp -93.27 112.23 24.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.359 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -90.24 108.33 19.69 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.251 0.548 . . . . 0.0 110.175 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.487 HG22 ' CE2' ' A' ' 114' ' ' PHE . 59.3 t -97.89 111.26 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.48 112.67 3.5 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.506 HG13 HG21 ' A' ' 55' ' ' VAL . 18.1 t -105.4 116.73 49.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -156.71 -177.27 6.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.675 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.42 ' HE1' ' H ' ' A' ' 55' ' ' VAL . 74.7 m-85 -93.98 161.01 14.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 t -73.38 -28.96 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.801 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.57 -16.29 60.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.017 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 8.6 tt0 -95.1 7.54 45.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.926 0.87 . . . . 0.0 109.483 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 122.45 57.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.288 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.39 179.44 4.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.031 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.761 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 14.6 mt-10 -87.58 -56.4 3.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.377 0.608 . . . . 0.0 109.801 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.63 104.23 5.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.621 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.79 158.34 35.36 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.758 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.38 101.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.785 1.656 . . . . 0.0 110.397 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -90.71 139.7 30.47 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.2 t70 -75.62 -92.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.516 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -165.85 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.008 0.433 . . . . 0.0 109.988 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -102.76 50.78 0.81 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.421 0.629 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -81.75 -167.51 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.916 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 64.6 mt -113.54 103.87 55.4 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 153.87 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.304 2.67 . . . . 0.0 112.049 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.53 172.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.798 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.77 -52.55 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.273 0.559 . . . . 0.0 110.266 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.428 HG23 HD12 ' A' ' 146' ' ' LEU . 57.3 t -123.47 140.43 47.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.745 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.94 110.75 18.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 178' ' ' VAL . 54.1 t -103.18 121.94 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 80.4 p -108.8 -173.11 2.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.953 0.406 . . . . 0.0 110.745 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.505 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 11.1 pt-20 -69.21 -18.8 63.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.302 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.505 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 29.7 mmtp -117.06 -65.37 1.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.403 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.59 168.68 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 112.105 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.571 HG21 HD21 ' A' ' 36' ' ' LEU . 61.4 t -114.45 123.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.51 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -102.94 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.642 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 -83.79 89.53 7.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.991 -165.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 7.6 mtpm? -62.3 -49.32 76.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 17.4 p -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.578 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.32 -58.34 9.05 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.749 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.49 -41.96 91.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.63 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -52.45 -51.57 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.796 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 9.9 mtmp? -64.49 -44.9 89.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.455 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.77 -45.78 84.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.551 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 120' ' ' VAL . 60.9 t -68.63 -33.06 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.642 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 15' ' ' ILE . 16.3 mt -56.95 -51.65 68.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -59.98 -43.35 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.15 -0.81 15.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.816 ' HD3' ' HG2' ' A' ' 54' ' ' GLU . 21.0 ttm180 -111.73 -41.21 4.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.73 0.3 . . . . 0.0 111.404 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 11' ' ' LEU . 32.2 pt -90.77 -18.16 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.32 -2.01 57.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.049 0.452 . . . . 0.0 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.76 149.31 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.723 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 m -63.3 132.85 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.51 -36.85 85.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.368 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.36 -35.23 79.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.333 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -72.92 -41.22 64.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.36 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -65.64 -37.05 85.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.697 HH21 ' HB2' ' A' ' 56' ' ' ASP . 3.0 tpm_? -58.51 -47.05 85.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.741 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -59.84 -47.96 83.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.12 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 29' ' ' VAL . 95.6 mt -63.32 -43.27 98.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.841 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 70.2 m -61.49 -37.64 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.904 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -58.05 -41.71 83.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 109.896 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.53 -40.59 85.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 25' ' ' LEU . 74.8 t -66.51 -41.43 88.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' SER . 74.9 mt -58.14 -45.06 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -69.63 -33.74 73.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.956 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.56 -44.85 81.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 0.0 110.237 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.69 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 24.4 tp -61.58 -42.6 99.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.07 -13.66 60.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.428 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 t -79.84 -26.61 40.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 33' ' ' LEU . 89.7 mt -60.53 122.52 68.42 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.613 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.48 -22.23 52.11 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.722 2.282 . . . . 0.0 111.701 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.14 -31.67 68.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.365 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.84 -43.8 97.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.875 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.491 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 40.5 mttm -70.95 -18.68 62.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.492 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -79.56 -38.71 33.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 65.9 m -71.82 120.62 17.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.258 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 36.4 mtpt -107.02 -28.23 10.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -89.04 92.53 9.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 57.9 t -112.4 111.21 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.922 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -102.98 134.68 46.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.199 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 7.4 mp -114.83 145.3 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -86.64 1.78 50.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.476 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.01 90.95 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.109 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.54 103.3 1.41 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.906 2.404 . . . . 0.0 112.314 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 1.7 pp -99.28 169.42 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.032 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 65.46 21.15 11.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.29 0.566 . . . . 0.0 110.019 -172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 -86.44 1.56 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.707 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.816 ' HG2' ' HD3' ' A' ' 14' ' ' ARG . 29.9 mt-10 60.88 -84.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG22 HG11 ' A' ' 150' ' ' VAL . 58.6 t -145.44 133.48 16.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.697 ' HB2' HH21 ' A' ' 23' ' ' ARG . 60.6 m-20 -71.45 79.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.88 0.372 . . . . 0.0 111.297 -178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 150' ' ' VAL . 90.6 mt -98.34 -16.98 19.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 109.777 174.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.676 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 6.5 m -63.69 -50.69 70.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.25 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 20.9 Cg_exo -67.97 3.65 1.87 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.339 2.026 . . . . 0.0 112.824 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -93.28 -9.59 38.49 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.501 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 19.5 m-30 -50.83 -49.65 78.59 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.248 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 73.1 Cg_exo -51.96 -35.76 61.84 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.2 1.933 . . . . 0.0 112.791 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.7 -11.91 49.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 68' ' ' LYS . 29.3 t -93.64 -40.52 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.69 -1.94 4.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 94.1 mttt -84.19 -52.67 6.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.647 0.26 . . . . 0.0 111.268 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.946 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 6.8 pt-20 -119.76 -9.72 9.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.946 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 mptp? -116.32 165.06 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.769 0.795 . . . . 0.0 112.185 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.59 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 37.1 mt-10 -98.87 114.79 27.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.326 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -78.93 124.16 27.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.467 . . . . 0.0 110.925 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 55.6 mt -114.48 117.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.199 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.0 mt -119.31 147.64 43.59 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.882 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 47' ' ' LEU . 91.6 Cg_endo -81.21 129.66 6.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.895 2.397 . . . . 0.0 113.443 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -127.34 109.56 11.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.13 105.84 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.201 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -10.84 59.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.689 -175.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.04 -42.95 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.705 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -137.14 -39.17 0.61 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.015 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.26 141.4 28.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.32 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -80.36 106.89 12.71 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.583 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.0 mt -74.31 117.63 16.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.953 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.445 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 5.2 m-85 -102.45 133.1 47.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.135 0.493 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 12.5 ttp180 -99.5 115.18 28.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.853 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -131.42 148.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.97 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -127.21 18.88 7.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.378 0.609 . . . . 0.0 109.518 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.2 m -139.06 141.72 30.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 6.7 Cg_exo -74.5 -174.53 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.931 2.421 . . . . 0.0 111.947 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.61 -30.49 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 112.237 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.407 ' H ' ' C ' ' A' ' 88' ' ' PRO . 34.4 m -76.37 1.74 15.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 110.681 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.5 mt -104.38 105.65 15.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.102 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -107.18 -163.16 21.93 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.816 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.91 121.9 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.63 -75.61 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.98 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.23 114.9 1.97 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.513 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 65.93 8.29 5.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.275 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.14 82.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.877 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.96 165.86 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 65.4 mtt -71.07 137.27 48.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.085 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.24 141.73 32.85 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.674 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 7.9 Cg_exo -72.26 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.485 2.123 . . . . 0.0 110.426 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.493 HG23 ' HG2' ' A' ' 103' ' ' GLU . 34.9 m -66.29 -22.53 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG2' HG23 ' A' ' 102' ' ' VAL . 9.3 pt-20 -152.91 166.94 30.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.379 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -171.99 21.62 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -109.45 154.56 22.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.922 0.391 . . . . 0.0 111.19 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.94 157.15 23.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 39.1 t -109.8 136.06 46.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.699 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -67.86 132.35 92.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.56 -41.23 45.19 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.912 2.408 . . . . 0.0 113.247 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.9 -4.11 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.361 0.601 . . . . 0.0 110.847 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.96 -19.28 30.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.491 175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.03 122.69 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.995 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.29 -43.43 5.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.69 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 23.8 t80 -126.03 123.97 39.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.427 HG21 ' HA ' ' A' ' 147' ' ' LYS . 13.5 tt -128.0 137.5 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.482 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.08 111.36 22.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.266 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.441 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 6.2 p -133.99 123.22 16.82 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.718 -178.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.416 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 1.4 Cg_endo -84.49 -122.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.997 2.465 . . . . 0.0 111.322 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 118' ' ' PRO . . . 114.88 -178.07 17.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.935 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 10' ' ' VAL . 98.5 t -100.27 125.64 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.574 -0.313 . . . . 0.0 111.387 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 128' ' ' ARG . . . 69.43 121.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.208 0.943 . . . . 0.0 112.73 171.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -128.91 158.23 39.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.539 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.511 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 38.9 p30 -137.94 -174.19 3.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.32 -6.62 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -89.99 -27.26 19.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 110.044 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.7 21.99 6.9 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.193 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.34 151.51 21.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.08 0.467 . . . . 0.0 110.91 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.514 HH22 ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -151.41 151.95 32.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.465 HD12 ' HB1' ' A' ' 121' ' ' ALA . 10.0 mp . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.142 0.496 . . . . 0.0 110.069 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.709 0.29 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.72 -31.68 72.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 110.192 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -67.34 -29.08 68.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.68 -34.29 46.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.44 -24.39 65.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.391 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -96.43 -4.16 42.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -91.87 -28.33 17.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.211 0.529 . . . . 0.0 110.026 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.88 114.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.63 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -92.56 7.25 44.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.73 166.57 54.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.112 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.16 102.58 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.073 0.463 . . . . 0.0 110.104 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 55.9 mtpt -72.19 102.97 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.728 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 65.6 t -97.7 117.65 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.431 . . . . 0.0 110.594 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -88.93 120.32 5.67 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.476 HG11 HG22 ' A' ' 55' ' ' VAL . 19.0 t -99.08 108.2 21.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -139.94 157.68 45.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.329 0.585 . . . . 0.0 112.212 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.38 155.24 17.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.546 ' OG ' ' HG3' ' A' ' 176' ' ' LYS . 3.7 m -52.14 -29.94 24.28 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.363 0.414 . . . . 0.0 111.762 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -68.81 -20.48 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.597 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -99.46 -2.91 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.69 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -104.44 128.44 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.149 0.5 . . . . 0.0 111.514 -173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.65 -165.99 1.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.643 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 43.0 mt-10 -88.67 -62.3 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -143.7 112.14 6.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.124 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.2 mt -102.99 161.52 22.89 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.657 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.69 140.48 74.71 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.35 2.034 . . . . 0.0 111.307 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 162' ' ' ARG . 47.1 mtt180 -76.41 117.72 18.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 165' ' ' TRP . 23.9 t70 -108.94 128.06 54.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 69.1 -14.81 0.29 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.994 0.809 . . . . 0.0 112.237 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.484 ' H ' ' C ' ' A' ' 163' ' ' ASP . 11.3 m-90 58.0 35.17 25.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.96 0.504 . . . . 0.0 111.366 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.514 ' HB3' HH22 ' A' ' 128' ' ' ARG . 14.1 t0 -68.63 153.31 44.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.663 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 13.4 tt -66.55 125.78 91.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.151 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 62.3 Cg_exo -51.54 151.97 13.19 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.302 2.668 . . . . 0.0 112.917 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 28.7 m -70.52 161.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.168 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -89.88 -43.61 10.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.186 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 81.4 t -131.66 132.91 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.05 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.776 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 55.8 tp -114.84 102.3 9.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.825 0.345 . . . . 0.0 110.1 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.59 111.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -113.31 165.7 12.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.6 -177.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -61.77 -30.8 71.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.014 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.546 ' HG3' ' OG ' ' A' ' 153' ' ' SER . 95.1 mttt -82.66 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.52 175.28 10.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.884 0.373 . . . . 0.0 110.535 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.56 114.3 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.649 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.776 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 4.9 tpm_? -93.66 98.97 11.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -75.75 120.09 20.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 169' ' ' VAL . 95.4 mt . . . . . 0 C--N 1.323 -0.573 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.754 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 161' ' ' PRO . 63.4 pttt -73.64 -13.77 61.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.219 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -64.26 -30.04 71.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.205 0.526 . . . . 0.0 110.357 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.18 -39.86 32.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.29 -38.26 83.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.735 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -57.87 -41.84 83.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.789 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.96 -39.16 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -57.83 -50.46 73.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.22 -42.64 91.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.499 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 tp -60.17 -35.5 75.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.131 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -58.28 -63.65 1.19 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.941 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -67.1 -27.04 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.304 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.525 ' NH1' ' HA ' ' A' ' 120' ' ' VAL . 18.4 ttt180 -60.4 -60.75 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.731 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 11' ' ' LEU . 36.2 pt -80.24 9.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.247 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -92.33 -10.64 37.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.459 HD11 ' HG2' ' A' ' 54' ' ' GLU . 87.8 mt -58.19 154.54 12.92 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.717 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . 1.2 m -77.74 160.36 28.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -62.57 -66.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.8 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -31.81 73.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.137 0.494 . . . . 0.0 110.098 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 18' ' ' SER . 39.3 tt0 -58.0 -52.5 65.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.78 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.692 HH12 ' HB2' ' A' ' 56' ' ' ASP . 35.7 ptt85 -70.55 -21.82 62.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.598 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -71.11 -41.77 70.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -72.33 -34.35 67.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.03 -41.87 97.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.3 m -63.82 -37.9 89.1 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.526 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -64.66 -39.75 94.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.9 t -74.12 -44.64 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.536 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.8 -37.05 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.77 0.319 . . . . 0.0 110.371 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 t -64.91 -36.41 84.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.463 . . . . 0.0 109.914 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.11 -49.94 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.349 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -31.78 71.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.763 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.11 -32.63 67.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.2 p -80.85 -17.01 52.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.144 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD22 ' HD2' ' A' ' 37' ' ' PRO . 1.1 tt -55.35 113.03 4.85 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.092 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 36' ' ' LEU . 32.6 Cg_exo -60.31 -39.04 71.02 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.624 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -24.51 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.309 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.54 -27.21 62.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 109.531 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -79.64 -24.11 42.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.572 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -78.17 -46.02 21.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 114' ' ' PHE . 43.4 t -59.85 149.06 32.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.565 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 38.1 tttp -138.17 -21.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.976 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.994 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 32.5 mmtp -96.7 92.48 6.21 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG22 ' HD3' ' A' ' 68' ' ' LYS . 29.2 t -108.17 110.78 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 111.343 -172.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -96.52 119.66 35.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.774 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 70' ' ' LEU . 7.7 mp -104.9 125.86 51.36 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -80.99 3.3 23.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.314 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m 63.16 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.253 0.549 . . . . 0.0 110.754 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 58.9 Cg_endo -73.12 81.98 1.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.456 2.104 . . . . 0.0 113.521 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' HD13 ' A' ' 51' ' ' ILE . 2.0 pp -81.01 127.65 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt 56.8 32.86 22.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.966 0.889 . . . . 0.0 109.556 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -110.04 104.51 1.85 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.638 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 4.5 mp0 -55.51 -30.39 60.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.572 0.349 . . . . 0.0 111.184 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' CZ ' ' A' ' 152' ' ' TYR . 6.8 t -78.16 96.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.692 ' HB2' HH12 ' A' ' 22' ' ' ARG . 4.9 t70 -82.71 110.13 17.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.431 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 93.6 mt -99.43 7.36 45.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -67.46 -41.04 29.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 58' ' ' THR . 31.4 Cg_exo -62.08 -6.02 7.31 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.051 1.834 . . . . 0.0 113.393 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' A' ' 63' ' ' GLU . 25.7 tp -87.53 -10.09 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.39 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 7.7 m-85 -55.7 -52.87 68.62 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.7 Cg_exo -53.48 -34.94 74.29 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.272 1.982 . . . . 0.0 112.801 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG3' HD13 ' A' ' 60' ' ' LEU . 11.5 mm-40 -66.23 -48.56 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.46 -40.39 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.285 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.419 HD21 HD22 ' A' ' 70' ' ' LEU . 97.2 mt -66.95 -11.12 55.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.722 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -77.62 -57.42 3.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.212 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' OE2' ' HG3' ' A' ' 68' ' ' LYS . 1.7 pp20? -134.67 -9.98 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HG3' ' OE2' ' A' ' 67' ' ' GLU . 43.8 mttp -95.88 179.6 5.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.186 0.517 . . . . 0.0 111.079 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 65.9 mm-40 -107.56 113.89 27.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.575 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 85' ' ' VAL . 49.3 tp -83.86 110.24 18.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.101 0.477 . . . . 0.0 109.999 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 56.4 mt -100.87 112.51 33.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.924 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 88.2 mt -108.62 145.0 30.69 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.689 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 7.8 Cg_endo -87.57 118.52 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.203 2.602 . . . . 0.0 112.457 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.693 ' HD2' ' CE2' ' A' ' 83' ' ' TYR . 36.0 tttp -105.49 121.37 43.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.883 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.67 105.19 7.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -15.87 61.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.988 0.423 . . . . 0.0 111.164 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.88 -44.51 0.28 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.86 -34.43 0.47 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.601 -0.299 . . . . 0.0 110.458 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -105.6 168.04 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.0 mt -107.17 133.89 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.522 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 t -119.03 132.35 56.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 90.5 mt -84.84 142.18 29.93 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 121.333 -0.147 . . . . 0.0 110.748 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.693 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 1.5 m-85 -116.75 138.45 51.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.577 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 72.2 ttt180 -100.96 104.89 16.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.218 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 13.4 t -133.07 154.59 39.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -148.41 46.0 1.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.59 0.709 . . . . 0.0 109.878 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -171.53 148.91 2.36 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.132 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.74 -61.84 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.483 2.122 . . . . 0.0 111.624 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.01 -93.48 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.3 m -125.94 27.5 6.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.438 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -78.25 114.22 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -127.42 -159.8 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.527 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.402 HG12 ' HA2' ' A' ' 97' ' ' GLY . 59.0 t -117.15 93.4 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.281 0.562 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -96.1 2.42 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.731 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -68.09 122.37 18.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 74.19 -44.6 0.57 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.648 0.779 . . . . 0.0 112.496 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 93' ' ' VAL . . . 131.23 6.69 3.41 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.113 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.4 pt -84.01 173.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.86 99.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.731 ' HG3' ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -110.35 111.89 57.37 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.86 -172.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.26 106.22 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.694 2.262 . . . . 0.0 111.858 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.3 -40.67 89.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -127.1 -177.65 4.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.467 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -177.65 16.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.837 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 1.5 mm-40 -115.88 154.27 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 111.225 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 12.8 mtm180 -86.58 159.32 19.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.784 -167.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 48.6 t -122.73 126.09 73.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.853 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -84.55 151.52 58.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.997 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 112' ' ' VAL . 52.7 Cg_exo -56.13 -20.06 29.44 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.986 2.457 . . . . 0.0 113.065 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -76.62 -9.44 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.088 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -111.11 2.73 18.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.53 . . . . 0.0 110.38 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 109' ' ' PRO . 86.5 t -74.14 106.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.249 0.547 . . . . 0.0 110.905 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.994 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 5.1 t0 -86.47 -54.04 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.468 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 148' ' ' VAL . 37.2 t80 -132.19 132.99 43.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.09 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -133.78 138.97 49.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.834 0.349 . . . . 0.0 110.419 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.54 111.56 19.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.302 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.55 117.35 29.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.402 0.62 . . . . 0.0 110.945 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.419 ' HG3' ' HB3' ' A' ' 50' ' ' PRO . 94.2 Cg_endo -86.89 73.94 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.872 2.381 . . . . 0.0 112.359 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.28 159.92 36.53 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.486 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.525 ' HA ' ' NH1' ' A' ' 14' ' ' ARG . 99.3 t -66.87 -50.1 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.494 0.188 . . . . 0.0 111.361 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.86 24.31 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.894 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -132.16 170.33 15.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.68 -177.02 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.536 0.208 . . . . 0.0 110.463 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.3 mt -83.2 8.72 12.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -109.38 -28.69 8.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 122.11 13.42 4.92 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.843 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -94.12 161.72 14.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.443 0.64 . . . . 0.0 111.999 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.538 ' HD3' ' OD1' ' A' ' 166' ' ' ASP . 2.1 ptm180 -101.96 147.75 26.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.27 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' A' ' 160' ' ' LEU . 53.2 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.907 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.241 0.614 0 CA-C-O 121.88 0.848 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.801 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 7.1 p-10 -74.92 7.06 3.44 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.677 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.63 -44.18 82.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 165.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.461 ' O ' HG21 ' A' ' 143' ' ' VAL . 9.9 tt -71.86 -43.77 64.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.974 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.801 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 55.7 mt -58.03 -41.06 82.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.835 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 111.384 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HD3' ' HG2' ' A' ' 109' ' ' PRO . 77.5 ttt180 -95.46 -12.48 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.941 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 139' ' ' LEU . 94.6 t -62.88 98.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.315 0.579 . . . . 0.0 110.232 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -95.11 14.1 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.69 0.757 . . . . 0.0 109.855 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.51 -166.26 30.93 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.885 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 171' ' ' VAL . 35.9 tp -78.69 112.89 16.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 110.947 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.86 ' HD3' HD11 ' A' ' 167' ' ' ILE . 16.0 mttp -93.86 114.24 26.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.516 HG21 ' HB ' ' A' ' 171' ' ' VAL . 74.7 t -109.99 115.76 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.205 0.526 . . . . 0.0 110.887 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.53 130.23 10.02 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 55' ' ' VAL . 21.9 t -115.66 109.76 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -161.6 170.86 19.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.681 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 48.0 m-85 -90.26 171.24 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 64.0 m -62.21 -28.74 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.348 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -86.39 10.87 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.104 0.478 . . . . 0.0 111.561 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -105.07 -7.56 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 167.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.34 116.72 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.395 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -105.88 -179.31 3.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.812 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 54.3 mt-10 -76.48 -46.84 25.04 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.122 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -150.63 144.25 25.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.361 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 129' ' ' LEU . 98.1 mt -128.9 147.13 63.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.362 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.527 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 31.2 Cg_exo -60.39 114.75 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.663 2.242 . . . . 0.0 111.82 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 80.3 mtt180 -104.14 147.12 27.8 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.77 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.25 -69.15 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.69 -85.45 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.64 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -120.31 74.29 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.432 0.634 . . . . 0.0 109.511 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.538 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 2.5 t70 -89.37 -174.07 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.729 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.86 HD11 ' HD3' ' A' ' 147' ' ' LYS . 4.1 tt -94.77 125.86 49.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 121.075 0.464 . . . . 0.0 111.801 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 98.0 Cg_endo -93.93 158.54 2.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.336 2.691 . . . . 0.0 111.96 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.45 147.9 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.82 -42.97 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.382 0.611 . . . . 0.0 110.059 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.553 HG21 HD13 ' A' ' 146' ' ' LEU . 98.5 t -125.21 133.69 68.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.209 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 41.4 tp -122.24 105.0 9.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.537 HG21 HG12 ' A' ' 178' ' ' VAL . 46.8 t -91.25 127.94 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 41.0 p -110.5 -166.24 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.53 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.681 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -84.32 -14.5 49.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -92.2 -59.91 1.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.916 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -155.52 170.57 21.66 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.147 0.498 . . . . 0.0 111.957 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 173' ' ' VAL . 97.1 t -83.98 106.69 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.477 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -98.99 93.28 5.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.857 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -72.4 106.66 4.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 C--N 1.324 -0.51 0 O-C-N 123.782 0.676 . . . . 0.0 112.569 -165.953 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.18 -25.31 65.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -75.73 -23.25 56.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.246 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 5.4 mm-40 -77.31 -35.02 55.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 10' ' ' VAL . 48.6 tp -77.66 -29.98 51.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.663 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.8 ttm-85 -53.26 -49.56 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 55.0 pttt -68.93 -31.44 70.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.832 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.21 -43.51 70.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.6 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 6' ' ' LEU . 39.1 t -70.19 -39.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.34 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.649 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -71.87 -38.57 70.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.263 0.554 . . . . 0.0 110.778 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -60.84 -41.96 96.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.868 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.1 pt -90.68 1.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.677 0.275 . . . . 0.0 111.501 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.59 -26.88 31.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.978 0.418 . . . . 0.0 110.804 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.13 143.67 57.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.788 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -85.96 -176.74 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.22 -52.13 65.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.348 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -52.31 -51.37 59.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.797 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.96 -58.23 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.62 0.248 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -57.43 -50.17 73.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.9 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -62.39 -40.6 97.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.972 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -71.05 -44.61 65.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.903 0.382 . . . . 0.0 110.915 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' O ' HG21 ' A' ' 29' ' ' VAL . 96.2 mt -65.01 -42.44 94.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.819 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -63.2 -39.31 94.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.525 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.29 -43.73 92.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.026 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -55.86 -51.34 67.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.731 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 25' ' ' LEU . 52.0 t -62.86 -42.76 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.389 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 56' ' ' ASP . 79.8 mt -62.51 -50.28 80.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.5 t -59.46 -45.18 92.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -63.4 -41.37 98.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.763 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 35.9 tp -63.33 -42.27 98.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.505 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -73.59 -21.1 60.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.7 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -74.35 -27.34 60.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.312 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.51 HD12 HD13 ' A' ' 33' ' ' LEU . 89.2 mt -57.63 132.49 82.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.778 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.4 -24.04 77.82 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.32 2.014 . . . . 0.0 110.64 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -63.99 -30.05 71.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.862 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.12 -38.32 82.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.012 0.434 . . . . 0.0 110.506 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -70.48 -26.43 63.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 109.759 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -84.34 -13.36 52.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 m -65.47 121.47 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -106.92 -54.87 2.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.862 0.839 . . . . 0.0 109.086 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.598 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 47.8 mmtt -105.06 99.74 9.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.237 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.58 108.82 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.059 0.456 . . . . 0.0 110.679 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.28 138.38 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.097 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.11 144.06 47.82 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.658 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 24.0 t80 -82.35 -4.16 56.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.9 m 62.1 92.8 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.728 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.4 133.98 27.6 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.339 2.026 . . . . 0.0 111.749 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.501 ' HB ' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -121.19 -35.49 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 0.0 110.083 -177.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.43 41.59 1.11 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.524 -177.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.41 -90.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 54.85 38.23 29.93 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.845 0.379 . . . . 0.0 111.849 168.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.7 t 73.17 119.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.35 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' O ' HD11 ' A' ' 30' ' ' ILE . 11.1 m-20 -69.07 83.25 0.33 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.273 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 99.1 mt -89.83 -4.63 57.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.839 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -46.88 94.92 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.074 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.71 -3.37 7.9 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.115 1.876 . . . . 0.0 112.951 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 63' ' ' GLU . 23.0 tp -93.23 -9.84 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.388 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.473 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 3.1 m-85 -54.28 -54.04 52.45 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.645 177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.4 Cg_endo -56.19 -39.97 87.85 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.362 2.041 . . . . 0.0 112.374 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' HG3' HD13 ' A' ' 60' ' ' LEU . 7.7 mm-40 -58.47 -42.39 87.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.065 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.82 -46.86 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.18 -24.55 64.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.877 0.37 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -38.5 78.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.093 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.87 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 7.2 pt-20 -138.27 -46.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.87 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 49.6 mttm -96.6 -173.32 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.995 0.426 . . . . 0.0 111.008 -170.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.578 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 39.2 mt-10 -100.14 128.32 46.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.7 tp -100.88 110.83 22.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.22 119.86 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.292 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.834 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 93.7 mt -122.49 145.6 45.18 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' CB ' HD11 ' A' ' 80' ' ' ILE . 72.7 Cg_endo -91.58 127.24 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.045 2.497 . . . . 0.0 113.688 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.769 ' HD3' ' HE2' ' A' ' 83' ' ' TYR . 34.8 tttm -105.98 126.08 51.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.18 128.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.698 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -139.14 100.4 4.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.886 0.374 . . . . 0.0 110.128 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.09 -106.17 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.764 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -124.8 21.3 8.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.426 0.631 . . . . 0.0 109.603 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.75 152.96 35.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 139' ' ' LEU . 16.8 tt -128.02 128.0 68.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.422 0.63 . . . . 0.0 110.773 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -104.11 108.61 20.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.704 HD13 HD11 ' A' ' 139' ' ' LEU . 97.0 mt -85.35 101.1 12.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.769 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 77.2 m-85 -96.17 130.82 43.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.286 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.578 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 20.1 ptt180 -92.59 130.17 38.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.15 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.433 -171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -135.17 14.31 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.336 0.588 . . . . 0.0 109.638 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.0 m -135.09 125.42 17.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.21 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.2 Cg_exo -61.87 -31.56 85.04 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 122.915 2.41 . . . . 0.0 113.423 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.66 -2.25 19.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.72 4.2 51.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.903 0.382 . . . . 0.0 110.663 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.7 mt -104.52 149.06 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.705 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.22 -142.2 6.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 133.06 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -127.27 -98.17 1.0 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.0 114.387 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.32 -2.85 21.82 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -166.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -122.93 -44.56 2.18 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.12 24.82 3.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.879 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.95 173.24 7.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 tpt -69.81 88.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.05 161.63 39.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.295 -172.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.834 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -76.13 125.5 8.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.507 2.138 . . . . 0.0 112.097 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.94 -41.76 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.011 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.99 173.85 11.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.87 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.09 -164.42 25.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.896 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -110.76 122.04 46.82 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.752 -0.264 . . . . 0.0 110.849 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.5 ptm180 -84.31 125.99 32.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.72 164.28 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.74 153.02 87.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.88 -11.56 24.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.975 2.45 . . . . 0.0 113.314 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -71.03 -20.44 62.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.494 . . . . 0.0 110.455 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.402 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 17.9 t70 -79.33 -16.44 56.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.459 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.67 124.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.299 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.598 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 19.0 t70 -99.2 -48.41 4.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.508 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.763 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 32.1 t80 -136.9 119.94 16.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -126.15 138.87 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.027 0.442 . . . . 0.0 110.962 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.4 111.4 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.202 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.81 105.8 54.27 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.922 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 48' ' ' TYR . 16.5 Cg_exo -68.59 119.32 6.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.489 2.126 . . . . 0.0 110.941 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.53 153.92 19.67 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.688 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.663 HG13 ' HG2' ' A' ' 7' ' ' ARG . 84.1 t -58.77 -49.26 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.188 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.88 36.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.584 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.25 151.84 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 5.0 p-10 -108.36 -163.72 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 97.7 mt -75.69 -19.52 59.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.81 -31.16 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.453 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . 119.39 35.06 0.96 Allowed Glycine 0 C--O 1.236 0.277 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.529 170.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.96 147.08 35.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.008 0.404 . . . . 0.0 110.16 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.584 ' HB3' ' OD2' ' A' ' 166' ' ' ASP . 25.4 ttp180 -86.78 -12.71 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.083 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.818 ' HB2' HD12 ' A' ' 160' ' ' LEU . 62.0 tp . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.552 0.741 . . . . 0.0 111.034 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 120.96 0.41 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.33 -29.81 57.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.46 -25.96 67.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.659 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.704 HD11 HD13 ' A' ' 82' ' ' LEU . 34.3 tp -78.43 -58.17 3.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.388 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.83 -30.99 69.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.233 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.57 -23.54 53.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.6 -6.06 44.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 139' ' ' LEU . 97.4 t -80.73 104.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.02 7.3 44.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.62 -168.5 44.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.987 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.69 104.01 15.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.491 ' HZ3' ' HB2' ' A' ' 147' ' ' LYS . 9.9 mtmp? -86.24 102.74 14.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.163 0.506 . . . . 0.0 110.22 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.4 116.86 43.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.641 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.99 121.72 5.56 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.33 120.3 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.87 169.81 21.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 111.597 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 155' ' ' GLN . 41.4 m-85 -86.3 168.86 13.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -77.15 -19.84 56.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 109.548 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -69.01 -10.2 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.487 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' A' ' 152' ' ' TYR . 59.9 mm-40 -111.29 10.26 21.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.625 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.74 131.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.15 -168.73 1.81 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.595 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 34.1 mt-10 -80.02 -59.27 2.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 109.971 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.5 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.4 mmt85 -147.2 144.94 29.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.709 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.818 HD12 ' HB2' ' A' ' 129' ' ' LEU . 68.6 mt -101.92 137.19 19.45 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 12.0 Cg_exo -70.88 101.92 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.636 2.224 . . . . 0.0 111.075 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 0.5 OUTLIER -130.67 178.33 6.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.211 -174.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -73.45 -67.2 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.4 ' HA ' HH11 ' A' ' 162' ' ' ARG . . . -151.41 -89.28 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.005 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -116.7 78.12 1.17 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.024 0.44 . . . . 0.0 110.836 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.584 ' OD2' ' HB3' ' A' ' 128' ' ' ARG . 34.9 t70 -70.08 134.66 48.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 62.8 mt -55.97 114.79 8.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 112.057 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.76 175.95 7.38 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.272 2.648 . . . . 0.0 112.851 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.12 160.56 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 14.0 m-20 -87.89 -35.14 17.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.239 0.542 . . . . 0.0 109.924 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.4 t -133.26 143.44 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.483 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.614 ' HB2' HD13 ' A' ' 181' ' ' LEU . 56.7 tp -115.64 117.61 30.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.71 116.2 51.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.013 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 70.9 p -109.92 -167.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.747 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.529 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 10.4 pt-20 -68.19 -17.42 64.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.199 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.529 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 9.8 mtmp? -128.71 -66.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -109.41 152.63 25.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.282 0.563 . . . . 0.0 112.077 -171.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 36' ' ' LEU . 61.2 t -118.64 133.87 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.904 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -129.49 146.34 51.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.994 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -89.57 117.06 28.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 172' ' ' LEU . 70.5 mt . . . . . 0 C--N 1.321 -0.673 0 CA-C-O 121.175 0.512 . . . . 0.0 110.869 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -76.5 -10.03 59.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -97.36 -48.33 5.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.181 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.51 -36.36 83.95 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.136 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -53.46 -41.01 65.73 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.386 0.429 . . . . 0.0 111.133 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -65.65 -35.17 80.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.168 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.35 -34.91 17.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -60.17 -52.4 65.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.054 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 98.0 t -62.3 -46.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.482 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 tp -59.77 -42.8 94.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.667 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -61.02 -44.13 97.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.899 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -71.73 -31.18 66.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.241 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 80.0 mtp180 -64.0 -53.6 47.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.715 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' LEU . 26.4 pt -78.44 8.57 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.005 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -94.98 -9.04 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.478 0.656 . . . . 0.0 109.523 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 ' HG2' ' A' ' 54' ' ' GLU . 92.8 mt -68.92 141.06 55.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.504 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -69.4 153.29 43.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 111.251 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 9.4 tp10 -56.64 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.768 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.57 -44.07 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.276 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 7.3 tp10 -61.18 -39.71 91.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 42.0 ttt180 -55.1 -47.96 74.24 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.577 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.3 mmt180 -62.56 -32.23 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.78 -29.78 68.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.382 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 59.0 mt -79.34 -40.43 30.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.263 0.554 . . . . 0.0 110.31 176.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 19.9 m -59.6 -40.02 86.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.906 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.78 -32.07 73.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.439 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.64 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 91.0 mttt -60.24 -53.98 51.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.86 -43.1 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.557 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.28 -46.46 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.979 0.419 . . . . 0.0 110.508 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 t -65.38 -42.81 92.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.938 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -70.02 -43.33 71.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.595 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.566 HD12 HD13 ' A' ' 36' ' ' LEU . 28.0 tp -66.89 -34.67 78.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -86.31 -3.37 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.15 0.5 . . . . 0.0 110.625 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.53 -28.12 31.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 33' ' ' LEU . 70.2 mt -61.45 123.77 77.94 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.141 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.46 -20.5 41.71 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.485 2.123 . . . . 0.0 112.162 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.28 -22.08 55.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.778 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -72.18 -14.99 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.08 -33.5 14.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.249 177.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.71 -38.23 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.612 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 p -61.89 152.0 33.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.612 ' HD2' ' O ' ' A' ' 42' ' ' SER . 12.8 mptt -132.71 -25.75 1.85 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.848 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 3.3 mptp? -103.9 95.52 6.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 60.9 t -111.4 118.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 111.169 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.17 124.34 49.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.204 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.55 123.68 48.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.96 -7.54 49.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.921 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.4 m 70.93 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 123.326 0.65 . . . . 0.0 111.964 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.37 95.48 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.952 2.435 . . . . 0.0 112.132 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 52' ' ' LYS . 27.2 pt -78.39 -40.21 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.097 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 51' ' ' ILE . 94.7 mttt -129.28 103.13 6.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.74 172.6 35.73 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.578 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.62 ' HG2' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -93.9 -10.3 34.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.923 0.392 . . . . 0.0 110.29 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.571 HG12 ' HG ' ' A' ' 57' ' ' LEU . 57.4 t -75.13 109.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 8.0 m-20 -90.54 84.09 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.512 . . . . 0.0 111.854 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.571 ' HG ' HG12 ' A' ' 55' ' ' VAL . 94.0 mt -96.18 -10.7 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.533 0.682 . . . . 0.0 109.248 171.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.464 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 5.6 m -61.17 -49.62 87.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.121 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 58' ' ' THR . 49.2 Cg_endo -69.22 2.27 3.37 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.01 1.807 . . . . 0.0 113.501 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' HG21 ' A' ' 64' ' ' VAL . 21.2 tp -94.84 -8.17 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.048 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.529 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 19.9 m-85 -53.98 -51.53 76.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 12.2 Cg_endo -56.34 -36.17 96.82 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.553 2.168 . . . . 0.0 112.515 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.604 ' HA ' ' NZ ' ' A' ' 66' ' ' LYS . 51.8 tp10 -71.58 -41.78 68.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 60' ' ' LEU . 77.0 t -57.97 -43.37 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.53 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.09 -1.52 7.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.604 ' NZ ' ' HA ' ' A' ' 63' ' ' GLU . 54.4 mttp -88.93 -26.39 21.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' HZ1' ' A' ' 68' ' ' LYS . 19.1 mt-10 -112.0 -50.66 2.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.112 -170.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 27.6 mtmm -131.83 -174.31 3.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.921 -168.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -96.84 142.48 28.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.52 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.97 109.4 21.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.24 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.56 118.22 44.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.102 0.477 . . . . 0.0 110.057 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.83 145.81 34.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.063 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' CB ' HD11 ' A' ' 80' ' ' ILE . 87.5 Cg_endo -89.34 120.33 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.183 2.589 . . . . 0.0 113.118 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.803 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 tttt -106.18 117.18 33.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.506 HG13 ' HE2' ' A' ' 96' ' ' PHE . 58.7 t -85.36 109.18 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -131.27 98.94 4.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.726 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 79' ' ' GLU . . . 81.39 36.81 19.46 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m120 71.15 -36.11 0.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 112.181 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' A' ' 77' ' ' GLY . 30.6 tt0 -73.87 143.52 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.49 HD11 ' CB ' ' A' ' 73' ' ' PRO . 15.5 tt -98.94 132.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.181 0.515 . . . . 0.0 111.426 -173.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.9 t -120.9 124.19 44.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.377 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 73' ' ' PRO . 77.5 mt -87.13 130.23 34.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.069 0.461 . . . . 0.0 110.85 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.646 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 9.8 m-85 -106.91 126.26 52.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.616 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HG2' ' HD2' ' A' ' 86' ' ' HIS . 71.3 ttt180 -85.45 92.67 8.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.424 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.77 111.59 23.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.537 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HD2' ' HG2' ' A' ' 84' ' ' ARG . 4.8 p80 -120.58 20.13 11.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.497 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 p -162.15 122.23 1.49 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.035 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.96 41.57 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.029 2.486 . . . . 0.0 112.97 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.74 -36.53 15.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.767 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.9 m -131.17 102.79 6.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.459 . . . . 0.0 111.428 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.0 mt -140.97 153.4 45.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.852 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.59 160.61 30.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.974 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.59 112.91 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.23 -154.96 6.63 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.357 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.32 -127.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.567 0.347 . . . . 0.0 110.701 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.506 ' HE2' HG13 ' A' ' 75' ' ' VAL . 88.4 m-85 -85.39 17.64 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.828 0.347 . . . . 0.0 110.812 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 46.8 2.73 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.74 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.0 pt -124.27 170.31 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.823 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.54 93.31 7.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.063 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.803 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 4.3 pt-20 -104.83 109.86 63.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.646 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 31.7 Cg_exo -59.63 127.41 23.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.377 2.051 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.43 -56.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.717 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.57 -176.79 4.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.53 -159.84 22.95 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.387 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -96.45 96.85 8.98 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -77.91 120.45 22.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.66 147.72 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.206 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.8 t-20 -58.58 138.91 85.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.463 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 108' ' ' ASN . 53.7 Cg_exo -53.92 -16.22 8.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.573 2.849 . . . . 0.0 114.271 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.443 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 42.7 tt0 -61.61 -28.18 69.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.397 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.34 -28.99 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 111.145 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' A' ' 44' ' ' LYS . 40.5 t -65.41 121.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.33 -20.77 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.603 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 32.6 t80 -135.96 114.34 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 143' ' ' VAL . 16.2 tt -121.28 139.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.15 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.91 106.48 17.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.259 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.35 123.48 34.95 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.773 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -92.84 -163.42 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.01 2.473 . . . . 0.0 112.004 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.73 -176.68 44.14 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.6 -41.46 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 117.046 0.423 . . . . 0.0 110.749 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.68 161.51 38.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.337 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.44 158.59 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.564 0.54 . . . . 0.0 109.781 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.518 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 9.3 p30 -120.34 -172.1 2.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.349 . . . . 0.0 110.678 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.5 mt -98.83 7.69 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.465 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -103.38 -30.3 10.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 133.9 -4.09 4.61 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.226 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -88.86 163.38 15.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.24 0.543 . . . . 0.0 111.215 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' A' ' 128' ' ' ARG . 7.6 mtm-85 -126.15 157.02 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.278 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.141 0.496 . . . . 0.0 110.546 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.56 -33.34 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -70.27 -8.42 50.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.45 HD23 HD12 ' A' ' 80' ' ' ILE . 21.2 tp -93.58 -72.27 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.401 ' HA ' HG23 ' A' ' 143' ' ' VAL . 95.5 mt -66.36 -17.7 64.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.313 -171.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.692 ' HG3' ' HB ' ' A' ' 167' ' ' ILE . 83.8 tttt -92.95 -12.1 31.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.671 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -121.33 0.95 10.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.323 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 115' ' ' ILE . 92.8 t -50.35 121.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.0 111.06 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 58.1 mtpt -87.82 -11.38 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.099 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.45 176.82 51.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.208 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.29 110.72 3.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.833 0.349 . . . . 0.0 110.686 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.417 ' HD3' ' HB ' ' A' ' 143' ' ' VAL . 11.6 mmmm -72.47 100.11 2.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.815 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.59 124.92 59.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.359 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -102.08 129.48 9.91 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.19 121.25 66.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.935 0.367 . . . . 0.0 110.84 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.27 165.51 31.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.264 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.578 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 47.8 m-85 -92.2 -178.79 5.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 t -68.47 -22.31 64.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.185 0.516 . . . . 0.0 109.973 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -72.75 -18.04 61.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.164 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.475 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.6 mp0 -95.64 -7.44 37.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.322 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.25 116.61 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.068 0.461 . . . . 0.0 111.701 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.55 174.35 6.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.372 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 26.8 mm-40 -74.26 -60.29 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 110.54 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.416 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 34.8 ttt180 -145.97 129.2 16.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 84.7 mt -93.62 160.7 32.31 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.194 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.59 101.64 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.221 . . . . 0.0 111.614 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -80.07 148.26 31.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.204 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 18.0 p-10 -77.1 -60.92 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.425 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . 169.54 -39.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.137 0.975 . . . . 0.0 109.711 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.47 ' O ' ' HE3' ' A' ' 141' ' ' LYS . 8.3 m-90 -136.13 21.83 3.24 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.06 149.75 18.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.896 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.692 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 6.6 tp -93.79 113.56 60.77 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.227 -175.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.678 ' HD2' HD12 ' A' ' 167' ' ' ILE . 57.6 Cg_endo -71.53 174.74 10.5 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.463 2.109 . . . . 0.0 112.853 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.78 157.94 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.961 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -91.91 -42.6 9.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.9 122.21 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.4 tp -106.35 108.0 19.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.056 0.455 . . . . 0.0 109.874 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.16 118.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.064 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 79.7 p -114.36 -178.93 3.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.64 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 14.9 pt-20 -71.61 -15.26 62.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.575 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 99.8 mttt -105.7 -60.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.544 -174.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.17 172.57 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 111.498 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.562 HG21 HD21 ' A' ' 36' ' ' LEU . 23.6 t -115.09 98.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.545 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -94.49 117.79 30.67 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.561 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.01 111.25 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.155 174.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' A' ' 126' ' ' GLY . 64.5 mt . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.3 0.571 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -69.23 -34.9 75.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.536 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -70.84 -44.48 66.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.4 -36.83 79.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.686 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.62 -50.85 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.297 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -62.29 -42.24 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.543 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.36 -33.74 75.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.653 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 29.6 ttmt -81.78 -46.03 14.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.312 -176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.22 -35.79 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.302 0.573 . . . . 0.0 110.365 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.7 tp -59.31 -37.13 76.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.938 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -58.6 -41.79 86.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.056 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -74.69 -40.67 61.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.523 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.621 HH11 ' HA ' ' A' ' 120' ' ' VAL . 15.7 ptm180 -70.4 -37.47 74.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.346 -175.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 11' ' ' LEU . 33.4 pt -82.83 -0.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.822 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -81.45 -24.88 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.61 137.34 57.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.591 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 t -122.7 -166.59 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.823 -175.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -66.53 -4.59 8.81 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.9 -65.03 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.033 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 10.2 tp10 -76.47 -42.06 45.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.684 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 34.2 ttp85 -66.95 -26.47 66.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 -175.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 54.1 ttt85 -58.97 -49.15 78.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -79.71 -25.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 68.3 mt -63.63 -56.04 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.743 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 50.4 m -67.7 -32.99 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.028 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -58.94 -47.59 84.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 109.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.63 ' HE2' ' HB2' ' A' ' 175' ' ' GLU . 49.6 mtpt -59.44 -39.57 84.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.025 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 175' ' ' GLU . 94.8 t -63.38 -50.31 79.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.716 0.293 . . . . 0.0 110.624 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 74.7 mt -58.86 -49.92 81.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.1 m -64.17 -36.95 85.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.718 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.7 -44.94 80.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.125 0.488 . . . . 0.0 109.978 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.5 tp -62.66 -39.43 93.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.746 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.94 -14.12 60.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.249 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -84.54 -19.63 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 110.088 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.55 114.3 18.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -56.4 -32.71 89.79 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.291 2.661 . . . . 0.0 113.829 -171.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 114' ' ' PHE . 6.3 tp10 -72.45 -23.86 61.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.604 0.24 . . . . 0.0 111.056 -175.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.1 -41.77 94.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.007 0.432 . . . . 0.0 110.552 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -85.67 -10.29 55.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.757 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -95.89 -9.7 30.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 -179.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -101.94 -176.77 3.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -136.0 -55.03 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 30.5 mtpt -89.07 101.99 14.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 111.194 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.89 119.78 62.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.57 131.67 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.392 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.95 138.67 50.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.74 -1.73 36.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.513 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.4 t 73.83 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.387 0 C-N-CA 123.47 0.708 . . . . 0.0 111.587 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.39 49.77 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.097 2.531 . . . . 0.0 112.259 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.789 HG13 ' H ' ' A' ' 52' ' ' LYS . 14.1 pt -56.46 -62.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.895 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.789 ' H ' HG13 ' A' ' 51' ' ' ILE . 94.4 mttt -122.29 9.29 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.719 0.771 . . . . 0.0 110.044 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.26 128.37 9.08 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -84.17 10.55 9.98 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -169.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.662 HG11 ' HG ' ' A' ' 57' ' ' LEU . 92.3 t -63.61 104.43 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.75 77.82 5.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.463 0.649 . . . . 0.0 111.145 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.662 ' HG ' HG11 ' A' ' 55' ' ' VAL . 96.6 mt -94.03 -2.08 53.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.178 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.481 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -56.65 -44.82 99.91 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.422 -178.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.8 Cg_endo -69.74 1.44 4.42 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.22 1.947 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.01 -18.36 24.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.294 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.83 -44.35 97.93 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 95.2 Cg_exo -45.49 -39.26 16.94 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.328 2.019 . . . . 0.0 113.244 174.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -77.68 -44.76 26.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.25 -42.84 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.413 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.48 -4.13 17.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 95.5 mttt -98.4 -59.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 6.4 pt-20 -105.45 -17.62 14.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.63 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.52 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 45.4 mmtm -111.76 168.51 9.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.455 0.645 . . . . 0.0 111.666 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.779 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.4 mm-40 -102.12 103.16 13.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.984 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.58 100.54 6.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 58.2 mt -91.86 114.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.5 mt -114.79 141.81 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.728 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.6 Cg_exo -80.11 129.19 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.868 2.379 . . . . 0.0 112.071 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.703 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 36.3 tttm -105.54 100.39 9.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.579 HG23 HG22 ' A' ' 80' ' ' ILE . 35.1 t -69.73 98.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -146.92 134.58 21.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.274 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 -92.1 0.47 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.651 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.24 10.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.979 0.419 . . . . 0.0 109.954 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -125.96 154.04 43.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.911 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.658 HG13 HD13 ' A' ' 139' ' ' LEU . 6.2 pt -96.62 92.46 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 166.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.1 t -80.52 110.85 16.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.846 -170.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.97 121.98 22.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.726 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.493 ' HB2' ' CG ' ' A' ' 101' ' ' PRO . 97.1 m-85 -121.85 148.94 44.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.006 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -88.45 134.92 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.09 126.86 68.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.848 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -124.05 -1.23 8.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.229 0.538 . . . . 0.0 110.004 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -153.97 151.11 24.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 90' ' ' CYS . 52.1 Cg_endo -69.38 -174.46 0.84 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.946 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.0 -36.09 0.35 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.193 0.597 . . . . 0.0 111.884 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.407 ' H ' ' C ' ' A' ' 88' ' ' PRO . 60.7 m -69.94 -3.46 16.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.501 0.667 . . . . 0.0 111.238 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.27 123.68 39.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.28 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.02 135.78 9.56 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.708 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.0 t -82.92 94.37 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.63 -24.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.385 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.408 ' HB3' ' CG1' ' A' ' 98' ' ' ILE . . . -85.19 -156.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 0.0 111.328 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.59 55.98 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.156 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.14 16.48 43.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.037 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 36.2 pt -120.27 165.29 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.85 90.47 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.021 0.438 . . . . 0.0 110.607 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.703 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -88.98 147.54 38.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.514 -177.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.493 ' CG ' ' HB2' ' A' ' 83' ' ' TYR . 18.3 Cg_endo -61.19 114.46 2.21 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.745 2.297 . . . . 0.0 112.092 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -91.07 -52.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.317 0.58 . . . . 0.0 109.876 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -97.54 87.18 4.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.152 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.54 170.69 35.83 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.198 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.48 137.04 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.764 0.282 . . . . 0.0 110.936 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -77.88 133.54 38.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.753 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.89 135.88 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.737 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -87.02 146.73 41.2 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.566 ' HB3' ' HA ' ' A' ' 143' ' ' VAL . 50.9 Cg_exo -55.39 -25.05 46.16 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.06 2.507 . . . . 0.0 113.371 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG3' ' HD2' ' A' ' 144' ' ' LYS . 43.2 tt0 -72.87 -20.33 61.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.165 0.507 . . . . 0.0 110.962 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -100.23 7.13 44.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.18 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.43 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 60.0 t -94.32 111.88 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.06 -54.22 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.406 ' HZ ' ' HB3' ' A' ' 38' ' ' GLU . 8.5 m-85 -124.67 139.34 53.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.603 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 147' ' ' LYS . 4.5 tp -134.22 108.24 10.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.435 0.636 . . . . 0.0 109.561 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.79 112.07 24.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.948 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.11 113.86 51.58 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 150' ' ' VAL . 3.8 Cg_exo -76.52 91.72 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.801 2.334 . . . . 0.0 111.341 175.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.98 158.27 48.03 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.896 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.621 ' HA ' HH11 ' A' ' 14' ' ' ARG . 57.5 t -74.7 -39.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 110.013 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.485 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -147.76 155.93 42.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.898 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -135.21 153.19 52.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.425 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 15.3 t70 -78.62 164.72 24.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.268 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.876 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 13.3 mt -55.44 -32.46 62.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.432 ' O ' HD11 ' A' ' 181' ' ' LEU . 46.6 mt-10 -87.53 -64.57 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.563 ' HA2' HD22 ' A' ' 172' ' ' LEU . . . 165.11 53.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.85 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' A' ' 123' ' ' ASP . 51.2 m-85 -99.46 161.15 13.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.27 155.6 17.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 112.451 -167.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.619 ' HB2' HD13 ' A' ' 160' ' ' LEU . 40.7 tp . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.381 168.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.4 -35.99 60.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.045 0.538 . . . . 0.0 111.813 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -60.47 -33.4 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.052 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.658 HD13 HG13 ' A' ' 80' ' ' ILE . 9.1 tt -83.43 -44.26 14.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.43 -18.11 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.775 0.322 . . . . 0.0 111.325 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.746 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 4.2 ttmp? -89.16 -15.5 33.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.065 0.46 . . . . 0.0 109.883 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.59 -21.82 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 60.7 t -63.58 127.73 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.163 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 110' ' ' GLU . 96.9 mttt -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 112' ' ' VAL . . . -79.63 -170.93 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.123 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.41 110.98 16.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.982 0.42 . . . . 0.0 109.95 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 115' ' ' ILE . 95.7 mttt -86.47 109.38 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 63.0 t -106.34 122.25 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.82 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.34 119.66 6.01 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 47.7 t -105.95 117.96 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.69 0.281 . . . . 0.0 110.982 -175.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.35 -178.08 6.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.894 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 35.0 m-85 -106.53 165.63 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -56.48 -30.44 62.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.21 -32.32 72.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.076 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.89 -7.97 50.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.77 117.88 33.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.965 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.63 174.48 5.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.876 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 45.9 mt-10 -69.69 -57.58 4.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 111.267 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.6 ttm105 -144.77 118.58 9.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 -169.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 129' ' ' LEU . 74.8 mt -98.53 141.19 22.51 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.698 0.285 . . . . 0.0 111.452 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.18 113.19 3.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.814 2.343 . . . . 0.0 111.666 174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -98.42 149.37 22.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.62 -75.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.235 -172.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -149.25 -76.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -100.05 69.05 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 109.393 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.04 149.63 37.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.329 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 65.9 mt -110.87 107.41 57.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.835 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.56 154.59 31.25 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.824 2.349 . . . . 0.0 111.214 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 m -88.39 158.96 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.343 -0.39 . . . . 0.0 109.992 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.57 -42.46 12.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.518 0.675 . . . . 0.0 109.502 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 75.7 t -126.35 116.48 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.496 176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 35.2 tp -99.87 103.65 15.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.911 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.05 125.87 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.128 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 54.0 p -107.83 -166.74 1.17 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.403 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.63 ' HB2' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.54 9.51 36.41 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.697 174.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -125.79 -55.21 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.556 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.12 160.03 39.91 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 111.505 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.2 113.98 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.96 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -92.49 93.66 8.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.728 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -86.18 121.24 28.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.642 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 125' ' ' GLU . 39.5 mt . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.477 ' HG ' ' H ' ' A' ' 4' ' ' SER . 50.0 tp . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -28.02 66.36 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.565 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.477 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 12.2 m -70.44 -35.72 73.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.115 0.484 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 33.5 tt0 -61.92 -53.73 51.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.859 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.576 ' O ' HG22 ' A' ' 10' ' ' VAL . 65.5 tp -57.66 -45.04 86.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.808 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 120' ' ' VAL . 18.0 ttp180 -55.32 -42.35 73.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.497 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.64 -37.0 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 110.601 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 5' ' ' GLU . 64.7 mttm -65.03 -37.71 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.413 0.625 . . . . 0.0 110.09 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 6' ' ' LEU . 46.3 t -69.5 -38.93 77.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.637 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.99 -37.43 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.275 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -56.18 -47.75 77.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.059 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 10' ' ' VAL . 62.6 pttt -77.23 -0.17 24.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.585 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.803 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 41.6 ttm180 -93.05 -48.86 6.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.649 ' HA ' HH12 ' A' ' 22' ' ' ARG . 31.3 pt -85.54 -11.97 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -89.54 5.16 46.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.124 0.488 . . . . 0.0 110.846 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.97 149.85 42.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.432 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -70.67 146.7 49.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -62.39 -40.35 96.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -52.15 -52.47 51.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.522 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 6.2 pt-20 -81.03 -31.32 34.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.24 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.649 HH12 ' HA ' ' A' ' 15' ' ' ILE . 35.9 ttm-85 -57.04 -49.44 75.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.861 0.362 . . . . 0.0 110.82 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.71 -31.57 70.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -80.22 -34.96 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 29' ' ' VAL . 92.7 mt -65.13 -46.12 82.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 30' ' ' ILE . 20.2 m -64.15 -33.38 75.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.518 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.06 -43.0 99.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.12 -39.63 86.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.355 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 25' ' ' LEU . 64.9 t -65.19 -46.03 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 26' ' ' SER . 76.0 mt -58.98 -46.96 91.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 110.171 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -60.02 -45.66 92.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.48 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.84 -45.08 95.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.427 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.48 -42.46 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.379 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -71.1 -26.18 62.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.014 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 m -73.18 -23.67 60.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.8 mt -60.16 122.08 63.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.306 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 33.8 Cg_exo -60.61 -21.29 68.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.166 2.577 . . . . 0.0 112.913 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -75.49 -39.65 58.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.94 -37.49 76.83 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.387 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -67.3 -37.7 83.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 3.7 tmmm? -78.57 -52.37 8.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.124 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -60.84 131.1 49.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -90.51 -42.49 10.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.91 106.9 18.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.98 0.419 . . . . 0.0 110.322 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.84 108.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.337 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.534 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -94.54 117.49 30.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -104.89 122.03 44.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.607 ' HA ' ' HG3' ' A' ' 73' ' ' PRO . 8.9 t80 -76.73 -6.5 52.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.563 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.3 m 69.75 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 121.43 0.633 . . . . 0.0 111.621 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.54 125.74 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.506 2.137 . . . . 0.0 112.923 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 53' ' ' GLY . 7.0 pt -109.66 145.22 16.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 69.1 -41.4 0.47 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.414 0.686 . . . . 0.0 111.765 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 172.12 -76.8 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.803 ' HA ' ' HD3' ' A' ' 14' ' ' ARG . 6.3 mm-40 56.69 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.889 0.875 . . . . 0.0 111.305 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 150' ' ' VAL . 95.8 t -153.33 128.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.434 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -82.12 90.15 6.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.204 0.526 . . . . 0.0 110.881 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.564 HD13 HG12 ' A' ' 150' ' ' VAL . 89.1 mt -102.2 6.61 40.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.837 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.566 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -61.03 -43.81 92.27 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.065 -175.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 58' ' ' THR . 19.3 Cg_endo -61.2 -7.07 7.5 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.121 1.881 . . . . 0.0 113.886 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.34 -13.93 39.48 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.1 m-85 -52.48 -49.77 83.82 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.4 Cg_exo -52.36 -36.05 67.32 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.41 2.073 . . . . 0.0 113.225 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mt-10 -74.18 -31.42 62.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.014 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.19 -36.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.429 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -68.04 -5.01 15.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.582 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 43.4 tttp -66.87 -64.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.742 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 11.2 pt-20 -143.92 -4.05 0.85 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 6.3 mptp? -92.92 164.08 13.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.337 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.805 ' HG3' ' HB2' ' A' ' 84' ' ' ARG . 3.0 tp10 -97.3 103.46 15.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.227 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.8 tp -76.78 94.11 3.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 0.0 110.758 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 56.4 mt -88.49 112.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 86.2 mt -110.06 149.59 40.27 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.663 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.607 ' HG3' ' HA ' ' A' ' 48' ' ' TYR . 9.6 Cg_endo -89.23 125.6 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.376 2.717 . . . . 0.0 113.097 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -105.62 105.63 15.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.429 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 80' ' ' ILE . 21.3 t -82.58 95.4 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.345 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.12 5.97 18.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.659 0.742 . . . . 0.0 109.835 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.49 -153.12 18.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -78.36 -6.24 54.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.109 0.48 . . . . 0.0 110.495 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.99 143.46 46.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.145 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 75' ' ' VAL . 49.6 mm -100.47 122.81 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.129 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m -85.84 122.67 30.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.506 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -101.32 133.19 46.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.684 0.278 . . . . 0.0 110.685 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . 93.9 m-85 -128.77 146.02 51.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.805 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 38.3 ptt85 -100.03 134.35 43.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.117 0.484 . . . . 0.0 110.012 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.78 139.38 51.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -124.76 -28.27 3.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.309 171.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.3 m -108.12 131.62 21.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 -10.14 25.35 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.141 2.561 . . . . 0.0 113.441 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.92 60.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.416 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 41.8 m -85.44 8.39 19.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.027 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.6 138.04 39.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.98 0.419 . . . . 0.0 111.5 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.86 176.41 20.68 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.549 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.78 90.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.846 0.355 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.98 -16.26 7.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.591 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.7 -171.05 3.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.303 0.241 . . . . 0.0 110.984 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -53.48 -53.66 48.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.102 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.85 50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.727 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.5 157.42 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.27 147.06 32.42 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.459 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HB2' ' HB2' ' A' ' 83' ' ' TYR . 72.9 Cg_endo -80.11 105.98 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.209 1.939 . . . . 0.0 111.458 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.71 -19.43 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.833 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -137.03 -171.97 3.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.916 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.53 -132.63 11.07 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 137.88 32.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -80.54 156.07 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.478 . . . . 0.0 111.68 -175.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.24 142.98 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.407 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -89.94 141.67 28.29 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.728 ' HB3' HG22 ' A' ' 143' ' ' VAL . 87.0 Cg_exo -46.7 -40.41 24.24 Favored 'Trans proline' 0 N--CA 1.476 0.441 0 C-N-CA 123.647 2.898 . . . . 0.0 114.225 -175.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.28 -19.27 64.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.41 -17.82 50.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.22 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 118.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.696 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -76.31 -55.66 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.33 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.8 t80 -128.35 136.35 50.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.684 -173.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -139.06 139.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.98 113.17 25.82 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.073 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 47.8 t -111.98 124.73 31.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.878 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 4.9 Cg_exo -77.83 131.04 10.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.104 2.536 . . . . 0.0 111.804 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.88 140.18 11.56 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 7' ' ' ARG . 48.6 t -70.93 -43.55 76.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 117.016 0.408 . . . . 0.0 110.836 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.493 ' HB1' HD23 ' A' ' 129' ' ' LEU . . . -143.42 130.91 21.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.74 169.29 9.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.01 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 26.4 p30 -132.1 -172.35 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.583 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.51 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 88.9 mt -87.29 3.17 47.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.27 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.96 -31.96 10.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.86 1.95 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.091 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 24.1 m-85 -94.23 156.61 16.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.534 0.667 . . . . 0.0 109.865 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 167' ' ' ILE . 0.0 OUTLIER -101.45 -33.42 9.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -163.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.512 ' HB2' HD12 ' A' ' 160' ' ' LEU . 35.6 tp . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.416 0.627 . . . . 0.0 111.908 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.8 t70 -70.38 161.05 31.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' A' ' 137' ' ' ASP . 28.4 ttt180 72.93 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 137' ' ' ASP . 30.8 tp -65.46 -65.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.661 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.668 ' HB2' HD12 ' A' ' 167' ' ' ILE . 97.4 mt -71.64 -11.99 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.573 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.61 -23.84 39.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 0.0 110.106 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -96.2 -35.75 11.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.705 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.3 t -73.39 93.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -101.91 26.37 7.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.431 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.95 -175.24 31.86 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.268 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -71.58 98.14 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.119 0.459 . . . . 0.0 109.931 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 115' ' ' ILE . 32.8 mtmm -84.74 102.89 13.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 171' ' ' VAL . 98.6 t -103.49 119.89 52.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.663 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.46 130.85 10.1 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.564 HG12 HD13 ' A' ' 57' ' ' LEU . 51.0 t -114.61 119.51 61.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -163.71 171.58 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.522 ' HB3' ' OE2' ' A' ' 175' ' ' GLU . 57.1 m-85 -87.21 162.53 17.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.436 ' HA ' HG22 ' A' ' 156' ' ' VAL . 5.8 p -77.35 -9.94 59.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 0.0 110.46 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -61.67 -29.64 70.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -105.86 20.43 18.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 111.281 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 153' ' ' SER . 64.0 t -103.42 116.27 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.944 0.402 . . . . 0.0 110.546 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -100.84 -171.57 2.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.262 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.51 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 13.0 mt-10 -92.02 -44.76 8.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -147.59 125.05 11.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.376 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 97.4 mt -84.89 143.97 41.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.643 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 3.7 Cg_exo -74.95 102.26 1.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.812 2.341 . . . . 0.0 110.548 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 28.6 mtt180 -108.87 155.83 20.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 -172.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.58 -55.38 24.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.15 -50.61 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.147 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -129.28 83.74 2.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.853 0.835 . . . . 0.0 111.368 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.01 151.2 33.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 167.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 140' ' ' LEU . 64.6 mt -75.05 113.46 25.2 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.81 0.338 . . . . 0.0 110.676 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . 97.5 Cg_endo -88.88 161.36 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.044 2.496 . . . . 0.0 113.186 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.17 176.45 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.166 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -99.28 -45.29 5.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.368 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.9 t -129.04 141.13 47.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.658 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.732 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 68.5 tp -117.51 115.56 25.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.98 122.73 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 77.1 p -115.79 -174.38 2.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 111.021 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.83 ' HG3' ' HD2' ' A' ' 176' ' ' LYS . 11.6 pt-20 -70.39 -13.68 62.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.096 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.83 ' HD2' ' HG3' ' A' ' 175' ' ' GLU . 10.1 mptt -121.67 -70.38 0.78 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -110.43 168.92 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.443 -167.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.4 119.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.669 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.732 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 39.0 mmt180 -94.16 102.86 14.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.039 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -79.88 89.62 5.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.718 -173.804 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -75.31 -37.26 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -70.17 -25.27 63.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.56 -38.54 70.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' HD23 ' A' ' 129' ' ' LEU . 58.1 tp -70.76 -40.06 72.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.756 176.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HG3' HG12 ' A' ' 120' ' ' VAL . 12.8 ttp180 -60.16 -44.33 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.428 174.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -64.78 -33.03 75.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.94 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -62.71 -47.31 84.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.266 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 121' ' ' ALA . 45.7 t -73.68 -43.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.615 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD13 ' HD3' ' A' ' 14' ' ' ARG . 51.4 tp -57.92 -33.44 68.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.048 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 9.7 t60 -60.44 -43.6 96.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.375 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 44.2 mttp -81.67 -24.66 36.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 0.0 111.033 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.526 ' HD3' HD13 ' A' ' 11' ' ' LEU . 41.1 ttt85 -57.77 -51.92 67.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.67 4.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.595 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 8.6 t30 -83.88 -19.21 35.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.35 132.65 52.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.757 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -70.65 153.16 43.11 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.041 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -43.66 79.82 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.334 0.396 . . . . 0.0 111.839 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.0 tp10 -60.95 -56.79 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.792 0.33 . . . . 0.0 111.081 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.46 -44.28 97.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.35 -42.1 98.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.013 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 12.7 tpt180 -62.11 -43.12 99.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.696 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 85.0 mtt180 -60.77 -38.79 86.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.6 -45.22 60.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.882 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -62.67 -35.04 78.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.33 -43.49 79.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -66.36 -39.3 89.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 175' ' ' GLU . 61.5 t -65.06 -47.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.693 0.282 . . . . 0.0 110.776 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.77 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 110.203 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -36.16 83.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.101 0.476 . . . . 0.0 109.971 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -69.32 -44.36 71.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 33' ' ' LEU . 5.2 tt -65.46 -38.55 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.991 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -67.11 -26.53 66.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 111.036 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -83.79 -16.77 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -68.02 112.35 10.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.142 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HD2' HD22 ' A' ' 36' ' ' LEU . 35.1 Cg_endo -64.74 -25.43 61.14 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.611 2.207 . . . . 0.0 112.795 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.35 -24.61 61.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.731 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.26 -42.57 99.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.89 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.952 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 89.3 mttt -83.92 -3.04 57.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.129 0.49 . . . . 0.0 110.808 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.606 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 4.1 ttmp? -85.22 -33.8 22.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.492 174.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.7 p -81.94 152.55 26.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.195 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 24.8 tptp -111.46 -40.33 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 109.732 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 22.2 mmtp -91.99 107.43 19.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.796 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.3 115.01 47.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.278 0.561 . . . . 0.0 111.511 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -104.19 133.07 49.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.39 129.0 51.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.0 0.428 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -88.02 109.88 20.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.0 m -52.68 116.17 8.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.536 0.523 . . . . 0.0 111.621 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.18 69.09 7.24 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.865 2.377 . . . . 0.0 112.44 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 52' ' ' LYS . 26.5 pt -55.0 -43.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.521 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' N ' HG13 ' A' ' 51' ' ' ILE . 64.5 mttm -112.98 30.53 7.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.401 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -99.78 149.71 18.89 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.152 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' OE2' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -91.06 -35.62 14.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.32 104.07 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.83 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.85 101.84 7.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.972 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.08 5.9 40.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.781 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.2 m -60.1 -52.92 69.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.427 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 18.6 Cg_exo -68.88 7.28 0.79 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 113.495 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.67 -13.81 38.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.357 . . . . 0.0 110.146 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.6 m-30 -55.75 -49.13 94.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.142 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 75.2 Cg_exo -53.55 -36.06 79.04 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.281 1.987 . . . . 0.0 113.067 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 4.4 tp10 -70.98 -31.33 67.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 110.151 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.52 -40.76 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.396 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.429 HD13 ' HD3' ' A' ' 88' ' ' PRO . 95.8 mt -65.65 -11.85 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 41.2 tttp -64.82 -60.5 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.252 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.809 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.8 pt-20 -120.65 -19.82 7.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -172.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.952 ' HZ1' ' HA ' ' A' ' 40' ' ' LYS . 50.6 mttm -116.38 -172.45 2.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.628 0.251 . . . . 0.0 110.664 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -112.93 143.0 44.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.869 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.9 tp -92.74 124.77 36.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.226 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 53.5 mt -111.23 126.52 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.997 0.427 . . . . 0.0 110.484 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -123.71 147.93 54.79 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.308 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.72 125.36 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.218 2.612 . . . . 0.0 112.753 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.504 ' HG3' ' OE1' ' A' ' 100' ' ' GLU . 85.1 tttt -113.32 139.69 48.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.845 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.71 99.27 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.469 ' OE1' ' HE2' ' A' ' 74' ' ' LYS . 10.6 mm-40 -81.66 82.57 7.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.734 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.18 -89.74 0.5 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -174.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -123.18 -7.29 8.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.88 0.371 . . . . 0.0 110.37 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.96 98.93 12.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.749 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.9 tt -91.94 127.58 44.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.341 0.591 . . . . 0.0 110.291 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -137.07 167.47 21.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.767 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.6 mt -99.32 138.1 36.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.372 . . . . 0.0 110.456 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -118.87 128.16 54.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -95.99 111.93 23.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.393 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 HD13 ' A' ' 91' ' ' LEU . 27.0 m -101.94 138.31 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.072 0.463 . . . . 0.0 110.386 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -96.87 -4.81 39.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.347 0.594 . . . . 0.0 109.805 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -167.81 144.7 3.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.893 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' HD13 ' A' ' 65' ' ' LEU . 54.3 Cg_endo -72.1 71.27 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.45 2.1 . . . . 0.0 111.818 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.37 -58.05 2.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.812 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 7.7 p -86.43 21.62 2.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.273 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.406 HD13 HG23 ' A' ' 85' ' ' VAL . 96.5 mt -99.12 108.53 21.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.14 10.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.74 108.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.098 0.449 . . . . 0.0 110.123 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 100' ' ' GLU . . . -150.48 -1.77 0.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.87 -161.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.312 . . . . 0.0 110.338 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.32 -18.75 63.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.257 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.18 -23.36 0.13 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.719 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -83.42 172.91 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.65 -0.275 . . . . 0.0 110.869 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -62.68 138.0 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.098 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 74' ' ' LYS . 3.3 tp10 -108.34 107.19 59.94 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.157 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.58 106.07 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.67 1.58 . . . . 0.0 110.903 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.83 -45.65 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.224 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.67 178.72 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.87 -130.18 4.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.176 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -118.49 118.91 33.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.603 0.239 . . . . 0.0 110.418 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -80.67 97.0 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 111' ' ' ASP . 88.1 t -99.08 119.94 47.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.967 -175.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.17 154.08 86.36 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.501 ' CB ' ' HA ' ' A' ' 143' ' ' VAL . 10.6 Cg_endo -54.1 -19.19 15.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.828 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.5 -41.12 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.937 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.561 ' HB3' HG12 ' A' ' 107' ' ' VAL . 22.1 t70 -87.24 -9.26 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.17 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.1 t -81.25 132.09 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.136 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.543 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 67.4 m-20 -91.7 -49.31 6.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.471 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 148' ' ' VAL . 47.5 t80 -130.31 138.43 50.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.541 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 tt -143.65 140.03 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.94 127.16 54.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -120.69 121.54 28.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.75 -41.26 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.722 2.282 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.25 -145.82 49.42 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.86 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.569 HG12 ' HG3' ' A' ' 7' ' ' ARG . 75.7 t -139.24 -45.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.456 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -161.15 157.07 25.28 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.381 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -135.92 166.01 24.32 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.157 0.285 . . . . 0.0 110.85 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -111.06 -171.74 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.881 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 52.9 mt -71.39 -14.38 62.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.63 -21.57 14.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.561 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.19 31.33 3.1 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.941 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -95.63 147.04 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.795 0.331 . . . . 0.0 110.435 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -84.06 150.13 25.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.861 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.619 HD23 ' HG ' ' A' ' 6' ' ' LEU . 28.7 tp . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.515 0.674 . . . . 0.0 109.967 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 121.372 0.606 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.24 -39.49 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.671 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 37.6 ttm180 -61.8 -17.65 56.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.402 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.487 ' O ' HG21 ' A' ' 143' ' ' VAL . 45.9 tp -92.9 -70.12 0.71 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.41 . . . . 0.0 111.028 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HB2' HD13 ' A' ' 167' ' ' ILE . 7.4 mp -63.49 -32.32 73.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.36 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 141' ' ' LYS . 34.4 ttmt -80.81 -16.59 53.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 138' ' ' ARG . 37.4 mtp180 -101.69 -5.57 24.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.287 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 109' ' ' PRO . 94.0 t -62.04 112.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.124 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -92.16 -7.09 49.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.792 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.34 -173.71 46.66 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.1 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.535 HD12 HG21 ' A' ' 171' ' ' VAL . 32.3 tp -80.21 108.11 13.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 115' ' ' ILE . 32.4 mtmm -86.25 106.19 17.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.044 0.45 . . . . 0.0 110.034 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.5 t -102.51 124.36 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.997 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.54 138.82 14.36 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.7 111.45 36.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -151.76 162.85 40.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.639 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 30.8 m-85 -86.16 170.38 12.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.393 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.1 t -72.13 -38.52 69.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.73 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -74.46 -9.07 58.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.486 . . . . 0.0 110.421 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -95.31 -7.7 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.019 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.46 110.29 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.408 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.46 179.99 5.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.242 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.881 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.36 -53.46 6.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.051 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -136.04 140.73 44.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 129' ' ' LEU . 96.7 mt -132.81 158.67 75.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.5 101.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.289 1.993 . . . . 0.0 110.933 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -96.7 128.33 43.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.941 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.904 ' HB3' ' HB2' ' A' ' 166' ' ' ASP . 9.6 t70 -95.11 137.16 34.54 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.59 57.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.81 0.338 . . . . 0.0 111.549 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -119.52 24.01 10.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 0.0 110.552 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.904 ' HB2' ' HB3' ' A' ' 163' ' ' ASP . 12.0 t70 -89.73 -157.61 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.542 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.749 HD13 ' HB2' ' A' ' 140' ' ' LEU . 56.9 mt -125.82 107.27 25.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.841 0.353 . . . . 0.0 111.305 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -93.12 174.49 1.75 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.247 2.632 . . . . 0.0 112.177 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.85 174.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.604 0.24 . . . . 0.0 110.758 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -106.88 -44.24 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.554 . . . . 0.0 109.902 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 146' ' ' LEU . 86.5 t -125.96 140.75 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.552 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.594 ' HB2' HD23 ' A' ' 181' ' ' LEU . 53.6 tp -121.0 103.12 8.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.0 110.687 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.95 119.03 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.907 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.7 p -110.34 -175.94 2.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.187 0.518 . . . . 0.0 111.222 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.639 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 9.5 pt-20 -60.12 -27.61 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.658 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.513 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 24.9 mtmm -118.45 -56.77 2.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -119.05 174.51 6.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 111.334 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.91 99.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 25.0 ttm-85 -79.05 124.2 28.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.984 -174.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 180' ' ' ARG . 4.6 mtp180 -92.22 97.52 10.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.569 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 172' ' ' LEU . 2.9 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.36 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.86 4.86 51.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 110.207 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 163' ' ' ASP . 16.6 ptmt -52.44 -50.38 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.681 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -70.93 -40.08 72.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.8 -37.43 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.115 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD21 HD21 ' A' ' 129' ' ' LEU . 38.0 tp -67.01 -37.23 83.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 3' ' ' LYS . 96.6 mtt180 -60.72 -44.96 95.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.245 0.545 . . . . 0.0 109.843 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.38 -50.92 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.121 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -62.63 -34.8 77.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.57 0.224 . . . . 0.0 111.576 -174.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.12 -40.4 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.366 . . . . 0.0 110.189 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD11 ' HD3' ' A' ' 14' ' ' ARG . 31.0 tp -62.21 -34.78 77.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -59.65 -43.92 93.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -81.97 -28.78 32.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.096 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.684 ' HD3' HD11 ' A' ' 11' ' ' LEU . 32.1 ttt85 -56.69 -43.96 81.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.293 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 pt -88.41 0.89 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.408 . . . . 0.0 111.115 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -89.57 -20.78 23.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.28 137.56 47.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.44 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.7 t -90.65 145.35 24.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.483 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 40.7 mm-40 -59.8 -25.14 64.71 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.284 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -53.25 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.379 0.609 . . . . 0.0 110.379 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.86 -40.62 65.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 66.9 ttt180 -56.34 -50.67 70.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.686 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -64.15 -33.73 76.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -70.97 -38.83 72.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.3 -37.5 71.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.437 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.483 ' HA ' HG12 ' A' ' 55' ' ' VAL . 70.7 m -59.32 -39.98 84.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.704 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.72 -44.19 85.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -62.35 -43.8 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -44.95 99.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.479 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 56' ' ' ASP . 67.1 mt -56.93 -53.87 37.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.0 m -59.28 -44.55 92.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.993 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.422 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 2.7 t-20 -61.1 -52.51 64.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD12 ' HZ ' ' A' ' 114' ' ' PHE . 20.0 tp -60.75 -38.35 84.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.078 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -79.4 -21.19 45.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.315 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -85.83 -18.93 31.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.208 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 32' ' ' ASN . 92.5 mt -55.94 119.61 27.53 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.728 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.21 -22.76 75.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.015 2.476 . . . . 0.0 112.764 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.95 -23.88 48.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.606 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.53 -23.04 59.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -71.43 -29.12 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.41 -37.35 11.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.272 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m -58.19 122.54 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -90.94 -41.9 10.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.553 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 18.7 mmtp -95.23 109.02 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.17 101.45 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -100.64 136.27 40.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.49 151.06 39.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' HD1' ' HA ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.84 -90.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.647 ' HG ' HG23 ' A' ' 51' ' ' ILE . 35.6 t 176.05 127.23 0.15 Allowed Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.254 0.346 . . . . 0.0 110.344 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.39 112.29 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.169 2.579 . . . . 0.0 110.932 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.647 HG23 ' HG ' ' A' ' 49' ' ' CYS . 10.7 pt -127.98 -47.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 51' ' ' ILE . 74.4 mmtt -96.7 -69.24 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -171.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.543 ' HA3' ' HG2' ' A' ' 14' ' ' ARG . . . -149.58 46.79 0.64 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.303 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HG3' HH21 ' A' ' 14' ' ' ARG . 3.9 mp0 -97.87 -156.18 0.53 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 26' ' ' SER . 91.6 t -101.41 138.35 25.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.608 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' O ' HD12 ' A' ' 30' ' ' ILE . 27.1 m-20 -72.35 75.18 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.16 0.505 . . . . 0.0 111.08 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD13 HG11 ' A' ' 150' ' ' VAL . 93.2 mt -90.72 -5.02 56.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.768 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -47.54 98.85 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.452 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.3 -7.66 20.72 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.252 1.968 . . . . 0.0 113.205 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 64' ' ' VAL . 40.9 tp -87.17 -7.08 58.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.794 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 13.0 m-30 -53.31 -50.65 81.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.943 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.8 Cg_exo -52.17 -42.05 61.74 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.239 1.96 . . . . 0.0 112.977 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -65.41 -43.82 89.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.647 0.261 . . . . 0.0 110.848 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 60' ' ' LEU . 56.0 t -64.66 -48.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.635 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.36 -33.87 66.09 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.435 0.459 . . . . 0.0 111.382 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -64.32 -45.87 86.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.705 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -101.81 -60.55 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -108.55 -171.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.021 0.439 . . . . 0.0 111.272 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.587 ' HG2' ' HD2' ' A' ' 84' ' ' ARG . 1.8 mp0 -96.35 116.8 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.253 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.79 116.06 18.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.642 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 58.0 mt -111.12 126.02 68.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.896 0.379 . . . . 0.0 110.623 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.3 mt -120.69 150.08 51.78 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HA ' HD23 ' A' ' 82' ' ' LEU . 58.8 Cg_endo -73.27 125.7 10.46 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.577 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 8.9 tmtm? -116.63 124.37 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.72 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG23 HG12 ' A' ' 80' ' ' ILE . 41.6 t -90.7 105.98 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.13 -24.97 18.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.753 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.44 80.63 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.83 -56.96 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 0.0 111.118 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.96 141.48 34.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 75' ' ' VAL . 67.5 mt -105.08 127.87 59.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -102.89 163.28 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.642 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 66.3 mt -115.8 124.54 50.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.04 0.448 . . . . 0.0 110.855 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -108.36 134.69 50.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.238 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.587 ' HD2' ' HG2' ' A' ' 69' ' ' GLU . 13.7 ptt180 -93.8 140.66 29.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.07 140.99 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.485 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.61 2.71 15.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.796 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 25.4 p -149.86 151.9 33.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.739 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.7 Cg_exo -76.6 44.37 1.39 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.997 2.465 . . . . 0.0 111.742 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 -74.31 0.42 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.848 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.4 t -95.2 92.81 6.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.116 0.484 . . . . 0.0 111.496 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt -138.21 98.82 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.388 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.28 152.65 17.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.218 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.54 107.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.458 . . . . 0.0 110.341 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.78 -40.88 1.39 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 98' ' ' ILE . . . -87.67 -152.48 0.2 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -78.37 58.35 2.11 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.453 0.644 . . . . 0.0 111.405 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.2 -13.67 60.08 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.979 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.411 ' CG1' ' HB1' ' A' ' 95' ' ' ALA . 41.0 pt -90.08 148.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.75 0.31 . . . . 0.0 110.89 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 ptp -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 16.8 pt-20 -138.01 147.52 56.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.79 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 3.7 Cg_exo -81.1 106.66 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.492 2.128 . . . . 0.0 111.418 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.63 -21.16 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.26 127.15 43.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.856 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.59 -143.4 8.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.12 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -106.85 116.79 32.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.966 0.413 . . . . 0.0 110.377 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -79.11 116.52 19.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.333 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 142.04 25.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.855 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.8 p30 -80.2 137.73 52.72 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.515 ' HA ' HD12 ' A' ' 82' ' ' LEU . 34.6 Cg_exo -58.88 -24.33 71.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.97 2.447 . . . . 0.0 113.847 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.99 -9.75 59.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.82 -10.86 54.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.349 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 66.7 t -77.21 121.98 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.343 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 11.5 m-20 -74.7 -52.98 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.468 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.527 ' CZ ' HG23 ' A' ' 148' ' ' VAL . 34.6 t80 -124.31 123.99 41.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.253 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 15.2 tt -130.38 139.83 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 110.741 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.61 109.48 20.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.259 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.513 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 11.6 m -119.74 120.05 30.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.289 0.566 . . . . 0.0 111.135 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 1.4 Cg_endo -84.1 163.96 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.025 2.483 . . . . 0.0 111.95 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.404 ' HA2' ' CZ ' ' A' ' 131' ' ' PHE . . . -150.41 154.15 25.47 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.6 t -55.97 -47.28 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.982 0.391 . . . . 0.0 110.894 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.5 147.84 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -129.78 167.19 18.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.979 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.508 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 1.3 p-10 -127.23 -169.62 2.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.699 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.1 mt -92.3 4.03 54.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.05 -25.82 10.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.649 0.261 . . . . 0.0 110.781 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.45 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . 117.86 26.07 2.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 174.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -102.23 158.07 16.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.782 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' OD2' ' A' ' 166' ' ' ASP . 33.0 mtm180 -124.35 -176.97 3.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.479 HD21 HD21 ' A' ' 6' ' ' LEU . 20.6 tp -113.55 0.57 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.28 0.562 . . . . 0.0 109.726 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.6 176.63 33.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.525 -0.762 . . . . 0.0 113.35 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.404 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 71.3 m-85 -119.83 -72.1 0.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.88 124.2 1.67 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -88.68 148.43 24.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.846 0.355 . . . . 0.0 110.498 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 162.17 -62.08 0.27 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.238 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.64 -27.16 1.54 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.912 0.387 . . . . 0.0 111.38 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -75.62 -30.77 59.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' HA ' HD13 ' A' ' 140' ' ' LEU . 6.5 p-10 -67.92 -23.85 65.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.008 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.99 -35.99 74.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.902 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.22 -36.76 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 137' ' ' ASP . 79.8 mt -67.66 -26.36 66.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.108 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 34.3 mmtp -76.72 -21.66 54.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 109' ' ' PRO . 27.5 mmt180 -77.52 -53.11 8.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.172 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.84 103.21 4.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.84 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -113.99 24.4 12.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.25 -139.75 5.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.808 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.93 101.36 13.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.62 ' HE2' HD12 ' A' ' 167' ' ' ILE . 18.9 mttp -88.54 106.67 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' A' ' 114' ' ' PHE . 67.7 t -101.0 116.98 45.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.801 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -78.94 121.57 5.6 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.432 HG11 HD13 ' A' ' 57' ' ' LEU . 61.9 t -113.65 115.86 50.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.552 0.215 . . . . 0.0 110.463 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.95 -179.81 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.084 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.407 ' O ' HG22 ' A' ' 156' ' ' VAL . 95.1 m-85 -97.56 156.1 16.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.86 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.3 p -61.23 -25.9 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.589 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.526 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 70.7 m-85 -61.78 -36.4 80.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -90.62 8.31 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 152' ' ' TYR . 61.5 t -109.66 133.79 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.892 0.377 . . . . 0.0 110.424 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.93 -169.52 1.85 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 48.2 mt-10 -84.74 -50.15 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.281 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.1 ptm180 -141.11 146.65 37.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 176.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 92.5 mt -116.6 149.16 43.35 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.995 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.35 104.57 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.274 1.983 . . . . 0.0 111.007 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -73.55 111.41 8.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.0 110.768 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' A' ' 3' ' ' LYS . 24.7 t70 -62.71 -78.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.963 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.6 -96.26 0.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.781 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -128.54 61.66 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.358 0.599 . . . . 0.0 111.25 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 128' ' ' ARG . 38.7 t70 -74.36 141.82 45.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.62 HD12 ' HE2' ' A' ' 147' ' ' LYS . 14.1 tt -79.11 120.26 80.08 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.941 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.5 Cg_exo -74.15 148.65 39.76 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.023 2.482 . . . . 0.0 111.807 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.94 169.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.011 0.434 . . . . 0.0 111.607 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -93.3 -40.08 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.297 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 148' ' ' VAL . 17.0 t -133.07 155.12 40.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 55.5 tp -135.43 118.31 16.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.97 126.45 73.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 0.0 110.799 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 71.7 p -114.56 -172.49 2.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.266 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 176' ' ' LYS . 2.5 pm0 -85.73 -15.05 43.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.031 0.443 . . . . 0.0 110.125 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.414 ' HG3' ' HG2' ' A' ' 175' ' ' GLU . 29.4 mtpp -112.31 -47.82 3.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.197 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -131.43 163.1 28.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 112.102 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.53 122.56 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.73 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 3.0 mmp_? -108.93 131.73 54.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.993 0.425 . . . . 0.0 110.186 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -121.74 128.39 51.72 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.45 HD11 ' HA3' ' A' ' 126' ' ' GLY . 23.4 mt -110.0 31.11 6.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.672 0.748 . . . . 0.0 110.247 -172.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -129.73 24.87 5.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.086 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.02 140.34 58.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.022 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.33 163.91 26.7 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.82 -59.4 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.1 0.45 . . . . 0.0 111.01 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.2 t -153.41 155.37 36.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.6 mt -131.17 132.77 44.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.742 0.306 . . . . 0.0 110.826 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -117.07 150.3 38.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -108.1 -76.36 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -128.31 76.59 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -113.24 -8.89 13.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.291 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -75.41 73.84 2.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.345 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 28.3 m170 72.02 159.58 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 C--O 1.246 0.913 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.019 179.325 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.22 -14.49 24.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -53.21 -57.83 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -60.66 -39.18 87.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.54 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.71 -52.34 21.61 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.091 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -61.88 -35.23 77.72 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.321 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -56.11 -59.42 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.451 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -74.25 -37.54 63.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.764 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.54 -39.79 92.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.494 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.1 t -86.19 -41.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.7 tp -60.34 -37.59 81.14 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.173 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 75.9 t60 -59.69 -31.04 69.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.741 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -82.71 -42.74 17.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.916 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.565 ' NH2' ' HA ' ' A' ' 151' ' ' ALA . 52.2 ttt180 -61.19 -38.75 87.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 0.0 111.103 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.1 pt -88.18 -4.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.368 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 66.1 t30 -98.4 -13.69 20.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.888 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.78 143.83 15.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -61.98 144.59 54.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -59.27 -49.33 78.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.548 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.81 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.786 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.09 -44.61 91.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.409 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -59.13 -42.57 90.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -25.5 66.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.688 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -83.86 -18.48 37.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.903 0.382 . . . . 0.0 110.785 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.7 mt -86.56 -53.52 4.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.094 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 m -57.17 -34.49 68.52 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.09 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -48.27 -50.44 29.83 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.086 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -80.59 -26.59 37.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.323 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 25' ' ' LEU . 58.0 t -65.07 -49.51 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.82 -46.42 96.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.619 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -62.09 -40.94 97.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.456 ' OD1' HG23 ' A' ' 178' ' ' VAL . 21.8 t-20 -66.51 -51.14 59.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.008 0.433 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.793 HD12 ' HZ ' ' A' ' 114' ' ' PHE . 36.9 tp -57.64 -38.61 75.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.4 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -72.85 -33.38 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.917 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -75.35 -16.87 60.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.346 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD11 HD11 ' A' ' 33' ' ' LEU . 79.7 mt -56.46 126.3 69.03 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.852 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -32.74 96.04 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.571 2.181 . . . . 0.0 111.593 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.27 -35.08 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -62.22 -30.31 71.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.078 0.466 . . . . 0.0 110.433 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -64.52 -40.08 94.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.73 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -80.79 -33.2 35.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.159 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.484 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 46.4 m -55.53 105.81 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.046 0.45 . . . . 0.0 111.1 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 84.4 tttt -98.47 -30.67 12.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.653 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -102.91 98.21 8.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.383 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.16 109.01 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 111.066 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.29 139.64 34.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.551 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.27 145.96 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.888 0.375 . . . . 0.0 110.831 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.29 -4.11 59.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.911 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 70.9 m 65.17 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 123.727 0.642 . . . . 0.0 111.465 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 95.92 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.502 2.135 . . . . 0.0 112.743 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 35.7 pt -90.65 161.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 67.4 mttm 70.91 -55.25 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.725 0.64 . . . . 0.0 110.805 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.22 -83.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 4.4 mm-40 45.53 39.55 4.87 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.801 0.84 . . . . 0.0 112.862 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG23 ' CZ ' ' A' ' 152' ' ' TYR . 53.3 t 68.26 101.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.084 -174.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.07 92.71 1.34 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.826 0.822 . . . . 0.0 111.183 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 150' ' ' VAL . 93.8 mt -88.49 15.19 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.792 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 8.8 p -62.35 -38.47 46.93 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 30.5 Cg_exo -64.38 -11.48 28.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.925 1.75 . . . . 0.0 112.717 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' O ' HG21 ' A' ' 64' ' ' VAL . 36.9 tp -89.24 -16.2 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.59 0.233 . . . . 0.0 110.741 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 23.9 m-85 -56.51 -50.65 86.54 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 50.4 Cg_exo -55.74 -35.19 92.97 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.13 1.887 . . . . 0.0 112.509 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.46 -43.73 76.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.485 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 60' ' ' LEU . 59.2 t -64.49 -44.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.26 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.51 -18.83 65.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.704 0.288 . . . . 0.0 111.549 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -75.99 -36.52 59.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.393 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -124.11 -46.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 31.1 mmtp -101.93 -175.04 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.017 0.437 . . . . 0.0 111.52 -168.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 38.6 mm-40 -98.3 120.0 37.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.595 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.05 102.44 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.2 mt -91.52 116.89 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.085 0.469 . . . . 0.0 110.494 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.8 mt -117.11 137.09 23.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.205 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.6 119.4 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -105.74 117.45 34.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.08 95.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -96.72 71.29 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 109.71 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.37 -111.18 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.429 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.55 -22.97 14.8 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -77.43 89.05 3.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.719 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.84 119.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -111.85 132.29 54.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.452 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -81.85 103.93 11.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.054 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 3.7 m-85 -95.97 120.19 35.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.197 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 24.2 ptt85 -83.42 131.3 35.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.68 133.19 68.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.998 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.23 12.83 7.69 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.5 m -112.05 109.68 54.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.536 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.2 Cg_exo -74.42 31.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.463 2.775 . . . . 0.0 112.915 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 -28.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.951 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 58.2 m -84.75 38.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -172.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.22 152.22 21.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -132.89 176.31 19.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.99 98.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.114 0.457 . . . . 0.0 110.031 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.19 -32.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.058 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.485 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -76.18 94.84 3.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.855 0.327 . . . . 0.0 111.072 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.1 t80 72.49 -52.13 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.199 0.599 . . . . 0.0 111.809 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.32 33.92 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 95' ' ' ALA . 41.5 pt -122.86 172.72 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 66.1 mtt -94.24 86.94 5.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 2.3 pm0 -87.93 148.36 43.17 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.983 0.421 . . . . 0.0 110.263 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 8.1 Cg_exo -72.17 106.09 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 103' ' ' GLU . 31.2 m -76.72 -25.01 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.499 0.666 . . . . 0.0 109.421 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 59.7 mm-40 -122.28 129.11 51.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.938 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.11 -159.2 28.37 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 34.3 tt0 -138.71 131.16 28.76 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -79.74 113.62 18.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.0 110.514 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.44 154.23 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.138 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -81.99 142.11 47.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.294 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HB2' HG23 ' A' ' 143' ' ' VAL . 24.2 Cg_endo -61.22 -23.21 76.67 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.299 2.666 . . . . 0.0 113.69 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.82 -19.67 63.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.88 0.371 . . . . 0.0 110.975 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.51 -12.56 53.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.391 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.98 114.22 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 110.847 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 42' ' ' SER . 38.8 t70 -90.47 -51.61 5.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.258 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.793 ' HZ ' HD12 ' A' ' 33' ' ' LEU . 38.3 t80 -130.43 139.39 50.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.471 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.6 tt -146.29 139.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 110.74 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.64 20.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.463 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 59.4 t -122.33 110.89 32.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.01 165.9 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.922 2.415 . . . . 0.0 112.081 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.78 163.89 30.57 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.01 -38.46 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.571 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.63 159.06 44.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.173 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.28 165.84 25.7 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.517 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 16.1 p30 -126.46 -172.09 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.69 -2.2 58.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.029 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -105.79 -28.7 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.809 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.17 30.64 0.85 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.869 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -108.99 151.83 25.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.318 0.559 . . . . 0.0 110.414 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -122.89 149.6 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.067 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 59.2 tp -88.45 128.25 35.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -91.31 -153.52 29.6 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.302 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -82.01 0.25 41.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.778 0.323 . . . . 0.0 111.2 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.93 35.06 61.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.889 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -155.37 1.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.623 0.249 . . . . 0.0 111.289 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 135' ' ' TYR . . . 78.75 -145.11 28.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.73 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 32.1 m-85 77.41 123.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.374 0.67 . . . . 0.0 111.46 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 71.09 1.51 3.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.795 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.38 -41.91 99.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.13 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.82 -25.6 65.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.851 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.07 -56.57 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.192 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.2 -12.85 61.69 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.769 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -76.47 -32.52 58.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -94.43 -40.81 9.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.083 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 109' ' ' PRO . 49.7 t -71.82 91.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.268 0.556 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 144' ' ' LYS . 5.6 tmtm? -103.89 68.21 0.91 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.554 0.692 . . . . 0.0 109.837 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.69 -150.29 19.01 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 113' ' ' ASP . 11.0 mp -83.29 89.03 6.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.979 0.889 . . . . 0.0 109.227 171.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -81.98 102.47 10.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.458 HG22 ' CE2' ' A' ' 114' ' ' PHE . 89.8 t -98.82 114.72 37.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.622 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -79.03 119.95 5.17 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.539 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.512 HG12 HD11 ' A' ' 57' ' ' LEU . 47.5 t -98.05 110.73 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.371 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.565 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . . . -154.05 176.5 12.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.248 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.446 ' CZ ' HG23 ' A' ' 55' ' ' VAL . 71.6 m-85 -96.69 151.96 19.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.0 t -62.28 -17.78 59.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.45 0.166 . . . . 0.0 111.071 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -62.73 -33.44 75.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.263 0.554 . . . . 0.0 110.389 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.52 -3.8 58.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.429 -174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 38.8 t -91.19 110.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -105.62 -179.17 3.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.523 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.31 -58.6 4.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.079 0.466 . . . . 0.0 110.039 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -144.77 138.54 27.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.848 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 90.5 mt -93.45 152.65 41.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.87 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 101.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.074 1.849 . . . . 0.0 109.653 167.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -73.63 150.09 41.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.263 0.554 . . . . 0.0 111.114 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -103.85 -172.91 2.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.087 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.58 35.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -96.82 64.19 2.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -74.98 108.36 7.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.863 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.2 103.98 55.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.867 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.49 159.75 10.93 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.839 2.359 . . . . 0.0 112.416 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.35 173.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.02 -52.52 3.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.038 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.2 130.97 68.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.24 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 57.0 tp -104.97 108.63 20.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.033 0.444 . . . . 0.0 110.218 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.01 130.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.434 ' HB ' ' OE2' ' A' ' 175' ' ' GLU . 40.2 p -126.55 -173.89 2.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.275 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.434 ' OE2' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -79.34 -9.0 59.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.097 0.475 . . . . 0.0 110.862 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -120.31 -62.01 1.52 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -110.01 151.75 26.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.316 0.579 . . . . 0.0 112.548 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.456 HG23 ' OD1' ' A' ' 32' ' ' ASN . 16.6 t -103.81 99.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.102 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 79.2 mtt85 -94.5 85.23 4.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.292 0.568 . . . . 0.0 110.782 -176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -76.27 99.42 4.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.1 mt -102.71 25.68 8.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.511 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -80.44 74.35 7.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.013 0.435 . . . . 0.0 110.16 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.76 156.64 27.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.26 -76.94 0.63 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.349 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 185' ' ' ARG . 6.1 tpm_? -169.19 28.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.428 ' HB2' ' OE2' ' A' ' 188' ' ' GLU . 80.9 p -74.33 138.08 43.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.932 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 29.2 tp -144.39 12.05 1.52 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 110.384 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 1.1 pm0 -81.63 52.32 1.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 0.0 110.808 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -57.41 -38.23 74.01 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.246 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -156.32 67.2 0.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -78.57 -31.2 47.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.7 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -83.31 113.8 20.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.173 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -91.23 -177.95 5.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.36 -179.225 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.77 0.319 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 tp -160.43 -47.08 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.883 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.634 ' HD2' ' HG ' ' A' ' 129' ' ' LEU . 65.3 pttt -72.72 -11.09 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -60.7 -47.57 85.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.546 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -34.18 71.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.814 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.25 -44.11 80.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.166 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 120' ' ' VAL . 4.9 tmt_? -58.39 -43.97 88.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.18 -41.37 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.52 -44.09 89.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 37.2 t -71.78 -46.12 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.322 . . . . 0.0 110.348 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.24 -39.61 83.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.782 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -53.16 -39.38 63.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.072 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -90.75 -1.24 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.653 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 62.6 mtp180 -97.34 -48.74 5.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.127 0.489 . . . . 0.0 111.435 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.59 -21.99 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.687 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -76.82 -16.1 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.35 153.62 26.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.628 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -63.1 144.89 56.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.79 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.66 -48.88 78.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 110.011 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 2.5 mp0 -54.33 -49.14 70.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.963 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.76 -53.04 62.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.631 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 22' ' ' ARG . 33.1 ttp180 -64.49 -38.87 92.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -69.67 -36.13 75.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.863 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -65.98 -30.16 70.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 109.88 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.94 -46.08 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.145 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 t -57.45 -35.31 69.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.289 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.64 -51.32 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.405 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -74.28 -28.11 61.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.974 -174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.17 -47.94 80.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.1 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.454 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 m -62.19 -40.42 95.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.32 -46.05 74.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.403 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.586 HD12 HD11 ' A' ' 36' ' ' LEU . 46.6 tp -61.49 -41.89 97.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.569 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -64.58 -33.16 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -70.15 -26.17 63.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.739 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.586 HD11 HD12 ' A' ' 33' ' ' LEU . 92.6 mt -61.91 120.12 54.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.169 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.44 -33.58 78.91 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.241 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -22.08 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' CZ ' ' HE2' ' A' ' 68' ' ' LYS . 50.4 t80 -68.84 -29.94 68.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.83 -31.08 15.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.18 -49.87 74.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 113' ' ' ASP . 70.1 m -86.82 122.1 30.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.37 -21.54 18.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -173.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.58 97.8 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.157 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.98 118.04 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.307 0.575 . . . . 0.0 110.858 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -98.75 137.12 37.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.46 139.28 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.72 0.295 . . . . 0.0 110.262 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -85.57 -6.12 59.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.8 t 67.11 102.08 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.306 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.1 124.41 9.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.429 2.086 . . . . 0.0 112.243 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.4 pp -111.57 152.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.296 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 63.08 20.19 12.13 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.098 0.475 . . . . 0.0 110.982 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.17 -88.19 0.63 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.83 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 70.8 mm-40 64.08 -85.01 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 122.925 0.49 . . . . 0.0 109.769 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 150' ' ' VAL . 88.1 t -148.95 116.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.51 101.41 2.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.78 9.54 24.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.501 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.482 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 68.5 p -65.21 -38.81 30.57 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 58' ' ' THR . 68.6 Cg_endo -74.14 4.56 4.19 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.62 1.547 . . . . 0.0 112.543 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 64' ' ' VAL . 27.9 tp -99.33 -17.28 18.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.594 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 30.9 m-85 -52.07 -46.25 93.26 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 87.4 Cg_exo -49.86 -45.39 32.47 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.083 1.856 . . . . 0.0 112.589 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.92 -32.96 65.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.692 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 60' ' ' LEU . 76.9 t -61.61 -45.2 99.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.93 -12.71 61.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.427 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 62' ' ' PRO . 31.4 mmmt -92.46 -58.45 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.087 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.24 -38.99 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.372 0.606 . . . . 0.0 110.684 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 22.6 mttp -125.63 -171.6 2.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.769 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 86' ' ' HIS . 42.8 tt0 -120.17 135.08 55.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.168 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.412 HD12 HG13 ' A' ' 64' ' ' VAL . 62.3 tp -92.47 132.48 36.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 111.391 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -119.83 127.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 97.4 mt -126.29 144.14 48.24 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.48 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.47 146.45 12.21 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.962 2.442 . . . . 0.0 112.593 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -135.0 135.1 41.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.93 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -99.23 124.51 52.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -119.13 44.21 2.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.03 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.64 -93.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.861 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -109.7 -27.47 9.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -92.75 134.75 34.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 tt -116.82 127.82 74.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.114 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -124.55 178.89 5.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.47 138.77 50.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 27.0 m-85 -121.5 146.68 46.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 0.0 111.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.802 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 21.6 ttm180 -91.2 118.43 30.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.962 -172.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 HD23 ' A' ' 91' ' ' LEU . 46.4 t -119.04 111.67 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.419 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.1 p-80 -139.06 30.31 2.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.514 0.674 . . . . 0.0 109.222 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.8 p -154.27 143.91 15.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.819 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.6 Cg_exo -73.18 171.77 16.93 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.934 2.422 . . . . 0.0 112.386 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.8 18.83 11.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.793 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 53.4 m -113.93 3.34 15.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.501 HD23 HG11 ' A' ' 85' ' ' VAL . 91.7 mt -108.3 126.05 52.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.211 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.92 -163.56 9.79 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.8 t -123.04 119.4 57.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.926 0.363 . . . . 0.0 110.09 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.37 -98.61 1.36 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 132.81 46.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.6 t80 72.12 -53.47 0.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.904 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.33 34.26 0.37 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.006 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.9 pt -108.35 172.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 91' ' ' LEU . 48.6 tpp -70.72 102.76 2.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 29.4 tt0 -114.31 134.59 22.23 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -172.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 11.3 Cg_exo -70.27 119.65 6.52 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.357 2.038 . . . . 0.0 109.812 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG11 ' HG2' ' A' ' 103' ' ' GLU . 13.6 t -54.04 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.678 0.611 . . . . 0.0 111.031 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG2' HG11 ' A' ' 102' ' ' VAL . 54.4 mm-40 -136.64 145.69 45.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.7 -148.61 13.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.622 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.802 ' HG3' ' HB3' ' A' ' 84' ' ' ARG . 6.3 pt-20 -91.2 151.24 21.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 111.433 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -100.41 162.33 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.751 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 50.5 t -125.57 136.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.073 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -82.77 139.04 43.4 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.555 ' HB3' HG22 ' A' ' 143' ' ' VAL . 52.2 Cg_exo -56.42 -23.82 49.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.642 2.228 . . . . 0.0 111.265 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.11 -32.59 71.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.158 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.86 -11.51 36.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.893 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -77.46 126.39 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.445 ' CB ' ' HB3' ' A' ' 42' ' ' SER . 15.0 m-20 -96.0 -51.94 4.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.522 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -123.23 148.35 45.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.895 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.56 138.9 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.012 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.46 112.3 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.09 126.42 28.04 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.503 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.2 -168.05 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.735 2.29 . . . . 0.0 111.768 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.7 150.51 6.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.935 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 7' ' ' ARG . 98.9 t -74.22 -38.69 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 0.0 110.943 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.53 166.08 25.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -140.7 148.7 41.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 111.389 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.654 ' OD2' ' HA ' ' A' ' 159' ' ' ARG . 11.5 t70 -101.97 156.85 17.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.871 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 49.4 mt -71.9 -26.76 62.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 111.226 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -85.81 -7.17 58.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.104 0.478 . . . . 0.0 110.029 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 111.27 -0.88 28.14 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.98 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.485 ' N ' ' HB3' ' A' ' 123' ' ' ASP . 95.1 m-85 -64.47 156.89 28.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.31 0.555 . . . . 0.0 110.689 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 37.0 mtm180 -103.99 -71.98 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.756 HD13 ' HB3' ' A' ' 160' ' ' LEU . 7.3 tt 71.45 -11.42 0.71 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.019 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -47.17 -51.88 13.78 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.709 0.643 . . . . 0.0 114.709 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -171.63 176.27 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.137 0.469 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 150.75 107.59 0.39 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.135 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 133' ' ' LYS . 39.1 mtpt -113.91 -58.2 2.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.8 145.01 46.16 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.593 ' HD2' ' HB2' ' A' ' 138' ' ' ARG . 1.7 t80 -81.96 54.58 2.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.167 0.508 . . . . 0.0 110.982 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -80.74 -12.26 59.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.655 0.74 . . . . 0.0 109.724 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.75 -24.54 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.593 ' HB2' ' HD2' ' A' ' 135' ' ' TYR . 79.5 ttt180 -62.07 -25.42 67.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.176 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 45.1 tp -83.84 -39.93 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.513 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.71 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.538 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.513 ' HG2' ' HB ' ' A' ' 167' ' ' ILE . 22.2 mtmm -86.37 -0.07 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.171 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -100.45 -36.32 9.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.93 0.395 . . . . 0.0 110.477 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.1 t -84.91 91.14 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 110.052 177.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.51 62.28 3.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.748 0.785 . . . . 0.0 110.193 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.81 -152.95 23.17 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.68 94.39 8.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.427 0.614 . . . . 0.0 109.827 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.474 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 9.5 mtmp? -77.49 104.91 8.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 76.3 t -95.12 113.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.484 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.404 ' O ' HD13 ' A' ' 172' ' ' LEU . . . -84.75 117.19 4.44 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 55' ' ' VAL . 22.6 t -105.8 109.15 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -159.01 -177.83 6.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.109 0.48 . . . . 0.0 111.362 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -100.06 166.92 10.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.176 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.5 m -77.02 -22.09 53.59 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -78.79 2.78 18.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.795 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -101.43 -10.78 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.041 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 t -91.63 115.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.503 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 96.3 m-85 -112.08 178.96 4.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -64.13 -76.72 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 110.837 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.654 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 43.2 mtm180 -141.18 132.91 27.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.774 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.756 ' HB3' HD13 ' A' ' 129' ' ' LEU . 52.4 mt -103.5 153.44 38.56 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.577 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.8 101.62 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.131 1.887 . . . . 0.0 111.57 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.765 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -90.57 147.33 23.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.564 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.7 -67.1 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.514 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.69 -85.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.612 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 14.9 m-90 -103.72 66.87 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.894 0.378 . . . . 0.0 111.21 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.05 110.17 18.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.513 ' HB ' ' HG2' ' A' ' 141' ' ' LYS . 19.4 tt -74.06 122.89 88.63 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.472 0.653 . . . . 0.0 111.661 -171.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 21.5 Cg_exo -67.2 154.66 73.56 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.154 2.569 . . . . 0.0 112.851 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -82.75 171.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.975 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -108.82 -46.59 3.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.586 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 46.5 t -123.06 113.51 38.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.686 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.844 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 62.3 tp -100.01 102.65 14.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 110.283 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.1 t -89.91 112.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.217 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.0 p -105.06 -175.93 2.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 12.4 pt-20 -72.69 -15.6 61.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.385 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.53 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 66.1 mttt -119.31 -48.71 2.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.48 168.82 18.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.625 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.426 HG23 HD21 ' A' ' 36' ' ' LEU . 23.3 t -91.81 105.03 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.844 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 11.7 mmt180 -80.25 86.21 5.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -78.34 103.49 8.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt -82.09 37.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.366 0.603 . . . . 0.0 111.164 -173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 182' ' ' ARG . 3.9 mmp_? -109.87 31.39 5.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.234 175.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 185' ' ' ARG . 27.3 t70 -57.09 -50.81 71.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.116 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.36 -9.04 74.73 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.984 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.508 ' HB3' ' OD2' ' A' ' 183' ' ' ASP . 17.7 ttt180 -85.74 105.62 16.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.479 0.64 . . . . 0.0 110.307 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.9 m -139.41 108.24 5.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.196 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.91 146.89 53.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.378 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 16.5 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.777 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -63.67 -14.83 55.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.954 0.407 . . . . 0.0 110.903 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -72.18 -6.64 44.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.226 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -61.28 106.04 0.57 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.815 0.817 . . . . 0.0 110.783 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -171.12 29.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -98.53 125.09 43.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.542 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.433 178.215 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tmm? . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 121.407 0.622 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -82.43 -5.24 58.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.127 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -61.51 -33.66 74.19 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.61 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -80.45 -31.36 37.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 111.184 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.76 -29.66 32.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.86 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' HE2' ' A' ' 9' ' ' LYS . 54.5 tp -58.3 -42.26 86.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 109.563 173.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 129' ' ' LEU . 39.6 ttp180 -58.33 -34.96 71.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.624 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -64.68 -49.18 71.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HE2' HD13 ' A' ' 6' ' ' LEU . 55.6 pttt -72.2 -31.95 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.543 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.544 HG13 ' HB1' ' A' ' 121' ' ' ALA . 86.6 t -69.54 -35.19 65.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.45 ' O ' HG12 ' A' ' 15' ' ' ILE . 54.1 tp -64.97 -51.17 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.802 174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 11.6 t-160 -59.47 -32.58 70.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -77.74 -40.0 42.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 15.8 ttm180 -66.1 -38.07 87.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.673 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.588 HG21 ' HA3' ' A' ' 53' ' ' GLY . 36.9 pt -91.41 7.87 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.784 0.325 . . . . 0.0 111.217 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 9.2 t30 -85.47 -18.43 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 109.612 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.434 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.99 144.7 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 48.6 mt-10 -71.42 -38.55 71.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.04 -39.47 93.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.0 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 24' ' ' ARG . 10.7 tp10 -62.47 -40.77 97.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.717 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -60.68 -41.62 95.49 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 17.1 mmt180 -56.7 -41.64 77.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.433 0.635 . . . . 0.0 110.184 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 21' ' ' GLU . 39.2 ttp180 -71.51 -43.34 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.253 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.73 -38.18 83.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.906 0.384 . . . . 0.0 110.756 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.464 ' HA ' HG12 ' A' ' 55' ' ' VAL . 68.6 m -58.38 -42.14 86.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.598 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.34 -37.83 73.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mtpt -60.97 -52.59 64.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 110.348 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG12 HG11 ' A' ' 150' ' ' VAL . 48.9 t -61.35 -43.88 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.836 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 81.7 mt -61.11 -45.72 98.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -64.68 -33.46 76.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.61 0.243 . . . . 0.0 110.942 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -66.41 -55.17 17.05 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.291 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.48 -31.53 71.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.069 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 23.3 tttp -68.26 -35.26 77.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.0 p -83.69 -14.56 51.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.275 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 38' ' ' GLU . 7.3 tt -58.51 123.34 66.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.847 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -55.63 -44.7 45.56 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.429 2.753 . . . . 0.0 113.452 -172.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 7.6 mp0 -60.95 -25.25 66.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.855 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.74 -36.4 73.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -82.22 -0.54 45.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -106.16 -52.45 2.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -70.08 158.72 35.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.867 -172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -113.31 -34.09 5.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.202 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.03 98.45 11.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.404 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 106.52 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.22 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -97.62 136.76 37.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.49 152.77 42.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' HB2' HG12 ' A' ' 117' ' ' VAL . 7.1 t80 -80.47 -98.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.189 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.67 ' HG ' HG21 ' A' ' 51' ' ' ILE . 49.1 t 177.89 116.46 0.18 Allowed Pre-proline 0 N--CA 1.462 0.154 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -88.46 103.12 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.177 2.585 . . . . 0.0 112.058 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.67 HG21 ' HG ' ' A' ' 49' ' ' CYS . 2.8 pp -118.09 140.99 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.361 177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 71.85 -51.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.267 0.627 . . . . 0.0 111.483 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.588 ' HA3' HG21 ' A' ' 15' ' ' ILE . . . -139.64 -158.68 7.71 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 14' ' ' ARG . 4.2 mm-40 77.34 150.75 0.12 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.974 0.892 . . . . 0.0 112.101 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 26' ' ' SER . 57.1 t -36.85 126.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 112.631 -2.077 . . . . 0.0 112.24 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 30' ' ' ILE . 3.5 m-20 -68.08 76.96 0.23 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.59 -10.3 54.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.838 0.351 . . . . 0.0 110.708 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.463 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -53.87 -49.89 86.91 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 58' ' ' THR . 36.7 Cg_endo -66.0 -8.02 18.72 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.087 1.858 . . . . 0.0 113.526 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.34 -14.09 29.25 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.137 -0.352 . . . . 0.0 110.803 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.484 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.3 m-85 -53.75 -52.35 68.28 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.985 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 53.8 Cg_exo -54.34 -37.11 88.74 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.321 2.014 . . . . 0.0 113.183 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.05 -52.35 36.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.623 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.69 -34.59 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.275 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 88' ' ' PRO . 38.1 tp -66.24 -26.23 67.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.297 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.69 -48.99 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.532 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.39 -45.58 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 111.815 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -123.29 -171.68 2.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.626 -163.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.61 100.93 11.4 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.4 tp -80.52 120.56 24.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.593 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.8 mt -102.42 119.81 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.848 0.356 . . . . 0.0 110.371 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.39 142.59 28.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.536 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HA ' HD21 ' A' ' 82' ' ' LEU . 74.3 Cg_endo -92.24 121.61 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.203 2.602 . . . . 0.0 113.279 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.788 ' HD2' ' HE2' ' A' ' 83' ' ' TYR . 55.9 tttm -105.97 133.97 49.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 102.4 8.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -86.69 -19.49 29.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.952 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 156.91 80.47 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.51 HD22 ' HB2' ' A' ' 135' ' ' TYR . 7.0 t30 70.44 -50.8 0.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.216 0.607 . . . . 0.0 111.103 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.38 156.53 25.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -104.63 131.94 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.055 0.455 . . . . 0.0 111.513 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -111.0 115.65 29.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 73' ' ' PRO . 80.6 mt -82.52 141.15 32.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.266 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.788 ' HE2' ' HD2' ' A' ' 74' ' ' LYS . 18.9 m-85 -112.59 141.62 46.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.187 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.548 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . 27.0 ttt180 -88.15 91.72 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.118 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.17 114.51 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.368 0.604 . . . . 0.0 111.936 -171.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -140.62 14.44 2.34 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 23.3 t -99.99 104.79 31.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.333 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' A' ' 65' ' ' LEU . 24.4 Cg_exo -63.64 -29.58 69.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.154 2.569 . . . . 0.0 113.524 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.55 -16.12 40.46 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.521 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 47.0 t -89.89 76.01 7.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.357 0.599 . . . . 0.0 110.485 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.9 mt -135.82 117.54 15.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.899 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.59 178.6 25.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.713 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.96 134.46 66.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.87 -74.58 0.93 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.842 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.42 153.74 40.01 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.896 -0.179 . . . . 0.0 111.3 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.4 t80 73.7 -47.55 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.656 0.782 . . . . 0.0 111.995 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.96 11.8 1.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.309 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -93.17 166.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.4 mtp -92.23 120.79 33.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.037 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.7 120.89 28.47 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.971 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.01 124.92 14.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.856 2.37 . . . . 0.0 111.575 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.25 -53.22 42.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.15 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.11 136.93 52.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.461 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.05 175.26 40.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.14 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HG2' ' HB3' ' A' ' 84' ' ' ARG . 1.1 pm0 -93.72 141.55 28.37 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 4.1 ptp85 -93.12 139.57 30.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.318 0.58 . . . . 0.0 111.229 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.65 143.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.629 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -92.98 152.92 41.83 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.12 -27.0 27.81 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.224 2.616 . . . . 0.0 113.307 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.17 -38.21 82.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.734 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.31 -13.35 57.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.23 110.84 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.261 0.553 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -80.0 -53.07 7.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.52 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.66 136.6 48.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.526 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.53 139.12 45.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.36 119.97 24.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 48' ' ' TYR . 35.7 m -125.46 139.56 34.23 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.849 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 95.3 Cg_endo -80.84 -174.94 2.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 111.506 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.78 -164.32 23.24 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.359 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.95 -50.0 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 10' ' ' VAL . . . -139.72 140.09 36.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.626 ' CE2' ' HB3' ' A' ' 128' ' ' ARG . 49.3 m-85 -134.67 168.79 18.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.736 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 24.2 p30 -135.27 -170.07 2.51 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.476 HD21 ' NH1' ' A' ' 179' ' ' ARG . 90.0 mt -82.23 -20.69 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.978 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.424 ' CD ' HH12 ' A' ' 162' ' ' ARG . 41.5 mt-10 -92.12 -12.12 33.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.692 0.282 . . . . 0.0 111.353 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.38 12.66 22.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.369 171.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -88.29 146.8 25.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.052 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -131.63 132.59 44.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 160' ' ' LEU . 11.1 mp -104.48 97.59 7.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -102.03 -170.39 27.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.881 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -109.53 124.31 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 172.07 172.85 38.35 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.961 -0.637 . . . . 0.0 111.749 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -156.09 95.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 0.0 109.972 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.44 177.17 27.54 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.51 ' HB2' HD22 ' A' ' 78' ' ' ASN . 96.5 m-85 -94.41 87.71 5.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.421 0.629 . . . . 0.0 110.864 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -87.11 21.44 2.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.078 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -56.34 -42.89 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.776 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -11.6 59.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.269 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 143' ' ' VAL . 61.8 tp -93.19 -73.17 0.57 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.33 -29.14 69.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -83.52 -14.62 51.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 111.292 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -102.06 -15.54 16.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.111 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 139' ' ' LEU . 93.0 t -71.26 123.42 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.44 1.07 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 110.051 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.67 -155.76 10.55 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.754 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.72 120.79 28.4 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.662 -0.316 . . . . 0.0 111.022 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.633 ' HG2' ' OD2' ' A' ' 170' ' ' ASP . 20.3 mmtm -87.04 106.51 17.9 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.44 114.63 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.909 0.385 . . . . 0.0 110.34 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.53 125.35 8.51 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.423 HG11 HG12 ' A' ' 29' ' ' VAL . 39.4 t -102.49 123.43 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.59 155.95 27.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 111.804 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.529 ' O ' HG22 ' A' ' 156' ' ' VAL . 69.0 m-85 -91.27 141.98 28.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.181 174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.3 m -57.3 -26.03 60.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.877 0.736 . . . . 0.0 111.829 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -59.28 -38.7 80.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' A' ' 14' ' ' ARG . 10.4 mm100 -108.28 24.03 13.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.601 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 152' ' ' TYR . 50.2 t -116.75 105.92 19.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.322 0.582 . . . . 0.0 109.454 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 82.2 m-85 -92.65 -178.41 4.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.761 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.95 -61.82 2.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.736 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 3.1 ptm180 -153.08 135.62 15.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.609 HD13 HD12 ' A' ' 129' ' ' LEU . 95.9 mt -98.57 155.26 36.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.748 -174.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.9 117.71 4.56 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.819 2.346 . . . . 0.0 111.199 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 162' ' ' ARG . 6.2 ptp180 -126.24 -179.65 4.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.122 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -105.51 -91.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.45 97.55 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.69 0.281 . . . . 0.0 111.576 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 53.16 78.81 0.13 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.599 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.572 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.6 t0 -83.84 -169.46 2.58 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.74 102.78 6.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.643 0.259 . . . . 0.0 110.387 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 0.9 OUTLIER -83.07 167.11 14.31 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.194 2.596 . . . . 0.0 112.345 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 147' ' ' LYS . 27.3 m -90.39 166.86 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.794 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 147' ' ' LYS . 24.8 m-20 -100.54 -38.04 8.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 110.388 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.47 112.85 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.871 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 35.6 tp -99.71 110.7 23.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.4 120.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.073 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 52.6 p -109.35 179.62 4.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.036 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.435 ' CD ' ' HZ2' ' A' ' 176' ' ' LYS . 1.0 OUTLIER -87.77 9.68 20.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.414 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.435 ' HZ2' ' CD ' ' A' ' 175' ' ' GLU . 62.4 mttp -133.23 -44.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -128.31 167.87 16.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.057 0.456 . . . . 0.0 111.056 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.35 113.38 41.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 92.6 mtt180 -94.01 99.04 11.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -88.64 108.46 19.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.367 0.603 . . . . 0.0 109.977 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.7 mt -102.13 14.42 32.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.58 -37.46 83.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.183 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.38 -53.31 2.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.32 16.77 79.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.951 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -114.66 2.64 14.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.275 0.559 . . . . 0.0 110.007 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.4 m -79.84 -4.7 53.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.324 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.15 149.96 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -74.59 145.94 42.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.61 140.6 57.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -76.11 72.57 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.486 0.66 . . . . 0.0 111.094 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -153.21 133.29 13.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.733 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -123.21 128.22 49.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -80.22 63.45 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.745 0.783 . . . . 0.0 111.571 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.435 177.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 93.1 mt -93.56 133.58 36.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.73 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.87 -30.67 71.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.766 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m -83.14 -30.09 28.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 tm-20 -70.35 -42.32 72.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 10' ' ' VAL . 61.9 tp -61.48 -39.9 92.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.753 174.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.11 77.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.54 -38.32 89.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -62.96 -43.8 97.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 6' ' ' LEU . 21.3 t -67.54 -48.76 75.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.001 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.11 -47.75 68.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.352 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -58.55 -51.39 70.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.033 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.35 -38.65 88.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.119 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.516 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 20.0 ttm180 -58.02 -49.74 75.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.931 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 pt -86.94 -0.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.637 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.35 -10.12 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.143 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.17 136.24 56.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -67.09 156.99 34.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.488 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.1 -55.15 31.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.647 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.88 -45.8 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.163 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.82 -45.51 85.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.582 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -62.62 -46.09 89.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.736 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 21.0 tpt180 -60.06 -36.8 78.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.908 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -38.4 90.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.046 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.58 -51.19 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.799 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -62.54 -34.91 77.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.26 -39.56 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.97 -38.14 87.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.305 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 175' ' ' GLU . 56.2 t -63.75 -47.42 91.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.422 . . . . 0.0 110.487 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.43 -48.13 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.72 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -60.86 -39.11 87.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.09 0.471 . . . . 0.0 110.359 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.19 -53.53 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.03 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.4 -40.61 97.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.87 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -62.61 -32.74 73.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.3 m -83.49 -19.87 35.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.351 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.425 HD21 ' HD2' ' A' ' 37' ' ' PRO . 2.0 tt -52.32 115.53 7.07 Favored Pre-proline 0 CA--C 1.533 0.295 0 O-C-N 123.26 0.35 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HD2' HD21 ' A' ' 36' ' ' LEU . 50.4 Cg_exo -54.78 -32.56 77.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.223 2.615 . . . . 0.0 113.45 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.54 -26.16 30.36 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.025 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -76.04 -14.82 60.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.149 0.976 . . . . 0.0 109.015 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.47 -22.82 40.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.742 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 54.4 mttp -104.69 -12.37 16.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.451 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -64.29 149.36 48.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 111.76 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -109.84 -65.83 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.731 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -91.28 95.29 9.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.703 -176.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.6 t -102.35 108.28 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.692 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -94.65 119.86 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.433 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.4 129.47 52.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' HB3' ' HD3' ' A' ' 118' ' ' PRO . 23.2 t80 -77.79 -2.02 34.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.373 -173.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.9 m 66.12 96.58 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.349 0.595 . . . . 0.0 111.548 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.61 128.06 7.57 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.762 2.308 . . . . 0.0 113.084 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.424 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 38.7 pt -129.51 158.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.437 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 68.5 -66.02 0.25 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.37 0.668 . . . . 0.0 112.481 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.89 21.15 0.37 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.494 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 51' ' ' ILE . 23.2 mm-40 -82.4 36.36 0.47 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.478 ' HA ' ' OH ' ' A' ' 152' ' ' TYR . 47.2 t 68.85 114.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 122.977 0.511 . . . . 0.0 110.528 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -71.53 80.66 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.957 0.884 . . . . 0.0 111.476 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 HG12 ' A' ' 150' ' ' VAL . 86.7 mt -86.08 3.82 40.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -53.92 -46.98 98.36 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 58' ' ' THR . 27.0 Cg_endo -62.99 -11.48 24.88 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.104 1.87 . . . . 0.0 113.332 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.6 tp -92.7 -14.28 28.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 14.9 m-85 -56.75 -48.38 97.37 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.878 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.29 -33.58 56.13 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.331 2.021 . . . . 0.0 113.322 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -71.48 -50.75 28.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.405 . . . . 0.0 110.837 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.63 -37.3 79.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.63 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 86' ' ' HIS . 23.7 tp -67.06 -24.39 65.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -93.81 -53.73 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.18 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -50.63 11.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -100.76 -171.78 2.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.183 0.516 . . . . 0.0 111.123 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -105.21 102.81 12.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.025 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -78.76 114.95 18.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.956 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 61.4 mt -101.39 117.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.059 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.617 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 98.0 mt -113.25 139.99 23.8 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.629 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.0 Cg_exo -74.99 120.04 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.873 2.382 . . . . 0.0 112.093 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 45.0 tttm -116.91 152.78 33.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.13 114.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.493 . . . . 0.0 110.413 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -111.56 107.1 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.147 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.75 39.21 97.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.8 t30 65.91 16.43 10.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.127 0.571 . . . . 0.0 111.114 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.16 136.39 54.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.433 ' HB ' ' CD1' ' A' ' 136' ' ' TYR . 20.4 tt -79.08 135.88 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.422 0.63 . . . . 0.0 111.244 -173.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.3 m -139.93 167.49 21.99 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.3 mt -109.89 131.56 54.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.93 0.395 . . . . 0.0 110.951 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.513 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 26.3 m-85 -117.66 124.12 47.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.193 0.521 . . . . 0.0 110.444 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -93.45 118.54 31.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.861 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.37 154.7 40.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.982 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.61 ' HA ' HD12 ' A' ' 65' ' ' LEU . 1.8 p80 -162.44 47.87 0.16 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.986 0.898 . . . . 0.0 109.119 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.401 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 43.9 m -156.05 160.41 30.81 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.259 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 87' ' ' SER . 41.7 Cg_endo -67.44 166.78 22.54 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.275 1.983 . . . . 0.0 112.601 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' O ' ' SG ' ' A' ' 90' ' ' CYS . . . 65.14 -155.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.788 0.68 . . . . 0.0 111.065 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 89' ' ' ALA . 15.2 p 60.53 6.33 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.717 1.207 . . . . 0.0 112.828 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.6 mt -97.51 149.34 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.36 -172.41 34.48 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.5 t -134.43 119.53 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.41 -33.28 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.238 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.52 -146.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.223 0.209 . . . . 0.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -39.5 -53.21 2.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.0 0.92 . . . . 0.0 112.971 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.56 47.99 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.17 148.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.2 mtt -72.26 93.43 1.47 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.073 0.463 . . . . 0.0 110.234 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.599 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 11.6 pt-20 -102.06 143.64 27.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.229 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.617 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 43.3 Cg_endo -72.27 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.928 1.752 . . . . 0.0 111.171 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.64 -44.19 69.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.11 171.67 7.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.623 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -148.03 19.19 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.909 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 124.32 40.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -75.8 126.8 31.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.178 0.513 . . . . 0.0 111.21 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 91.4 t -122.11 139.24 49.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.594 ' OD1' ' HD2' ' A' ' 109' ' ' PRO . 64.8 t30 -84.42 135.9 40.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.594 ' HD2' ' OD1' ' A' ' 108' ' ' ASN . 5.1 Cg_endo -47.52 -23.67 3.7 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.744 2.962 . . . . 0.0 113.856 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.67 -34.15 72.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 111.234 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.75 -15.67 53.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.584 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.52 116.15 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -93.85 -25.17 17.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.369 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -134.79 122.68 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.413 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.08 139.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.89 0.376 . . . . 0.0 110.692 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.45 108.74 15.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 51.6 t -116.24 120.68 34.7 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.493 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 7.0 Cg_exo -74.57 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.917 2.411 . . . . 0.0 111.94 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.64 128.64 1.2 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 39.7 t -58.01 -40.88 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 111.81 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 129' ' ' LEU . . . -132.42 127.76 36.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.774 0.321 . . . . 0.0 111.091 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -121.62 161.72 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.58 174.41 6.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.02 3.84 47.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 37.6 mt-10 -101.31 -33.96 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.584 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 134.31 16.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.179 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.99 158.64 16.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.526 0.663 . . . . 0.0 111.119 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -115.65 157.68 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.693 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 25.2 tp -97.82 -0.08 45.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.162 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.37 -175.98 45.41 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.969 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -144.11 98.19 3.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.828 0.347 . . . . 0.0 110.207 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.0 -77.3 1.15 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.403 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -121.69 -174.88 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -146.91 95.23 0.17 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.008 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -130.79 -168.51 2.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' CD1' ' HB ' ' A' ' 80' ' ' ILE . 69.6 m-85 65.11 29.62 11.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.68 -31.19 72.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.527 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -57.94 -23.66 54.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 143' ' ' VAL . 13.8 tp -93.58 -59.89 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.231 0.539 . . . . 0.0 109.945 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -33.32 72.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.679 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -75.55 -22.58 56.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.748 0.309 . . . . 0.0 111.307 -175.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -102.85 -15.05 16.33 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.696 -0.402 . . . . 0.0 112.053 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 139' ' ' LEU . 62.0 t -67.92 95.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.193 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -86.44 -4.04 59.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.611 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.57 166.75 15.49 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.109 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 46.8 tp -53.0 111.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.095 0.474 . . . . 0.0 110.778 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -82.88 99.6 9.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.123 -176.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.42 123.99 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -101.25 138.19 13.72 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.566 HG12 HD12 ' A' ' 57' ' ' LEU . 67.3 t -120.89 124.81 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.081 0.441 . . . . 0.0 110.515 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -164.17 167.47 20.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.505 ' O ' HG23 ' A' ' 156' ' ' VAL . 50.5 m-85 -84.34 149.95 25.7 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.305 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 85.0 p -67.55 -25.03 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.368 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -58.64 -26.53 63.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.025 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.516 ' OE1' ' HB2' ' A' ' 14' ' ' ARG . 21.3 mm-40 -115.42 11.98 16.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.881 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 152' ' ' TYR . 88.1 t -108.46 114.3 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.191 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 91.4 m-85 -94.84 157.09 16.08 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.836 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -54.75 -54.55 40.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -147.22 150.73 35.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.027 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.08 158.54 72.49 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.889 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.47 112.66 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.955 1.77 . . . . 0.0 110.586 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 162' ' ' ARG . 16.6 ttp180 -73.52 131.73 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.642 -170.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.38 -166.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.913 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.97 107.29 15.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.201 0.524 . . . . 0.0 110.857 -174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 79.62 13.07 1.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.076 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.85 123.35 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.0 tt -76.2 116.83 59.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.382 0.611 . . . . 0.0 111.27 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 8.2 Cg_exo -72.15 150.37 53.66 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.996 2.464 . . . . 0.0 112.547 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.472 HG12 ' HG3' ' A' ' 147' ' ' LYS . 34.3 m -86.02 148.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.57 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 182' ' ' ARG . 16.9 t70 -87.35 -40.77 14.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.411 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.701 HG23 ' HG2' ' A' ' 180' ' ' ARG . 61.0 t -120.08 130.44 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.437 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 53.7 tp -111.51 115.92 30.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.054 0.454 . . . . 0.0 110.082 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.1 111.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.352 0.596 . . . . 0.0 109.766 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -109.01 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.264 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 29' ' ' VAL . 9.9 pt-20 -54.9 -34.26 62.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.892 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.419 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 47.2 mttm -87.49 -58.64 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.306 -171.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -155.53 174.72 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.85 121.59 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.802 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -126.33 119.15 26.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' HG23 ' A' ' 171' ' ' VAL . 57.1 mtt180 -81.87 139.5 34.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.406 ' HB2' ' H ' ' A' ' 182' ' ' ARG . 38.9 mt -104.97 -97.06 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.476 ' HD2' ' OD2' ' A' ' 170' ' ' ASP . 35.7 ttt85 70.99 -49.18 0.68 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 170.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.01 115.22 5.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.825 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -141.24 103.42 0.34 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.743 ' HE ' ' HA ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -90.41 78.93 6.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.352 0.596 . . . . 0.0 110.394 -177.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.6 p -112.52 -28.71 7.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.718 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.4 mt 57.57 31.19 19.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.222 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.76 93.84 0.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.066 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -144.16 105.18 4.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.987 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -65.39 113.53 4.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -132.66 136.91 46.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -135.44 110.26 8.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -54.34 -59.98 3.95 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.2 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.276 176.153 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 10.7 mp 61.87 95.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.685 0.615 . . . . 0.0 110.823 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -70.33 -35.72 73.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.875 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 t -72.63 -29.87 63.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.247 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 2' ' ' LEU . 1.8 mp0 -89.24 -25.33 21.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.823 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.69 -44.95 93.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.62 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -66.55 -24.06 66.3 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.865 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 5' ' ' GLU . 98.6 mttt -73.16 -43.19 61.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.311 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.6 -29.56 70.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.6 HG12 ' NE2' ' A' ' 155' ' ' GLN . 77.1 t -75.63 -55.24 12.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.749 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -46.05 91.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.504 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -66.54 -21.23 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.111 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -76.56 -46.71 25.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.47 . . . . 0.0 110.496 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 36.7 mtm180 -73.2 -29.7 63.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.861 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -80.81 3.0 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.929 0.395 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -117.16 -98.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.4 mt 58.38 173.06 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.513 0.673 . . . . 0.0 111.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 m -76.37 123.34 25.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.06 -29.1 60.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.401 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.8 mp0 -63.53 -45.04 92.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.12 -50.13 74.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.445 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -52.55 -44.67 65.98 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.774 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.85 -47.16 69.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 2.6 ptt85 -73.53 -19.72 60.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.449 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 48.8 mt -78.0 -40.67 38.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 172.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -60.91 -35.19 76.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.403 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 28' ' ' LYS . 1.1 tm-20 -57.66 -41.15 80.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 46.6 mmtm -69.61 -42.65 74.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.572 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.0 t -62.33 -45.92 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.08 -44.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.673 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.5 m -60.37 -38.51 84.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -71.19 -47.24 58.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD13 ' HZ ' ' A' ' 114' ' ' PHE . 49.6 tp -62.61 -38.93 92.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.013 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.21 -16.71 54.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.162 0.506 . . . . 0.0 110.513 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.5 t -75.89 -25.76 56.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.705 HD21 HG23 ' A' ' 178' ' ' VAL . 58.4 mt -55.66 130.78 71.65 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.083 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.6 Cg_exo -64.87 -21.37 64.31 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.63 2.22 . . . . 0.0 111.456 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 2.5 mp0 -69.45 -24.72 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.856 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -68.18 -29.25 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 109.51 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.18 -29.33 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.039 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . 62.4 mttp -63.86 -38.92 92.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.965 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 t -90.78 136.43 33.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.645 0.736 . . . . 0.0 112.038 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -92.31 -17.57 24.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.361 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HB3' HD11 ' A' ' 71' ' ' ILE . 78.9 mttt -121.2 97.29 5.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.764 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.02 107.51 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HB ' ' A' ' 71' ' ' ILE . . . -98.41 130.2 45.04 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.996 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.91 130.14 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.06 4.5 14.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.269 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 18.6 t 71.32 125.62 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.29 0.636 . . . . 0.0 111.181 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 4.4 Cg_exo -77.84 45.32 1.75 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.221 2.614 . . . . 0.0 112.929 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 52' ' ' LYS . 2.1 pp -61.28 -32.08 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' N ' HD11 ' A' ' 51' ' ' ILE . 72.5 mmtt -136.33 33.63 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.44 146.71 18.33 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.683 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 7.2 pt-20 -83.71 -15.57 48.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.088 0.47 . . . . 0.0 111.241 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.87 132.23 54.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.735 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.87 86.76 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.98 0.419 . . . . 0.0 110.273 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -88.92 -1.17 57.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.274 0.559 . . . . 0.0 110.25 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -61.08 -47.09 96.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.02 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 58' ' ' THR . 51.0 Cg_endo -69.68 -5.32 15.87 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.592 1.528 . . . . 0.0 113.236 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.7 tp -88.73 -20.61 24.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.82 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.0 m-30 -49.73 -52.22 53.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 83.4 Cg_exo -50.28 -40.36 52.37 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.551 2.167 . . . . 0.0 113.362 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 17.0 tt0 -78.27 -37.44 45.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.349 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 70' ' ' LEU . 61.1 t -60.16 -44.83 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.4 -27.02 68.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.988 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 63' ' ' GLU . 31.9 ttpt -74.16 -36.01 64.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.783 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -95.9 -67.32 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.194 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -124.98 -171.79 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.43 . . . . 0.0 111.981 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.01 118.31 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.153 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.495 HD13 HG12 ' A' ' 64' ' ' VAL . 58.6 tp -94.36 107.96 19.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 44' ' ' LYS . 61.8 mt -89.0 116.93 31.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.439 HD12 HG21 ' A' ' 85' ' ' VAL . 91.4 mt -115.2 151.31 45.63 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 80' ' ' ILE . 5.2 Cg_exo -80.51 127.43 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 112.916 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 101' ' ' PRO . 25.6 tptp -105.8 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -85.61 103.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.876 0.37 . . . . 0.0 110.678 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.83 78.06 1.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.688 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.26 -80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.007 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.464 ' ND2' ' HG3' ' A' ' 79' ' ' GLU . 3.2 p-10 -123.72 -16.26 6.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' CB ' ' A' ' 135' ' ' TYR . 21.0 mt-10 -126.53 167.42 15.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.493 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.511 ' HB ' HD23 ' A' ' 139' ' ' LEU . 65.3 mt -118.43 126.9 75.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 -175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.7 m -96.65 134.46 39.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.289 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 109' ' ' PRO . 98.1 mt -90.43 131.83 35.97 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.57 147.81 44.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.313 0.578 . . . . 0.0 111.939 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' HD3' ' OE1' ' A' ' 105' ' ' GLU . 39.6 ttt180 -81.6 108.59 15.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.121 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 90' ' ' CYS . 47.3 t -110.07 118.08 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.108 0.48 . . . . 0.0 110.486 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -124.65 -29.19 3.47 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 15.9 m -89.85 126.3 58.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.25 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.1 Cg_exo -61.29 -12.56 24.17 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.196 2.597 . . . . 0.0 113.011 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 4.22 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.853 0.359 . . . . 0.0 111.417 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.478 ' HB3' HG13 ' A' ' 85' ' ' VAL . 49.0 t -88.67 -0.51 57.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 111.073 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.95 113.32 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.021 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.56 158.71 22.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.966 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 61.5 t -79.71 127.99 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 0.0 110.244 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.582 ' HA3' ' OE2' ' A' ' 100' ' ' GLU . . . -81.98 -131.1 1.36 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.655 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.72 2.83 22.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.06 30.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.453 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.28 76.96 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.457 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 24.1 pt -114.1 163.92 10.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.53 119.02 38.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 110.504 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' OE2' ' HA3' ' A' ' 94' ' ' GLY . 8.5 pt-20 -138.87 155.06 73.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.529 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.614 ' O ' ' HD3' ' A' ' 74' ' ' LYS . 33.5 Cg_endo -64.65 120.45 7.73 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.308 2.672 . . . . 0.0 113.398 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.36 -37.39 7.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 11.6 mm-40 -136.37 109.63 7.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.058 0.456 . . . . 0.0 111.78 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.17 43.68 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.544 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 21.1 mp0 -81.49 121.44 26.29 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -70.25 132.52 45.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 109.956 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.87 133.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.624 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.87 132.97 95.05 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . 50.2 Cg_exo -55.2 -33.03 82.96 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.573 2.182 . . . . 0.0 112.674 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -71.75 -19.72 61.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.718 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' A' ' 44' ' ' LYS . 23.9 t70 -80.95 -17.5 50.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.394 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.45 ' HB ' HG12 ' A' ' 143' ' ' VAL . 93.9 t -60.88 131.76 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.265 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.74 -41.59 7.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.522 ' HZ ' HD13 ' A' ' 33' ' ' LEU . 54.0 t80 -132.9 130.45 39.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.276 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.52 138.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 110.894 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.92 115.95 28.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.82 118.6 36.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.37 90.69 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.301 175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.1 156.54 53.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.004 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.485 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 48.8 t -63.76 -47.72 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.44 157.93 34.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.97 156.34 46.36 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.11 0.257 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -109.67 -171.71 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 94.1 mt -79.37 6.03 11.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -119.85 -36.71 3.24 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.63 11.95 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.576 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -95.52 167.18 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.57 -162.49 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.776 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 HD11 ' HD2' ' A' ' 161' ' ' PRO . 35.8 tp -118.04 20.2 13.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.651 0.739 . . . . 0.0 109.748 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.73 -179.62 49.1 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.245 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -142.81 -33.53 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.97 174.07 33.36 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -100.33 129.74 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.7 -134.75 2.32 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.512 ' CB ' ' HG2' ' A' ' 79' ' ' GLU . 88.3 m-85 -128.95 10.81 5.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.0 110.296 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -70.57 -38.94 74.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.18 -33.73 70.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.985 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -66.3 -30.8 71.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.772 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.511 HD23 ' HB ' ' A' ' 80' ' ' ILE . 48.2 tp -67.42 -45.29 76.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.29 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.82 -38.52 75.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.877 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 167' ' ' ILE . 55.7 tttm -81.14 -21.67 39.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.247 0.546 . . . . 0.0 110.465 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.514 ' HG2' ' HB2' ' A' ' 109' ' ' PRO . 30.0 ttp180 -77.35 -24.61 50.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.951 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.45 HG12 ' HB ' ' A' ' 112' ' ' VAL . 75.6 t -78.66 118.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.724 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.487 ' HZ1' ' HB2' ' A' ' 144' ' ' LYS . 3.6 ttmp? -97.16 -2.02 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 110.785 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.58 -179.23 41.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.03 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.37 122.52 17.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.364 . . . . 0.0 110.57 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.72 109.64 21.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 171' ' ' VAL . 80.9 t -107.68 128.95 62.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.562 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -100.54 122.31 7.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.37 114.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.538 0.169 . . . . 0.0 110.629 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.16 164.63 32.75 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.501 0.501 . . . . 0.0 110.13 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 75.6 m-85 -86.76 158.44 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.511 . . . . 0.0 111.051 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.7 p -61.79 -25.95 67.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.792 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -77.1 -9.23 58.6 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.635 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.6 ' NE2' HG12 ' A' ' 10' ' ' VAL . 8.5 mm100 -108.54 9.4 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.27 116.69 44.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -111.18 179.7 3.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.799 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 30.4 mt-10 -70.8 -68.71 0.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 0.0 111.273 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.75 117.2 13.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.314 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.83 154.05 37.99 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.456 ' HD2' HD11 ' A' ' 129' ' ' LEU . 49.9 Cg_exo -56.14 111.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.259 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -88.31 151.07 22.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.675 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.24 143.15 50.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.18 -15.9 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -110.98 13.12 22.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -89.93 115.3 27.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 141' ' ' LYS . 40.3 mt -74.77 112.09 16.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.666 -172.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.94 163.75 28.16 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.547 2.165 . . . . 0.0 112.209 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.45 HG22 HD13 ' A' ' 181' ' ' LEU . 28.6 m -103.6 166.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.637 177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.33 -41.02 6.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.258 0.551 . . . . 0.0 110.588 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 148' ' ' VAL . 61.8 t -116.84 120.67 65.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.405 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.8 tp -101.05 114.08 27.68 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 122.36 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.654 ' HB ' ' OE1' ' A' ' 175' ' ' GLU . 46.6 p -111.37 -168.3 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.654 ' OE1' ' HB ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -72.29 -25.17 61.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.113 0.482 . . . . 0.0 110.215 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -115.11 -47.56 2.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.401 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.42 172.99 11.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.309 0.576 . . . . 0.0 112.053 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.705 HG23 HD21 ' A' ' 36' ' ' LEU . 98.9 t -126.06 115.03 41.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.632 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -100.03 116.38 31.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -73.71 95.03 2.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.866 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.45 HD13 HG22 ' A' ' 169' ' ' VAL . 69.6 mt -69.0 -41.78 77.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 62.45 99.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.91 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -77.27 -35.69 54.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.077 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.91 90.89 1.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.024 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.89 -176.81 5.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.644 0.259 . . . . 0.0 110.799 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.2 m -62.79 114.17 3.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.7 tp -88.16 132.96 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.676 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 190' ' ' HIS . 19.4 mm-40 64.66 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.678 0.611 . . . . 0.0 111.318 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 74.85 -29.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.607 0.763 . . . . 0.0 111.701 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 188' ' ' GLU . 58.6 m80 -97.08 -51.51 4.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 110.567 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -74.35 105.18 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.493 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -178.5 -61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.501 0.501 . . . . 0.0 110.403 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -159.09 139.88 12.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.315 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 59.4 m170 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.665 173.537 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.727 0.299 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 88.6 mt -74.66 161.86 29.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -70.86 -52.04 22.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.807 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -66.5 -24.63 66.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.469 . . . . 0.0 110.036 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 42.4 tt0 -58.37 -54.66 44.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.424 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.68 -35.77 75.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.168 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.15 -42.7 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.962 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.13 -42.76 99.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.108 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 26.8 mtpp -63.94 -51.89 62.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.61 -44.78 97.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.99 -35.79 77.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.426 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 24.8 t-80 -67.04 -37.8 84.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.371 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 7.4 mtpm? -66.27 -31.68 72.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 110.44 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 50.8 mtt180 -63.34 -54.45 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.176 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.673 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 27.0 pt -88.03 5.88 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.161 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -84.28 -30.83 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.28 144.99 55.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.863 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.5 m -71.79 151.21 43.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.703 0.287 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 22' ' ' ARG . 5.1 tp10 -59.44 -36.61 76.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.589 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 50.7 mt-10 -55.23 -52.55 63.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.088 0.471 . . . . 0.0 110.623 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.11 -39.81 95.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.379 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.673 ' NH1' ' HA ' ' A' ' 15' ' ' ILE . 23.6 mtm180 -65.76 -39.13 90.74 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.37 -37.5 87.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.0 110.841 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 49.5 mtt85 -69.56 -48.27 60.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -67.79 -43.36 79.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.451 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.478 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.6 t -62.03 -43.75 98.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.896 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.75 -35.44 81.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.848 0.356 . . . . 0.0 110.124 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.697 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 33.2 ttmt -59.02 -44.5 91.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.441 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 25' ' ' LEU . 42.9 t -67.76 -39.48 82.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 26' ' ' SER . 80.8 mt -61.41 -49.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -64.72 -37.19 86.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.13 -39.44 94.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.242 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD12 ' HZ ' ' A' ' 114' ' ' PHE . 46.8 tp -65.79 -34.18 77.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.475 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 45.9 mtpt -72.76 -25.52 61.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -78.89 -21.3 47.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.902 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 38' ' ' GLU . 2.4 tt -58.28 121.46 52.01 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.134 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD2' HD21 ' A' ' 36' ' ' LEU . 69.4 Cg_exo -52.89 -37.71 77.84 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.309 2.672 . . . . 0.0 114.058 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.504 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -18.57 58.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.11 -15.65 63.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.967 0.413 . . . . 0.0 111.2 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -76.41 -45.34 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.748 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -74.69 -35.8 62.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.1 p -73.39 95.99 2.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.293 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' HE2' ' HG3' ' A' ' 69' ' ' GLU . 79.1 tttt -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 111' ' ' ASP . 40.5 mttm -99.23 101.55 12.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.458 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.95 114.98 48.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -96.66 134.49 39.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.509 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -120.17 136.03 54.76 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.871 ' HB2' HG13 ' A' ' 117' ' ' VAL . 26.0 t80 -74.67 -10.67 59.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.019 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.2 t 67.84 106.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.406 0 CA-C-O 121.3 0.572 . . . . 0.0 110.824 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.65 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 76.1 Cg_endo -78.08 151.14 26.89 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.616 2.211 . . . . 0.0 113.437 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -134.85 166.66 27.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.257 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 34.4 mtpt 64.59 8.63 4.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.327 0.392 . . . . 0.0 111.556 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.24 -106.58 2.41 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.583 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 70.4 mt-10 61.66 -83.44 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.616 0.767 . . . . 0.0 110.764 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 150' ' ' VAL . 51.2 t -132.8 96.18 2.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 104.71 15.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.65 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 91.6 mt -95.91 3.73 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.671 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.3 m -59.17 -39.5 73.75 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 58' ' ' THR . 50.2 Cg_exo -57.78 -9.71 6.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.175 1.916 . . . . 0.0 114.136 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.8 tp -84.92 -12.93 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.622 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m-30 -54.99 -53.85 56.74 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.644 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 84.4 Cg_exo -52.59 -31.39 49.3 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.73 2.286 . . . . 0.0 113.476 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.0 -43.78 51.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 68' ' ' LYS . 84.0 t -72.98 -42.43 59.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.606 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt -65.93 -5.78 10.38 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 62' ' ' PRO . 63.4 mttp -66.1 -57.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.588 0.233 . . . . 0.0 110.903 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.45 -17.83 1.3 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HB2' HG12 ' A' ' 64' ' ' VAL . 68.0 mttm -91.69 173.64 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.003 0.43 . . . . 0.0 110.888 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG3' ' HE2' ' A' ' 43' ' ' LYS . 42.7 mt-10 -100.93 118.7 37.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.453 175.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.54 111.01 21.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 59.5 mt -97.89 112.37 29.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 98.1 mt -114.78 145.07 33.17 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.199 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.39 132.24 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.009 2.473 . . . . 0.0 112.544 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.868 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 5.5 mtpp -105.76 125.89 51.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.985 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.85 89.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.19 17.59 19.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.991 175.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.4 -121.22 2.13 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.78 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -91.14 -10.09 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 0.0 111.185 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -105.18 109.34 21.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.306 0.574 . . . . 0.0 110.285 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.572 HD13 ' HD1' ' A' ' 136' ' ' TYR . 57.1 mt -87.38 110.86 21.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.868 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 19.3 m -82.98 106.8 15.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.879 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 139' ' ' LEU . 94.4 mt -74.65 100.54 3.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 1.2 m-85 -96.11 116.22 28.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.617 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 3.0 ptp180 -83.89 124.29 30.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 101' ' ' PRO . 58.0 t -135.82 133.16 51.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -118.43 -9.98 10.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.5 m -91.4 136.58 26.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.483 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.6 Cg_exo -77.86 165.6 26.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.932 2.422 . . . . 0.0 112.105 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.72 4.76 3.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.1 m -95.94 28.25 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.786 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -113.62 138.39 50.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.03 143.37 15.04 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -91.3 128.15 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.92 -163.12 26.87 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 96' ' ' PHE . . . 47.63 78.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 77.7 t80 72.71 -50.83 0.7 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.879 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.94 36.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.061 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.39 172.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.2 ptm -123.75 99.34 6.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.396 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 5.3 pt-20 -96.67 159.0 32.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.343 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.516 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.14 116.3 4.34 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.48 2.12 . . . . 0.0 111.429 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.23 -22.14 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 110.55 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.38 152.78 51.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.005 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.66 -153.17 25.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -141.44 135.64 30.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.024 0.412 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -77.23 127.16 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.14 160.97 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.322 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.03 145.93 78.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.543 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.01 -17.15 10.41 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.391 2.727 . . . . 0.0 113.456 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.37 -29.73 70.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.061 0.458 . . . . 0.0 110.686 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 21.3 t70 -83.49 -10.35 58.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.83 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.57 95.55 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.401 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.33 -32.41 33.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.093 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.58 ' HZ ' HD12 ' A' ' 33' ' ' LEU . 42.7 t80 -137.51 138.82 40.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.427 HG12 HG12 ' A' ' 117' ' ' VAL . 16.0 tt -146.88 140.54 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.751 0.31 . . . . 0.0 110.401 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.13 112.34 18.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.871 HG13 ' HB2' ' A' ' 48' ' ' TYR . 27.3 m -126.33 128.63 24.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.429 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.33 108.81 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.429 2.086 . . . . 0.0 111.485 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.58 157.04 18.28 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.452 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.81 109.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.18 134.52 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.135 0.897 . . . . 0.0 112.512 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.14 146.09 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.886 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -103.27 -172.38 2.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.422 . . . . 0.0 111.219 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.939 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 70.5 mt -79.45 -3.97 49.03 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -105.56 -38.11 6.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.853 0.358 . . . . 0.0 110.284 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.6 11.65 1.67 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.682 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.58 168.4 11.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.304 0.552 . . . . 0.0 110.233 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -153.63 135.18 14.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.571 -166.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.9 tp -58.57 -64.74 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.956 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.99 171.03 22.44 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.321 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.3 -62.22 1.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.619 0.247 . . . . 0.0 110.995 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.51 -51.93 2.6 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.537 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 129' ' ' LEU . 33.7 tptt 73.53 112.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.555 0.742 . . . . 0.0 111.237 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 19.65 55.89 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.963 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.09 -80.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.666 -175.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.572 ' HD1' HD13 ' A' ' 80' ' ' ILE . 31.9 m-85 -78.08 -23.73 47.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -22.63 65.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -69.93 -13.77 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 110.583 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 82' ' ' LEU . 48.5 tp -89.81 -42.89 11.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.423 ' O ' ' HD3' ' A' ' 147' ' ' LYS . 94.2 mt -57.05 -38.68 73.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.667 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -64.72 -26.97 68.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.94 -18.25 29.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.051 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.07 114.72 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -90.45 -6.06 55.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.382 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.72 43.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.39 109.58 11.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.963 0.411 . . . . 0.0 110.261 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 140' ' ' LEU . 32.6 mtmm -82.71 103.12 11.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.829 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.483 HG21 ' HB ' ' A' ' 171' ' ' VAL . 84.9 t -99.05 122.37 50.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.677 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -94.7 133.32 11.52 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.681 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.463 ' CG1' HG11 ' A' ' 55' ' ' VAL . 43.5 t -107.64 120.07 58.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.95 154.73 40.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.042 0.449 . . . . 0.0 111.898 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.96 160.9 21.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.836 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 m -55.37 -27.58 48.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.599 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.0 -15.76 63.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.664 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -99.43 -6.22 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.414 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 45.0 t -91.64 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.8 -176.63 2.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.151 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.939 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 33.8 mt-10 -90.79 -66.98 0.88 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -125.4 115.04 19.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.18 143.57 26.86 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.94 101.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.776 1.651 . . . . 0.0 110.165 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -109.74 177.14 4.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.196 -172.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.71 168.3 10.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.454 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.69 64.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -102.39 66.19 0.97 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.571 0.701 . . . . 0.0 109.339 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.66 162.82 12.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.633 HD11 ' HD2' ' A' ' 168' ' ' PRO . 3.9 tp -138.99 111.52 8.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.139 0.495 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.633 ' HD2' HD11 ' A' ' 167' ' ' ILE . 72.5 Cg_endo -77.27 173.56 14.15 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.667 2.245 . . . . 0.0 112.572 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 181' ' ' LEU . 21.1 m -112.17 151.98 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.211 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.03 -30.16 34.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.179 0.514 . . . . 0.0 110.083 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.484 HG12 HD11 ' A' ' 36' ' ' LEU . 49.0 t -142.22 135.03 27.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.648 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 179' ' ' ARG . 61.0 tp -114.33 118.34 33.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.519 HG23 HG12 ' A' ' 178' ' ' VAL . 63.2 t -109.22 123.22 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.185 0.517 . . . . 0.0 110.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 75.1 p -108.46 -164.86 0.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.601 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.697 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 5.7 pt-20 -73.16 -22.33 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.654 0.264 . . . . 0.0 110.98 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.499 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 64.8 mttp -122.26 -61.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.758 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.98 141.03 30.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.216 0.531 . . . . 0.0 112.037 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 173' ' ' VAL . 57.6 t -109.47 102.32 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.658 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.743 HH22 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mtp-105 -85.69 99.82 11.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.423 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -76.34 92.39 3.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 169' ' ' VAL . 88.0 mt -81.23 6.05 15.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.782 -170.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -71.24 -20.66 62.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.03 80.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.545 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -130.43 79.69 0.36 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.67 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -148.42 17.81 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.73 0.776 . . . . 0.0 109.874 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.0 p -76.94 -27.42 54.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.812 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.05 -67.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -85.72 85.34 7.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.532 0.682 . . . . 0.0 110.117 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -102.51 108.32 19.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.446 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.32 11.5 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.48 -174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -111.98 161.61 16.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -87.66 -62.25 1.54 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -172.63 176.74 3.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.836 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.57 175.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.867 0.365 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -133.68 86.0 2.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.681 0.277 . . . . 0.0 111.34 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -95.42 -45.48 7.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 0.0 109.719 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -58.85 -55.08 39.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.065 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' HG2' ' HD2' ' A' ' 9' ' ' LYS . 37.9 tt0 -59.04 -52.54 65.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.49 -46.31 90.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 131' ' ' PHE . 8.0 tmm_? -58.67 -45.68 88.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.038 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.01 -45.11 71.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.437 -175.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 13.4 ptmm? -70.36 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.583 HG11 ' HB1' ' A' ' 121' ' ' ALA . 84.0 t -70.14 -35.19 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.004 0.431 . . . . 0.0 110.467 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.74 -46.57 87.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.269 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' HA ' HG12 ' A' ' 15' ' ' ILE . 33.8 t-80 -66.76 -34.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.682 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 68.8 mmtt -51.88 -41.48 61.94 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.455 0.472 . . . . 0.0 111.144 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' NH2' ' HB3' ' A' ' 54' ' ' GLU . 36.7 ttp180 -72.85 -38.36 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 12' ' ' HIS . 34.0 pt -90.71 -9.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.554 ' C ' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -93.09 -6.51 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.536 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 13' ' ' LYS . 98.7 mt -67.4 161.02 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.602 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.7 m -62.74 127.27 30.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.335 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.9 -42.49 90.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.648 0.261 . . . . 0.0 111.356 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -67.99 -32.18 72.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.954 0.407 . . . . 0.0 110.089 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' CB ' ' HB2' ' A' ' 18' ' ' SER . 9.7 tp10 -63.13 -50.57 69.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.259 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 18' ' ' SER . 72.3 mtp180 -60.41 -37.45 80.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.94 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -56.74 -50.68 71.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.532 . . . . 0.0 110.527 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.95 -33.19 73.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.022 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.7 mt -69.58 -47.15 64.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.657 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.6 m -63.34 -31.71 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -56.76 -42.45 79.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.145 0.498 . . . . 0.0 110.255 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.56 -34.3 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 175' ' ' GLU . 66.0 t -62.19 -47.96 90.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.517 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 72.0 mt -57.48 -46.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.144 0.497 . . . . 0.0 110.097 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -61.76 -38.47 88.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.87 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.33 -43.66 81.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 0.0 110.324 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.535 HD12 HD13 ' A' ' 36' ' ' LEU . 40.2 tp -61.26 -36.68 80.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.365 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.39 -13.77 59.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.004 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.7 m -82.61 -23.43 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.535 HD13 HD12 ' A' ' 33' ' ' LEU . 74.3 mt -61.8 118.61 40.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.093 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.21 -23.0 53.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.417 2.078 . . . . 0.0 110.774 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.08 -31.26 70.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.312 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.22 -24.96 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -70.49 -49.62 46.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -72.34 -26.28 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.707 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 114' ' ' PHE . 31.1 m -71.26 98.04 1.66 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 30.9 mtmm -86.35 -25.16 25.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.23 -171.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -110.48 108.58 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 t -109.02 113.05 43.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 71' ' ' ILE . . . -96.5 124.58 40.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.483 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.75 130.99 55.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.25 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -72.62 -27.57 62.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.8 t 72.24 133.73 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.855 0.722 . . . . 0.0 111.226 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 14.4 Cg_exo -69.36 140.59 44.55 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.677 2.251 . . . . 0.0 111.824 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 pt -124.15 -27.58 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 18.6 tptt -124.38 -35.73 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.628 . . . . 0.0 110.41 -175.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.51 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 138.53 88.13 0.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -121.07 -87.15 0.65 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG22 HG11 ' A' ' 150' ' ' VAL . 58.6 t -135.09 131.58 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.3 96.57 4.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.294 0.569 . . . . 0.0 110.688 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.57 13.67 20.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.496 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -66.34 -44.8 58.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.536 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 58' ' ' THR . 42.5 Cg_endo -68.81 -0.96 6.84 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.769 1.646 . . . . 0.0 112.773 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 63' ' ' GLU . 60.0 tp -92.07 -17.26 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 30.9 m-85 -50.93 -51.27 68.76 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.8 Cg_endo -56.64 -41.6 74.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.192 1.928 . . . . 0.0 112.471 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HB2' HD13 ' A' ' 60' ' ' LEU . 6.1 mt-10 -66.5 -36.34 82.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.52 -41.79 91.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.434 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 86' ' ' HIS . 65.1 mt -66.3 -14.19 61.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -82.15 -61.9 1.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.99 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -93.04 -29.66 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 27.1 mmtp -124.45 -174.47 3.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.536 0.684 . . . . 0.0 112.234 -166.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.06 128.24 48.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.975 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 112.63 24.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 44' ' ' LYS . 61.5 mt -98.41 117.64 43.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.923 0.392 . . . . 0.0 110.101 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.8 mt -118.96 133.97 23.64 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -84.25 123.17 2.99 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.722 2.281 . . . . 0.0 112.621 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 57.0 tttm -105.42 101.48 11.01 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -82.15 92.72 2.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.313 0.578 . . . . 0.0 109.846 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -101.21 107.15 18.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.236 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.28 -90.97 0.92 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.59 11.61 1.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 109.828 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.22 120.51 40.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.27 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.649 HD12 ' HD1' ' A' ' 136' ' ' TYR . 56.7 mt -85.07 99.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.331 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -95.97 112.11 23.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.68 131.14 35.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.07 144.93 48.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.421 0.629 . . . . 0.0 111.697 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -90.65 96.81 10.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.693 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.0 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' HA ' HD21 ' A' ' 65' ' ' LEU . 1.7 t60 -136.39 16.28 3.18 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -121.31 120.0 29.23 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.023 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.96 -8.62 22.55 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.622 2.215 . . . . 0.0 112.307 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.32 12.46 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.4 t -95.69 -144.93 0.27 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.6 mt 64.57 113.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.799 0.687 . . . . 0.0 112.616 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.95 127.08 4.28 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.18 110.2 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.934 0.367 . . . . 0.0 110.279 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.91 -98.94 0.65 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.014 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.455 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . -60.03 127.23 30.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.322 0.249 . . . . 0.0 111.638 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.7 t80 70.47 -38.55 0.42 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.021 0.826 . . . . 0.0 112.061 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ALA . . . 130.07 10.02 2.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.926 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 pt -91.34 172.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.725 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtm -93.42 100.71 12.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.651 ' HB3' ' HE2' ' A' ' 74' ' ' LYS . 43.2 mt-10 -84.86 132.34 46.38 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.438 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 24.5 Cg_exo -64.15 114.26 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.388 2.059 . . . . 0.0 111.426 174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.79 -17.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.317 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -148.1 150.27 33.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.3 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.06 -158.45 27.74 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.811 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -112.44 161.65 16.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -89.26 126.14 35.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.36 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.58 130.66 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 110.738 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.69 152.23 38.99 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.58 -23.71 41.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.66 -22.07 66.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 44' ' ' LYS . 4.7 t70 -94.7 -3.41 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.229 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.92 112.63 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.239 0.543 . . . . 0.0 111.527 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -60.18 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.187 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.686 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 21.3 t80 -134.84 139.61 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.9 139.2 41.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.5 111.65 21.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.497 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 46.1 t -117.89 108.62 42.35 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.18 62.74 8.12 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.206 2.604 . . . . 0.0 111.299 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.06 169.13 22.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.436 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.29 107.35 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB1' HG11 ' A' ' 10' ' ' VAL . . . 71.99 133.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.275 0.984 . . . . 0.0 112.335 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.36 165.24 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.244 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.517 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -135.12 -178.72 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.443 HD11 ' HG2' ' A' ' 158' ' ' GLU . 90.6 mt -74.46 -12.72 60.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.496 ' HB2' ' NH1' ' A' ' 159' ' ' ARG . 7.0 tp10 -81.97 -42.16 19.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.08 24.9 2.88 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.192 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -101.31 -176.41 3.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.126 0.489 . . . . 0.0 111.381 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -122.2 -171.84 2.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.556 -173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 40.6 tp -120.69 143.21 48.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.484 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.79 103.99 1.15 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.773 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.605 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 87.4 t80 -69.64 -36.81 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 111.397 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.24 -108.95 2.0 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.686 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -78.27 85.13 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 110.592 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.62 50.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -78.13 83.53 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.167 0.508 . . . . 0.0 111.079 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.649 ' HD1' HD12 ' A' ' 80' ' ' ILE . 66.1 m-85 -108.95 19.7 19.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.683 0.754 . . . . 0.0 108.969 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.77 -34.73 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.068 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -55.91 -34.42 65.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.116 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.584 ' O ' HG21 ' A' ' 143' ' ' VAL . 56.9 tp -84.75 -54.14 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.64 ' HB3' HG23 ' A' ' 167' ' ' ILE . 96.9 mt -57.37 -38.55 74.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.8 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.626 ' HD3' HG13 ' A' ' 167' ' ' ILE . 25.9 tptp -74.24 -15.88 60.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 -176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 142' ' ' ARG . 19.7 mtp180 -109.36 -4.5 16.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.417 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 139' ' ' LEU . 96.2 t -69.15 104.63 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.078 0.466 . . . . 0.0 109.889 174.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.843 ' HB3' ' HZ2' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -92.55 12.88 21.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.603 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.29 -174.28 46.25 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 103.1 8.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.511 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 9.8 mtmp? -87.12 102.86 14.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.766 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.7 t -104.97 119.25 53.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -90.87 136.5 13.4 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 174.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.489 HG11 HG22 ' A' ' 55' ' ' VAL . 13.7 t -122.67 124.45 70.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.24 164.13 35.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.529 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.403 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 94.3 m-85 -75.61 169.4 18.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.016 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.6 t -69.12 -26.08 64.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.335 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -74.88 -5.68 44.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.055 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -106.47 4.67 28.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.666 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.19 114.9 44.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.615 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -103.0 179.62 4.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.142 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 124' ' ' LEU . 4.8 tm-20 -89.12 -50.9 5.88 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 125' ' ' GLU . 4.9 tpp180 -149.06 123.62 9.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.335 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.5 mt -101.26 159.09 30.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.162 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.75 103.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.419 2.079 . . . . 0.0 111.223 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -92.6 159.49 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -123.61 179.88 4.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.75 -49.19 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.594 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -93.14 9.27 36.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.341 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.62 159.43 33.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.455 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 140' ' ' LEU . 3.9 mp -105.12 111.86 65.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.338 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.87 148.79 7.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.79 2.327 . . . . 0.0 112.871 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.64 174.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.172 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 25.1 m-20 -108.62 -49.44 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.93 145.59 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.593 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.1 tp -124.34 103.37 8.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.824 0.345 . . . . 0.0 110.616 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.513 HG21 HG12 ' A' ' 178' ' ' VAL . 49.1 t -87.05 120.1 35.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 p -105.97 -177.4 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 10.0 pt-20 -71.03 -7.23 44.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.634 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.512 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 30.0 mmtp -119.95 -62.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.142 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.86 161.98 30.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.359 . . . . 0.0 111.14 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 173' ' ' VAL . 70.7 t -87.39 101.46 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -88.39 91.91 8.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.671 -175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -74.41 108.71 7.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.14 -43.5 86.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 182' ' ' ARG . 1.5 ppt_? -166.79 156.54 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.832 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.09 -52.93 3.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.525 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 62.96 29.32 73.93 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.657 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.96 -48.22 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.311 . . . . 0.0 111.649 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.4 t -98.29 162.65 13.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.244 0.545 . . . . 0.0 111.579 -171.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.18 6.8 47.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.533 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.57 -38.54 69.48 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.62 104.51 16.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -78.55 80.94 4.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.83 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -159.38 111.13 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.392 173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 167.24 12.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -88.48 139.46 30.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.29 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 m170 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.696 174.427 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp 64.57 31.48 12.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.28 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -60.23 -45.75 92.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.453 0.644 . . . . 0.0 110.026 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -71.75 -40.27 69.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.641 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.95 -45.79 76.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.901 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 tp -53.65 -40.82 66.19 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.33 0.394 . . . . 0.0 111.391 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 1.093 ' HD3' ' HA ' ' A' ' 131' ' ' PHE . 39.2 ttm180 -61.01 -54.74 41.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.264 0.554 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -25.51 64.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.766 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.48 -55.05 11.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.185 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG11 ' HG3' ' A' ' 155' ' ' GLN . 61.1 t -70.99 -33.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.013 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.563 HD11 ' HG2' ' A' ' 52' ' ' LYS . 54.9 tp -62.19 -29.98 70.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.411 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 10.8 t60 -67.72 -36.7 81.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.992 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -68.32 -32.27 72.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 17.6 mmt180 -52.78 -57.82 8.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.342 0.591 . . . . 0.0 110.602 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.3 9.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.445 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -88.1 -25.63 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.121 -0.362 . . . . 0.0 110.334 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.2 142.73 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.067 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 t -64.96 148.26 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.45 -42.36 70.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.88 -51.07 64.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.891 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.21 -44.55 95.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.455 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.588 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 5.3 tmm_? -57.77 -47.23 83.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.731 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -62.07 -46.22 90.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.097 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -60.11 -47.96 83.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.667 0.27 . . . . 0.0 111.035 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.8 mt -66.69 -37.54 84.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 31.1 t -58.96 -49.53 77.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.918 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -59.79 -34.94 73.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -42.02 91.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.579 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 25' ' ' LEU . 45.5 t -62.19 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.073 0.463 . . . . 0.0 109.994 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' SER . 69.8 mt -58.39 -40.12 77.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.505 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.0 m -61.15 -40.28 93.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -42.41 84.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD13 HD12 ' A' ' 36' ' ' LEU . 39.9 tp -62.32 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.205 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HE3' ' CE2' ' A' ' 39' ' ' PHE . 2.5 mmpt? -66.94 -30.97 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.26 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.1 m -71.58 -24.59 61.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 178' ' ' VAL . 46.4 mt -61.18 116.79 21.04 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.348 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.1 -35.89 84.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.036 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.69 -37.32 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.798 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 69.7 t80 -74.08 -17.15 60.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.207 0.527 . . . . 0.0 110.776 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.88 -41.91 10.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -81.54 -33.23 31.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.761 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 t -84.9 122.04 28.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 92.7 mttt -93.28 -3.93 52.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.714 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 8.7 mmpt? -89.31 86.13 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 68' ' ' LYS . 45.8 t -121.61 118.15 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 111.475 -173.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -111.62 138.96 47.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.161 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 57' ' ' LEU . 7.4 mp -120.2 144.17 47.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.784 ' HB2' HG12 ' A' ' 117' ' ' VAL . 37.8 t80 -77.33 -6.63 53.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.152 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.1 t 70.8 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.825 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.732 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 2.7 Cg_exo -75.1 98.18 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.864 2.376 . . . . 0.0 112.436 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.798 HG13 ' HD3' ' A' ' 52' ' ' LYS . 40.7 pt -89.4 -5.45 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.227 0.537 . . . . 0.0 110.144 173.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HD3' HG13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -107.19 144.85 33.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.78 72.63 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.708 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' HG3' ' H ' ' A' ' 55' ' ' VAL . 5.2 pt-20 -129.52 -79.62 0.56 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.595 0.358 . . . . 0.0 110.203 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.712 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 38.3 t -100.17 123.74 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' CG ' HH12 ' A' ' 22' ' ' ARG . 20.6 m-20 -79.14 71.88 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.898 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.732 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 88.2 mt -85.51 -10.46 56.0 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.232 0.539 . . . . 0.0 109.581 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.721 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m -62.49 -53.3 58.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.177 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 21.9 Cg_exo -67.31 -6.55 16.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.175 1.917 . . . . 0.0 112.217 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -89.32 -15.25 33.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.389 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.637 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.0 m-85 -55.74 -52.38 72.65 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.319 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 61.1 Cg_exo -54.93 -34.37 85.95 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.396 2.064 . . . . 0.0 112.898 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 1.3 tm-20 -65.38 -50.62 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 109.925 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.618 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 84.9 t -64.87 -41.51 92.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.586 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 88' ' ' PRO . 50.8 tp -67.48 -16.77 64.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.509 . . . . 0.0 111.198 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 13.7 tppt? -71.16 -52.22 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.467 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.4 pt-20 -121.81 -30.01 4.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.074 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 64' ' ' VAL . 30.2 mtmm -103.4 -173.03 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.239 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' OE2' ' HD3' ' A' ' 84' ' ' ARG . 49.2 mt-10 -106.63 119.34 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -89.81 106.06 18.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.047 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 46' ' ' ALA . 59.3 mt -93.69 123.83 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.2 mt -120.12 141.68 32.08 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.094 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -76.81 110.86 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.962 2.441 . . . . 0.0 111.724 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.82 114.82 29.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.26 101.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.418 . . . . 0.0 109.874 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -90.74 85.25 6.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.556 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.74 0.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.16 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -112.13 -9.08 13.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -115.33 109.42 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.669 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.74 135.82 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 m -140.33 149.45 42.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.353 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 3.3 mm? -84.64 114.25 21.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.415 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.8 124.67 39.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.513 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 17.5 ttm180 -84.31 102.72 12.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 110.21 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 90' ' ' CYS . 55.2 t -89.65 111.81 23.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.253 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -114.85 -4.87 12.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.637 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -117.69 126.65 27.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.609 -178.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.656 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.3 Cg_exo -60.95 -22.2 73.69 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.812 2.342 . . . . 0.0 113.293 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.15 -5.03 58.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.863 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 87' ' ' SER . 61.3 m -84.44 1.76 43.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 111.495 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.9 129.64 48.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.279 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.5 161.17 29.09 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 t -88.15 86.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.307 0.575 . . . . 0.0 110.374 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.5 -155.91 10.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.58 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.518 ' HB2' HG12 ' A' ' 98' ' ' ILE . . . 55.79 -129.56 1.98 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.564 0.346 . . . . 0.0 110.616 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -97.07 24.05 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.032 0.444 . . . . 0.0 110.783 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.45 51.11 1.0 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.379 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.518 HG12 ' HB2' ' A' ' 95' ' ' ALA . 40.1 pt -131.41 163.78 36.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.621 0.248 . . . . 0.0 110.369 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 tpp -81.03 90.97 6.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.79 158.0 36.08 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.991 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 43.9 Cg_endo -72.64 107.92 2.42 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.138 1.892 . . . . 0.0 111.166 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -77.22 -22.97 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.3 0.572 . . . . 0.0 110.224 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.05 -175.52 4.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.527 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.35 -138.38 11.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.418 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -141.69 128.17 20.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -78.16 101.94 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.538 0.685 . . . . 0.0 110.453 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.42 153.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.741 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.569 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 28.5 p-10 -70.93 146.33 92.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.18 -8.45 12.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.238 2.625 . . . . 0.0 112.714 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.569 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 42.0 tt0 -69.29 -23.84 63.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.481 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.64 -19.45 57.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.585 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.31 110.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 25.7 t70 -91.06 -36.36 14.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.122 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CZ ' HG23 ' A' ' 148' ' ' VAL . 31.2 t80 -133.53 127.74 33.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.619 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 147' ' ' LYS . 12.9 tt -135.46 139.74 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.78 118.92 30.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 48' ' ' TYR . 19.9 m -118.25 127.35 26.64 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.131 0.491 . . . . 0.0 111.332 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 6.1 Cg_exo -79.91 84.1 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.983 2.456 . . . . 0.0 111.178 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.33 162.25 19.86 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.886 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 50.8 t -99.08 128.06 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . . . 67.75 114.72 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.2 0.938 . . . . 0.0 112.684 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -137.6 166.81 23.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.587 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 16.2 p30 -137.83 -165.14 1.73 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.748 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.93 -5.66 59.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -104.51 -31.48 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.231 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 121.64 17.75 3.8 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.954 172.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.429 ' OH ' ' HD2' ' A' ' 162' ' ' ARG . 22.7 m-30 -69.72 144.43 52.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 117.371 0.585 . . . . 0.0 110.142 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 2.0 tmm_? -122.62 106.04 10.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 110.731 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 28.7 tp -76.79 -40.01 49.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.53 -129.69 49.11 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.922 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 1.093 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 88.9 t80 -162.97 140.93 8.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.61 169.61 30.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.615 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -75.42 -34.73 61.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 0.0 110.646 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 162.64 -109.93 0.41 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 65.91 -71.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.304 0.642 . . . . 0.0 111.827 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -94.21 3.08 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.008 -171.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -67.03 -28.19 68.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 109.654 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 138' ' ' ARG . 59.7 mtt85 -76.62 -27.18 55.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.272 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 tp -66.34 -35.56 80.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.74 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.93 -30.71 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 167' ' ' ILE . 23.9 ttmm -72.44 -27.24 62.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -78.37 -23.05 47.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.497 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.25 96.2 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.172 0.51 . . . . 0.0 109.81 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -90.09 16.49 8.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.055 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.9 -162.86 34.87 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.33 99.39 9.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.761 0.315 . . . . 0.0 110.169 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 36.9 mtmm -78.87 102.93 8.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.786 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 171' ' ' VAL . 62.1 t -98.41 124.39 51.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.402 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.11 121.43 6.69 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.41 111.95 33.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.831 0.348 . . . . 0.0 110.088 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -145.65 151.76 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.193 0.521 . . . . 0.0 112.094 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.34 151.92 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.124 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -60.38 -23.74 64.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.759 0.314 . . . . 0.0 111.425 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -66.48 -25.06 66.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.67 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 2.8 mp0 -98.37 2.42 47.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.831 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.96 124.82 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.08 -169.4 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.434 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.19 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 11.2 ttp180 -155.78 141.5 17.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.17 158.94 69.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.768 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.57 107.79 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 111.157 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.429 ' HD2' ' OH ' ' A' ' 127' ' ' TYR . 25.5 ttt180 -73.67 121.96 21.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.52 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.64 -67.76 0.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.981 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.02 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.499 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -117.61 72.52 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.336 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 33.3 t70 -88.92 145.96 25.21 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.177 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 141' ' ' LYS . 65.2 mt -89.93 107.87 22.03 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.6 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 6.9 Cg_exo -73.36 157.04 50.13 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.143 2.562 . . . . 0.0 112.317 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 30.6 m -86.61 176.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.593 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 -44.76 7.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.003 0.43 . . . . 0.0 110.95 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.7 t -132.4 134.94 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.475 HD23 HH11 ' A' ' 179' ' ' ARG . 60.5 tp -115.14 112.52 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.885 0.374 . . . . 0.0 110.199 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.4 t -99.21 118.01 45.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 0.0 110.349 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.22 169.76 8.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -84.45 65.7 9.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -175.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 175' ' ' GLU . 10.3 mmtp 179.02 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.262 0.976 . . . . 0.0 110.89 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -144.17 156.92 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 0.0 111.271 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 36' ' ' LEU . 48.0 t -102.54 106.55 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.257 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.475 HH11 HD23 ' A' ' 172' ' ' LEU . 40.8 ttm105 -93.58 95.43 9.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.747 -173.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -78.45 123.89 27.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 169' ' ' VAL . 73.7 mt -94.39 27.57 2.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.037 0.446 . . . . 0.0 111.109 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -50.17 -57.76 7.04 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.22 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.549 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.0 5.16 83.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.809 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -99.08 13.7 31.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.805 0.336 . . . . 0.0 110.554 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.2 m -59.22 -30.44 68.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.982 0.42 . . . . 0.0 110.417 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -132.2 26.59 4.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.111 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.513 ' OE2' ' HB2' ' A' ' 190' ' ' HIS . 0.1 OUTLIER -142.91 157.54 44.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -177.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.29 9.46 2.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.513 ' HB2' ' OE2' ' A' ' 188' ' ' GLU . 55.5 m80 -77.13 125.98 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.327 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -103.44 -17.28 15.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 61.53 -159.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.859 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -147.06 153.98 40.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.353 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.508 0.194 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 6.4 mp -86.45 77.21 9.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.21 0.528 . . . . 0.0 109.88 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.508 ' HB3' ' HG2' ' A' ' 161' ' ' PRO . 29.2 pttt -68.87 -28.28 66.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.921 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.2 t -78.82 -36.08 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.945 0.402 . . . . 0.0 110.01 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 17.7 tp10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.07 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.67 -48.95 78.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.383 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -56.04 -44.7 79.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.729 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -60.8 -46.91 88.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.923 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HG3' ' A' ' 5' ' ' GLU . 61.7 mttm -58.97 -43.97 91.47 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.189 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG13 ' HG3' ' A' ' 155' ' ' GLN . 43.8 t -67.76 -46.5 82.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.476 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.37 -40.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.121 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.62 -48.11 82.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -78.87 -30.36 45.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.553 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.494 ' NH1' ' HG2' ' A' ' 54' ' ' GLU . 30.5 ttp180 -57.18 -46.91 82.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 52' ' ' LYS . 33.2 pt -90.82 3.27 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.699 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -101.92 2.1 37.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 154' ' ' PHE . 89.1 mt -67.43 138.12 56.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 p -70.95 155.9 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.59 -58.72 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.562 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.08 -48.93 79.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.582 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.21 -44.24 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -61.62 -46.39 90.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.445 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -69.16 -34.69 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -66.21 -31.03 71.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 0.0 110.923 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.55 -41.77 21.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.253 0.549 . . . . 0.0 110.007 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -61.5 -36.3 80.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.006 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.62 -42.24 82.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.591 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.49 -34.92 75.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 55' ' ' VAL . 42.0 t -66.36 -42.95 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.925 0.393 . . . . 0.0 110.361 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.64 -44.22 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.271 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.8 m -64.52 -32.71 74.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.711 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -63.96 -54.37 35.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.88 -33.33 74.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.703 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -67.83 -30.58 70.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -87.61 -14.25 40.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tt -64.11 113.69 11.17 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.4 -48.34 13.85 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.869 2.38 . . . . 0.0 112.861 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.79 -20.1 65.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.501 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.1 -46.7 41.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 57.3 tttm -73.47 -29.75 62.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.719 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -68.76 -37.3 79.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -82.7 148.29 27.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 110.753 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 35.7 mtmt -101.35 -37.04 8.65 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.069 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -89.28 96.52 10.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.14 122.88 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.927 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.02 124.02 44.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.968 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.88 122.27 45.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.741 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.677 ' HD2' ' HD2' ' A' ' 118' ' ' PRO . 6.4 t80 -83.42 98.85 9.72 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.6 m -51.9 114.85 5.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.895 0.747 . . . . 0.0 112.673 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.88 131.67 23.01 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.816 2.344 . . . . 0.0 111.108 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.416 HG23 HG23 ' A' ' 98' ' ' ILE . 2.4 pp -120.01 -8.93 10.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 41.0 mttp -145.72 70.37 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.379 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -114.76 3.88 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HG2' ' NH1' ' A' ' 14' ' ' ARG . 29.7 mt-10 61.32 25.48 15.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 169.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG21 HG11 ' A' ' 29' ' ' VAL . 98.0 t 69.69 106.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.431 0.634 . . . . 0.0 110.485 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.28 96.52 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.677 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.7 mt -88.12 9.63 22.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.674 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.444 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -62.62 -47.39 88.29 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.3 Cg_endo -70.95 1.13 5.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.694 1.596 . . . . 0.0 112.905 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 tp -88.77 -16.91 30.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.794 0.33 . . . . 0.0 110.599 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.414 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 21.2 m-85 -56.7 -48.02 97.98 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 93.9 Cg_exo -48.1 -31.84 17.32 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 122.53 2.153 . . . . 0.0 113.546 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.59 -48.28 12.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 68' ' ' LYS . 98.9 t -61.89 -39.33 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.512 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 96.2 mt -64.18 -14.77 57.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -88.73 -48.46 7.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.043 0.449 . . . . 0.0 111.34 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 28.3 mt-10 -93.69 -38.0 11.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.45 . . . . 0.0 112.057 -171.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.587 ' HZ1' ' HA ' ' A' ' 40' ' ' LYS . 33.9 mttp -119.66 167.31 12.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -161.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -93.24 121.44 34.6 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.646 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HG ' ' HG ' ' A' ' 72' ' ' LEU . 58.6 tp -84.02 112.69 20.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.243 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.22 115.87 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.897 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -121.26 136.01 25.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.666 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.5 132.78 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 0.0 111.86 176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 53.2 tttm -105.95 128.81 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.0 104.02 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.48 12.18 30.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.0 -105.02 1.26 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.7 -15.26 22.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.279 0.561 . . . . 0.0 109.805 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -89.52 143.45 26.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.123 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.689 HD13 ' HD1' ' A' ' 136' ' ' TYR . 62.0 mt -113.64 111.64 36.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.212 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 20.1 m -94.95 108.53 20.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.135 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.2 104.13 6.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.98 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.21 140.2 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.853 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.37 151.35 37.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.0 176.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.886 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -139.27 11.05 2.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.365 0.602 . . . . 0.0 109.872 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 p -162.7 150.51 11.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.711 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.8 Cg_exo -76.07 49.76 2.64 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.012 2.475 . . . . 0.0 111.496 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.82 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 38.4 t -124.6 94.41 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.269 0.557 . . . . 0.0 110.834 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 101' ' ' PRO . 95.3 mt -123.07 120.82 34.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.64 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.06 -171.33 27.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.6 t -136.82 116.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.67 -59.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.995 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.403 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -107.92 139.1 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.799 -0.236 . . . . 0.0 111.326 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 65.2 10.88 6.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 0.0 111.935 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.66 16.26 67.55 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.782 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.416 HG23 HG23 ' A' ' 51' ' ' ILE . 39.1 pt -105.58 172.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.833 0.349 . . . . 0.0 110.953 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -73.4 131.26 41.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.281 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -117.04 121.42 32.56 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.237 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 74' ' ' LYS . 24.8 Cg_endo -62.54 118.15 5.04 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.607 2.205 . . . . 0.0 112.398 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 58.5 t -93.18 -55.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.792 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -105.05 154.59 19.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.746 0.308 . . . . 0.0 110.601 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.54 162.77 10.63 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.37 135.8 35.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 106' ' ' ARG . 17.8 ptt85 -87.48 145.28 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.74 153.09 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -82.71 161.88 57.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.53 -14.83 5.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.284 2.656 . . . . 0.0 113.476 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.3 -37.14 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.313 0.578 . . . . 0.0 110.763 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.76 -23.68 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.9 107.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.974 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.87 -49.7 5.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.573 ' CZ ' HG23 ' A' ' 148' ' ' VAL . 20.7 t80 -118.75 129.82 55.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.5 tt -139.19 139.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.993 0.425 . . . . 0.0 110.574 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.27 116.05 23.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.066 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 48' ' ' TYR . 33.7 m -124.86 127.35 25.15 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 0.0 111.274 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.677 ' HD2' ' HD2' ' A' ' 48' ' ' TYR . 2.2 Cg_endo -83.35 -164.46 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.001 2.468 . . . . 0.0 111.166 171.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.51 175.55 32.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.782 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -99.98 121.33 50.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 72.58 126.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.32 1.012 . . . . 0.0 112.654 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.501 ' HA ' HD13 ' A' ' 160' ' ' LEU . 63.0 m-85 -138.09 168.41 19.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 45.3 p30 -126.3 -164.55 1.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.268 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.75 -13.8 37.15 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.586 ' O ' HD12 ' A' ' 181' ' ' LEU . 44.7 mt-10 -110.51 -62.49 1.52 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.97 62.32 0.13 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.924 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -82.91 134.03 35.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.2 82.82 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.7 tp -59.22 -57.14 14.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.616 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.25 -105.98 2.95 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.468 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -140.29 -65.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.661 0.267 . . . . 0.0 111.168 -172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.01 175.19 22.33 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.48 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -94.56 111.29 23.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.425 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.37 75.56 1.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.144 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -144.57 -90.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.067 0.46 . . . . 0.0 110.344 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.689 ' HD1' HD13 ' A' ' 80' ' ' ILE . 95.3 m-85 -100.61 6.39 44.11 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.786 0.803 . . . . 0.0 110.567 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.32 -16.95 63.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.55 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -54.74 -34.52 62.62 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 143' ' ' VAL . 51.6 tp -87.22 -51.22 6.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.142 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.64 -26.93 62.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.11 -28.55 63.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.74 -2.57 15.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.784 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 139' ' ' LEU . 98.4 t -70.19 102.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -97.19 10.98 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.92 -176.42 43.56 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.683 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.0 100.71 1.26 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.986 0.393 . . . . 0.0 110.283 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.43 100.06 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.091 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 114' ' ' PHE . 92.3 t -96.29 114.93 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.025 0.441 . . . . 0.0 110.014 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.35 124.26 7.72 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.723 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.27 116.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.23 161.51 40.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.672 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -96.61 156.31 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -62.43 -31.44 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.43 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 26.8 p90 -78.18 -6.2 54.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.421 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.505 ' HG3' HG13 ' A' ' 10' ' ' VAL . 28.5 tt0 -100.95 -6.23 24.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 0.0 109.816 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.5 115.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.64 -166.39 1.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 33.6 tt0 -69.69 -67.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.92 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -145.43 132.62 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.462 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 122' ' ' PHE . 80.9 mt -96.52 138.87 21.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.616 0.246 . . . . 0.0 110.75 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.508 ' HG2' ' HB3' ' A' ' 3' ' ' LYS . 3.1 Cg_exo -76.36 101.87 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.789 2.326 . . . . 0.0 111.25 174.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.72 148.66 29.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.102 -177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -114.81 -135.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.328 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.69 -23.79 66.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.42 0.628 . . . . 0.0 110.312 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -87.58 67.68 9.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.278 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 168' ' ' PRO . 31.5 t70 -59.38 -74.18 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.367 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 41.2 mt 41.04 81.38 0.25 Allowed Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 124.285 0.991 . . . . 0.0 113.246 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.4 ' HD3' ' OD2' ' A' ' 166' ' ' ASP . 90.8 Cg_endo -89.04 165.49 5.75 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.44 2.093 . . . . 0.0 111.798 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.58 177.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 182' ' ' ARG . 1.0 OUTLIER -111.75 -43.26 3.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.473 0.654 . . . . 0.0 109.369 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.41 122.33 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 42.5 tp -101.95 109.93 21.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.12 123.68 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.85 3.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.403 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -26.29 28.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.134 0.492 . . . . 0.0 110.479 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.597 ' HB3' ' HZ1' ' A' ' 176' ' ' LYS . 9.9 mtpm? -91.2 -34.2 15.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.34 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.5 171.66 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.946 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 t -113.58 111.49 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 42.0 ttm180 -89.56 96.3 10.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.284 0.564 . . . . 0.0 111.132 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.87 115.26 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.391 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 125' ' ' GLU . 75.6 mt -98.03 -46.77 5.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 111.042 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.577 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 15.1 ttt180 -83.87 95.87 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.287 0.565 . . . . 0.0 110.431 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -100.83 -160.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.197 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.82 45.74 2.77 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.002 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -73.47 97.91 2.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.0 110.655 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.9 m -149.1 141.55 24.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.538 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -125.74 133.59 52.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.331 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 67.79 165.51 0.23 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -92.1 106.67 18.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.321 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -106.88 20.37 19.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.533 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -126.51 73.59 1.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.614 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -94.39 -15.42 24.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.633 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -95.35 -47.32 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.029 0.442 . . . . 0.0 109.878 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.887 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.25 155.22 20.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 111.682 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -48.77 70.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 m -63.88 -35.59 81.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.946 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.99 -53.95 52.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.654 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.54 -48.37 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.512 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.04 -49.45 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -65.08 -43.07 93.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.612 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.51 -46.77 68.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.863 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.17 -37.15 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.0 tp -57.24 -37.49 72.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.285 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.573 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 15.0 t-80 -67.13 -25.93 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.963 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 45.9 mmtt -95.67 -16.22 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 110.968 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 155' ' ' GLN . 25.0 ttt85 -75.66 -42.98 49.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.3 pt -90.78 6.84 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.256 0.551 . . . . 0.0 110.68 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -77.25 -26.09 52.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.896 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.09 135.35 57.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.639 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -65.3 142.53 58.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.122 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -52.69 -43.15 65.4 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.3 -59.44 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.152 0.501 . . . . 0.0 110.957 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.4 -44.85 81.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.143 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -62.21 -41.83 98.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.967 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -71.07 -35.38 71.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.661 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -65.66 -35.53 81.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.025 0.44 . . . . 0.0 110.469 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.83 -37.49 70.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.444 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 30' ' ' ILE . 38.0 m -65.67 -30.75 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.53 -42.88 79.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.217 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -60.99 -46.52 90.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.127 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 175' ' ' GLU . 37.0 t -61.49 -42.07 92.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.128 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 26' ' ' SER . 80.6 mt -61.18 -50.27 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 110.634 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -60.69 -41.78 95.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.6 -51.25 66.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.79 -36.37 83.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.032 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -76.31 -17.45 59.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.833 0.349 . . . . 0.0 110.706 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -88.52 -18.95 27.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.543 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.448 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.1 tt -55.38 117.3 14.31 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD2' HD23 ' A' ' 36' ' ' LEU . 44.6 Cg_exo -56.48 -42.66 63.23 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.169 2.579 . . . . 0.0 113.273 -176.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.4 -27.81 67.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.84 -34.96 74.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.267 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -64.81 -42.09 95.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.29 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -73.55 -24.0 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.466 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -66.59 124.84 23.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.375 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 61.8 mttm -103.85 -37.1 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.501 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.637 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 26.5 mmtp -96.43 108.76 21.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.12 110.51 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.968 0.414 . . . . 0.0 111.152 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -91.64 114.05 26.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.35 121.71 45.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.291 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -79.03 105.88 10.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.523 ' HB3' HG22 ' A' ' 98' ' ' ILE . 43.3 t -58.42 115.28 10.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.503 0.502 . . . . 0.0 110.996 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.872 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 Cg_exo -73.14 108.23 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.977 2.452 . . . . 0.0 111.899 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.668 HG13 ' HG2' ' A' ' 52' ' ' LYS . 44.7 pt -78.37 -22.55 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.268 -175.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.668 ' HG2' HG13 ' A' ' 51' ' ' ILE . 71.7 mmtt -117.31 25.24 10.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 110.884 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.07 -71.42 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.872 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 6.1 mm-40 39.74 53.05 2.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.146 0.978 . . . . 0.0 113.029 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HA ' ' HH ' ' A' ' 152' ' ' TYR . 47.7 t 68.03 100.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.34 0.591 . . . . 0.0 109.778 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.71 111.97 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.203 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.07 14.91 15.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.643 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 59' ' ' PRO . 42.6 p -63.02 -41.37 70.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 23.4 Cg_exo -66.27 -10.94 29.29 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.879 1.719 . . . . 0.0 112.594 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.97 -21.84 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.291 . . . . 0.0 110.669 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.5 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.5 m-85 -57.94 -52.7 72.54 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.015 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.0 Cg_exo -54.52 -34.1 80.85 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.363 2.042 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -66.47 -53.0 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.4 -36.12 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.204 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.9 mt -61.11 -26.24 67.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 66' ' ' LYS . 70.9 mmtt -114.17 -7.87 13.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.93 -31.14 9.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.225 0.536 . . . . 0.0 110.702 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 47.7 mttm -142.1 -171.86 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.085 -169.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -105.69 126.48 52.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 54.6 tp -82.58 144.69 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 69.6 mt -126.86 114.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.459 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 62.8 mt -109.65 138.89 20.75 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.61 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.0 126.54 5.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.846 2.364 . . . . 0.0 112.936 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.579 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 9.3 tmtm? -105.5 97.71 7.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 77' ' ' GLY . 11.5 t -92.86 117.81 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.658 -170.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -87.96 5.18 41.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.648 ' H ' HG13 ' A' ' 75' ' ' VAL . . . 106.52 -51.87 0.71 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -104.11 -48.49 3.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.5 -0.35 . . . . 0.0 110.456 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -91.49 149.44 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.051 0.453 . . . . 0.0 111.118 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.712 HD13 ' HD1' ' A' ' 136' ' ' TYR . 65.1 mt -124.26 101.38 8.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.524 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 m -85.6 112.67 21.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.023 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.5 mt -84.47 136.15 33.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CE1' ' HG2' ' A' ' 106' ' ' ARG . 88.8 m-85 -128.55 144.1 51.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 0.0 111.248 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.536 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 45.2 mtp180 -79.26 106.99 11.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.649 175.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 51.0 t -89.56 111.43 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -107.02 -28.47 10.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.504 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -141.1 158.21 65.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.292 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.86 -155.48 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 74.45 -46.06 0.6 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.561 0.745 . . . . 0.0 112.199 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 5.7 t -81.68 34.96 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.222 0.535 . . . . 0.0 110.903 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -117.25 131.18 56.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.417 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.12 -169.9 12.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.987 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -136.0 123.36 34.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.463 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -132.52 -85.13 0.28 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.502 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.4 155.48 18.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.558 0.218 . . . . 0.0 111.397 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 72.49 -46.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.926 0.891 . . . . 0.0 111.975 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 20.79 5.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.92 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.523 HG22 ' HB3' ' A' ' 49' ' ' CYS . 2.1 pp -101.62 172.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.618 0.247 . . . . 0.0 111.205 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.09 105.03 6.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.862 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 2.3 mt-10 -83.6 115.46 59.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.976 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 2.8 Cg_exo -74.39 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 110.56 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 27.9 t -73.34 -58.74 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.415 -173.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.95 178.62 6.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 111.067 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.66 -139.06 10.12 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.6 138.05 51.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' HG2' ' CE1' ' A' ' 83' ' ' TYR . 83.4 mtt180 -83.35 140.75 32.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.948 0.404 . . . . 0.0 110.394 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 84' ' ' ARG . 21.9 t -117.99 137.3 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.577 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -104.69 150.58 38.76 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.33 -35.63 16.12 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.008 3.139 . . . . 0.0 114.998 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.699 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 43.3 tt0 -65.05 -26.98 68.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 14.0 t70 -80.83 -13.69 58.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 0.0 111.148 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.83 131.37 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.618 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.637 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 13.0 m-20 -83.94 -52.42 6.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.629 0.728 . . . . 0.0 110.017 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.5 ' CE2' HG22 ' A' ' 148' ' ' VAL . 46.2 t80 -129.85 131.03 45.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.528 -170.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.2 tt -125.79 137.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.968 0.413 . . . . 0.0 109.943 173.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.481 ' HB3' ' HE1' ' A' ' 114' ' ' PHE . . . -121.23 115.72 23.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.631 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.22 118.95 33.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.82 110.12 2.28 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.336 2.024 . . . . 0.0 111.258 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 122' ' ' PHE . . . -100.0 131.68 10.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.43 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.73 -30.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 122.476 0.31 . . . . 0.0 111.205 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.91 142.13 19.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.635 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 28.7 m-85 -137.77 168.65 19.26 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.505 0.503 . . . . 0.0 110.254 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.54 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 34.0 p-10 -137.96 -167.82 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.76 -0.29 57.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.274 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -97.32 -36.81 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.413 ' CA ' ' HG ' ' A' ' 181' ' ' LEU . . . 113.98 39.99 1.02 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.734 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -108.29 169.27 8.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.485 . . . . 0.0 111.433 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 157.65 32.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.433 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.03 -88.56 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.672 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 148.01 -165.67 28.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.367 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -111.21 -58.65 2.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.564 0.221 . . . . 0.0 110.594 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.19 -175.02 20.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.79 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.88 139.02 31.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.017 0.437 . . . . 0.0 111.049 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.63 33.75 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -96.82 28.07 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.33 0.586 . . . . 0.0 110.188 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.712 ' HD1' HD13 ' A' ' 80' ' ' ILE . 18.2 m-85 -68.2 -27.22 66.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.224 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -70.86 -33.84 71.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.149 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.36 -34.48 77.38 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 143' ' ' VAL . 52.6 tp -70.5 -59.24 2.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.416 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.67 -38.55 78.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.187 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -78.71 -11.16 59.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 111.098 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -107.55 -5.82 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.661 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 139' ' ' LEU . 93.9 t -57.62 118.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.699 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 52.8 tttm -87.69 -2.61 58.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 110.509 -175.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -96.2 -161.91 32.96 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.11 131.49 38.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.94 0.37 . . . . 0.0 110.75 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -93.03 110.6 22.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.5 HG22 ' CE2' ' A' ' 114' ' ' PHE . 89.3 t -109.84 128.16 66.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 0.0 110.973 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 122' ' ' PHE . . . -98.92 132.95 11.11 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.635 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.63 122.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.661 0.267 . . . . 0.0 110.659 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -158.44 168.29 27.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.876 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.401 ' HH ' ' HA ' ' A' ' 55' ' ' VAL . 89.0 m-85 -88.74 170.91 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.5 p -63.74 -27.3 69.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.242 0.544 . . . . 0.0 110.938 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -68.05 -25.59 65.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.089 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.447 ' HG2' HH11 ' A' ' 14' ' ' ARG . 2.3 mp0 -92.67 4.54 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.531 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.03 113.22 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.402 . . . . 0.0 110.631 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -106.98 178.67 4.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.807 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.47 -54.57 6.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.582 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 71.7 ttp85 -149.28 139.46 22.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.025 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 67.9 mt -98.98 158.39 32.4 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.743 174.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.71 105.79 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.38 2.053 . . . . 0.0 112.539 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.74 100.9 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.96 -77.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.186 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.77 -69.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -80.78 -3.92 52.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -165.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.41 -175.49 5.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.311 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.782 HD13 ' HD2' ' A' ' 168' ' ' PRO . 4.1 tp -135.19 129.38 18.85 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.594 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.782 ' HD2' HD13 ' A' ' 167' ' ' ILE . 56.5 Cg_endo -72.2 159.74 48.98 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.514 2.143 . . . . 0.0 112.701 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.34 -177.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -100.42 -56.08 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.451 ' HB ' HG21 ' A' ' 148' ' ' VAL . 45.8 t -128.13 140.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.62 116.01 30.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.671 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.7 t -106.83 125.28 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 0.0 110.247 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 50.3 p -119.54 -169.67 1.8 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.679 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 9.6 pt-20 -68.75 -27.52 65.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.868 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 56.9 mtpt -125.89 -21.47 4.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.76 143.6 50.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -172.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.409 HG11 ' HG ' ' A' ' 36' ' ' LEU . 63.5 t -111.52 102.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -122.25 112.41 18.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.166 0.507 . . . . 0.0 112.082 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.6 ttm105 -70.3 152.44 44.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' A' ' 181' ' ' LEU . 3.7 mm? -78.42 65.47 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.103 0.954 . . . . 0.0 112.214 -166.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -132.48 124.53 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.296 167.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.29 130.47 47.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 110.499 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.91 58.16 4.32 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.357 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -68.53 125.79 27.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 m -86.06 90.17 8.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.324 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.3 tt 179.91 -45.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.031 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 192' ' ' HIS . 2.7 tm-20 62.41 -111.83 0.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -149.3 13.75 0.86 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 67.41 11.66 8.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.667 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -99.04 -47.21 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 188' ' ' GLU . 32.3 m80 -104.0 151.27 23.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 166.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -102.64 123.5 46.47 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.369 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 15.3 t60 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.239 175.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.884 0.373 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.08 152.51 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.922 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 129' ' ' LEU . 15.7 ptpt -66.41 -22.89 66.24 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.94 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.8 t -59.16 -29.5 67.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.184 0.516 . . . . 0.0 110.684 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.32 -45.27 18.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.067 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.17 -35.72 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.628 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 131' ' ' PHE . 8.5 tmm_? -55.38 -45.98 76.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.848 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.37 -39.08 88.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -60.35 -49.69 76.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.6 -42.33 80.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 15' ' ' ILE . 62.1 tp -61.43 -42.51 98.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.667 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 5.0 t60 -58.35 -44.57 88.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.243 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 26.3 mtpp -67.65 -35.48 78.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.314 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 44.2 ttm-85 -60.77 -50.77 72.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.259 0.552 . . . . 0.0 110.652 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 11' ' ' LEU . 18.5 pt -83.67 9.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.0 111.369 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -101.37 -11.62 19.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 152.4 24.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.279 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -75.09 156.53 35.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.544 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 37.8 tt0 -68.28 -39.42 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.261 . . . . 0.0 110.906 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.56 -44.07 97.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 109.742 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.92 -34.47 76.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.401 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 7.5 mmt85 -55.18 -61.49 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.01 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 66.6 ttt180 -62.81 -37.01 85.03 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.035 0.445 . . . . 0.0 110.708 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 52.7 ttt180 -60.56 -44.87 95.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.952 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -86.57 -37.85 17.73 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.267 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.4 t -66.09 -31.86 72.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.528 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 8.7 tt0 -69.77 -26.1 64.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 74.1 mmtt -74.84 -43.94 51.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.901 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.78 -48.26 89.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.742 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 79.0 mt -60.13 -47.35 92.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -61.82 -39.41 91.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.505 HD22 ' HA ' ' A' ' 177' ' ' ASN . 8.3 t-20 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.244 0.545 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.56 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.464 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.691 ' HE2' ' HG2' ' A' ' 63' ' ' GLU . 2.8 mmmp? -71.43 -31.12 66.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.602 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -84.38 -9.26 58.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.129 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -71.51 111.45 10.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.67 -33.11 96.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.999 2.466 . . . . 0.0 113.529 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.63 -34.67 77.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.784 0.326 . . . . 0.0 110.334 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.79 -25.3 63.72 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.89 -34.87 74.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.262 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -100.44 -21.64 15.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.084 -171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -58.93 123.87 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 110.916 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 1.1 mmpp? -74.71 -63.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.644 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 113.48 25.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.149 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' O ' HD11 ' A' ' 70' ' ' LEU . 46.0 t -116.41 115.14 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 71' ' ' ILE . . . -99.34 143.69 29.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -136.93 148.26 46.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.794 0.33 . . . . 0.0 110.551 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' CE1' HG12 ' A' ' 117' ' ' VAL . 64.6 m-85 -97.06 141.6 30.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.898 171.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.536 ' HB2' HG23 ' A' ' 98' ' ' ILE . 67.5 m -73.75 146.8 86.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.569 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.69 106.52 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.049 2.499 . . . . 0.0 113.042 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.852 HG13 ' H ' ' A' ' 52' ' ' LYS . 8.9 pt -99.96 -85.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.472 174.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.852 ' H ' HG13 ' A' ' 51' ' ' ILE . 45.8 mttp -91.62 -6.82 51.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.24 0.543 . . . . 0.0 109.761 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 14' ' ' ARG . . . -98.07 120.89 6.94 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 174.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.49 7.43 38.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.746 0.308 . . . . 0.0 111.249 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG23 ' CZ ' ' A' ' 152' ' ' TYR . 21.5 t -70.51 100.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.418 ' OD1' ' HD3' ' A' ' 59' ' ' PRO . 6.6 t70 -86.19 102.76 14.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.237 0.541 . . . . 0.0 111.047 -171.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.1 15.77 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.365 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.488 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 m -62.71 -50.62 77.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 22.0 Cg_exo -67.07 -0.65 5.05 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -85.87 -19.04 31.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.691 0.282 . . . . 0.0 110.516 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.517 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.2 m-85 -59.63 -49.58 91.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 76.1 Cg_exo -53.11 -32.77 60.68 Favored 'Trans proline' 0 C--N 1.359 1.132 0 C-N-CA 122.296 1.997 . . . . 0.0 112.687 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.691 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 18.3 tp10 -71.69 -52.57 17.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.17 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.9 t -57.27 -45.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.221 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -65.17 -12.6 52.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -97.05 -14.22 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.936 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.64 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 43.1 mt-10 -110.56 -56.67 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 0.0 110.94 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.64 ' HD2' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -129.43 -171.53 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 -171.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.07 138.29 32.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 41.6 tp -98.94 157.38 16.36 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.661 ' HB ' ' HB3' ' A' ' 46' ' ' ALA . 67.2 mt -138.52 131.28 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 96.1 mt -129.32 132.6 24.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.37 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.84 2.36 . . . . 0.0 111.77 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.701 ' HG2' ' HB2' ' A' ' 100' ' ' GLU . 2.8 tmtp? -105.89 113.63 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.92 106.71 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.091 0.472 . . . . 0.0 111.1 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -104.45 88.92 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.373 174.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 -98.73 1.04 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -123.18 -4.18 8.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 109.87 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.23 106.71 18.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.435 HD13 ' HD1' ' A' ' 136' ' ' TYR . 55.5 mt -82.72 102.37 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.089 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -84.74 122.72 29.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.495 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.91 100.17 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.521 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 40.8 m-85 -103.21 130.36 50.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -79.04 153.26 30.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.134 176.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 98.5 t -130.68 124.08 56.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.469 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -148.85 25.12 0.94 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.2 m -146.37 149.52 37.98 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.741 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.4 Cg_exo -78.23 160.5 29.52 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.742 2.295 . . . . 0.0 111.958 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.27 19.39 11.68 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 85' ' ' VAL . 30.7 p -103.61 5.78 36.75 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.023 -0.423 . . . . 0.0 110.63 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -100.94 129.48 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.43 171.08 25.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.144 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.34 102.06 13.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.967 0.413 . . . . 0.0 110.374 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.31 -34.6 1.92 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' HG12 ' A' ' 98' ' ' ILE . . . -82.24 -163.34 0.66 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.905 0.383 . . . . 0.0 111.209 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -54.85 -43.28 72.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 58.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.628 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 49' ' ' CYS . 43.0 pt -131.3 166.66 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -106.41 96.35 6.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.701 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 3.3 pt-20 -105.25 154.38 38.94 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.639 -173.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.521 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 11.0 Cg_exo -71.15 112.45 3.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.62 2.213 . . . . 0.0 111.985 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.43 -48.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -121.1 99.08 6.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.842 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.42 -162.42 9.1 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.908 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 36.9 mt-10 -127.02 142.34 51.57 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -77.27 128.33 34.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.097 0.475 . . . . 0.0 111.613 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 84' ' ' ARG . 84.1 t -124.18 145.13 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.949 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 110' ' ' GLU . 9.5 p30 -97.9 157.46 34.56 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.83 -25.22 42.12 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.503 2.802 . . . . 0.0 114.645 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.461 ' HB3' ' OD1' ' A' ' 108' ' ' ASN . 20.6 tt0 -68.92 -23.59 64.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.846 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -93.42 0.03 56.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.939 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.76 103.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.12 -58.04 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.791 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 23.4 t80 -124.06 144.72 49.69 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.337 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 17.3 tt -149.66 141.01 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.662 0.267 . . . . 0.0 110.494 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.61 120.43 38.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.484 HG12 ' CE1' ' A' ' 48' ' ' TYR . 27.5 m -116.82 120.78 33.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.216 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 4.1 Cg_exo -77.37 104.69 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.787 2.325 . . . . 0.0 111.217 174.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.57 156.5 15.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.852 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 125.65 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.1 106.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.164 0.915 . . . . 0.0 112.491 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -127.84 157.43 40.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.596 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -103.94 -173.98 2.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.895 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 46.1 mt -87.06 15.74 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.56 -15.59 6.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.861 0.362 . . . . 0.0 110.571 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.433 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 118.05 5.46 13.39 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.71 169.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -85.92 132.35 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.542 0.671 . . . . 0.0 111.213 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -94.25 128.6 40.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.357 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 160' ' ' LEU . 30.6 tp -55.39 -48.26 74.6 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.535 0.522 . . . . 0.0 110.56 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.14 -178.61 33.27 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.353 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 84.0 m-85 -110.94 -73.66 0.67 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.087 0.47 . . . . 0.0 110.507 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.527 ' C ' ' HD2' ' A' ' 133' ' ' LYS . . . 142.17 -34.22 1.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HD2' ' C ' ' A' ' 132' ' ' GLY . 1.7 mptp? -125.76 148.7 49.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.23 60.87 3.4 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -66.04 -65.16 0.71 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.559 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HD1' HD13 ' A' ' 80' ' ' ILE . 66.2 m-85 61.3 13.85 5.22 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 111.057 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 9.6 p-10 -65.89 -29.37 69.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -49.94 -39.72 41.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.035 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.408 HD23 ' HH ' ' A' ' 48' ' ' TYR . 50.5 tp -81.85 -40.64 22.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.148 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.01 -16.64 64.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.454 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 32.1 mmtp -73.2 -29.22 62.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -95.75 -27.83 15.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.194 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.43 98.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.076 0.465 . . . . 0.0 110.118 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -134.46 56.62 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.096 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.43 9.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 114' ' ' PHE . 23.7 tp -83.39 89.2 7.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HB3' ' OD1' ' A' ' 170' ' ' ASP . 25.1 ttpt -91.07 105.38 17.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.688 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' A' ' 114' ' ' PHE . 45.6 t -104.49 124.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.143 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.2 10.61 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.53 115.99 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.44 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -158.59 175.03 14.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.713 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.603 ' HD1' ' HG3' ' A' ' 175' ' ' GLU . 46.4 m-85 -102.09 153.37 19.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 176' ' ' LYS . 29.6 t -61.08 -13.14 15.01 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.717 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -71.66 -23.55 61.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.585 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 16.4 mp0 -107.58 13.86 26.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.921 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.1 t -117.92 120.92 66.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.181 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.73 -175.16 2.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.391 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.895 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -89.94 -36.74 14.83 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.274 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -138.11 145.34 41.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 129' ' ' LEU . 95.3 mt -132.77 161.84 61.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.95 101.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.572 1.515 . . . . 0.0 110.892 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -104.67 141.0 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 11.3 t70 -128.08 -163.49 1.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.145 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.48 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . -81.6 -40.91 22.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 0.0 110.674 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -85.0 43.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.404 0.621 . . . . 0.0 110.241 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.55 110.77 22.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.303 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.98 114.06 53.61 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.579 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.07 160.02 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.172 2.582 . . . . 0.0 113.08 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.401 ' HA ' ' HE3' ' A' ' 147' ' ' LYS . 31.1 m -103.25 -179.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.698 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 8.1 m-20 -107.8 -32.79 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.815 0.34 . . . . 0.0 110.903 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 148' ' ' VAL . 43.8 t -136.05 153.13 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.552 ' HB2' HD12 ' A' ' 181' ' ' LEU . 44.1 tp -128.94 122.15 29.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.604 HG23 HG11 ' A' ' 178' ' ' VAL . 86.2 t -109.14 126.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.166 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.2 p -127.19 -174.6 3.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.322 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.603 ' HG3' ' HD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -85.79 -1.48 57.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 110.113 175.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.444 ' HZ2' ' HB3' ' A' ' 153' ' ' SER . 40.5 mmtm -93.56 -64.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.141 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.505 ' HA ' HD22 ' A' ' 32' ' ' ASN . 8.3 t-20 -155.62 174.87 14.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.022 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 173' ' ' VAL . 4.4 m -108.04 99.6 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.64 . . . . 0.0 110.26 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 179' ' ' ARG . 33.1 ttt180 -103.7 116.57 32.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -74.7 132.74 41.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.521 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' A' ' 172' ' ' LEU . 61.6 mt -109.75 15.37 22.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.184 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.734 ' HA ' ' HE ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -100.21 143.66 30.14 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -68.7 160.05 31.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.497 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -96.11 36.67 3.74 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.34 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -149.6 113.29 5.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.103 0.478 . . . . 0.0 110.135 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.7 m -152.08 7.11 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.959 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.07 12.56 26.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.557 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -91.76 -3.63 55.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.433 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' A' ' 190' ' ' HIS . 21.5 p-80 -137.11 161.29 36.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.427 ' O ' ' HD2' ' A' ' 189' ' ' HIS . 13.1 m170 -65.85 161.44 21.06 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.282 0.364 . . . . 0.0 110.858 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -64.28 -79.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.028 -173.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -101.69 -52.36 3.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -161.62 10.69 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.321 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 t60 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.555 -174.272 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.143 0.497 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.73 8.77 39.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.679 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -54.18 -40.66 67.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.542 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -62.12 -36.09 80.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.425 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 6.0 mm-40 -77.9 -43.43 30.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.482 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.07 -38.22 85.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -54.54 -53.86 48.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -68.42 -24.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.332 -173.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -74.18 -47.08 38.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 110.394 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.29 -44.63 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.297 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 tp -59.73 -45.57 91.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.558 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 13.7 t-80 -62.05 -43.02 99.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.66 -41.49 99.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.447 HH21 ' N ' ' A' ' 54' ' ' GLU . 10.8 tpt180 -63.95 -53.59 47.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.339 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.2 pt -80.97 4.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 111.599 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 6.5 t30 -78.67 -28.69 45.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.15 142.56 46.86 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.619 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.61 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 38.9 p -76.91 160.49 29.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.079 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.16 -30.06 71.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.9 -52.28 64.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.57 -30.78 36.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.386 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 18' ' ' SER . 83.7 mtt180 -56.9 -59.19 5.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.3 -40.35 77.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.38 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.63 -45.8 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.082 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -70.68 -44.65 66.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -61.23 -33.56 73.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.08 -39.28 78.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.427 0.632 . . . . 0.0 110.179 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -74.27 -34.23 63.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 175' ' ' GLU . 44.9 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.415 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 HG22 HD13 ' A' ' 60' ' ' LEU . 77.5 mt -58.21 -44.27 87.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.114 0.483 . . . . 0.0 110.325 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.1 m -65.25 -36.56 84.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -67.98 -42.35 80.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.888 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.804 HD12 HD12 ' A' ' 36' ' ' LEU . 26.3 tp -62.68 -46.61 87.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.652 ' HD3' ' HE2' ' A' ' 39' ' ' PHE . 23.4 mmtp -60.38 -28.94 68.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 176.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -82.97 -17.82 42.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.519 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.804 HD12 HD12 ' A' ' 33' ' ' LEU . 44.6 mt -61.43 120.52 56.31 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.1 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.03 -35.6 81.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.756 2.304 . . . . 0.0 111.388 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -60.01 -52.67 64.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.652 ' HE2' ' HD3' ' A' ' 34' ' ' LYS . 88.2 t80 -73.34 -30.22 63.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -58.04 -41.39 83.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.04 -23.28 33.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.5 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.523 ' OG ' ' HA ' ' A' ' 39' ' ' PHE . 49.9 m -50.8 123.19 8.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.248 0.546 . . . . 0.0 111.696 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -102.99 -34.57 8.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -113.52 97.96 6.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.075 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.47 122.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.145 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 116' ' ' ALA . 54.1 mt -111.78 136.52 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.065 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -85.64 -0.52 55.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.158 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.5 t 65.89 98.76 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.119 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 41.9 Cg_endo -68.35 97.76 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.467 2.111 . . . . 0.0 112.398 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' GLY . 24.5 pt -87.18 154.82 3.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 tptp 71.63 -15.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.807 0.692 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 133.28 -77.89 0.37 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' HH21 ' A' ' 14' ' ' ARG . 3.3 mm-40 22.93 77.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 113.708 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 150' ' ' VAL . 58.4 t 62.56 94.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.402 -174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.76 88.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.793 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 97.5 mt -100.2 9.45 42.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.005 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.48 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -60.09 -44.52 96.72 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 58' ' ' THR . 52.8 Cg_endo -70.19 -5.78 17.26 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.691 1.594 . . . . 0.0 112.488 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 63' ' ' GLU . 60.6 tp -87.81 -18.38 29.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.781 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.521 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 14.2 m-85 -54.31 -54.92 42.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 47.7 Cg_exo -58.84 -34.74 99.19 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.939 1.759 . . . . 0.0 112.278 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HB3' HD11 ' A' ' 60' ' ' LEU . 49.6 tp10 -64.91 -45.7 84.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.441 HG21 ' HG ' ' A' ' 60' ' ' LEU . 93.2 t -66.85 -41.88 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.92 -27.13 67.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.332 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -74.01 -55.5 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.447 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -81.26 -51.72 8.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.75 -174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -118.83 -171.92 2.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.353 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 40.5 mt-10 -104.16 130.71 51.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.696 175.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.1 tp -102.36 121.23 41.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.558 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.2 mp -99.14 118.84 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.429 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.68 142.44 28.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.94 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.44 ' HA ' HD21 ' A' ' 82' ' ' LEU . 56.3 Cg_endo -71.69 128.82 14.73 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.752 2.301 . . . . 0.0 112.198 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -119.64 117.49 28.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.916 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.07 106.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -92.43 21.7 5.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 81.15 1.46 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.91 -59.05 0.52 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.322 0.649 . . . . 0.0 110.324 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -58.23 118.26 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.995 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.532 HD11 ' HD1' ' A' ' 136' ' ' TYR . 14.4 tt -110.76 136.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 t -130.81 176.75 7.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.4 mt -119.45 122.51 41.87 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m-85 -110.91 127.27 55.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.097 0.475 . . . . 0.0 111.223 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.488 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 23.7 ttp85 -86.75 119.55 27.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.482 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -118.66 145.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.638 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -139.23 22.88 2.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 t -141.06 122.93 9.27 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.805 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.92 -31.2 93.37 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.155 2.57 . . . . 0.0 113.315 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.73 1.31 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.3 t -109.11 4.14 22.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.255 0.55 . . . . 0.0 110.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.41 136.61 33.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.651 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.91 159.92 30.33 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.986 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.35 113.95 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.758 0.279 . . . . 0.0 110.54 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.18 -58.15 0.41 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.689 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.68 142.55 47.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.882 0.372 . . . . 0.0 111.702 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 73.22 -54.4 0.69 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.021 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.61 44.35 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.916 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.79 168.94 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 72.8 mtm -91.77 100.01 12.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.151 0.501 . . . . 0.0 110.155 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.74 157.34 37.07 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.828 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.18 115.56 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.963 1.776 . . . . 0.0 110.273 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.04 -45.71 70.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.262 0.553 . . . . 0.0 109.545 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -129.82 -157.04 0.79 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.793 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.77 -161.61 14.21 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.358 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 84' ' ' ARG . 35.9 mt-10 -124.03 111.11 15.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 26.2 ptt180 -74.28 148.11 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.908 0.861 . . . . 0.0 112.754 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.32 136.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.473 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.69 142.82 91.78 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.73 -18.42 12.18 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.389 2.726 . . . . 0.0 112.879 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.65 ' HG3' ' HE3' ' A' ' 144' ' ' LYS . 43.2 tt0 -64.33 -31.12 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -94.06 4.55 53.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.911 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.9 t -82.74 120.34 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.22 -46.48 6.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.258 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.609 ' HZ ' HD13 ' A' ' 33' ' ' LEU . 35.7 t80 -125.14 129.93 51.16 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.61 139.17 45.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.596 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.431 ' HB3' HD23 ' A' ' 47' ' ' LEU . . . -110.84 113.47 26.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -118.56 113.74 36.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.43 ' HG2' ' HA ' ' A' ' 50' ' ' PRO . 11.6 Cg_exo -71.98 118.66 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.595 2.197 . . . . 0.0 110.579 171.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -121.16 142.24 15.34 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.689 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.5 106.07 14.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.53 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.266 0.979 . . . . 0.0 112.932 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 161.75 25.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -175.87 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.761 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 79.3 mt -68.47 -29.45 68.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.47 -39.19 19.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.121 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.5 31.46 0.46 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.468 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -99.93 156.87 16.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.193 0.521 . . . . 0.0 111.057 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -99.63 157.45 16.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.499 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.77 -36.46 37.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.089 0.471 . . . . 0.0 109.978 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.08 135.28 8.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.235 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -146.35 15.62 1.3 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.75 0.31 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 158.84 154.1 7.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.989 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -146.02 147.2 31.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 166.72 -142.81 7.86 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -72.96 -25.85 61.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.463 . . . . 0.0 110.591 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.532 ' HD1' HD11 ' A' ' 80' ' ' ILE . 2.1 m-85 -69.31 -31.08 69.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.657 0.742 . . . . 0.0 109.264 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.01 -51.96 48.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.571 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -57.71 -37.5 73.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.039 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 82' ' ' LEU . 26.5 tp -58.41 -48.23 81.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.949 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.4 mt -59.18 -37.22 76.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.24 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -89.67 0.4 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.977 0.418 . . . . 0.0 110.7 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.554 ' HE ' ' HA ' ' A' ' 142' ' ' ARG . 1.9 tpm_? -95.3 -29.04 14.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.147 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.96 107.56 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.079 0.466 . . . . 0.0 110.478 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.65 ' HE3' ' HG3' ' A' ' 110' ' ' GLU . 19.7 pttp -85.66 9.32 16.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.19 -154.66 30.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.201 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.428 HD12 HG23 ' A' ' 171' ' ' VAL . 31.8 tp -93.27 112.23 24.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.359 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -90.24 108.33 19.69 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.251 0.548 . . . . 0.0 110.175 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.487 HG22 ' CE2' ' A' ' 114' ' ' PHE . 59.3 t -97.89 111.26 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.48 112.67 3.5 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.506 HG13 HG21 ' A' ' 55' ' ' VAL . 18.1 t -105.4 116.73 49.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -156.71 -177.27 6.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.675 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.42 ' HE1' ' H ' ' A' ' 55' ' ' VAL . 74.7 m-85 -93.98 161.01 14.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 t -73.38 -28.96 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.801 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.57 -16.29 60.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.017 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 8.6 tt0 -95.1 7.54 45.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.926 0.87 . . . . 0.0 109.483 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 122.45 57.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.288 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.39 179.44 4.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.031 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.761 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 14.6 mt-10 -87.58 -56.4 3.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.377 0.608 . . . . 0.0 109.801 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.63 104.23 5.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.621 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.79 158.34 35.36 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.758 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.38 101.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.785 1.656 . . . . 0.0 110.397 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -90.71 139.7 30.47 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.2 t70 -75.62 -92.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.516 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -165.85 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.008 0.433 . . . . 0.0 109.988 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -102.76 50.78 0.81 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.421 0.629 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -81.75 -167.51 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.916 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 64.6 mt -113.54 103.87 55.4 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 153.87 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.304 2.67 . . . . 0.0 112.049 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.53 172.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.798 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.77 -52.55 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.273 0.559 . . . . 0.0 110.266 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.428 HG23 HD12 ' A' ' 146' ' ' LEU . 57.3 t -123.47 140.43 47.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.745 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.94 110.75 18.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 178' ' ' VAL . 54.1 t -103.18 121.94 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 80.4 p -108.8 -173.11 2.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.953 0.406 . . . . 0.0 110.745 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.505 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 11.1 pt-20 -69.21 -18.8 63.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.302 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.505 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 29.7 mmtp -117.06 -65.37 1.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.403 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.59 168.68 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 112.105 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.571 HG21 HD21 ' A' ' 36' ' ' LEU . 61.4 t -114.45 123.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.51 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -102.94 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.642 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 54.5 mtp85 -83.79 89.53 7.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 80.4 mt -64.37 -41.84 96.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.991 -165.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 182' ' ' ARG . 31.2 ttp-105 -116.45 28.15 8.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.329 0.585 . . . . 0.0 110.515 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 21.6 t70 -135.92 113.34 10.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.562 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.97 158.8 8.71 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 68.51 124.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.541 0.736 . . . . 0.0 112.454 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.9 t -150.57 154.3 37.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.571 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 26.7 tp -154.77 24.67 0.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.622 0.725 . . . . 0.0 109.382 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.85 125.8 47.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.225 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -111.32 -148.79 0.43 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 163.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -63.02 118.34 7.7 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -60.03 136.75 58.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.996 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -84.08 26.0 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.732 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -154.8 137.48 15.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.05 177.396 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.819 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 17.4 ttt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.819 ' H ' ' HG2' ' A' ' 1' ' ' MET . 60.2 tp -64.09 -26.23 68.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.263 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 7.6 mtpm? -62.3 -49.32 76.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 17.4 p -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.578 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.32 -58.34 9.05 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.749 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.49 -41.96 91.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.63 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -52.45 -51.57 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.796 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 9.9 mtmp? -64.49 -44.9 89.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.455 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.77 -45.78 84.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.551 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 120' ' ' VAL . 60.9 t -68.63 -33.06 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.642 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 15' ' ' ILE . 16.3 mt -56.95 -51.65 68.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -59.98 -43.35 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.15 -0.81 15.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.816 ' HD3' ' HG2' ' A' ' 54' ' ' GLU . 21.0 ttm180 -111.73 -41.21 4.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.73 0.3 . . . . 0.0 111.404 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 11' ' ' LEU . 32.2 pt -90.77 -18.16 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.32 -2.01 57.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.049 0.452 . . . . 0.0 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.76 149.31 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.723 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 m -63.3 132.85 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.51 -36.85 85.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.368 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.36 -35.23 79.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.333 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -72.92 -41.22 64.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.36 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -65.64 -37.05 85.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.697 HH21 ' HB2' ' A' ' 56' ' ' ASP . 3.0 tpm_? -58.51 -47.05 85.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.741 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -59.84 -47.96 83.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.12 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG22 ' A' ' 29' ' ' VAL . 95.6 mt -63.32 -43.27 98.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.841 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 70.2 m -61.49 -37.64 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.904 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -58.05 -41.71 83.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 109.896 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.53 -40.59 85.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 25' ' ' LEU . 74.8 t -66.51 -41.43 88.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' SER . 74.9 mt -58.14 -45.06 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -69.63 -33.74 73.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.956 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.56 -44.85 81.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 0.0 110.237 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.69 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 24.4 tp -61.58 -42.6 99.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.07 -13.66 60.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.428 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 t -79.84 -26.61 40.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 33' ' ' LEU . 89.7 mt -60.53 122.52 68.42 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.613 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.48 -22.23 52.11 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.722 2.282 . . . . 0.0 111.701 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.14 -31.67 68.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.365 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.84 -43.8 97.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.875 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.491 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 40.5 mttm -70.95 -18.68 62.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.492 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -79.56 -38.71 33.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 65.9 m -71.82 120.62 17.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.258 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 36.4 mtpt -107.02 -28.23 10.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -89.04 92.53 9.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 57.9 t -112.4 111.21 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.922 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -102.98 134.68 46.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.199 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 7.4 mp -114.83 145.3 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -86.64 1.78 50.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.476 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.01 90.95 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.109 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.54 103.3 1.41 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.906 2.404 . . . . 0.0 112.314 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 1.7 pp -99.28 169.42 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.032 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 65.46 21.15 11.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.29 0.566 . . . . 0.0 110.019 -172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 -86.44 1.56 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.707 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.816 ' HG2' ' HD3' ' A' ' 14' ' ' ARG . 29.9 mt-10 60.88 -84.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG22 HG11 ' A' ' 150' ' ' VAL . 58.6 t -145.44 133.48 16.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.697 ' HB2' HH21 ' A' ' 23' ' ' ARG . 60.6 m-20 -71.45 79.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.88 0.372 . . . . 0.0 111.297 -178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 150' ' ' VAL . 90.6 mt -98.34 -16.98 19.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 109.777 174.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.676 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 6.5 m -63.69 -50.69 70.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.25 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.676 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 20.9 Cg_exo -67.97 3.65 1.87 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.339 2.026 . . . . 0.0 112.824 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -93.28 -9.59 38.49 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.501 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 19.5 m-30 -50.83 -49.65 78.59 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.248 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 73.1 Cg_exo -51.96 -35.76 61.84 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.2 1.933 . . . . 0.0 112.791 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.7 -11.91 49.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 68' ' ' LYS . 29.3 t -93.64 -40.52 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.69 -1.94 4.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 94.1 mttt -84.19 -52.67 6.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.647 0.26 . . . . 0.0 111.268 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.946 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 6.8 pt-20 -119.76 -9.72 9.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.946 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 mptp? -116.32 165.06 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.769 0.795 . . . . 0.0 112.185 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 37.1 mt-10 -98.87 114.79 27.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.326 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -78.93 124.16 27.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.467 . . . . 0.0 110.925 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 55.6 mt -114.48 117.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.199 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.0 mt -119.31 147.64 43.59 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.882 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 47' ' ' LEU . 91.6 Cg_endo -81.21 129.66 6.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.895 2.397 . . . . 0.0 113.443 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -127.34 109.56 11.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.13 105.84 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.201 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -10.84 59.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.689 -175.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.04 -42.95 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.705 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -137.14 -39.17 0.61 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.015 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.26 141.4 28.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.32 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -80.36 106.89 12.71 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.583 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.0 mt -74.31 117.63 16.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.953 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.445 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 5.2 m-85 -102.45 133.1 47.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.135 0.493 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 12.5 ttp180 -99.5 115.18 28.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.853 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -131.42 148.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.97 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -127.21 18.88 7.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.378 0.609 . . . . 0.0 109.518 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.2 m -139.06 141.72 30.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 6.7 Cg_exo -74.5 -174.53 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.931 2.421 . . . . 0.0 111.947 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.61 -30.49 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 112.237 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.407 ' H ' ' C ' ' A' ' 88' ' ' PRO . 34.4 m -76.37 1.74 15.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 110.681 177.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.5 mt -104.38 105.65 15.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.102 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -107.18 -163.16 21.93 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.816 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.91 121.9 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.63 -75.61 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.98 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.23 114.9 1.97 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.513 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 65.93 8.29 5.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.275 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.14 82.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.877 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.96 165.86 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 65.4 mtt -71.07 137.27 48.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.085 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.24 141.73 32.85 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.674 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 7.9 Cg_exo -72.26 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.485 2.123 . . . . 0.0 110.426 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.493 HG23 ' HG2' ' A' ' 103' ' ' GLU . 34.9 m -66.29 -22.53 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG2' HG23 ' A' ' 102' ' ' VAL . 9.3 pt-20 -152.91 166.94 30.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.379 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -171.99 21.62 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -109.45 154.56 22.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.922 0.391 . . . . 0.0 111.19 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.94 157.15 23.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 39.1 t -109.8 136.06 46.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.699 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -67.86 132.35 92.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.56 -41.23 45.19 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.912 2.408 . . . . 0.0 113.247 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.9 -4.11 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.361 0.601 . . . . 0.0 110.847 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.96 -19.28 30.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.491 175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.03 122.69 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.995 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.29 -43.43 5.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.69 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 23.8 t80 -126.03 123.97 39.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.427 HG21 ' HA ' ' A' ' 147' ' ' LYS . 13.5 tt -128.0 137.5 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.482 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.08 111.36 22.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.266 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.441 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 6.2 p -133.99 123.22 16.82 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.718 -178.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.416 ' HB2' ' OE2' ' A' ' 54' ' ' GLU . 1.4 Cg_endo -84.49 -122.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.997 2.465 . . . . 0.0 111.322 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' A' ' 130' ' ' GLY . . . 114.88 -178.07 17.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.935 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 10' ' ' VAL . 98.5 t -100.27 125.64 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.574 -0.313 . . . . 0.0 111.387 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 128' ' ' ARG . . . 69.43 121.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.208 0.943 . . . . 0.0 112.73 171.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -128.91 158.23 39.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.539 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.511 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 38.9 p30 -137.94 -174.19 3.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.32 -6.62 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -89.99 -27.26 19.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 110.044 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.7 21.99 6.9 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.193 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.34 151.51 21.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.08 0.467 . . . . 0.0 110.91 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.514 HH22 ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -151.41 151.95 32.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.465 HD12 ' HB1' ' A' ' 121' ' ' ALA . 10.0 mp -83.71 -30.17 26.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.142 0.496 . . . . 0.0 110.069 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.43 ' HA2' ' HA3' ' A' ' 119' ' ' GLY . . . 67.63 -154.66 53.0 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.13 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -83.68 -39.07 20.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.88 0.372 . . . . 0.0 110.261 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 134.76 -130.96 5.68 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.505 ' HD3' ' HE2' ' A' ' 136' ' ' TYR . 98.0 mttt 56.73 77.46 0.26 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.048 0.452 . . . . 0.0 111.516 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.54 51.18 2.97 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.811 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -127.37 -22.19 3.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.342 0.592 . . . . 0.0 109.943 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.505 ' HE2' ' HD3' ' A' ' 133' ' ' LYS . 46.2 m-85 -104.13 9.36 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.107 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.72 -31.68 72.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 110.192 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -67.34 -29.08 68.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.68 -34.29 46.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.44 -24.39 65.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.391 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -96.43 -4.16 42.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -91.87 -28.33 17.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.211 0.529 . . . . 0.0 110.026 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.88 114.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.63 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -92.56 7.25 44.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.73 166.57 54.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.112 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.16 102.58 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.073 0.463 . . . . 0.0 110.104 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 55.9 mtpt -72.19 102.97 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.728 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 65.6 t -97.7 117.65 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.431 . . . . 0.0 110.594 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -88.93 120.32 5.67 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.476 HG11 HG22 ' A' ' 55' ' ' VAL . 19.0 t -99.08 108.2 21.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -139.94 157.68 45.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.329 0.585 . . . . 0.0 112.212 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.38 155.24 17.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.546 ' OG ' ' HG3' ' A' ' 176' ' ' LYS . 3.7 m -52.14 -29.94 24.28 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.363 0.414 . . . . 0.0 111.762 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -68.81 -20.48 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.597 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -99.46 -2.91 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.69 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -104.44 128.44 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.149 0.5 . . . . 0.0 111.514 -173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.65 -165.99 1.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.643 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 43.0 mt-10 -88.67 -62.3 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -143.7 112.14 6.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.124 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.2 mt -102.99 161.52 22.89 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.657 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.69 140.48 74.71 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.35 2.034 . . . . 0.0 111.307 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 162' ' ' ARG . 47.1 mtt180 -76.41 117.72 18.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 165' ' ' TRP . 23.9 t70 -108.94 128.06 54.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 69.1 -14.81 0.29 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.994 0.809 . . . . 0.0 112.237 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.484 ' H ' ' C ' ' A' ' 163' ' ' ASP . 11.3 m-90 58.0 35.17 25.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.96 0.504 . . . . 0.0 111.366 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.514 ' HB3' HH22 ' A' ' 128' ' ' ARG . 14.1 t0 -68.63 153.31 44.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.663 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 13.4 tt -66.55 125.78 91.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.151 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 62.3 Cg_exo -51.54 151.97 13.19 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.302 2.668 . . . . 0.0 112.917 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 28.7 m -70.52 161.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.168 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.454 ' OD2' ' HD3' ' A' ' 182' ' ' ARG . 16.9 t70 -89.88 -43.61 10.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.186 -175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 81.4 t -131.66 132.91 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.05 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.776 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 55.8 tp -114.84 102.3 9.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.825 0.345 . . . . 0.0 110.1 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.59 111.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -113.31 165.7 12.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.6 -177.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -61.77 -30.8 71.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.014 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.546 ' HG3' ' OG ' ' A' ' 153' ' ' SER . 95.1 mttt -82.66 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.52 175.28 10.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.884 0.373 . . . . 0.0 110.535 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.56 114.3 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.649 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.776 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 4.9 tpm_? -93.66 98.97 11.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -75.75 120.09 20.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 169' ' ' VAL . 95.4 mt -105.95 -23.69 12.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.754 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 37.8 ttp-105 -78.91 82.24 5.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.164 0.507 . . . . 0.0 109.811 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -163.15 -178.34 5.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.001 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.97 23.99 1.77 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 175.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 64.24 -76.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 111.225 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.8 t -178.98 161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.0 103.45 12.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 191' ' ' HIS . 34.4 tt0 -88.17 107.78 18.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.948 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -81.57 112.1 18.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.394 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 55.08 82.05 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.027 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 188' ' ' GLU . 56.5 p-80 -97.55 167.82 10.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -143.13 156.72 44.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 74.77 -72.36 0.11 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.807 0.692 . . . . 0.0 111.376 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.438 -178.797 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG2' ' HG ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 1' ' ' MET . 91.9 mt 73.68 149.99 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.846 0.716 . . . . 0.0 110.933 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 161' ' ' PRO . 63.4 pttt -73.64 -13.77 61.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.219 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -64.26 -30.04 71.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.205 0.526 . . . . 0.0 110.357 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.18 -39.86 32.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.29 -38.26 83.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.735 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.605 ' HD2' ' HD1' ' A' ' 131' ' ' PHE . 54.4 ttp180 -57.87 -41.84 83.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.789 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.96 -39.16 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -57.83 -50.46 73.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.22 -42.64 91.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.499 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 tp -60.17 -35.5 75.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.131 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -58.28 -63.65 1.19 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.941 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -67.1 -27.04 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.304 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.525 ' NH1' ' HA ' ' A' ' 120' ' ' VAL . 18.4 ttt180 -60.4 -60.75 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.731 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 11' ' ' LEU . 36.2 pt -80.24 9.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.247 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -92.33 -10.64 37.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.459 HD11 ' HG2' ' A' ' 54' ' ' GLU . 87.8 mt -58.19 154.54 12.92 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.717 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . 1.2 m -77.74 160.36 28.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -62.57 -66.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.8 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -31.81 73.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.137 0.494 . . . . 0.0 110.098 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 18' ' ' SER . 39.3 tt0 -58.0 -52.5 65.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.78 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.692 HH12 ' HB2' ' A' ' 56' ' ' ASP . 35.7 ptt85 -70.55 -21.82 62.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.598 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -71.11 -41.77 70.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -72.33 -34.35 67.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -64.03 -41.87 97.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.3 m -63.82 -37.9 89.1 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.526 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -64.66 -39.75 94.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.9 t -74.12 -44.64 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.536 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.8 -37.05 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.77 0.319 . . . . 0.0 110.371 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 t -64.91 -36.41 84.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.463 . . . . 0.0 109.914 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.11 -49.94 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.349 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -31.78 71.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.763 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.11 -32.63 67.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.2 p -80.85 -17.01 52.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.144 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD22 ' HD2' ' A' ' 37' ' ' PRO . 1.1 tt -55.35 113.03 4.85 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.092 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 36' ' ' LEU . 32.6 Cg_exo -60.31 -39.04 71.02 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.624 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -24.51 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.309 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.54 -27.21 62.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 109.531 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -79.64 -24.11 42.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.572 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -78.17 -46.02 21.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.403 ' OG ' ' HB2' ' A' ' 114' ' ' PHE . 43.4 t -59.85 149.06 32.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.565 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 38.1 tttp -138.17 -21.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.976 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.994 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 32.5 mmtp -96.7 92.48 6.21 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG22 ' HD3' ' A' ' 68' ' ' LYS . 29.2 t -108.17 110.78 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 111.343 -172.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -96.52 119.66 35.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.774 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 70' ' ' LEU . 7.7 mp -104.9 125.86 51.36 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -80.99 3.3 23.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.314 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m 63.16 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.253 0.549 . . . . 0.0 110.754 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 58.9 Cg_endo -73.12 81.98 1.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.456 2.104 . . . . 0.0 113.521 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' HD13 ' A' ' 51' ' ' ILE . 2.0 pp -81.01 127.65 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt 56.8 32.86 22.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.966 0.889 . . . . 0.0 109.556 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -110.04 104.51 1.85 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.638 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 4.5 mp0 -55.51 -30.39 60.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.572 0.349 . . . . 0.0 111.184 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' CZ ' ' A' ' 152' ' ' TYR . 6.8 t -78.16 96.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.692 ' HB2' HH12 ' A' ' 22' ' ' ARG . 4.9 t70 -82.71 110.13 17.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.431 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 93.6 mt -99.43 7.36 45.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -67.46 -41.04 29.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 58' ' ' THR . 31.4 Cg_exo -62.08 -6.02 7.31 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.051 1.834 . . . . 0.0 113.393 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' A' ' 63' ' ' GLU . 25.7 tp -87.53 -10.09 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.39 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 7.7 m-85 -55.7 -52.87 68.62 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.7 Cg_exo -53.48 -34.94 74.29 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.272 1.982 . . . . 0.0 112.801 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG3' HD13 ' A' ' 60' ' ' LEU . 11.5 mm-40 -66.23 -48.56 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.46 -40.39 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.285 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.419 HD21 HD22 ' A' ' 70' ' ' LEU . 97.2 mt -66.95 -11.12 55.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.722 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -77.62 -57.42 3.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.212 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' OE2' ' HG3' ' A' ' 68' ' ' LYS . 1.7 pp20? -134.67 -9.98 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HG3' ' OE2' ' A' ' 67' ' ' GLU . 43.8 mttp -95.88 179.6 5.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.186 0.517 . . . . 0.0 111.079 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 65.9 mm-40 -107.56 113.89 27.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.575 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 85' ' ' VAL . 49.3 tp -83.86 110.24 18.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.101 0.477 . . . . 0.0 109.999 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 56.4 mt -100.87 112.51 33.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.924 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 88.2 mt -108.62 145.0 30.69 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.689 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 7.8 Cg_endo -87.57 118.52 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.203 2.602 . . . . 0.0 112.457 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.693 ' HD2' ' CE2' ' A' ' 83' ' ' TYR . 36.0 tttp -105.49 121.37 43.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.883 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.67 105.19 7.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -15.87 61.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.988 0.423 . . . . 0.0 111.164 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.88 -44.51 0.28 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.86 -34.43 0.47 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.601 -0.299 . . . . 0.0 110.458 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -105.6 168.04 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.0 mt -107.17 133.89 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.522 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 t -119.03 132.35 56.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 90.5 mt -84.84 142.18 29.93 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 121.333 -0.147 . . . . 0.0 110.748 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.693 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 1.5 m-85 -116.75 138.45 51.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.577 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 72.2 ttt180 -100.96 104.89 16.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.218 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 13.4 t -133.07 154.59 39.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -148.41 46.0 1.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.59 0.709 . . . . 0.0 109.878 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -171.53 148.91 2.36 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.132 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.74 -61.84 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.483 2.122 . . . . 0.0 111.624 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.01 -93.48 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.3 m -125.94 27.5 6.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.438 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -78.25 114.22 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -127.42 -159.8 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.527 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.402 HG12 ' HA2' ' A' ' 97' ' ' GLY . 59.0 t -117.15 93.4 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.281 0.562 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -96.1 2.42 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.731 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -68.09 122.37 18.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 74.19 -44.6 0.57 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.648 0.779 . . . . 0.0 112.496 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 93' ' ' VAL . . . 131.23 6.69 3.41 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.113 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.4 pt -84.01 173.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.86 99.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.731 ' HG3' ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -110.35 111.89 57.37 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.86 -172.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.26 106.22 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.694 2.262 . . . . 0.0 111.858 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.3 -40.67 89.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -127.1 -177.65 4.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.467 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -177.65 16.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.837 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 1.5 mm-40 -115.88 154.27 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 111.225 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 12.8 mtm180 -86.58 159.32 19.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.784 -167.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 48.6 t -122.73 126.09 73.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.853 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -84.55 151.52 58.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.997 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 112' ' ' VAL . 52.7 Cg_exo -56.13 -20.06 29.44 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.986 2.457 . . . . 0.0 113.065 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -76.62 -9.44 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.088 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -111.11 2.73 18.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.53 . . . . 0.0 110.38 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 109' ' ' PRO . 86.5 t -74.14 106.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.249 0.547 . . . . 0.0 110.905 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.994 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 5.1 t0 -86.47 -54.04 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.468 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 148' ' ' VAL . 37.2 t80 -132.19 132.99 43.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.09 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -133.78 138.97 49.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.834 0.349 . . . . 0.0 110.419 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.54 111.56 19.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.302 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.55 117.35 29.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.402 0.62 . . . . 0.0 110.945 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.419 ' HG3' ' HB3' ' A' ' 50' ' ' PRO . 94.2 Cg_endo -86.89 73.94 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.872 2.381 . . . . 0.0 112.359 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.28 159.92 36.53 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.486 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.525 ' HA ' ' NH1' ' A' ' 14' ' ' ARG . 99.3 t -66.87 -50.1 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.494 0.188 . . . . 0.0 111.361 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.86 24.31 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.894 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -132.16 170.33 15.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.68 -177.02 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.536 0.208 . . . . 0.0 110.463 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.3 mt -83.2 8.72 12.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -109.38 -28.69 8.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 122.11 13.42 4.92 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.843 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -94.12 161.72 14.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.443 0.64 . . . . 0.0 111.999 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.538 ' HD3' ' OD1' ' A' ' 166' ' ' ASP . 2.1 ptm180 -101.96 147.75 26.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.27 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' A' ' 160' ' ' LEU . 53.2 tp -67.11 -58.41 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.907 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.52 104.56 0.29 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.605 ' HD1' ' HD2' ' A' ' 7' ' ' ARG . 68.0 t80 -162.26 126.4 3.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.44 150.54 5.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.196 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -115.19 143.27 45.49 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.57 4.72 76.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.643 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.647 ' HD2' ' HB2' ' A' ' 138' ' ' ARG . 26.2 t80 65.39 57.45 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.34 0.591 . . . . 0.0 109.935 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -64.04 -22.91 67.13 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.88 0.848 . . . . 0.0 110.364 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.801 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 7.1 p-10 -74.92 7.06 3.44 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.677 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.647 ' HB2' ' HD2' ' A' ' 135' ' ' TYR . 41.1 ttm180 -66.63 -44.18 82.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 165.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.461 ' O ' HG21 ' A' ' 143' ' ' VAL . 9.9 tt -71.86 -43.77 64.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.974 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.801 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 55.7 mt -58.03 -41.06 82.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.835 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 111.384 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HD3' ' HG2' ' A' ' 109' ' ' PRO . 77.5 ttt180 -95.46 -12.48 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.941 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 139' ' ' LEU . 94.6 t -62.88 98.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.315 0.579 . . . . 0.0 110.232 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -95.11 14.1 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.69 0.757 . . . . 0.0 109.855 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.51 -166.26 30.93 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.885 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 171' ' ' VAL . 35.9 tp -78.69 112.89 16.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 110.947 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.86 ' HD3' HD11 ' A' ' 167' ' ' ILE . 16.0 mttp -93.86 114.24 26.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.516 HG21 ' HB ' ' A' ' 171' ' ' VAL . 74.7 t -109.99 115.76 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.205 0.526 . . . . 0.0 110.887 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.53 130.23 10.02 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 55' ' ' VAL . 21.9 t -115.66 109.76 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -161.6 170.86 19.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.681 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 48.0 m-85 -90.26 171.24 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 64.0 m -62.21 -28.74 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.348 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -86.39 10.87 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.104 0.478 . . . . 0.0 111.561 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -105.07 -7.56 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 167.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.34 116.72 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.395 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -105.88 -179.31 3.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.812 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 54.3 mt-10 -76.48 -46.84 25.04 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.122 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -150.63 144.25 25.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.361 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' A' ' 129' ' ' LEU . 98.1 mt -128.9 147.13 63.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.362 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.527 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 31.2 Cg_exo -60.39 114.75 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.663 2.242 . . . . 0.0 111.82 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 80.3 mtt180 -104.14 147.12 27.8 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.77 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.25 -69.15 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.69 -85.45 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.64 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -120.31 74.29 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.432 0.634 . . . . 0.0 109.511 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.538 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 2.5 t70 -89.37 -174.07 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.729 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.86 HD11 ' HD3' ' A' ' 147' ' ' LYS . 4.1 tt -94.77 125.86 49.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 121.075 0.464 . . . . 0.0 111.801 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 98.0 Cg_endo -93.93 158.54 2.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.336 2.691 . . . . 0.0 111.96 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.45 147.9 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.82 -42.97 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.382 0.611 . . . . 0.0 110.059 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.553 HG21 HD13 ' A' ' 146' ' ' LEU . 98.5 t -125.21 133.69 68.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.209 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 41.4 tp -122.24 105.0 9.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.537 HG21 HG12 ' A' ' 178' ' ' VAL . 46.8 t -91.25 127.94 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 41.0 p -110.5 -166.24 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.53 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.681 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -84.32 -14.5 49.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -92.2 -59.91 1.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.916 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -155.52 170.57 21.66 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.147 0.498 . . . . 0.0 111.957 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 173' ' ' VAL . 97.1 t -83.98 106.69 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.477 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -98.99 93.28 5.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.857 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -72.4 106.66 4.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.6 mt -56.57 -25.55 52.67 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.782 0.676 . . . . 0.0 112.569 -165.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -161.79 130.59 4.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.11 -88.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 174.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.94 -65.28 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.606 -0.33 . . . . 0.0 113.519 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -62.79 103.46 0.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 p -139.4 144.23 38.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.389 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.436 HD21 ' NE2' ' A' ' 189' ' ' HIS . 17.1 tp -103.46 128.31 50.66 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.47 81.38 2.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.431 0.634 . . . . 0.0 109.954 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.436 ' NE2' HD21 ' A' ' 187' ' ' LEU . 21.7 m80 -75.71 -19.94 58.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.03 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' ' 192' ' ' HIS . 16.8 t-80 -140.48 106.24 5.14 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -57.86 -37.33 73.7 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.274 0.359 . . . . 0.0 111.391 -176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 190' ' ' HIS . 40.7 m-70 -66.09 106.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.086 0.469 . . . . 0.0 110.08 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -87.38 136.71 32.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.185 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.933 177.084 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.753 0.311 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.83 28.62 0.27 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.18 -25.31 65.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -75.73 -23.25 56.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.246 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 5.4 mm-40 -77.31 -35.02 55.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 10' ' ' VAL . 48.6 tp -77.66 -29.98 51.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.663 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.8 ttm-85 -53.26 -49.56 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 55.0 pttt -68.93 -31.44 70.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.832 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.21 -43.51 70.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.6 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 6' ' ' LEU . 39.1 t -70.19 -39.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.34 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.649 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -71.87 -38.57 70.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.263 0.554 . . . . 0.0 110.778 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -60.84 -41.96 96.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.868 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.1 pt -90.68 1.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.677 0.275 . . . . 0.0 111.501 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.59 -26.88 31.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.978 0.418 . . . . 0.0 110.804 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.13 143.67 57.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.788 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -85.96 -176.74 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.22 -52.13 65.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.348 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -52.31 -51.37 59.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.797 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.96 -58.23 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.62 0.248 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -57.43 -50.17 73.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.9 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -62.39 -40.6 97.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.972 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -71.05 -44.61 65.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.903 0.382 . . . . 0.0 110.915 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' O ' HG21 ' A' ' 29' ' ' VAL . 96.2 mt -65.01 -42.44 94.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.819 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -63.2 -39.31 94.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.525 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.29 -43.73 92.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.026 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -55.86 -51.34 67.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.731 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 25' ' ' LEU . 52.0 t -62.86 -42.76 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.389 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 56' ' ' ASP . 79.8 mt -62.51 -50.28 80.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.5 t -59.46 -45.18 92.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -63.4 -41.37 98.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.763 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 35.9 tp -63.33 -42.27 98.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.505 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -73.59 -21.1 60.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.7 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -74.35 -27.34 60.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.312 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.51 HD12 HD13 ' A' ' 33' ' ' LEU . 89.2 mt -57.63 132.49 82.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.778 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.4 -24.04 77.82 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.32 2.014 . . . . 0.0 110.64 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -63.99 -30.05 71.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.862 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.12 -38.32 82.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.012 0.434 . . . . 0.0 110.506 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -70.48 -26.43 63.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 109.759 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -84.34 -13.36 52.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 m -65.47 121.47 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -106.92 -54.87 2.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.862 0.839 . . . . 0.0 109.086 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.598 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 47.8 mmtt -105.06 99.74 9.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.237 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.58 108.82 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.059 0.456 . . . . 0.0 110.679 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.28 138.38 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.097 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.11 144.06 47.82 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.658 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 24.0 t80 -82.35 -4.16 56.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.9 m 62.1 92.8 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.728 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.4 133.98 27.6 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.339 2.026 . . . . 0.0 111.749 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.501 ' HB ' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -121.19 -35.49 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 0.0 110.083 -177.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.43 41.59 1.11 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.524 -177.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.41 -90.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 54.85 38.23 29.93 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.845 0.379 . . . . 0.0 111.849 168.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.7 t 73.17 119.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.35 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' O ' HD11 ' A' ' 30' ' ' ILE . 11.1 m-20 -69.07 83.25 0.33 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.273 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 99.1 mt -89.83 -4.63 57.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.839 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -46.88 94.92 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.074 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.71 -3.37 7.9 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.115 1.876 . . . . 0.0 112.951 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 63' ' ' GLU . 23.0 tp -93.23 -9.84 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.388 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.473 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 3.1 m-85 -54.28 -54.04 52.45 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.645 177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.4 Cg_endo -56.19 -39.97 87.85 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.362 2.041 . . . . 0.0 112.374 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' HG3' HD13 ' A' ' 60' ' ' LEU . 7.7 mm-40 -58.47 -42.39 87.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.065 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.82 -46.86 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.18 -24.55 64.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.877 0.37 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -38.5 78.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.093 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.87 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 7.2 pt-20 -138.27 -46.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.87 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 49.6 mttm -96.6 -173.32 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.995 0.426 . . . . 0.0 111.008 -170.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.578 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 39.2 mt-10 -100.14 128.32 46.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.7 tp -100.88 110.83 22.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.22 119.86 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.292 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.834 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 93.7 mt -122.49 145.6 45.18 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' CB ' HD11 ' A' ' 80' ' ' ILE . 72.7 Cg_endo -91.58 127.24 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.045 2.497 . . . . 0.0 113.688 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.769 ' HD3' ' HE2' ' A' ' 83' ' ' TYR . 34.8 tttm -105.98 126.08 51.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.18 128.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.698 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -139.14 100.4 4.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.886 0.374 . . . . 0.0 110.128 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.09 -106.17 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.764 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -124.8 21.3 8.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.426 0.631 . . . . 0.0 109.603 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.75 152.96 35.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 139' ' ' LEU . 16.8 tt -128.02 128.0 68.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.422 0.63 . . . . 0.0 110.773 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -104.11 108.61 20.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.704 HD13 HD11 ' A' ' 139' ' ' LEU . 97.0 mt -85.35 101.1 12.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.769 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 77.2 m-85 -96.17 130.82 43.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.286 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.578 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 20.1 ptt180 -92.59 130.17 38.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.15 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.433 -171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -135.17 14.31 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.336 0.588 . . . . 0.0 109.638 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.0 m -135.09 125.42 17.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.21 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.2 Cg_exo -61.87 -31.56 85.04 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 122.915 2.41 . . . . 0.0 113.423 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.66 -2.25 19.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.72 4.2 51.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.903 0.382 . . . . 0.0 110.663 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.7 mt -104.52 149.06 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.705 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.22 -142.2 6.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 133.06 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -127.27 -98.17 1.0 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.0 114.387 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.32 -2.85 21.82 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -166.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -122.93 -44.56 2.18 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.12 24.82 3.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.879 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.95 173.24 7.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 tpt -69.81 88.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.05 161.63 39.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.295 -172.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.834 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -76.13 125.5 8.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.507 2.138 . . . . 0.0 112.097 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.94 -41.76 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.011 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.99 173.85 11.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.87 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.09 -164.42 25.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.896 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -110.76 122.04 46.82 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.752 -0.264 . . . . 0.0 110.849 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.5 ptm180 -84.31 125.99 32.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.72 164.28 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.74 153.02 87.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.88 -11.56 24.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.975 2.45 . . . . 0.0 113.314 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -71.03 -20.44 62.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.494 . . . . 0.0 110.455 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.402 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 17.9 t70 -79.33 -16.44 56.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.459 -178.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.67 124.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.299 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.598 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 19.0 t70 -99.2 -48.41 4.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.508 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.763 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 32.1 t80 -136.9 119.94 16.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.465 HG21 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -126.15 138.87 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.027 0.442 . . . . 0.0 110.962 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.4 111.4 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.202 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.81 105.8 54.27 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.922 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 48' ' ' TYR . 16.5 Cg_exo -68.59 119.32 6.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.489 2.126 . . . . 0.0 110.941 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.53 153.92 19.67 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.688 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.663 HG13 ' HG2' ' A' ' 7' ' ' ARG . 84.1 t -58.77 -49.26 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.188 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.88 36.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.584 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.25 151.84 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 5.0 p-10 -108.36 -163.72 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 97.7 mt -75.69 -19.52 59.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.81 -31.16 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.453 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . 119.39 35.06 0.96 Allowed Glycine 0 C--O 1.236 0.277 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.529 170.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.96 147.08 35.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.008 0.404 . . . . 0.0 110.16 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.584 ' HB3' ' OD2' ' A' ' 166' ' ' ASP . 25.4 ttp180 -86.78 -12.71 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.083 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.818 ' HB2' HD12 ' A' ' 160' ' ' LEU . 62.0 tp 73.68 -60.21 0.54 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.552 0.741 . . . . 0.0 111.034 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.24 113.14 0.66 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.175 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -73.61 -37.55 65.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.071 0.462 . . . . 0.0 110.262 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -132.51 -144.1 5.21 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -69.15 -72.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 0.0 110.05 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.17 38.04 0.37 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -109.78 171.42 7.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.708 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 70.1 5.3 5.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.049 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.33 -29.81 57.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.46 -25.96 67.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.659 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.704 HD11 HD13 ' A' ' 82' ' ' LEU . 34.3 tp -78.43 -58.17 3.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.388 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.83 -30.99 69.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.233 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.57 -23.54 53.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.6 -6.06 44.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 139' ' ' LEU . 97.4 t -80.73 104.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.02 7.3 44.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.62 -168.5 44.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.987 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.69 104.01 15.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.491 ' HZ3' ' HB2' ' A' ' 147' ' ' LYS . 9.9 mtmp? -86.24 102.74 14.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.163 0.506 . . . . 0.0 110.22 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.4 116.86 43.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.641 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.99 121.72 5.56 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.33 120.3 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.87 169.81 21.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 111.597 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 155' ' ' GLN . 41.4 m-85 -86.3 168.86 13.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -77.15 -19.84 56.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 109.548 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -69.01 -10.2 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.487 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' A' ' 152' ' ' TYR . 59.9 mm-40 -111.29 10.26 21.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.625 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.74 131.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.15 -168.73 1.81 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.595 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 34.1 mt-10 -80.02 -59.27 2.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 109.971 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.5 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.4 mmt85 -147.2 144.94 29.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.709 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.818 HD12 ' HB2' ' A' ' 129' ' ' LEU . 68.6 mt -101.92 137.19 19.45 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 12.0 Cg_exo -70.88 101.92 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.636 2.224 . . . . 0.0 111.075 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 0.5 OUTLIER -130.67 178.33 6.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.211 -174.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -73.45 -67.2 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.4 ' HA ' HH11 ' A' ' 162' ' ' ARG . . . -151.41 -89.28 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.005 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -116.7 78.12 1.17 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.024 0.44 . . . . 0.0 110.836 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.584 ' OD2' ' HB3' ' A' ' 128' ' ' ARG . 34.9 t70 -70.08 134.66 48.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 62.8 mt -55.97 114.79 8.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 112.057 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.76 175.95 7.38 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.272 2.648 . . . . 0.0 112.851 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.12 160.56 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 14.0 m-20 -87.89 -35.14 17.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.239 0.542 . . . . 0.0 109.924 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.4 t -133.26 143.44 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.483 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.614 ' HB2' HD13 ' A' ' 181' ' ' LEU . 56.7 tp -115.64 117.61 30.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.71 116.2 51.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.013 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 70.9 p -109.92 -167.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.747 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.529 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 10.4 pt-20 -68.19 -17.42 64.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.199 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.529 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 9.8 mtmp? -128.71 -66.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -109.41 152.63 25.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.282 0.563 . . . . 0.0 112.077 -171.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 36' ' ' LEU . 61.2 t -118.64 133.87 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.904 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -129.49 146.34 51.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.994 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -89.57 117.06 28.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 172' ' ' LEU . 70.5 mt -106.23 7.3 31.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.175 0.512 . . . . 0.0 110.869 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.14 -177.86 4.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.718 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.609 ' HB3' ' HE ' ' A' ' 185' ' ' ARG . 3.5 m-20 -60.15 105.69 0.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.013 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.57 70.81 2.17 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.609 ' HE ' ' HB3' ' A' ' 183' ' ' ASP . 26.1 mmt180 -87.33 17.77 4.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.9 m -78.23 72.62 4.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.817 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.45 38.09 1.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.341 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -54.64 117.93 3.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.347 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -142.68 80.19 1.68 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.79 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -62.01 134.29 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.931 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -75.58 94.26 3.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.555 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -77.34 172.27 13.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.598 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -92.08 -54.03 4.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 . . . . . 0 C--O 1.248 1.012 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.607 173.477 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.609 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 23.5 mmt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.36 -66.16 0.58 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -76.5 -10.03 59.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 1' ' ' MET . 3.3 p -97.36 -48.33 5.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.181 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 43.7 mt-10 -64.51 -36.36 83.95 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.136 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -53.46 -41.01 65.73 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.386 0.429 . . . . 0.0 111.133 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -65.65 -35.17 80.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.168 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.35 -34.91 17.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -60.17 -52.4 65.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.054 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 98.0 t -62.3 -46.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.482 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 tp -59.77 -42.8 94.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.667 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -61.02 -44.13 97.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.899 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -71.73 -31.18 66.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.241 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 80.0 mtp180 -64.0 -53.6 47.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.715 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 11' ' ' LEU . 26.4 pt -78.44 8.57 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.005 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -94.98 -9.04 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.478 0.656 . . . . 0.0 109.523 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 ' HG2' ' A' ' 54' ' ' GLU . 92.8 mt -68.92 141.06 55.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.504 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -69.4 153.29 43.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 111.251 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 9.4 tp10 -56.64 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.768 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.57 -44.07 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.276 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 7.3 tp10 -61.18 -39.71 91.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 42.0 ttt180 -55.1 -47.96 74.24 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.577 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.3 mmt180 -62.56 -32.23 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.78 -29.78 68.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.382 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 59.0 mt -79.34 -40.43 30.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.263 0.554 . . . . 0.0 110.31 176.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 19.9 m -59.6 -40.02 86.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.906 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.78 -32.07 73.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.439 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.64 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 91.0 mttt -60.24 -53.98 51.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.86 -43.1 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.557 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.28 -46.46 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.979 0.419 . . . . 0.0 110.508 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 t -65.38 -42.81 92.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.938 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -70.02 -43.33 71.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.595 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.566 HD12 HD13 ' A' ' 36' ' ' LEU . 28.0 tp -66.89 -34.67 78.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -86.31 -3.37 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.15 0.5 . . . . 0.0 110.625 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.53 -28.12 31.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 33' ' ' LEU . 70.2 mt -61.45 123.77 77.94 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.141 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.46 -20.5 41.71 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.485 2.123 . . . . 0.0 112.162 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.28 -22.08 55.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.778 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -72.18 -14.99 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.08 -33.5 14.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.249 177.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.71 -38.23 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.612 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 p -61.89 152.0 33.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.612 ' HD2' ' O ' ' A' ' 42' ' ' SER . 12.8 mptt -132.71 -25.75 1.85 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.848 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 3.3 mptp? -103.9 95.52 6.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 60.9 t -111.4 118.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 111.169 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.17 124.34 49.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.204 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.55 123.68 48.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.96 -7.54 49.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.921 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.4 m 70.93 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 123.326 0.65 . . . . 0.0 111.964 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.37 95.48 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.952 2.435 . . . . 0.0 112.132 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 52' ' ' LYS . 27.2 pt -78.39 -40.21 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.097 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 51' ' ' ILE . 94.7 mttt -129.28 103.13 6.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.74 172.6 35.73 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.578 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.62 ' HG2' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -93.9 -10.3 34.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.923 0.392 . . . . 0.0 110.29 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG12 ' HG ' ' A' ' 57' ' ' LEU . 57.4 t -75.13 109.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.617 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 8.0 m-20 -90.54 84.09 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.512 . . . . 0.0 111.854 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.571 ' HG ' HG12 ' A' ' 55' ' ' VAL . 94.0 mt -96.18 -10.7 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.533 0.682 . . . . 0.0 109.248 171.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.464 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 5.6 m -61.17 -49.62 87.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.121 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 58' ' ' THR . 49.2 Cg_endo -69.22 2.27 3.37 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.01 1.807 . . . . 0.0 113.501 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' HG21 ' A' ' 64' ' ' VAL . 21.2 tp -94.84 -8.17 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.048 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 19.9 m-85 -53.98 -51.53 76.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 12.2 Cg_endo -56.34 -36.17 96.82 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.553 2.168 . . . . 0.0 112.515 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.604 ' HA ' ' NZ ' ' A' ' 66' ' ' LYS . 51.8 tp10 -71.58 -41.78 68.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 60' ' ' LEU . 77.0 t -57.97 -43.37 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.53 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.09 -1.52 7.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.604 ' NZ ' ' HA ' ' A' ' 63' ' ' GLU . 54.4 mttp -88.93 -26.39 21.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HB2' ' HZ1' ' A' ' 68' ' ' LYS . 19.1 mt-10 -112.0 -50.66 2.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.112 -170.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 27.6 mtmm -131.83 -174.31 3.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.921 -168.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -96.84 142.48 28.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.52 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.97 109.4 21.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.24 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.56 118.22 44.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.102 0.477 . . . . 0.0 110.057 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.83 145.81 34.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.063 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' CB ' HD11 ' A' ' 80' ' ' ILE . 87.5 Cg_endo -89.34 120.33 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.183 2.589 . . . . 0.0 113.118 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.803 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 tttt -106.18 117.18 33.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.506 HG13 ' HE2' ' A' ' 96' ' ' PHE . 58.7 t -85.36 109.18 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -131.27 98.94 4.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.726 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 79' ' ' GLU . . . 81.39 36.81 19.46 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m120 71.15 -36.11 0.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 112.181 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' A' ' 77' ' ' GLY . 30.6 tt0 -73.87 143.52 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.49 HD11 ' CB ' ' A' ' 73' ' ' PRO . 15.5 tt -98.94 132.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.181 0.515 . . . . 0.0 111.426 -173.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.9 t -120.9 124.19 44.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.377 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 73' ' ' PRO . 77.5 mt -87.13 130.23 34.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.069 0.461 . . . . 0.0 110.85 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.646 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 9.8 m-85 -106.91 126.26 52.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.616 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HG2' ' HD2' ' A' ' 86' ' ' HIS . 71.3 ttt180 -85.45 92.67 8.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.424 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.77 111.59 23.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.537 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HD2' ' HG2' ' A' ' 84' ' ' ARG . 4.8 p80 -120.58 20.13 11.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.497 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 p -162.15 122.23 1.49 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.035 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.96 41.57 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.029 2.486 . . . . 0.0 112.97 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.74 -36.53 15.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.767 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.9 m -131.17 102.79 6.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.459 . . . . 0.0 111.428 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.0 mt -140.97 153.4 45.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.852 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.59 160.61 30.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.974 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.59 112.91 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.23 -154.96 6.63 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.357 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.32 -127.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.567 0.347 . . . . 0.0 110.701 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.506 ' HE2' HG13 ' A' ' 75' ' ' VAL . 88.4 m-85 -85.39 17.64 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.828 0.347 . . . . 0.0 110.812 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 46.8 2.73 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.74 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.0 pt -124.27 170.31 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.823 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.54 93.31 7.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.063 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.803 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 4.3 pt-20 -104.83 109.86 63.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.646 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 31.7 Cg_exo -59.63 127.41 23.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.377 2.051 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.43 -56.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.717 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.57 -176.79 4.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.53 -159.84 22.95 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.387 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -96.45 96.85 8.98 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -77.91 120.45 22.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.66 147.72 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.206 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.8 t-20 -58.58 138.91 85.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.463 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 108' ' ' ASN . 53.7 Cg_exo -53.92 -16.22 8.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.573 2.849 . . . . 0.0 114.271 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.443 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 42.7 tt0 -61.61 -28.18 69.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.397 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.34 -28.99 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 111.145 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' A' ' 44' ' ' LYS . 40.5 t -65.41 121.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.33 -20.77 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.603 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 32.6 t80 -135.96 114.34 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 143' ' ' VAL . 16.2 tt -121.28 139.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.15 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.91 106.48 17.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.259 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.35 123.48 34.95 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.773 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -92.84 -163.42 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.01 2.473 . . . . 0.0 112.004 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.73 -176.68 44.14 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.6 -41.46 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 117.046 0.423 . . . . 0.0 110.749 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.68 161.51 38.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.337 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.44 158.59 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.564 0.54 . . . . 0.0 109.781 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.518 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 9.3 p30 -120.34 -172.1 2.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.349 . . . . 0.0 110.678 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.5 mt -98.83 7.69 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.465 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -103.38 -30.3 10.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 133.9 -4.09 4.61 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.226 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -88.86 163.38 15.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.24 0.543 . . . . 0.0 111.215 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' A' ' 128' ' ' ARG . 7.6 mtm-85 -126.15 157.02 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.278 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.75 2.58 19.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.141 0.496 . . . . 0.0 110.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.65 -149.12 51.43 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.979 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -155.39 -62.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.05 179.5 40.17 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -83.93 125.75 32.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 110.565 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 -171.34 15.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -102.81 16.64 25.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.345 0.593 . . . . 0.0 109.876 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -99.65 4.13 45.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.677 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.56 -33.34 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -70.27 -8.42 50.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.45 HD23 HD12 ' A' ' 80' ' ' ILE . 21.2 tp -93.58 -72.27 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.401 ' HA ' HG23 ' A' ' 143' ' ' VAL . 95.5 mt -66.36 -17.7 64.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.313 -171.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.692 ' HG3' ' HB ' ' A' ' 167' ' ' ILE . 83.8 tttt -92.95 -12.1 31.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.671 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -121.33 0.95 10.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.323 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 115' ' ' ILE . 92.8 t -50.35 121.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.0 111.06 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 58.1 mtpt -87.82 -11.38 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.099 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.45 176.82 51.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.208 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.29 110.72 3.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.833 0.349 . . . . 0.0 110.686 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.417 ' HD3' ' HB ' ' A' ' 143' ' ' VAL . 11.6 mmmm -72.47 100.11 2.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.815 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.59 124.92 59.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.359 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -102.08 129.48 9.91 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.19 121.25 66.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.935 0.367 . . . . 0.0 110.84 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.27 165.51 31.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.264 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.578 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 47.8 m-85 -92.2 -178.79 5.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 t -68.47 -22.31 64.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.185 0.516 . . . . 0.0 109.973 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -72.75 -18.04 61.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.164 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.475 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.6 mp0 -95.64 -7.44 37.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.322 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.25 116.61 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.068 0.461 . . . . 0.0 111.701 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.55 174.35 6.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.372 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 26.8 mm-40 -74.26 -60.29 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 110.54 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.416 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 34.8 ttt180 -145.97 129.2 16.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 84.7 mt -93.62 160.7 32.31 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.194 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.59 101.64 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.221 . . . . 0.0 111.614 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -80.07 148.26 31.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.204 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 18.0 p-10 -77.1 -60.92 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.425 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . 169.54 -39.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.137 0.975 . . . . 0.0 109.711 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.47 ' O ' ' HE3' ' A' ' 141' ' ' LYS . 8.3 m-90 -136.13 21.83 3.24 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.06 149.75 18.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.896 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.692 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 6.6 tp -93.79 113.56 60.77 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.227 -175.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.678 ' HD2' HD12 ' A' ' 167' ' ' ILE . 57.6 Cg_endo -71.53 174.74 10.5 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.463 2.109 . . . . 0.0 112.853 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.78 157.94 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.961 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.519 ' OD2' ' HA ' ' A' ' 182' ' ' ARG . 15.2 t70 -91.91 -42.6 9.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.9 122.21 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.4 tp -106.35 108.0 19.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.056 0.455 . . . . 0.0 109.874 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.16 118.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.064 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 79.7 p -114.36 -178.93 3.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.64 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 14.9 pt-20 -71.61 -15.26 62.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.575 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 99.8 mttt -105.7 -60.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.544 -174.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.17 172.57 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 111.498 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.562 HG21 HD21 ' A' ' 36' ' ' LEU . 23.6 t -115.09 98.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.545 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -94.49 117.79 30.67 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.561 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.01 111.25 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.155 174.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' A' ' 126' ' ' GLY . 64.5 mt -81.64 -45.77 15.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.519 ' HA ' ' OD2' ' A' ' 170' ' ' ASP . 41.7 mtm180 66.12 -178.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.22 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.44 115.31 28.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.225 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -107.41 -164.44 21.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.857 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 185' ' ' ARG . 21.2 ttt180 65.43 28.46 11.63 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.624 0.726 . . . . 0.0 110.0 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.7 t -72.44 -2.65 20.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.781 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.36 -31.43 67.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.537 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -133.62 143.52 48.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.514 0.673 . . . . 0.0 111.278 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 -167.49 2.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -52.28 128.03 23.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.611 0.641 . . . . 0.0 109.911 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -74.78 91.56 2.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -168.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -151.51 77.2 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.036 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -86.79 -11.92 49.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.886 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 C--O 1.244 0.775 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.649 179.816 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.7 tp 65.85 17.04 10.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.3 0.571 . . . . 0.0 111.107 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -69.23 -34.9 75.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.536 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -70.84 -44.48 66.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.4 -36.83 79.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.686 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.62 -50.85 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.297 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.583 ' HG3' ' HA2' ' A' ' 130' ' ' GLY . 7.8 tmm_? -62.29 -42.24 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.543 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.36 -33.74 75.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.653 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 29.6 ttmt -81.78 -46.03 14.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.312 -176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.22 -35.79 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.302 0.573 . . . . 0.0 110.365 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.7 tp -59.31 -37.13 76.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.938 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -58.6 -41.79 86.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.056 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -74.69 -40.67 61.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.523 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.621 HH11 ' HA ' ' A' ' 120' ' ' VAL . 15.7 ptm180 -70.4 -37.47 74.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.346 -175.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 11' ' ' LEU . 33.4 pt -82.83 -0.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.822 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -81.45 -24.88 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.61 137.34 57.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.591 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 t -122.7 -166.59 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.823 -175.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -66.53 -4.59 8.81 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.9 -65.03 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.033 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 10.2 tp10 -76.47 -42.06 45.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.684 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 34.2 ttp85 -66.95 -26.47 66.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 -175.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 54.1 ttt85 -58.97 -49.15 78.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -79.71 -25.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 68.3 mt -63.63 -56.04 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.743 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 50.4 m -67.7 -32.99 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.028 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -58.94 -47.59 84.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 109.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.63 ' HE2' ' HB2' ' A' ' 175' ' ' GLU . 49.6 mtpt -59.44 -39.57 84.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.025 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 175' ' ' GLU . 94.8 t -63.38 -50.31 79.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.716 0.293 . . . . 0.0 110.624 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 74.7 mt -58.86 -49.92 81.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.1 m -64.17 -36.95 85.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.718 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.7 -44.94 80.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.125 0.488 . . . . 0.0 109.978 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.5 tp -62.66 -39.43 93.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.746 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -75.94 -14.12 60.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.249 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -84.54 -19.63 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 110.088 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.55 114.3 18.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -56.4 -32.71 89.79 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.291 2.661 . . . . 0.0 113.829 -171.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB3' ' HZ ' ' A' ' 114' ' ' PHE . 6.3 tp10 -72.45 -23.86 61.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.604 0.24 . . . . 0.0 111.056 -175.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.1 -41.77 94.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.007 0.432 . . . . 0.0 110.552 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -85.67 -10.29 55.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.757 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -95.89 -9.7 30.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 -179.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -101.94 -176.77 3.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -136.0 -55.03 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 30.5 mtpt -89.07 101.99 14.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 111.194 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.89 119.78 62.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.57 131.67 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.392 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.95 138.67 50.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.74 -1.73 36.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.513 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.4 t 73.83 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.387 0 C-N-CA 123.47 0.708 . . . . 0.0 111.587 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.39 49.77 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.097 2.531 . . . . 0.0 112.259 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.789 HG13 ' H ' ' A' ' 52' ' ' LYS . 14.1 pt -56.46 -62.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.895 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.789 ' H ' HG13 ' A' ' 51' ' ' ILE . 94.4 mttt -122.29 9.29 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.719 0.771 . . . . 0.0 110.044 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.26 128.37 9.08 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -84.17 10.55 9.98 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -169.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.662 HG11 ' HG ' ' A' ' 57' ' ' LEU . 92.3 t -63.61 104.43 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.75 77.82 5.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.463 0.649 . . . . 0.0 111.145 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.662 ' HG ' HG11 ' A' ' 55' ' ' VAL . 96.6 mt -94.03 -2.08 53.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.178 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.481 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -56.65 -44.82 99.91 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.422 -178.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.8 Cg_endo -69.74 1.44 4.42 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.22 1.947 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.01 -18.36 24.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.294 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.83 -44.35 97.93 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 95.2 Cg_exo -45.49 -39.26 16.94 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.328 2.019 . . . . 0.0 113.244 174.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -77.68 -44.76 26.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.25 -42.84 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.413 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.48 -4.13 17.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 95.5 mttt -98.4 -59.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 6.4 pt-20 -105.45 -17.62 14.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.63 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.52 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 45.4 mmtm -111.76 168.51 9.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.455 0.645 . . . . 0.0 111.666 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.779 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.4 mm-40 -102.12 103.16 13.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.984 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.58 100.54 6.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 58.2 mt -91.86 114.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.5 mt -114.79 141.81 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.728 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.6 Cg_exo -80.11 129.19 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.868 2.379 . . . . 0.0 112.071 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.703 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 36.3 tttm -105.54 100.39 9.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.579 HG23 HG22 ' A' ' 80' ' ' ILE . 35.1 t -69.73 98.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -146.92 134.58 21.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.274 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 -92.1 0.47 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.651 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.24 10.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.979 0.419 . . . . 0.0 109.954 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -125.96 154.04 43.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.911 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.658 HG13 HD13 ' A' ' 139' ' ' LEU . 6.2 pt -96.62 92.46 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 166.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.1 t -80.52 110.85 16.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.846 -170.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.97 121.98 22.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.726 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.493 ' HB2' ' CG ' ' A' ' 101' ' ' PRO . 97.1 m-85 -121.85 148.94 44.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.006 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -88.45 134.92 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.09 126.86 68.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.848 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -124.05 -1.23 8.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.229 0.538 . . . . 0.0 110.004 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -153.97 151.11 24.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 90' ' ' CYS . 52.1 Cg_endo -69.38 -174.46 0.84 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.946 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.0 -36.09 0.35 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.193 0.597 . . . . 0.0 111.884 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.407 ' H ' ' C ' ' A' ' 88' ' ' PRO . 60.7 m -69.94 -3.46 16.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.501 0.667 . . . . 0.0 111.238 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.27 123.68 39.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.28 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.02 135.78 9.56 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.708 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.0 t -82.92 94.37 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.63 -24.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.385 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.408 ' HB3' ' CG1' ' A' ' 98' ' ' ILE . . . -85.19 -156.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 0.0 111.328 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.59 55.98 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.156 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.14 16.48 43.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.037 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 36.2 pt -120.27 165.29 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.85 90.47 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.021 0.438 . . . . 0.0 110.607 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.703 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -88.98 147.54 38.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.514 -177.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.493 ' CG ' ' HB2' ' A' ' 83' ' ' TYR . 18.3 Cg_endo -61.19 114.46 2.21 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.745 2.297 . . . . 0.0 112.092 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -91.07 -52.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.317 0.58 . . . . 0.0 109.876 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -97.54 87.18 4.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.152 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.54 170.69 35.83 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.198 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.48 137.04 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.764 0.282 . . . . 0.0 110.936 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -77.88 133.54 38.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.753 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.89 135.88 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.737 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -87.02 146.73 41.2 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.566 ' HB3' ' HA ' ' A' ' 143' ' ' VAL . 50.9 Cg_exo -55.39 -25.05 46.16 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.06 2.507 . . . . 0.0 113.371 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.43 ' HG3' ' HD2' ' A' ' 144' ' ' LYS . 43.2 tt0 -72.87 -20.33 61.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.165 0.507 . . . . 0.0 110.962 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -100.23 7.13 44.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.18 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.43 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 60.0 t -94.32 111.88 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.06 -54.22 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.406 ' HZ ' ' HB3' ' A' ' 38' ' ' GLU . 8.5 m-85 -124.67 139.34 53.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.603 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.477 HG22 ' HA ' ' A' ' 147' ' ' LYS . 4.5 tp -134.22 108.24 10.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.435 0.636 . . . . 0.0 109.561 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.79 112.07 24.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.948 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.11 113.86 51.58 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 150' ' ' VAL . 3.8 Cg_exo -76.52 91.72 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.801 2.334 . . . . 0.0 111.341 175.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.98 158.27 48.03 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.896 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.621 ' HA ' HH11 ' A' ' 14' ' ' ARG . 57.5 t -74.7 -39.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 110.013 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.485 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -147.76 155.93 42.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.898 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -135.21 153.19 52.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.425 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 15.3 t70 -78.62 164.72 24.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.268 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.876 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 13.3 mt -55.44 -32.46 62.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.432 ' O ' HD11 ' A' ' 181' ' ' LEU . 46.6 mt-10 -87.53 -64.57 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.563 ' HA2' HD22 ' A' ' 172' ' ' LEU . . . 165.11 53.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.85 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' A' ' 123' ' ' ASP . 51.2 m-85 -99.46 161.15 13.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.27 155.6 17.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 112.451 -167.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.619 ' HB2' HD13 ' A' ' 160' ' ' LEU . 40.7 tp -160.31 120.29 2.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.381 168.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.583 ' HA2' ' HG3' ' A' ' 7' ' ' ARG . . . 166.97 -111.48 0.45 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.291 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.77 174.57 5.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.91 7.03 13.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.464 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -80.56 64.28 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 109.499 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.3 107.04 1.19 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.974 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 67.31 -176.5 0.2 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.181 0.592 . . . . 0.0 110.522 -175.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 72.24 -47.57 0.67 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.778 0.831 . . . . 0.0 112.182 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.4 -35.99 60.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.045 0.538 . . . . 0.0 111.813 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -60.47 -33.4 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.052 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.658 HD13 HG13 ' A' ' 80' ' ' ILE . 9.1 tt -83.43 -44.26 14.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.43 -18.11 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.775 0.322 . . . . 0.0 111.325 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.746 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 4.2 ttmp? -89.16 -15.5 33.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.065 0.46 . . . . 0.0 109.883 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.59 -21.82 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 60.7 t -63.58 127.73 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.163 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 110' ' ' GLU . 96.9 mttt -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 112' ' ' VAL . . . -79.63 -170.93 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.123 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.41 110.98 16.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.982 0.42 . . . . 0.0 109.95 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 115' ' ' ILE . 95.7 mttt -86.47 109.38 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 63.0 t -106.34 122.25 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.82 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.34 119.66 6.01 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 47.7 t -105.95 117.96 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.69 0.281 . . . . 0.0 110.982 -175.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.35 -178.08 6.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.894 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 35.0 m-85 -106.53 165.63 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -56.48 -30.44 62.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.21 -32.32 72.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.076 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.89 -7.97 50.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.77 117.88 33.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.965 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.63 174.48 5.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.876 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 45.9 mt-10 -69.69 -57.58 4.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 111.267 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.6 ttm105 -144.77 118.58 9.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 -169.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 129' ' ' LEU . 74.8 mt -98.53 141.19 22.51 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.698 0.285 . . . . 0.0 111.452 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.18 113.19 3.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.814 2.343 . . . . 0.0 111.666 174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -98.42 149.37 22.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.62 -75.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.235 -172.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -149.25 -76.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -100.05 69.05 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 109.393 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.04 149.63 37.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.329 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 65.9 mt -110.87 107.41 57.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.835 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.56 154.59 31.25 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.824 2.349 . . . . 0.0 111.214 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 m -88.39 158.96 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.343 -0.39 . . . . 0.0 109.992 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 182' ' ' ARG . 11.6 t70 -88.57 -42.46 12.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.518 0.675 . . . . 0.0 109.502 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 75.7 t -126.35 116.48 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.496 176.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 35.2 tp -99.87 103.65 15.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.911 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.05 125.87 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.128 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 54.0 p -107.83 -166.74 1.17 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.403 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.63 ' HB2' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.54 9.51 36.41 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.697 174.393 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -125.79 -55.21 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.556 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.12 160.03 39.91 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 111.505 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.2 113.98 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.96 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -92.49 93.66 8.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.728 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -86.18 121.24 28.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.642 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 125' ' ' GLU . 39.5 mt -109.17 -59.34 1.91 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 182' ' ' ARG . 1.4 tpm_? 68.92 -75.24 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.213 0.605 . . . . 0.0 112.348 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -161.68 162.09 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.79 148.38 46.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.542 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -88.22 13.82 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.656 0.265 . . . . 0.0 111.283 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 50.3 m -63.35 105.35 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.35 176.92 9.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.614 ' HG3' ' H ' ' A' ' 190' ' ' HIS . 8.8 tp10 -77.11 149.63 35.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 190' ' ' HIS . 34.2 t-80 -88.64 -6.99 57.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.614 ' H ' ' HG3' ' A' ' 188' ' ' GLU . 23.7 m80 71.73 117.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.475 0.655 . . . . 0.0 110.724 -174.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -77.45 64.69 2.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.238 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.34 -1.53 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.723 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -176.76 -45.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 . . . . . 0 C--O 1.244 0.788 0 CA-C-O 118.0 -1.0 . . . . 0.0 108.962 170.059 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.477 ' HG ' ' H ' ' A' ' 4' ' ' SER . 50.0 tp -160.55 141.4 11.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -28.02 66.36 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.565 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.477 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 12.2 m -70.44 -35.72 73.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.115 0.484 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 33.5 tt0 -61.92 -53.73 51.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.859 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.576 ' O ' HG22 ' A' ' 10' ' ' VAL . 65.5 tp -57.66 -45.04 86.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.808 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 120' ' ' VAL . 18.0 ttp180 -55.32 -42.35 73.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.497 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.64 -37.0 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 110.601 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 5' ' ' GLU . 64.7 mttm -65.03 -37.71 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.413 0.625 . . . . 0.0 110.09 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 6' ' ' LEU . 46.3 t -69.5 -38.93 77.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.637 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.99 -37.43 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.275 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -56.18 -47.75 77.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.059 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 10' ' ' VAL . 62.6 pttt -77.23 -0.17 24.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.585 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.803 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 41.6 ttm180 -93.05 -48.86 6.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.649 ' HA ' HH12 ' A' ' 22' ' ' ARG . 31.3 pt -85.54 -11.97 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -89.54 5.16 46.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.124 0.488 . . . . 0.0 110.846 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.97 149.85 42.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.432 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -70.67 146.7 49.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -62.39 -40.35 96.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -52.15 -52.47 51.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.522 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 6.2 pt-20 -81.03 -31.32 34.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.24 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.649 HH12 ' HA ' ' A' ' 15' ' ' ILE . 35.9 ttm-85 -57.04 -49.44 75.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.861 0.362 . . . . 0.0 110.82 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.71 -31.57 70.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -80.22 -34.96 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' HG21 ' A' ' 29' ' ' VAL . 92.7 mt -65.13 -46.12 82.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 30' ' ' ILE . 20.2 m -64.15 -33.38 75.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.518 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.06 -43.0 99.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.12 -39.63 86.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.355 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 25' ' ' LEU . 64.9 t -65.19 -46.03 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 26' ' ' SER . 76.0 mt -58.98 -46.96 91.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 110.171 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -60.02 -45.66 92.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.48 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.84 -45.08 95.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.427 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.48 -42.46 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.379 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -71.1 -26.18 62.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.014 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 m -73.18 -23.67 60.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.8 mt -60.16 122.08 63.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.306 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 33.8 Cg_exo -60.61 -21.29 68.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.166 2.577 . . . . 0.0 112.913 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -75.49 -39.65 58.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.94 -37.49 76.83 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.387 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -67.3 -37.7 83.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 3.7 tmmm? -78.57 -52.37 8.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.124 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -60.84 131.1 49.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -90.51 -42.49 10.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.91 106.9 18.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.98 0.419 . . . . 0.0 110.322 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.84 108.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.337 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.534 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -94.54 117.49 30.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -104.89 122.03 44.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.607 ' HA ' ' HG3' ' A' ' 73' ' ' PRO . 8.9 t80 -76.73 -6.5 52.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.563 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.3 m 69.75 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 121.43 0.633 . . . . 0.0 111.621 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.54 125.74 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.506 2.137 . . . . 0.0 112.923 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 53' ' ' GLY . 7.0 pt -109.66 145.22 16.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 69.1 -41.4 0.47 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.414 0.686 . . . . 0.0 111.765 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 172.12 -76.8 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 176.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.803 ' HA ' ' HD3' ' A' ' 14' ' ' ARG . 6.3 mm-40 56.69 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.889 0.875 . . . . 0.0 111.305 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 150' ' ' VAL . 95.8 t -153.33 128.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.434 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -82.12 90.15 6.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.204 0.526 . . . . 0.0 110.881 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.564 HD13 HG12 ' A' ' 150' ' ' VAL . 89.1 mt -102.2 6.61 40.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.837 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.566 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -61.03 -43.81 92.27 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.065 -175.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 58' ' ' THR . 19.3 Cg_endo -61.2 -7.07 7.5 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.121 1.881 . . . . 0.0 113.886 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.34 -13.93 39.48 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.1 m-85 -52.48 -49.77 83.82 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.4 Cg_exo -52.36 -36.05 67.32 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.41 2.073 . . . . 0.0 113.225 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mt-10 -74.18 -31.42 62.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.014 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.19 -36.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.429 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -68.04 -5.01 15.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.582 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 43.4 tttp -66.87 -64.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.742 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 11.2 pt-20 -143.92 -4.05 0.85 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 6.3 mptp? -92.92 164.08 13.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.337 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.805 ' HG3' ' HB2' ' A' ' 84' ' ' ARG . 3.0 tp10 -97.3 103.46 15.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.227 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.8 tp -76.78 94.11 3.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 0.0 110.758 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 56.4 mt -88.49 112.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 86.2 mt -110.06 149.59 40.27 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.663 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.607 ' HG3' ' HA ' ' A' ' 48' ' ' TYR . 9.6 Cg_endo -89.23 125.6 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.376 2.717 . . . . 0.0 113.097 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -105.62 105.63 15.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.429 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 80' ' ' ILE . 21.3 t -82.58 95.4 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.345 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.12 5.97 18.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.659 0.742 . . . . 0.0 109.835 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.49 -153.12 18.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -78.36 -6.24 54.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.109 0.48 . . . . 0.0 110.495 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.99 143.46 46.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.145 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 75' ' ' VAL . 49.6 mm -100.47 122.81 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.129 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m -85.84 122.67 30.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.506 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -101.32 133.19 46.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.684 0.278 . . . . 0.0 110.685 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . 93.9 m-85 -128.77 146.02 51.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.805 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 38.3 ptt85 -100.03 134.35 43.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.117 0.484 . . . . 0.0 110.012 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.78 139.38 51.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -124.76 -28.27 3.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.309 171.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.3 m -108.12 131.62 21.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 -10.14 25.35 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.141 2.561 . . . . 0.0 113.441 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.92 60.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.416 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 41.8 m -85.44 8.39 19.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.027 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.6 138.04 39.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.98 0.419 . . . . 0.0 111.5 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.86 176.41 20.68 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.549 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.78 90.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.846 0.355 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.98 -16.26 7.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.591 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.7 -171.05 3.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.303 0.241 . . . . 0.0 110.984 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -53.48 -53.66 48.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.102 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.85 50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.727 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.5 157.42 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.27 147.06 32.42 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.459 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HB2' ' HB2' ' A' ' 83' ' ' TYR . 72.9 Cg_endo -80.11 105.98 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.209 1.939 . . . . 0.0 111.458 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.71 -19.43 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.833 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -137.03 -171.97 3.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.916 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.53 -132.63 11.07 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 137.88 32.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -80.54 156.07 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.478 . . . . 0.0 111.68 -175.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.24 142.98 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.407 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -89.94 141.67 28.29 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.728 ' HB3' HG22 ' A' ' 143' ' ' VAL . 87.0 Cg_exo -46.7 -40.41 24.24 Favored 'Trans proline' 0 N--CA 1.476 0.441 0 C-N-CA 123.647 2.898 . . . . 0.0 114.225 -175.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.28 -19.27 64.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.41 -17.82 50.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.22 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 118.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.696 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -76.31 -55.66 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.33 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 148' ' ' VAL . 40.8 t80 -128.35 136.35 50.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.684 -173.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -139.06 139.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.98 113.17 25.82 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.073 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 47.8 t -111.98 124.73 31.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.878 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 4.9 Cg_exo -77.83 131.04 10.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.104 2.536 . . . . 0.0 111.804 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.88 140.18 11.56 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 7' ' ' ARG . 48.6 t -70.93 -43.55 76.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 117.016 0.408 . . . . 0.0 110.836 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.493 ' HB1' HD23 ' A' ' 129' ' ' LEU . . . -143.42 130.91 21.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.74 169.29 9.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.01 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 26.4 p30 -132.1 -172.35 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.583 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.51 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 88.9 mt -87.29 3.17 47.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.27 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.96 -31.96 10.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.75 29.86 1.95 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.091 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 24.1 m-85 -94.23 156.61 16.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.534 0.667 . . . . 0.0 109.865 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 167' ' ' ILE . 0.0 OUTLIER -101.45 -33.42 9.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -163.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.512 ' HB2' HD12 ' A' ' 160' ' ' LEU . 35.6 tp 36.51 70.35 0.17 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.416 0.627 . . . . 0.0 111.908 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.35 -160.07 36.17 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.69 92.69 0.67 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 0.0 110.637 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.18 170.3 45.97 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.474 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 166' ' ' ASP . 46.6 tttm -139.32 169.34 17.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 133' ' ' LYS . . . 87.23 -49.01 3.89 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -76.91 154.91 33.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 71.03 0.51 3.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.266 0.626 . . . . 0.0 111.059 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.8 t70 -70.38 161.05 31.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' A' ' 137' ' ' ASP . 28.4 ttt180 72.93 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.434 ' H ' ' C ' ' A' ' 137' ' ' ASP . 30.8 tp -65.46 -65.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.661 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.668 ' HB2' HD12 ' A' ' 167' ' ' ILE . 97.4 mt -71.64 -11.99 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.573 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.61 -23.84 39.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 0.0 110.106 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -96.2 -35.75 11.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.705 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.3 t -73.39 93.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -101.91 26.37 7.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.431 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.95 -175.24 31.86 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.268 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -71.58 98.14 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.119 0.459 . . . . 0.0 109.931 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 115' ' ' ILE . 32.8 mtmm -84.74 102.89 13.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 171' ' ' VAL . 98.6 t -103.49 119.89 52.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.663 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.46 130.85 10.1 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.564 HG12 HD13 ' A' ' 57' ' ' LEU . 51.0 t -114.61 119.51 61.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -163.71 171.58 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.522 ' HB3' ' OE2' ' A' ' 175' ' ' GLU . 57.1 m-85 -87.21 162.53 17.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.436 ' HA ' HG22 ' A' ' 156' ' ' VAL . 5.8 p -77.35 -9.94 59.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 0.0 110.46 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -61.67 -29.64 70.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -105.86 20.43 18.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 111.281 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 153' ' ' SER . 64.0 t -103.42 116.27 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.944 0.402 . . . . 0.0 110.546 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -100.84 -171.57 2.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.262 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.51 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 13.0 mt-10 -92.02 -44.76 8.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -147.59 125.05 11.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.376 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 97.4 mt -84.89 143.97 41.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.643 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 3.7 Cg_exo -74.95 102.26 1.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.812 2.341 . . . . 0.0 110.548 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 28.6 mtt180 -108.87 155.83 20.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 -172.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.58 -55.38 24.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.15 -50.61 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.147 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -129.28 83.74 2.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.853 0.835 . . . . 0.0 111.368 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.592 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.3 t70 -78.01 151.2 33.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 167.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 140' ' ' LEU . 64.6 mt -75.05 113.46 25.2 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.81 0.338 . . . . 0.0 110.676 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 127' ' ' TYR . 97.5 Cg_endo -88.88 161.36 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.044 2.496 . . . . 0.0 113.186 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.17 176.45 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.166 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.709 ' HA ' ' HD2' ' A' ' 182' ' ' ARG . 38.6 m-20 -99.28 -45.29 5.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.368 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.9 t -129.04 141.13 47.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.658 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.732 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 68.5 tp -117.51 115.56 25.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.98 122.73 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 77.1 p -115.79 -174.38 2.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 111.021 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.83 ' HG3' ' HD2' ' A' ' 176' ' ' LYS . 11.6 pt-20 -70.39 -13.68 62.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.096 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.83 ' HD2' ' HG3' ' A' ' 175' ' ' GLU . 10.1 mptt -121.67 -70.38 0.78 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -110.43 168.92 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.443 -167.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.4 119.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.669 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.732 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 39.0 mmt180 -94.16 102.86 14.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.039 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -79.88 89.62 5.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.2 mt -81.36 -51.38 8.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.718 -173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -87.75 -88.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.2 t70 58.1 -91.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.226 0.61 . . . . 0.0 112.526 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -104.14 47.63 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.89 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.414 ' HE ' ' HA ' ' A' ' 185' ' ' ARG . 1.8 tpm_? -83.32 -66.68 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.5 p 46.58 -158.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.825 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 88.6 mt -113.73 137.66 51.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.239 -0.288 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 69.04 -78.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.01 0.819 . . . . 0.0 111.495 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -154.37 164.91 37.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.013 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -129.77 99.95 5.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.657 ' HA ' ' OXT' ' A' ' 194' ' ' HIS . 9.0 t-80 -83.38 64.62 7.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.299 0.571 . . . . 0.0 110.665 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -117.86 -2.75 11.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.494 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -146.58 -45.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . 0.657 ' OXT' ' HA ' ' A' ' 191' ' ' HIS . 58.2 t-80 . . . . . 0 C--O 1.249 1.068 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.21 85.45 5.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.937 0.398 . . . . 0.0 110.447 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -75.31 -37.26 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -70.17 -25.27 63.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.56 -38.54 70.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' HD23 ' A' ' 129' ' ' LEU . 58.1 tp -70.76 -40.06 72.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.756 176.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HD3' ' HA3' ' A' ' 130' ' ' GLY . 12.8 ttp180 -60.16 -44.33 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.428 174.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -64.78 -33.03 75.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.94 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -62.71 -47.31 84.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.266 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 121' ' ' ALA . 45.7 t -73.68 -43.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.615 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD13 ' HD3' ' A' ' 14' ' ' ARG . 51.4 tp -57.92 -33.44 68.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.048 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 9.7 t60 -60.44 -43.6 96.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.375 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 44.2 mttp -81.67 -24.66 36.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 0.0 111.033 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.526 ' HD3' HD13 ' A' ' 11' ' ' LEU . 41.1 ttt85 -57.77 -51.92 67.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.67 4.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.595 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 8.6 t30 -83.88 -19.21 35.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.35 132.65 52.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.757 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -70.65 153.16 43.11 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.041 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -43.66 79.82 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.334 0.396 . . . . 0.0 111.839 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.0 tp10 -60.95 -56.79 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.792 0.33 . . . . 0.0 111.081 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.46 -44.28 97.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.35 -42.1 98.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.013 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 12.7 tpt180 -62.11 -43.12 99.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.696 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 85.0 mtt180 -60.77 -38.79 86.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.6 -45.22 60.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.882 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -62.67 -35.04 78.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.33 -43.49 79.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -66.36 -39.3 89.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 175' ' ' GLU . 61.5 t -65.06 -47.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.693 0.282 . . . . 0.0 110.776 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.77 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 110.203 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -36.16 83.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.101 0.476 . . . . 0.0 109.971 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -69.32 -44.36 71.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 33' ' ' LEU . 5.2 tt -65.46 -38.55 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.991 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -67.11 -26.53 66.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 111.036 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -83.79 -16.77 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.52 HD22 ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -68.02 112.35 10.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.142 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HD2' HD22 ' A' ' 36' ' ' LEU . 35.1 Cg_endo -64.74 -25.43 61.14 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.611 2.207 . . . . 0.0 112.795 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.35 -24.61 61.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.731 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.26 -42.57 99.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.89 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.952 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 89.3 mttt -83.92 -3.04 57.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.129 0.49 . . . . 0.0 110.808 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.606 ' HB2' ' HZ3' ' A' ' 41' ' ' LYS . 4.1 ttmp? -85.22 -33.8 22.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.492 174.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.7 p -81.94 152.55 26.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.195 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 24.8 tptp -111.46 -40.33 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 109.732 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 22.2 mmtp -91.99 107.43 19.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.796 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.3 115.01 47.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.278 0.561 . . . . 0.0 111.511 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -104.19 133.07 49.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.39 129.0 51.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.0 0.428 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -88.02 109.88 20.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.0 m -52.68 116.17 8.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.536 0.523 . . . . 0.0 111.621 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.18 69.09 7.24 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.865 2.377 . . . . 0.0 112.44 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 52' ' ' LYS . 26.5 pt -55.0 -43.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.521 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' N ' HG13 ' A' ' 51' ' ' ILE . 64.5 mttm -112.98 30.53 7.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.401 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -99.78 149.71 18.89 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.152 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' OE2' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -91.06 -35.62 14.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.32 104.07 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.83 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.85 101.84 7.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.972 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.08 5.9 40.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.781 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.2 m -60.1 -52.92 69.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.427 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 18.6 Cg_exo -68.88 7.28 0.79 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 113.495 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.67 -13.81 38.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.357 . . . . 0.0 110.146 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.6 m-30 -55.75 -49.13 94.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.142 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 75.2 Cg_exo -53.55 -36.06 79.04 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.281 1.987 . . . . 0.0 113.067 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 4.4 tp10 -70.98 -31.33 67.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 110.151 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.52 -40.76 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.396 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.429 HD13 ' HD3' ' A' ' 88' ' ' PRO . 95.8 mt -65.65 -11.85 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 41.2 tttp -64.82 -60.5 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.252 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.809 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.8 pt-20 -120.65 -19.82 7.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -172.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.952 ' HZ1' ' HA ' ' A' ' 40' ' ' LYS . 50.6 mttm -116.38 -172.45 2.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.628 0.251 . . . . 0.0 110.664 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -112.93 143.0 44.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.869 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.9 tp -92.74 124.77 36.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.226 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 53.5 mt -111.23 126.52 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.997 0.427 . . . . 0.0 110.484 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -123.71 147.93 54.79 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.308 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.72 125.36 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.218 2.612 . . . . 0.0 112.753 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.504 ' HG3' ' OE1' ' A' ' 100' ' ' GLU . 85.1 tttt -113.32 139.69 48.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.845 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.71 99.27 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.469 ' OE1' ' HE2' ' A' ' 74' ' ' LYS . 10.6 mm-40 -81.66 82.57 7.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.734 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.18 -89.74 0.5 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -174.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -123.18 -7.29 8.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.88 0.371 . . . . 0.0 110.37 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.96 98.93 12.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.749 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.9 tt -91.94 127.58 44.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.341 0.591 . . . . 0.0 110.291 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -137.07 167.47 21.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.767 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.6 mt -99.32 138.1 36.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.372 . . . . 0.0 110.456 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -118.87 128.16 54.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -95.99 111.93 23.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.393 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 HD13 ' A' ' 91' ' ' LEU . 27.0 m -101.94 138.31 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.072 0.463 . . . . 0.0 110.386 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -96.87 -4.81 39.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.347 0.594 . . . . 0.0 109.805 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -167.81 144.7 3.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.893 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' HD13 ' A' ' 65' ' ' LEU . 54.3 Cg_endo -72.1 71.27 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.45 2.1 . . . . 0.0 111.818 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.37 -58.05 2.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.812 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 7.7 p -86.43 21.62 2.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.273 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.406 HD13 HG23 ' A' ' 85' ' ' VAL . 96.5 mt -99.12 108.53 21.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.14 10.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.74 108.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.098 0.449 . . . . 0.0 110.123 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 100' ' ' GLU . . . -150.48 -1.77 0.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.87 -161.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.312 . . . . 0.0 110.338 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.32 -18.75 63.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.257 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.18 -23.36 0.13 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.719 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -83.42 172.91 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.65 -0.275 . . . . 0.0 110.869 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -62.68 138.0 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.098 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.504 ' OE1' ' HG3' ' A' ' 74' ' ' LYS . 3.3 tp10 -108.34 107.19 59.94 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.157 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.58 106.07 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.67 1.58 . . . . 0.0 110.903 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.83 -45.65 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.224 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.67 178.72 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.87 -130.18 4.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.176 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -118.49 118.91 33.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.603 0.239 . . . . 0.0 110.418 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -80.67 97.0 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 111' ' ' ASP . 88.1 t -99.08 119.94 47.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.967 -175.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.17 154.08 86.36 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.501 ' CB ' ' HA ' ' A' ' 143' ' ' VAL . 10.6 Cg_endo -54.1 -19.19 15.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.828 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.5 -41.12 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.937 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.561 ' HB3' HG12 ' A' ' 107' ' ' VAL . 22.1 t70 -87.24 -9.26 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.17 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.1 t -81.25 132.09 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.136 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.543 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 67.4 m-20 -91.7 -49.31 6.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.471 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CE2' HG23 ' A' ' 148' ' ' VAL . 47.5 t80 -130.31 138.43 50.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.541 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 tt -143.65 140.03 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.94 127.16 54.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -120.69 121.54 28.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.75 -41.26 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.722 2.282 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.25 -145.82 49.42 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.86 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 131' ' ' PHE . 75.7 t -139.24 -45.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.456 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -161.15 157.07 25.28 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.381 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -135.92 166.01 24.32 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.157 0.285 . . . . 0.0 110.85 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -111.06 -171.74 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.881 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 52.9 mt -71.39 -14.38 62.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.63 -21.57 14.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.561 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.19 31.33 3.1 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.941 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -95.63 147.04 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.795 0.331 . . . . 0.0 110.435 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -84.06 150.13 25.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.861 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.619 HD23 ' HG ' ' A' ' 6' ' ' LEU . 28.7 tp -94.53 15.37 18.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.515 0.674 . . . . 0.0 109.967 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.6 ' HA3' ' HD3' ' A' ' 7' ' ' ARG . . . 135.05 -143.07 14.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.12 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.86 ' HB2' HG23 ' A' ' 120' ' ' VAL . 60.4 t80 73.71 111.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.527 0.731 . . . . 0.0 110.522 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 118.49 61.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.229 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -68.29 131.05 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 110.233 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.04 2.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.555 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -133.81 -95.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 63.81 14.23 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.372 0.606 . . . . 0.0 111.45 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.24 -39.49 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.671 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 37.6 ttm180 -61.8 -17.65 56.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.402 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.487 ' O ' HG21 ' A' ' 143' ' ' VAL . 45.9 tp -92.9 -70.12 0.71 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.41 . . . . 0.0 111.028 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HB2' HD13 ' A' ' 167' ' ' ILE . 7.4 mp -63.49 -32.32 73.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.36 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 141' ' ' LYS . 34.4 ttmt -80.81 -16.59 53.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 138' ' ' ARG . 37.4 mtp180 -101.69 -5.57 24.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.287 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 109' ' ' PRO . 94.0 t -62.04 112.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.124 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -92.16 -7.09 49.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.792 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.34 -173.71 46.66 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.1 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.535 HD12 HG21 ' A' ' 171' ' ' VAL . 32.3 tp -80.21 108.11 13.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 115' ' ' ILE . 32.4 mtmm -86.25 106.19 17.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.044 0.45 . . . . 0.0 110.034 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.5 t -102.51 124.36 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.997 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.54 138.82 14.36 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.7 111.45 36.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -151.76 162.85 40.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.639 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 30.8 m-85 -86.16 170.38 12.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.393 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.1 t -72.13 -38.52 69.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.73 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -74.46 -9.07 58.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.486 . . . . 0.0 110.421 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -95.31 -7.7 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.019 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.46 110.29 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.408 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.46 179.99 5.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.242 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.881 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.36 -53.46 6.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.051 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -136.04 140.73 44.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 129' ' ' LEU . 96.7 mt -132.81 158.67 75.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.5 101.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.289 1.993 . . . . 0.0 110.933 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -96.7 128.33 43.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.941 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.904 ' HB3' ' HB2' ' A' ' 166' ' ' ASP . 9.6 t70 -95.11 137.16 34.54 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.59 57.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.81 0.338 . . . . 0.0 111.549 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -119.52 24.01 10.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 0.0 110.552 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.904 ' HB2' ' HB3' ' A' ' 163' ' ' ASP . 12.0 t70 -89.73 -157.61 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.542 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.749 HD13 ' HB2' ' A' ' 140' ' ' LEU . 56.9 mt -125.82 107.27 25.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.841 0.353 . . . . 0.0 111.305 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -93.12 174.49 1.75 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.247 2.632 . . . . 0.0 112.177 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.85 174.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.604 0.24 . . . . 0.0 110.758 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -106.88 -44.24 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.554 . . . . 0.0 109.902 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 146' ' ' LEU . 86.5 t -125.96 140.75 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.552 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.594 ' HB2' HD23 ' A' ' 181' ' ' LEU . 53.6 tp -121.0 103.12 8.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.0 110.687 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.95 119.03 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.907 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.7 p -110.34 -175.94 2.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.187 0.518 . . . . 0.0 111.222 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.639 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 9.5 pt-20 -60.12 -27.61 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.658 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.513 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 24.9 mtmm -118.45 -56.77 2.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -119.05 174.51 6.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 111.334 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.91 99.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 25.0 ttm-85 -79.05 124.2 28.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.984 -174.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 183' ' ' ASP . 4.6 mtp180 -92.22 97.52 10.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.569 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 172' ' ' LEU . 2.9 mm? -64.41 -55.17 22.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.36 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.0 mmm-85 -117.08 30.96 7.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.684 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 180' ' ' ARG . 15.1 t70 67.04 -81.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.751 0.657 . . . . 0.0 110.324 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.22 16.79 69.41 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.697 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -130.64 -2.99 4.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.144 0.472 . . . . 0.0 111.289 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 43.4 m -74.78 129.02 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.9 -157.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.773 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 189' ' ' HIS . 1.6 tm-20 -74.41 -178.98 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.89 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.412 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 47.3 m80 -110.87 -17.62 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.858 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -74.22 110.56 8.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.53 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -72.71 127.34 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.07 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -121.88 -130.79 0.28 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -61.65 -32.68 72.85 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.046 169.897 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.987 0.422 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -52.44 -50.38 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.681 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -70.93 -40.08 72.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.8 -37.43 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.115 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.499 HD23 HD22 ' A' ' 129' ' ' LEU . 38.0 tp -67.01 -37.23 83.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.72 -44.96 95.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.245 0.545 . . . . 0.0 109.843 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.38 -50.92 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.121 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -34.8 77.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.57 0.224 . . . . 0.0 111.576 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.12 -40.4 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.366 . . . . 0.0 110.189 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HD3' ' A' ' 14' ' ' ARG . 31.0 tp -62.21 -34.78 77.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -59.65 -43.92 93.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -81.97 -28.78 32.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.096 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.703 ' HD3' HD12 ' A' ' 11' ' ' LEU . 32.1 ttt85 -56.69 -43.96 81.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.293 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 pt -88.41 0.89 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.408 . . . . 0.0 111.115 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -89.57 -20.78 23.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.28 137.56 47.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.44 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.7 t -90.65 145.35 24.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.483 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 40.7 mm-40 -59.8 -25.14 64.71 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.284 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -53.25 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.379 0.609 . . . . 0.0 110.379 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.86 -40.62 65.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 66.9 ttt180 -56.34 -50.67 70.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.686 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -64.15 -33.73 76.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -70.97 -38.83 72.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.3 -37.5 71.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.437 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 55' ' ' VAL . 70.7 m -59.32 -39.98 84.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.704 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.72 -44.19 85.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -62.35 -43.8 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -44.95 99.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.479 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 56' ' ' ASP . 67.1 mt -56.93 -53.87 37.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.0 m -59.28 -44.55 92.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.993 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.432 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 2.7 t-20 -61.1 -52.51 64.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 20.0 tp -60.75 -38.35 84.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.078 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -79.4 -21.19 45.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.315 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -85.83 -18.93 31.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.208 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 32' ' ' ASN . 92.5 mt -55.94 119.61 27.53 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.728 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 39.3 Cg_exo -61.21 -22.76 75.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.015 2.476 . . . . 0.0 112.764 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.95 -23.88 48.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.606 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.53 -23.04 59.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -71.43 -29.12 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.41 -37.35 11.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.272 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m -58.19 122.54 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -90.94 -41.9 10.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.553 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' VAL . 18.7 mmtp -95.23 109.02 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.17 101.45 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -100.64 136.27 40.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.49 151.06 39.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.84 -90.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 35.6 t 176.05 127.23 0.15 Allowed Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.254 0.346 . . . . 0.0 110.344 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.39 112.29 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.169 2.579 . . . . 0.0 110.932 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.6 HG13 ' HG2' ' A' ' 52' ' ' LYS . 10.7 pt -127.98 -47.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HG2' HG13 ' A' ' 51' ' ' ILE . 74.4 mmtt -96.7 -69.24 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -171.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 14' ' ' ARG . . . -149.58 46.79 0.64 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.303 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HG3' HH21 ' A' ' 14' ' ' ARG . 3.9 mp0 -97.87 -156.18 0.53 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 26' ' ' SER . 91.6 t -101.41 138.35 25.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.608 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HD11 ' A' ' 30' ' ' ILE . 27.1 m-20 -72.35 75.18 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.16 0.505 . . . . 0.0 111.08 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 150' ' ' VAL . 93.2 mt -90.72 -5.02 56.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.768 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -47.54 98.85 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.452 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 17.2 Cg_exo -68.3 -7.66 20.72 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.252 1.968 . . . . 0.0 113.205 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 40.9 tp -87.17 -7.08 58.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.794 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.538 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 13.0 m-30 -53.31 -50.65 81.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.943 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.8 Cg_exo -52.17 -42.05 61.74 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.239 1.96 . . . . 0.0 112.977 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -65.41 -43.82 89.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.647 0.261 . . . . 0.0 110.848 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' LEU . 56.0 t -64.66 -48.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.635 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.36 -33.87 66.09 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.435 0.459 . . . . 0.0 111.382 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -64.32 -45.87 86.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.705 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -101.81 -60.55 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -108.55 -171.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.021 0.439 . . . . 0.0 111.272 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HG2' ' HD2' ' A' ' 84' ' ' ARG . 1.8 mp0 -96.35 116.8 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.253 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.79 116.06 18.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.654 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 58.0 mt -111.12 126.02 68.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.896 0.379 . . . . 0.0 110.623 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.3 mt -120.69 150.08 51.78 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 58.8 Cg_endo -73.27 125.7 10.46 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.577 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 8.9 tmtm? -116.63 124.37 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.72 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 80' ' ' ILE . 41.6 t -90.7 105.98 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.13 -24.97 18.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.753 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.44 80.63 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.83 -56.96 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 0.0 111.118 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.96 141.48 34.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 75' ' ' VAL . 67.5 mt -105.08 127.87 59.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -102.89 163.28 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.654 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 66.3 mt -115.8 124.54 50.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.04 0.448 . . . . 0.0 110.855 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -108.36 134.69 50.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.238 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.618 ' HD2' ' HG2' ' A' ' 69' ' ' GLU . 13.7 ptt180 -93.8 140.66 29.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.07 140.99 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.485 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.61 2.71 15.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.796 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 25.4 p -149.86 151.9 33.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.739 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.7 Cg_exo -76.6 44.37 1.39 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.997 2.465 . . . . 0.0 111.742 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 -74.31 0.42 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.848 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.4 t -95.2 92.81 6.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.116 0.484 . . . . 0.0 111.496 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt -138.21 98.82 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.388 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.28 152.65 17.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.218 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.54 107.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.458 . . . . 0.0 110.341 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.78 -40.88 1.39 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 98' ' ' ILE . . . -87.67 -152.48 0.2 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -78.37 58.35 2.11 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.453 0.644 . . . . 0.0 111.405 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.2 -13.67 60.08 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.979 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.407 ' CG1' ' HB3' ' A' ' 95' ' ' ALA . 41.0 pt -90.08 148.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.75 0.31 . . . . 0.0 110.89 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 ptp -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 16.8 pt-20 -138.01 147.52 56.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.79 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 3.7 Cg_exo -81.1 106.66 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.492 2.128 . . . . 0.0 111.418 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.63 -21.16 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.26 127.15 43.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.856 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.59 -143.4 8.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.12 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -106.85 116.79 32.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.966 0.413 . . . . 0.0 110.377 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -79.11 116.52 19.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.333 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 142.04 25.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.855 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.8 p30 -80.2 137.73 52.72 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 82' ' ' LEU . 34.6 Cg_exo -58.88 -24.33 71.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.97 2.447 . . . . 0.0 113.847 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.99 -9.75 59.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.82 -10.86 54.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.349 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 66.7 t -77.21 121.98 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.343 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.485 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 11.5 m-20 -74.7 -52.98 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.468 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 34.6 t80 -124.31 123.99 41.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.253 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 15.2 tt -130.38 139.83 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 110.741 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.61 109.48 20.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.259 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.525 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 11.6 m -119.74 120.05 30.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.289 0.566 . . . . 0.0 111.135 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 1.4 Cg_endo -84.1 163.96 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.025 2.483 . . . . 0.0 111.95 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.41 154.15 25.47 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.6 t -55.97 -47.28 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.982 0.391 . . . . 0.0 110.894 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.5 147.84 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -129.78 167.19 18.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.979 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 1.3 p-10 -127.23 -169.62 2.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.706 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.1 mt -92.3 4.03 54.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 42.7 mt-10 -110.05 -25.82 10.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.649 0.261 . . . . 0.0 110.781 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.518 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 117.86 26.07 2.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 174.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -102.23 158.07 16.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.782 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' OD2' ' A' ' 166' ' ' ASP . 33.0 mtm180 -124.35 -176.97 3.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.499 HD22 HD23 ' A' ' 6' ' ' LEU . 20.6 tp . . . . . 0 C--N 1.319 -0.725 0 CA-C-O 121.28 0.562 . . . . 0.0 109.726 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' LEU . 6.5 p-10 -67.92 -23.85 65.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.008 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.99 -35.99 74.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.902 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.22 -36.76 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 137' ' ' ASP . 79.8 mt -67.66 -26.36 66.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.108 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 34.3 mmtp -76.72 -21.66 54.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 109' ' ' PRO . 27.5 mmt180 -77.52 -53.11 8.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.172 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.84 103.21 4.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.84 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -113.99 24.4 12.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.25 -139.75 5.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.808 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.93 101.36 13.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HE2' HD11 ' A' ' 167' ' ' ILE . 18.9 mttp -88.54 106.67 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 171' ' ' VAL . 67.7 t -101.0 116.98 45.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.801 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -78.94 121.57 5.6 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 57' ' ' LEU . 61.9 t -113.65 115.86 50.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.552 0.215 . . . . 0.0 110.463 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.95 -179.81 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.084 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 156' ' ' VAL . 95.1 m-85 -97.56 156.1 16.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.86 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.3 p -61.23 -25.9 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.589 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.545 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 70.7 m-85 -61.78 -36.4 80.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.545 ' OE1' ' HB2' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -90.62 8.31 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' TYR . 61.5 t -109.66 133.79 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.892 0.377 . . . . 0.0 110.424 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.93 -169.52 1.85 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 48.2 mt-10 -84.74 -50.15 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.281 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.1 ptm180 -141.11 146.65 37.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 176.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 92.5 mt -116.6 149.16 43.35 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.995 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.35 104.57 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.274 1.983 . . . . 0.0 111.007 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -73.55 111.41 8.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.0 110.768 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.71 -78.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.6 -96.26 0.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.781 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -128.54 61.66 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.358 0.599 . . . . 0.0 111.25 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 128' ' ' ARG . 38.7 t70 -74.36 141.82 45.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 ' HE2' ' A' ' 147' ' ' LYS . 14.1 tt -79.11 120.26 80.08 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.941 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.5 Cg_exo -74.15 148.65 39.76 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.023 2.482 . . . . 0.0 111.807 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.94 169.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.011 0.434 . . . . 0.0 111.607 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -93.3 -40.08 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.297 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 148' ' ' VAL . 17.0 t -133.07 155.12 40.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 55.5 tp -135.43 118.31 16.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.97 126.45 73.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 0.0 110.799 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 71.7 p -114.56 -172.49 2.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.266 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 176' ' ' LYS . 2.5 pm0 -85.73 -15.05 43.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.031 0.443 . . . . 0.0 110.125 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 175' ' ' GLU . 29.4 mtpp -112.31 -47.82 3.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.197 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.43 163.1 28.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 112.102 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.53 122.56 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.73 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 3.0 mmp_? -108.93 131.73 54.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.993 0.425 . . . . 0.0 110.186 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -121.74 128.39 51.72 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.518 HD13 ' HA3' ' A' ' 126' ' ' GLY . 23.4 mt . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 121.672 0.748 . . . . 0.0 110.247 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -53.21 -57.83 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -60.66 -39.18 87.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.54 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.71 -52.34 21.61 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.091 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -61.88 -35.23 77.72 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.321 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -56.11 -59.42 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.451 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -74.25 -37.54 63.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.764 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.54 -39.79 92.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.494 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.1 t -86.19 -41.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.7 tp -60.34 -37.59 81.14 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.173 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 75.9 t60 -59.69 -31.04 69.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.741 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -82.71 -42.74 17.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.916 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.569 ' NH2' ' HA ' ' A' ' 151' ' ' ALA . 52.2 ttt180 -61.19 -38.75 87.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 0.0 111.103 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.1 pt -88.18 -4.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.368 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 66.1 t30 -98.4 -13.69 20.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.888 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.78 143.83 15.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -61.98 144.59 54.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -59.27 -49.33 78.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.548 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.81 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.786 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.09 -44.61 91.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.409 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -59.13 -42.57 90.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -25.5 66.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.688 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -83.86 -18.48 37.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.903 0.382 . . . . 0.0 110.785 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.7 mt -86.56 -53.52 4.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.094 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 m -57.17 -34.49 68.52 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.09 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -48.27 -50.44 29.83 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.086 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -80.59 -26.59 37.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.323 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 25' ' ' LEU . 58.0 t -65.07 -49.51 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.82 -46.42 96.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.619 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -62.09 -40.94 97.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 178' ' ' VAL . 21.8 t-20 -66.51 -51.14 59.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.008 0.433 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.802 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 36.9 tp -57.64 -38.61 75.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.4 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -72.85 -33.38 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.917 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -75.35 -16.87 60.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.346 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 33' ' ' LEU . 79.7 mt -56.46 126.3 69.03 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.852 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -32.74 96.04 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.571 2.181 . . . . 0.0 111.593 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.27 -35.08 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -62.22 -30.31 71.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.078 0.466 . . . . 0.0 110.433 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -64.52 -40.08 94.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.73 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -80.79 -33.2 35.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.159 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.494 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 46.4 m -55.53 105.81 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.046 0.45 . . . . 0.0 111.1 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 84.4 tttt -98.47 -30.67 12.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.653 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -102.91 98.21 8.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.383 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.16 109.01 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 111.066 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.29 139.64 34.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.551 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.27 145.96 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.888 0.375 . . . . 0.0 110.831 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.29 -4.11 59.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.911 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 70.9 m 65.17 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 123.727 0.642 . . . . 0.0 111.465 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 95.92 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.502 2.135 . . . . 0.0 112.743 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 35.7 pt -90.65 161.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 67.4 mttm 70.91 -55.25 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.725 0.64 . . . . 0.0 110.805 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.22 -83.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 4.4 mm-40 45.53 39.55 4.87 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.801 0.84 . . . . 0.0 112.862 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 53.3 t 68.26 101.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.084 -174.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.07 92.71 1.34 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.826 0.822 . . . . 0.0 111.183 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 150' ' ' VAL . 93.8 mt -88.49 15.19 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.792 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 8.8 p -62.35 -38.47 46.93 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 30.5 Cg_exo -64.38 -11.48 28.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.925 1.75 . . . . 0.0 112.717 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 64' ' ' VAL . 36.9 tp -89.24 -16.2 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.59 0.233 . . . . 0.0 110.741 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 23.9 m-85 -56.51 -50.65 86.54 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 50.4 Cg_exo -55.74 -35.19 92.97 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.13 1.887 . . . . 0.0 112.509 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.46 -43.73 76.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.485 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 60' ' ' LEU . 59.2 t -64.49 -44.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.26 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.51 -18.83 65.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.704 0.288 . . . . 0.0 111.549 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -75.99 -36.52 59.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.393 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -124.11 -46.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 31.1 mmtp -101.93 -175.04 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.017 0.437 . . . . 0.0 111.52 -168.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 38.6 mm-40 -98.3 120.0 37.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.595 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.05 102.44 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.2 mt -91.52 116.89 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.085 0.469 . . . . 0.0 110.494 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.8 mt -117.11 137.09 23.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.205 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.6 119.4 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -105.74 117.45 34.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.08 95.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -96.72 71.29 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 109.71 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.37 -111.18 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.429 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.55 -22.97 14.8 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -77.43 89.05 3.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.719 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.84 119.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -111.85 132.29 54.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.452 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -81.85 103.93 11.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.054 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 3.7 m-85 -95.97 120.19 35.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.197 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 24.2 ptt85 -83.42 131.3 35.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.68 133.19 68.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.998 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.23 12.83 7.69 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.5 m -112.05 109.68 54.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.536 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.2 Cg_exo -74.42 31.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.463 2.775 . . . . 0.0 112.915 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 -28.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 58.2 m -84.75 38.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -172.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.22 152.22 21.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -132.89 176.31 19.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.99 98.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.114 0.457 . . . . 0.0 110.031 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.19 -32.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.058 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -76.18 94.84 3.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.855 0.327 . . . . 0.0 111.072 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 80.1 t80 72.49 -52.13 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.199 0.599 . . . . 0.0 111.809 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.32 33.92 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 95' ' ' ALA . 41.5 pt -122.86 172.72 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 66.1 mtt -94.24 86.94 5.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 2.3 pm0 -87.93 148.36 43.17 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.983 0.421 . . . . 0.0 110.263 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 8.1 Cg_exo -72.17 106.09 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' A' ' 103' ' ' GLU . 31.2 m -76.72 -25.01 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.499 0.666 . . . . 0.0 109.421 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.984 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 59.7 mm-40 -122.28 129.11 51.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.938 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.11 -159.2 28.37 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 34.3 tt0 -138.71 131.16 28.76 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 106' ' ' ARG . 20.7 ttt180 -79.74 113.62 18.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.0 110.514 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.44 154.23 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.138 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -81.99 142.11 47.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.294 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' VAL . 24.2 Cg_endo -61.22 -23.21 76.67 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.299 2.666 . . . . 0.0 113.69 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.82 -19.67 63.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.88 0.371 . . . . 0.0 110.975 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.51 -12.56 53.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.391 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.98 114.22 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 110.847 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 42' ' ' SER . 38.8 t70 -90.47 -51.61 5.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.258 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.802 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 38.3 t80 -130.43 139.39 50.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.471 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 147' ' ' LYS . 15.6 tt -146.29 139.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 110.74 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.64 20.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.463 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 59.4 t -122.33 110.89 32.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.01 165.9 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.922 2.415 . . . . 0.0 112.081 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.78 163.89 30.57 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.01 -38.46 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.571 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.63 159.06 44.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.173 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.28 165.84 25.7 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.524 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 16.1 p30 -126.46 -172.09 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 96.0 mt -88.69 -2.2 58.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.029 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -105.79 -28.7 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.809 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.17 30.64 0.85 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.869 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -108.99 151.83 25.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.318 0.559 . . . . 0.0 110.414 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -122.89 149.6 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.067 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.197 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.442 0.639 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.38 -41.91 99.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.13 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.82 -25.6 65.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.851 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.07 -56.57 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.192 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.2 -12.85 61.69 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.769 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -76.47 -32.52 58.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -94.43 -40.81 9.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.083 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 109' ' ' PRO . 49.7 t -71.82 91.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.268 0.556 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 144' ' ' LYS . 5.6 tmtm? -103.89 68.21 0.91 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.554 0.692 . . . . 0.0 109.837 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.69 -150.29 19.01 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 113' ' ' ASP . 11.0 mp -83.29 89.03 6.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.979 0.889 . . . . 0.0 109.227 171.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HA ' HG23 ' A' ' 115' ' ' ILE . 54.4 mtmt -81.98 102.47 10.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.8 t -98.82 114.72 37.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.622 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -79.03 119.95 5.17 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.539 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 57' ' ' LEU . 47.5 t -98.05 110.73 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.371 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.569 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . . . -154.05 176.5 12.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.248 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.454 ' CZ ' HG22 ' A' ' 55' ' ' VAL . 71.6 m-85 -96.69 151.96 19.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.0 t -62.28 -17.78 59.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.45 0.166 . . . . 0.0 111.071 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -62.73 -33.44 75.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.263 0.554 . . . . 0.0 110.389 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.52 -3.8 58.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.429 -174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 172' ' ' LEU . 38.8 t -91.19 110.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.405 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 35.4 m-85 -105.62 -179.17 3.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.523 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.31 -58.6 4.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.079 0.466 . . . . 0.0 110.039 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -144.77 138.54 27.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.848 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 90.5 mt -93.45 152.65 41.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.87 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 101.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.074 1.849 . . . . 0.0 109.653 167.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -73.63 150.09 41.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.263 0.554 . . . . 0.0 111.114 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -103.85 -172.91 2.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.087 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.58 35.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -96.82 64.19 2.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -74.98 108.36 7.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.863 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.2 103.98 55.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.867 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.49 159.75 10.93 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.839 2.359 . . . . 0.0 112.416 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.35 173.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.02 -52.52 3.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.038 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.2 130.97 68.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.24 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 57.0 tp -104.97 108.63 20.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.033 0.444 . . . . 0.0 110.218 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.01 130.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 175' ' ' GLU . 40.2 p -126.55 -173.89 2.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.275 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -79.34 -9.0 59.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.097 0.475 . . . . 0.0 110.862 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -120.31 -62.01 1.52 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -110.01 151.75 26.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.316 0.579 . . . . 0.0 112.548 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.463 HG22 ' OD1' ' A' ' 32' ' ' ASN . 16.6 t -103.81 99.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.102 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 79.2 mtt85 -94.5 85.23 4.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.292 0.568 . . . . 0.0 110.782 -176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -76.27 99.42 4.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.511 -170.087 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 121.169 0.509 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.644 ' HD2' ' HG ' ' A' ' 129' ' ' LEU . 65.3 pttt -72.72 -11.09 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -60.7 -47.57 85.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.546 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -34.18 71.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.814 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.25 -44.11 80.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.166 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' O ' HG11 ' A' ' 120' ' ' VAL . 4.9 tmt_? -58.39 -43.97 88.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.18 -41.37 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.52 -44.09 89.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 37.2 t -71.78 -46.12 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.322 . . . . 0.0 110.348 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.24 -39.61 83.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.782 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -53.16 -39.38 63.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.072 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -90.75 -1.24 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.653 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 62.6 mtp180 -97.34 -48.74 5.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.127 0.489 . . . . 0.0 111.435 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.59 -21.99 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.687 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -76.82 -16.1 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.35 153.62 26.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.628 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -63.1 144.89 56.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.79 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.66 -48.88 78.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 110.011 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 2.5 mp0 -54.33 -49.14 70.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.963 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.76 -53.04 62.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.631 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 22' ' ' ARG . 33.1 ttp180 -64.49 -38.87 92.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -69.67 -36.13 75.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.863 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -65.98 -30.16 70.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 109.88 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.94 -46.08 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.145 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 t -57.45 -35.31 69.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.289 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.64 -51.32 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.405 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -74.28 -28.11 61.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.974 -174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.17 -47.94 80.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.1 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.454 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 m -62.19 -40.42 95.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.32 -46.05 74.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.403 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 36' ' ' LEU . 46.6 tp -61.49 -41.89 97.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.569 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -64.58 -33.16 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -70.15 -26.17 63.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.739 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 33' ' ' LEU . 92.6 mt -61.91 120.12 54.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.169 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.44 -33.58 78.91 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.241 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -22.08 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 68' ' ' LYS . 50.4 t80 -68.84 -29.94 68.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.83 -31.08 15.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.18 -49.87 74.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 113' ' ' ASP . 70.1 m -86.82 122.1 30.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.37 -21.54 18.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -173.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.58 97.8 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.157 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.98 118.04 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.307 0.575 . . . . 0.0 110.858 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -98.75 137.12 37.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.46 139.28 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.72 0.295 . . . . 0.0 110.262 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -85.57 -6.12 59.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.8 t 67.11 102.08 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.306 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.1 124.41 9.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.429 2.086 . . . . 0.0 112.243 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.4 pp -111.57 152.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.296 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 63.08 20.19 12.13 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.098 0.475 . . . . 0.0 110.982 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.17 -88.19 0.63 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.83 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 70.8 mm-40 64.08 -85.01 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 122.925 0.49 . . . . 0.0 109.769 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 150' ' ' VAL . 88.1 t -148.95 116.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.51 101.41 2.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.78 9.54 24.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.501 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 68.5 p -65.21 -38.81 30.57 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 58' ' ' THR . 68.6 Cg_endo -74.14 4.56 4.19 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.62 1.547 . . . . 0.0 112.543 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.9 tp -99.33 -17.28 18.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.594 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 30.9 m-85 -52.07 -46.25 93.26 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 87.4 Cg_exo -49.86 -45.39 32.47 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.083 1.856 . . . . 0.0 112.589 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.92 -32.96 65.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.692 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 60' ' ' LEU . 76.9 t -61.61 -45.2 99.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.93 -12.71 61.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.427 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 62' ' ' PRO . 31.4 mmmt -92.46 -58.45 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.087 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.24 -38.99 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.372 0.606 . . . . 0.0 110.684 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.614 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 22.6 mttp -125.63 -171.6 2.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.769 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 86' ' ' HIS . 42.8 tt0 -120.17 135.08 55.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.168 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 64' ' ' VAL . 62.3 tp -92.47 132.48 36.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 111.391 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -119.83 127.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 97.4 mt -126.29 144.14 48.24 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.48 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.47 146.45 12.21 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.962 2.442 . . . . 0.0 112.593 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -135.0 135.1 41.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.93 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -99.23 124.51 52.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -119.13 44.21 2.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.03 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.64 -93.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.861 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -109.7 -27.47 9.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -92.75 134.75 34.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 tt -116.82 127.82 74.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.114 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -124.55 178.89 5.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.47 138.77 50.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 27.0 m-85 -121.5 146.68 46.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 0.0 111.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.825 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 21.6 ttm180 -91.2 118.43 30.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.962 -172.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 91' ' ' LEU . 46.4 t -119.04 111.67 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.419 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.1 p-80 -139.06 30.31 2.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.514 0.674 . . . . 0.0 109.222 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.8 p -154.27 143.91 15.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.819 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.6 Cg_exo -73.18 171.77 16.93 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.934 2.422 . . . . 0.0 112.386 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.8 18.83 11.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.793 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 53.4 m -113.93 3.34 15.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 85' ' ' VAL . 91.7 mt -108.3 126.05 52.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.211 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.92 -163.56 9.79 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.8 t -123.04 119.4 57.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.926 0.363 . . . . 0.0 110.09 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.37 -98.61 1.36 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 132.81 46.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.6 t80 72.12 -53.47 0.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.904 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.33 34.26 0.37 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.006 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.9 pt -108.35 172.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 91' ' ' LEU . 48.6 tpp -70.72 102.76 2.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 29.4 tt0 -114.31 134.59 22.23 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -172.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 11.3 Cg_exo -70.27 119.65 6.52 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.357 2.038 . . . . 0.0 109.812 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 103' ' ' GLU . 13.6 t -54.04 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.678 0.611 . . . . 0.0 111.031 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 102' ' ' VAL . 54.4 mm-40 -136.64 145.69 45.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.7 -148.61 13.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.622 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.825 ' HG3' ' HB3' ' A' ' 84' ' ' ARG . 6.3 pt-20 -91.2 151.24 21.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 111.433 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -100.41 162.33 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.751 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 50.5 t -125.57 136.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.073 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -82.77 139.04 43.4 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 143' ' ' VAL . 52.2 Cg_exo -56.42 -23.82 49.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.642 2.228 . . . . 0.0 111.265 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.11 -32.59 71.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.158 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.86 -11.51 36.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.893 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -77.46 126.39 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' SER . 15.0 m-20 -96.0 -51.94 4.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.522 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -123.23 148.35 45.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.895 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.56 138.9 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.012 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.46 112.3 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.09 126.42 28.04 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.503 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.2 -168.05 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.735 2.29 . . . . 0.0 111.768 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.7 150.51 6.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.935 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 7' ' ' ARG . 98.9 t -74.22 -38.69 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 0.0 110.943 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.53 166.08 25.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -140.7 148.7 41.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 111.389 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 159' ' ' ARG . 11.5 t70 -101.97 156.85 17.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.871 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 49.4 mt -71.9 -26.76 62.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 111.226 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -85.81 -7.17 58.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.104 0.478 . . . . 0.0 110.029 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 111.27 -0.88 28.14 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.98 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.501 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 95.1 m-85 -64.47 156.89 28.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.31 0.555 . . . . 0.0 110.689 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 37.0 mtm180 -103.99 -71.98 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 160' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.472 0.632 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.019 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.655 0.74 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.75 -24.54 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.07 -25.42 67.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.176 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 45.1 tp -83.84 -39.93 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.513 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.71 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.538 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.519 ' HG2' ' HB ' ' A' ' 167' ' ' ILE . 22.2 mtmm -86.37 -0.07 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.171 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -100.45 -36.32 9.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.93 0.395 . . . . 0.0 110.477 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.1 t -84.91 91.14 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 110.052 177.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.51 62.28 3.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.748 0.785 . . . . 0.0 110.193 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.81 -152.95 23.17 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 146' ' ' LEU . 3.8 mm? -83.68 94.39 8.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.427 0.614 . . . . 0.0 109.827 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' HE2' ' CD1' ' A' ' 167' ' ' ILE . 9.5 mtmp? -77.49 104.91 8.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 76.3 t -95.12 113.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.484 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -84.75 117.19 4.44 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.441 HG12 HG21 ' A' ' 55' ' ' VAL . 22.6 t -105.8 109.15 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -159.01 -177.83 6.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.109 0.48 . . . . 0.0 111.362 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -100.06 166.92 10.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.176 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.5 m -77.02 -22.09 53.59 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -78.79 2.78 18.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.795 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -101.43 -10.78 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.041 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 t -91.63 115.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.51 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 96.3 m-85 -112.08 178.96 4.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 124' ' ' LEU . 30.0 mt-10 -64.13 -76.72 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 110.837 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.669 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 43.2 mtm180 -141.18 132.91 27.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.774 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 129' ' ' LEU . 52.4 mt -103.5 153.44 38.56 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.577 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.8 101.62 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.131 1.887 . . . . 0.0 111.57 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.845 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -90.57 147.33 23.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.564 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.7 -67.1 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.514 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.69 -85.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.612 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 14.9 m-90 -103.72 66.87 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.894 0.378 . . . . 0.0 111.21 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.05 110.17 18.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 141' ' ' LYS . 19.4 tt -74.06 122.89 88.63 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.472 0.653 . . . . 0.0 111.661 -171.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 21.5 Cg_exo -67.2 154.66 73.56 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.154 2.569 . . . . 0.0 112.851 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -82.75 171.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.975 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -108.82 -46.59 3.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.586 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 46.5 t -123.06 113.51 38.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.686 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.866 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 62.3 tp -100.01 102.65 14.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 110.283 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 33' ' ' LEU . 95.1 t -89.91 112.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.217 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.0 p -105.06 -175.93 2.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 12.4 pt-20 -72.69 -15.6 61.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.385 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.531 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 66.1 mttt -119.31 -48.71 2.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.48 168.82 18.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.625 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 36' ' ' LEU . 23.3 t -91.81 105.03 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 11.7 mmt180 -80.25 86.21 5.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -78.34 103.49 8.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 121.366 0.603 . . . . 0.0 111.164 -173.936 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -61.51 -33.66 74.19 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.61 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -80.45 -31.36 37.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 111.184 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.76 -29.66 32.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.86 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HE2' ' A' ' 9' ' ' LYS . 54.5 tp -58.3 -42.26 86.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 109.563 173.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HB2' HD23 ' A' ' 129' ' ' LEU . 39.6 ttp180 -58.33 -34.96 71.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.624 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -64.68 -49.18 71.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 6' ' ' LEU . 55.6 pttt -72.2 -31.95 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.543 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG11 ' HB2' ' A' ' 121' ' ' ALA . 86.6 t -69.54 -35.19 65.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 15' ' ' ILE . 54.1 tp -64.97 -51.17 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.802 174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 11.6 t-160 -59.47 -32.58 70.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -77.74 -40.0 42.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 15.8 ttm180 -66.1 -38.07 87.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.673 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.616 HG22 ' HA3' ' A' ' 53' ' ' GLY . 36.9 pt -91.41 7.87 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.784 0.325 . . . . 0.0 111.217 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 9.2 t30 -85.47 -18.43 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 109.612 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.434 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.99 144.7 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 48.6 mt-10 -71.42 -38.55 71.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.04 -39.47 93.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.0 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 24' ' ' ARG . 10.7 tp10 -62.47 -40.77 97.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.717 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -60.68 -41.62 95.49 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 17.1 mmt180 -56.7 -41.64 77.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.433 0.635 . . . . 0.0 110.184 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 21' ' ' GLU . 39.2 ttp180 -71.51 -43.34 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.253 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.73 -38.18 83.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.906 0.384 . . . . 0.0 110.756 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 55' ' ' VAL . 68.6 m -58.38 -42.14 86.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.598 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.34 -37.83 73.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mtpt -60.97 -52.59 64.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 110.348 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG11 HG13 ' A' ' 150' ' ' VAL . 48.9 t -61.35 -43.88 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.836 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 81.7 mt -61.11 -45.72 98.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -64.68 -33.46 76.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.61 0.243 . . . . 0.0 110.942 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -66.41 -55.17 17.05 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.291 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.48 -31.53 71.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.069 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 23.3 tttp -68.26 -35.26 77.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.0 p -83.69 -14.56 51.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.275 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.3 tt -58.51 123.34 66.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.847 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -55.63 -44.7 45.56 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.429 2.753 . . . . 0.0 113.452 -172.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 7.6 mp0 -60.95 -25.25 66.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.855 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.74 -36.4 73.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -82.22 -0.54 45.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -106.16 -52.45 2.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -70.08 158.72 35.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.867 -172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -113.31 -34.09 5.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.202 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.03 98.45 11.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.404 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 106.52 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.22 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -97.62 136.76 37.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.49 152.77 42.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.538 ' HB2' HG12 ' A' ' 117' ' ' VAL . 7.1 t80 -80.47 -98.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.189 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 48' ' ' TYR . 49.1 t 177.89 116.46 0.18 Allowed Pre-proline 0 N--CA 1.462 0.154 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 6.6 Cg_endo -88.46 103.12 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.177 2.585 . . . . 0.0 112.058 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.09 140.99 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.361 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 71.85 -51.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.267 0.627 . . . . 0.0 111.483 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 15' ' ' ILE . . . -139.64 -158.68 7.71 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.64 ' OE1' ' HD3' ' A' ' 14' ' ' ARG . 4.2 mm-40 77.34 150.75 0.12 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.974 0.892 . . . . 0.0 112.101 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 26' ' ' SER . 57.1 t -36.85 126.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 112.631 -2.077 . . . . 0.0 112.24 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD11 ' A' ' 30' ' ' ILE . 3.5 m-20 -68.08 76.96 0.23 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.59 -10.3 54.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.838 0.351 . . . . 0.0 110.708 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.473 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -53.87 -49.89 86.91 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 58' ' ' THR . 36.7 Cg_endo -66.0 -8.02 18.72 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.087 1.858 . . . . 0.0 113.526 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.34 -14.09 29.25 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.137 -0.352 . . . . 0.0 110.803 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.524 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.3 m-85 -53.75 -52.35 68.28 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.985 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 53.8 Cg_exo -54.34 -37.11 88.74 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.321 2.014 . . . . 0.0 113.183 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.05 -52.35 36.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.623 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.69 -34.59 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.275 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 88' ' ' PRO . 38.1 tp -66.24 -26.23 67.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.297 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.69 -48.99 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.532 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.39 -45.58 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 111.815 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -123.29 -171.68 2.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.626 -163.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.61 100.93 11.4 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.4 tp -80.52 120.56 24.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.593 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.8 mt -102.42 119.81 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.848 0.356 . . . . 0.0 110.371 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.39 142.59 28.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.536 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.24 121.61 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.203 2.602 . . . . 0.0 113.279 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.808 ' HD2' ' HE2' ' A' ' 83' ' ' TYR . 55.9 tttm -105.97 133.97 49.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 102.4 8.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -86.69 -19.49 29.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.952 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 156.91 80.47 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 7.0 t30 70.44 -50.8 0.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.216 0.607 . . . . 0.0 111.103 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.38 156.53 25.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -104.63 131.94 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.055 0.455 . . . . 0.0 111.513 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -111.0 115.65 29.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 80.6 mt -82.52 141.15 32.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.266 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.808 ' HE2' ' HD2' ' A' ' 74' ' ' LYS . 18.9 m-85 -112.59 141.62 46.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.187 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . 27.0 ttt180 -88.15 91.72 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.118 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.17 114.51 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.368 0.604 . . . . 0.0 111.936 -171.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -140.62 14.44 2.34 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 23.3 t -99.99 104.79 31.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.333 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' HD21 ' A' ' 65' ' ' LEU . 24.4 Cg_exo -63.64 -29.58 69.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.154 2.569 . . . . 0.0 113.524 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.55 -16.12 40.46 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.521 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 47.0 t -89.89 76.01 7.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.357 0.599 . . . . 0.0 110.485 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.9 mt -135.82 117.54 15.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.899 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.59 178.6 25.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.713 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.96 134.46 66.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.87 -74.58 0.93 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.842 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.42 153.74 40.01 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.896 -0.179 . . . . 0.0 111.3 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.4 t80 73.7 -47.55 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.656 0.782 . . . . 0.0 111.995 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.96 11.8 1.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.309 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -93.17 166.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.4 mtp -92.23 120.79 33.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.037 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.7 120.89 28.47 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.971 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.01 124.92 14.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.856 2.37 . . . . 0.0 111.575 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.25 -53.22 42.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.15 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.11 136.93 52.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.461 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.05 175.26 40.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.14 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 84' ' ' ARG . 1.1 pm0 -93.72 141.55 28.37 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 4.1 ptp85 -93.12 139.57 30.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.318 0.58 . . . . 0.0 111.229 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.65 143.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.629 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 31.4 p-10 -92.98 152.92 41.83 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 112' ' ' VAL . 77.3 Cg_exo -52.12 -27.0 27.81 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.224 2.616 . . . . 0.0 113.307 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 43.5 tt0 -60.17 -38.21 82.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.734 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.31 -13.35 57.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 109' ' ' PRO . 88.3 t -60.23 110.84 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.261 0.553 . . . . 0.0 110.773 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -80.0 -53.07 7.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.52 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.66 136.6 48.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.526 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.53 139.12 45.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.36 119.97 24.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 48' ' ' TYR . 35.7 m -125.46 139.56 34.23 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.849 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.618 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 95.3 Cg_endo -80.84 -174.94 2.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 111.506 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.78 -164.32 23.24 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.359 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.95 -50.0 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.574 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -139.72 140.09 36.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' HB3' ' A' ' 128' ' ' ARG . 49.3 m-85 -134.67 168.79 18.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 24.2 p30 -135.27 -170.07 2.51 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.481 HD23 ' NH1' ' A' ' 179' ' ' ARG . 90.0 mt -82.23 -20.69 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.978 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.428 ' CD ' HH12 ' A' ' 162' ' ' ARG . 41.5 mt-10 -92.12 -12.12 33.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.692 0.282 . . . . 0.0 111.353 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.38 12.66 22.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.369 171.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.445 ' HE2' ' H ' ' A' ' 166' ' ' ASP . 48.9 m-85 -88.29 146.8 25.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.052 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.639 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -131.63 132.59 44.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 160' ' ' LEU . 11.1 mp . . . . . 0 C--N 1.318 -0.788 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.346 0.594 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -56.34 -42.89 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.776 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -11.6 59.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.269 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 143' ' ' VAL . 61.8 tp -93.19 -73.17 0.57 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.33 -29.14 69.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -83.52 -14.62 51.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 111.292 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -102.06 -15.54 16.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.111 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.0 t -71.26 123.42 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.44 1.07 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 110.051 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.67 -155.76 10.55 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.754 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.72 120.79 28.4 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.662 -0.316 . . . . 0.0 111.022 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.644 ' HG2' ' OD2' ' A' ' 170' ' ' ASP . 20.3 mmtm -87.04 106.51 17.9 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.44 114.63 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.909 0.385 . . . . 0.0 110.34 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.53 125.35 8.51 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.436 HG13 HG11 ' A' ' 29' ' ' VAL . 39.4 t -102.49 123.43 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.59 155.95 27.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 111.804 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 156' ' ' VAL . 69.0 m-85 -91.27 141.98 28.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.181 174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.3 m -57.3 -26.03 60.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.877 0.736 . . . . 0.0 111.829 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -59.28 -38.7 80.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.434 ' HB2' HH21 ' A' ' 14' ' ' ARG . 10.4 mm100 -108.28 24.03 13.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.601 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 152' ' ' TYR . 50.2 t -116.75 105.92 19.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.322 0.582 . . . . 0.0 109.454 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 82.2 m-85 -92.65 -178.41 4.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.761 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.95 -61.82 2.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 3.1 ptm180 -153.08 135.62 15.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 129' ' ' LEU . 95.9 mt -98.57 155.26 36.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.748 -174.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.9 117.71 4.56 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.819 2.346 . . . . 0.0 111.199 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 162' ' ' ARG . 6.2 ptp180 -126.24 -179.65 4.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.122 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -105.51 -91.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.45 97.55 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.69 0.281 . . . . 0.0 111.576 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 53.16 78.81 0.13 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.599 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.6 t0 -83.84 -169.46 2.58 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.74 102.78 6.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.643 0.259 . . . . 0.0 110.387 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 0.9 OUTLIER -83.07 167.11 14.31 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.194 2.596 . . . . 0.0 112.345 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 147' ' ' LYS . 27.3 m -90.39 166.86 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.794 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.644 ' OD2' ' HG2' ' A' ' 147' ' ' LYS . 24.8 m-20 -100.54 -38.04 8.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 110.388 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.47 112.85 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.871 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 35.6 tp -99.71 110.7 23.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.4 120.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.073 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 52.6 p -109.35 179.62 4.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.036 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.77 9.68 20.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.414 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -133.23 -44.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -128.31 167.87 16.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.057 0.456 . . . . 0.0 111.056 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.35 113.38 41.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 92.6 mtt180 -94.01 99.04 11.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -88.64 108.46 19.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.367 0.603 . . . . 0.0 109.977 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 -174.26 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 93.1 mt . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.87 -30.67 71.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.766 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.449 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 49.0 m -83.14 -30.09 28.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.865 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 tm-20 -70.35 -42.32 72.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.9 tp -61.48 -39.9 92.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.753 174.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -58.78 -38.11 77.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.54 -38.32 89.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -62.96 -43.8 97.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 6' ' ' LEU . 21.3 t -67.54 -48.76 75.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.001 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.11 -47.75 68.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.352 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -58.55 -51.39 70.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.033 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.35 -38.65 88.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.119 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 120' ' ' VAL . 20.0 ttm180 -58.02 -49.74 75.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.931 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 pt -86.94 -0.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.637 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -89.35 -10.12 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.143 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.17 136.24 56.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -67.09 156.99 34.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.488 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.1 -55.15 31.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.647 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.88 -45.8 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.163 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.82 -45.51 85.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.582 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -62.62 -46.09 89.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.736 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.431 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 21.0 tpt180 -60.06 -36.8 78.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.908 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -38.4 90.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.046 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.58 -51.19 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.799 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -62.54 -34.91 77.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.26 -39.56 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.97 -38.14 87.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.305 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 175' ' ' GLU . 56.2 t -63.75 -47.42 91.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.422 . . . . 0.0 110.487 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.43 -48.13 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.72 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -60.86 -39.11 87.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.09 0.471 . . . . 0.0 110.359 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.19 -53.53 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.03 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.4 -40.61 97.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.87 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -62.61 -32.74 73.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.3 m -83.49 -19.87 35.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.351 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.432 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.0 tt -52.32 115.53 7.07 Favored Pre-proline 0 CA--C 1.533 0.295 0 O-C-N 123.26 0.35 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD2' HD23 ' A' ' 36' ' ' LEU . 50.4 Cg_exo -54.78 -32.56 77.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.223 2.615 . . . . 0.0 113.45 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.54 -26.16 30.36 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.025 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -76.04 -14.82 60.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.149 0.976 . . . . 0.0 109.015 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.47 -22.82 40.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.742 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 54.4 mttp -104.69 -12.37 16.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.451 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -64.29 149.36 48.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 111.76 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -109.84 -65.83 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.731 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HB3' HD11 ' A' ' 71' ' ' ILE . 30.1 mmtp -91.28 95.29 9.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.703 -176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.6 t -102.35 108.28 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.692 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -94.65 119.86 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.433 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.4 129.47 52.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.457 ' HB3' ' HD3' ' A' ' 118' ' ' PRO . 23.2 t80 -77.79 -2.02 34.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.373 -173.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.9 m 66.12 96.58 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.349 0.595 . . . . 0.0 111.548 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.61 128.06 7.57 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.762 2.308 . . . . 0.0 113.084 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 38.7 pt -129.51 158.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.437 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 68.5 -66.02 0.25 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.37 0.668 . . . . 0.0 112.481 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.89 21.15 0.37 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.494 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 51' ' ' ILE . 23.2 mm-40 -82.4 36.36 0.47 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.495 ' HA ' ' OH ' ' A' ' 152' ' ' TYR . 47.2 t 68.85 114.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 122.977 0.511 . . . . 0.0 110.528 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -71.53 80.66 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.957 0.884 . . . . 0.0 111.476 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 150' ' ' VAL . 86.7 mt -86.08 3.82 40.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -53.92 -46.98 98.36 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 58' ' ' THR . 27.0 Cg_endo -62.99 -11.48 24.88 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.104 1.87 . . . . 0.0 113.332 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.6 tp -92.7 -14.28 28.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 14.9 m-85 -56.75 -48.38 97.37 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.878 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.29 -33.58 56.13 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.331 2.021 . . . . 0.0 113.322 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -71.48 -50.75 28.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.405 . . . . 0.0 110.837 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.63 -37.3 79.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.63 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 86' ' ' HIS . 23.7 tp -67.06 -24.39 65.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -93.81 -53.73 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.18 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -50.63 11.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -100.76 -171.78 2.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.183 0.516 . . . . 0.0 111.123 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 39.8 mt-10 -105.21 102.81 12.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.025 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -78.76 114.95 18.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.956 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 61.4 mt -101.39 117.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.059 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 98.0 mt -113.25 139.99 23.8 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.629 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.0 Cg_exo -74.99 120.04 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.873 2.382 . . . . 0.0 112.093 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.606 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 45.0 tttm -116.91 152.78 33.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.13 114.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.493 . . . . 0.0 110.413 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -111.56 107.1 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.147 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.75 39.21 97.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.8 t30 65.91 16.43 10.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.127 0.571 . . . . 0.0 111.114 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.16 136.39 54.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' CD1' ' A' ' 136' ' ' TYR . 20.4 tt -79.08 135.88 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.422 0.63 . . . . 0.0 111.244 -173.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.3 m -139.93 167.49 21.99 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.3 mt -109.89 131.56 54.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.93 0.395 . . . . 0.0 110.951 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.559 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 26.3 m-85 -117.66 124.12 47.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.193 0.521 . . . . 0.0 110.444 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 22.9 ttp180 -93.45 118.54 31.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.861 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.37 154.7 40.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.982 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 65' ' ' LEU . 1.8 p80 -162.44 47.87 0.16 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.986 0.898 . . . . 0.0 109.119 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 43.9 m -156.05 160.41 30.81 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.259 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 87' ' ' SER . 41.7 Cg_endo -67.44 166.78 22.54 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.275 1.983 . . . . 0.0 112.601 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' O ' ' SG ' ' A' ' 90' ' ' CYS . . . 65.14 -155.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.788 0.68 . . . . 0.0 111.065 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 89' ' ' ALA . 15.2 p 60.53 6.33 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.717 1.207 . . . . 0.0 112.828 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.6 mt -97.51 149.34 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.36 -172.41 34.48 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.5 t -134.43 119.53 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.41 -33.28 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.238 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.52 -146.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.223 0.209 . . . . 0.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -39.5 -53.21 2.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.0 0.92 . . . . 0.0 112.971 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.56 47.99 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.17 148.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.2 mtt -72.26 93.43 1.47 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.073 0.463 . . . . 0.0 110.234 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.606 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 11.6 pt-20 -102.06 143.64 27.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.229 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 43.3 Cg_endo -72.27 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.928 1.752 . . . . 0.0 111.171 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.64 -44.19 69.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.11 171.67 7.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.623 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -148.03 19.19 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.909 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 124.32 40.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -75.8 126.8 31.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.178 0.513 . . . . 0.0 111.21 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 91.4 t -122.11 139.24 49.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.58 ' OD1' ' HD2' ' A' ' 109' ' ' PRO . 64.8 t30 -84.42 135.9 40.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HD2' ' OD1' ' A' ' 108' ' ' ASN . 5.1 Cg_endo -47.52 -23.67 3.7 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.744 2.962 . . . . 0.0 113.856 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.67 -34.15 72.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 111.234 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.75 -15.67 53.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.584 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.52 116.15 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -93.85 -25.17 17.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.369 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -134.79 122.68 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.413 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.08 139.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.89 0.376 . . . . 0.0 110.692 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.45 108.74 15.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.466 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 51.6 t -116.24 120.68 34.7 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.493 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 7.0 Cg_exo -74.57 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.917 2.411 . . . . 0.0 111.94 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.64 128.64 1.2 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 39.7 t -58.01 -40.88 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 111.81 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . -132.42 127.76 36.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.774 0.321 . . . . 0.0 111.091 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -121.62 161.72 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.58 174.41 6.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.02 3.84 47.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 37.6 mt-10 -101.31 -33.96 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.584 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 134.31 16.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.179 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.99 158.64 16.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.526 0.663 . . . . 0.0 111.119 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -115.65 157.68 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.693 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 25.2 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 80' ' ' ILE . 69.6 m-85 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.68 -31.19 72.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.527 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -57.94 -23.66 54.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 13.8 tp -93.58 -59.89 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.231 0.539 . . . . 0.0 109.945 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -33.32 72.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.679 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -75.55 -22.58 56.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.748 0.309 . . . . 0.0 111.307 -175.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -102.85 -15.05 16.33 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.696 -0.402 . . . . 0.0 112.053 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' LEU . 62.0 t -67.92 95.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.193 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -86.44 -4.04 59.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.611 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.57 166.75 15.49 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.109 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 46.8 tp -53.0 111.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.095 0.474 . . . . 0.0 110.778 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.499 ' HG3' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -82.88 99.6 9.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.123 -176.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.42 123.99 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -101.25 138.19 13.72 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 57' ' ' LEU . 67.3 t -120.89 124.81 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.081 0.441 . . . . 0.0 110.515 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -164.17 167.47 20.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 156' ' ' VAL . 50.5 m-85 -84.34 149.95 25.7 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.305 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 85.0 p -67.55 -25.03 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.368 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -58.64 -26.53 63.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.025 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 14' ' ' ARG . 21.3 mm-40 -115.42 11.98 16.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.881 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 152' ' ' TYR . 88.1 t -108.46 114.3 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.191 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 91.4 m-85 -94.84 157.09 16.08 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.836 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -54.75 -54.55 40.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -147.22 150.73 35.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.027 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.08 158.54 72.49 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.889 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.47 112.66 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.955 1.77 . . . . 0.0 110.586 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 162' ' ' ARG . 16.6 ttp180 -73.52 131.73 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.642 -170.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.38 -166.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.913 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.97 107.29 15.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.201 0.524 . . . . 0.0 110.857 -174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 79.62 13.07 1.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.076 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.85 123.35 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.0 tt -76.2 116.83 59.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.382 0.611 . . . . 0.0 111.27 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 8.2 Cg_exo -72.15 150.37 53.66 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.996 2.464 . . . . 0.0 112.547 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.499 HG12 ' HG3' ' A' ' 147' ' ' LYS . 34.3 m -86.02 148.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.57 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -87.35 -40.77 14.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.411 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' A' ' 180' ' ' ARG . 61.0 t -120.08 130.44 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.437 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 53.7 tp -111.51 115.92 30.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.054 0.454 . . . . 0.0 110.082 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.1 111.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.352 0.596 . . . . 0.0 109.766 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -109.01 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.264 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' VAL . 9.9 pt-20 -54.9 -34.26 62.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.892 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 47.2 mttm -87.49 -58.64 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.306 -171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -155.53 174.72 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.85 121.59 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.802 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -126.33 119.15 26.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 171' ' ' VAL . 57.1 mtt180 -81.87 139.5 34.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--N 1.318 -0.769 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 10.7 mp . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -70.33 -35.72 73.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.875 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 t -72.63 -29.87 63.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.247 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 2' ' ' LEU . 1.8 mp0 -89.24 -25.33 21.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.823 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.69 -44.95 93.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.62 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' A' ' 129' ' ' LEU . 4.0 ptp180 -66.55 -24.06 66.3 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.865 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HD2' ' HA ' ' A' ' 5' ' ' GLU . 98.6 mttt -73.16 -43.19 61.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.311 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.6 -29.56 70.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG13 ' NE2' ' A' ' 155' ' ' GLN . 77.1 t -75.63 -55.24 12.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.749 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -46.05 91.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.504 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -66.54 -21.23 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.111 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -76.56 -46.71 25.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.47 . . . . 0.0 110.496 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 36.7 mtm180 -73.2 -29.7 63.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.861 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -80.81 3.0 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.929 0.395 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -117.16 -98.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.4 mt 58.38 173.06 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.513 0.673 . . . . 0.0 111.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 m -76.37 123.34 25.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.06 -29.1 60.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.401 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.8 mp0 -63.53 -45.04 92.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.12 -50.13 74.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.445 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -52.55 -44.67 65.98 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.774 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.85 -47.16 69.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 2.6 ptt85 -73.53 -19.72 60.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.449 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 48.8 mt -78.0 -40.67 38.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 172.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -60.91 -35.19 76.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.403 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.66 -41.15 80.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -69.61 -42.65 74.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.0 t -62.33 -45.92 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.08 -44.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.673 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.5 m -60.37 -38.51 84.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -71.19 -47.24 58.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 49.6 tp -62.61 -38.93 92.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.013 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.21 -16.71 54.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.162 0.506 . . . . 0.0 110.513 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.5 t -75.89 -25.76 56.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 178' ' ' VAL . 58.4 mt -55.66 130.78 71.65 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.083 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.6 Cg_exo -64.87 -21.37 64.31 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.63 2.22 . . . . 0.0 111.456 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 2.5 mp0 -69.45 -24.72 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.856 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.411 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 68.3 t80 -68.18 -29.25 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 109.51 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.18 -29.33 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.039 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . 62.4 mttp -63.86 -38.92 92.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.965 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 t -90.78 136.43 33.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.645 0.736 . . . . 0.0 112.038 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -92.31 -17.57 24.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.361 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 71' ' ' ILE . 78.9 mttt -121.2 97.29 5.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.764 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.02 107.51 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -98.41 130.2 45.04 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.996 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.91 130.14 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.06 4.5 14.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.269 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 18.6 t 71.32 125.62 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.29 0.636 . . . . 0.0 111.181 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 4.4 Cg_exo -77.84 45.32 1.75 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.221 2.614 . . . . 0.0 112.929 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.1 pp -61.28 -32.08 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' ILE . 72.5 mmtt -136.33 33.63 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.44 146.71 18.33 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.683 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 7.2 pt-20 -83.71 -15.57 48.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.088 0.47 . . . . 0.0 111.241 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.87 132.23 54.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.735 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.87 86.76 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.98 0.419 . . . . 0.0 110.273 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -88.92 -1.17 57.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.274 0.559 . . . . 0.0 110.25 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -61.08 -47.09 96.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.02 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 58' ' ' THR . 51.0 Cg_endo -69.68 -5.32 15.87 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.592 1.528 . . . . 0.0 113.236 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' HG ' HG23 ' A' ' 64' ' ' VAL . 48.7 tp -88.73 -20.61 24.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.82 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.611 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.0 m-30 -49.73 -52.22 53.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 83.4 Cg_exo -50.28 -40.36 52.37 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.551 2.167 . . . . 0.0 113.362 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 17.0 tt0 -78.27 -37.44 45.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.349 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 70' ' ' LEU . 61.1 t -60.16 -44.83 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.4 -27.02 68.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.988 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 63' ' ' GLU . 31.9 ttpt -74.16 -36.01 64.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.783 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -95.9 -67.32 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.194 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 39' ' ' PHE . 40.4 mttp -124.98 -171.79 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.43 . . . . 0.0 111.981 -165.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.01 118.31 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.153 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 64' ' ' VAL . 58.6 tp -94.36 107.96 19.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 61.8 mt -89.0 116.93 31.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 91.4 mt -115.2 151.31 45.63 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HB3' HG21 ' A' ' 80' ' ' ILE . 5.2 Cg_exo -80.51 127.43 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 112.916 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 101' ' ' PRO . 25.6 tptp -105.8 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -85.61 103.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.876 0.37 . . . . 0.0 110.678 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.83 78.06 1.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.688 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.26 -80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.007 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -123.72 -16.26 6.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -126.53 167.42 15.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.493 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 139' ' ' LEU . 65.3 mt -118.43 126.9 75.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 -175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.7 m -96.65 134.46 39.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.289 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 109' ' ' PRO . 98.1 mt -90.43 131.83 35.97 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.57 147.81 44.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.313 0.578 . . . . 0.0 111.939 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 105' ' ' GLU . 39.6 ttt180 -81.6 108.59 15.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.121 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 90' ' ' CYS . 47.3 t -110.07 118.08 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.108 0.48 . . . . 0.0 110.486 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -124.65 -29.19 3.47 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 15.9 m -89.85 126.3 58.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.25 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.1 Cg_exo -61.29 -12.56 24.17 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.196 2.597 . . . . 0.0 113.011 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 4.22 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.853 0.359 . . . . 0.0 111.417 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.525 ' HB3' HG13 ' A' ' 85' ' ' VAL . 49.0 t -88.67 -0.51 57.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 111.073 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.95 113.32 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.021 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.56 158.71 22.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.966 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 61.5 t -79.71 127.99 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 0.0 110.244 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.596 ' HA3' ' OE2' ' A' ' 100' ' ' GLU . . . -81.98 -131.1 1.36 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.655 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.72 2.83 22.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.06 30.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.453 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.28 76.96 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.457 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 24.1 pt -114.1 163.92 10.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.53 119.02 38.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 110.504 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.596 ' OE2' ' HA3' ' A' ' 94' ' ' GLY . 8.5 pt-20 -138.87 155.06 73.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.529 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' HD3' ' A' ' 74' ' ' LYS . 33.5 Cg_endo -64.65 120.45 7.73 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.308 2.672 . . . . 0.0 113.398 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.36 -37.39 7.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 11.6 mm-40 -136.37 109.63 7.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.058 0.456 . . . . 0.0 111.78 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.17 43.68 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 21.1 mp0 -81.49 121.44 26.29 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -70.25 132.52 45.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 109.956 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.87 133.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.624 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.87 132.97 95.05 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . 50.2 Cg_exo -55.2 -33.03 82.96 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.573 2.182 . . . . 0.0 112.674 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -71.75 -19.72 61.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.718 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.95 -17.5 50.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.394 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.463 ' HB ' HG13 ' A' ' 143' ' ' VAL . 93.9 t -60.88 131.76 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.265 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.74 -41.59 7.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.512 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 54.0 t80 -132.9 130.45 39.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.276 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.52 138.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 110.894 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.92 115.95 28.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.82 118.6 36.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.37 90.69 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.301 175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.1 156.54 53.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.004 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.496 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 48.8 t -63.76 -47.72 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -157.44 157.93 34.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.97 156.34 46.36 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.11 0.257 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -109.67 -171.71 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 94.1 mt -79.37 6.03 11.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -119.85 -36.71 3.24 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.63 11.95 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.576 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -95.52 167.18 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.57 -162.49 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.776 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 161' ' ' PRO . 35.8 tp . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.651 0.739 . . . . 0.0 109.748 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.18 -33.73 70.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.985 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -66.3 -30.8 71.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.772 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 80' ' ' ILE . 48.2 tp -67.42 -45.29 76.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.29 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.82 -38.52 75.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.877 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 167' ' ' ILE . 55.7 tttm -81.14 -21.67 39.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.247 0.546 . . . . 0.0 110.465 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HG2' ' HB2' ' A' ' 109' ' ' PRO . 30.0 ttp180 -77.35 -24.61 50.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.951 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.463 HG13 ' HB ' ' A' ' 112' ' ' VAL . 75.6 t -78.66 118.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.724 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -97.16 -2.02 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 110.785 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.58 -179.23 41.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.03 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.37 122.52 17.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.364 . . . . 0.0 110.57 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.72 109.64 21.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 171' ' ' VAL . 80.9 t -107.68 128.95 62.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.562 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -100.54 122.31 7.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.37 114.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.538 0.169 . . . . 0.0 110.629 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.16 164.63 32.75 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.501 0.501 . . . . 0.0 110.13 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.468 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 75.6 m-85 -86.76 158.44 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.511 . . . . 0.0 111.051 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.7 p -61.79 -25.95 67.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.792 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -77.1 -9.23 58.6 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.635 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.593 ' NE2' HG13 ' A' ' 10' ' ' VAL . 8.5 mm100 -108.54 9.4 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.27 116.69 44.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -111.18 179.7 3.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.799 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 30.4 mt-10 -70.8 -68.71 0.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 0.0 111.273 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.75 117.2 13.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.314 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.83 154.05 37.99 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.461 ' HD2' HD13 ' A' ' 129' ' ' LEU . 49.9 Cg_exo -56.14 111.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.259 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -88.31 151.07 22.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.675 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.24 143.15 50.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.18 -15.9 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -110.98 13.12 22.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -89.93 115.3 27.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 141' ' ' LYS . 40.3 mt -74.77 112.09 16.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.666 -172.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.94 163.75 28.16 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.547 2.165 . . . . 0.0 112.209 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 181' ' ' LEU . 28.6 m -103.6 166.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.637 177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.33 -41.02 6.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.258 0.551 . . . . 0.0 110.588 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 148' ' ' VAL . 61.8 t -116.84 120.67 65.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.405 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.8 tp -101.05 114.08 27.68 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 122.36 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.664 ' HB ' ' OE1' ' A' ' 175' ' ' GLU . 46.6 p -111.37 -168.3 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -72.29 -25.17 61.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.113 0.482 . . . . 0.0 110.215 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -115.11 -47.56 2.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.401 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.42 172.99 11.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.309 0.576 . . . . 0.0 112.053 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 98.9 t -126.06 115.03 41.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.632 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -100.03 116.38 31.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -73.71 95.03 2.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.866 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 169' ' ' VAL . 69.6 mt . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 88.6 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -70.86 -52.04 22.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.807 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -66.5 -24.63 66.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.469 . . . . 0.0 110.036 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 42.4 tt0 -58.37 -54.66 44.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.424 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.68 -35.77 75.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.168 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.15 -42.7 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.962 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.13 -42.76 99.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.108 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 26.8 mtpp -63.94 -51.89 62.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.61 -44.78 97.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.99 -35.79 77.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.426 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 24.8 t-80 -67.04 -37.8 84.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.371 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 7.4 mtpm? -66.27 -31.68 72.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 110.44 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 50.8 mtt180 -63.34 -54.45 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.176 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.679 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 27.0 pt -88.03 5.88 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.161 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -84.28 -30.83 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.28 144.99 55.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.863 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.5 m -71.79 151.21 43.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.703 0.287 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 22' ' ' ARG . 5.1 tp10 -59.44 -36.61 76.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.589 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 50.7 mt-10 -55.23 -52.55 63.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.088 0.471 . . . . 0.0 110.623 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.11 -39.81 95.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.379 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.679 ' NH1' ' HA ' ' A' ' 15' ' ' ILE . 23.6 mtm180 -65.76 -39.13 90.74 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.37 -37.5 87.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.0 110.841 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 49.5 mtt85 -69.56 -48.27 60.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -67.79 -43.36 79.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.451 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.6 t -62.03 -43.75 98.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.896 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.75 -35.44 81.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.848 0.356 . . . . 0.0 110.124 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 33.2 ttmt -59.02 -44.5 91.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.441 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 175' ' ' GLU . 42.9 t -67.76 -39.48 82.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 26' ' ' SER . 80.8 mt -61.41 -49.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -64.72 -37.19 86.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.13 -39.44 94.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.242 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.585 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 46.8 tp -65.79 -34.18 77.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.475 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 45.9 mtpt -72.76 -25.52 61.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -78.89 -21.3 47.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.902 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 171' ' ' VAL . 2.4 tt -58.28 121.46 52.01 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.134 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' HD23 ' A' ' 36' ' ' LEU . 69.4 Cg_exo -52.89 -37.71 77.84 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.309 2.672 . . . . 0.0 114.058 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -18.57 58.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.11 -15.65 63.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.967 0.413 . . . . 0.0 111.2 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -76.41 -45.34 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.748 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -74.69 -35.8 62.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.1 p -73.39 95.99 2.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.293 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HE2' ' HG3' ' A' ' 69' ' ' GLU . 79.1 tttt -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 111' ' ' ASP . 40.5 mttm -99.23 101.55 12.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.458 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.95 114.98 48.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -96.66 134.49 39.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.509 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -120.17 136.03 54.76 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 117' ' ' VAL . 26.0 t80 -74.67 -10.67 59.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.019 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' TYR . 41.2 t 67.84 106.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.406 0 CA-C-O 121.3 0.572 . . . . 0.0 110.824 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 76.1 Cg_endo -78.08 151.14 26.89 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.616 2.211 . . . . 0.0 113.437 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -134.85 166.66 27.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.257 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 34.4 mtpt 64.59 8.63 4.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.327 0.392 . . . . 0.0 111.556 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.24 -106.58 2.41 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 70.4 mt-10 61.66 -83.44 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.616 0.767 . . . . 0.0 110.764 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 150' ' ' VAL . 51.2 t -132.8 96.18 2.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 104.71 15.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.691 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 91.6 mt -95.91 3.73 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.671 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.3 m -59.17 -39.5 73.75 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 58' ' ' THR . 50.2 Cg_exo -57.78 -9.71 6.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.175 1.916 . . . . 0.0 114.136 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.8 tp -84.92 -12.93 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.654 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m-30 -54.99 -53.85 56.74 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.644 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 84.4 Cg_exo -52.59 -31.39 49.3 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.73 2.286 . . . . 0.0 113.476 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.0 -43.78 51.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 68' ' ' LYS . 84.0 t -72.98 -42.43 59.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.606 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt -65.93 -5.78 10.38 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' PRO . 63.4 mttp -66.1 -57.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.588 0.233 . . . . 0.0 110.903 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.45 -17.83 1.3 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 64' ' ' VAL . 68.0 mttm -91.69 173.64 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.003 0.43 . . . . 0.0 110.888 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' HE2' ' A' ' 43' ' ' LYS . 42.7 mt-10 -100.93 118.7 37.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.453 175.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.54 111.01 21.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 59.5 mt -97.89 112.37 29.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 98.1 mt -114.78 145.07 33.17 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.199 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.39 132.24 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.009 2.473 . . . . 0.0 112.544 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 5.5 mtpp -105.76 125.89 51.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.985 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.85 89.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.19 17.59 19.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.991 175.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.4 -121.22 2.13 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.78 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -91.14 -10.09 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 0.0 111.185 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -105.18 109.34 21.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.306 0.574 . . . . 0.0 110.285 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.578 HD11 ' HD1' ' A' ' 136' ' ' TYR . 57.1 mt -87.38 110.86 21.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.897 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 19.3 m -82.98 106.8 15.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.879 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 139' ' ' LEU . 94.4 mt -74.65 100.54 3.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 1.2 m-85 -96.11 116.22 28.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.617 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 3.0 ptp180 -83.89 124.29 30.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 101' ' ' PRO . 58.0 t -135.82 133.16 51.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -118.43 -9.98 10.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.5 m -91.4 136.58 26.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.483 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.6 Cg_exo -77.86 165.6 26.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.932 2.422 . . . . 0.0 112.105 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.72 4.76 3.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.1 m -95.94 28.25 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.786 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -113.62 138.39 50.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.03 143.37 15.04 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -91.3 128.15 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.92 -163.12 26.87 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 96' ' ' PHE . . . 47.63 78.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 77.7 t80 72.71 -50.83 0.7 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.879 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.94 36.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.061 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.39 172.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.2 ptm -123.75 99.34 6.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.396 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 5.3 pt-20 -96.67 159.0 32.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.343 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.566 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.14 116.3 4.34 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.48 2.12 . . . . 0.0 111.429 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.23 -22.14 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 110.55 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.38 152.78 51.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.005 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.66 -153.17 25.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -141.44 135.64 30.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.024 0.412 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -77.23 127.16 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.14 160.97 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.322 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.03 145.93 78.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.543 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.01 -17.15 10.41 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.391 2.727 . . . . 0.0 113.456 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.37 -29.73 70.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.061 0.458 . . . . 0.0 110.686 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 21.3 t70 -83.49 -10.35 58.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.83 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.57 95.55 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.401 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.33 -32.41 33.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.093 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.585 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 42.7 t80 -137.51 138.82 40.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.434 HG12 HG13 ' A' ' 117' ' ' VAL . 16.0 tt -146.88 140.54 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.751 0.31 . . . . 0.0 110.401 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.13 112.34 18.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 48' ' ' TYR . 27.3 m -126.33 128.63 24.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.429 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.33 108.81 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.429 2.086 . . . . 0.0 111.485 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.58 157.04 18.28 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.452 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.81 109.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.18 134.52 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.135 0.897 . . . . 0.0 112.512 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.14 146.09 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.886 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -103.27 -172.38 2.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.422 . . . . 0.0 111.219 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 70.5 mt -79.45 -3.97 49.03 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -105.56 -38.11 6.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.853 0.358 . . . . 0.0 110.284 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.6 11.65 1.67 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.682 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.58 168.4 11.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.304 0.552 . . . . 0.0 110.233 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -153.63 135.18 14.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.571 -166.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.956 178.231 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 80' ' ' ILE . 31.9 m-85 . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -22.63 65.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -69.93 -13.77 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 110.583 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 82' ' ' LEU . 48.5 tp -89.81 -42.89 11.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 147' ' ' LYS . 94.2 mt -57.05 -38.68 73.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.667 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -64.72 -26.97 68.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.94 -18.25 29.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.051 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.07 114.72 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -90.45 -6.06 55.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.382 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.72 43.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.39 109.58 11.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.963 0.411 . . . . 0.0 110.261 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 140' ' ' LEU . 32.6 mtmm -82.71 103.12 11.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.829 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.9 t -99.05 122.37 50.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.677 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -94.7 133.32 11.52 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.681 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.488 HG13 HG11 ' A' ' 29' ' ' VAL . 43.5 t -107.64 120.07 58.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.95 154.73 40.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.042 0.449 . . . . 0.0 111.898 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.96 160.9 21.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.836 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 m -55.37 -27.58 48.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.599 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.0 -15.76 63.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.664 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -99.43 -6.22 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.414 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 45.0 t -91.64 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.8 -176.63 2.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.151 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.945 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 33.8 mt-10 -90.79 -66.98 0.88 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 158' ' ' GLU . 10.8 mpt_? -125.4 115.04 19.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.18 143.57 26.86 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.94 101.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.776 1.651 . . . . 0.0 110.165 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -109.74 177.14 4.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.196 -172.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.71 168.3 10.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.454 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.69 64.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -102.39 66.19 0.97 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.571 0.701 . . . . 0.0 109.339 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.66 162.82 12.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.645 HD12 ' HD2' ' A' ' 168' ' ' PRO . 3.9 tp -138.99 111.52 8.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.139 0.495 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.645 ' HD2' HD12 ' A' ' 167' ' ' ILE . 72.5 Cg_endo -77.27 173.56 14.15 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.667 2.245 . . . . 0.0 112.572 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.474 HG23 HD12 ' A' ' 181' ' ' LEU . 21.1 m -112.17 151.98 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.211 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.03 -30.16 34.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.179 0.514 . . . . 0.0 110.083 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 36' ' ' LEU . 49.0 t -142.22 135.03 27.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.648 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 179' ' ' ARG . 61.0 tp -114.33 118.34 33.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 178' ' ' VAL . 63.2 t -109.22 123.22 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.185 0.517 . . . . 0.0 110.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 75.1 p -108.46 -164.86 0.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.601 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.709 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 5.7 pt-20 -73.16 -22.33 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.654 0.264 . . . . 0.0 110.98 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 64.8 mttp -122.26 -61.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.758 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.98 141.03 30.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.216 0.531 . . . . 0.0 112.037 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.538 HG13 HG22 ' A' ' 173' ' ' VAL . 57.6 t -109.47 102.32 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.658 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.783 HH22 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mtp-105 -85.69 99.82 11.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.423 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -76.34 92.39 3.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.474 HD12 HG23 ' A' ' 169' ' ' VAL . 88.0 mt . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.782 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.681 0.277 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -95.42 -45.48 7.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 0.0 109.719 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -58.85 -55.08 39.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.065 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' HD2' ' A' ' 9' ' ' LYS . 37.9 tt0 -59.04 -52.54 65.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.49 -46.31 90.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 8.0 tmm_? -58.67 -45.68 88.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.038 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.01 -45.11 71.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.437 -175.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 13.4 ptmm? -70.36 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.645 HG11 ' HB2' ' A' ' 121' ' ' ALA . 84.0 t -70.14 -35.19 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.004 0.431 . . . . 0.0 110.467 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.74 -46.57 87.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.269 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' HA ' HG12 ' A' ' 15' ' ' ILE . 33.8 t-80 -66.76 -34.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.682 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 68.8 mmtt -51.88 -41.48 61.94 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.455 0.472 . . . . 0.0 111.144 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 54' ' ' GLU . 36.7 ttp180 -72.85 -38.36 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 12' ' ' HIS . 34.0 pt -90.71 -9.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -93.09 -6.51 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.536 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 13' ' ' LYS . 98.7 mt -67.4 161.02 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.602 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.7 m -62.74 127.27 30.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.335 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.9 -42.49 90.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.648 0.261 . . . . 0.0 111.356 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -67.99 -32.18 72.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.954 0.407 . . . . 0.0 110.089 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' CB ' ' HB2' ' A' ' 18' ' ' SER . 9.7 tp10 -63.13 -50.57 69.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.259 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 18' ' ' SER . 72.3 mtp180 -60.41 -37.45 80.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.94 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -56.74 -50.68 71.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.532 . . . . 0.0 110.527 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.95 -33.19 73.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.022 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 97.7 mt -69.58 -47.15 64.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.657 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.6 m -63.34 -31.71 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -56.76 -42.45 79.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.145 0.498 . . . . 0.0 110.255 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.56 -34.3 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 175' ' ' GLU . 66.0 t -62.19 -47.96 90.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.517 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 26' ' ' SER . 72.0 mt -57.48 -46.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.144 0.497 . . . . 0.0 110.097 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -61.76 -38.47 88.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.87 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.33 -43.66 81.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 0.0 110.324 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 36' ' ' LEU . 40.2 tp -61.26 -36.68 80.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.365 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.39 -13.77 59.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.004 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.7 m -82.61 -23.43 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 33' ' ' LEU . 74.3 mt -61.8 118.61 40.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.093 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.21 -23.0 53.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.417 2.078 . . . . 0.0 110.774 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.08 -31.26 70.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.312 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.22 -24.96 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -70.49 -49.62 46.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -72.34 -26.28 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.707 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 114' ' ' PHE . 31.1 m -71.26 98.04 1.66 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 30.9 mtmm -86.35 -25.16 25.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.23 -171.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -110.48 108.58 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.008 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 t -109.02 113.05 43.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.5 124.58 40.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.483 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.75 130.99 55.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.25 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' CYS . 48.4 t80 -72.62 -27.57 62.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.8 t 72.24 133.73 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.855 0.722 . . . . 0.0 111.226 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 14.4 Cg_exo -69.36 140.59 44.55 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.677 2.251 . . . . 0.0 111.824 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 pt -124.15 -27.58 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 18.6 tptt -124.38 -35.73 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.628 . . . . 0.0 110.41 -175.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.537 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 138.53 88.13 0.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -121.07 -87.15 0.65 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.552 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -135.09 131.58 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.3 96.57 4.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.294 0.569 . . . . 0.0 110.688 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.57 13.67 20.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.505 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -66.34 -44.8 58.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.536 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 58' ' ' THR . 42.5 Cg_endo -68.81 -0.96 6.84 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.769 1.646 . . . . 0.0 112.773 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 63' ' ' GLU . 60.0 tp -92.07 -17.26 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 30.9 m-85 -50.93 -51.27 68.76 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.8 Cg_endo -56.64 -41.6 74.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.192 1.928 . . . . 0.0 112.471 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' A' ' 60' ' ' LEU . 6.1 mt-10 -66.5 -36.34 82.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.52 -41.79 91.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.434 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 86' ' ' HIS . 65.1 mt -66.3 -14.19 61.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -82.15 -61.9 1.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.99 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -93.04 -29.66 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 27.1 mmtp -124.45 -174.47 3.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.536 0.684 . . . . 0.0 112.234 -166.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.06 128.24 48.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.975 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 112.63 24.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 44' ' ' LYS . 61.5 mt -98.41 117.64 43.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.923 0.392 . . . . 0.0 110.101 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.8 mt -118.96 133.97 23.64 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -84.25 123.17 2.99 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.722 2.281 . . . . 0.0 112.621 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 57.0 tttm -105.42 101.48 11.01 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -82.15 92.72 2.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.313 0.578 . . . . 0.0 109.846 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -101.21 107.15 18.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.236 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.28 -90.97 0.92 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.59 11.61 1.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 109.828 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.22 120.51 40.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.27 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.649 HD11 ' HD1' ' A' ' 136' ' ' TYR . 56.7 mt -85.07 99.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.331 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -95.97 112.11 23.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.68 131.14 35.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.07 144.93 48.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.421 0.629 . . . . 0.0 111.697 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.7 ttt85 -90.65 96.81 10.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.693 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.0 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.466 ' HA ' HD22 ' A' ' 65' ' ' LEU . 1.7 t60 -136.39 16.28 3.18 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -121.31 120.0 29.23 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.023 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.96 -8.62 22.55 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.622 2.215 . . . . 0.0 112.307 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.32 12.46 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.4 t -95.69 -144.93 0.27 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.6 mt 64.57 113.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.799 0.687 . . . . 0.0 112.616 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.95 127.08 4.28 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.18 110.2 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.934 0.367 . . . . 0.0 110.279 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.91 -98.94 0.65 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.014 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . -60.03 127.23 30.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.322 0.249 . . . . 0.0 111.638 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.7 t80 70.47 -38.55 0.42 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.021 0.826 . . . . 0.0 112.061 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 95' ' ' ALA . . . 130.07 10.02 2.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.926 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 pt -91.34 172.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.725 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtm -93.42 100.71 12.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.662 ' HB3' ' HE2' ' A' ' 74' ' ' LYS . 43.2 mt-10 -84.86 132.34 46.38 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.438 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 24.5 Cg_exo -64.15 114.26 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.388 2.059 . . . . 0.0 111.426 174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.79 -17.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.317 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -148.1 150.27 33.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.3 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.06 -158.45 27.74 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.811 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -112.44 161.65 16.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -89.26 126.14 35.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.36 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.58 130.66 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 110.738 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.69 152.23 38.99 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.58 -23.71 41.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.66 -22.07 66.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 44' ' ' LYS . 4.7 t70 -94.7 -3.41 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.229 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.92 112.63 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.239 0.543 . . . . 0.0 111.527 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -60.18 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.187 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 21.3 t80 -134.84 139.61 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.9 139.2 41.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.5 111.65 21.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.497 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 46.1 t -117.89 108.62 42.35 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.18 62.74 8.12 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.206 2.604 . . . . 0.0 111.299 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.06 169.13 22.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.436 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.29 107.35 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . 71.99 133.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.275 0.984 . . . . 0.0 112.335 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.36 165.24 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.244 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.545 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -135.12 -178.72 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.436 HD12 ' HG2' ' A' ' 158' ' ' GLU . 90.6 mt -74.46 -12.72 60.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.51 ' HB2' ' NH1' ' A' ' 159' ' ' ARG . 7.0 tp10 -81.97 -42.16 19.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.08 24.9 2.88 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.192 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -101.31 -176.41 3.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.126 0.489 . . . . 0.0 111.381 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -122.2 -171.84 2.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.556 -173.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 40.6 tp . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.484 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.649 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.1 m-85 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.683 0.754 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.77 -34.73 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.068 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -55.91 -34.42 65.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.116 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 143' ' ' VAL . 56.9 tp -84.75 -54.14 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' A' ' 167' ' ' ILE . 96.9 mt -57.37 -38.55 74.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.8 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.653 ' HD3' HG13 ' A' ' 167' ' ' ILE . 25.9 tptp -74.24 -15.88 60.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 -176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 142' ' ' ARG . 19.7 mtp180 -109.36 -4.5 16.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.417 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.2 t -69.15 104.63 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.078 0.466 . . . . 0.0 109.889 174.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -92.55 12.88 21.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.603 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.29 -174.28 46.25 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 103.1 8.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.428 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 9.8 mtmp? -87.12 102.86 14.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.766 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.7 t -104.97 119.25 53.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -90.87 136.5 13.4 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 174.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.552 HG12 HG21 ' A' ' 55' ' ' VAL . 13.7 t -122.67 124.45 70.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.24 164.13 35.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.529 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.402 ' HE2' HH21 ' A' ' 22' ' ' ARG . 94.3 m-85 -75.61 169.4 18.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.016 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.6 t -69.12 -26.08 64.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.335 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -74.88 -5.68 44.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.055 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -106.47 4.67 28.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.666 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.19 114.9 44.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.615 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -103.0 179.62 4.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.142 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.436 ' HG2' HD12 ' A' ' 124' ' ' LEU . 4.8 tm-20 -89.12 -50.9 5.88 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 125' ' ' GLU . 4.9 tpp180 -149.06 123.62 9.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.335 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.5 mt -101.26 159.09 30.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.162 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.75 103.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.419 2.079 . . . . 0.0 111.223 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 162' ' ' ARG . 39.0 mtm180 -92.6 159.49 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -123.61 179.88 4.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.75 -49.19 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.594 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -93.14 9.27 36.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.341 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.62 159.43 33.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.455 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.665 HG21 ' HB3' ' A' ' 140' ' ' LEU . 3.9 mp -105.12 111.86 65.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.338 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.87 148.79 7.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.79 2.327 . . . . 0.0 112.871 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.64 174.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.172 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 25.1 m-20 -108.62 -49.44 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.93 145.59 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.593 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.1 tp -124.34 103.37 8.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.824 0.345 . . . . 0.0 110.616 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 178' ' ' VAL . 49.1 t -87.05 120.1 35.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 p -105.97 -177.4 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 10.0 pt-20 -71.03 -7.23 44.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.634 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 30.0 mmtp -119.95 -62.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.142 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.86 161.98 30.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.359 . . . . 0.0 111.14 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 173' ' ' VAL . 70.7 t -87.39 101.46 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -88.39 91.91 8.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.671 -175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -74.41 108.71 7.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -174.184 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.732 0.301 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -60.23 -45.75 92.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.453 0.644 . . . . 0.0 110.026 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -71.75 -40.27 69.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.641 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.95 -45.79 76.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.901 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 tp -53.65 -40.82 66.19 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.33 0.394 . . . . 0.0 111.391 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -61.01 -54.74 41.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.264 0.554 . . . . 0.0 110.807 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -25.51 64.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.766 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.48 -55.05 11.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.185 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 155' ' ' GLN . 61.1 t -70.99 -33.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.013 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.593 HD11 ' HG2' ' A' ' 52' ' ' LYS . 54.9 tp -62.19 -29.98 70.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.411 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 10.8 t60 -67.72 -36.7 81.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.992 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -68.32 -32.27 72.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 17.6 mmt180 -52.78 -57.82 8.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.342 0.591 . . . . 0.0 110.602 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.3 9.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.445 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -88.1 -25.63 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.121 -0.362 . . . . 0.0 110.334 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.2 142.73 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.067 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 18.5 t -64.96 148.26 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.45 -42.36 70.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.88 -51.07 64.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.891 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 18' ' ' SER . 1.7 mp0 -60.21 -44.55 95.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.455 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 5.3 tmm_? -57.77 -47.23 83.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.731 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -62.07 -46.22 90.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.097 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -60.11 -47.96 83.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.667 0.27 . . . . 0.0 111.035 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.8 mt -66.69 -37.54 84.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 30' ' ' ILE . 31.1 t -58.96 -49.53 77.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.918 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -59.79 -34.94 73.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -42.02 91.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.579 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 25' ' ' LEU . 45.5 t -62.19 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.073 0.463 . . . . 0.0 109.994 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 26' ' ' SER . 69.8 mt -58.39 -40.12 77.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.505 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.0 m -61.15 -40.28 93.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -67.24 -42.41 84.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 36' ' ' LEU . 39.9 tp -62.32 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.205 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 39' ' ' PHE . 2.5 mmpt? -66.94 -30.97 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.26 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.1 m -71.58 -24.59 61.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 178' ' ' VAL . 46.4 mt -61.18 116.79 21.04 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.348 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.1 -35.89 84.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.036 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.69 -37.32 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.798 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 69.7 t80 -74.08 -17.15 60.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.207 0.527 . . . . 0.0 110.776 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.88 -41.91 10.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -81.54 -33.23 31.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.761 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 t -84.9 122.04 28.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 92.7 mttt -93.28 -3.93 52.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.714 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 8.7 mmpt? -89.31 86.13 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.61 118.15 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 111.475 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -111.62 138.96 47.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.161 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 57' ' ' LEU . 7.4 mp -120.2 144.17 47.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.787 ' HB2' HG12 ' A' ' 117' ' ' VAL . 37.8 t80 -77.33 -6.63 53.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.152 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.1 t 70.8 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.825 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 2.7 Cg_exo -75.1 98.18 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.864 2.376 . . . . 0.0 112.436 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.837 HG13 ' HD3' ' A' ' 52' ' ' LYS . 40.7 pt -89.4 -5.45 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.227 0.537 . . . . 0.0 110.144 173.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' HG13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -107.19 144.85 33.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.78 72.63 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.708 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HG3' ' H ' ' A' ' 55' ' ' VAL . 5.2 pt-20 -129.52 -79.62 0.56 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.595 0.358 . . . . 0.0 110.203 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.711 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 38.3 t -100.17 123.74 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 22' ' ' ARG . 20.6 m-20 -79.14 71.88 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.898 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 88.2 mt -85.51 -10.46 56.0 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.232 0.539 . . . . 0.0 109.581 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m -62.49 -53.3 58.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.177 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 21.9 Cg_exo -67.31 -6.55 16.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.175 1.917 . . . . 0.0 112.217 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -89.32 -15.25 33.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.389 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.0 m-85 -55.74 -52.38 72.65 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.319 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 61.1 Cg_exo -54.93 -34.37 85.95 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.396 2.064 . . . . 0.0 112.898 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 1.3 tm-20 -65.38 -50.62 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 109.925 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 84.9 t -64.87 -41.51 92.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.586 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' A' ' 88' ' ' PRO . 50.8 tp -67.48 -16.77 64.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.509 . . . . 0.0 111.198 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 13.7 tppt? -71.16 -52.22 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.467 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.4 pt-20 -121.81 -30.01 4.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.074 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.634 ' HE2' ' HA ' ' A' ' 64' ' ' VAL . 30.2 mtmm -103.4 -173.03 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.239 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' A' ' 84' ' ' ARG . 49.2 mt-10 -106.63 119.34 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -89.81 106.06 18.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.047 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 59.3 mt -93.69 123.83 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.2 mt -120.12 141.68 32.08 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.094 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 5.6 Cg_exo -76.81 110.86 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.962 2.441 . . . . 0.0 111.724 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.82 114.82 29.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.26 101.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.418 . . . . 0.0 109.874 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -90.74 85.25 6.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.556 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.74 0.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.16 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -112.13 -9.08 13.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -115.33 109.42 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.669 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.74 135.82 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 m -140.33 149.45 42.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.353 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 3.3 mm? -84.64 114.25 21.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.415 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 10.8 m-85 -95.8 124.67 39.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 17.5 ttm180 -84.31 102.72 12.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 110.21 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 90' ' ' CYS . 55.2 t -89.65 111.81 23.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.253 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -114.85 -4.87 12.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.635 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -117.69 126.65 27.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.609 -178.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.604 ' HA ' HD21 ' A' ' 65' ' ' LEU . 36.3 Cg_exo -60.95 -22.2 73.69 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.812 2.342 . . . . 0.0 113.293 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.15 -5.03 58.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.863 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 87' ' ' SER . 61.3 m -84.44 1.76 43.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 111.495 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.9 129.64 48.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.279 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.5 161.17 29.09 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 t -88.15 86.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.307 0.575 . . . . 0.0 110.374 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.5 -155.91 10.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.58 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.53 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . 55.79 -129.56 1.98 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.564 0.346 . . . . 0.0 110.616 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -97.07 24.05 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.032 0.444 . . . . 0.0 110.783 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.45 51.11 1.0 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.379 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 95' ' ' ALA . 40.1 pt -131.41 163.78 36.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.621 0.248 . . . . 0.0 110.369 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 tpp -81.03 90.97 6.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.79 158.0 36.08 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.991 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 43.9 Cg_endo -72.64 107.92 2.42 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.138 1.892 . . . . 0.0 111.166 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -77.22 -22.97 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.3 0.572 . . . . 0.0 110.224 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.05 -175.52 4.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.527 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.35 -138.38 11.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.418 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -141.69 128.17 20.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 15.4 ptm180 -78.16 101.94 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.538 0.685 . . . . 0.0 110.453 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.42 153.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.741 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 28.5 p-10 -70.93 146.33 92.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.18 -8.45 12.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.238 2.625 . . . . 0.0 112.714 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 42.0 tt0 -69.29 -23.84 63.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.481 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.64 -19.45 57.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.585 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.31 110.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 25.7 t70 -91.06 -36.36 14.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.122 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 31.2 t80 -133.53 127.74 33.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.619 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 147' ' ' LYS . 12.9 tt -135.46 139.74 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.78 118.92 30.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 48' ' ' TYR . 19.9 m -118.25 127.35 26.64 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.131 0.491 . . . . 0.0 111.332 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 6.1 Cg_exo -79.91 84.1 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.983 2.456 . . . . 0.0 111.178 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.33 162.25 19.86 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.886 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 50.8 t -99.08 128.06 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . 67.75 114.72 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.2 0.938 . . . . 0.0 112.684 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -137.6 166.81 23.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.587 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.822 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 16.2 p30 -137.83 -165.14 1.73 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.748 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.93 -5.66 59.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -104.51 -31.48 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.231 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 121.64 17.75 3.8 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.954 172.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 162' ' ' ARG . 22.7 m-30 -69.72 144.43 52.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 117.371 0.585 . . . . 0.0 110.142 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 2.0 tmm_? -122.62 106.04 10.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 110.731 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 28.7 tp . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.145 0.498 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -67.03 -28.19 68.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 109.654 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 138' ' ' ARG . 59.7 mtt85 -76.62 -27.18 55.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.272 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 tp -66.34 -35.56 80.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.74 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.93 -30.71 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' A' ' 167' ' ' ILE . 23.9 ttmm -72.44 -27.24 62.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -78.37 -23.05 47.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.497 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.25 96.2 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.172 0.51 . . . . 0.0 109.81 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -90.09 16.49 8.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.055 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.9 -162.86 34.87 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.33 99.39 9.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.761 0.315 . . . . 0.0 110.169 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 36.9 mtmm -78.87 102.93 8.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.786 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 171' ' ' VAL . 62.1 t -98.41 124.39 51.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.402 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.11 121.43 6.69 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.424 HG12 HG21 ' A' ' 55' ' ' VAL . 43.3 t -102.41 111.95 33.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.831 0.348 . . . . 0.0 110.088 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -145.65 151.76 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.193 0.521 . . . . 0.0 112.094 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.34 151.92 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.124 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -60.38 -23.74 64.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.759 0.314 . . . . 0.0 111.425 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -66.48 -25.06 66.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.67 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 1.8 mp0 -98.37 2.42 47.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.831 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.96 124.82 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.08 -169.4 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.434 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.19 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.822 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 11.2 ttp180 -155.78 141.5 17.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.17 158.94 69.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.768 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.57 107.79 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 111.157 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HD2' ' OH ' ' A' ' 127' ' ' TYR . 25.5 ttt180 -73.67 121.96 21.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.52 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.64 -67.76 0.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.981 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.02 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.499 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -117.61 72.52 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.336 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 33.3 t70 -88.92 145.96 25.21 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.177 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 141' ' ' LYS . 65.2 mt -89.93 107.87 22.03 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.6 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.9 Cg_exo -73.36 157.04 50.13 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.143 2.562 . . . . 0.0 112.317 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 30.6 m -86.61 176.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.593 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 -44.76 7.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.003 0.43 . . . . 0.0 110.95 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.7 t -132.4 134.94 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.484 HD23 HH11 ' A' ' 179' ' ' ARG . 60.5 tp -115.14 112.52 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.885 0.374 . . . . 0.0 110.199 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.4 t -99.21 118.01 45.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 0.0 110.349 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.22 169.76 8.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -84.45 65.7 9.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -175.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 175' ' ' GLU . 10.3 mmtp 179.02 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.262 0.976 . . . . 0.0 110.89 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -144.17 156.92 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 0.0 111.271 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 36' ' ' LEU . 48.0 t -102.54 106.55 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.257 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.484 HH11 HD23 ' A' ' 172' ' ' LEU . 40.8 ttm105 -93.58 95.43 9.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.747 -173.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -78.45 123.89 27.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 169' ' ' VAL . 73.7 mt . . . . . 0 C--N 1.319 -0.754 0 CA-C-O 121.037 0.446 . . . . 0.0 111.109 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.21 0.528 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 161' ' ' PRO . 29.2 pttt -68.87 -28.28 66.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.921 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.2 t -78.82 -36.08 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.945 0.402 . . . . 0.0 110.01 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 17.7 tp10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.07 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.67 -48.95 78.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.383 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -56.04 -44.7 79.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.729 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -60.8 -46.91 88.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.923 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HE2' ' HG3' ' A' ' 5' ' ' GLU . 61.7 mttm -58.97 -43.97 91.47 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.189 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG11 ' HG3' ' A' ' 155' ' ' GLN . 43.8 t -67.76 -46.5 82.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.476 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.37 -40.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.121 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.62 -48.11 82.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -78.87 -30.36 45.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.553 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 54' ' ' GLU . 30.5 ttp180 -57.18 -46.91 82.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 52' ' ' LYS . 33.2 pt -90.82 3.27 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.699 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -101.92 2.1 37.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD11 ' CZ ' ' A' ' 154' ' ' PHE . 89.1 mt -67.43 138.12 56.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 p -70.95 155.9 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.59 -58.72 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.562 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.08 -48.93 79.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.582 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.21 -44.24 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -61.62 -46.39 90.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.445 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -69.16 -34.69 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -66.21 -31.03 71.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 0.0 110.923 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.55 -41.77 21.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.253 0.549 . . . . 0.0 110.007 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -61.5 -36.3 80.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.006 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.62 -42.24 82.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.591 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.49 -34.92 75.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 55' ' ' VAL . 42.0 t -66.36 -42.95 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.925 0.393 . . . . 0.0 110.361 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.64 -44.22 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.271 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.8 m -64.52 -32.71 74.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.711 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -63.96 -54.37 35.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.88 -33.33 74.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.703 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -67.83 -30.58 70.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -87.61 -14.25 40.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tt -64.11 113.69 11.17 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 35.5 Cg_exo -59.4 -48.34 13.85 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.869 2.38 . . . . 0.0 112.861 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.79 -20.1 65.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.501 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 77.8 t80 -74.1 -46.7 41.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 57.3 tttm -73.47 -29.75 62.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.719 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 34.1 mmtp -68.76 -37.3 79.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -82.7 148.29 27.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 110.753 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 35.7 mtmt -101.35 -37.04 8.65 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.069 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -89.28 96.52 10.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.14 122.88 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.927 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.02 124.02 44.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.968 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.88 122.27 45.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.741 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.707 ' HD2' ' HD2' ' A' ' 118' ' ' PRO . 6.4 t80 -83.42 98.85 9.72 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 58.6 m -51.9 114.85 5.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.895 0.747 . . . . 0.0 112.673 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 42.2 Cg_endo -68.88 131.67 23.01 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.816 2.344 . . . . 0.0 111.108 174.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.423 HG22 HG21 ' A' ' 98' ' ' ILE . 2.4 pp -120.01 -8.93 10.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 41.0 mttp -145.72 70.37 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.379 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -114.76 3.88 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HG2' ' NH1' ' A' ' 14' ' ' ARG . 29.7 mt-10 61.32 25.48 15.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 169.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 29' ' ' VAL . 98.0 t 69.69 106.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.431 0.634 . . . . 0.0 110.485 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.28 96.52 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.677 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.7 mt -88.12 9.63 22.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.674 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.454 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -62.62 -47.39 88.29 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.3 Cg_endo -70.95 1.13 5.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.694 1.596 . . . . 0.0 112.905 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 tp -88.77 -16.91 30.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.794 0.33 . . . . 0.0 110.599 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.2 m-85 -56.7 -48.02 97.98 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 93.9 Cg_exo -48.1 -31.84 17.32 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 122.53 2.153 . . . . 0.0 113.546 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.59 -48.28 12.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 68' ' ' LYS . 98.9 t -61.89 -39.33 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.512 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 96.2 mt -64.18 -14.77 57.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -88.73 -48.46 7.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.043 0.449 . . . . 0.0 111.34 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 28.3 mt-10 -93.69 -38.0 11.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.45 . . . . 0.0 112.057 -171.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 33.9 mttp -119.66 167.31 12.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -161.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -93.24 121.44 34.6 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.646 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' HG ' ' A' ' 72' ' ' LEU . 58.6 tp -84.02 112.69 20.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.243 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.22 115.87 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.897 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -121.26 136.01 25.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.666 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.5 132.78 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 0.0 111.86 176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 53.2 tttm -105.95 128.81 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.0 104.02 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.48 12.18 30.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.0 -105.02 1.26 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.7 -15.26 22.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.279 0.561 . . . . 0.0 109.805 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -89.52 143.45 26.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.123 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.691 HD11 ' HD1' ' A' ' 136' ' ' TYR . 62.0 mt -113.64 111.64 36.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.212 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 20.1 m -94.95 108.53 20.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.135 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.2 104.13 6.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.98 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.21 140.2 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.853 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.37 151.35 37.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.0 176.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.886 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -139.27 11.05 2.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.365 0.602 . . . . 0.0 109.872 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 p -162.7 150.51 11.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.711 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.8 Cg_exo -76.07 49.76 2.64 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.012 2.475 . . . . 0.0 111.496 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.82 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 38.4 t -124.6 94.41 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.269 0.557 . . . . 0.0 110.834 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 101' ' ' PRO . 95.3 mt -123.07 120.82 34.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.64 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.06 -171.33 27.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.6 t -136.82 116.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.67 -59.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.995 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -107.92 139.1 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.799 -0.236 . . . . 0.0 111.326 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 65.2 10.88 6.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 0.0 111.935 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.66 16.26 67.55 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.782 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 95' ' ' ALA . 39.1 pt -105.58 172.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.833 0.349 . . . . 0.0 110.953 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -73.4 131.26 41.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.281 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -117.04 121.42 32.56 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.237 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 74' ' ' LYS . 24.8 Cg_endo -62.54 118.15 5.04 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.607 2.205 . . . . 0.0 112.398 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 58.5 t -93.18 -55.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.792 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -105.05 154.59 19.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.746 0.308 . . . . 0.0 110.601 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.54 162.77 10.63 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.37 135.8 35.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 106' ' ' ARG . 17.8 ptt85 -87.48 145.28 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.74 153.09 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -82.71 161.88 57.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.53 -14.83 5.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.284 2.656 . . . . 0.0 113.476 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.3 -37.14 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.313 0.578 . . . . 0.0 110.763 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.76 -23.68 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.9 107.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.974 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.87 -49.7 5.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 20.7 t80 -118.75 129.82 55.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.5 tt -139.19 139.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.993 0.425 . . . . 0.0 110.574 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.27 116.05 23.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.066 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 48' ' ' TYR . 33.7 m -124.86 127.35 25.15 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 0.0 111.274 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.707 ' HD2' ' HD2' ' A' ' 48' ' ' TYR . 2.2 Cg_endo -83.35 -164.46 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.001 2.468 . . . . 0.0 111.166 171.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.51 175.55 32.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.782 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -99.98 121.33 50.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 72.58 126.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.32 1.012 . . . . 0.0 112.654 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.502 ' HA ' HD11 ' A' ' 160' ' ' LEU . 63.0 m-85 -138.09 168.41 19.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 45.3 p30 -126.3 -164.55 1.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.268 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.75 -13.8 37.15 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.614 ' O ' HD11 ' A' ' 181' ' ' LEU . 44.7 mt-10 -110.51 -62.49 1.52 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.97 62.32 0.13 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.924 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -82.91 134.03 35.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.2 82.82 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.7 tp . . . . . 0 C--O 1.232 0.16 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.616 175.366 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.691 ' HD1' HD11 ' A' ' 80' ' ' ILE . 95.3 m-85 . . . . . 0 C--O 1.238 0.45 0 CA-C-O 121.786 0.803 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.32 -16.95 63.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.55 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -54.74 -34.52 62.62 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 143' ' ' VAL . 51.6 tp -87.22 -51.22 6.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.142 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.64 -26.93 62.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.11 -28.55 63.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.74 -2.57 15.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.784 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 139' ' ' LEU . 98.4 t -70.19 102.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -97.19 10.98 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.92 -176.42 43.56 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.683 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.0 100.71 1.26 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.986 0.393 . . . . 0.0 110.283 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.43 100.06 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.091 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.582 HG21 ' CZ ' ' A' ' 114' ' ' PHE . 92.3 t -96.29 114.93 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.025 0.441 . . . . 0.0 110.014 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.35 124.26 7.72 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.723 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.27 116.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.23 161.51 40.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.672 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -96.61 156.31 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -62.43 -31.44 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 26.8 p90 -78.18 -6.2 54.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.421 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.525 ' HG3' HG11 ' A' ' 10' ' ' VAL . 28.5 tt0 -100.95 -6.23 24.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 0.0 109.816 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.5 115.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.64 -166.39 1.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 33.6 tt0 -69.69 -67.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.92 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 123' ' ' ASP . 5.1 tpm_? -145.43 132.62 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.462 -173.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 122' ' ' PHE . 80.9 mt -96.52 138.87 21.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.616 0.246 . . . . 0.0 110.75 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 3' ' ' LYS . 3.1 Cg_exo -76.36 101.87 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.789 2.326 . . . . 0.0 111.25 174.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.72 148.66 29.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.102 -177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.1 m-20 -114.81 -135.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.328 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -61.69 -23.79 66.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.42 0.628 . . . . 0.0 110.312 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -87.58 67.68 9.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.278 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.38 -74.18 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.367 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 41.2 mt 41.04 81.38 0.25 Allowed Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 124.285 0.991 . . . . 0.0 113.246 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.04 165.49 5.75 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.44 2.093 . . . . 0.0 111.798 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.58 177.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.75 -43.26 3.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.473 0.654 . . . . 0.0 109.369 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.41 122.33 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 42.5 tp -101.95 109.93 21.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.12 123.68 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.85 3.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.403 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -26.29 28.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.134 0.492 . . . . 0.0 110.479 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.2 -34.2 15.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.34 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.5 171.66 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.946 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 t -113.58 111.49 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 42.0 ttm180 -89.56 96.3 10.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.284 0.564 . . . . 0.0 111.132 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.87 115.26 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.391 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.614 HD11 ' O ' ' A' ' 125' ' ' GLU . 75.6 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 111.042 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -48.77 70.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 m -63.88 -35.59 81.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.946 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.99 -53.95 52.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.654 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.54 -48.37 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.512 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.04 -49.45 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -65.08 -43.07 93.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.612 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.51 -46.77 68.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.863 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.17 -37.15 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.0 tp -57.24 -37.49 72.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.285 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 15.0 t-80 -67.13 -25.93 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.963 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 45.9 mmtt -95.67 -16.22 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 110.968 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.459 HH11 ' HG2' ' A' ' 155' ' ' GLN . 25.0 ttt85 -75.66 -42.98 49.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.3 pt -90.78 6.84 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.256 0.551 . . . . 0.0 110.68 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -77.25 -26.09 52.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.896 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.09 135.35 57.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.639 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -65.3 142.53 58.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.122 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -52.69 -43.15 65.4 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.3 -59.44 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.152 0.501 . . . . 0.0 110.957 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.4 -44.85 81.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.143 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -62.21 -41.83 98.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.967 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -71.07 -35.38 71.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.661 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -65.66 -35.53 81.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.025 0.44 . . . . 0.0 110.469 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.83 -37.49 70.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.444 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 30' ' ' ILE . 38.0 m -65.67 -30.75 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.53 -42.88 79.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.217 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -60.99 -46.52 90.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.127 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 175' ' ' GLU . 37.0 t -61.49 -42.07 92.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.128 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' SER . 80.6 mt -61.18 -50.27 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 110.634 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -60.69 -41.78 95.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.6 -51.25 66.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.79 -36.37 83.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.032 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -76.31 -17.45 59.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.833 0.349 . . . . 0.0 110.706 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -88.52 -18.95 27.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.543 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.459 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.1 tt -55.38 117.3 14.31 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD2' HD23 ' A' ' 36' ' ' LEU . 44.6 Cg_exo -56.48 -42.66 63.23 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.169 2.579 . . . . 0.0 113.273 -176.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.4 -27.81 67.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.84 -34.96 74.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.267 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -64.81 -42.09 95.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.29 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -73.55 -24.0 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.466 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -66.59 124.84 23.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.375 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 61.8 mttm -103.85 -37.1 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.501 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 26.5 mmtp -96.43 108.76 21.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.12 110.51 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.968 0.414 . . . . 0.0 111.152 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -91.64 114.05 26.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 70' ' ' LEU . 89.3 mt -107.35 121.71 45.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.291 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -79.03 105.88 10.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.525 ' HB3' HG22 ' A' ' 98' ' ' ILE . 43.3 t -58.42 115.28 10.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.503 0.502 . . . . 0.0 110.996 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 Cg_exo -73.14 108.23 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.977 2.452 . . . . 0.0 111.899 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.667 HG13 ' HG2' ' A' ' 52' ' ' LYS . 44.7 pt -78.37 -22.55 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.268 -175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.667 ' HG2' HG13 ' A' ' 51' ' ' ILE . 71.7 mmtt -117.31 25.24 10.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 110.884 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.07 -71.42 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 6.1 mm-40 39.74 53.05 2.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.146 0.978 . . . . 0.0 113.029 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t 68.03 100.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.34 0.591 . . . . 0.0 109.778 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.71 111.97 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.203 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.07 14.91 15.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.643 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.525 ' OG1' ' HD3' ' A' ' 59' ' ' PRO . 42.6 p -63.02 -41.37 70.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.525 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 23.4 Cg_exo -66.27 -10.94 29.29 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.879 1.719 . . . . 0.0 112.594 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.97 -21.84 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.291 . . . . 0.0 110.669 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.5 m-85 -57.94 -52.7 72.54 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.015 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.0 Cg_exo -54.52 -34.1 80.85 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.363 2.042 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -66.47 -53.0 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.4 -36.12 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.204 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 70.9 mt -61.11 -26.24 67.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' LYS . 70.9 mmtt -114.17 -7.87 13.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.93 -31.14 9.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.225 0.536 . . . . 0.0 110.702 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 47.7 mttm -142.1 -171.86 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.085 -169.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -105.69 126.48 52.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 54.6 tp -82.58 144.69 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 44' ' ' LYS . 69.6 mt -126.86 114.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 62.8 mt -109.65 138.89 20.75 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.61 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.0 126.54 5.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.846 2.364 . . . . 0.0 112.936 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 9.3 tmtm? -105.5 97.71 7.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 77' ' ' GLY . 11.5 t -92.86 117.81 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.658 -170.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -87.96 5.18 41.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 75' ' ' VAL . . . 106.52 -51.87 0.71 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -104.11 -48.49 3.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.5 -0.35 . . . . 0.0 110.456 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -91.49 149.44 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.051 0.453 . . . . 0.0 111.118 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' HD1' ' A' ' 136' ' ' TYR . 65.1 mt -124.26 101.38 8.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.524 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 15.2 m -85.6 112.67 21.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 90.5 mt -84.47 136.15 33.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 106' ' ' ARG . 88.8 m-85 -128.55 144.1 51.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 0.0 111.248 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 45.2 mtp180 -79.26 106.99 11.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.649 175.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 51.0 t -89.56 111.43 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -107.02 -28.47 10.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.504 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -141.1 158.21 65.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.292 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.86 -155.48 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 74.45 -46.06 0.6 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.561 0.745 . . . . 0.0 112.199 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 5.7 t -81.68 34.96 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.222 0.535 . . . . 0.0 110.903 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -117.25 131.18 56.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.417 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.12 -169.9 12.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.987 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -136.0 123.36 34.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.497 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -132.52 -85.13 0.28 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.502 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.4 155.48 18.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.558 0.218 . . . . 0.0 111.397 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 72.49 -46.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.926 0.891 . . . . 0.0 111.975 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 20.79 5.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.92 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 49' ' ' CYS . 2.1 pp -101.62 172.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.618 0.247 . . . . 0.0 111.205 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.09 105.03 6.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.862 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 2.3 mt-10 -83.6 115.46 59.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.976 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 2.8 Cg_exo -74.39 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 110.56 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.468 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 27.9 t -73.34 -58.74 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.415 -173.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.95 178.62 6.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 111.067 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.66 -139.06 10.12 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.6 138.05 51.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HG2' ' CE1' ' A' ' 83' ' ' TYR . 83.4 mtt180 -83.35 140.75 32.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.948 0.404 . . . . 0.0 110.394 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.555 ' CG2' ' HG3' ' A' ' 84' ' ' ARG . 21.9 t -117.99 137.3 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.577 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -104.69 150.58 38.76 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.33 -35.63 16.12 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.008 3.139 . . . . 0.0 114.998 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.733 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 43.3 tt0 -65.05 -26.98 68.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 14.0 t70 -80.83 -13.69 58.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 0.0 111.148 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.83 131.37 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.618 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 13.0 m-20 -83.94 -52.42 6.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.629 0.728 . . . . 0.0 110.017 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 148' ' ' VAL . 46.2 t80 -129.85 131.03 45.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.528 -170.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.2 tt -125.79 137.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.968 0.413 . . . . 0.0 109.943 173.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' HE1' ' A' ' 114' ' ' PHE . . . -121.23 115.72 23.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.631 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.22 118.95 33.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 37.6 Cg_endo -68.82 110.12 2.28 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.336 2.024 . . . . 0.0 111.258 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 122' ' ' PHE . . . -100.0 131.68 10.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.43 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.73 -30.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 122.476 0.31 . . . . 0.0 111.205 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.91 142.13 19.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.635 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 28.7 m-85 -137.77 168.65 19.26 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.505 0.503 . . . . 0.0 110.254 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.557 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 34.0 p-10 -137.96 -167.82 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.76 -0.29 57.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.274 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 159' ' ' ARG . 34.9 mm-40 -97.32 -36.81 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.411 ' CA ' ' HG ' ' A' ' 181' ' ' LEU . . . 113.98 39.99 1.02 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.734 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -108.29 169.27 8.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.485 . . . . 0.0 111.433 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 157.65 32.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.433 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.672 -179.704 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.725 ' HD1' HD11 ' A' ' 80' ' ' ILE . 18.2 m-85 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -70.86 -33.84 71.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.149 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.36 -34.48 77.38 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 143' ' ' VAL . 52.6 tp -70.5 -59.24 2.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.416 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.67 -38.55 78.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.187 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -78.71 -11.16 59.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 111.098 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -107.55 -5.82 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.661 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.9 t -57.62 118.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.733 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 52.8 tttm -87.69 -2.61 58.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 110.509 -175.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -96.2 -161.91 32.96 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.11 131.49 38.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.94 0.37 . . . . 0.0 110.75 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -93.03 110.6 22.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.3 t -109.84 128.16 66.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 0.0 110.973 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' HA3' ' CZ ' ' A' ' 122' ' ' PHE . . . -98.92 132.95 11.11 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.635 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.63 122.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.661 0.267 . . . . 0.0 110.659 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -158.44 168.29 27.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.876 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 170.91 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.5 p -63.74 -27.3 69.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.242 0.544 . . . . 0.0 110.938 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -68.05 -25.59 65.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.089 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.459 ' HG2' HH11 ' A' ' 14' ' ' ARG . 2.3 mp0 -92.67 4.54 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.531 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.03 113.22 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.402 . . . . 0.0 110.631 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -106.98 178.67 4.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.807 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.47 -54.57 6.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.582 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 71.7 ttp85 -149.28 139.46 22.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.025 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 67.9 mt -98.98 158.39 32.4 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.743 174.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.71 105.79 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.38 2.053 . . . . 0.0 112.539 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.74 100.9 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.96 -77.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.186 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.77 -69.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -80.78 -3.92 52.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -165.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.41 -175.49 5.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.311 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.791 HD12 ' HD2' ' A' ' 168' ' ' PRO . 4.1 tp -135.19 129.38 18.85 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.594 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.791 ' HD2' HD12 ' A' ' 167' ' ' ILE . 56.5 Cg_endo -72.2 159.74 48.98 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.514 2.143 . . . . 0.0 112.701 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.34 -177.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -100.42 -56.08 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.467 ' HB ' HG22 ' A' ' 148' ' ' VAL . 45.8 t -128.13 140.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.62 116.01 30.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.671 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.7 t -106.83 125.28 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 0.0 110.247 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 50.3 p -119.54 -169.67 1.8 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.679 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 9.6 pt-20 -68.75 -27.52 65.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.868 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 56.9 mtpt -125.89 -21.47 4.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.424 HD22 ' C ' ' A' ' 176' ' ' LYS . 0.8 OUTLIER -131.76 143.6 50.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -172.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.403 HG11 ' HG ' ' A' ' 36' ' ' LEU . 63.5 t -111.52 102.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -122.25 112.41 18.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.166 0.507 . . . . 0.0 112.082 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 180' ' ' ARG . 30.6 ttm105 -70.3 152.44 44.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 181' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 122.103 0.954 . . . . 0.0 112.214 -166.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 129' ' ' LEU . 15.7 ptpt -66.41 -22.89 66.24 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.94 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.8 t -59.16 -29.5 67.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.184 0.516 . . . . 0.0 110.684 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.32 -45.27 18.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.067 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.17 -35.72 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.628 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -55.38 -45.98 76.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.848 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.37 -39.08 88.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -60.35 -49.69 76.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.6 -42.33 80.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 15' ' ' ILE . 62.1 tp -61.43 -42.51 98.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.667 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 5.0 t60 -58.35 -44.57 88.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.243 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 26.3 mtpp -67.65 -35.48 78.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.314 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 44.2 ttm-85 -60.77 -50.77 72.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.259 0.552 . . . . 0.0 110.652 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 11' ' ' LEU . 18.5 pt -83.67 9.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.0 111.369 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -101.37 -11.62 19.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 152.4 24.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.279 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -75.09 156.53 35.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.544 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 37.8 tt0 -68.28 -39.42 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.261 . . . . 0.0 110.906 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.56 -44.07 97.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 109.742 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.92 -34.47 76.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.401 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 7.5 mmt85 -55.18 -61.49 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.01 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 66.6 ttt180 -62.81 -37.01 85.03 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.035 0.445 . . . . 0.0 110.708 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 52.7 ttt180 -60.56 -44.87 95.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.952 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -86.57 -37.85 17.73 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.267 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.4 t -66.09 -31.86 72.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.528 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 8.7 tt0 -69.77 -26.1 64.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 74.1 mmtt -74.84 -43.94 51.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.901 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.78 -48.26 89.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.742 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 79.0 mt -60.13 -47.35 92.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -61.82 -39.41 91.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.244 0.545 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.56 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.464 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HE2' ' HG2' ' A' ' 63' ' ' GLU . 2.8 mmmp? -71.43 -31.12 66.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.602 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -84.38 -9.26 58.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.129 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 2.2 tt -71.51 111.45 10.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 36' ' ' LEU . 18.0 Cg_endo -59.67 -33.11 96.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.999 2.466 . . . . 0.0 113.529 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.63 -34.67 77.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.784 0.326 . . . . 0.0 110.334 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.79 -25.3 63.72 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.89 -34.87 74.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.262 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -100.44 -21.64 15.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.084 -171.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -58.93 123.87 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 110.916 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 1.1 mmpp? -74.71 -63.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.644 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 113.48 25.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.149 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' HD12 ' A' ' 70' ' ' LEU . 46.0 t -116.41 115.14 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.34 143.69 29.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -136.93 148.26 46.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.794 0.33 . . . . 0.0 110.551 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 117' ' ' VAL . 64.6 m-85 -97.06 141.6 30.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.898 171.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.546 ' HB2' HG22 ' A' ' 98' ' ' ILE . 67.5 m -73.75 146.8 86.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.569 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 36.5 Cg_exo -58.69 106.52 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.049 2.499 . . . . 0.0 113.042 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.831 HG13 ' H ' ' A' ' 52' ' ' LYS . 8.9 pt -99.96 -85.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.472 174.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.831 ' H ' HG13 ' A' ' 51' ' ' ILE . 45.8 mttp -91.62 -6.82 51.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.24 0.543 . . . . 0.0 109.761 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 14' ' ' ARG . . . -98.07 120.89 6.94 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 174.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.49 7.43 38.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.746 0.308 . . . . 0.0 111.249 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 21.5 t -70.51 100.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD1' ' HD3' ' A' ' 59' ' ' PRO . 6.6 t70 -86.19 102.76 14.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.237 0.541 . . . . 0.0 111.047 -171.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.1 15.77 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.365 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 m -62.71 -50.62 77.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 22.0 Cg_exo -67.07 -0.65 5.05 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -85.87 -19.04 31.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.691 0.282 . . . . 0.0 110.516 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.2 m-85 -59.63 -49.58 91.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 76.1 Cg_exo -53.11 -32.77 60.68 Favored 'Trans proline' 0 C--N 1.359 1.132 0 C-N-CA 122.296 1.997 . . . . 0.0 112.687 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.721 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 18.3 tp10 -71.69 -52.57 17.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.17 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.9 t -57.27 -45.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.221 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -65.17 -12.6 52.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -97.05 -14.22 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.936 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 43.1 mt-10 -110.56 -56.67 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 0.0 110.94 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.67 ' HD2' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -129.43 -171.53 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 -171.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.07 138.29 32.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 41.6 tp -98.94 157.38 16.36 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 67.2 mt -138.52 131.28 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 96.1 mt -129.32 132.6 24.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.37 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.84 2.36 . . . . 0.0 111.77 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 100' ' ' GLU . 2.8 tmtp? -105.89 113.63 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.92 106.71 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.091 0.472 . . . . 0.0 111.1 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -104.45 88.92 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.373 174.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 -98.73 1.04 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -123.18 -4.18 8.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 109.87 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.23 106.71 18.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 ' HD1' ' A' ' 136' ' ' TYR . 55.5 mt -82.72 102.37 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.089 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -84.74 122.72 29.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.495 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.91 100.17 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.541 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 40.8 m-85 -103.21 130.36 50.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.554 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -79.04 153.26 30.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.134 176.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 98.5 t -130.68 124.08 56.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.469 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.416 ' HD2' ' HD3' ' A' ' 84' ' ' ARG . 9.1 p80 -148.85 25.12 0.94 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.2 m -146.37 149.52 37.98 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.741 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.4 Cg_exo -78.23 160.5 29.52 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.742 2.295 . . . . 0.0 111.958 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.27 19.39 11.68 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 85' ' ' VAL . 30.7 p -103.61 5.78 36.75 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.023 -0.423 . . . . 0.0 110.63 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -100.94 129.48 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.43 171.08 25.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.144 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.34 102.06 13.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.967 0.413 . . . . 0.0 110.374 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.31 -34.6 1.92 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -82.24 -163.34 0.66 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.905 0.383 . . . . 0.0 111.209 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -54.85 -43.28 72.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 58.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.628 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 49' ' ' CYS . 43.0 pt -131.3 166.66 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -106.41 96.35 6.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 3.3 pt-20 -105.25 154.38 38.94 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.639 -173.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 11.0 Cg_exo -71.15 112.45 3.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.62 2.213 . . . . 0.0 111.985 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.43 -48.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -121.1 99.08 6.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.842 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.42 -162.42 9.1 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.908 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.45 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 36.9 mt-10 -127.02 142.34 51.57 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -77.27 128.33 34.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.097 0.475 . . . . 0.0 111.613 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 84' ' ' ARG . 84.1 t -124.18 145.13 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.949 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 110' ' ' GLU . 9.5 p30 -97.9 157.46 34.56 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.83 -25.22 42.12 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.503 2.802 . . . . 0.0 114.645 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 108' ' ' ASN . 20.6 tt0 -68.92 -23.59 64.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.846 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -93.42 0.03 56.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.939 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.76 103.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.12 -58.04 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.791 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 23.4 t80 -124.06 144.72 49.69 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.337 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 17.3 tt -149.66 141.01 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.662 0.267 . . . . 0.0 110.494 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.61 120.43 38.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.493 HG12 ' CE1' ' A' ' 48' ' ' TYR . 27.5 m -116.82 120.78 33.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.216 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 4.1 Cg_exo -77.37 104.69 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.787 2.325 . . . . 0.0 111.217 174.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.57 156.5 15.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.852 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 125.65 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.1 106.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.164 0.915 . . . . 0.0 112.491 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -127.84 157.43 40.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.596 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -103.94 -173.98 2.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 46.1 mt -87.06 15.74 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.56 -15.59 6.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.861 0.362 . . . . 0.0 110.571 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.447 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 118.05 5.46 13.39 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.71 169.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -85.92 132.35 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.542 0.671 . . . . 0.0 111.213 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -94.25 128.6 40.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.357 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.554 ' HB2' HD13 ' A' ' 160' ' ' LEU . 30.6 tp . . . . . 0 C--N 1.33 -0.281 0 O-C-N 123.535 0.522 . . . . 0.0 110.56 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.2 m-85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.755 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 9.6 p-10 -65.89 -29.37 69.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -49.94 -39.72 41.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.035 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 80' ' ' ILE . 50.5 tp -81.85 -40.64 22.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.148 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.01 -16.64 64.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.454 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.755 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 32.1 mmtp -73.2 -29.22 62.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -95.75 -27.83 15.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.194 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.43 98.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.076 0.465 . . . . 0.0 110.118 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -134.46 56.62 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.096 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.43 9.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 114' ' ' PHE . 23.7 tp -83.39 89.2 7.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 170' ' ' ASP . 25.1 ttpt -91.07 105.38 17.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.688 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 171' ' ' VAL . 45.6 t -104.49 124.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.143 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.2 10.61 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.53 115.99 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.44 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -158.59 175.03 14.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.713 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.623 ' HD1' ' HG3' ' A' ' 175' ' ' GLU . 46.4 m-85 -102.09 153.37 19.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 176' ' ' LYS . 29.6 t -61.08 -13.14 15.01 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.717 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -71.66 -23.55 61.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.585 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 16.4 mp0 -107.58 13.86 26.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.921 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.1 t -117.92 120.92 66.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.181 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.73 -175.16 2.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.391 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.906 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -89.94 -36.74 14.83 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.274 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -138.11 145.34 41.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 129' ' ' LEU . 95.3 mt -132.77 161.84 61.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.95 101.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.572 1.515 . . . . 0.0 110.892 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -104.67 141.0 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 11.3 t70 -128.08 -163.49 1.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.145 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . -81.6 -40.91 22.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 0.0 110.674 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -85.0 43.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.404 0.621 . . . . 0.0 110.241 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.55 110.77 22.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.303 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.98 114.06 53.61 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.579 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.07 160.02 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.172 2.582 . . . . 0.0 113.08 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.419 ' HA ' ' HE3' ' A' ' 147' ' ' LYS . 31.1 m -103.25 -179.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.698 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 8.1 m-20 -107.8 -32.79 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.815 0.34 . . . . 0.0 110.903 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.528 ' HB ' HG22 ' A' ' 148' ' ' VAL . 43.8 t -136.05 153.13 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 181' ' ' LEU . 44.1 tp -128.94 122.15 29.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.631 HG22 HG12 ' A' ' 178' ' ' VAL . 86.2 t -109.14 126.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.166 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.2 p -127.19 -174.6 3.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.322 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.623 ' HG3' ' HD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -85.79 -1.48 57.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 110.113 175.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.444 ' HZ3' ' HB3' ' A' ' 153' ' ' SER . 40.5 mmtm -93.56 -64.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.141 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -155.62 174.87 14.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.022 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 173' ' ' VAL . 4.4 m -108.04 99.6 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.64 . . . . 0.0 110.26 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 179' ' ' ARG . 33.1 ttt180 -103.7 116.57 32.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -74.7 132.74 41.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.521 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 172' ' ' LEU . 61.6 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.184 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -54.18 -40.66 67.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.542 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -62.12 -36.09 80.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.425 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 6.0 mm-40 -77.9 -43.43 30.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.482 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.07 -38.22 85.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -54.54 -53.86 48.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -68.42 -24.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.332 -173.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -74.18 -47.08 38.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 110.394 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.29 -44.63 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.297 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 tp -59.73 -45.57 91.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.558 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 13.7 t-80 -62.05 -43.02 99.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.66 -41.49 99.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.464 HH21 ' N ' ' A' ' 54' ' ' GLU . 10.8 tpt180 -63.95 -53.59 47.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.339 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.2 pt -80.97 4.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 111.599 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 6.5 t30 -78.67 -28.69 45.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.15 142.56 46.86 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.619 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 38.9 p -76.91 160.49 29.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.079 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.16 -30.06 71.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.9 -52.28 64.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.57 -30.78 36.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.386 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 18' ' ' SER . 83.7 mtt180 -56.9 -59.19 5.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.3 -40.35 77.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.38 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.63 -45.8 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.082 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -70.68 -44.65 66.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -61.23 -33.56 73.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.08 -39.28 78.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.427 0.632 . . . . 0.0 110.179 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -74.27 -34.23 63.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 175' ' ' GLU . 44.9 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.415 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.481 HG23 HD13 ' A' ' 60' ' ' LEU . 77.5 mt -58.21 -44.27 87.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.114 0.483 . . . . 0.0 110.325 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.1 m -65.25 -36.56 84.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -67.98 -42.35 80.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.888 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 36' ' ' LEU . 26.3 tp -62.68 -46.61 87.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 39' ' ' PHE . 23.4 mmtp -60.38 -28.94 68.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 176.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -82.97 -17.82 42.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.519 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 33' ' ' LEU . 44.6 mt -61.43 120.52 56.31 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.1 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.03 -35.6 81.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.756 2.304 . . . . 0.0 111.388 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -60.01 -52.67 64.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.651 ' HE2' ' HD3' ' A' ' 34' ' ' LYS . 88.2 t80 -73.34 -30.22 63.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -58.04 -41.39 83.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.04 -23.28 33.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.5 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 39' ' ' PHE . 49.9 m -50.8 123.19 8.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.248 0.546 . . . . 0.0 111.696 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -102.99 -34.57 8.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -113.52 97.96 6.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.075 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.47 122.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.145 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 116' ' ' ALA . 54.1 mt -111.78 136.52 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.065 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -85.64 -0.52 55.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.158 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 45.5 t 65.89 98.76 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.119 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 41.9 Cg_endo -68.35 97.76 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.467 2.111 . . . . 0.0 112.398 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 24.5 pt -87.18 154.82 3.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 tptp 71.63 -15.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.807 0.692 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 133.28 -77.89 0.37 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' HH21 ' A' ' 14' ' ' ARG . 3.3 mm-40 22.93 77.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 113.708 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 HG12 ' A' ' 150' ' ' VAL . 58.4 t 62.56 94.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.402 -174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.76 88.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.793 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 97.5 mt -100.2 9.45 42.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.005 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.485 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -60.09 -44.52 96.72 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 58' ' ' THR . 52.8 Cg_endo -70.19 -5.78 17.26 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.691 1.594 . . . . 0.0 112.488 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 63' ' ' GLU . 60.6 tp -87.81 -18.38 29.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.781 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.551 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 14.2 m-85 -54.31 -54.92 42.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 47.7 Cg_exo -58.84 -34.74 99.19 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.939 1.759 . . . . 0.0 112.278 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.51 ' HB3' HD12 ' A' ' 60' ' ' LEU . 49.6 tp10 -64.91 -45.7 84.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 60' ' ' LEU . 93.2 t -66.85 -41.88 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.92 -27.13 67.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.332 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 30.6 ttpt -74.01 -55.5 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.447 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 66' ' ' LYS . 89.0 mt-10 -81.26 -51.72 8.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.75 -174.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -118.83 -171.92 2.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.353 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 40.5 mt-10 -104.16 130.71 51.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.696 175.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 64' ' ' VAL . 40.1 tp -102.36 121.23 41.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.2 mp -99.14 118.84 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.429 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.68 142.44 28.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.94 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 82' ' ' LEU . 56.3 Cg_endo -71.69 128.82 14.73 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.752 2.301 . . . . 0.0 112.198 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -119.64 117.49 28.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.916 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.07 106.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -92.43 21.7 5.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 81.15 1.46 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 69.91 -59.05 0.52 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.322 0.649 . . . . 0.0 110.324 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -58.23 118.26 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.995 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.539 HD12 ' HD1' ' A' ' 136' ' ' TYR . 14.4 tt -110.76 136.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 t -130.81 176.75 7.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.4 mt -119.45 122.51 41.87 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m-85 -110.91 127.27 55.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.097 0.475 . . . . 0.0 111.223 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 23.7 ttp85 -86.75 119.55 27.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.482 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -118.66 145.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.638 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -139.23 22.88 2.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 18.5 t -141.06 122.93 9.27 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.805 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 31.5 Cg_exo -59.92 -31.2 93.37 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.155 2.57 . . . . 0.0 113.315 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.73 1.31 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.3 t -109.11 4.14 22.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.255 0.55 . . . . 0.0 110.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.41 136.61 33.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.651 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.91 159.92 30.33 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.986 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.35 113.95 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.758 0.279 . . . . 0.0 110.54 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.18 -58.15 0.41 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.689 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.68 142.55 47.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.882 0.372 . . . . 0.0 111.702 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 73.22 -54.4 0.69 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.021 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.61 44.35 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.916 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.79 168.94 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 72.8 mtm -91.77 100.01 12.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.151 0.501 . . . . 0.0 110.155 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.74 157.34 37.07 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.828 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.18 115.56 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.963 1.776 . . . . 0.0 110.273 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.04 -45.71 70.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.262 0.553 . . . . 0.0 109.545 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -129.82 -157.04 0.79 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.793 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.77 -161.61 14.21 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.358 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' ARG . 35.9 mt-10 -124.03 111.11 15.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 26.2 ptt180 -74.28 148.11 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.908 0.861 . . . . 0.0 112.754 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.32 136.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.473 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.69 142.82 91.78 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HA ' HG23 ' A' ' 112' ' ' VAL . 9.5 Cg_endo -53.73 -18.42 12.18 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.389 2.726 . . . . 0.0 112.879 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' A' ' 144' ' ' LYS . 43.2 tt0 -64.33 -31.12 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -94.06 4.55 53.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.911 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 109' ' ' PRO . 99.9 t -82.74 120.34 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.22 -46.48 6.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.258 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.61 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 35.7 t80 -125.14 129.93 51.16 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.61 139.17 45.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.596 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB3' HD23 ' A' ' 47' ' ' LEU . . . -110.84 113.47 26.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -118.56 113.74 36.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.98 118.66 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.595 2.197 . . . . 0.0 110.579 171.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -121.16 142.24 15.34 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.689 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.5 106.07 14.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.53 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.266 0.979 . . . . 0.0 112.932 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 161.75 25.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -175.87 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 79.3 mt -68.47 -29.45 68.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.47 -39.19 19.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.121 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.404 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 132.5 31.46 0.46 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.468 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -99.93 156.87 16.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.193 0.521 . . . . 0.0 111.057 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -99.63 157.45 16.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.499 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.089 0.471 . . . . 0.0 109.978 175.281 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.539 ' HD1' HD12 ' A' ' 80' ' ' ILE . 2.1 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.657 0.742 . . . . 0.0 109.264 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.01 -51.96 48.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.571 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -57.71 -37.5 73.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.039 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 82' ' ' LEU . 26.5 tp -58.41 -48.23 81.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.949 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.4 mt -59.18 -37.22 76.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.24 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -89.67 0.4 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.977 0.418 . . . . 0.0 110.7 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.601 ' HE ' ' HA ' ' A' ' 142' ' ' ARG . 1.9 tpm_? -95.3 -29.04 14.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.147 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 145' ' ' GLY . 62.0 t -64.96 107.56 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.079 0.466 . . . . 0.0 110.478 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.683 ' HE3' ' HG3' ' A' ' 110' ' ' GLU . 19.7 pttp -85.66 9.32 16.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 143' ' ' VAL . . . -90.19 -154.66 30.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.201 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 171' ' ' VAL . 31.8 tp -93.27 112.23 24.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.359 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -90.24 108.33 19.69 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.251 0.548 . . . . 0.0 110.175 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 114' ' ' PHE . 59.3 t -97.89 111.26 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.48 112.67 3.5 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 55' ' ' VAL . 18.1 t -105.4 116.73 49.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -156.71 -177.27 6.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.675 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.45 ' HE1' ' H ' ' A' ' 55' ' ' VAL . 74.7 m-85 -93.98 161.01 14.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 t -73.38 -28.96 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.801 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.57 -16.29 60.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.017 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 8.6 tt0 -95.1 7.54 45.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.926 0.87 . . . . 0.0 109.483 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 122.45 57.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.288 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.39 179.44 4.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.031 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.766 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 14.6 mt-10 -87.58 -56.4 3.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.377 0.608 . . . . 0.0 109.801 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.63 104.23 5.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.621 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.79 158.34 35.36 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.758 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.38 101.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.785 1.656 . . . . 0.0 110.397 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -90.71 139.7 30.47 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.2 t70 -75.62 -92.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -165.85 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.008 0.433 . . . . 0.0 109.988 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -102.76 50.78 0.81 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.421 0.629 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -81.75 -167.51 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.916 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 64.6 mt -113.54 103.87 55.4 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 153.87 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.304 2.67 . . . . 0.0 112.049 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.53 172.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.798 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.77 -52.55 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.273 0.559 . . . . 0.0 110.266 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.463 HG23 HD11 ' A' ' 146' ' ' LEU . 57.3 t -123.47 140.43 47.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.745 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.94 110.75 18.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.487 HG13 HG22 ' A' ' 178' ' ' VAL . 54.1 t -103.18 121.94 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 80.4 p -108.8 -173.11 2.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.953 0.406 . . . . 0.0 110.745 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 11.1 pt-20 -69.21 -18.8 63.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.302 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 29.7 mmtp -117.06 -65.37 1.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.403 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -121.59 168.68 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 112.105 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.613 HG21 HD21 ' A' ' 36' ' ' LEU . 61.4 t -114.45 123.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.51 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -102.94 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.642 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 -83.79 89.53 7.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.404 HD13 ' CA ' ' A' ' 126' ' ' GLY . 80.4 mt . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.991 -165.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 7.6 mtpm? -62.3 -49.32 76.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 17.4 p -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.578 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.32 -58.34 9.05 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.749 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.49 -41.96 91.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.63 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -52.45 -51.57 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.553 ' HB2' ' HZ2' ' A' ' 8' ' ' LYS . 9.9 mtmp? -64.49 -44.9 89.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.455 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.77 -45.78 84.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.551 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 120' ' ' VAL . 60.9 t -68.63 -33.06 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.642 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 15' ' ' ILE . 16.3 mt -56.95 -51.65 68.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -59.98 -43.35 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.15 -0.81 15.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.828 ' HD3' ' HG2' ' A' ' 54' ' ' GLU . 21.0 ttm180 -111.73 -41.21 4.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.73 0.3 . . . . 0.0 111.404 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 11' ' ' LEU . 32.2 pt -90.77 -18.16 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.32 -2.01 57.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.049 0.452 . . . . 0.0 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.76 149.31 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.723 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 m -63.3 132.85 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.51 -36.85 85.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.368 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.36 -35.23 79.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.333 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 42.2 tt0 -72.92 -41.22 64.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.36 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -65.64 -37.05 85.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.711 HH21 ' HB2' ' A' ' 56' ' ' ASP . 3.0 tpm_? -58.51 -47.05 85.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.741 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -59.84 -47.96 83.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.12 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -63.32 -43.27 98.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.841 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 30' ' ' ILE . 70.2 m -61.49 -37.64 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.904 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -58.05 -41.71 83.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 109.896 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.53 -40.59 85.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 25' ' ' LEU . 74.8 t -66.51 -41.43 88.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 26' ' ' SER . 74.9 mt -58.14 -45.06 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -69.63 -33.74 73.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.956 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.56 -44.85 81.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 0.0 110.237 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.699 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 24.4 tp -61.58 -42.6 99.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.07 -13.66 60.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.428 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 t -79.84 -26.61 40.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 33' ' ' LEU . 89.7 mt -60.53 122.52 68.42 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.613 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.3 Cg_exo -66.48 -22.23 52.11 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.722 2.282 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.14 -31.67 68.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.365 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.84 -43.8 97.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.875 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -70.95 -18.68 62.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.492 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -79.56 -38.71 33.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 65.9 m -71.82 120.62 17.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.258 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -107.02 -28.23 10.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -89.04 92.53 9.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 57.9 t -112.4 111.21 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.922 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -102.98 134.68 46.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.199 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 7.4 mp -114.83 145.3 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -86.64 1.78 50.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.476 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.01 90.95 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.109 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.54 103.3 1.41 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.906 2.404 . . . . 0.0 112.314 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 1.7 pp -99.28 169.42 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.032 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 65.46 21.15 11.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.29 0.566 . . . . 0.0 110.019 -172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 -86.44 1.56 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.707 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG2' ' HD3' ' A' ' 14' ' ' ARG . 29.9 mt-10 60.88 -84.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.534 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -145.44 133.48 16.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.711 ' HB2' HH21 ' A' ' 23' ' ' ARG . 60.6 m-20 -71.45 79.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.88 0.372 . . . . 0.0 111.297 -178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 150' ' ' VAL . 90.6 mt -98.34 -16.98 19.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 109.777 174.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 6.5 m -63.69 -50.69 70.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.25 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 20.9 Cg_exo -67.97 3.65 1.87 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.339 2.026 . . . . 0.0 112.824 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -93.28 -9.59 38.49 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.522 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 19.5 m-30 -50.83 -49.65 78.59 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.248 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 73.1 Cg_exo -51.96 -35.76 61.84 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.2 1.933 . . . . 0.0 112.791 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.7 -11.91 49.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 68' ' ' LYS . 29.3 t -93.64 -40.52 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.69 -1.94 4.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 94.1 mttt -84.19 -52.67 6.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.647 0.26 . . . . 0.0 111.268 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.967 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 6.8 pt-20 -119.76 -9.72 9.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.967 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 mptp? -116.32 165.06 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.769 0.795 . . . . 0.0 112.185 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 37.1 mt-10 -98.87 114.79 27.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.326 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -78.93 124.16 27.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.467 . . . . 0.0 110.925 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 55.6 mt -114.48 117.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.199 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.0 mt -119.31 147.64 43.59 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.882 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 47' ' ' LEU . 91.6 Cg_endo -81.21 129.66 6.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.895 2.397 . . . . 0.0 113.443 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -127.34 109.56 11.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.13 105.84 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.201 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -81.08 -10.84 59.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.689 -175.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.04 -42.95 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.705 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -137.14 -39.17 0.61 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.015 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.26 141.4 28.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.32 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -80.36 106.89 12.71 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.0 mt -74.31 117.63 16.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.953 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 5.2 m-85 -102.45 133.1 47.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.135 0.493 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.608 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 12.5 ttp180 -99.5 115.18 28.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.853 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -131.42 148.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.97 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -127.21 18.88 7.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.378 0.609 . . . . 0.0 109.518 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.2 m -139.06 141.72 30.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 6.7 Cg_exo -74.5 -174.53 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.931 2.421 . . . . 0.0 111.947 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.61 -30.49 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 112.237 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.4 m -76.37 1.74 15.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 110.681 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.5 mt -104.38 105.65 15.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.102 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -107.18 -163.16 21.93 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.816 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.91 121.9 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.63 -75.61 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.98 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.23 114.9 1.97 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.513 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 65.93 8.29 5.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.275 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.14 82.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.877 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.96 165.86 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 65.4 mtt -71.07 137.27 48.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.085 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.24 141.73 32.85 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.674 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 7.9 Cg_exo -72.26 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.485 2.123 . . . . 0.0 110.426 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.505 HG23 ' HG2' ' A' ' 103' ' ' GLU . 34.9 m -66.29 -22.53 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.505 ' HG2' HG23 ' A' ' 102' ' ' VAL . 9.3 pt-20 -152.91 166.94 30.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.379 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -171.99 21.62 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -109.45 154.56 22.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.922 0.391 . . . . 0.0 111.19 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.94 157.15 23.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 39.1 t -109.8 136.06 46.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.699 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -67.86 132.35 92.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.56 -41.23 45.19 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.912 2.408 . . . . 0.0 113.247 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.9 -4.11 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.361 0.601 . . . . 0.0 110.847 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.96 -19.28 30.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.491 175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.03 122.69 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.995 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.29 -43.43 5.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.699 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 23.8 t80 -126.03 123.97 39.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.443 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.5 tt -128.0 137.5 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.482 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.08 111.36 22.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.266 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 6.2 p -133.99 123.22 16.82 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.718 -178.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.515 ' HB2' ' H ' ' A' ' 119' ' ' GLY . 1.4 Cg_endo -84.49 -122.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.997 2.465 . . . . 0.0 111.322 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 118' ' ' PRO . . . 114.88 -178.07 17.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.935 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 10' ' ' VAL . 98.5 t -100.27 125.64 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.574 -0.313 . . . . 0.0 111.387 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 128' ' ' ARG . . . 69.43 121.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.208 0.943 . . . . 0.0 112.73 171.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -128.91 158.23 39.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.539 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.528 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 38.9 p30 -137.94 -174.19 3.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.32 -6.62 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -89.99 -27.26 19.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 110.044 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.7 21.99 6.9 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.193 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.34 151.51 21.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.08 0.467 . . . . 0.0 110.91 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -151.41 151.95 32.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 121' ' ' ALA . 10.0 mp . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.142 0.496 . . . . 0.0 110.069 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.709 0.29 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.72 -31.68 72.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 110.192 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -67.34 -29.08 68.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.68 -34.29 46.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.44 -24.39 65.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.391 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -96.43 -4.16 42.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -91.87 -28.33 17.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.211 0.529 . . . . 0.0 110.026 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.88 114.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.63 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -92.56 7.25 44.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.73 166.57 54.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.112 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.16 102.58 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.073 0.463 . . . . 0.0 110.104 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 55.9 mtpt -72.19 102.97 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.728 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 65.6 t -97.7 117.65 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.431 . . . . 0.0 110.594 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -88.93 120.32 5.67 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.534 HG12 HG21 ' A' ' 55' ' ' VAL . 19.0 t -99.08 108.2 21.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -139.94 157.68 45.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.329 0.585 . . . . 0.0 112.212 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.38 155.24 17.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.542 ' OG ' ' HG3' ' A' ' 176' ' ' LYS . 3.7 m -52.14 -29.94 24.28 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.363 0.414 . . . . 0.0 111.762 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -68.81 -20.48 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.597 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -99.46 -2.91 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.69 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -104.44 128.44 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.149 0.5 . . . . 0.0 111.514 -173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.65 -165.99 1.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.643 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 43.0 mt-10 -88.67 -62.3 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 3.0 tpm_? -143.7 112.14 6.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.124 -175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.2 mt -102.99 161.52 22.89 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.657 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.69 140.48 74.71 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.35 2.034 . . . . 0.0 111.307 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 162' ' ' ARG . 47.1 mtt180 -76.41 117.72 18.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 165' ' ' TRP . 23.9 t70 -108.94 128.06 54.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 69.1 -14.81 0.29 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.994 0.809 . . . . 0.0 112.237 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.443 ' H ' ' C ' ' A' ' 163' ' ' ASP . 11.3 m-90 58.0 35.17 25.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.96 0.504 . . . . 0.0 111.366 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.536 ' HB3' HH22 ' A' ' 128' ' ' ARG . 14.1 t0 -68.63 153.31 44.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.663 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 13.4 tt -66.55 125.78 91.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.151 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 62.3 Cg_exo -51.54 151.97 13.19 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.302 2.668 . . . . 0.0 112.917 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 HD12 ' A' ' 181' ' ' LEU . 28.7 m -70.52 161.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.168 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -89.88 -43.61 10.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.186 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 81.4 t -131.66 132.91 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.05 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 55.8 tp -114.84 102.3 9.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.825 0.345 . . . . 0.0 110.1 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.59 111.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -113.31 165.7 12.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.6 -177.146 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -61.77 -30.8 71.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.014 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' OG ' ' A' ' 153' ' ' SER . 95.1 mttt -82.66 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -147.52 175.28 10.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.884 0.373 . . . . 0.0 110.535 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.56 114.3 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.649 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.796 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 4.9 tpm_? -93.66 98.97 11.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -75.75 120.09 20.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.536 HD12 HG23 ' A' ' 169' ' ' VAL . 95.4 mt . . . . . 0 C--N 1.323 -0.573 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.754 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 161' ' ' PRO . 63.4 pttt -73.64 -13.77 61.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.219 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -64.26 -30.04 71.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.205 0.526 . . . . 0.0 110.357 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.18 -39.86 32.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.29 -38.26 83.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.735 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -57.87 -41.84 83.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.789 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.96 -39.16 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -57.83 -50.46 73.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.22 -42.64 91.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.499 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 tp -60.17 -35.5 75.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.131 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -58.28 -63.65 1.19 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.941 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -67.1 -27.04 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.304 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' HA ' ' A' ' 120' ' ' VAL . 18.4 ttt180 -60.4 -60.75 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.731 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 11' ' ' LEU . 36.2 pt -80.24 9.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.247 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -92.33 -10.64 37.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD12 ' HG2' ' A' ' 54' ' ' GLU . 87.8 mt -58.19 154.54 12.92 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.717 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . 1.2 m -77.74 160.36 28.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -62.57 -66.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.8 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -31.81 73.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.137 0.494 . . . . 0.0 110.098 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 18' ' ' SER . 39.3 tt0 -58.0 -52.5 65.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.78 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.698 HH12 ' HB2' ' A' ' 56' ' ' ASP . 35.7 ptt85 -70.55 -21.82 62.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.598 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -71.11 -41.77 70.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -72.33 -34.35 67.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' VAL . 90.5 mt -64.03 -41.87 97.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.3 m -63.82 -37.9 89.1 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.526 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -64.66 -39.75 94.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.9 t -74.12 -44.64 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.536 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.8 -37.05 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.77 0.319 . . . . 0.0 110.371 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 t -64.91 -36.41 84.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.463 . . . . 0.0 109.914 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.11 -49.94 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.349 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -31.78 71.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.763 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.11 -32.63 67.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.2 p -80.85 -17.01 52.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.144 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.43 HD23 ' HD2' ' A' ' 37' ' ' PRO . 1.1 tt -55.35 113.03 4.85 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.092 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 36' ' ' LEU . 32.6 Cg_exo -60.31 -39.04 71.02 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.624 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -24.51 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.309 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.54 -27.21 62.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 109.531 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -79.64 -24.11 42.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.572 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -78.17 -46.02 21.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 114' ' ' PHE . 43.4 t -59.85 149.06 32.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.565 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 38.1 tttp -138.17 -21.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.976 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 1.001 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 32.5 mmtp -96.7 92.48 6.21 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.456 HG21 ' HD3' ' A' ' 68' ' ' LYS . 29.2 t -108.17 110.78 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 111.343 -172.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.52 119.66 35.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.774 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 70' ' ' LEU . 7.7 mp -104.9 125.86 51.36 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -80.99 3.3 23.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.314 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m 63.16 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.253 0.549 . . . . 0.0 110.754 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 58.9 Cg_endo -73.12 81.98 1.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.456 2.104 . . . . 0.0 113.521 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.0 pp -81.01 127.65 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt 56.8 32.86 22.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.966 0.889 . . . . 0.0 109.556 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -110.04 104.51 1.85 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.638 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 4.5 mp0 -55.51 -30.39 60.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.572 0.349 . . . . 0.0 111.184 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 6.8 t -78.16 96.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.698 ' HB2' HH12 ' A' ' 22' ' ' ARG . 4.9 t70 -82.71 110.13 17.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.52 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 93.6 mt -99.43 7.36 45.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -67.46 -41.04 29.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD3' ' OD1' ' A' ' 56' ' ' ASP . 31.4 Cg_exo -62.08 -6.02 7.31 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.051 1.834 . . . . 0.0 113.393 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HG3' ' A' ' 63' ' ' GLU . 25.7 tp -87.53 -10.09 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.39 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 7.7 m-85 -55.7 -52.87 68.62 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.7 Cg_exo -53.48 -34.94 74.29 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.272 1.982 . . . . 0.0 112.801 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' A' ' 60' ' ' LEU . 11.5 mm-40 -66.23 -48.56 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.46 -40.39 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.285 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 70' ' ' LEU . 97.2 mt -66.95 -11.12 55.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.722 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 26.3 tptp -77.62 -57.42 3.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' OE2' ' HG3' ' A' ' 68' ' ' LYS . 1.7 pp20? -134.67 -9.98 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 43.8 mttp -95.88 179.6 5.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.186 0.517 . . . . 0.0 111.079 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 65.9 mm-40 -107.56 113.89 27.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.575 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' VAL . 49.3 tp -83.86 110.24 18.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.101 0.477 . . . . 0.0 109.999 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 56.4 mt -100.87 112.51 33.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.924 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 88.2 mt -108.62 145.0 30.69 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.689 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 7.8 Cg_endo -87.57 118.52 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.203 2.602 . . . . 0.0 112.457 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 83' ' ' TYR . 36.0 tttp -105.49 121.37 43.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.883 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.67 105.19 7.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -15.87 61.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.988 0.423 . . . . 0.0 111.164 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.88 -44.51 0.28 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.86 -34.43 0.47 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.601 -0.299 . . . . 0.0 110.458 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -105.6 168.04 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.0 mt -107.17 133.89 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.522 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 t -119.03 132.35 56.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 90.5 mt -84.84 142.18 29.93 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 121.333 -0.147 . . . . 0.0 110.748 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.714 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 1.5 m-85 -116.75 138.45 51.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.588 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 72.2 ttt180 -100.96 104.89 16.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.218 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 13.4 t -133.07 154.59 39.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -148.41 46.0 1.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.59 0.709 . . . . 0.0 109.878 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -171.53 148.91 2.36 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.132 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.74 -61.84 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.483 2.122 . . . . 0.0 111.624 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.01 -93.48 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.3 m -125.94 27.5 6.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.438 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -78.25 114.22 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -127.42 -159.8 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.527 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' HA2' ' A' ' 97' ' ' GLY . 59.0 t -117.15 93.4 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.281 0.562 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -96.1 2.42 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.763 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -68.09 122.37 18.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 74.19 -44.6 0.57 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.648 0.779 . . . . 0.0 112.496 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' HA2' HG13 ' A' ' 93' ' ' VAL . . . 131.23 6.69 3.41 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.113 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.4 pt -84.01 173.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.86 99.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.763 ' HG3' ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -110.35 111.89 57.37 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.86 -172.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.26 106.22 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.694 2.262 . . . . 0.0 111.858 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.3 -40.67 89.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -127.1 -177.65 4.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.467 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -177.65 16.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.837 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 1.5 mm-40 -115.88 154.27 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 111.225 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 12.8 mtm180 -86.58 159.32 19.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.784 -167.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 48.6 t -122.73 126.09 73.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.853 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -84.55 151.52 58.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.997 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 112' ' ' VAL . 52.7 Cg_exo -56.13 -20.06 29.44 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.986 2.457 . . . . 0.0 113.065 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -76.62 -9.44 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.088 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -111.11 2.73 18.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.53 . . . . 0.0 110.38 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 109' ' ' PRO . 86.5 t -74.14 106.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.249 0.547 . . . . 0.0 110.905 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 1.001 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 5.1 t0 -86.47 -54.04 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.468 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 148' ' ' VAL . 37.2 t80 -132.19 132.99 43.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.09 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -133.78 138.97 49.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.834 0.349 . . . . 0.0 110.419 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.54 111.56 19.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.302 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.55 117.35 29.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.402 0.62 . . . . 0.0 110.945 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 50' ' ' PRO . 94.2 Cg_endo -86.89 73.94 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.872 2.381 . . . . 0.0 112.359 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.28 159.92 36.53 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.486 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.535 ' HA ' ' NH1' ' A' ' 14' ' ' ARG . 99.3 t -66.87 -50.1 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.494 0.188 . . . . 0.0 111.361 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.86 24.31 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.894 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -132.16 170.33 15.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.68 -177.02 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.536 0.208 . . . . 0.0 110.463 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.587 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.3 mt -83.2 8.72 12.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -109.38 -28.69 8.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 122.11 13.42 4.92 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.843 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -94.12 161.72 14.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.443 0.64 . . . . 0.0 111.999 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.538 ' HD3' ' OD1' ' A' ' 166' ' ' ASP . 2.1 ptm180 -101.96 147.75 26.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.27 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.658 ' HB2' HD13 ' A' ' 160' ' ' LEU . 53.2 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.907 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.241 0.614 0 CA-C-O 121.88 0.848 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 7.1 p-10 -74.92 7.06 3.44 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.677 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.63 -44.18 82.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 165.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 9.9 tt -71.86 -43.77 64.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.974 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 55.7 mt -58.03 -41.06 82.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.835 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 111.384 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 109' ' ' PRO . 77.5 ttt180 -95.46 -12.48 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.941 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' LEU . 94.6 t -62.88 98.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.315 0.579 . . . . 0.0 110.232 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -95.11 14.1 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.69 0.757 . . . . 0.0 109.855 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.51 -166.26 30.93 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.885 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.574 HD11 HG23 ' A' ' 171' ' ' VAL . 35.9 tp -78.69 112.89 16.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 110.947 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.868 ' HD3' HD11 ' A' ' 167' ' ' ILE . 16.0 mttp -93.86 114.24 26.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 171' ' ' VAL . 74.7 t -109.99 115.76 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.205 0.526 . . . . 0.0 110.887 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.53 130.23 10.02 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 55' ' ' VAL . 21.9 t -115.66 109.76 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -161.6 170.86 19.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.694 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 48.0 m-85 -90.26 171.24 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 64.0 m -62.21 -28.74 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.348 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -86.39 10.87 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.104 0.478 . . . . 0.0 111.561 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -105.07 -7.56 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 167.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.34 116.72 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.395 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -105.88 -179.31 3.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.812 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.587 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 54.3 mt-10 -76.48 -46.84 25.04 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.122 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -150.63 144.25 25.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.361 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' A' ' 129' ' ' LEU . 98.1 mt -128.9 147.13 63.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.362 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 31.2 Cg_exo -60.39 114.75 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.663 2.242 . . . . 0.0 111.82 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 80.3 mtt180 -104.14 147.12 27.8 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.77 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.25 -69.15 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.69 -85.45 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.64 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -120.31 74.29 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.432 0.634 . . . . 0.0 109.511 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.538 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 2.5 t70 -89.37 -174.07 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.729 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.868 HD11 ' HD3' ' A' ' 147' ' ' LYS . 4.1 tt -94.77 125.86 49.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 121.075 0.464 . . . . 0.0 111.801 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 98.0 Cg_endo -93.93 158.54 2.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.336 2.691 . . . . 0.0 111.96 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.45 147.9 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.82 -42.97 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.382 0.611 . . . . 0.0 110.059 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.574 HG23 HD11 ' A' ' 146' ' ' LEU . 98.5 t -125.21 133.69 68.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.209 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 41.4 tp -122.24 105.0 9.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 178' ' ' VAL . 46.8 t -91.25 127.94 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 41.0 p -110.5 -166.24 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.53 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -84.32 -14.5 49.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -92.2 -59.91 1.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.916 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -155.52 170.57 21.66 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.147 0.498 . . . . 0.0 111.957 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 173' ' ' VAL . 97.1 t -83.98 106.69 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.477 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 179' ' ' ARG . 44.3 mtt180 -98.99 93.28 5.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.857 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -72.4 106.66 4.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 C--N 1.324 -0.51 0 O-C-N 123.782 0.676 . . . . 0.0 112.569 -165.953 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.18 -25.31 65.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -75.73 -23.25 56.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.246 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 5.4 mm-40 -77.31 -35.02 55.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 10' ' ' VAL . 48.6 tp -77.66 -29.98 51.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.686 ' HG2' HG11 ' A' ' 120' ' ' VAL . 3.8 ttm-85 -53.26 -49.56 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 55.0 pttt -68.93 -31.44 70.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.832 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.21 -43.51 70.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.6 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 6' ' ' LEU . 39.1 t -70.19 -39.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.34 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.649 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -71.87 -38.57 70.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.263 0.554 . . . . 0.0 110.778 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -60.84 -41.96 96.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.868 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.1 pt -90.68 1.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.677 0.275 . . . . 0.0 111.501 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.59 -26.88 31.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.978 0.418 . . . . 0.0 110.804 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.13 143.67 57.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.788 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -85.96 -176.74 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.22 -52.13 65.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.348 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -52.31 -51.37 59.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.797 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.96 -58.23 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.62 0.248 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -57.43 -50.17 73.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.9 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -62.39 -40.6 97.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.972 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -71.05 -44.61 65.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.903 0.382 . . . . 0.0 110.915 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.2 mt -65.01 -42.44 94.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.819 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -63.2 -39.31 94.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.525 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.29 -43.73 92.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.026 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -55.86 -51.34 67.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.731 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 25' ' ' LEU . 52.0 t -62.86 -42.76 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.389 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 56' ' ' ASP . 79.8 mt -62.51 -50.28 80.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.5 t -59.46 -45.18 92.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -63.4 -41.37 98.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.778 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 35.9 tp -63.33 -42.27 98.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.505 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -73.59 -21.1 60.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.7 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -74.35 -27.34 60.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.312 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 33' ' ' LEU . 89.2 mt -57.63 132.49 82.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.778 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.4 -24.04 77.82 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.32 2.014 . . . . 0.0 110.64 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -63.99 -30.05 71.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.862 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.12 -38.32 82.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.012 0.434 . . . . 0.0 110.506 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -70.48 -26.43 63.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 109.759 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -84.34 -13.36 52.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 m -65.47 121.47 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -106.92 -54.87 2.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.862 0.839 . . . . 0.0 109.086 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.663 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 47.8 mmtt -105.06 99.74 9.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.237 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.58 108.82 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.059 0.456 . . . . 0.0 110.679 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -102.28 138.38 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.097 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.11 144.06 47.82 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 24.0 t80 -82.35 -4.16 56.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.9 m 62.1 92.8 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.728 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.4 133.98 27.6 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.339 2.026 . . . . 0.0 111.749 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -121.19 -35.49 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 0.0 110.083 -177.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.43 41.59 1.11 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.524 -177.135 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.41 -90.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 35.3 mt-10 54.85 38.23 29.93 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.845 0.379 . . . . 0.0 111.849 168.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 54' ' ' GLU . 81.7 t 73.17 119.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.35 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 30' ' ' ILE . 11.1 m-20 -69.07 83.25 0.33 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.273 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 99.1 mt -89.83 -4.63 57.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.839 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -61.38 -46.88 94.92 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.074 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.71 -3.37 7.9 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.115 1.876 . . . . 0.0 112.951 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 63' ' ' GLU . 23.0 tp -93.23 -9.84 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.388 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 3.1 m-85 -54.28 -54.04 52.45 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.645 177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.4 Cg_endo -56.19 -39.97 87.85 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.362 2.041 . . . . 0.0 112.374 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.452 ' HG3' HD12 ' A' ' 60' ' ' LEU . 7.7 mm-40 -58.47 -42.39 87.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.065 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.82 -46.86 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.18 -24.55 64.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.877 0.37 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -38.5 78.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.093 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.895 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 7.2 pt-20 -138.27 -46.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.895 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 49.6 mttm -96.6 -173.32 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.995 0.426 . . . . 0.0 111.008 -170.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.59 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 39.2 mt-10 -100.14 128.32 46.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.7 tp -100.88 110.83 22.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.4 mt -96.22 119.86 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.292 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.873 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 93.7 mt -122.49 145.6 45.18 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CB ' HD11 ' A' ' 80' ' ' ILE . 72.7 Cg_endo -91.58 127.24 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.045 2.497 . . . . 0.0 113.688 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.788 ' HD3' ' HE2' ' A' ' 83' ' ' TYR . 34.8 tttm -105.98 126.08 51.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.18 128.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.698 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -139.14 100.4 4.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.886 0.374 . . . . 0.0 110.128 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.09 -106.17 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.764 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -124.8 21.3 8.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.426 0.631 . . . . 0.0 109.603 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.75 152.96 35.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.525 HD13 HD22 ' A' ' 139' ' ' LEU . 16.8 tt -128.02 128.0 68.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.422 0.63 . . . . 0.0 110.773 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -104.11 108.61 20.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 139' ' ' LEU . 97.0 mt -85.35 101.1 12.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.788 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 77.2 m-85 -96.17 130.82 43.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.286 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 20.1 ptt180 -92.59 130.17 38.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.15 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.433 -171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -135.17 14.31 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.336 0.588 . . . . 0.0 109.638 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.473 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.0 m -135.09 125.42 17.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.21 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.2 Cg_exo -61.87 -31.56 85.04 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 122.915 2.41 . . . . 0.0 113.423 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.66 -2.25 19.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.72 4.2 51.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.903 0.382 . . . . 0.0 110.663 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.7 mt -104.52 149.06 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.705 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.22 -142.2 6.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 133.06 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -127.27 -98.17 1.0 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.0 114.387 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.32 -2.85 21.82 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -166.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -122.93 -44.56 2.18 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.12 24.82 3.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.879 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.95 173.24 7.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 tpt -69.81 88.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.05 161.63 39.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.295 -172.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.873 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -76.13 125.5 8.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.507 2.138 . . . . 0.0 112.097 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.94 -41.76 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.011 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.99 173.85 11.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.87 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.09 -164.42 25.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.896 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -110.76 122.04 46.82 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.752 -0.264 . . . . 0.0 110.849 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.5 ptm180 -84.31 125.99 32.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 108' ' ' ASN . 3.4 t -122.72 164.28 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.4 ' N ' HG12 ' A' ' 107' ' ' VAL . 92.3 m-20 -74.74 153.02 87.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.88 -11.56 24.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.975 2.45 . . . . 0.0 113.314 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -71.03 -20.44 62.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.494 . . . . 0.0 110.455 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.33 -16.44 56.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.459 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.67 124.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.299 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.663 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 19.0 t70 -99.2 -48.41 4.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.508 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.778 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 32.1 t80 -136.9 119.94 16.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -126.15 138.87 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.027 0.442 . . . . 0.0 110.962 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.4 111.4 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.202 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.81 105.8 54.27 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.922 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 48' ' ' TYR . 16.5 Cg_exo -68.59 119.32 6.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.489 2.126 . . . . 0.0 110.941 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.53 153.92 19.67 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.688 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 7' ' ' ARG . 84.1 t -58.77 -49.26 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.188 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.88 36.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.584 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.25 151.84 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 5.0 p-10 -108.36 -163.72 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 97.7 mt -75.69 -19.52 59.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.81 -31.16 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 119.39 35.06 0.96 Allowed Glycine 0 C--O 1.236 0.277 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.529 170.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.96 147.08 35.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.008 0.404 . . . . 0.0 110.16 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.585 ' HB3' ' OD2' ' A' ' 166' ' ' ASP . 25.4 ttp180 -86.78 -12.71 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.083 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.835 ' HB2' HD13 ' A' ' 160' ' ' LEU . 62.0 tp . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.552 0.741 . . . . 0.0 111.034 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 120.96 0.41 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.33 -29.81 57.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.46 -25.96 67.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.659 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 82' ' ' LEU . 34.3 tp -78.43 -58.17 3.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.388 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.83 -30.99 69.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.233 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.57 -23.54 53.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.6 -6.06 44.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 139' ' ' LEU . 97.4 t -80.73 104.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.02 7.3 44.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.62 -168.5 44.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.987 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.69 104.01 15.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.502 ' HA ' HG23 ' A' ' 115' ' ' ILE . 9.9 mtmp? -86.24 102.74 14.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.163 0.506 . . . . 0.0 110.22 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.4 116.86 43.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.641 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.99 121.72 5.56 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 29' ' ' VAL . 85.3 t -109.33 120.3 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.87 169.81 21.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 111.597 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' A' ' 155' ' ' GLN . 41.4 m-85 -86.3 168.86 13.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -77.15 -19.84 56.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 109.548 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -69.01 -10.2 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.487 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 152' ' ' TYR . 59.9 mm-40 -111.29 10.26 21.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.625 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.74 131.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.15 -168.73 1.81 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.602 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 34.1 mt-10 -80.02 -59.27 2.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 109.971 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.4 mmt85 -147.2 144.94 29.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.709 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 129' ' ' LEU . 68.6 mt -101.92 137.19 19.45 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 12.0 Cg_exo -70.88 101.92 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.636 2.224 . . . . 0.0 111.075 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 0.5 OUTLIER -130.67 178.33 6.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.211 -174.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -73.45 -67.2 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HA ' HH11 ' A' ' 162' ' ' ARG . . . -151.41 -89.28 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.005 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -116.7 78.12 1.17 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.024 0.44 . . . . 0.0 110.836 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 128' ' ' ARG . 34.9 t70 -70.08 134.66 48.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 62.8 mt -55.97 114.79 8.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 112.057 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.76 175.95 7.38 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.272 2.648 . . . . 0.0 112.851 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.12 160.56 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 14.0 m-20 -87.89 -35.14 17.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.239 0.542 . . . . 0.0 109.924 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.4 t -133.26 143.44 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.483 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 181' ' ' LEU . 56.7 tp -115.64 117.61 30.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.71 116.2 51.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.013 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 70.9 p -109.92 -167.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.747 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 10.4 pt-20 -68.19 -17.42 64.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.199 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 9.8 mtmp? -128.71 -66.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -109.41 152.63 25.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.282 0.563 . . . . 0.0 112.077 -171.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.473 HG21 HD21 ' A' ' 36' ' ' LEU . 61.2 t -118.64 133.87 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.904 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -129.49 146.34 51.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.994 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -89.57 117.06 28.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 172' ' ' LEU . 70.5 mt . . . . . 0 C--N 1.321 -0.673 0 CA-C-O 121.175 0.512 . . . . 0.0 110.869 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -76.5 -10.03 59.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -97.36 -48.33 5.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.181 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.51 -36.36 83.95 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.136 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -53.46 -41.01 65.73 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.386 0.429 . . . . 0.0 111.133 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 7' ' ' ARG . 44.1 ttm180 -65.65 -35.17 80.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.168 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.35 -34.91 17.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -60.17 -52.4 65.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.054 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 98.0 t -62.3 -46.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.482 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 tp -59.77 -42.8 94.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.667 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -61.02 -44.13 97.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.899 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -71.73 -31.18 66.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.241 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 80.0 mtp180 -64.0 -53.6 47.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.715 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 11' ' ' LEU . 26.4 pt -78.44 8.57 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.005 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.98 -9.04 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.478 0.656 . . . . 0.0 109.523 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 54' ' ' GLU . 92.8 mt -68.92 141.06 55.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.504 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -69.4 153.29 43.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 111.251 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 9.4 tp10 -56.64 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.768 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.57 -44.07 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.276 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 7.3 tp10 -61.18 -39.71 91.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 42.0 ttt180 -55.1 -47.96 74.24 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.577 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.3 mmt180 -62.56 -32.23 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.78 -29.78 68.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.382 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 59.0 mt -79.34 -40.43 30.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.263 0.554 . . . . 0.0 110.31 176.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 19.9 m -59.6 -40.02 86.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.906 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.78 -32.07 73.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.439 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 91.0 mttt -60.24 -53.98 51.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.86 -43.1 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.557 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.28 -46.46 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.979 0.419 . . . . 0.0 110.508 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 t -65.38 -42.81 92.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.938 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -70.02 -43.33 71.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.595 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 36' ' ' LEU . 28.0 tp -66.89 -34.67 78.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -86.31 -3.37 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.15 0.5 . . . . 0.0 110.625 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.53 -28.12 31.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 178' ' ' VAL . 70.2 mt -61.45 123.77 77.94 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.141 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.46 -20.5 41.71 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.485 2.123 . . . . 0.0 112.162 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.28 -22.08 55.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.778 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -72.18 -14.99 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.08 -33.5 14.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.249 177.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.71 -38.23 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.624 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 p -61.89 152.0 33.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 42' ' ' SER . 12.8 mptt -132.71 -25.75 1.85 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.848 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 3.3 mptp? -103.9 95.52 6.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 60.9 t -111.4 118.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 111.169 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -106.17 124.34 49.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.204 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.55 123.68 48.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.96 -7.54 49.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.921 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 68.4 m 70.93 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 123.326 0.65 . . . . 0.0 111.964 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 2.9 Cg_exo -75.37 95.48 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.952 2.435 . . . . 0.0 112.132 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 52' ' ' LYS . 27.2 pt -78.39 -40.21 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.097 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 51' ' ' ILE . 94.7 mttt -129.28 103.13 6.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.74 172.6 35.73 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.578 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -93.9 -10.3 34.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.923 0.392 . . . . 0.0 110.29 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG12 ' HG ' ' A' ' 57' ' ' LEU . 57.4 t -75.13 109.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 8.0 m-20 -90.54 84.09 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.512 . . . . 0.0 111.854 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.585 ' HG ' HG12 ' A' ' 55' ' ' VAL . 94.0 mt -96.18 -10.7 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.533 0.682 . . . . 0.0 109.248 171.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.475 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 5.6 m -61.17 -49.62 87.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.121 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 58' ' ' THR . 49.2 Cg_endo -69.22 2.27 3.37 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.01 1.807 . . . . 0.0 113.501 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 64' ' ' VAL . 21.2 tp -94.84 -8.17 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.048 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 19.9 m-85 -53.98 -51.53 76.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 12.2 Cg_endo -56.34 -36.17 96.82 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.553 2.168 . . . . 0.0 112.515 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 66' ' ' LYS . 51.8 tp10 -71.58 -41.78 68.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' LEU . 77.0 t -57.97 -43.37 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.53 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.09 -1.52 7.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 63' ' ' GLU . 54.4 mttp -88.93 -26.39 21.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -112.0 -50.66 2.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.112 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 27.6 mtmm -131.83 -174.31 3.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.921 -168.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 36.7 mt-10 -96.84 142.48 28.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.52 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.97 109.4 21.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.24 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 66.9 mt -98.56 118.22 44.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.102 0.477 . . . . 0.0 110.057 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.83 145.81 34.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.063 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' CB ' HD11 ' A' ' 80' ' ' ILE . 87.5 Cg_endo -89.34 120.33 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.183 2.589 . . . . 0.0 113.118 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.831 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 tttt -106.18 117.18 33.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG11 ' HE2' ' A' ' 96' ' ' PHE . 58.7 t -85.36 109.18 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -131.27 98.94 4.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.726 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.81 19.46 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m120 71.15 -36.11 0.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 112.181 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.87 143.52 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.501 HD13 HD22 ' A' ' 139' ' ' LEU . 15.5 tt -98.94 132.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.181 0.515 . . . . 0.0 111.426 -173.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.9 t -120.9 124.19 44.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.377 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 73' ' ' PRO . 77.5 mt -87.13 130.23 34.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.069 0.461 . . . . 0.0 110.85 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.659 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 9.8 m-85 -106.91 126.26 52.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.616 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 71.3 ttt180 -85.45 92.67 8.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.424 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.77 111.59 23.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.537 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.406 ' HD2' ' HG2' ' A' ' 84' ' ' ARG . 4.8 p80 -120.58 20.13 11.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.497 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 p -162.15 122.23 1.49 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.035 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.96 41.57 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.029 2.486 . . . . 0.0 112.97 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.74 -36.53 15.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.767 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.9 m -131.17 102.79 6.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.459 . . . . 0.0 111.428 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.0 mt -140.97 153.4 45.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.852 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.59 160.61 30.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.974 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.59 112.91 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.23 -154.96 6.63 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.357 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.32 -127.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.567 0.347 . . . . 0.0 110.701 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HE2' HG11 ' A' ' 75' ' ' VAL . 88.4 m-85 -85.39 17.64 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.828 0.347 . . . . 0.0 110.812 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 46.8 2.73 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.74 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.0 pt -124.27 170.31 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.823 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.54 93.31 7.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.063 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.831 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 4.3 pt-20 -104.83 109.86 63.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 31.7 Cg_exo -59.63 127.41 23.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.377 2.051 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.43 -56.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.717 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.57 -176.79 4.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.53 -159.84 22.95 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.387 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -96.45 96.85 8.98 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -77.91 120.45 22.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.66 147.72 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.206 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.8 t-20 -58.58 138.91 85.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.463 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' ASN . 53.7 Cg_exo -53.92 -16.22 8.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.573 2.849 . . . . 0.0 114.271 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 42.7 tt0 -61.61 -28.18 69.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.397 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.34 -28.99 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 111.145 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 44' ' ' LYS . 40.5 t -65.41 121.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.33 -20.77 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.603 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 32.6 t80 -135.96 114.34 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 143' ' ' VAL . 16.2 tt -121.28 139.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.15 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.91 106.48 17.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.259 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.35 123.48 34.95 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.773 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -92.84 -163.42 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.01 2.473 . . . . 0.0 112.004 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.73 -176.68 44.14 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.6 -41.46 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 117.046 0.423 . . . . 0.0 110.749 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.68 161.51 38.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.337 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.44 158.59 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.564 0.54 . . . . 0.0 109.781 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 9.3 p30 -120.34 -172.1 2.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.349 . . . . 0.0 110.678 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.5 mt -98.83 7.69 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.465 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -103.38 -30.3 10.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 133.9 -4.09 4.61 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.226 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -88.86 163.38 15.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.24 0.543 . . . . 0.0 111.215 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 128' ' ' ARG . 7.6 mtm-85 -126.15 157.02 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.278 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.141 0.496 . . . . 0.0 110.546 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 6.9 p-10 -67.56 -33.34 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -70.27 -8.42 50.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 80' ' ' ILE . 21.2 tp -93.58 -72.27 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.439 ' HA ' HG23 ' A' ' 143' ' ' VAL . 95.5 mt -66.36 -17.7 64.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.313 -171.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.706 ' HG3' ' HB ' ' A' ' 167' ' ' ILE . 83.8 tttt -92.95 -12.1 31.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.671 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -121.33 0.95 10.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.323 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 115' ' ' ILE . 92.8 t -50.35 121.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.0 111.06 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 58.1 mtpt -87.82 -11.38 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.099 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.45 176.82 51.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.208 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.29 110.72 3.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.833 0.349 . . . . 0.0 110.686 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 143' ' ' VAL . 11.6 mmmm -72.47 100.11 2.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.815 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.59 124.92 59.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.359 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -102.08 129.48 9.91 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.19 121.25 66.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.935 0.367 . . . . 0.0 110.84 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.27 165.51 31.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.264 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.579 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 47.8 m-85 -92.2 -178.79 5.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 t -68.47 -22.31 64.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.185 0.516 . . . . 0.0 109.973 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -72.75 -18.04 61.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.164 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.519 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.6 mp0 -95.64 -7.44 37.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.322 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.25 116.61 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.068 0.461 . . . . 0.0 111.701 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.55 174.35 6.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.372 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 26.8 mm-40 -74.26 -60.29 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 110.54 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 34.8 ttt180 -145.97 129.2 16.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 84.7 mt -93.62 160.7 32.31 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.194 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.59 101.64 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.221 . . . . 0.0 111.614 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -80.07 148.26 31.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.204 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -77.1 -60.92 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 169.54 -39.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.137 0.975 . . . . 0.0 109.711 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.467 ' O ' ' HE3' ' A' ' 141' ' ' LYS . 8.3 m-90 -136.13 21.83 3.24 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.06 149.75 18.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.896 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.706 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 6.6 tp -93.79 113.56 60.77 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.227 -175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 167' ' ' ILE . 57.6 Cg_endo -71.53 174.74 10.5 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.463 2.109 . . . . 0.0 112.853 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.78 157.94 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.961 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -91.91 -42.6 9.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.9 122.21 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.4 tp -106.35 108.0 19.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.056 0.455 . . . . 0.0 109.874 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.16 118.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.064 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 79.7 p -114.36 -178.93 3.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 14.9 pt-20 -71.61 -15.26 62.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.575 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.541 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 99.8 mttt -105.7 -60.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.544 -174.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.17 172.57 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 111.498 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 36' ' ' LEU . 23.6 t -115.09 98.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.545 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -94.49 117.79 30.67 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.561 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.01 111.25 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.155 174.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.458 HD13 ' HA2' ' A' ' 126' ' ' GLY . 64.5 mt . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.3 0.571 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -69.23 -34.9 75.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.536 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -70.84 -44.48 66.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.4 -36.83 79.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.686 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.62 -50.85 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.297 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -62.29 -42.24 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.543 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.36 -33.74 75.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.653 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 29.6 ttmt -81.78 -46.03 14.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.312 -176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.22 -35.79 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.302 0.573 . . . . 0.0 110.365 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.7 tp -59.31 -37.13 76.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.938 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -58.6 -41.79 86.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.056 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -74.69 -40.67 61.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.523 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.632 HH11 ' HA ' ' A' ' 120' ' ' VAL . 15.7 ptm180 -70.4 -37.47 74.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.346 -175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 11' ' ' LEU . 33.4 pt -82.83 -0.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.822 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -81.45 -24.88 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.61 137.34 57.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.591 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 t -122.7 -166.59 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.823 -175.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -66.53 -4.59 8.81 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.9 -65.03 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.033 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 10.2 tp10 -76.47 -42.06 45.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.684 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 34.2 ttp85 -66.95 -26.47 66.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 -175.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 54.1 ttt85 -58.97 -49.15 78.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -79.71 -25.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 68.3 mt -63.63 -56.04 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.743 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 50.4 m -67.7 -32.99 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.028 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -58.94 -47.59 84.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 109.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 175' ' ' GLU . 49.6 mtpt -59.44 -39.57 84.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.025 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 175' ' ' GLU . 94.8 t -63.38 -50.31 79.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.716 0.293 . . . . 0.0 110.624 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 74.7 mt -58.86 -49.92 81.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.1 m -64.17 -36.95 85.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.718 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -66.7 -44.94 80.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.125 0.488 . . . . 0.0 109.978 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.5 tp -62.66 -39.43 93.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.746 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 28.0 mtpp -75.94 -14.12 60.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.249 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -84.54 -19.63 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 110.088 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.55 114.3 18.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -56.4 -32.71 89.79 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.291 2.661 . . . . 0.0 113.829 -171.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.45 -23.86 61.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.604 0.24 . . . . 0.0 111.056 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.1 -41.77 94.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.007 0.432 . . . . 0.0 110.552 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -85.67 -10.29 55.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.757 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -9.7 30.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -101.94 -176.77 3.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -136.0 -55.03 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.798 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 30.5 mtpt -89.07 101.99 14.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 111.194 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.89 119.78 62.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.57 131.67 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.392 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.95 138.67 50.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.74 -1.73 36.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.513 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.4 t 73.83 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.387 0 C-N-CA 123.47 0.708 . . . . 0.0 111.587 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.39 49.77 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.097 2.531 . . . . 0.0 112.259 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.792 HG13 ' H ' ' A' ' 52' ' ' LYS . 14.1 pt -56.46 -62.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.895 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.792 ' H ' HG13 ' A' ' 51' ' ' ILE . 94.4 mttt -122.29 9.29 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.719 0.771 . . . . 0.0 110.044 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.26 128.37 9.08 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -84.17 10.55 9.98 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -169.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.671 HG12 ' HG ' ' A' ' 57' ' ' LEU . 92.3 t -63.61 104.43 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.75 77.82 5.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.463 0.649 . . . . 0.0 111.145 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' A' ' 55' ' ' VAL . 96.6 mt -94.03 -2.08 53.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.178 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.496 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -56.65 -44.82 99.91 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.422 -178.262 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.8 Cg_endo -69.74 1.44 4.42 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.22 1.947 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.01 -18.36 24.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.294 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.83 -44.35 97.93 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 95.2 Cg_exo -45.49 -39.26 16.94 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.328 2.019 . . . . 0.0 113.244 174.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -77.68 -44.76 26.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 68' ' ' LYS . 65.1 t -57.25 -42.84 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.413 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.48 -4.13 17.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 95.5 mttt -98.4 -59.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 6.4 pt-20 -105.45 -17.62 14.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.63 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 45.4 mmtm -111.76 168.51 9.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.455 0.645 . . . . 0.0 111.666 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.798 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.4 mm-40 -102.12 103.16 13.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.984 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.58 100.54 6.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 58.2 mt -91.86 114.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.5 mt -114.79 141.81 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.728 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.6 Cg_exo -80.11 129.19 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.868 2.379 . . . . 0.0 112.071 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 36.3 tttm -105.54 100.39 9.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 80' ' ' ILE . 35.1 t -69.73 98.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -146.92 134.58 21.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.274 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 -92.1 0.47 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.651 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.24 10.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.979 0.419 . . . . 0.0 109.954 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -125.96 154.04 43.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.911 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD13 ' A' ' 139' ' ' LEU . 6.2 pt -96.62 92.46 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 166.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.1 t -80.52 110.85 16.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.846 -170.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.97 121.98 22.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.726 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 97.1 m-85 -121.85 148.94 44.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.006 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -88.45 134.92 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.09 126.86 68.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.848 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -124.05 -1.23 8.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.229 0.538 . . . . 0.0 110.004 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -153.97 151.11 24.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 -174.46 0.84 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.946 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.0 -36.09 0.35 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.193 0.597 . . . . 0.0 111.884 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.94 -3.46 16.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.501 0.667 . . . . 0.0 111.238 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.27 123.68 39.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.28 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.02 135.78 9.56 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.708 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.0 t -82.92 94.37 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.63 -24.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.385 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.19 -156.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 0.0 111.328 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.59 55.98 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.156 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.14 16.48 43.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.037 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 36.2 pt -120.27 165.29 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.85 90.47 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.021 0.438 . . . . 0.0 110.607 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.714 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -88.98 147.54 38.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.514 -177.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 18.3 Cg_endo -61.19 114.46 2.21 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.745 2.297 . . . . 0.0 112.092 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -91.07 -52.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.317 0.58 . . . . 0.0 109.876 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -97.54 87.18 4.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.152 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.54 170.69 35.83 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.198 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.48 137.04 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.764 0.282 . . . . 0.0 110.936 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -77.88 133.54 38.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.753 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.89 135.88 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.737 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -87.02 146.73 41.2 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.593 ' HB3' ' HA ' ' A' ' 143' ' ' VAL . 50.9 Cg_exo -55.39 -25.05 46.16 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.06 2.507 . . . . 0.0 113.371 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 144' ' ' LYS . 43.2 tt0 -72.87 -20.33 61.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.165 0.507 . . . . 0.0 110.962 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -100.23 7.13 44.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.18 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.445 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 60.0 t -94.32 111.88 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.06 -54.22 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -124.67 139.34 53.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.603 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 147' ' ' LYS . 4.5 tp -134.22 108.24 10.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.435 0.636 . . . . 0.0 109.561 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.79 112.07 24.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.948 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.11 113.86 51.58 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 150' ' ' VAL . 3.8 Cg_exo -76.52 91.72 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.801 2.334 . . . . 0.0 111.341 175.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.98 158.27 48.03 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.896 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' HH11 ' A' ' 14' ' ' ARG . 57.5 t -74.7 -39.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 110.013 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.539 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -147.76 155.93 42.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.898 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -135.21 153.19 52.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.425 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.605 ' HB3' ' H ' ' A' ' 127' ' ' TYR . 15.3 t70 -78.62 164.72 24.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.268 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.888 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 13.3 mt -55.44 -32.46 62.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 181' ' ' LEU . 46.6 mt-10 -87.53 -64.57 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 172' ' ' LEU . . . 165.11 53.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.85 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.605 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 51.2 m-85 -99.46 161.15 13.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 166' ' ' ASP . 40.3 ptt180 -93.27 155.6 17.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 112.451 -167.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.644 ' HB2' HD13 ' A' ' 160' ' ' LEU . 40.7 tp . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.381 168.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.4 -35.99 60.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.045 0.538 . . . . 0.0 111.813 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -60.47 -33.4 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.052 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.675 HD13 HG13 ' A' ' 80' ' ' ILE . 9.1 tt -83.43 -44.26 14.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.43 -18.11 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.775 0.322 . . . . 0.0 111.325 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 141' ' ' LYS . 4.2 ttmp? -89.16 -15.5 33.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.065 0.46 . . . . 0.0 109.883 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.59 -21.82 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 60.7 t -63.58 127.73 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.163 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD2' ' HG3' ' A' ' 110' ' ' GLU . 96.9 mttt -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 112' ' ' VAL . . . -79.63 -170.93 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.123 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.41 110.98 16.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.982 0.42 . . . . 0.0 109.95 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HA ' HG23 ' A' ' 115' ' ' ILE . 95.7 mttt -86.47 109.38 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 63.0 t -106.34 122.25 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.82 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.34 119.66 6.01 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 47.7 t -105.95 117.96 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.69 0.281 . . . . 0.0 110.982 -175.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.35 -178.08 6.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.894 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 35.0 m-85 -106.53 165.63 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -56.48 -30.44 62.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.21 -32.32 72.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.076 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.414 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 12.2 mm100 -90.89 -7.97 50.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.77 117.88 33.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.965 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.63 174.48 5.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.888 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 45.9 mt-10 -69.69 -57.58 4.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 111.267 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.6 ttm105 -144.77 118.58 9.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 -169.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 129' ' ' LEU . 74.8 mt -98.53 141.19 22.51 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.698 0.285 . . . . 0.0 111.452 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.18 113.19 3.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.814 2.343 . . . . 0.0 111.666 174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -98.42 149.37 22.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.62 -75.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.235 -172.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -149.25 -76.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -100.05 69.05 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 109.393 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.4 ' HA ' ' NH2' ' A' ' 128' ' ' ARG . 13.9 t70 -76.04 149.63 37.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.329 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.408 HD11 ' HZ1' ' A' ' 141' ' ' LYS . 65.9 mt -110.87 107.41 57.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.835 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.56 154.59 31.25 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.824 2.349 . . . . 0.0 111.214 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 m -88.39 158.96 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.343 -0.39 . . . . 0.0 109.992 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.57 -42.46 12.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.518 0.675 . . . . 0.0 109.502 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 75.7 t -126.35 116.48 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.496 176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 35.2 tp -99.87 103.65 15.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.911 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.05 125.87 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.128 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 54.0 p -107.83 -166.74 1.17 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.403 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.649 ' HB2' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.54 9.51 36.41 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.697 174.393 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -125.79 -55.21 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.556 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.12 160.03 39.91 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 111.505 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.411 HG12 ' HG3' ' A' ' 180' ' ' ARG . 64.9 t -101.2 113.98 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.96 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -92.49 93.66 8.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.728 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 178' ' ' VAL . 86.1 mtm180 -86.18 121.24 28.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.642 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 125' ' ' GLU . 39.5 mt . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 4' ' ' SER . 50.0 tp . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -28.02 66.36 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.565 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.542 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 12.2 m -70.44 -35.72 73.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.115 0.484 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 33.5 tt0 -61.92 -53.73 51.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.859 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 10' ' ' VAL . 65.5 tp -57.66 -45.04 86.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.808 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 120' ' ' VAL . 18.0 ttp180 -55.32 -42.35 73.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.497 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.64 -37.0 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 110.601 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HE2' ' HG2' ' A' ' 5' ' ' GLU . 64.7 mttm -65.03 -37.71 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.413 0.625 . . . . 0.0 110.09 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' LEU . 46.3 t -69.5 -38.93 77.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.637 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.99 -37.43 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.275 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -56.18 -47.75 77.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.059 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 10' ' ' VAL . 62.6 pttt -77.23 -0.17 24.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.585 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 41.6 ttm180 -93.05 -48.86 6.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.672 ' HA ' HH12 ' A' ' 22' ' ' ARG . 31.3 pt -85.54 -11.97 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -89.54 5.16 46.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.124 0.488 . . . . 0.0 110.846 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.97 149.85 42.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.432 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -70.67 146.7 49.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -62.39 -40.35 96.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -52.15 -52.47 51.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.522 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 6.2 pt-20 -81.03 -31.32 34.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.24 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.672 HH12 ' HA ' ' A' ' 15' ' ' ILE . 35.9 ttm-85 -57.04 -49.44 75.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.861 0.362 . . . . 0.0 110.82 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.71 -31.57 70.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -80.22 -34.96 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' VAL . 92.7 mt -65.13 -46.12 82.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 30' ' ' ILE . 20.2 m -64.15 -33.38 75.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.518 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.06 -43.0 99.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.12 -39.63 86.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.355 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' LEU . 64.9 t -65.19 -46.03 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 26' ' ' SER . 76.0 mt -58.98 -46.96 91.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 110.171 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -60.02 -45.66 92.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.48 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.84 -45.08 95.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.427 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.48 -42.46 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.379 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -71.1 -26.18 62.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.014 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 m -73.18 -23.67 60.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.8 mt -60.16 122.08 63.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.306 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 33.8 Cg_exo -60.61 -21.29 68.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.166 2.577 . . . . 0.0 112.913 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -75.49 -39.65 58.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.94 -37.49 76.83 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.387 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -67.3 -37.7 83.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 3.7 tmmm? -78.57 -52.37 8.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.124 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -60.84 131.1 49.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -90.51 -42.49 10.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.91 106.9 18.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.98 0.419 . . . . 0.0 110.322 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.84 108.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.337 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -94.54 117.49 30.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -104.89 122.03 44.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.648 ' HA ' ' HG3' ' A' ' 73' ' ' PRO . 8.9 t80 -76.73 -6.5 52.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.563 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.3 m 69.75 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 121.43 0.633 . . . . 0.0 111.621 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.54 125.74 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.506 2.137 . . . . 0.0 112.923 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.66 145.22 16.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 69.1 -41.4 0.47 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.414 0.686 . . . . 0.0 111.765 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.12 -76.8 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.819 ' HA ' ' HD3' ' A' ' 14' ' ' ARG . 6.3 mm-40 56.69 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.889 0.875 . . . . 0.0 111.305 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 150' ' ' VAL . 95.8 t -153.33 128.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.434 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -82.12 90.15 6.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.204 0.526 . . . . 0.0 110.881 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.583 HD11 HG11 ' A' ' 150' ' ' VAL . 89.1 mt -102.2 6.61 40.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.837 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -61.03 -43.81 92.27 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.065 -175.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 58' ' ' THR . 19.3 Cg_endo -61.2 -7.07 7.5 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.121 1.881 . . . . 0.0 113.886 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.34 -13.93 39.48 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.456 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.1 m-85 -52.48 -49.77 83.82 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.4 Cg_exo -52.36 -36.05 67.32 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.41 2.073 . . . . 0.0 113.225 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mt-10 -74.18 -31.42 62.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.014 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.19 -36.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.429 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -68.04 -5.01 15.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.582 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 43.4 tttp -66.87 -64.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.742 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 11.2 pt-20 -143.92 -4.05 0.85 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 6.3 mptp? -92.92 164.08 13.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.337 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.83 ' HG3' ' HB2' ' A' ' 84' ' ' ARG . 3.0 tp10 -97.3 103.46 15.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.227 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.8 tp -76.78 94.11 3.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 0.0 110.758 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 56.4 mt -88.49 112.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 86.2 mt -110.06 149.59 40.27 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.663 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 48' ' ' TYR . 9.6 Cg_endo -89.23 125.6 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.376 2.717 . . . . 0.0 113.097 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -105.62 105.63 15.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.429 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 80' ' ' ILE . 21.3 t -82.58 95.4 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.345 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.12 5.97 18.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.659 0.742 . . . . 0.0 109.835 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.49 -153.12 18.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -78.36 -6.24 54.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.109 0.48 . . . . 0.0 110.495 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.99 143.46 46.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.145 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 75' ' ' VAL . 49.6 mm -100.47 122.81 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.129 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m -85.84 122.67 30.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.506 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -101.32 133.19 46.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.684 0.278 . . . . 0.0 110.685 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . 93.9 m-85 -128.77 146.02 51.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.83 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 38.3 ptt85 -100.03 134.35 43.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.117 0.484 . . . . 0.0 110.012 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.78 139.38 51.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -124.76 -28.27 3.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.309 171.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.3 m -108.12 131.62 21.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 -10.14 25.35 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.141 2.561 . . . . 0.0 113.441 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.92 60.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.416 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 41.8 m -85.44 8.39 19.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.027 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.6 138.04 39.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.98 0.419 . . . . 0.0 111.5 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.86 176.41 20.68 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.549 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.78 90.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.846 0.355 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.98 -16.26 7.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.591 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.7 -171.05 3.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.303 0.241 . . . . 0.0 110.984 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -53.48 -53.66 48.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.102 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.85 50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.727 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.5 157.42 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.27 147.06 32.42 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.459 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 83' ' ' TYR . 72.9 Cg_endo -80.11 105.98 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.209 1.939 . . . . 0.0 111.458 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.71 -19.43 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.833 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -137.03 -171.97 3.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.916 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.53 -132.63 11.07 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 137.88 32.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -80.54 156.07 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.478 . . . . 0.0 111.68 -175.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.24 142.98 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.407 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -89.94 141.67 28.29 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.721 ' HB3' HG22 ' A' ' 143' ' ' VAL . 87.0 Cg_exo -46.7 -40.41 24.24 Favored 'Trans proline' 0 N--CA 1.476 0.441 0 C-N-CA 123.647 2.898 . . . . 0.0 114.225 -175.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.28 -19.27 64.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.41 -17.82 50.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.22 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 118.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.696 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -76.31 -55.66 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.33 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 148' ' ' VAL . 40.8 t80 -128.35 136.35 50.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.684 -173.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -139.06 139.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.98 113.17 25.82 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.073 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 47.8 t -111.98 124.73 31.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.878 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 4.9 Cg_exo -77.83 131.04 10.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.104 2.536 . . . . 0.0 111.804 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.88 140.18 11.56 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.539 HG11 ' HG2' ' A' ' 7' ' ' ARG . 48.6 t -70.93 -43.55 76.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 117.016 0.408 . . . . 0.0 110.836 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -143.42 130.91 21.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.74 169.29 9.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.01 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 26.4 p30 -132.1 -172.35 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.583 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 88.9 mt -87.29 3.17 47.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.27 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.96 -31.96 10.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.421 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 117.75 29.86 1.95 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.091 169.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.23 156.61 16.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.534 0.667 . . . . 0.0 109.865 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 167' ' ' ILE . 0.0 OUTLIER -101.45 -33.42 9.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -163.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 160' ' ' LEU . 35.6 tp . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.416 0.627 . . . . 0.0 111.908 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.8 t70 -70.38 161.05 31.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 137' ' ' ASP . 28.4 ttt180 72.93 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 137' ' ' ASP . 30.8 tp -65.46 -65.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.661 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.69 ' HB2' HD13 ' A' ' 167' ' ' ILE . 97.4 mt -71.64 -11.99 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.573 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.61 -23.84 39.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 0.0 110.106 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -96.2 -35.75 11.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.705 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.3 t -73.39 93.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -101.91 26.37 7.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.431 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.95 -175.24 31.86 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.268 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -71.58 98.14 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.119 0.459 . . . . 0.0 109.931 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.518 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.8 mtmm -84.74 102.89 13.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 171' ' ' VAL . 98.6 t -103.49 119.89 52.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.663 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.46 130.85 10.1 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 57' ' ' LEU . 51.0 t -114.61 119.51 61.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -163.71 171.58 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.528 ' HB3' ' OE2' ' A' ' 175' ' ' GLU . 57.1 m-85 -87.21 162.53 17.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 156' ' ' VAL . 5.8 p -77.35 -9.94 59.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 0.0 110.46 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -61.67 -29.64 70.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -105.86 20.43 18.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 111.281 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 153' ' ' SER . 64.0 t -103.42 116.27 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.944 0.402 . . . . 0.0 110.546 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -100.84 -171.57 2.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.262 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.518 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 13.0 mt-10 -92.02 -44.76 8.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -147.59 125.05 11.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.376 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 97.4 mt -84.89 143.97 41.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.643 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 3.7 Cg_exo -74.95 102.26 1.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.812 2.341 . . . . 0.0 110.548 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 28.6 mtt180 -108.87 155.83 20.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 -172.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.58 -55.38 24.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.15 -50.61 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.147 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -129.28 83.74 2.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.853 0.835 . . . . 0.0 111.368 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.01 151.2 33.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 167.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 140' ' ' LEU . 64.6 mt -75.05 113.46 25.2 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.81 0.338 . . . . 0.0 110.676 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -88.88 161.36 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.044 2.496 . . . . 0.0 113.186 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.17 176.45 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.166 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -99.28 -45.29 5.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.368 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.9 t -129.04 141.13 47.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.658 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 68.5 tp -117.51 115.56 25.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.98 122.73 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 77.1 p -115.79 -174.38 2.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 111.021 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.859 ' HG3' ' HD2' ' A' ' 176' ' ' LYS . 11.6 pt-20 -70.39 -13.68 62.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.096 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.859 ' HD2' ' HG3' ' A' ' 175' ' ' GLU . 10.1 mptt -121.67 -70.38 0.78 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -110.43 168.92 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.443 -167.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.4 119.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.669 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.751 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 39.0 mmt180 -94.16 102.86 14.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.039 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -79.88 89.62 5.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' CA ' ' A' ' 126' ' ' GLY . 34.2 mt . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.718 -173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -75.31 -37.26 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -70.17 -25.27 63.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.56 -38.54 70.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 129' ' ' LEU . 58.1 tp -70.76 -40.06 72.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.756 176.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.597 ' HG3' HG11 ' A' ' 120' ' ' VAL . 12.8 ttp180 -60.16 -44.33 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.428 174.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -64.78 -33.03 75.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.94 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -62.71 -47.31 84.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.266 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 121' ' ' ALA . 45.7 t -73.68 -43.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.615 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 14' ' ' ARG . 51.4 tp -57.92 -33.44 68.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.048 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 9.7 t60 -60.44 -43.6 96.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.375 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 44.2 mttp -81.67 -24.66 36.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 0.0 111.033 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 11' ' ' LEU . 41.1 ttt85 -57.77 -51.92 67.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.67 4.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.595 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 8.6 t30 -83.88 -19.21 35.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.35 132.65 52.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.757 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -70.65 153.16 43.11 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.041 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -43.66 79.82 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.334 0.396 . . . . 0.0 111.839 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.0 tp10 -60.95 -56.79 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.792 0.33 . . . . 0.0 111.081 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.46 -44.28 97.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.35 -42.1 98.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.013 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 12.7 tpt180 -62.11 -43.12 99.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.696 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 85.0 mtt180 -60.77 -38.79 86.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 98.4 mt -72.6 -45.22 60.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.882 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -62.67 -35.04 78.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.33 -43.49 79.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -66.36 -39.3 89.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 175' ' ' GLU . 61.5 t -65.06 -47.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.693 0.282 . . . . 0.0 110.776 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.77 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 110.203 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -36.16 83.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.101 0.476 . . . . 0.0 109.971 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -69.32 -44.36 71.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 33' ' ' LEU . 5.2 tt -65.46 -38.55 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.991 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -67.11 -26.53 66.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 111.036 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -83.79 -16.77 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -68.02 112.35 10.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.142 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HD2' HD23 ' A' ' 36' ' ' LEU . 35.1 Cg_endo -64.74 -25.43 61.14 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.611 2.207 . . . . 0.0 112.795 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.35 -24.61 61.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.731 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.26 -42.57 99.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.89 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HA ' ' NZ ' ' A' ' 68' ' ' LYS . 89.3 mttt -83.92 -3.04 57.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.129 0.49 . . . . 0.0 110.808 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.22 -33.8 22.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.492 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.7 p -81.94 152.55 26.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.195 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 24.8 tptp -111.46 -40.33 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 109.732 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 22.2 mmtp -91.99 107.43 19.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.796 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.3 115.01 47.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.278 0.561 . . . . 0.0 111.511 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -104.19 133.07 49.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.39 129.0 51.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.0 0.428 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -88.02 109.88 20.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.0 m -52.68 116.17 8.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.536 0.523 . . . . 0.0 111.621 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.18 69.09 7.24 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.865 2.377 . . . . 0.0 112.44 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 52' ' ' LYS . 26.5 pt -55.0 -43.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.521 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' N ' HG13 ' A' ' 51' ' ' ILE . 64.5 mttm -112.98 30.53 7.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -99.78 149.71 18.89 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.152 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' OE2' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -91.06 -35.62 14.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.32 104.07 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.83 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.85 101.84 7.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.972 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.08 5.9 40.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.781 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.2 m -60.1 -52.92 69.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.427 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 18.6 Cg_exo -68.88 7.28 0.79 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 113.495 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.67 -13.81 38.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.357 . . . . 0.0 110.146 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.6 m-30 -55.75 -49.13 94.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.142 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 75.2 Cg_exo -53.55 -36.06 79.04 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.281 1.987 . . . . 0.0 113.067 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 4.4 tp10 -70.98 -31.33 67.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 110.151 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.52 -40.76 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.396 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 88' ' ' PRO . 95.8 mt -65.65 -11.85 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 41.2 tttp -64.82 -60.5 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.252 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.844 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.8 pt-20 -120.65 -19.82 7.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -172.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.844 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 50.6 mttm -116.38 -172.45 2.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.628 0.251 . . . . 0.0 110.664 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -112.93 143.0 44.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.869 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.9 tp -92.74 124.77 36.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.226 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.55 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 53.5 mt -111.23 126.52 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.997 0.427 . . . . 0.0 110.484 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -123.71 147.93 54.79 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.308 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.72 125.36 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.218 2.612 . . . . 0.0 112.753 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' OE1' ' A' ' 100' ' ' GLU . 85.1 tttt -113.32 139.69 48.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.845 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.71 99.27 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HE2' ' A' ' 74' ' ' LYS . 10.6 mm-40 -81.66 82.57 7.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.734 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.18 -89.74 0.5 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -174.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.18 -7.29 8.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.88 0.371 . . . . 0.0 110.37 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.96 98.93 12.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.749 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.9 tt -91.94 127.58 44.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.341 0.591 . . . . 0.0 110.291 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -137.07 167.47 21.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.767 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.6 mt -99.32 138.1 36.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.372 . . . . 0.0 110.456 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -118.87 128.16 54.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -95.99 111.93 23.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.393 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 91' ' ' LEU . 27.0 m -101.94 138.31 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.072 0.463 . . . . 0.0 110.386 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -96.87 -4.81 39.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.347 0.594 . . . . 0.0 109.805 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -167.81 144.7 3.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.893 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD3' HD13 ' A' ' 65' ' ' LEU . 54.3 Cg_endo -72.1 71.27 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.45 2.1 . . . . 0.0 111.818 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.37 -58.05 2.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.812 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 7.7 p -86.43 21.62 2.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.273 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 85' ' ' VAL . 96.5 mt -99.12 108.53 21.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.14 10.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.74 108.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.098 0.449 . . . . 0.0 110.123 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 100' ' ' GLU . . . -150.48 -1.77 0.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.87 -161.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.312 . . . . 0.0 110.338 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.32 -18.75 63.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.257 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.18 -23.36 0.13 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.719 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -83.42 172.91 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.65 -0.275 . . . . 0.0 110.869 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -62.68 138.0 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.098 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.516 ' OE1' ' HG3' ' A' ' 74' ' ' LYS . 3.3 tp10 -108.34 107.19 59.94 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.157 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.58 106.07 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.67 1.58 . . . . 0.0 110.903 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.83 -45.65 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.224 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.67 178.72 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.87 -130.18 4.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.176 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -118.49 118.91 33.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.603 0.239 . . . . 0.0 110.418 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -80.67 97.0 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 111' ' ' ASP . 88.1 t -99.08 119.94 47.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.967 -175.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.17 154.08 86.36 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 143' ' ' VAL . 10.6 Cg_endo -54.1 -19.19 15.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.828 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.5 -41.12 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.937 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.577 ' HB3' HG13 ' A' ' 107' ' ' VAL . 22.1 t70 -87.24 -9.26 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.17 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.1 t -81.25 132.09 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.136 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.574 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 67.4 m-20 -91.7 -49.31 6.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.471 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 148' ' ' VAL . 47.5 t80 -130.31 138.43 50.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.541 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 tt -143.65 140.03 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.94 127.16 54.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -120.69 121.54 28.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.75 -41.26 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.722 2.282 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.25 -145.82 49.42 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.86 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.597 HG11 ' HG3' ' A' ' 7' ' ' ARG . 75.7 t -139.24 -45.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -161.15 157.07 25.28 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.381 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -135.92 166.01 24.32 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.157 0.285 . . . . 0.0 110.85 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -111.06 -171.74 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.892 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 52.9 mt -71.39 -14.38 62.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.63 -21.57 14.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.561 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.19 31.33 3.1 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.941 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -95.63 147.04 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.795 0.331 . . . . 0.0 110.435 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -84.06 150.13 25.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.861 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 6' ' ' LEU . 28.7 tp . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.515 0.674 . . . . 0.0 109.967 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 121.372 0.606 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.24 -39.49 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.671 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 37.6 ttm180 -61.8 -17.65 56.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.402 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 45.9 tp -92.9 -70.12 0.71 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.41 . . . . 0.0 111.028 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.775 ' HB2' HD13 ' A' ' 167' ' ' ILE . 7.4 mp -63.49 -32.32 73.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.36 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 141' ' ' LYS . 34.4 ttmt -80.81 -16.59 53.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 138' ' ' ARG . 37.4 mtp180 -101.69 -5.57 24.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.287 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 109' ' ' PRO . 94.0 t -62.04 112.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.124 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -92.16 -7.09 49.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.792 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.34 -173.71 46.66 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.1 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.544 HD11 HG23 ' A' ' 171' ' ' VAL . 32.3 tp -80.21 108.11 13.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.4 mtmm -86.25 106.19 17.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.044 0.45 . . . . 0.0 110.034 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.5 t -102.51 124.36 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.997 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.54 138.82 14.36 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.7 111.45 36.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -151.76 162.85 40.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.65 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 30.8 m-85 -86.16 170.38 12.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.393 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.1 t -72.13 -38.52 69.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.73 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -74.46 -9.07 58.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.486 . . . . 0.0 110.421 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -95.31 -7.7 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.019 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.46 110.29 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.408 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.46 179.99 5.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.242 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.892 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.36 -53.46 6.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.051 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -136.04 140.73 44.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 129' ' ' LEU . 96.7 mt -132.81 158.67 75.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.5 101.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.289 1.993 . . . . 0.0 110.933 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -96.7 128.33 43.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.941 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.926 ' HB3' ' HB2' ' A' ' 166' ' ' ASP . 9.6 t70 -95.11 137.16 34.54 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.59 57.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.81 0.338 . . . . 0.0 111.549 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -119.52 24.01 10.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 0.0 110.552 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.926 ' HB2' ' HB3' ' A' ' 163' ' ' ASP . 12.0 t70 -89.73 -157.61 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.542 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.775 HD13 ' HB2' ' A' ' 140' ' ' LEU . 56.9 mt -125.82 107.27 25.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.841 0.353 . . . . 0.0 111.305 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -93.12 174.49 1.75 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.247 2.632 . . . . 0.0 112.177 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.85 174.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.604 0.24 . . . . 0.0 110.758 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -106.88 -44.24 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.554 . . . . 0.0 109.902 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.544 HG23 HD11 ' A' ' 146' ' ' LEU . 86.5 t -125.96 140.75 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.552 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.62 ' HB2' HD21 ' A' ' 181' ' ' LEU . 53.6 tp -121.0 103.12 8.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.0 110.687 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.95 119.03 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.907 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.7 p -110.34 -175.94 2.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.187 0.518 . . . . 0.0 111.222 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.65 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 9.5 pt-20 -60.12 -27.61 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.658 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 24.9 mtmm -118.45 -56.77 2.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -119.05 174.51 6.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 111.334 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.91 99.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 25.0 ttm-85 -79.05 124.2 28.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.984 -174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 180' ' ' ARG . 4.6 mtp180 -92.22 97.52 10.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.569 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 172' ' ' LEU . 2.9 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.36 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.86 4.86 51.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 110.207 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -52.44 -50.38 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.681 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -70.93 -40.08 72.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.8 -37.43 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.115 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.499 HD23 HD22 ' A' ' 129' ' ' LEU . 38.0 tp -67.01 -37.23 83.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.72 -44.96 95.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.245 0.545 . . . . 0.0 109.843 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.38 -50.92 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.121 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -34.8 77.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.57 0.224 . . . . 0.0 111.576 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.12 -40.4 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.366 . . . . 0.0 110.189 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HD3' ' A' ' 14' ' ' ARG . 31.0 tp -62.21 -34.78 77.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -59.65 -43.92 93.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -81.97 -28.78 32.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.096 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.703 ' HD3' HD12 ' A' ' 11' ' ' LEU . 32.1 ttt85 -56.69 -43.96 81.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.293 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 pt -88.41 0.89 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.408 . . . . 0.0 111.115 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -89.57 -20.78 23.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.28 137.56 47.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.44 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.7 t -90.65 145.35 24.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.483 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 40.7 mm-40 -59.8 -25.14 64.71 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.284 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -53.25 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.379 0.609 . . . . 0.0 110.379 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.86 -40.62 65.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 66.9 ttt180 -56.34 -50.67 70.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.686 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -64.15 -33.73 76.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -70.97 -38.83 72.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.3 -37.5 71.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.437 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 55' ' ' VAL . 70.7 m -59.32 -39.98 84.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.704 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.72 -44.19 85.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -62.35 -43.8 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -44.95 99.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.479 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 56' ' ' ASP . 67.1 mt -56.93 -53.87 37.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.0 m -59.28 -44.55 92.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.993 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.432 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 2.7 t-20 -61.1 -52.51 64.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 20.0 tp -60.75 -38.35 84.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.078 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -79.4 -21.19 45.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.315 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -85.83 -18.93 31.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.208 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 32' ' ' ASN . 92.5 mt -55.94 119.61 27.53 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.728 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 39.3 Cg_exo -61.21 -22.76 75.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.015 2.476 . . . . 0.0 112.764 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.95 -23.88 48.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.606 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.53 -23.04 59.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -71.43 -29.12 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.41 -37.35 11.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.272 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m -58.19 122.54 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -90.94 -41.9 10.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.553 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' VAL . 18.7 mmtp -95.23 109.02 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.17 101.45 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -100.64 136.27 40.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.49 151.06 39.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.84 -90.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 35.6 t 176.05 127.23 0.15 Allowed Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.254 0.346 . . . . 0.0 110.344 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.39 112.29 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.169 2.579 . . . . 0.0 110.932 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.6 HG13 ' HG2' ' A' ' 52' ' ' LYS . 10.7 pt -127.98 -47.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HG2' HG13 ' A' ' 51' ' ' ILE . 74.4 mmtt -96.7 -69.24 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -171.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 14' ' ' ARG . . . -149.58 46.79 0.64 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.303 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HG3' HH21 ' A' ' 14' ' ' ARG . 3.9 mp0 -97.87 -156.18 0.53 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 26' ' ' SER . 91.6 t -101.41 138.35 25.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.608 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HD11 ' A' ' 30' ' ' ILE . 27.1 m-20 -72.35 75.18 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.16 0.505 . . . . 0.0 111.08 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 150' ' ' VAL . 93.2 mt -90.72 -5.02 56.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.768 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -47.54 98.85 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.452 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 17.2 Cg_exo -68.3 -7.66 20.72 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.252 1.968 . . . . 0.0 113.205 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 40.9 tp -87.17 -7.08 58.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.794 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.538 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 13.0 m-30 -53.31 -50.65 81.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.943 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.8 Cg_exo -52.17 -42.05 61.74 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.239 1.96 . . . . 0.0 112.977 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -65.41 -43.82 89.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.647 0.261 . . . . 0.0 110.848 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' LEU . 56.0 t -64.66 -48.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.635 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.36 -33.87 66.09 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.435 0.459 . . . . 0.0 111.382 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -64.32 -45.87 86.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.705 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -101.81 -60.55 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -108.55 -171.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.021 0.439 . . . . 0.0 111.272 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HG2' ' HD2' ' A' ' 84' ' ' ARG . 1.8 mp0 -96.35 116.8 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.253 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.79 116.06 18.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.654 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 58.0 mt -111.12 126.02 68.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.896 0.379 . . . . 0.0 110.623 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.3 mt -120.69 150.08 51.78 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 58.8 Cg_endo -73.27 125.7 10.46 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.577 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 8.9 tmtm? -116.63 124.37 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.72 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 80' ' ' ILE . 41.6 t -90.7 105.98 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.13 -24.97 18.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.753 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.44 80.63 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.83 -56.96 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 0.0 111.118 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.96 141.48 34.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 75' ' ' VAL . 67.5 mt -105.08 127.87 59.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -102.89 163.28 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.654 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 66.3 mt -115.8 124.54 50.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.04 0.448 . . . . 0.0 110.855 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -108.36 134.69 50.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.238 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.618 ' HD2' ' HG2' ' A' ' 69' ' ' GLU . 13.7 ptt180 -93.8 140.66 29.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.07 140.99 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.485 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.61 2.71 15.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.796 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 25.4 p -149.86 151.9 33.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.739 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.7 Cg_exo -76.6 44.37 1.39 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.997 2.465 . . . . 0.0 111.742 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 -74.31 0.42 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.848 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.4 t -95.2 92.81 6.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.116 0.484 . . . . 0.0 111.496 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt -138.21 98.82 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.388 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.28 152.65 17.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.218 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.54 107.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.458 . . . . 0.0 110.341 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.78 -40.88 1.39 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 98' ' ' ILE . . . -87.67 -152.48 0.2 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -78.37 58.35 2.11 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.453 0.644 . . . . 0.0 111.405 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.2 -13.67 60.08 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.979 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.407 ' CG1' ' HB3' ' A' ' 95' ' ' ALA . 41.0 pt -90.08 148.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.75 0.31 . . . . 0.0 110.89 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 ptp -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 16.8 pt-20 -138.01 147.52 56.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.79 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 3.7 Cg_exo -81.1 106.66 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.492 2.128 . . . . 0.0 111.418 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.63 -21.16 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.26 127.15 43.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.856 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.59 -143.4 8.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.12 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -106.85 116.79 32.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.966 0.413 . . . . 0.0 110.377 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -79.11 116.52 19.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.333 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 142.04 25.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.855 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.8 p30 -80.2 137.73 52.72 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 82' ' ' LEU . 34.6 Cg_exo -58.88 -24.33 71.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.97 2.447 . . . . 0.0 113.847 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.99 -9.75 59.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.82 -10.86 54.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.349 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 66.7 t -77.21 121.98 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.343 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 11.5 m-20 -74.7 -52.98 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.468 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 34.6 t80 -124.31 123.99 41.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.253 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 15.2 tt -130.38 139.83 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 110.741 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.61 109.48 20.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.259 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.525 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 11.6 m -119.74 120.05 30.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.289 0.566 . . . . 0.0 111.135 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 1.4 Cg_endo -84.1 163.96 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.025 2.483 . . . . 0.0 111.95 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 131' ' ' PHE . . . -150.41 154.15 25.47 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.6 t -55.97 -47.28 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.982 0.391 . . . . 0.0 110.894 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.5 147.84 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -129.78 167.19 18.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.979 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 1.3 p-10 -127.23 -169.62 2.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.706 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.1 mt -92.3 4.03 54.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 42.7 mt-10 -110.05 -25.82 10.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.649 0.261 . . . . 0.0 110.781 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.518 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 117.86 26.07 2.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 174.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -102.23 158.07 16.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.782 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' OD2' ' A' ' 166' ' ' ASP . 33.0 mtm180 -124.35 -176.97 3.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.499 HD22 HD23 ' A' ' 6' ' ' LEU . 20.6 tp -113.55 0.57 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.28 0.562 . . . . 0.0 109.726 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.6 176.63 33.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.525 -0.762 . . . . 0.0 113.35 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 71.3 m-85 -119.83 -72.1 0.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.88 124.2 1.67 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -88.68 148.43 24.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.846 0.355 . . . . 0.0 110.498 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 162.17 -62.08 0.27 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.238 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.402 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 28.6 m-85 -133.64 -27.16 1.54 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.912 0.387 . . . . 0.0 111.38 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -75.62 -30.77 59.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' LEU . 6.5 p-10 -67.92 -23.85 65.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.008 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 135' ' ' TYR . 40.0 ttm180 -69.99 -35.99 74.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.902 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.22 -36.76 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 137' ' ' ASP . 79.8 mt -67.66 -26.36 66.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.108 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 34.3 mmtp -76.72 -21.66 54.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 109' ' ' PRO . 27.5 mmt180 -77.52 -53.11 8.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.172 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.84 103.21 4.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.84 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -113.99 24.4 12.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.25 -139.75 5.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.808 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.93 101.36 13.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HE2' HD11 ' A' ' 167' ' ' ILE . 18.9 mttp -88.54 106.67 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 171' ' ' VAL . 67.7 t -101.0 116.98 45.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.801 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -78.94 121.57 5.6 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 57' ' ' LEU . 61.9 t -113.65 115.86 50.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.552 0.215 . . . . 0.0 110.463 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.95 -179.81 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.084 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 156' ' ' VAL . 95.1 m-85 -97.56 156.1 16.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.86 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.3 p -61.23 -25.9 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.589 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.545 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 70.7 m-85 -61.78 -36.4 80.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.545 ' OE1' ' HB2' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -90.62 8.31 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' TYR . 61.5 t -109.66 133.79 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.892 0.377 . . . . 0.0 110.424 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.93 -169.52 1.85 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 48.2 mt-10 -84.74 -50.15 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.281 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.1 ptm180 -141.11 146.65 37.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 176.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 92.5 mt -116.6 149.16 43.35 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.995 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.35 104.57 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.274 1.983 . . . . 0.0 111.007 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -73.55 111.41 8.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.0 110.768 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.71 -78.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.6 -96.26 0.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.781 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -128.54 61.66 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.358 0.599 . . . . 0.0 111.25 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 128' ' ' ARG . 38.7 t70 -74.36 141.82 45.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 ' HE2' ' A' ' 147' ' ' LYS . 14.1 tt -79.11 120.26 80.08 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.941 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.5 Cg_exo -74.15 148.65 39.76 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.023 2.482 . . . . 0.0 111.807 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.94 169.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.011 0.434 . . . . 0.0 111.607 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -93.3 -40.08 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.297 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 148' ' ' VAL . 17.0 t -133.07 155.12 40.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 55.5 tp -135.43 118.31 16.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.97 126.45 73.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 0.0 110.799 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 71.7 p -114.56 -172.49 2.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.266 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 176' ' ' LYS . 2.5 pm0 -85.73 -15.05 43.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.031 0.443 . . . . 0.0 110.125 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 175' ' ' GLU . 29.4 mtpp -112.31 -47.82 3.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.197 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.43 163.1 28.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 112.102 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.53 122.56 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.73 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 3.0 mmp_? -108.93 131.73 54.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.993 0.425 . . . . 0.0 110.186 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -121.74 128.39 51.72 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.518 HD13 ' HA3' ' A' ' 126' ' ' GLY . 23.4 mt -110.0 31.11 6.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.672 0.748 . . . . 0.0 110.247 -172.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -129.73 24.87 5.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.086 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.02 140.34 58.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.022 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.33 163.91 26.7 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.82 -59.4 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.1 0.45 . . . . 0.0 111.01 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.2 t -153.41 155.37 36.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.6 mt -131.17 132.77 44.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.742 0.306 . . . . 0.0 110.826 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -117.07 150.3 38.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -108.1 -76.36 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -128.31 76.59 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -113.24 -8.89 13.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.291 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -75.41 73.84 2.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.345 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 28.3 m170 72.02 159.58 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 C--O 1.246 0.913 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.019 179.325 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.22 -14.49 24.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -53.21 -57.83 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -60.66 -39.18 87.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.54 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.71 -52.34 21.61 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.091 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -61.88 -35.23 77.72 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.321 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -56.11 -59.42 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.451 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -74.25 -37.54 63.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.764 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.54 -39.79 92.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.494 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.1 t -86.19 -41.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.7 tp -60.34 -37.59 81.14 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.173 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 75.9 t60 -59.69 -31.04 69.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.741 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -82.71 -42.74 17.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.916 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' NH2' ' HA ' ' A' ' 151' ' ' ALA . 52.2 ttt180 -61.19 -38.75 87.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 0.0 111.103 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.1 pt -88.18 -4.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.368 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 66.1 t30 -98.4 -13.69 20.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.888 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.78 143.83 15.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -61.98 144.59 54.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -59.27 -49.33 78.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.548 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.81 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.786 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.09 -44.61 91.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.409 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -59.13 -42.57 90.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -25.5 66.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.688 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -83.86 -18.48 37.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.903 0.382 . . . . 0.0 110.785 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.7 mt -86.56 -53.52 4.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.094 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 m -57.17 -34.49 68.52 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.09 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -48.27 -50.44 29.83 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.086 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -80.59 -26.59 37.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.323 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 25' ' ' LEU . 58.0 t -65.07 -49.51 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.82 -46.42 96.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.619 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -62.09 -40.94 97.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 178' ' ' VAL . 21.8 t-20 -66.51 -51.14 59.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.008 0.433 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.802 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 36.9 tp -57.64 -38.61 75.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.4 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -72.85 -33.38 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.917 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -75.35 -16.87 60.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.346 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 33' ' ' LEU . 79.7 mt -56.46 126.3 69.03 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.852 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -32.74 96.04 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.571 2.181 . . . . 0.0 111.593 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.27 -35.08 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -62.22 -30.31 71.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.078 0.466 . . . . 0.0 110.433 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -64.52 -40.08 94.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.73 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -80.79 -33.2 35.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.159 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.494 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 46.4 m -55.53 105.81 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.046 0.45 . . . . 0.0 111.1 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 84.4 tttt -98.47 -30.67 12.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.653 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -102.91 98.21 8.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.383 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.16 109.01 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 111.066 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.29 139.64 34.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.551 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.27 145.96 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.888 0.375 . . . . 0.0 110.831 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.29 -4.11 59.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.911 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 70.9 m 65.17 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 123.727 0.642 . . . . 0.0 111.465 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 95.92 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.502 2.135 . . . . 0.0 112.743 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 35.7 pt -90.65 161.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 67.4 mttm 70.91 -55.25 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.725 0.64 . . . . 0.0 110.805 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.22 -83.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 4.4 mm-40 45.53 39.55 4.87 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.801 0.84 . . . . 0.0 112.862 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 53.3 t 68.26 101.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.084 -174.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.07 92.71 1.34 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.826 0.822 . . . . 0.0 111.183 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 150' ' ' VAL . 93.8 mt -88.49 15.19 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.792 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 8.8 p -62.35 -38.47 46.93 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 30.5 Cg_exo -64.38 -11.48 28.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.925 1.75 . . . . 0.0 112.717 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 64' ' ' VAL . 36.9 tp -89.24 -16.2 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.59 0.233 . . . . 0.0 110.741 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 23.9 m-85 -56.51 -50.65 86.54 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 50.4 Cg_exo -55.74 -35.19 92.97 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.13 1.887 . . . . 0.0 112.509 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.46 -43.73 76.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.485 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 60' ' ' LEU . 59.2 t -64.49 -44.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.26 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.51 -18.83 65.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.704 0.288 . . . . 0.0 111.549 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -75.99 -36.52 59.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.393 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -124.11 -46.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 31.1 mmtp -101.93 -175.04 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.017 0.437 . . . . 0.0 111.52 -168.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 38.6 mm-40 -98.3 120.0 37.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.595 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.05 102.44 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.2 mt -91.52 116.89 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.085 0.469 . . . . 0.0 110.494 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.8 mt -117.11 137.09 23.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.205 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.6 119.4 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -105.74 117.45 34.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.08 95.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -96.72 71.29 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 109.71 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.37 -111.18 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.429 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.55 -22.97 14.8 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -77.43 89.05 3.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.719 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.84 119.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -111.85 132.29 54.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.452 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -81.85 103.93 11.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.054 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 3.7 m-85 -95.97 120.19 35.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.197 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 24.2 ptt85 -83.42 131.3 35.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.68 133.19 68.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.998 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.23 12.83 7.69 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.5 m -112.05 109.68 54.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.536 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.2 Cg_exo -74.42 31.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.463 2.775 . . . . 0.0 112.915 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 -28.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 58.2 m -84.75 38.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -172.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.22 152.22 21.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -132.89 176.31 19.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.99 98.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.114 0.457 . . . . 0.0 110.031 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.19 -32.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.058 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -76.18 94.84 3.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.855 0.327 . . . . 0.0 111.072 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 80.1 t80 72.49 -52.13 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.199 0.599 . . . . 0.0 111.809 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.32 33.92 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 95' ' ' ALA . 41.5 pt -122.86 172.72 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 66.1 mtt -94.24 86.94 5.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 2.3 pm0 -87.93 148.36 43.17 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.983 0.421 . . . . 0.0 110.263 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 8.1 Cg_exo -72.17 106.09 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' A' ' 103' ' ' GLU . 31.2 m -76.72 -25.01 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.499 0.666 . . . . 0.0 109.421 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.984 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 59.7 mm-40 -122.28 129.11 51.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.938 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.11 -159.2 28.37 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 34.3 tt0 -138.71 131.16 28.76 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 106' ' ' ARG . 20.7 ttt180 -79.74 113.62 18.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.0 110.514 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.44 154.23 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.138 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -81.99 142.11 47.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.294 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' VAL . 24.2 Cg_endo -61.22 -23.21 76.67 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.299 2.666 . . . . 0.0 113.69 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.82 -19.67 63.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.88 0.371 . . . . 0.0 110.975 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.51 -12.56 53.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.391 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.98 114.22 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 110.847 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 42' ' ' SER . 38.8 t70 -90.47 -51.61 5.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.258 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.802 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 38.3 t80 -130.43 139.39 50.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.471 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 147' ' ' LYS . 15.6 tt -146.29 139.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 110.74 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.64 20.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.463 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 59.4 t -122.33 110.89 32.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.01 165.9 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.922 2.415 . . . . 0.0 112.081 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.78 163.89 30.57 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.01 -38.46 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.571 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.63 159.06 44.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.173 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.28 165.84 25.7 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.524 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 16.1 p30 -126.46 -172.09 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 96.0 mt -88.69 -2.2 58.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.029 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -105.79 -28.7 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.809 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.17 30.64 0.85 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.869 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -108.99 151.83 25.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.318 0.559 . . . . 0.0 110.414 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -122.89 149.6 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.067 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 59.2 tp -88.45 128.25 35.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -91.31 -153.52 29.6 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.302 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -82.01 0.25 41.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.778 0.323 . . . . 0.0 111.2 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.93 35.06 61.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.889 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -155.37 1.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.623 0.249 . . . . 0.0 111.289 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 135' ' ' TYR . . . 78.75 -145.11 28.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.73 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 32.1 m-85 77.41 123.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.374 0.67 . . . . 0.0 111.46 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 71.09 1.51 3.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.795 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.38 -41.91 99.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.13 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.82 -25.6 65.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.851 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.07 -56.57 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.192 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.2 -12.85 61.69 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.769 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -76.47 -32.52 58.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -94.43 -40.81 9.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.083 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 109' ' ' PRO . 49.7 t -71.82 91.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.268 0.556 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 144' ' ' LYS . 5.6 tmtm? -103.89 68.21 0.91 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.554 0.692 . . . . 0.0 109.837 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.69 -150.29 19.01 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 113' ' ' ASP . 11.0 mp -83.29 89.03 6.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.979 0.889 . . . . 0.0 109.227 171.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HA ' HG23 ' A' ' 115' ' ' ILE . 54.4 mtmt -81.98 102.47 10.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.8 t -98.82 114.72 37.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.622 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -79.03 119.95 5.17 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.539 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 57' ' ' LEU . 47.5 t -98.05 110.73 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.371 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.569 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . . . -154.05 176.5 12.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.248 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.454 ' CZ ' HG22 ' A' ' 55' ' ' VAL . 71.6 m-85 -96.69 151.96 19.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.0 t -62.28 -17.78 59.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.45 0.166 . . . . 0.0 111.071 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -62.73 -33.44 75.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.263 0.554 . . . . 0.0 110.389 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.52 -3.8 58.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.429 -174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 172' ' ' LEU . 38.8 t -91.19 110.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.405 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 35.4 m-85 -105.62 -179.17 3.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.523 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.31 -58.6 4.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.079 0.466 . . . . 0.0 110.039 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -144.77 138.54 27.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.848 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 90.5 mt -93.45 152.65 41.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.87 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 101.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.074 1.849 . . . . 0.0 109.653 167.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -73.63 150.09 41.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.263 0.554 . . . . 0.0 111.114 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -103.85 -172.91 2.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.087 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.58 35.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -96.82 64.19 2.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -74.98 108.36 7.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.863 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.2 103.98 55.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.867 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.49 159.75 10.93 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.839 2.359 . . . . 0.0 112.416 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.35 173.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.02 -52.52 3.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.038 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.2 130.97 68.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.24 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 57.0 tp -104.97 108.63 20.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.033 0.444 . . . . 0.0 110.218 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.01 130.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 175' ' ' GLU . 40.2 p -126.55 -173.89 2.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.275 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -79.34 -9.0 59.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.097 0.475 . . . . 0.0 110.862 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -120.31 -62.01 1.52 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -110.01 151.75 26.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.316 0.579 . . . . 0.0 112.548 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.463 HG22 ' OD1' ' A' ' 32' ' ' ASN . 16.6 t -103.81 99.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.102 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 79.2 mtt85 -94.5 85.23 4.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.292 0.568 . . . . 0.0 110.782 -176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -76.27 99.42 4.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.1 mt -102.71 25.68 8.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.511 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -80.44 74.35 7.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.013 0.435 . . . . 0.0 110.16 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.76 156.64 27.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.26 -76.94 0.63 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.349 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.553 ' HA ' ' NE ' ' A' ' 185' ' ' ARG . 6.1 tpm_? -169.19 28.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.441 ' HB2' ' OE2' ' A' ' 188' ' ' GLU . 80.9 p -74.33 138.08 43.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.932 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 29.2 tp -144.39 12.05 1.52 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 110.384 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.552 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 1.1 pm0 -81.63 52.32 1.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 0.0 110.808 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -57.41 -38.23 74.01 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.246 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -156.32 67.2 0.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -78.57 -31.2 47.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.7 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -83.31 113.8 20.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.173 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -91.23 -177.95 5.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.36 -179.225 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.77 0.319 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 tp -160.43 -47.08 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.883 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.644 ' HD2' ' HG ' ' A' ' 129' ' ' LEU . 65.3 pttt -72.72 -11.09 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -60.7 -47.57 85.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.546 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -34.18 71.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.814 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.25 -44.11 80.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.166 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' O ' HG11 ' A' ' 120' ' ' VAL . 4.9 tmt_? -58.39 -43.97 88.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.18 -41.37 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.52 -44.09 89.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 37.2 t -71.78 -46.12 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.322 . . . . 0.0 110.348 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.24 -39.61 83.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.782 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -53.16 -39.38 63.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.072 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -90.75 -1.24 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.653 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 62.6 mtp180 -97.34 -48.74 5.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.127 0.489 . . . . 0.0 111.435 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.59 -21.99 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.687 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -76.82 -16.1 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.35 153.62 26.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.628 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -63.1 144.89 56.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.79 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.66 -48.88 78.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 110.011 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 2.5 mp0 -54.33 -49.14 70.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.963 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.76 -53.04 62.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.631 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 22' ' ' ARG . 33.1 ttp180 -64.49 -38.87 92.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -69.67 -36.13 75.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.863 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -65.98 -30.16 70.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 109.88 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.94 -46.08 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.145 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 t -57.45 -35.31 69.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.289 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.64 -51.32 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.405 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -74.28 -28.11 61.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.974 -174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.17 -47.94 80.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.1 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.454 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 m -62.19 -40.42 95.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.32 -46.05 74.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.403 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 36' ' ' LEU . 46.6 tp -61.49 -41.89 97.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.569 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -64.58 -33.16 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -70.15 -26.17 63.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.739 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 33' ' ' LEU . 92.6 mt -61.91 120.12 54.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.169 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.44 -33.58 78.91 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.241 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -22.08 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 68' ' ' LYS . 50.4 t80 -68.84 -29.94 68.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.83 -31.08 15.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.18 -49.87 74.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 113' ' ' ASP . 70.1 m -86.82 122.1 30.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.37 -21.54 18.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -173.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.58 97.8 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.157 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.98 118.04 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.307 0.575 . . . . 0.0 110.858 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -98.75 137.12 37.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.46 139.28 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.72 0.295 . . . . 0.0 110.262 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -85.57 -6.12 59.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.8 t 67.11 102.08 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.306 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.1 124.41 9.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.429 2.086 . . . . 0.0 112.243 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.4 pp -111.57 152.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.296 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 63.08 20.19 12.13 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.098 0.475 . . . . 0.0 110.982 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.17 -88.19 0.63 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.83 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 70.8 mm-40 64.08 -85.01 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 122.925 0.49 . . . . 0.0 109.769 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 150' ' ' VAL . 88.1 t -148.95 116.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.51 101.41 2.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.78 9.54 24.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.501 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 68.5 p -65.21 -38.81 30.57 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 58' ' ' THR . 68.6 Cg_endo -74.14 4.56 4.19 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.62 1.547 . . . . 0.0 112.543 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.9 tp -99.33 -17.28 18.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.594 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 30.9 m-85 -52.07 -46.25 93.26 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 87.4 Cg_exo -49.86 -45.39 32.47 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.083 1.856 . . . . 0.0 112.589 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.92 -32.96 65.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.692 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 60' ' ' LEU . 76.9 t -61.61 -45.2 99.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.93 -12.71 61.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.427 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 62' ' ' PRO . 31.4 mmmt -92.46 -58.45 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.087 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.24 -38.99 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.372 0.606 . . . . 0.0 110.684 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.614 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 22.6 mttp -125.63 -171.6 2.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.769 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 86' ' ' HIS . 42.8 tt0 -120.17 135.08 55.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.168 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 64' ' ' VAL . 62.3 tp -92.47 132.48 36.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 111.391 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -119.83 127.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 97.4 mt -126.29 144.14 48.24 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.48 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.47 146.45 12.21 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.962 2.442 . . . . 0.0 112.593 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -135.0 135.1 41.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.93 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -99.23 124.51 52.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -119.13 44.21 2.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.03 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.64 -93.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.861 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -109.7 -27.47 9.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -92.75 134.75 34.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 tt -116.82 127.82 74.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.114 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -124.55 178.89 5.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.47 138.77 50.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 27.0 m-85 -121.5 146.68 46.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 0.0 111.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.825 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 21.6 ttm180 -91.2 118.43 30.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.962 -172.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 91' ' ' LEU . 46.4 t -119.04 111.67 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.419 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.1 p-80 -139.06 30.31 2.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.514 0.674 . . . . 0.0 109.222 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.8 p -154.27 143.91 15.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.819 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.6 Cg_exo -73.18 171.77 16.93 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.934 2.422 . . . . 0.0 112.386 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.8 18.83 11.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.793 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 53.4 m -113.93 3.34 15.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 85' ' ' VAL . 91.7 mt -108.3 126.05 52.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.211 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.92 -163.56 9.79 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.8 t -123.04 119.4 57.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.926 0.363 . . . . 0.0 110.09 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.37 -98.61 1.36 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 132.81 46.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.6 t80 72.12 -53.47 0.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.904 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.33 34.26 0.37 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.006 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.9 pt -108.35 172.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 91' ' ' LEU . 48.6 tpp -70.72 102.76 2.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 29.4 tt0 -114.31 134.59 22.23 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -172.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 11.3 Cg_exo -70.27 119.65 6.52 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.357 2.038 . . . . 0.0 109.812 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 103' ' ' GLU . 13.6 t -54.04 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.678 0.611 . . . . 0.0 111.031 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 102' ' ' VAL . 54.4 mm-40 -136.64 145.69 45.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.7 -148.61 13.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.622 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.825 ' HG3' ' HB3' ' A' ' 84' ' ' ARG . 6.3 pt-20 -91.2 151.24 21.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 111.433 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -100.41 162.33 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.751 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 50.5 t -125.57 136.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.073 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -82.77 139.04 43.4 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 143' ' ' VAL . 52.2 Cg_exo -56.42 -23.82 49.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.642 2.228 . . . . 0.0 111.265 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.11 -32.59 71.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.158 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.86 -11.51 36.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.893 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -77.46 126.39 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' SER . 15.0 m-20 -96.0 -51.94 4.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.522 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -123.23 148.35 45.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.895 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.56 138.9 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.012 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.46 112.3 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.09 126.42 28.04 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.503 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.2 -168.05 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.735 2.29 . . . . 0.0 111.768 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.7 150.51 6.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.935 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 7' ' ' ARG . 98.9 t -74.22 -38.69 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 0.0 110.943 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.53 166.08 25.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -140.7 148.7 41.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 111.389 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 159' ' ' ARG . 11.5 t70 -101.97 156.85 17.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.871 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 49.4 mt -71.9 -26.76 62.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 111.226 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -85.81 -7.17 58.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.104 0.478 . . . . 0.0 110.029 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 111.27 -0.88 28.14 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.98 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.501 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 95.1 m-85 -64.47 156.89 28.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.31 0.555 . . . . 0.0 110.689 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 37.0 mtm180 -103.99 -71.98 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 160' ' ' LEU . 7.3 tt 71.45 -11.42 0.71 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.019 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -47.17 -51.88 13.78 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.709 0.643 . . . . 0.0 114.709 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -171.63 176.27 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.137 0.469 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 150.75 107.59 0.39 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.135 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 133' ' ' LYS . 39.1 mtpt -113.91 -58.2 2.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.8 145.01 46.16 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' ' 138' ' ' ARG . 1.7 t80 -81.96 54.58 2.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.167 0.508 . . . . 0.0 110.982 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -80.74 -12.26 59.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.655 0.74 . . . . 0.0 109.724 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.75 -24.54 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.602 ' HB2' ' HD2' ' A' ' 135' ' ' TYR . 79.5 ttt180 -62.07 -25.42 67.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.176 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 45.1 tp -83.84 -39.93 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.513 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.71 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.538 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.519 ' HG2' ' HB ' ' A' ' 167' ' ' ILE . 22.2 mtmm -86.37 -0.07 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.171 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -100.45 -36.32 9.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.93 0.395 . . . . 0.0 110.477 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.1 t -84.91 91.14 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 110.052 177.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.51 62.28 3.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.748 0.785 . . . . 0.0 110.193 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.81 -152.95 23.17 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 146' ' ' LEU . 3.8 mm? -83.68 94.39 8.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.427 0.614 . . . . 0.0 109.827 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.419 ' HE2' ' CD1' ' A' ' 167' ' ' ILE . 9.5 mtmp? -77.49 104.91 8.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 76.3 t -95.12 113.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.484 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -84.75 117.19 4.44 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.441 HG12 HG21 ' A' ' 55' ' ' VAL . 22.6 t -105.8 109.15 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -159.01 -177.83 6.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.109 0.48 . . . . 0.0 111.362 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -100.06 166.92 10.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.176 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.5 m -77.02 -22.09 53.59 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -78.79 2.78 18.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.795 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -101.43 -10.78 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.041 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 t -91.63 115.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.51 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 96.3 m-85 -112.08 178.96 4.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 124' ' ' LEU . 30.0 mt-10 -64.13 -76.72 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 110.837 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.669 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 43.2 mtm180 -141.18 132.91 27.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.774 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 129' ' ' LEU . 52.4 mt -103.5 153.44 38.56 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.577 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.8 101.62 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.131 1.887 . . . . 0.0 111.57 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.845 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -90.57 147.33 23.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.564 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.7 -67.1 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.514 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.69 -85.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.612 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 14.9 m-90 -103.72 66.87 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.894 0.378 . . . . 0.0 111.21 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.05 110.17 18.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 141' ' ' LYS . 19.4 tt -74.06 122.89 88.63 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.472 0.653 . . . . 0.0 111.661 -171.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 21.5 Cg_exo -67.2 154.66 73.56 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.154 2.569 . . . . 0.0 112.851 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -82.75 171.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.975 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -108.82 -46.59 3.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.586 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 46.5 t -123.06 113.51 38.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.686 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.866 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 62.3 tp -100.01 102.65 14.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 110.283 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 33' ' ' LEU . 95.1 t -89.91 112.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.217 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.0 p -105.06 -175.93 2.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 12.4 pt-20 -72.69 -15.6 61.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.385 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.531 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 66.1 mttt -119.31 -48.71 2.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.48 168.82 18.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.625 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 36' ' ' LEU . 23.3 t -91.81 105.03 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 11.7 mmt180 -80.25 86.21 5.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -78.34 103.49 8.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt -82.09 37.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.366 0.603 . . . . 0.0 111.164 -173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 182' ' ' ARG . 3.9 mmp_? -109.87 31.39 5.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.234 175.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.524 ' OD2' ' HB3' ' A' ' 185' ' ' ARG . 27.3 t70 -57.09 -50.81 71.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.116 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.36 -9.04 74.73 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.984 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.524 ' HB3' ' OD2' ' A' ' 183' ' ' ASP . 17.7 ttt180 -85.74 105.62 16.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.479 0.64 . . . . 0.0 110.307 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.9 m -139.41 108.24 5.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.196 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.91 146.89 53.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.378 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 16.5 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.777 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -63.67 -14.83 55.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.954 0.407 . . . . 0.0 110.903 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -72.18 -6.64 44.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.226 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -61.28 106.04 0.57 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.815 0.817 . . . . 0.0 110.783 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -171.12 29.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -98.53 125.09 43.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.542 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.433 178.215 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tmm? . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 121.407 0.622 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -82.43 -5.24 58.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.127 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -61.51 -33.66 74.19 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.61 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -80.45 -31.36 37.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 111.184 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.76 -29.66 32.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.86 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HE2' ' A' ' 9' ' ' LYS . 54.5 tp -58.3 -42.26 86.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 109.563 173.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HB2' HD23 ' A' ' 129' ' ' LEU . 39.6 ttp180 -58.33 -34.96 71.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.624 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -64.68 -49.18 71.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 6' ' ' LEU . 55.6 pttt -72.2 -31.95 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.543 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG11 ' HB2' ' A' ' 121' ' ' ALA . 86.6 t -69.54 -35.19 65.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 15' ' ' ILE . 54.1 tp -64.97 -51.17 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.802 174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 11.6 t-160 -59.47 -32.58 70.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -77.74 -40.0 42.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 15.8 ttm180 -66.1 -38.07 87.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.673 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.616 HG22 ' HA3' ' A' ' 53' ' ' GLY . 36.9 pt -91.41 7.87 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.784 0.325 . . . . 0.0 111.217 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 9.2 t30 -85.47 -18.43 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 109.612 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.434 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.99 144.7 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 48.6 mt-10 -71.42 -38.55 71.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.04 -39.47 93.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.0 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 24' ' ' ARG . 10.7 tp10 -62.47 -40.77 97.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.717 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -60.68 -41.62 95.49 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 17.1 mmt180 -56.7 -41.64 77.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.433 0.635 . . . . 0.0 110.184 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 21' ' ' GLU . 39.2 ttp180 -71.51 -43.34 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.253 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.73 -38.18 83.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.906 0.384 . . . . 0.0 110.756 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 55' ' ' VAL . 68.6 m -58.38 -42.14 86.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.598 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.34 -37.83 73.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mtpt -60.97 -52.59 64.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 110.348 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG11 HG13 ' A' ' 150' ' ' VAL . 48.9 t -61.35 -43.88 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.836 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 81.7 mt -61.11 -45.72 98.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -64.68 -33.46 76.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.61 0.243 . . . . 0.0 110.942 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -66.41 -55.17 17.05 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.291 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.48 -31.53 71.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.069 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 23.3 tttp -68.26 -35.26 77.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.0 p -83.69 -14.56 51.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.275 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.3 tt -58.51 123.34 66.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.847 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -55.63 -44.7 45.56 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.429 2.753 . . . . 0.0 113.452 -172.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 7.6 mp0 -60.95 -25.25 66.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.855 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.74 -36.4 73.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -82.22 -0.54 45.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -106.16 -52.45 2.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -70.08 158.72 35.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.867 -172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -113.31 -34.09 5.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.202 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.03 98.45 11.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.404 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 106.52 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.22 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -97.62 136.76 37.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.49 152.77 42.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.538 ' HB2' HG12 ' A' ' 117' ' ' VAL . 7.1 t80 -80.47 -98.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.189 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 48' ' ' TYR . 49.1 t 177.89 116.46 0.18 Allowed Pre-proline 0 N--CA 1.462 0.154 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 6.6 Cg_endo -88.46 103.12 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.177 2.585 . . . . 0.0 112.058 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.09 140.99 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.361 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 71.85 -51.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.267 0.627 . . . . 0.0 111.483 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 15' ' ' ILE . . . -139.64 -158.68 7.71 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.64 ' OE1' ' HD3' ' A' ' 14' ' ' ARG . 4.2 mm-40 77.34 150.75 0.12 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.974 0.892 . . . . 0.0 112.101 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 26' ' ' SER . 57.1 t -36.85 126.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 112.631 -2.077 . . . . 0.0 112.24 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD11 ' A' ' 30' ' ' ILE . 3.5 m-20 -68.08 76.96 0.23 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.59 -10.3 54.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.838 0.351 . . . . 0.0 110.708 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.473 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -53.87 -49.89 86.91 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 58' ' ' THR . 36.7 Cg_endo -66.0 -8.02 18.72 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.087 1.858 . . . . 0.0 113.526 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.34 -14.09 29.25 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.137 -0.352 . . . . 0.0 110.803 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.3 m-85 -53.75 -52.35 68.28 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.985 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 53.8 Cg_exo -54.34 -37.11 88.74 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.321 2.014 . . . . 0.0 113.183 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.05 -52.35 36.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.623 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.69 -34.59 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.275 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 88' ' ' PRO . 38.1 tp -66.24 -26.23 67.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.297 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.69 -48.99 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.532 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.39 -45.58 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 111.815 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -123.29 -171.68 2.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.626 -163.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.61 100.93 11.4 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.4 tp -80.52 120.56 24.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.593 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.8 mt -102.42 119.81 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.848 0.356 . . . . 0.0 110.371 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.39 142.59 28.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.536 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.24 121.61 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.203 2.602 . . . . 0.0 113.279 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.808 ' HD2' ' HE2' ' A' ' 83' ' ' TYR . 55.9 tttm -105.97 133.97 49.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 102.4 8.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -86.69 -19.49 29.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.952 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 156.91 80.47 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.54 HD21 ' HB2' ' A' ' 135' ' ' TYR . 7.0 t30 70.44 -50.8 0.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.216 0.607 . . . . 0.0 111.103 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.38 156.53 25.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -104.63 131.94 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.055 0.455 . . . . 0.0 111.513 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -111.0 115.65 29.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 80.6 mt -82.52 141.15 32.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.266 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.808 ' HE2' ' HD2' ' A' ' 74' ' ' LYS . 18.9 m-85 -112.59 141.62 46.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.187 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . 27.0 ttt180 -88.15 91.72 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.118 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.17 114.51 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.368 0.604 . . . . 0.0 111.936 -171.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -140.62 14.44 2.34 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 23.3 t -99.99 104.79 31.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.333 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' HD21 ' A' ' 65' ' ' LEU . 24.4 Cg_exo -63.64 -29.58 69.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.154 2.569 . . . . 0.0 113.524 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.55 -16.12 40.46 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.521 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 47.0 t -89.89 76.01 7.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.357 0.599 . . . . 0.0 110.485 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.9 mt -135.82 117.54 15.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.899 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.59 178.6 25.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.713 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.96 134.46 66.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.87 -74.58 0.93 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.842 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.42 153.74 40.01 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.896 -0.179 . . . . 0.0 111.3 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.4 t80 73.7 -47.55 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.656 0.782 . . . . 0.0 111.995 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.96 11.8 1.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.309 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -93.17 166.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.4 mtp -92.23 120.79 33.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.037 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.7 120.89 28.47 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.971 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.01 124.92 14.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.856 2.37 . . . . 0.0 111.575 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.25 -53.22 42.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.15 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.11 136.93 52.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.461 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.05 175.26 40.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.14 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 84' ' ' ARG . 1.1 pm0 -93.72 141.55 28.37 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 4.1 ptp85 -93.12 139.57 30.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.318 0.58 . . . . 0.0 111.229 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.65 143.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.629 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 31.4 p-10 -92.98 152.92 41.83 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 112' ' ' VAL . 77.3 Cg_exo -52.12 -27.0 27.81 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.224 2.616 . . . . 0.0 113.307 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 43.5 tt0 -60.17 -38.21 82.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.734 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.31 -13.35 57.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 109' ' ' PRO . 88.3 t -60.23 110.84 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.261 0.553 . . . . 0.0 110.773 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -80.0 -53.07 7.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.52 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.66 136.6 48.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.526 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.53 139.12 45.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.36 119.97 24.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 48' ' ' TYR . 35.7 m -125.46 139.56 34.23 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.849 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.618 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 95.3 Cg_endo -80.84 -174.94 2.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 111.506 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.78 -164.32 23.24 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.359 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.95 -50.0 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.574 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -139.72 140.09 36.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' HB3' ' A' ' 128' ' ' ARG . 49.3 m-85 -134.67 168.79 18.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 24.2 p30 -135.27 -170.07 2.51 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.481 HD23 ' NH1' ' A' ' 179' ' ' ARG . 90.0 mt -82.23 -20.69 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.978 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.428 ' CD ' HH12 ' A' ' 162' ' ' ARG . 41.5 mt-10 -92.12 -12.12 33.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.692 0.282 . . . . 0.0 111.353 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.38 12.66 22.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.369 171.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.445 ' HE2' ' H ' ' A' ' 166' ' ' ASP . 48.9 m-85 -88.29 146.8 25.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.052 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.639 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -131.63 132.59 44.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 160' ' ' LEU . 11.1 mp -104.48 97.59 7.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -102.03 -170.39 27.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.881 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -109.53 124.31 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 172.07 172.85 38.35 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.961 -0.637 . . . . 0.0 111.749 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -156.09 95.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 0.0 109.972 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.44 177.17 27.54 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.54 ' HB2' HD21 ' A' ' 78' ' ' ASN . 96.5 m-85 -94.41 87.71 5.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.421 0.629 . . . . 0.0 110.864 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -87.11 21.44 2.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.078 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -56.34 -42.89 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.776 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -11.6 59.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.269 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 143' ' ' VAL . 61.8 tp -93.19 -73.17 0.57 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.33 -29.14 69.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -83.52 -14.62 51.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 111.292 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -102.06 -15.54 16.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.111 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.0 t -71.26 123.42 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.44 1.07 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 110.051 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.67 -155.76 10.55 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.754 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.72 120.79 28.4 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.662 -0.316 . . . . 0.0 111.022 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.644 ' HG2' ' OD2' ' A' ' 170' ' ' ASP . 20.3 mmtm -87.04 106.51 17.9 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.44 114.63 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.909 0.385 . . . . 0.0 110.34 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.53 125.35 8.51 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.436 HG13 HG11 ' A' ' 29' ' ' VAL . 39.4 t -102.49 123.43 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.59 155.95 27.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 111.804 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 156' ' ' VAL . 69.0 m-85 -91.27 141.98 28.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.181 174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.3 m -57.3 -26.03 60.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.877 0.736 . . . . 0.0 111.829 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -59.28 -38.7 80.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.434 ' HB2' HH21 ' A' ' 14' ' ' ARG . 10.4 mm100 -108.28 24.03 13.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.601 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 152' ' ' TYR . 50.2 t -116.75 105.92 19.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.322 0.582 . . . . 0.0 109.454 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 82.2 m-85 -92.65 -178.41 4.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.761 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.95 -61.82 2.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 3.1 ptm180 -153.08 135.62 15.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 129' ' ' LEU . 95.9 mt -98.57 155.26 36.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.748 -174.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.9 117.71 4.56 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.819 2.346 . . . . 0.0 111.199 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 162' ' ' ARG . 6.2 ptp180 -126.24 -179.65 4.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.122 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -105.51 -91.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.45 97.55 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.69 0.281 . . . . 0.0 111.576 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 53.16 78.81 0.13 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.599 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.6 t0 -83.84 -169.46 2.58 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.74 102.78 6.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.643 0.259 . . . . 0.0 110.387 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 0.9 OUTLIER -83.07 167.11 14.31 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.194 2.596 . . . . 0.0 112.345 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 147' ' ' LYS . 27.3 m -90.39 166.86 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.794 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.644 ' OD2' ' HG2' ' A' ' 147' ' ' LYS . 24.8 m-20 -100.54 -38.04 8.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 110.388 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.47 112.85 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.871 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 35.6 tp -99.71 110.7 23.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.4 120.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.073 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 52.6 p -109.35 179.62 4.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.036 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.77 9.68 20.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.414 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -133.23 -44.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -128.31 167.87 16.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.057 0.456 . . . . 0.0 111.056 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.35 113.38 41.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 92.6 mtt180 -94.01 99.04 11.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -88.64 108.46 19.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.367 0.603 . . . . 0.0 109.977 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.7 mt -102.13 14.42 32.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.58 -37.46 83.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.183 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.38 -53.31 2.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.32 16.77 79.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.951 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -114.66 2.64 14.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.275 0.559 . . . . 0.0 110.007 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.4 m -79.84 -4.7 53.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.324 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.15 149.96 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -74.59 145.94 42.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.61 140.6 57.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -76.11 72.57 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.486 0.66 . . . . 0.0 111.094 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -153.21 133.29 13.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.733 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -123.21 128.22 49.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -80.22 63.45 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.745 0.783 . . . . 0.0 111.571 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.435 177.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 93.1 mt -93.56 133.58 36.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.73 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.87 -30.67 71.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.766 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.449 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 49.0 m -83.14 -30.09 28.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.865 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 tm-20 -70.35 -42.32 72.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.9 tp -61.48 -39.9 92.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.753 174.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -58.78 -38.11 77.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.54 -38.32 89.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -62.96 -43.8 97.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 6' ' ' LEU . 21.3 t -67.54 -48.76 75.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.001 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.11 -47.75 68.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.352 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -58.55 -51.39 70.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.033 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.35 -38.65 88.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.119 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 120' ' ' VAL . 20.0 ttm180 -58.02 -49.74 75.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.931 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 pt -86.94 -0.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.637 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -89.35 -10.12 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.143 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.17 136.24 56.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -67.09 156.99 34.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.488 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.1 -55.15 31.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.647 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.88 -45.8 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.163 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.82 -45.51 85.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.582 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -62.62 -46.09 89.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.736 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.431 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 21.0 tpt180 -60.06 -36.8 78.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.908 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -38.4 90.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.046 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.58 -51.19 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.799 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -62.54 -34.91 77.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.26 -39.56 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.97 -38.14 87.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.305 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 175' ' ' GLU . 56.2 t -63.75 -47.42 91.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.422 . . . . 0.0 110.487 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.43 -48.13 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.72 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -60.86 -39.11 87.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.09 0.471 . . . . 0.0 110.359 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.19 -53.53 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.03 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.4 -40.61 97.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.87 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -62.61 -32.74 73.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.3 m -83.49 -19.87 35.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.351 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.432 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.0 tt -52.32 115.53 7.07 Favored Pre-proline 0 CA--C 1.533 0.295 0 O-C-N 123.26 0.35 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD2' HD23 ' A' ' 36' ' ' LEU . 50.4 Cg_exo -54.78 -32.56 77.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.223 2.615 . . . . 0.0 113.45 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.54 -26.16 30.36 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.025 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -76.04 -14.82 60.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.149 0.976 . . . . 0.0 109.015 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.47 -22.82 40.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.742 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 54.4 mttp -104.69 -12.37 16.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.451 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -64.29 149.36 48.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 111.76 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -109.84 -65.83 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.731 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HB3' HD11 ' A' ' 71' ' ' ILE . 30.1 mmtp -91.28 95.29 9.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.703 -176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.6 t -102.35 108.28 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.692 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -94.65 119.86 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.433 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.4 129.47 52.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.457 ' HB3' ' HD3' ' A' ' 118' ' ' PRO . 23.2 t80 -77.79 -2.02 34.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.373 -173.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.9 m 66.12 96.58 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.349 0.595 . . . . 0.0 111.548 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.61 128.06 7.57 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.762 2.308 . . . . 0.0 113.084 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 38.7 pt -129.51 158.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.437 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 68.5 -66.02 0.25 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.37 0.668 . . . . 0.0 112.481 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.89 21.15 0.37 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.494 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 51' ' ' ILE . 23.2 mm-40 -82.4 36.36 0.47 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.495 ' HA ' ' OH ' ' A' ' 152' ' ' TYR . 47.2 t 68.85 114.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 122.977 0.511 . . . . 0.0 110.528 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -71.53 80.66 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.957 0.884 . . . . 0.0 111.476 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 150' ' ' VAL . 86.7 mt -86.08 3.82 40.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -53.92 -46.98 98.36 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 58' ' ' THR . 27.0 Cg_endo -62.99 -11.48 24.88 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.104 1.87 . . . . 0.0 113.332 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.6 tp -92.7 -14.28 28.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 14.9 m-85 -56.75 -48.38 97.37 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.878 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.29 -33.58 56.13 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.331 2.021 . . . . 0.0 113.322 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -71.48 -50.75 28.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.405 . . . . 0.0 110.837 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.63 -37.3 79.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.63 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 86' ' ' HIS . 23.7 tp -67.06 -24.39 65.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -93.81 -53.73 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.18 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -50.63 11.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -100.76 -171.78 2.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.183 0.516 . . . . 0.0 111.123 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 39.8 mt-10 -105.21 102.81 12.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.025 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -78.76 114.95 18.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.956 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 61.4 mt -101.39 117.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.059 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 98.0 mt -113.25 139.99 23.8 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.629 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.0 Cg_exo -74.99 120.04 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.873 2.382 . . . . 0.0 112.093 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.606 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 45.0 tttm -116.91 152.78 33.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.13 114.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.493 . . . . 0.0 110.413 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -111.56 107.1 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.147 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.75 39.21 97.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.8 t30 65.91 16.43 10.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.127 0.571 . . . . 0.0 111.114 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.16 136.39 54.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' CD1' ' A' ' 136' ' ' TYR . 20.4 tt -79.08 135.88 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.422 0.63 . . . . 0.0 111.244 -173.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.3 m -139.93 167.49 21.99 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.3 mt -109.89 131.56 54.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.93 0.395 . . . . 0.0 110.951 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.559 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 26.3 m-85 -117.66 124.12 47.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.193 0.521 . . . . 0.0 110.444 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 22.9 ttp180 -93.45 118.54 31.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.861 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.37 154.7 40.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.982 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 65' ' ' LEU . 1.8 p80 -162.44 47.87 0.16 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.986 0.898 . . . . 0.0 109.119 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 43.9 m -156.05 160.41 30.81 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.259 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 87' ' ' SER . 41.7 Cg_endo -67.44 166.78 22.54 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.275 1.983 . . . . 0.0 112.601 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' O ' ' SG ' ' A' ' 90' ' ' CYS . . . 65.14 -155.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.788 0.68 . . . . 0.0 111.065 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 89' ' ' ALA . 15.2 p 60.53 6.33 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.717 1.207 . . . . 0.0 112.828 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.6 mt -97.51 149.34 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.36 -172.41 34.48 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.5 t -134.43 119.53 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.41 -33.28 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.238 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.52 -146.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.223 0.209 . . . . 0.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -39.5 -53.21 2.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.0 0.92 . . . . 0.0 112.971 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.56 47.99 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.17 148.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.2 mtt -72.26 93.43 1.47 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.073 0.463 . . . . 0.0 110.234 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.606 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 11.6 pt-20 -102.06 143.64 27.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.229 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 43.3 Cg_endo -72.27 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.928 1.752 . . . . 0.0 111.171 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.64 -44.19 69.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.11 171.67 7.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.623 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -148.03 19.19 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.909 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 124.32 40.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -75.8 126.8 31.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.178 0.513 . . . . 0.0 111.21 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 91.4 t -122.11 139.24 49.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.58 ' OD1' ' HD2' ' A' ' 109' ' ' PRO . 64.8 t30 -84.42 135.9 40.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HD2' ' OD1' ' A' ' 108' ' ' ASN . 5.1 Cg_endo -47.52 -23.67 3.7 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.744 2.962 . . . . 0.0 113.856 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.67 -34.15 72.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 111.234 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.75 -15.67 53.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.584 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.52 116.15 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -93.85 -25.17 17.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.369 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -134.79 122.68 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.413 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.08 139.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.89 0.376 . . . . 0.0 110.692 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.45 108.74 15.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.466 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 51.6 t -116.24 120.68 34.7 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.493 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 7.0 Cg_exo -74.57 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.917 2.411 . . . . 0.0 111.94 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.64 128.64 1.2 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 39.7 t -58.01 -40.88 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 111.81 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . -132.42 127.76 36.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.774 0.321 . . . . 0.0 111.091 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -121.62 161.72 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.58 174.41 6.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.02 3.84 47.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 37.6 mt-10 -101.31 -33.96 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.584 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 134.31 16.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.179 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.99 158.64 16.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.526 0.663 . . . . 0.0 111.119 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -115.65 157.68 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.693 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 25.2 tp -97.82 -0.08 45.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.162 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.37 -175.98 45.41 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.969 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -144.11 98.19 3.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.828 0.347 . . . . 0.0 110.207 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.0 -77.3 1.15 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.403 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -121.69 -174.88 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -146.91 95.23 0.17 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.008 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -130.79 -168.51 2.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 80' ' ' ILE . 69.6 m-85 65.11 29.62 11.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.68 -31.19 72.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.527 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -57.94 -23.66 54.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 13.8 tp -93.58 -59.89 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.231 0.539 . . . . 0.0 109.945 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -33.32 72.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.679 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -75.55 -22.58 56.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.748 0.309 . . . . 0.0 111.307 -175.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -102.85 -15.05 16.33 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.696 -0.402 . . . . 0.0 112.053 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' LEU . 62.0 t -67.92 95.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.193 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -86.44 -4.04 59.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.611 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.57 166.75 15.49 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.109 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 46.8 tp -53.0 111.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.095 0.474 . . . . 0.0 110.778 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.499 ' HG3' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -82.88 99.6 9.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.123 -176.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.42 123.99 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -101.25 138.19 13.72 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 57' ' ' LEU . 67.3 t -120.89 124.81 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.081 0.441 . . . . 0.0 110.515 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -164.17 167.47 20.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 156' ' ' VAL . 50.5 m-85 -84.34 149.95 25.7 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.305 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 85.0 p -67.55 -25.03 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.368 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -58.64 -26.53 63.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.025 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 14' ' ' ARG . 21.3 mm-40 -115.42 11.98 16.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.881 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 152' ' ' TYR . 88.1 t -108.46 114.3 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.191 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 91.4 m-85 -94.84 157.09 16.08 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.836 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -54.75 -54.55 40.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -147.22 150.73 35.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.027 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.08 158.54 72.49 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.889 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.47 112.66 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.955 1.77 . . . . 0.0 110.586 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 162' ' ' ARG . 16.6 ttp180 -73.52 131.73 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.642 -170.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.38 -166.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.913 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.97 107.29 15.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.201 0.524 . . . . 0.0 110.857 -174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 79.62 13.07 1.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.076 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.85 123.35 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.0 tt -76.2 116.83 59.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.382 0.611 . . . . 0.0 111.27 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 8.2 Cg_exo -72.15 150.37 53.66 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.996 2.464 . . . . 0.0 112.547 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.499 HG12 ' HG3' ' A' ' 147' ' ' LYS . 34.3 m -86.02 148.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.57 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' OD2' ' HD2' ' A' ' 182' ' ' ARG . 16.9 t70 -87.35 -40.77 14.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.411 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' A' ' 180' ' ' ARG . 61.0 t -120.08 130.44 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.437 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 53.7 tp -111.51 115.92 30.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.054 0.454 . . . . 0.0 110.082 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.1 111.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.352 0.596 . . . . 0.0 109.766 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -109.01 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.264 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' VAL . 9.9 pt-20 -54.9 -34.26 62.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.892 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 47.2 mttm -87.49 -58.64 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.306 -171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -155.53 174.72 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.85 121.59 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.802 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -126.33 119.15 26.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 171' ' ' VAL . 57.1 mtt180 -81.87 139.5 34.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.9 mt -104.97 -97.06 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 170' ' ' ASP . 35.7 ttt85 70.99 -49.18 0.68 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 170.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.01 115.22 5.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.825 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -141.24 103.42 0.34 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.761 ' HE ' ' HA ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -90.41 78.93 6.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.352 0.596 . . . . 0.0 110.394 -177.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.6 p -112.52 -28.71 7.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.718 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.4 mt 57.57 31.19 19.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.222 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.76 93.84 0.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.066 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -144.16 105.18 4.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.987 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -65.39 113.53 4.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -132.66 136.91 46.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -135.44 110.26 8.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -54.34 -59.98 3.95 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.2 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 27.7 p80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.276 176.153 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 10.7 mp 61.87 95.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.685 0.615 . . . . 0.0 110.823 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -70.33 -35.72 73.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.875 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 t -72.63 -29.87 63.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.247 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 2' ' ' LEU . 1.8 mp0 -89.24 -25.33 21.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.823 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.69 -44.95 93.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.62 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' A' ' 129' ' ' LEU . 4.0 ptp180 -66.55 -24.06 66.3 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.865 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HD2' ' HA ' ' A' ' 5' ' ' GLU . 98.6 mttt -73.16 -43.19 61.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.311 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.6 -29.56 70.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG13 ' NE2' ' A' ' 155' ' ' GLN . 77.1 t -75.63 -55.24 12.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.749 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -46.05 91.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.504 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -66.54 -21.23 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.111 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -76.56 -46.71 25.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.47 . . . . 0.0 110.496 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 36.7 mtm180 -73.2 -29.7 63.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.861 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -80.81 3.0 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.929 0.395 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -117.16 -98.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.4 mt 58.38 173.06 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.513 0.673 . . . . 0.0 111.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 m -76.37 123.34 25.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.06 -29.1 60.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.401 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.8 mp0 -63.53 -45.04 92.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.12 -50.13 74.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.445 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -52.55 -44.67 65.98 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.774 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.85 -47.16 69.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 2.6 ptt85 -73.53 -19.72 60.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.449 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 48.8 mt -78.0 -40.67 38.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 172.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -60.91 -35.19 76.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.403 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.66 -41.15 80.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -69.61 -42.65 74.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.0 t -62.33 -45.92 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.08 -44.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.673 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.5 m -60.37 -38.51 84.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -71.19 -47.24 58.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 49.6 tp -62.61 -38.93 92.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.013 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.21 -16.71 54.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.162 0.506 . . . . 0.0 110.513 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.5 t -75.89 -25.76 56.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 178' ' ' VAL . 58.4 mt -55.66 130.78 71.65 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.083 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.6 Cg_exo -64.87 -21.37 64.31 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.63 2.22 . . . . 0.0 111.456 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 2.5 mp0 -69.45 -24.72 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.856 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.411 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 68.3 t80 -68.18 -29.25 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 109.51 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.18 -29.33 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.039 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . 62.4 mttp -63.86 -38.92 92.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.965 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 t -90.78 136.43 33.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.645 0.736 . . . . 0.0 112.038 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -92.31 -17.57 24.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.361 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 71' ' ' ILE . 78.9 mttt -121.2 97.29 5.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.764 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.02 107.51 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -98.41 130.2 45.04 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.996 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.91 130.14 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.06 4.5 14.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.269 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 18.6 t 71.32 125.62 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.29 0.636 . . . . 0.0 111.181 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 4.4 Cg_exo -77.84 45.32 1.75 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.221 2.614 . . . . 0.0 112.929 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.1 pp -61.28 -32.08 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' ILE . 72.5 mmtt -136.33 33.63 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.44 146.71 18.33 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.683 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 7.2 pt-20 -83.71 -15.57 48.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.088 0.47 . . . . 0.0 111.241 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.87 132.23 54.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.735 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.87 86.76 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.98 0.419 . . . . 0.0 110.273 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -88.92 -1.17 57.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.274 0.559 . . . . 0.0 110.25 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -61.08 -47.09 96.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.02 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 58' ' ' THR . 51.0 Cg_endo -69.68 -5.32 15.87 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.592 1.528 . . . . 0.0 113.236 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' HG ' HG23 ' A' ' 64' ' ' VAL . 48.7 tp -88.73 -20.61 24.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.82 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.611 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.0 m-30 -49.73 -52.22 53.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 83.4 Cg_exo -50.28 -40.36 52.37 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.551 2.167 . . . . 0.0 113.362 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 17.0 tt0 -78.27 -37.44 45.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.349 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 70' ' ' LEU . 61.1 t -60.16 -44.83 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.4 -27.02 68.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.988 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 63' ' ' GLU . 31.9 ttpt -74.16 -36.01 64.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.783 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -95.9 -67.32 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.194 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 39' ' ' PHE . 40.4 mttp -124.98 -171.79 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.43 . . . . 0.0 111.981 -165.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.01 118.31 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.153 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 64' ' ' VAL . 58.6 tp -94.36 107.96 19.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 61.8 mt -89.0 116.93 31.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 91.4 mt -115.2 151.31 45.63 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HB3' HG21 ' A' ' 80' ' ' ILE . 5.2 Cg_exo -80.51 127.43 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 112.916 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 101' ' ' PRO . 25.6 tptp -105.8 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -85.61 103.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.876 0.37 . . . . 0.0 110.678 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.83 78.06 1.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.688 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.26 -80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.007 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -123.72 -16.26 6.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' HG2' ' CB ' ' A' ' 135' ' ' TYR . 21.0 mt-10 -126.53 167.42 15.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.493 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 139' ' ' LEU . 65.3 mt -118.43 126.9 75.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 -175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.7 m -96.65 134.46 39.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.289 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 109' ' ' PRO . 98.1 mt -90.43 131.83 35.97 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.57 147.81 44.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.313 0.578 . . . . 0.0 111.939 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 105' ' ' GLU . 39.6 ttt180 -81.6 108.59 15.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.121 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 90' ' ' CYS . 47.3 t -110.07 118.08 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.108 0.48 . . . . 0.0 110.486 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -124.65 -29.19 3.47 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 15.9 m -89.85 126.3 58.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.25 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.1 Cg_exo -61.29 -12.56 24.17 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.196 2.597 . . . . 0.0 113.011 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 4.22 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.853 0.359 . . . . 0.0 111.417 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.525 ' HB3' HG13 ' A' ' 85' ' ' VAL . 49.0 t -88.67 -0.51 57.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 111.073 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.95 113.32 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.021 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.56 158.71 22.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.966 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 61.5 t -79.71 127.99 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 0.0 110.244 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.596 ' HA3' ' OE2' ' A' ' 100' ' ' GLU . . . -81.98 -131.1 1.36 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.655 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.72 2.83 22.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.06 30.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.453 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.28 76.96 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.457 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 24.1 pt -114.1 163.92 10.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.53 119.02 38.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 110.504 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.596 ' OE2' ' HA3' ' A' ' 94' ' ' GLY . 8.5 pt-20 -138.87 155.06 73.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.529 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' HD3' ' A' ' 74' ' ' LYS . 33.5 Cg_endo -64.65 120.45 7.73 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.308 2.672 . . . . 0.0 113.398 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.36 -37.39 7.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 11.6 mm-40 -136.37 109.63 7.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.058 0.456 . . . . 0.0 111.78 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.17 43.68 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 21.1 mp0 -81.49 121.44 26.29 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -70.25 132.52 45.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 109.956 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.87 133.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.624 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.87 132.97 95.05 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . 50.2 Cg_exo -55.2 -33.03 82.96 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.573 2.182 . . . . 0.0 112.674 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -71.75 -19.72 61.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.718 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.95 -17.5 50.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.394 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.463 ' HB ' HG13 ' A' ' 143' ' ' VAL . 93.9 t -60.88 131.76 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.265 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.74 -41.59 7.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.512 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 54.0 t80 -132.9 130.45 39.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.276 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.52 138.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 110.894 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.92 115.95 28.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.82 118.6 36.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.37 90.69 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.301 175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.1 156.54 53.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.004 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.496 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 48.8 t -63.76 -47.72 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -157.44 157.93 34.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.97 156.34 46.36 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.11 0.257 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -109.67 -171.71 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 94.1 mt -79.37 6.03 11.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -119.85 -36.71 3.24 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.63 11.95 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.576 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -95.52 167.18 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.57 -162.49 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.776 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 161' ' ' PRO . 35.8 tp -118.04 20.2 13.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.651 0.739 . . . . 0.0 109.748 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.73 -179.62 49.1 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.245 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -142.81 -33.53 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.97 174.07 33.36 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -100.33 129.74 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.7 -134.75 2.32 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.524 ' CB ' ' HG2' ' A' ' 79' ' ' GLU . 88.3 m-85 -128.95 10.81 5.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.0 110.296 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -70.57 -38.94 74.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.18 -33.73 70.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.985 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -66.3 -30.8 71.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.772 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 80' ' ' ILE . 48.2 tp -67.42 -45.29 76.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.29 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.82 -38.52 75.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.877 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 167' ' ' ILE . 55.7 tttm -81.14 -21.67 39.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.247 0.546 . . . . 0.0 110.465 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HG2' ' HB2' ' A' ' 109' ' ' PRO . 30.0 ttp180 -77.35 -24.61 50.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.951 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.463 HG13 ' HB ' ' A' ' 112' ' ' VAL . 75.6 t -78.66 118.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.724 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -97.16 -2.02 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 110.785 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.58 -179.23 41.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.03 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.37 122.52 17.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.364 . . . . 0.0 110.57 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.72 109.64 21.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 171' ' ' VAL . 80.9 t -107.68 128.95 62.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.562 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -100.54 122.31 7.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.37 114.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.538 0.169 . . . . 0.0 110.629 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.16 164.63 32.75 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.501 0.501 . . . . 0.0 110.13 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.468 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 75.6 m-85 -86.76 158.44 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.511 . . . . 0.0 111.051 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.7 p -61.79 -25.95 67.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.792 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -77.1 -9.23 58.6 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.635 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.593 ' NE2' HG13 ' A' ' 10' ' ' VAL . 8.5 mm100 -108.54 9.4 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.27 116.69 44.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -111.18 179.7 3.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.799 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 30.4 mt-10 -70.8 -68.71 0.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 0.0 111.273 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.75 117.2 13.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.314 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.83 154.05 37.99 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.461 ' HD2' HD13 ' A' ' 129' ' ' LEU . 49.9 Cg_exo -56.14 111.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.259 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -88.31 151.07 22.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.675 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.24 143.15 50.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.18 -15.9 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -110.98 13.12 22.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -89.93 115.3 27.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 141' ' ' LYS . 40.3 mt -74.77 112.09 16.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.666 -172.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.94 163.75 28.16 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.547 2.165 . . . . 0.0 112.209 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 181' ' ' LEU . 28.6 m -103.6 166.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.637 177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.33 -41.02 6.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.258 0.551 . . . . 0.0 110.588 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 148' ' ' VAL . 61.8 t -116.84 120.67 65.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.405 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.8 tp -101.05 114.08 27.68 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 122.36 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.664 ' HB ' ' OE1' ' A' ' 175' ' ' GLU . 46.6 p -111.37 -168.3 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -72.29 -25.17 61.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.113 0.482 . . . . 0.0 110.215 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -115.11 -47.56 2.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.401 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.42 172.99 11.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.309 0.576 . . . . 0.0 112.053 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 98.9 t -126.06 115.03 41.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.632 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -100.03 116.38 31.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -73.71 95.03 2.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.866 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 169' ' ' VAL . 69.6 mt -69.0 -41.78 77.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 62.45 99.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.91 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -77.27 -35.69 54.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.077 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.91 90.89 1.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.024 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.89 -176.81 5.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.644 0.259 . . . . 0.0 110.799 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.2 m -62.79 114.17 3.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.7 tp -88.16 132.96 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.676 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 64.66 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.678 0.611 . . . . 0.0 111.318 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 74.85 -29.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.607 0.763 . . . . 0.0 111.701 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -97.08 -51.51 4.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 110.567 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -74.35 105.18 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.493 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -178.5 -61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.501 0.501 . . . . 0.0 110.403 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -159.09 139.88 12.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.315 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 59.4 m170 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.665 173.537 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.727 0.299 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 88.6 mt -74.66 161.86 29.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -70.86 -52.04 22.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.807 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -66.5 -24.63 66.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.469 . . . . 0.0 110.036 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 42.4 tt0 -58.37 -54.66 44.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.424 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.68 -35.77 75.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.168 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.15 -42.7 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.962 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.13 -42.76 99.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.108 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 26.8 mtpp -63.94 -51.89 62.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.61 -44.78 97.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.99 -35.79 77.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.426 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 24.8 t-80 -67.04 -37.8 84.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.371 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 7.4 mtpm? -66.27 -31.68 72.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 110.44 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 50.8 mtt180 -63.34 -54.45 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.176 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.679 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 27.0 pt -88.03 5.88 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.161 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -84.28 -30.83 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.28 144.99 55.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.863 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.5 m -71.79 151.21 43.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.703 0.287 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 22' ' ' ARG . 5.1 tp10 -59.44 -36.61 76.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.589 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 50.7 mt-10 -55.23 -52.55 63.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.088 0.471 . . . . 0.0 110.623 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.11 -39.81 95.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.379 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.679 ' NH1' ' HA ' ' A' ' 15' ' ' ILE . 23.6 mtm180 -65.76 -39.13 90.74 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.37 -37.5 87.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.0 110.841 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 49.5 mtt85 -69.56 -48.27 60.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -67.79 -43.36 79.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.451 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.6 t -62.03 -43.75 98.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.896 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.75 -35.44 81.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.848 0.356 . . . . 0.0 110.124 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 33.2 ttmt -59.02 -44.5 91.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.441 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 175' ' ' GLU . 42.9 t -67.76 -39.48 82.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 26' ' ' SER . 80.8 mt -61.41 -49.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -64.72 -37.19 86.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.13 -39.44 94.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.242 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.585 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 46.8 tp -65.79 -34.18 77.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.475 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 45.9 mtpt -72.76 -25.52 61.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -78.89 -21.3 47.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.902 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 171' ' ' VAL . 2.4 tt -58.28 121.46 52.01 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.134 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' HD23 ' A' ' 36' ' ' LEU . 69.4 Cg_exo -52.89 -37.71 77.84 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.309 2.672 . . . . 0.0 114.058 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -18.57 58.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.11 -15.65 63.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.967 0.413 . . . . 0.0 111.2 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -76.41 -45.34 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.748 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -74.69 -35.8 62.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.1 p -73.39 95.99 2.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.293 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HE2' ' HG3' ' A' ' 69' ' ' GLU . 79.1 tttt -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 111' ' ' ASP . 40.5 mttm -99.23 101.55 12.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.458 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.95 114.98 48.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -96.66 134.49 39.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.509 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -120.17 136.03 54.76 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 117' ' ' VAL . 26.0 t80 -74.67 -10.67 59.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.019 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' TYR . 41.2 t 67.84 106.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.406 0 CA-C-O 121.3 0.572 . . . . 0.0 110.824 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 76.1 Cg_endo -78.08 151.14 26.89 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.616 2.211 . . . . 0.0 113.437 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -134.85 166.66 27.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.257 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 34.4 mtpt 64.59 8.63 4.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.327 0.392 . . . . 0.0 111.556 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.24 -106.58 2.41 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 70.4 mt-10 61.66 -83.44 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.616 0.767 . . . . 0.0 110.764 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 150' ' ' VAL . 51.2 t -132.8 96.18 2.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 104.71 15.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.691 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 91.6 mt -95.91 3.73 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.671 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.3 m -59.17 -39.5 73.75 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 58' ' ' THR . 50.2 Cg_exo -57.78 -9.71 6.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.175 1.916 . . . . 0.0 114.136 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.8 tp -84.92 -12.93 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.654 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m-30 -54.99 -53.85 56.74 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.644 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 84.4 Cg_exo -52.59 -31.39 49.3 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.73 2.286 . . . . 0.0 113.476 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.0 -43.78 51.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 68' ' ' LYS . 84.0 t -72.98 -42.43 59.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.606 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt -65.93 -5.78 10.38 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' PRO . 63.4 mttp -66.1 -57.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.588 0.233 . . . . 0.0 110.903 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.45 -17.83 1.3 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 64' ' ' VAL . 68.0 mttm -91.69 173.64 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.003 0.43 . . . . 0.0 110.888 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' HE2' ' A' ' 43' ' ' LYS . 42.7 mt-10 -100.93 118.7 37.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.453 175.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.54 111.01 21.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 59.5 mt -97.89 112.37 29.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 98.1 mt -114.78 145.07 33.17 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.199 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.39 132.24 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.009 2.473 . . . . 0.0 112.544 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 5.5 mtpp -105.76 125.89 51.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.985 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.85 89.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.19 17.59 19.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.991 175.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.4 -121.22 2.13 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.78 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -91.14 -10.09 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 0.0 111.185 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -105.18 109.34 21.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.306 0.574 . . . . 0.0 110.285 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.578 HD11 ' HD1' ' A' ' 136' ' ' TYR . 57.1 mt -87.38 110.86 21.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.897 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 19.3 m -82.98 106.8 15.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.879 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 139' ' ' LEU . 94.4 mt -74.65 100.54 3.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 1.2 m-85 -96.11 116.22 28.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.617 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 3.0 ptp180 -83.89 124.29 30.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 101' ' ' PRO . 58.0 t -135.82 133.16 51.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -118.43 -9.98 10.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.5 m -91.4 136.58 26.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.483 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.6 Cg_exo -77.86 165.6 26.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.932 2.422 . . . . 0.0 112.105 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.72 4.76 3.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.1 m -95.94 28.25 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.786 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -113.62 138.39 50.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.03 143.37 15.04 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -91.3 128.15 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.92 -163.12 26.87 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 96' ' ' PHE . . . 47.63 78.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 77.7 t80 72.71 -50.83 0.7 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.879 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.94 36.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.061 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.39 172.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.2 ptm -123.75 99.34 6.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.396 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 5.3 pt-20 -96.67 159.0 32.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.343 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.566 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.14 116.3 4.34 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.48 2.12 . . . . 0.0 111.429 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.23 -22.14 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 110.55 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.38 152.78 51.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.005 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.66 -153.17 25.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -141.44 135.64 30.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.024 0.412 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -77.23 127.16 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.14 160.97 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.322 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.03 145.93 78.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.543 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.01 -17.15 10.41 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.391 2.727 . . . . 0.0 113.456 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.37 -29.73 70.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.061 0.458 . . . . 0.0 110.686 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 21.3 t70 -83.49 -10.35 58.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.83 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.57 95.55 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.401 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.33 -32.41 33.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.093 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.585 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 42.7 t80 -137.51 138.82 40.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.434 HG12 HG13 ' A' ' 117' ' ' VAL . 16.0 tt -146.88 140.54 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.751 0.31 . . . . 0.0 110.401 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.13 112.34 18.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 48' ' ' TYR . 27.3 m -126.33 128.63 24.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.429 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.33 108.81 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.429 2.086 . . . . 0.0 111.485 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.58 157.04 18.28 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.452 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.81 109.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.18 134.52 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.135 0.897 . . . . 0.0 112.512 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.14 146.09 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.886 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -103.27 -172.38 2.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.422 . . . . 0.0 111.219 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 70.5 mt -79.45 -3.97 49.03 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -105.56 -38.11 6.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.853 0.358 . . . . 0.0 110.284 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.6 11.65 1.67 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.682 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.58 168.4 11.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.304 0.552 . . . . 0.0 110.233 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -153.63 135.18 14.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.571 -166.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.9 tp -58.57 -64.74 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.956 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.99 171.03 22.44 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.321 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.3 -62.22 1.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.619 0.247 . . . . 0.0 110.995 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.51 -51.93 2.6 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.537 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 129' ' ' LEU . 33.7 tptt 73.53 112.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.555 0.742 . . . . 0.0 111.237 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 19.65 55.89 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.963 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.09 -80.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.666 -175.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 80' ' ' ILE . 31.9 m-85 -78.08 -23.73 47.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -22.63 65.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -69.93 -13.77 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 110.583 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 82' ' ' LEU . 48.5 tp -89.81 -42.89 11.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 147' ' ' LYS . 94.2 mt -57.05 -38.68 73.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.667 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -64.72 -26.97 68.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.94 -18.25 29.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.051 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.07 114.72 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -90.45 -6.06 55.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.382 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.72 43.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.39 109.58 11.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.963 0.411 . . . . 0.0 110.261 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 140' ' ' LEU . 32.6 mtmm -82.71 103.12 11.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.829 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.9 t -99.05 122.37 50.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.677 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -94.7 133.32 11.52 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.681 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.488 HG13 HG11 ' A' ' 29' ' ' VAL . 43.5 t -107.64 120.07 58.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.95 154.73 40.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.042 0.449 . . . . 0.0 111.898 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.96 160.9 21.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.836 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 m -55.37 -27.58 48.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.599 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.0 -15.76 63.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.664 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -99.43 -6.22 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.414 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 45.0 t -91.64 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.8 -176.63 2.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.151 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.945 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 33.8 mt-10 -90.79 -66.98 0.88 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 158' ' ' GLU . 10.8 mpt_? -125.4 115.04 19.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.18 143.57 26.86 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.94 101.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.776 1.651 . . . . 0.0 110.165 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -109.74 177.14 4.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.196 -172.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.71 168.3 10.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.454 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.69 64.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -102.39 66.19 0.97 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.571 0.701 . . . . 0.0 109.339 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.66 162.82 12.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.645 HD12 ' HD2' ' A' ' 168' ' ' PRO . 3.9 tp -138.99 111.52 8.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.139 0.495 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.645 ' HD2' HD12 ' A' ' 167' ' ' ILE . 72.5 Cg_endo -77.27 173.56 14.15 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.667 2.245 . . . . 0.0 112.572 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.474 HG23 HD12 ' A' ' 181' ' ' LEU . 21.1 m -112.17 151.98 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.211 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.03 -30.16 34.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.179 0.514 . . . . 0.0 110.083 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 36' ' ' LEU . 49.0 t -142.22 135.03 27.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.648 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 179' ' ' ARG . 61.0 tp -114.33 118.34 33.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 178' ' ' VAL . 63.2 t -109.22 123.22 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.185 0.517 . . . . 0.0 110.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 75.1 p -108.46 -164.86 0.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.601 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.709 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 5.7 pt-20 -73.16 -22.33 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.654 0.264 . . . . 0.0 110.98 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 64.8 mttp -122.26 -61.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.758 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.98 141.03 30.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.216 0.531 . . . . 0.0 112.037 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.538 HG13 HG22 ' A' ' 173' ' ' VAL . 57.6 t -109.47 102.32 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.658 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.783 HH22 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mtp-105 -85.69 99.82 11.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.423 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -76.34 92.39 3.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.474 HD12 HG23 ' A' ' 169' ' ' VAL . 88.0 mt -81.23 6.05 15.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.782 -170.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -71.24 -20.66 62.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.03 80.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.545 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -130.43 79.69 0.36 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.67 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -148.42 17.81 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.73 0.776 . . . . 0.0 109.874 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.0 p -76.94 -27.42 54.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.812 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.05 -67.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -85.72 85.34 7.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.532 0.682 . . . . 0.0 110.117 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -102.51 108.32 19.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.446 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.32 11.5 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.48 -174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -111.98 161.61 16.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -87.66 -62.25 1.54 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -172.63 176.74 3.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.836 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.57 175.9 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.867 0.365 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -133.68 86.0 2.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.681 0.277 . . . . 0.0 111.34 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -95.42 -45.48 7.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 0.0 109.719 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -58.85 -55.08 39.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.065 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' HD2' ' A' ' 9' ' ' LYS . 37.9 tt0 -59.04 -52.54 65.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.49 -46.31 90.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HG3' ' HA ' ' A' ' 131' ' ' PHE . 8.0 tmm_? -58.67 -45.68 88.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.038 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.01 -45.11 71.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.437 -175.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 13.4 ptmm? -70.36 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.645 HG11 ' HB2' ' A' ' 121' ' ' ALA . 84.0 t -70.14 -35.19 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.004 0.431 . . . . 0.0 110.467 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.74 -46.57 87.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.269 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' HA ' HG12 ' A' ' 15' ' ' ILE . 33.8 t-80 -66.76 -34.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.682 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 68.8 mmtt -51.88 -41.48 61.94 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.455 0.472 . . . . 0.0 111.144 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 54' ' ' GLU . 36.7 ttp180 -72.85 -38.36 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 12' ' ' HIS . 34.0 pt -90.71 -9.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -93.09 -6.51 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.536 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 13' ' ' LYS . 98.7 mt -67.4 161.02 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.602 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.7 m -62.74 127.27 30.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.335 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.9 -42.49 90.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.648 0.261 . . . . 0.0 111.356 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -67.99 -32.18 72.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.954 0.407 . . . . 0.0 110.089 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' CB ' ' HB2' ' A' ' 18' ' ' SER . 9.7 tp10 -63.13 -50.57 69.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.259 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 18' ' ' SER . 72.3 mtp180 -60.41 -37.45 80.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.94 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -56.74 -50.68 71.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.532 . . . . 0.0 110.527 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.95 -33.19 73.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.022 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 97.7 mt -69.58 -47.15 64.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.657 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.6 m -63.34 -31.71 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -56.76 -42.45 79.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.145 0.498 . . . . 0.0 110.255 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.56 -34.3 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 175' ' ' GLU . 66.0 t -62.19 -47.96 90.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.517 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 26' ' ' SER . 72.0 mt -57.48 -46.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.144 0.497 . . . . 0.0 110.097 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -61.76 -38.47 88.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.87 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.33 -43.66 81.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 0.0 110.324 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 36' ' ' LEU . 40.2 tp -61.26 -36.68 80.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.365 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.39 -13.77 59.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.004 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.7 m -82.61 -23.43 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 33' ' ' LEU . 74.3 mt -61.8 118.61 40.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.093 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.21 -23.0 53.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.417 2.078 . . . . 0.0 110.774 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.08 -31.26 70.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.312 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.22 -24.96 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -70.49 -49.62 46.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -72.34 -26.28 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.707 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 114' ' ' PHE . 31.1 m -71.26 98.04 1.66 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 30.9 mtmm -86.35 -25.16 25.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.23 -171.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -110.48 108.58 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.008 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 t -109.02 113.05 43.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.5 124.58 40.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.483 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.75 130.99 55.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.25 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' CYS . 48.4 t80 -72.62 -27.57 62.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.8 t 72.24 133.73 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.855 0.722 . . . . 0.0 111.226 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 14.4 Cg_exo -69.36 140.59 44.55 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.677 2.251 . . . . 0.0 111.824 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 pt -124.15 -27.58 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 18.6 tptt -124.38 -35.73 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.628 . . . . 0.0 110.41 -175.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.537 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 138.53 88.13 0.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -121.07 -87.15 0.65 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.552 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -135.09 131.58 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.3 96.57 4.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.294 0.569 . . . . 0.0 110.688 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.57 13.67 20.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.505 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -66.34 -44.8 58.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.536 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 58' ' ' THR . 42.5 Cg_endo -68.81 -0.96 6.84 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.769 1.646 . . . . 0.0 112.773 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 63' ' ' GLU . 60.0 tp -92.07 -17.26 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 30.9 m-85 -50.93 -51.27 68.76 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.8 Cg_endo -56.64 -41.6 74.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.192 1.928 . . . . 0.0 112.471 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' A' ' 60' ' ' LEU . 6.1 mt-10 -66.5 -36.34 82.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.52 -41.79 91.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.434 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 86' ' ' HIS . 65.1 mt -66.3 -14.19 61.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -82.15 -61.9 1.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.99 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -93.04 -29.66 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 27.1 mmtp -124.45 -174.47 3.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.536 0.684 . . . . 0.0 112.234 -166.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.06 128.24 48.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.975 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 112.63 24.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 44' ' ' LYS . 61.5 mt -98.41 117.64 43.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.923 0.392 . . . . 0.0 110.101 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.8 mt -118.96 133.97 23.64 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -84.25 123.17 2.99 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.722 2.281 . . . . 0.0 112.621 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 57.0 tttm -105.42 101.48 11.01 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -82.15 92.72 2.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.313 0.578 . . . . 0.0 109.846 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -101.21 107.15 18.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.236 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.28 -90.97 0.92 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.59 11.61 1.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 109.828 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.22 120.51 40.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.27 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.649 HD11 ' HD1' ' A' ' 136' ' ' TYR . 56.7 mt -85.07 99.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.331 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -95.97 112.11 23.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.68 131.14 35.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.07 144.93 48.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.421 0.629 . . . . 0.0 111.697 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.7 ttt85 -90.65 96.81 10.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.693 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.0 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.466 ' HA ' HD22 ' A' ' 65' ' ' LEU . 1.7 t60 -136.39 16.28 3.18 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -121.31 120.0 29.23 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.023 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.96 -8.62 22.55 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.622 2.215 . . . . 0.0 112.307 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.32 12.46 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.4 t -95.69 -144.93 0.27 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.6 mt 64.57 113.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.799 0.687 . . . . 0.0 112.616 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.95 127.08 4.28 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.18 110.2 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.934 0.367 . . . . 0.0 110.279 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.91 -98.94 0.65 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.014 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . -60.03 127.23 30.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.322 0.249 . . . . 0.0 111.638 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.7 t80 70.47 -38.55 0.42 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.021 0.826 . . . . 0.0 112.061 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 95' ' ' ALA . . . 130.07 10.02 2.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.926 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 pt -91.34 172.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.725 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtm -93.42 100.71 12.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.662 ' HB3' ' HE2' ' A' ' 74' ' ' LYS . 43.2 mt-10 -84.86 132.34 46.38 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.438 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 24.5 Cg_exo -64.15 114.26 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.388 2.059 . . . . 0.0 111.426 174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.79 -17.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.317 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -148.1 150.27 33.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.3 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.06 -158.45 27.74 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.811 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -112.44 161.65 16.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -89.26 126.14 35.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.36 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.58 130.66 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 110.738 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.69 152.23 38.99 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.58 -23.71 41.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.66 -22.07 66.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 44' ' ' LYS . 4.7 t70 -94.7 -3.41 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.229 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.92 112.63 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.239 0.543 . . . . 0.0 111.527 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -60.18 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.187 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 21.3 t80 -134.84 139.61 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.9 139.2 41.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.5 111.65 21.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.497 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 46.1 t -117.89 108.62 42.35 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.18 62.74 8.12 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.206 2.604 . . . . 0.0 111.299 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.06 169.13 22.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.436 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.29 107.35 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . 71.99 133.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.275 0.984 . . . . 0.0 112.335 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.36 165.24 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.244 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.545 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -135.12 -178.72 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.436 HD12 ' HG2' ' A' ' 158' ' ' GLU . 90.6 mt -74.46 -12.72 60.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.51 ' HB2' ' NH1' ' A' ' 159' ' ' ARG . 7.0 tp10 -81.97 -42.16 19.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.08 24.9 2.88 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.192 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -101.31 -176.41 3.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.126 0.489 . . . . 0.0 111.381 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -122.2 -171.84 2.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.556 -173.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 40.6 tp -120.69 143.21 48.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.484 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.79 103.99 1.15 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.773 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 87.4 t80 -69.64 -36.81 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 111.397 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.24 -108.95 2.0 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.686 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -78.27 85.13 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 110.592 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.62 50.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -78.13 83.53 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.167 0.508 . . . . 0.0 111.079 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.649 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.1 m-85 -108.95 19.7 19.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.683 0.754 . . . . 0.0 108.969 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.77 -34.73 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.068 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -55.91 -34.42 65.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.116 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 143' ' ' VAL . 56.9 tp -84.75 -54.14 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' A' ' 167' ' ' ILE . 96.9 mt -57.37 -38.55 74.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.8 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.653 ' HD3' HG13 ' A' ' 167' ' ' ILE . 25.9 tptp -74.24 -15.88 60.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 -176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 142' ' ' ARG . 19.7 mtp180 -109.36 -4.5 16.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.417 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.2 t -69.15 104.63 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.078 0.466 . . . . 0.0 109.889 174.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -92.55 12.88 21.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.603 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.29 -174.28 46.25 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 103.1 8.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.428 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 9.8 mtmp? -87.12 102.86 14.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.766 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.7 t -104.97 119.25 53.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -90.87 136.5 13.4 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 174.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.552 HG12 HG21 ' A' ' 55' ' ' VAL . 13.7 t -122.67 124.45 70.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.24 164.13 35.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.529 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.402 ' HE2' HH21 ' A' ' 22' ' ' ARG . 94.3 m-85 -75.61 169.4 18.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.016 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.6 t -69.12 -26.08 64.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.335 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -74.88 -5.68 44.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.055 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -106.47 4.67 28.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.666 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.19 114.9 44.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.615 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -103.0 179.62 4.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.142 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.436 ' HG2' HD12 ' A' ' 124' ' ' LEU . 4.8 tm-20 -89.12 -50.9 5.88 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 125' ' ' GLU . 4.9 tpp180 -149.06 123.62 9.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.335 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.5 mt -101.26 159.09 30.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.162 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.75 103.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.419 2.079 . . . . 0.0 111.223 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 162' ' ' ARG . 39.0 mtm180 -92.6 159.49 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -123.61 179.88 4.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.75 -49.19 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.594 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -93.14 9.27 36.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.341 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.62 159.43 33.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.455 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.665 HG21 ' HB3' ' A' ' 140' ' ' LEU . 3.9 mp -105.12 111.86 65.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.338 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.87 148.79 7.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.79 2.327 . . . . 0.0 112.871 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.64 174.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.172 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 25.1 m-20 -108.62 -49.44 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.93 145.59 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.593 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.1 tp -124.34 103.37 8.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.824 0.345 . . . . 0.0 110.616 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 178' ' ' VAL . 49.1 t -87.05 120.1 35.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 p -105.97 -177.4 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 10.0 pt-20 -71.03 -7.23 44.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.634 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 30.0 mmtp -119.95 -62.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.142 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.86 161.98 30.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.359 . . . . 0.0 111.14 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 173' ' ' VAL . 70.7 t -87.39 101.46 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -88.39 91.91 8.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.671 -175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -74.41 108.71 7.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.14 -43.5 86.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 182' ' ' ARG . 1.5 ppt_? -166.79 156.54 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.832 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.09 -52.93 3.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.525 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 62.96 29.32 73.93 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.657 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -133.96 -48.22 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.311 . . . . 0.0 111.649 -176.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.4 t -98.29 162.65 13.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.244 0.545 . . . . 0.0 111.579 -171.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.18 6.8 47.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.533 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.57 -38.54 69.48 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.62 104.51 16.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -78.55 80.94 4.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.83 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -159.38 111.13 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.392 173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 167.24 12.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -88.48 139.46 30.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.29 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 m170 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.696 174.427 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp 64.57 31.48 12.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.28 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -60.23 -45.75 92.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.453 0.644 . . . . 0.0 110.026 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -71.75 -40.27 69.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.641 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.95 -45.79 76.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.901 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 tp -53.65 -40.82 66.19 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.33 0.394 . . . . 0.0 111.391 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 1.102 ' HD3' ' HA ' ' A' ' 131' ' ' PHE . 39.2 ttm180 -61.01 -54.74 41.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.264 0.554 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -25.51 64.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.766 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.48 -55.05 11.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.185 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 155' ' ' GLN . 61.1 t -70.99 -33.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.013 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.593 HD11 ' HG2' ' A' ' 52' ' ' LYS . 54.9 tp -62.19 -29.98 70.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.411 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 10.8 t60 -67.72 -36.7 81.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.992 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -68.32 -32.27 72.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 17.6 mmt180 -52.78 -57.82 8.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.342 0.591 . . . . 0.0 110.602 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.3 9.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.445 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -88.1 -25.63 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.121 -0.362 . . . . 0.0 110.334 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.2 142.73 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.067 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 18.5 t -64.96 148.26 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.45 -42.36 70.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.88 -51.07 64.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.891 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 18' ' ' SER . 1.7 mp0 -60.21 -44.55 95.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.455 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 5.3 tmm_? -57.77 -47.23 83.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.731 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -62.07 -46.22 90.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.097 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -60.11 -47.96 83.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.667 0.27 . . . . 0.0 111.035 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.8 mt -66.69 -37.54 84.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 30' ' ' ILE . 31.1 t -58.96 -49.53 77.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.918 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -59.79 -34.94 73.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -42.02 91.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.579 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 25' ' ' LEU . 45.5 t -62.19 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.073 0.463 . . . . 0.0 109.994 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 26' ' ' SER . 69.8 mt -58.39 -40.12 77.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.505 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.0 m -61.15 -40.28 93.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -67.24 -42.41 84.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 36' ' ' LEU . 39.9 tp -62.32 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.205 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 39' ' ' PHE . 2.5 mmpt? -66.94 -30.97 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.26 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.1 m -71.58 -24.59 61.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 178' ' ' VAL . 46.4 mt -61.18 116.79 21.04 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.348 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.1 -35.89 84.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.036 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.69 -37.32 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.798 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 69.7 t80 -74.08 -17.15 60.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.207 0.527 . . . . 0.0 110.776 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.88 -41.91 10.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -81.54 -33.23 31.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.761 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 t -84.9 122.04 28.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 92.7 mttt -93.28 -3.93 52.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.714 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 8.7 mmpt? -89.31 86.13 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.61 118.15 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 111.475 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -111.62 138.96 47.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.161 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 57' ' ' LEU . 7.4 mp -120.2 144.17 47.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.787 ' HB2' HG12 ' A' ' 117' ' ' VAL . 37.8 t80 -77.33 -6.63 53.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.152 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.1 t 70.8 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.825 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 2.7 Cg_exo -75.1 98.18 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.864 2.376 . . . . 0.0 112.436 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.837 HG13 ' HD3' ' A' ' 52' ' ' LYS . 40.7 pt -89.4 -5.45 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.227 0.537 . . . . 0.0 110.144 173.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' HG13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -107.19 144.85 33.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.78 72.63 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.708 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HG3' ' H ' ' A' ' 55' ' ' VAL . 5.2 pt-20 -129.52 -79.62 0.56 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.595 0.358 . . . . 0.0 110.203 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.711 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 38.3 t -100.17 123.74 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 22' ' ' ARG . 20.6 m-20 -79.14 71.88 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.898 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 88.2 mt -85.51 -10.46 56.0 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.232 0.539 . . . . 0.0 109.581 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m -62.49 -53.3 58.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.177 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 21.9 Cg_exo -67.31 -6.55 16.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.175 1.917 . . . . 0.0 112.217 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -89.32 -15.25 33.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.389 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.0 m-85 -55.74 -52.38 72.65 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.319 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 61.1 Cg_exo -54.93 -34.37 85.95 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.396 2.064 . . . . 0.0 112.898 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 1.3 tm-20 -65.38 -50.62 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 109.925 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 84.9 t -64.87 -41.51 92.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.586 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' A' ' 88' ' ' PRO . 50.8 tp -67.48 -16.77 64.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.509 . . . . 0.0 111.198 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 13.7 tppt? -71.16 -52.22 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.467 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.4 pt-20 -121.81 -30.01 4.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.074 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.634 ' HE2' ' HA ' ' A' ' 64' ' ' VAL . 30.2 mtmm -103.4 -173.03 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.239 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' A' ' 84' ' ' ARG . 49.2 mt-10 -106.63 119.34 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -89.81 106.06 18.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.047 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 59.3 mt -93.69 123.83 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.2 mt -120.12 141.68 32.08 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.094 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 5.6 Cg_exo -76.81 110.86 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.962 2.441 . . . . 0.0 111.724 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.82 114.82 29.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.26 101.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.418 . . . . 0.0 109.874 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -90.74 85.25 6.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.556 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.74 0.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.16 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -112.13 -9.08 13.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -115.33 109.42 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.669 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.74 135.82 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 m -140.33 149.45 42.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.353 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 3.3 mm? -84.64 114.25 21.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.415 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 10.8 m-85 -95.8 124.67 39.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 17.5 ttm180 -84.31 102.72 12.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 110.21 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 90' ' ' CYS . 55.2 t -89.65 111.81 23.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.253 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -114.85 -4.87 12.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.635 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -117.69 126.65 27.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.609 -178.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.604 ' HA ' HD21 ' A' ' 65' ' ' LEU . 36.3 Cg_exo -60.95 -22.2 73.69 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.812 2.342 . . . . 0.0 113.293 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.15 -5.03 58.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.863 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 87' ' ' SER . 61.3 m -84.44 1.76 43.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 111.495 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.9 129.64 48.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.279 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.5 161.17 29.09 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 t -88.15 86.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.307 0.575 . . . . 0.0 110.374 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.5 -155.91 10.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.58 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.53 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . 55.79 -129.56 1.98 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.564 0.346 . . . . 0.0 110.616 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -97.07 24.05 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.032 0.444 . . . . 0.0 110.783 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.45 51.11 1.0 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.379 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 95' ' ' ALA . 40.1 pt -131.41 163.78 36.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.621 0.248 . . . . 0.0 110.369 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 tpp -81.03 90.97 6.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.79 158.0 36.08 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.991 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 43.9 Cg_endo -72.64 107.92 2.42 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.138 1.892 . . . . 0.0 111.166 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -77.22 -22.97 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.3 0.572 . . . . 0.0 110.224 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.05 -175.52 4.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.527 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.35 -138.38 11.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.418 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -141.69 128.17 20.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 15.4 ptm180 -78.16 101.94 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.538 0.685 . . . . 0.0 110.453 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.42 153.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.741 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 28.5 p-10 -70.93 146.33 92.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.18 -8.45 12.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.238 2.625 . . . . 0.0 112.714 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 42.0 tt0 -69.29 -23.84 63.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.481 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.64 -19.45 57.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.585 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.31 110.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 25.7 t70 -91.06 -36.36 14.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.122 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 31.2 t80 -133.53 127.74 33.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.619 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 147' ' ' LYS . 12.9 tt -135.46 139.74 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.78 118.92 30.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 48' ' ' TYR . 19.9 m -118.25 127.35 26.64 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.131 0.491 . . . . 0.0 111.332 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 6.1 Cg_exo -79.91 84.1 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.983 2.456 . . . . 0.0 111.178 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.33 162.25 19.86 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.886 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 50.8 t -99.08 128.06 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . 67.75 114.72 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.2 0.938 . . . . 0.0 112.684 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -137.6 166.81 23.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.587 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.822 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 16.2 p30 -137.83 -165.14 1.73 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.748 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.93 -5.66 59.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -104.51 -31.48 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.231 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 121.64 17.75 3.8 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.954 172.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 162' ' ' ARG . 22.7 m-30 -69.72 144.43 52.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 117.371 0.585 . . . . 0.0 110.142 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 2.0 tmm_? -122.62 106.04 10.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 110.731 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 28.7 tp -76.79 -40.01 49.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.53 -129.69 49.11 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.922 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 1.102 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 88.9 t80 -162.97 140.93 8.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.61 169.61 30.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.615 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -75.42 -34.73 61.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 0.0 110.646 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 162.64 -109.93 0.41 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 65.91 -71.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.304 0.642 . . . . 0.0 111.827 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -94.21 3.08 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.008 -171.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -67.03 -28.19 68.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 109.654 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 138' ' ' ARG . 59.7 mtt85 -76.62 -27.18 55.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.272 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 tp -66.34 -35.56 80.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.74 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.93 -30.71 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' A' ' 167' ' ' ILE . 23.9 ttmm -72.44 -27.24 62.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -78.37 -23.05 47.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.497 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.25 96.2 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.172 0.51 . . . . 0.0 109.81 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -90.09 16.49 8.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.055 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.9 -162.86 34.87 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.33 99.39 9.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.761 0.315 . . . . 0.0 110.169 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 36.9 mtmm -78.87 102.93 8.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.786 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 171' ' ' VAL . 62.1 t -98.41 124.39 51.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.402 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.11 121.43 6.69 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.424 HG12 HG21 ' A' ' 55' ' ' VAL . 43.3 t -102.41 111.95 33.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.831 0.348 . . . . 0.0 110.088 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -145.65 151.76 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.193 0.521 . . . . 0.0 112.094 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.34 151.92 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.124 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -60.38 -23.74 64.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.759 0.314 . . . . 0.0 111.425 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -66.48 -25.06 66.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.67 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 1.8 mp0 -98.37 2.42 47.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.831 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.96 124.82 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.08 -169.4 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.434 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.19 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.822 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 11.2 ttp180 -155.78 141.5 17.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.17 158.94 69.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.768 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.57 107.79 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 111.157 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HD2' ' OH ' ' A' ' 127' ' ' TYR . 25.5 ttt180 -73.67 121.96 21.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.52 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.64 -67.76 0.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.981 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.02 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.499 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -117.61 72.52 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.336 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 33.3 t70 -88.92 145.96 25.21 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.177 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 141' ' ' LYS . 65.2 mt -89.93 107.87 22.03 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.6 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.9 Cg_exo -73.36 157.04 50.13 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.143 2.562 . . . . 0.0 112.317 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 30.6 m -86.61 176.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.593 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 -44.76 7.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.003 0.43 . . . . 0.0 110.95 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.7 t -132.4 134.94 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.484 HD23 HH11 ' A' ' 179' ' ' ARG . 60.5 tp -115.14 112.52 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.885 0.374 . . . . 0.0 110.199 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.4 t -99.21 118.01 45.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 0.0 110.349 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.22 169.76 8.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -84.45 65.7 9.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -175.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 175' ' ' GLU . 10.3 mmtp 179.02 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.262 0.976 . . . . 0.0 110.89 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -144.17 156.92 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 0.0 111.271 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 36' ' ' LEU . 48.0 t -102.54 106.55 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.257 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.484 HH11 HD23 ' A' ' 172' ' ' LEU . 40.8 ttm105 -93.58 95.43 9.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.747 -173.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -78.45 123.89 27.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 169' ' ' VAL . 73.7 mt -94.39 27.57 2.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.037 0.446 . . . . 0.0 111.109 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -50.17 -57.76 7.04 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.22 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.549 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.0 5.16 83.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.809 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -99.08 13.7 31.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.805 0.336 . . . . 0.0 110.554 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.2 m -59.22 -30.44 68.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.982 0.42 . . . . 0.0 110.417 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -132.2 26.59 4.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.111 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' OE2' ' HB2' ' A' ' 190' ' ' HIS . 0.1 OUTLIER -142.91 157.54 44.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -177.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.29 9.46 2.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.509 ' HB2' ' OE2' ' A' ' 188' ' ' GLU . 55.5 m80 -77.13 125.98 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.327 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -103.44 -17.28 15.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 61.53 -159.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.859 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -147.06 153.98 40.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.353 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.508 0.194 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 6.4 mp -86.45 77.21 9.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.21 0.528 . . . . 0.0 109.88 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 161' ' ' PRO . 29.2 pttt -68.87 -28.28 66.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.921 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.2 t -78.82 -36.08 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.945 0.402 . . . . 0.0 110.01 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 17.7 tp10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.07 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.67 -48.95 78.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.383 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -56.04 -44.7 79.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.729 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -60.8 -46.91 88.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.923 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HE2' ' HG3' ' A' ' 5' ' ' GLU . 61.7 mttm -58.97 -43.97 91.47 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.189 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG11 ' HG3' ' A' ' 155' ' ' GLN . 43.8 t -67.76 -46.5 82.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.476 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.37 -40.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.121 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.62 -48.11 82.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -78.87 -30.36 45.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.553 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 54' ' ' GLU . 30.5 ttp180 -57.18 -46.91 82.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 52' ' ' LYS . 33.2 pt -90.82 3.27 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.699 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -101.92 2.1 37.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD11 ' CZ ' ' A' ' 154' ' ' PHE . 89.1 mt -67.43 138.12 56.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 p -70.95 155.9 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.59 -58.72 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.562 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.08 -48.93 79.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.582 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.21 -44.24 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -61.62 -46.39 90.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.445 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -69.16 -34.69 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -66.21 -31.03 71.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 0.0 110.923 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.55 -41.77 21.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.253 0.549 . . . . 0.0 110.007 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -61.5 -36.3 80.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.006 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.62 -42.24 82.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.591 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.49 -34.92 75.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 55' ' ' VAL . 42.0 t -66.36 -42.95 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.925 0.393 . . . . 0.0 110.361 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.64 -44.22 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.271 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.8 m -64.52 -32.71 74.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.711 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -63.96 -54.37 35.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.88 -33.33 74.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.703 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -67.83 -30.58 70.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -87.61 -14.25 40.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tt -64.11 113.69 11.17 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 35.5 Cg_exo -59.4 -48.34 13.85 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.869 2.38 . . . . 0.0 112.861 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.79 -20.1 65.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.501 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 77.8 t80 -74.1 -46.7 41.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 57.3 tttm -73.47 -29.75 62.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.719 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 34.1 mmtp -68.76 -37.3 79.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -82.7 148.29 27.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 110.753 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 35.7 mtmt -101.35 -37.04 8.65 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.069 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -89.28 96.52 10.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.14 122.88 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.927 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.02 124.02 44.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.968 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.88 122.27 45.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.741 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.707 ' HD2' ' HD2' ' A' ' 118' ' ' PRO . 6.4 t80 -83.42 98.85 9.72 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 58.6 m -51.9 114.85 5.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.895 0.747 . . . . 0.0 112.673 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 42.2 Cg_endo -68.88 131.67 23.01 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.816 2.344 . . . . 0.0 111.108 174.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.423 HG22 HG21 ' A' ' 98' ' ' ILE . 2.4 pp -120.01 -8.93 10.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 41.0 mttp -145.72 70.37 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.379 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -114.76 3.88 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HG2' ' NH1' ' A' ' 14' ' ' ARG . 29.7 mt-10 61.32 25.48 15.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 169.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 29' ' ' VAL . 98.0 t 69.69 106.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.431 0.634 . . . . 0.0 110.485 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.28 96.52 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.677 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.7 mt -88.12 9.63 22.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.674 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.454 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -62.62 -47.39 88.29 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.3 Cg_endo -70.95 1.13 5.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.694 1.596 . . . . 0.0 112.905 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 tp -88.77 -16.91 30.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.794 0.33 . . . . 0.0 110.599 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.2 m-85 -56.7 -48.02 97.98 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 93.9 Cg_exo -48.1 -31.84 17.32 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 122.53 2.153 . . . . 0.0 113.546 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.59 -48.28 12.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 68' ' ' LYS . 98.9 t -61.89 -39.33 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.512 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 96.2 mt -64.18 -14.77 57.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -88.73 -48.46 7.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.043 0.449 . . . . 0.0 111.34 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 28.3 mt-10 -93.69 -38.0 11.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.45 . . . . 0.0 112.057 -171.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 33.9 mttp -119.66 167.31 12.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -161.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -93.24 121.44 34.6 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.646 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' HG ' ' A' ' 72' ' ' LEU . 58.6 tp -84.02 112.69 20.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.243 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.22 115.87 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.897 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -121.26 136.01 25.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.666 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.5 132.78 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 0.0 111.86 176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 53.2 tttm -105.95 128.81 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.0 104.02 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.48 12.18 30.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.0 -105.02 1.26 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.7 -15.26 22.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.279 0.561 . . . . 0.0 109.805 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -89.52 143.45 26.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.123 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.691 HD11 ' HD1' ' A' ' 136' ' ' TYR . 62.0 mt -113.64 111.64 36.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.212 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 20.1 m -94.95 108.53 20.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.135 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.2 104.13 6.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.98 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.21 140.2 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.853 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.37 151.35 37.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.0 176.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.886 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -139.27 11.05 2.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.365 0.602 . . . . 0.0 109.872 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 p -162.7 150.51 11.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.711 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.8 Cg_exo -76.07 49.76 2.64 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.012 2.475 . . . . 0.0 111.496 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.82 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 38.4 t -124.6 94.41 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.269 0.557 . . . . 0.0 110.834 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 101' ' ' PRO . 95.3 mt -123.07 120.82 34.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.64 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.06 -171.33 27.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.6 t -136.82 116.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.67 -59.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.995 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -107.92 139.1 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.799 -0.236 . . . . 0.0 111.326 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 65.2 10.88 6.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 0.0 111.935 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.66 16.26 67.55 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.782 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 95' ' ' ALA . 39.1 pt -105.58 172.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.833 0.349 . . . . 0.0 110.953 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -73.4 131.26 41.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.281 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -117.04 121.42 32.56 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.237 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 74' ' ' LYS . 24.8 Cg_endo -62.54 118.15 5.04 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.607 2.205 . . . . 0.0 112.398 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 58.5 t -93.18 -55.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.792 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -105.05 154.59 19.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.746 0.308 . . . . 0.0 110.601 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.54 162.77 10.63 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.37 135.8 35.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 106' ' ' ARG . 17.8 ptt85 -87.48 145.28 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.74 153.09 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -82.71 161.88 57.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.53 -14.83 5.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.284 2.656 . . . . 0.0 113.476 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.3 -37.14 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.313 0.578 . . . . 0.0 110.763 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.76 -23.68 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.9 107.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.974 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.87 -49.7 5.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 20.7 t80 -118.75 129.82 55.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.5 tt -139.19 139.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.993 0.425 . . . . 0.0 110.574 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.27 116.05 23.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.066 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 48' ' ' TYR . 33.7 m -124.86 127.35 25.15 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 0.0 111.274 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.707 ' HD2' ' HD2' ' A' ' 48' ' ' TYR . 2.2 Cg_endo -83.35 -164.46 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.001 2.468 . . . . 0.0 111.166 171.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.51 175.55 32.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.782 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -99.98 121.33 50.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 72.58 126.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.32 1.012 . . . . 0.0 112.654 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.502 ' HA ' HD11 ' A' ' 160' ' ' LEU . 63.0 m-85 -138.09 168.41 19.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 45.3 p30 -126.3 -164.55 1.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.268 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.75 -13.8 37.15 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.614 ' O ' HD11 ' A' ' 181' ' ' LEU . 44.7 mt-10 -110.51 -62.49 1.52 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.97 62.32 0.13 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.924 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -82.91 134.03 35.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.2 82.82 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.7 tp -59.22 -57.14 14.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.616 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.25 -105.98 2.95 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.468 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -140.29 -65.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.661 0.267 . . . . 0.0 111.168 -172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.01 175.19 22.33 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.48 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -94.56 111.29 23.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.425 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.37 75.56 1.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.144 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -144.57 -90.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.067 0.46 . . . . 0.0 110.344 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.691 ' HD1' HD11 ' A' ' 80' ' ' ILE . 95.3 m-85 -100.61 6.39 44.11 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.786 0.803 . . . . 0.0 110.567 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.32 -16.95 63.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.55 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -54.74 -34.52 62.62 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 143' ' ' VAL . 51.6 tp -87.22 -51.22 6.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.142 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.64 -26.93 62.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.11 -28.55 63.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.74 -2.57 15.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.784 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 139' ' ' LEU . 98.4 t -70.19 102.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -97.19 10.98 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.92 -176.42 43.56 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.683 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.0 100.71 1.26 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.986 0.393 . . . . 0.0 110.283 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.43 100.06 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.091 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.582 HG21 ' CZ ' ' A' ' 114' ' ' PHE . 92.3 t -96.29 114.93 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.025 0.441 . . . . 0.0 110.014 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.35 124.26 7.72 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.723 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.27 116.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.23 161.51 40.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.672 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -96.61 156.31 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -62.43 -31.44 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 26.8 p90 -78.18 -6.2 54.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.421 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.525 ' HG3' HG11 ' A' ' 10' ' ' VAL . 28.5 tt0 -100.95 -6.23 24.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 0.0 109.816 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.5 115.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.64 -166.39 1.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 33.6 tt0 -69.69 -67.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.92 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 123' ' ' ASP . 5.1 tpm_? -145.43 132.62 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.462 -173.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 122' ' ' PHE . 80.9 mt -96.52 138.87 21.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.616 0.246 . . . . 0.0 110.75 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 3' ' ' LYS . 3.1 Cg_exo -76.36 101.87 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.789 2.326 . . . . 0.0 111.25 174.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.72 148.66 29.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.102 -177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.1 m-20 -114.81 -135.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.328 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -61.69 -23.79 66.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.42 0.628 . . . . 0.0 110.312 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -87.58 67.68 9.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.278 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.38 -74.18 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.367 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 41.2 mt 41.04 81.38 0.25 Allowed Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 124.285 0.991 . . . . 0.0 113.246 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.04 165.49 5.75 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.44 2.093 . . . . 0.0 111.798 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.58 177.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 182' ' ' ARG . 1.0 OUTLIER -111.75 -43.26 3.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.473 0.654 . . . . 0.0 109.369 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.41 122.33 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 42.5 tp -101.95 109.93 21.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.12 123.68 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.85 3.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.403 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -26.29 28.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.134 0.492 . . . . 0.0 110.479 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.2 -34.2 15.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.34 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.5 171.66 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.946 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 t -113.58 111.49 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 42.0 ttm180 -89.56 96.3 10.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.284 0.564 . . . . 0.0 111.132 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.87 115.26 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.391 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.614 HD11 ' O ' ' A' ' 125' ' ' GLU . 75.6 mt -98.03 -46.77 5.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 111.042 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 15.1 ttt180 -83.87 95.87 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.287 0.565 . . . . 0.0 110.431 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -100.83 -160.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.197 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.82 45.74 2.77 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.002 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 185' ' ' ARG . 20.1 mtt180 -73.47 97.91 2.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.0 110.655 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.9 m -149.1 141.55 24.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.538 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -125.74 133.59 52.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.331 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 67.79 165.51 0.23 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -92.1 106.67 18.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.321 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -106.88 20.37 19.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.533 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -126.51 73.59 1.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.614 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -94.39 -15.42 24.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.633 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -95.35 -47.32 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.029 0.442 . . . . 0.0 109.878 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.887 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.25 155.22 20.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 111.682 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -48.77 70.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 m -63.88 -35.59 81.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.946 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.99 -53.95 52.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.654 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.54 -48.37 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.512 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.04 -49.45 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -65.08 -43.07 93.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.612 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.51 -46.77 68.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.863 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.17 -37.15 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.0 tp -57.24 -37.49 72.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.285 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 15.0 t-80 -67.13 -25.93 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.963 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 45.9 mmtt -95.67 -16.22 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 110.968 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.459 HH11 ' HG2' ' A' ' 155' ' ' GLN . 25.0 ttt85 -75.66 -42.98 49.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.3 pt -90.78 6.84 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.256 0.551 . . . . 0.0 110.68 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -77.25 -26.09 52.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.896 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.09 135.35 57.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.639 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -65.3 142.53 58.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.122 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -52.69 -43.15 65.4 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.3 -59.44 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.152 0.501 . . . . 0.0 110.957 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.4 -44.85 81.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.143 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -62.21 -41.83 98.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.967 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -71.07 -35.38 71.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.661 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -65.66 -35.53 81.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.025 0.44 . . . . 0.0 110.469 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.83 -37.49 70.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.444 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 30' ' ' ILE . 38.0 m -65.67 -30.75 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.53 -42.88 79.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.217 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -60.99 -46.52 90.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.127 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 175' ' ' GLU . 37.0 t -61.49 -42.07 92.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.128 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' SER . 80.6 mt -61.18 -50.27 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 110.634 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -60.69 -41.78 95.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.6 -51.25 66.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.79 -36.37 83.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.032 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -76.31 -17.45 59.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.833 0.349 . . . . 0.0 110.706 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -88.52 -18.95 27.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.543 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.459 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.1 tt -55.38 117.3 14.31 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD2' HD23 ' A' ' 36' ' ' LEU . 44.6 Cg_exo -56.48 -42.66 63.23 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.169 2.579 . . . . 0.0 113.273 -176.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.4 -27.81 67.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.84 -34.96 74.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.267 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -64.81 -42.09 95.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.29 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -73.55 -24.0 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.466 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -66.59 124.84 23.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.375 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 61.8 mttm -103.85 -37.1 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.501 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 26.5 mmtp -96.43 108.76 21.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.12 110.51 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.968 0.414 . . . . 0.0 111.152 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -91.64 114.05 26.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 70' ' ' LEU . 89.3 mt -107.35 121.71 45.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.291 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -79.03 105.88 10.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.525 ' HB3' HG22 ' A' ' 98' ' ' ILE . 43.3 t -58.42 115.28 10.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.503 0.502 . . . . 0.0 110.996 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 Cg_exo -73.14 108.23 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.977 2.452 . . . . 0.0 111.899 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.667 HG13 ' HG2' ' A' ' 52' ' ' LYS . 44.7 pt -78.37 -22.55 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.268 -175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.667 ' HG2' HG13 ' A' ' 51' ' ' ILE . 71.7 mmtt -117.31 25.24 10.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 110.884 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.07 -71.42 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 6.1 mm-40 39.74 53.05 2.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.146 0.978 . . . . 0.0 113.029 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t 68.03 100.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.34 0.591 . . . . 0.0 109.778 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.71 111.97 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.203 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.07 14.91 15.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.643 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.525 ' OG1' ' HD3' ' A' ' 59' ' ' PRO . 42.6 p -63.02 -41.37 70.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.525 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 23.4 Cg_exo -66.27 -10.94 29.29 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.879 1.719 . . . . 0.0 112.594 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.97 -21.84 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.291 . . . . 0.0 110.669 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.5 m-85 -57.94 -52.7 72.54 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.015 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.0 Cg_exo -54.52 -34.1 80.85 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.363 2.042 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -66.47 -53.0 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.4 -36.12 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.204 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 70.9 mt -61.11 -26.24 67.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' LYS . 70.9 mmtt -114.17 -7.87 13.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.93 -31.14 9.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.225 0.536 . . . . 0.0 110.702 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 47.7 mttm -142.1 -171.86 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.085 -169.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -105.69 126.48 52.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 54.6 tp -82.58 144.69 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 44' ' ' LYS . 69.6 mt -126.86 114.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 62.8 mt -109.65 138.89 20.75 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.61 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.0 126.54 5.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.846 2.364 . . . . 0.0 112.936 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 9.3 tmtm? -105.5 97.71 7.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 77' ' ' GLY . 11.5 t -92.86 117.81 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.658 -170.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -87.96 5.18 41.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 75' ' ' VAL . . . 106.52 -51.87 0.71 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -104.11 -48.49 3.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.5 -0.35 . . . . 0.0 110.456 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -91.49 149.44 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.051 0.453 . . . . 0.0 111.118 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' HD1' ' A' ' 136' ' ' TYR . 65.1 mt -124.26 101.38 8.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.524 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 15.2 m -85.6 112.67 21.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 90.5 mt -84.47 136.15 33.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 106' ' ' ARG . 88.8 m-85 -128.55 144.1 51.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 0.0 111.248 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 45.2 mtp180 -79.26 106.99 11.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.649 175.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 51.0 t -89.56 111.43 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -107.02 -28.47 10.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.504 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -141.1 158.21 65.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.292 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.86 -155.48 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 74.45 -46.06 0.6 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.561 0.745 . . . . 0.0 112.199 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 5.7 t -81.68 34.96 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.222 0.535 . . . . 0.0 110.903 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -117.25 131.18 56.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.417 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.12 -169.9 12.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.987 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -136.0 123.36 34.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.497 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -132.52 -85.13 0.28 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.502 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.4 155.48 18.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.558 0.218 . . . . 0.0 111.397 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 72.49 -46.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.926 0.891 . . . . 0.0 111.975 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 20.79 5.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.92 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 49' ' ' CYS . 2.1 pp -101.62 172.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.618 0.247 . . . . 0.0 111.205 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.09 105.03 6.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.862 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 2.3 mt-10 -83.6 115.46 59.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.976 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 2.8 Cg_exo -74.39 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 110.56 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.468 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 27.9 t -73.34 -58.74 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.415 -173.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.95 178.62 6.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 111.067 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.66 -139.06 10.12 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.6 138.05 51.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HG2' ' CE1' ' A' ' 83' ' ' TYR . 83.4 mtt180 -83.35 140.75 32.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.948 0.404 . . . . 0.0 110.394 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.555 ' CG2' ' HG3' ' A' ' 84' ' ' ARG . 21.9 t -117.99 137.3 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.577 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -104.69 150.58 38.76 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.33 -35.63 16.12 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.008 3.139 . . . . 0.0 114.998 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.733 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 43.3 tt0 -65.05 -26.98 68.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 14.0 t70 -80.83 -13.69 58.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 0.0 111.148 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.83 131.37 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.618 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 13.0 m-20 -83.94 -52.42 6.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.629 0.728 . . . . 0.0 110.017 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 148' ' ' VAL . 46.2 t80 -129.85 131.03 45.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.528 -170.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.2 tt -125.79 137.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.968 0.413 . . . . 0.0 109.943 173.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' HE1' ' A' ' 114' ' ' PHE . . . -121.23 115.72 23.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.631 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.22 118.95 33.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 37.6 Cg_endo -68.82 110.12 2.28 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.336 2.024 . . . . 0.0 111.258 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 122' ' ' PHE . . . -100.0 131.68 10.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.43 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.73 -30.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 122.476 0.31 . . . . 0.0 111.205 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.91 142.13 19.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.635 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 28.7 m-85 -137.77 168.65 19.26 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.505 0.503 . . . . 0.0 110.254 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.557 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 34.0 p-10 -137.96 -167.82 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.76 -0.29 57.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.274 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 159' ' ' ARG . 34.9 mm-40 -97.32 -36.81 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.411 ' CA ' ' HG ' ' A' ' 181' ' ' LEU . . . 113.98 39.99 1.02 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.734 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -108.29 169.27 8.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.485 . . . . 0.0 111.433 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 157.65 32.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.433 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.03 -88.56 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.672 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 148.01 -165.67 28.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.367 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -111.21 -58.65 2.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.564 0.221 . . . . 0.0 110.594 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.19 -175.02 20.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.79 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.88 139.02 31.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.017 0.437 . . . . 0.0 111.049 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.63 33.75 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -96.82 28.07 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.33 0.586 . . . . 0.0 110.188 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.725 ' HD1' HD11 ' A' ' 80' ' ' ILE . 18.2 m-85 -68.2 -27.22 66.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.224 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -70.86 -33.84 71.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.149 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.36 -34.48 77.38 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 143' ' ' VAL . 52.6 tp -70.5 -59.24 2.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.416 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.67 -38.55 78.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.187 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -78.71 -11.16 59.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 111.098 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -107.55 -5.82 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.661 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.9 t -57.62 118.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.733 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 52.8 tttm -87.69 -2.61 58.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 110.509 -175.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -96.2 -161.91 32.96 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.11 131.49 38.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.94 0.37 . . . . 0.0 110.75 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -93.03 110.6 22.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.3 t -109.84 128.16 66.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 0.0 110.973 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' HA3' ' CZ ' ' A' ' 122' ' ' PHE . . . -98.92 132.95 11.11 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.635 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.63 122.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.661 0.267 . . . . 0.0 110.659 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -158.44 168.29 27.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.876 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 170.91 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.5 p -63.74 -27.3 69.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.242 0.544 . . . . 0.0 110.938 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -68.05 -25.59 65.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.089 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.459 ' HG2' HH11 ' A' ' 14' ' ' ARG . 2.3 mp0 -92.67 4.54 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.531 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.03 113.22 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.402 . . . . 0.0 110.631 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -106.98 178.67 4.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.807 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.47 -54.57 6.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.582 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 71.7 ttp85 -149.28 139.46 22.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.025 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 67.9 mt -98.98 158.39 32.4 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.743 174.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.71 105.79 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.38 2.053 . . . . 0.0 112.539 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.74 100.9 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.96 -77.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.186 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.77 -69.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -80.78 -3.92 52.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -165.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.41 -175.49 5.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.311 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.791 HD12 ' HD2' ' A' ' 168' ' ' PRO . 4.1 tp -135.19 129.38 18.85 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.594 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.791 ' HD2' HD12 ' A' ' 167' ' ' ILE . 56.5 Cg_endo -72.2 159.74 48.98 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.514 2.143 . . . . 0.0 112.701 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.34 -177.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -100.42 -56.08 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.467 ' HB ' HG22 ' A' ' 148' ' ' VAL . 45.8 t -128.13 140.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.62 116.01 30.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.671 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.7 t -106.83 125.28 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 0.0 110.247 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 50.3 p -119.54 -169.67 1.8 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.679 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 9.6 pt-20 -68.75 -27.52 65.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.868 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 56.9 mtpt -125.89 -21.47 4.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.424 HD22 ' C ' ' A' ' 176' ' ' LYS . 0.8 OUTLIER -131.76 143.6 50.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -172.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.403 HG11 ' HG ' ' A' ' 36' ' ' LEU . 63.5 t -111.52 102.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -122.25 112.41 18.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.166 0.507 . . . . 0.0 112.082 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 180' ' ' ARG . 30.6 ttm105 -70.3 152.44 44.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 181' ' ' LEU . 3.7 mm? -78.42 65.47 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.103 0.954 . . . . 0.0 112.214 -166.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -132.48 124.53 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.296 167.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.29 130.47 47.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 110.499 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.91 58.16 4.32 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.357 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -68.53 125.79 27.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 m -86.06 90.17 8.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.324 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.3 tt 179.91 -45.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.031 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 192' ' ' HIS . 2.7 tm-20 62.41 -111.83 0.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.428 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 71.8 m80 -149.3 13.75 0.86 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 67.41 11.66 8.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.667 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -99.04 -47.21 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' HIS . . . . . 0.536 ' HB2' ' HG3' ' A' ' 188' ' ' GLU . 32.3 m80 -104.0 151.27 23.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 166.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -102.64 123.5 46.47 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.369 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.239 175.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.884 0.373 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.08 152.51 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.922 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 129' ' ' LEU . 15.7 ptpt -66.41 -22.89 66.24 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.94 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.8 t -59.16 -29.5 67.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.184 0.516 . . . . 0.0 110.684 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.32 -45.27 18.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.067 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.17 -35.72 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.628 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HG3' ' HA ' ' A' ' 131' ' ' PHE . 8.5 tmm_? -55.38 -45.98 76.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.848 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.37 -39.08 88.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -60.35 -49.69 76.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.6 -42.33 80.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 15' ' ' ILE . 62.1 tp -61.43 -42.51 98.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.667 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 5.0 t60 -58.35 -44.57 88.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.243 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 26.3 mtpp -67.65 -35.48 78.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.314 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 44.2 ttm-85 -60.77 -50.77 72.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.259 0.552 . . . . 0.0 110.652 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 11' ' ' LEU . 18.5 pt -83.67 9.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.0 111.369 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -101.37 -11.62 19.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 152.4 24.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.279 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -75.09 156.53 35.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.544 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 37.8 tt0 -68.28 -39.42 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.261 . . . . 0.0 110.906 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.56 -44.07 97.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 109.742 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.92 -34.47 76.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.401 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 7.5 mmt85 -55.18 -61.49 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.01 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 66.6 ttt180 -62.81 -37.01 85.03 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.035 0.445 . . . . 0.0 110.708 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 52.7 ttt180 -60.56 -44.87 95.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.952 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -86.57 -37.85 17.73 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.267 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.4 t -66.09 -31.86 72.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.528 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 8.7 tt0 -69.77 -26.1 64.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 74.1 mmtt -74.84 -43.94 51.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.901 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.78 -48.26 89.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.742 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 79.0 mt -60.13 -47.35 92.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -61.82 -39.41 91.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.244 0.545 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.56 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.464 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HE2' ' HG2' ' A' ' 63' ' ' GLU . 2.8 mmmp? -71.43 -31.12 66.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.602 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -84.38 -9.26 58.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.129 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 2.2 tt -71.51 111.45 10.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 36' ' ' LEU . 18.0 Cg_endo -59.67 -33.11 96.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.999 2.466 . . . . 0.0 113.529 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.63 -34.67 77.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.784 0.326 . . . . 0.0 110.334 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.79 -25.3 63.72 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.89 -34.87 74.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.262 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -100.44 -21.64 15.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.084 -171.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -58.93 123.87 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 110.916 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 1.1 mmpp? -74.71 -63.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.644 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 113.48 25.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.149 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' HD12 ' A' ' 70' ' ' LEU . 46.0 t -116.41 115.14 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.34 143.69 29.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -136.93 148.26 46.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.794 0.33 . . . . 0.0 110.551 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 117' ' ' VAL . 64.6 m-85 -97.06 141.6 30.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.898 171.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.546 ' HB2' HG22 ' A' ' 98' ' ' ILE . 67.5 m -73.75 146.8 86.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.569 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 36.5 Cg_exo -58.69 106.52 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.049 2.499 . . . . 0.0 113.042 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.831 HG13 ' H ' ' A' ' 52' ' ' LYS . 8.9 pt -99.96 -85.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.472 174.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.831 ' H ' HG13 ' A' ' 51' ' ' ILE . 45.8 mttp -91.62 -6.82 51.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.24 0.543 . . . . 0.0 109.761 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 14' ' ' ARG . . . -98.07 120.89 6.94 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 174.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.49 7.43 38.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.746 0.308 . . . . 0.0 111.249 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 21.5 t -70.51 100.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD1' ' HD3' ' A' ' 59' ' ' PRO . 6.6 t70 -86.19 102.76 14.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.237 0.541 . . . . 0.0 111.047 -171.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.1 15.77 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.365 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 m -62.71 -50.62 77.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 22.0 Cg_exo -67.07 -0.65 5.05 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -85.87 -19.04 31.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.691 0.282 . . . . 0.0 110.516 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.2 m-85 -59.63 -49.58 91.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 76.1 Cg_exo -53.11 -32.77 60.68 Favored 'Trans proline' 0 C--N 1.359 1.132 0 C-N-CA 122.296 1.997 . . . . 0.0 112.687 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.721 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 18.3 tp10 -71.69 -52.57 17.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.17 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.9 t -57.27 -45.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.221 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -65.17 -12.6 52.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -97.05 -14.22 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.936 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 43.1 mt-10 -110.56 -56.67 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 0.0 110.94 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.67 ' HD2' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -129.43 -171.53 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 -171.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.07 138.29 32.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 41.6 tp -98.94 157.38 16.36 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 67.2 mt -138.52 131.28 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 96.1 mt -129.32 132.6 24.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.37 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.84 2.36 . . . . 0.0 111.77 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 100' ' ' GLU . 2.8 tmtp? -105.89 113.63 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.92 106.71 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.091 0.472 . . . . 0.0 111.1 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -104.45 88.92 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.373 174.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 -98.73 1.04 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -123.18 -4.18 8.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 109.87 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.23 106.71 18.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 ' HD1' ' A' ' 136' ' ' TYR . 55.5 mt -82.72 102.37 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.089 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -84.74 122.72 29.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.495 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.91 100.17 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.541 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 40.8 m-85 -103.21 130.36 50.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.554 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -79.04 153.26 30.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.134 176.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 98.5 t -130.68 124.08 56.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.469 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.416 ' HD2' ' HD3' ' A' ' 84' ' ' ARG . 9.1 p80 -148.85 25.12 0.94 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.2 m -146.37 149.52 37.98 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.741 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.4 Cg_exo -78.23 160.5 29.52 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.742 2.295 . . . . 0.0 111.958 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.27 19.39 11.68 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 85' ' ' VAL . 30.7 p -103.61 5.78 36.75 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.023 -0.423 . . . . 0.0 110.63 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -100.94 129.48 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.43 171.08 25.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.144 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.34 102.06 13.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.967 0.413 . . . . 0.0 110.374 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.31 -34.6 1.92 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -82.24 -163.34 0.66 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.905 0.383 . . . . 0.0 111.209 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -54.85 -43.28 72.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 58.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.628 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 49' ' ' CYS . 43.0 pt -131.3 166.66 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -106.41 96.35 6.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 3.3 pt-20 -105.25 154.38 38.94 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.639 -173.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 11.0 Cg_exo -71.15 112.45 3.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.62 2.213 . . . . 0.0 111.985 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.43 -48.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -121.1 99.08 6.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.842 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.42 -162.42 9.1 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.908 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.45 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 36.9 mt-10 -127.02 142.34 51.57 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -77.27 128.33 34.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.097 0.475 . . . . 0.0 111.613 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 84' ' ' ARG . 84.1 t -124.18 145.13 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.949 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 110' ' ' GLU . 9.5 p30 -97.9 157.46 34.56 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.83 -25.22 42.12 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.503 2.802 . . . . 0.0 114.645 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 108' ' ' ASN . 20.6 tt0 -68.92 -23.59 64.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.846 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -93.42 0.03 56.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.939 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.76 103.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.12 -58.04 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.791 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 23.4 t80 -124.06 144.72 49.69 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.337 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 17.3 tt -149.66 141.01 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.662 0.267 . . . . 0.0 110.494 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.61 120.43 38.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.493 HG12 ' CE1' ' A' ' 48' ' ' TYR . 27.5 m -116.82 120.78 33.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.216 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 4.1 Cg_exo -77.37 104.69 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.787 2.325 . . . . 0.0 111.217 174.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.57 156.5 15.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.852 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 125.65 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.1 106.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.164 0.915 . . . . 0.0 112.491 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -127.84 157.43 40.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.596 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -103.94 -173.98 2.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 46.1 mt -87.06 15.74 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.56 -15.59 6.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.861 0.362 . . . . 0.0 110.571 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.447 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 118.05 5.46 13.39 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.71 169.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -85.92 132.35 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.542 0.671 . . . . 0.0 111.213 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -94.25 128.6 40.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.357 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.554 ' HB2' HD13 ' A' ' 160' ' ' LEU . 30.6 tp -55.39 -48.26 74.6 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.535 0.522 . . . . 0.0 110.56 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.14 -178.61 33.27 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.353 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.471 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 84.0 m-85 -110.94 -73.66 0.67 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.087 0.47 . . . . 0.0 110.507 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.524 ' C ' ' HD2' ' A' ' 133' ' ' LYS . . . 142.17 -34.22 1.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HD2' ' C ' ' A' ' 132' ' ' GLY . 1.7 mptp? -125.76 148.7 49.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.23 60.87 3.4 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -66.04 -65.16 0.71 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.559 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.2 m-85 61.3 13.85 5.22 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 111.057 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.755 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 9.6 p-10 -65.89 -29.37 69.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -49.94 -39.72 41.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.035 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 80' ' ' ILE . 50.5 tp -81.85 -40.64 22.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.148 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.01 -16.64 64.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.454 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.755 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 32.1 mmtp -73.2 -29.22 62.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -95.75 -27.83 15.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.194 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.43 98.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.076 0.465 . . . . 0.0 110.118 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -134.46 56.62 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.096 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.43 9.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 114' ' ' PHE . 23.7 tp -83.39 89.2 7.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 170' ' ' ASP . 25.1 ttpt -91.07 105.38 17.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.688 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 171' ' ' VAL . 45.6 t -104.49 124.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.143 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.2 10.61 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.53 115.99 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.44 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -158.59 175.03 14.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.713 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.623 ' HD1' ' HG3' ' A' ' 175' ' ' GLU . 46.4 m-85 -102.09 153.37 19.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 176' ' ' LYS . 29.6 t -61.08 -13.14 15.01 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.717 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -71.66 -23.55 61.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.585 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 16.4 mp0 -107.58 13.86 26.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.921 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.1 t -117.92 120.92 66.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.181 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.73 -175.16 2.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.391 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.906 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -89.94 -36.74 14.83 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.274 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -138.11 145.34 41.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 129' ' ' LEU . 95.3 mt -132.77 161.84 61.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.95 101.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.572 1.515 . . . . 0.0 110.892 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -104.67 141.0 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 11.3 t70 -128.08 -163.49 1.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.145 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . -81.6 -40.91 22.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 0.0 110.674 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -85.0 43.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.404 0.621 . . . . 0.0 110.241 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.55 110.77 22.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.303 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.98 114.06 53.61 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.579 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.07 160.02 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.172 2.582 . . . . 0.0 113.08 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.419 ' HA ' ' HE3' ' A' ' 147' ' ' LYS . 31.1 m -103.25 -179.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.698 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 8.1 m-20 -107.8 -32.79 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.815 0.34 . . . . 0.0 110.903 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.528 ' HB ' HG22 ' A' ' 148' ' ' VAL . 43.8 t -136.05 153.13 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 181' ' ' LEU . 44.1 tp -128.94 122.15 29.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.631 HG22 HG12 ' A' ' 178' ' ' VAL . 86.2 t -109.14 126.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.166 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.2 p -127.19 -174.6 3.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.322 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.623 ' HG3' ' HD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -85.79 -1.48 57.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 110.113 175.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.444 ' HZ3' ' HB3' ' A' ' 153' ' ' SER . 40.5 mmtm -93.56 -64.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.141 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -155.62 174.87 14.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.022 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 173' ' ' VAL . 4.4 m -108.04 99.6 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.64 . . . . 0.0 110.26 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 179' ' ' ARG . 33.1 ttt180 -103.7 116.57 32.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -74.7 132.74 41.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.521 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 172' ' ' LEU . 61.6 mt -109.75 15.37 22.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.184 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.762 ' HA ' ' HE ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -100.21 143.66 30.14 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -68.7 160.05 31.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.497 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -96.11 36.67 3.74 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.34 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -149.6 113.29 5.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.103 0.478 . . . . 0.0 110.135 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.7 m -152.08 7.11 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.959 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.07 12.56 26.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.557 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -91.76 -3.63 55.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.433 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -137.11 161.29 36.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -65.85 161.44 21.06 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.282 0.364 . . . . 0.0 110.858 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -64.28 -79.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.028 -173.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -101.69 -52.36 3.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -161.62 10.69 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.321 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 t60 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.555 -174.272 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.143 0.497 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.73 8.77 39.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.679 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -54.18 -40.66 67.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.542 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -62.12 -36.09 80.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.425 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 6.0 mm-40 -77.9 -43.43 30.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.482 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.07 -38.22 85.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -54.54 -53.86 48.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -68.42 -24.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.332 -173.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -74.18 -47.08 38.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 110.394 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.29 -44.63 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.297 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 tp -59.73 -45.57 91.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.558 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 13.7 t-80 -62.05 -43.02 99.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.66 -41.49 99.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.464 HH21 ' N ' ' A' ' 54' ' ' GLU . 10.8 tpt180 -63.95 -53.59 47.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.339 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.2 pt -80.97 4.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 111.599 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 6.5 t30 -78.67 -28.69 45.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.15 142.56 46.86 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.619 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 38.9 p -76.91 160.49 29.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.079 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.16 -30.06 71.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.9 -52.28 64.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.57 -30.78 36.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.386 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 18' ' ' SER . 83.7 mtt180 -56.9 -59.19 5.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.3 -40.35 77.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.38 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.63 -45.8 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.082 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -70.68 -44.65 66.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -61.23 -33.56 73.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.08 -39.28 78.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.427 0.632 . . . . 0.0 110.179 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -74.27 -34.23 63.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 175' ' ' GLU . 44.9 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.415 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.481 HG23 HD13 ' A' ' 60' ' ' LEU . 77.5 mt -58.21 -44.27 87.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.114 0.483 . . . . 0.0 110.325 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.1 m -65.25 -36.56 84.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -67.98 -42.35 80.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.888 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 36' ' ' LEU . 26.3 tp -62.68 -46.61 87.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 39' ' ' PHE . 23.4 mmtp -60.38 -28.94 68.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 176.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -82.97 -17.82 42.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.519 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 33' ' ' LEU . 44.6 mt -61.43 120.52 56.31 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.1 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.03 -35.6 81.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.756 2.304 . . . . 0.0 111.388 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -60.01 -52.67 64.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.651 ' HE2' ' HD3' ' A' ' 34' ' ' LYS . 88.2 t80 -73.34 -30.22 63.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -58.04 -41.39 83.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.04 -23.28 33.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.5 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 39' ' ' PHE . 49.9 m -50.8 123.19 8.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.248 0.546 . . . . 0.0 111.696 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -102.99 -34.57 8.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -113.52 97.96 6.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.075 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.47 122.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.145 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 116' ' ' ALA . 54.1 mt -111.78 136.52 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.065 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -85.64 -0.52 55.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.158 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 45.5 t 65.89 98.76 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.119 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 41.9 Cg_endo -68.35 97.76 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.467 2.111 . . . . 0.0 112.398 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 24.5 pt -87.18 154.82 3.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 tptp 71.63 -15.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.807 0.692 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 133.28 -77.89 0.37 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' HH21 ' A' ' 14' ' ' ARG . 3.3 mm-40 22.93 77.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 113.708 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 HG12 ' A' ' 150' ' ' VAL . 58.4 t 62.56 94.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.402 -174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.76 88.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.793 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 97.5 mt -100.2 9.45 42.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.005 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.485 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -60.09 -44.52 96.72 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 58' ' ' THR . 52.8 Cg_endo -70.19 -5.78 17.26 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.691 1.594 . . . . 0.0 112.488 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 63' ' ' GLU . 60.6 tp -87.81 -18.38 29.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.781 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.551 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 14.2 m-85 -54.31 -54.92 42.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 47.7 Cg_exo -58.84 -34.74 99.19 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.939 1.759 . . . . 0.0 112.278 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.51 ' HB3' HD12 ' A' ' 60' ' ' LEU . 49.6 tp10 -64.91 -45.7 84.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 60' ' ' LEU . 93.2 t -66.85 -41.88 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.92 -27.13 67.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.332 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 30.6 ttpt -74.01 -55.5 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.447 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 66' ' ' LYS . 89.0 mt-10 -81.26 -51.72 8.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.75 -174.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -118.83 -171.92 2.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.353 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 40.5 mt-10 -104.16 130.71 51.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.696 175.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 64' ' ' VAL . 40.1 tp -102.36 121.23 41.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.2 mp -99.14 118.84 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.429 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.68 142.44 28.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.94 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 82' ' ' LEU . 56.3 Cg_endo -71.69 128.82 14.73 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.752 2.301 . . . . 0.0 112.198 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -119.64 117.49 28.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.916 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.07 106.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -92.43 21.7 5.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 81.15 1.46 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 69.91 -59.05 0.52 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.322 0.649 . . . . 0.0 110.324 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -58.23 118.26 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.995 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.539 HD12 ' HD1' ' A' ' 136' ' ' TYR . 14.4 tt -110.76 136.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 t -130.81 176.75 7.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.4 mt -119.45 122.51 41.87 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m-85 -110.91 127.27 55.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.097 0.475 . . . . 0.0 111.223 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 23.7 ttp85 -86.75 119.55 27.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.482 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -118.66 145.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.638 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -139.23 22.88 2.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 18.5 t -141.06 122.93 9.27 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.805 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 31.5 Cg_exo -59.92 -31.2 93.37 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.155 2.57 . . . . 0.0 113.315 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.73 1.31 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.3 t -109.11 4.14 22.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.255 0.55 . . . . 0.0 110.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.41 136.61 33.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.651 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.91 159.92 30.33 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.986 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.35 113.95 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.758 0.279 . . . . 0.0 110.54 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.18 -58.15 0.41 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.689 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.68 142.55 47.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.882 0.372 . . . . 0.0 111.702 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 73.22 -54.4 0.69 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.021 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.61 44.35 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.916 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.79 168.94 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 72.8 mtm -91.77 100.01 12.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.151 0.501 . . . . 0.0 110.155 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.74 157.34 37.07 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.828 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.18 115.56 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.963 1.776 . . . . 0.0 110.273 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.04 -45.71 70.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.262 0.553 . . . . 0.0 109.545 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -129.82 -157.04 0.79 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.793 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.77 -161.61 14.21 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.358 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' ARG . 35.9 mt-10 -124.03 111.11 15.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 26.2 ptt180 -74.28 148.11 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.908 0.861 . . . . 0.0 112.754 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.32 136.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.473 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.69 142.82 91.78 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HA ' HG23 ' A' ' 112' ' ' VAL . 9.5 Cg_endo -53.73 -18.42 12.18 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.389 2.726 . . . . 0.0 112.879 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' A' ' 144' ' ' LYS . 43.2 tt0 -64.33 -31.12 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -94.06 4.55 53.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.911 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 109' ' ' PRO . 99.9 t -82.74 120.34 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.22 -46.48 6.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.258 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.61 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 35.7 t80 -125.14 129.93 51.16 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.61 139.17 45.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.596 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB3' HD23 ' A' ' 47' ' ' LEU . . . -110.84 113.47 26.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -118.56 113.74 36.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.98 118.66 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.595 2.197 . . . . 0.0 110.579 171.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -121.16 142.24 15.34 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.689 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.5 106.07 14.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.53 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.266 0.979 . . . . 0.0 112.932 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 161.75 25.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -175.87 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 79.3 mt -68.47 -29.45 68.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.47 -39.19 19.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.121 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.404 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 132.5 31.46 0.46 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.468 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -99.93 156.87 16.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.193 0.521 . . . . 0.0 111.057 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -99.63 157.45 16.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.499 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.77 -36.46 37.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.089 0.471 . . . . 0.0 109.978 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.08 135.28 8.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.235 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -146.35 15.62 1.3 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.75 0.31 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 158.84 154.1 7.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.989 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -146.02 147.2 31.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 166.72 -142.81 7.86 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -72.96 -25.85 61.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.463 . . . . 0.0 110.591 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.539 ' HD1' HD12 ' A' ' 80' ' ' ILE . 2.1 m-85 -69.31 -31.08 69.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.657 0.742 . . . . 0.0 109.264 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.01 -51.96 48.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.571 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -57.71 -37.5 73.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.039 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 82' ' ' LEU . 26.5 tp -58.41 -48.23 81.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.949 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.4 mt -59.18 -37.22 76.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.24 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -89.67 0.4 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.977 0.418 . . . . 0.0 110.7 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.601 ' HE ' ' HA ' ' A' ' 142' ' ' ARG . 1.9 tpm_? -95.3 -29.04 14.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.147 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 145' ' ' GLY . 62.0 t -64.96 107.56 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.079 0.466 . . . . 0.0 110.478 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.683 ' HE3' ' HG3' ' A' ' 110' ' ' GLU . 19.7 pttp -85.66 9.32 16.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 143' ' ' VAL . . . -90.19 -154.66 30.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.201 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 171' ' ' VAL . 31.8 tp -93.27 112.23 24.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.359 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -90.24 108.33 19.69 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.251 0.548 . . . . 0.0 110.175 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 114' ' ' PHE . 59.3 t -97.89 111.26 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.48 112.67 3.5 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 55' ' ' VAL . 18.1 t -105.4 116.73 49.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -156.71 -177.27 6.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.675 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.45 ' HE1' ' H ' ' A' ' 55' ' ' VAL . 74.7 m-85 -93.98 161.01 14.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 t -73.38 -28.96 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.801 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.57 -16.29 60.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.017 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 8.6 tt0 -95.1 7.54 45.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.926 0.87 . . . . 0.0 109.483 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 122.45 57.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.288 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.39 179.44 4.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.031 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.766 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 14.6 mt-10 -87.58 -56.4 3.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.377 0.608 . . . . 0.0 109.801 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.63 104.23 5.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.621 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.79 158.34 35.36 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.758 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.38 101.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.785 1.656 . . . . 0.0 110.397 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -90.71 139.7 30.47 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.2 t70 -75.62 -92.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -165.85 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.008 0.433 . . . . 0.0 109.988 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -102.76 50.78 0.81 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.421 0.629 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -81.75 -167.51 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.916 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 64.6 mt -113.54 103.87 55.4 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 153.87 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.304 2.67 . . . . 0.0 112.049 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.53 172.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.798 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.77 -52.55 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.273 0.559 . . . . 0.0 110.266 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.463 HG23 HD11 ' A' ' 146' ' ' LEU . 57.3 t -123.47 140.43 47.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.745 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.94 110.75 18.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.487 HG13 HG22 ' A' ' 178' ' ' VAL . 54.1 t -103.18 121.94 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 80.4 p -108.8 -173.11 2.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.953 0.406 . . . . 0.0 110.745 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 11.1 pt-20 -69.21 -18.8 63.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.302 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 29.7 mmtp -117.06 -65.37 1.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.403 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -121.59 168.68 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 112.105 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.613 HG21 HD21 ' A' ' 36' ' ' LEU . 61.4 t -114.45 123.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.51 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -102.94 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.642 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 54.5 mtp85 -83.79 89.53 7.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.404 HD13 ' CA ' ' A' ' 126' ' ' GLY . 80.4 mt -64.37 -41.84 96.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.991 -165.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 31.2 ttp-105 -116.45 28.15 8.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.329 0.585 . . . . 0.0 110.515 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 21.6 t70 -135.92 113.34 10.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.562 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.97 158.8 8.71 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 68.51 124.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.541 0.736 . . . . 0.0 112.454 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.9 t -150.57 154.3 37.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.571 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 26.7 tp -154.77 24.67 0.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.622 0.725 . . . . 0.0 109.382 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.85 125.8 47.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.225 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -111.32 -148.79 0.43 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 163.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -63.02 118.34 7.7 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -60.03 136.75 58.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.996 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -84.08 26.0 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.732 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -154.8 137.48 15.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.05 177.396 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.826 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 17.4 ttt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.826 ' H ' ' HG2' ' A' ' 1' ' ' MET . 60.2 tp -64.09 -26.23 68.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.263 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 7.6 mtpm? -62.3 -49.32 76.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 17.4 p -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.578 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.32 -58.34 9.05 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.749 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.49 -41.96 91.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.63 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -52.45 -51.57 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.553 ' HB2' ' HZ2' ' A' ' 8' ' ' LYS . 9.9 mtmp? -64.49 -44.9 89.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.455 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.77 -45.78 84.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.551 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 120' ' ' VAL . 60.9 t -68.63 -33.06 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.642 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 15' ' ' ILE . 16.3 mt -56.95 -51.65 68.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -59.98 -43.35 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.15 -0.81 15.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.828 ' HD3' ' HG2' ' A' ' 54' ' ' GLU . 21.0 ttm180 -111.73 -41.21 4.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.73 0.3 . . . . 0.0 111.404 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 11' ' ' LEU . 32.2 pt -90.77 -18.16 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.32 -2.01 57.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.049 0.452 . . . . 0.0 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.76 149.31 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.723 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 m -63.3 132.85 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.51 -36.85 85.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.368 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.36 -35.23 79.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.333 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 42.2 tt0 -72.92 -41.22 64.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.36 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -65.64 -37.05 85.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.711 HH21 ' HB2' ' A' ' 56' ' ' ASP . 3.0 tpm_? -58.51 -47.05 85.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.741 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -59.84 -47.96 83.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.12 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -63.32 -43.27 98.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.841 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 30' ' ' ILE . 70.2 m -61.49 -37.64 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.904 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -58.05 -41.71 83.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 109.896 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.53 -40.59 85.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 25' ' ' LEU . 74.8 t -66.51 -41.43 88.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 26' ' ' SER . 74.9 mt -58.14 -45.06 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -69.63 -33.74 73.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.956 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.56 -44.85 81.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 0.0 110.237 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.699 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 24.4 tp -61.58 -42.6 99.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.07 -13.66 60.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.428 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 t -79.84 -26.61 40.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 33' ' ' LEU . 89.7 mt -60.53 122.52 68.42 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.613 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.3 Cg_exo -66.48 -22.23 52.11 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.722 2.282 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.14 -31.67 68.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.365 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.84 -43.8 97.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.875 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -70.95 -18.68 62.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.492 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -79.56 -38.71 33.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 65.9 m -71.82 120.62 17.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.258 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -107.02 -28.23 10.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -89.04 92.53 9.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 57.9 t -112.4 111.21 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.922 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -102.98 134.68 46.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.199 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 7.4 mp -114.83 145.3 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -86.64 1.78 50.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.476 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.01 90.95 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.109 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.54 103.3 1.41 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.906 2.404 . . . . 0.0 112.314 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 1.7 pp -99.28 169.42 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.032 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 65.46 21.15 11.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.29 0.566 . . . . 0.0 110.019 -172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 -86.44 1.56 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.707 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG2' ' HD3' ' A' ' 14' ' ' ARG . 29.9 mt-10 60.88 -84.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.534 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -145.44 133.48 16.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.711 ' HB2' HH21 ' A' ' 23' ' ' ARG . 60.6 m-20 -71.45 79.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.88 0.372 . . . . 0.0 111.297 -178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 150' ' ' VAL . 90.6 mt -98.34 -16.98 19.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 109.777 174.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 6.5 m -63.69 -50.69 70.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.25 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 20.9 Cg_exo -67.97 3.65 1.87 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.339 2.026 . . . . 0.0 112.824 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -93.28 -9.59 38.49 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.522 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 19.5 m-30 -50.83 -49.65 78.59 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.248 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 73.1 Cg_exo -51.96 -35.76 61.84 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.2 1.933 . . . . 0.0 112.791 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.7 -11.91 49.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 68' ' ' LYS . 29.3 t -93.64 -40.52 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.69 -1.94 4.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 94.1 mttt -84.19 -52.67 6.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.647 0.26 . . . . 0.0 111.268 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.967 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 6.8 pt-20 -119.76 -9.72 9.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.967 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 mptp? -116.32 165.06 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.769 0.795 . . . . 0.0 112.185 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 37.1 mt-10 -98.87 114.79 27.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.326 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -78.93 124.16 27.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.467 . . . . 0.0 110.925 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 55.6 mt -114.48 117.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.199 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.0 mt -119.31 147.64 43.59 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.882 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 47' ' ' LEU . 91.6 Cg_endo -81.21 129.66 6.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.895 2.397 . . . . 0.0 113.443 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -127.34 109.56 11.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.13 105.84 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.201 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -81.08 -10.84 59.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.689 -175.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.04 -42.95 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.705 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -137.14 -39.17 0.61 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.015 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.26 141.4 28.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.32 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -80.36 106.89 12.71 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.0 mt -74.31 117.63 16.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.953 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 5.2 m-85 -102.45 133.1 47.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.135 0.493 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.608 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 12.5 ttp180 -99.5 115.18 28.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.853 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -131.42 148.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.97 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -127.21 18.88 7.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.378 0.609 . . . . 0.0 109.518 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.2 m -139.06 141.72 30.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 6.7 Cg_exo -74.5 -174.53 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.931 2.421 . . . . 0.0 111.947 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.61 -30.49 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 112.237 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.4 m -76.37 1.74 15.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 110.681 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.5 mt -104.38 105.65 15.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.102 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -107.18 -163.16 21.93 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.816 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.91 121.9 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.63 -75.61 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.98 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.23 114.9 1.97 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.513 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 65.93 8.29 5.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.275 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.14 82.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.877 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.96 165.86 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 65.4 mtt -71.07 137.27 48.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.085 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.24 141.73 32.85 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.674 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 7.9 Cg_exo -72.26 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.485 2.123 . . . . 0.0 110.426 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.505 HG23 ' HG2' ' A' ' 103' ' ' GLU . 34.9 m -66.29 -22.53 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.505 ' HG2' HG23 ' A' ' 102' ' ' VAL . 9.3 pt-20 -152.91 166.94 30.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.379 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -171.99 21.62 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -109.45 154.56 22.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.922 0.391 . . . . 0.0 111.19 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.94 157.15 23.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 39.1 t -109.8 136.06 46.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.699 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -67.86 132.35 92.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.56 -41.23 45.19 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.912 2.408 . . . . 0.0 113.247 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.9 -4.11 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.361 0.601 . . . . 0.0 110.847 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.96 -19.28 30.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.491 175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.03 122.69 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.995 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.29 -43.43 5.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.699 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 23.8 t80 -126.03 123.97 39.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.443 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.5 tt -128.0 137.5 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.482 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.08 111.36 22.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.266 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 6.2 p -133.99 123.22 16.82 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.718 -178.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.515 ' HB2' ' H ' ' A' ' 119' ' ' GLY . 1.4 Cg_endo -84.49 -122.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.997 2.465 . . . . 0.0 111.322 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 118' ' ' PRO . . . 114.88 -178.07 17.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.935 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 10' ' ' VAL . 98.5 t -100.27 125.64 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.574 -0.313 . . . . 0.0 111.387 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 128' ' ' ARG . . . 69.43 121.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.208 0.943 . . . . 0.0 112.73 171.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -128.91 158.23 39.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.539 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.528 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 38.9 p30 -137.94 -174.19 3.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.32 -6.62 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -89.99 -27.26 19.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 110.044 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.7 21.99 6.9 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.193 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.34 151.51 21.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.08 0.467 . . . . 0.0 110.91 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -151.41 151.95 32.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 121' ' ' ALA . 10.0 mp -83.71 -30.17 26.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.142 0.496 . . . . 0.0 110.069 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.457 ' HA2' ' HA3' ' A' ' 119' ' ' GLY . . . 67.63 -154.66 53.0 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.13 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -83.68 -39.07 20.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.88 0.372 . . . . 0.0 110.261 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 134.76 -130.96 5.68 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.52 ' HD3' ' HE2' ' A' ' 136' ' ' TYR . 98.0 mttt 56.73 77.46 0.26 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.048 0.452 . . . . 0.0 111.516 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.54 51.18 2.97 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.811 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -127.37 -22.19 3.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.342 0.592 . . . . 0.0 109.943 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.52 ' HE2' ' HD3' ' A' ' 133' ' ' LYS . 46.2 m-85 -104.13 9.36 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.107 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.72 -31.68 72.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 110.192 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -67.34 -29.08 68.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.68 -34.29 46.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.44 -24.39 65.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.391 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -96.43 -4.16 42.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -91.87 -28.33 17.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.211 0.529 . . . . 0.0 110.026 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.88 114.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.63 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -92.56 7.25 44.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.73 166.57 54.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.112 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.16 102.58 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.073 0.463 . . . . 0.0 110.104 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 55.9 mtpt -72.19 102.97 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.728 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 65.6 t -97.7 117.65 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.431 . . . . 0.0 110.594 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -88.93 120.32 5.67 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.534 HG12 HG21 ' A' ' 55' ' ' VAL . 19.0 t -99.08 108.2 21.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -139.94 157.68 45.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.329 0.585 . . . . 0.0 112.212 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.38 155.24 17.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.542 ' OG ' ' HG3' ' A' ' 176' ' ' LYS . 3.7 m -52.14 -29.94 24.28 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.363 0.414 . . . . 0.0 111.762 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -68.81 -20.48 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.597 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -99.46 -2.91 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.69 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -104.44 128.44 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.149 0.5 . . . . 0.0 111.514 -173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.65 -165.99 1.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.643 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 43.0 mt-10 -88.67 -62.3 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 3.0 tpm_? -143.7 112.14 6.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.124 -175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.2 mt -102.99 161.52 22.89 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.657 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.69 140.48 74.71 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.35 2.034 . . . . 0.0 111.307 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 162' ' ' ARG . 47.1 mtt180 -76.41 117.72 18.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 165' ' ' TRP . 23.9 t70 -108.94 128.06 54.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 69.1 -14.81 0.29 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.994 0.809 . . . . 0.0 112.237 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.443 ' H ' ' C ' ' A' ' 163' ' ' ASP . 11.3 m-90 58.0 35.17 25.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.96 0.504 . . . . 0.0 111.366 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.536 ' HB3' HH22 ' A' ' 128' ' ' ARG . 14.1 t0 -68.63 153.31 44.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.663 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 13.4 tt -66.55 125.78 91.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.151 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 62.3 Cg_exo -51.54 151.97 13.19 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.302 2.668 . . . . 0.0 112.917 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 HD12 ' A' ' 181' ' ' LEU . 28.7 m -70.52 161.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.168 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.454 ' OD2' ' HD3' ' A' ' 182' ' ' ARG . 16.9 t70 -89.88 -43.61 10.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.186 -175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 81.4 t -131.66 132.91 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.05 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 55.8 tp -114.84 102.3 9.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.825 0.345 . . . . 0.0 110.1 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.59 111.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -113.31 165.7 12.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.6 -177.146 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -61.77 -30.8 71.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.014 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' OG ' ' A' ' 153' ' ' SER . 95.1 mttt -82.66 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -147.52 175.28 10.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.884 0.373 . . . . 0.0 110.535 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.56 114.3 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.649 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.796 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 4.9 tpm_? -93.66 98.97 11.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -75.75 120.09 20.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.536 HD12 HG23 ' A' ' 169' ' ' VAL . 95.4 mt -105.95 -23.69 12.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.754 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 37.8 ttp-105 -78.91 82.24 5.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.164 0.507 . . . . 0.0 109.811 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -163.15 -178.34 5.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.001 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.97 23.99 1.77 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 175.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 64.24 -76.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 111.225 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.8 t -178.98 161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.0 103.45 12.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 191' ' ' HIS . 34.4 tt0 -88.17 107.78 18.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.948 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -81.57 112.1 18.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.394 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 55.08 82.05 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.027 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 188' ' ' GLU . 56.5 p-80 -97.55 167.82 10.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -143.13 156.72 44.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 74.77 -72.36 0.11 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.807 0.692 . . . . 0.0 111.376 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.438 -178.797 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' HG ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' HG ' ' HG2' ' A' ' 1' ' ' MET . 91.9 mt 73.68 149.99 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.846 0.716 . . . . 0.0 110.933 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 161' ' ' PRO . 63.4 pttt -73.64 -13.77 61.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.219 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -64.26 -30.04 71.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.205 0.526 . . . . 0.0 110.357 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.18 -39.86 32.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.29 -38.26 83.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.735 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.619 ' HD2' ' HD1' ' A' ' 131' ' ' PHE . 54.4 ttp180 -57.87 -41.84 83.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.789 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.96 -39.16 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -57.83 -50.46 73.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.22 -42.64 91.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.499 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 tp -60.17 -35.5 75.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.131 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -58.28 -63.65 1.19 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.941 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -67.1 -27.04 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.304 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' HA ' ' A' ' 120' ' ' VAL . 18.4 ttt180 -60.4 -60.75 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.731 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 11' ' ' LEU . 36.2 pt -80.24 9.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.247 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -92.33 -10.64 37.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD12 ' HG2' ' A' ' 54' ' ' GLU . 87.8 mt -58.19 154.54 12.92 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.717 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . 1.2 m -77.74 160.36 28.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -62.57 -66.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.8 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -31.81 73.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.137 0.494 . . . . 0.0 110.098 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 18' ' ' SER . 39.3 tt0 -58.0 -52.5 65.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.78 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.698 HH12 ' HB2' ' A' ' 56' ' ' ASP . 35.7 ptt85 -70.55 -21.82 62.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.598 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -71.11 -41.77 70.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -72.33 -34.35 67.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' VAL . 90.5 mt -64.03 -41.87 97.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.3 m -63.82 -37.9 89.1 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.526 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -64.66 -39.75 94.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.9 t -74.12 -44.64 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.536 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.8 -37.05 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.77 0.319 . . . . 0.0 110.371 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 t -64.91 -36.41 84.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.463 . . . . 0.0 109.914 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.11 -49.94 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.349 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -31.78 71.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.763 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.11 -32.63 67.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.2 p -80.85 -17.01 52.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.144 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.43 HD23 ' HD2' ' A' ' 37' ' ' PRO . 1.1 tt -55.35 113.03 4.85 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.092 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 36' ' ' LEU . 32.6 Cg_exo -60.31 -39.04 71.02 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.624 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -24.51 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.309 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.54 -27.21 62.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 109.531 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -79.64 -24.11 42.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.572 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -78.17 -46.02 21.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 114' ' ' PHE . 43.4 t -59.85 149.06 32.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.565 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 38.1 tttp -138.17 -21.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.976 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 1.001 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 32.5 mmtp -96.7 92.48 6.21 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.456 HG21 ' HD3' ' A' ' 68' ' ' LYS . 29.2 t -108.17 110.78 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 111.343 -172.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.52 119.66 35.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.774 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 70' ' ' LEU . 7.7 mp -104.9 125.86 51.36 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -80.99 3.3 23.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.314 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m 63.16 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.253 0.549 . . . . 0.0 110.754 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 58.9 Cg_endo -73.12 81.98 1.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.456 2.104 . . . . 0.0 113.521 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.0 pp -81.01 127.65 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt 56.8 32.86 22.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.966 0.889 . . . . 0.0 109.556 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -110.04 104.51 1.85 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.638 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 4.5 mp0 -55.51 -30.39 60.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.572 0.349 . . . . 0.0 111.184 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 6.8 t -78.16 96.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.698 ' HB2' HH12 ' A' ' 22' ' ' ARG . 4.9 t70 -82.71 110.13 17.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.52 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 93.6 mt -99.43 7.36 45.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -67.46 -41.04 29.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD3' ' OD1' ' A' ' 56' ' ' ASP . 31.4 Cg_exo -62.08 -6.02 7.31 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.051 1.834 . . . . 0.0 113.393 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HG3' ' A' ' 63' ' ' GLU . 25.7 tp -87.53 -10.09 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.39 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 7.7 m-85 -55.7 -52.87 68.62 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.7 Cg_exo -53.48 -34.94 74.29 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.272 1.982 . . . . 0.0 112.801 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' A' ' 60' ' ' LEU . 11.5 mm-40 -66.23 -48.56 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.46 -40.39 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.285 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 70' ' ' LEU . 97.2 mt -66.95 -11.12 55.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.722 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 26.3 tptp -77.62 -57.42 3.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' OE2' ' HG3' ' A' ' 68' ' ' LYS . 1.7 pp20? -134.67 -9.98 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 43.8 mttp -95.88 179.6 5.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.186 0.517 . . . . 0.0 111.079 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 65.9 mm-40 -107.56 113.89 27.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.575 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' VAL . 49.3 tp -83.86 110.24 18.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.101 0.477 . . . . 0.0 109.999 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 56.4 mt -100.87 112.51 33.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.924 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 88.2 mt -108.62 145.0 30.69 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.689 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 7.8 Cg_endo -87.57 118.52 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.203 2.602 . . . . 0.0 112.457 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 83' ' ' TYR . 36.0 tttp -105.49 121.37 43.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.883 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.67 105.19 7.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -15.87 61.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.988 0.423 . . . . 0.0 111.164 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.88 -44.51 0.28 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.86 -34.43 0.47 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.601 -0.299 . . . . 0.0 110.458 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -105.6 168.04 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.0 mt -107.17 133.89 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.522 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 t -119.03 132.35 56.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 90.5 mt -84.84 142.18 29.93 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 121.333 -0.147 . . . . 0.0 110.748 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.714 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 1.5 m-85 -116.75 138.45 51.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.588 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 72.2 ttt180 -100.96 104.89 16.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.218 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 13.4 t -133.07 154.59 39.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -148.41 46.0 1.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.59 0.709 . . . . 0.0 109.878 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -171.53 148.91 2.36 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.132 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.74 -61.84 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.483 2.122 . . . . 0.0 111.624 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.01 -93.48 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.3 m -125.94 27.5 6.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.438 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -78.25 114.22 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -127.42 -159.8 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.527 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' HA2' ' A' ' 97' ' ' GLY . 59.0 t -117.15 93.4 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.281 0.562 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -96.1 2.42 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.763 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -68.09 122.37 18.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 74.19 -44.6 0.57 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.648 0.779 . . . . 0.0 112.496 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' HA2' HG13 ' A' ' 93' ' ' VAL . . . 131.23 6.69 3.41 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.113 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.4 pt -84.01 173.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.86 99.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.763 ' HG3' ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -110.35 111.89 57.37 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.86 -172.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.26 106.22 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.694 2.262 . . . . 0.0 111.858 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.3 -40.67 89.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -127.1 -177.65 4.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.467 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -177.65 16.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.837 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 1.5 mm-40 -115.88 154.27 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 111.225 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 12.8 mtm180 -86.58 159.32 19.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.784 -167.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 48.6 t -122.73 126.09 73.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.853 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -84.55 151.52 58.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.997 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 112' ' ' VAL . 52.7 Cg_exo -56.13 -20.06 29.44 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.986 2.457 . . . . 0.0 113.065 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -76.62 -9.44 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.088 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -111.11 2.73 18.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.53 . . . . 0.0 110.38 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 109' ' ' PRO . 86.5 t -74.14 106.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.249 0.547 . . . . 0.0 110.905 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 1.001 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 5.1 t0 -86.47 -54.04 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.468 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 148' ' ' VAL . 37.2 t80 -132.19 132.99 43.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.09 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -133.78 138.97 49.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.834 0.349 . . . . 0.0 110.419 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.54 111.56 19.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.302 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.55 117.35 29.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.402 0.62 . . . . 0.0 110.945 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 50' ' ' PRO . 94.2 Cg_endo -86.89 73.94 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.872 2.381 . . . . 0.0 112.359 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.28 159.92 36.53 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.486 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.535 ' HA ' ' NH1' ' A' ' 14' ' ' ARG . 99.3 t -66.87 -50.1 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.494 0.188 . . . . 0.0 111.361 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.86 24.31 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.894 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -132.16 170.33 15.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.68 -177.02 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.536 0.208 . . . . 0.0 110.463 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.587 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.3 mt -83.2 8.72 12.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -109.38 -28.69 8.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 122.11 13.42 4.92 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.843 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -94.12 161.72 14.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.443 0.64 . . . . 0.0 111.999 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.538 ' HD3' ' OD1' ' A' ' 166' ' ' ASP . 2.1 ptm180 -101.96 147.75 26.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.27 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.658 ' HB2' HD13 ' A' ' 160' ' ' LEU . 53.2 tp -67.11 -58.41 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.907 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.52 104.56 0.29 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.619 ' HD1' ' HD2' ' A' ' 7' ' ' ARG . 68.0 t80 -162.26 126.4 3.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.44 150.54 5.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.196 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -115.19 143.27 45.49 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.57 4.72 76.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.643 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.652 ' HD2' ' HB2' ' A' ' 138' ' ' ARG . 26.2 t80 65.39 57.45 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.34 0.591 . . . . 0.0 109.935 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -64.04 -22.91 67.13 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.88 0.848 . . . . 0.0 110.364 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 7.1 p-10 -74.92 7.06 3.44 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.677 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 135' ' ' TYR . 41.1 ttm180 -66.63 -44.18 82.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 165.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 9.9 tt -71.86 -43.77 64.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.974 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 55.7 mt -58.03 -41.06 82.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.835 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 111.384 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 109' ' ' PRO . 77.5 ttt180 -95.46 -12.48 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.941 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' LEU . 94.6 t -62.88 98.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.315 0.579 . . . . 0.0 110.232 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -95.11 14.1 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.69 0.757 . . . . 0.0 109.855 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.51 -166.26 30.93 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.885 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.574 HD11 HG23 ' A' ' 171' ' ' VAL . 35.9 tp -78.69 112.89 16.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 110.947 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.868 ' HD3' HD11 ' A' ' 167' ' ' ILE . 16.0 mttp -93.86 114.24 26.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 171' ' ' VAL . 74.7 t -109.99 115.76 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.205 0.526 . . . . 0.0 110.887 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.53 130.23 10.02 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 55' ' ' VAL . 21.9 t -115.66 109.76 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -161.6 170.86 19.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.694 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 48.0 m-85 -90.26 171.24 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 64.0 m -62.21 -28.74 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.348 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -86.39 10.87 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.104 0.478 . . . . 0.0 111.561 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -105.07 -7.56 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 167.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.34 116.72 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.395 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -105.88 -179.31 3.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.812 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.587 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 54.3 mt-10 -76.48 -46.84 25.04 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.122 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -150.63 144.25 25.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.361 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' A' ' 129' ' ' LEU . 98.1 mt -128.9 147.13 63.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.362 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 31.2 Cg_exo -60.39 114.75 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.663 2.242 . . . . 0.0 111.82 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 80.3 mtt180 -104.14 147.12 27.8 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.77 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.25 -69.15 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.69 -85.45 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.64 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -120.31 74.29 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.432 0.634 . . . . 0.0 109.511 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.538 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 2.5 t70 -89.37 -174.07 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.729 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.868 HD11 ' HD3' ' A' ' 147' ' ' LYS . 4.1 tt -94.77 125.86 49.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 121.075 0.464 . . . . 0.0 111.801 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 98.0 Cg_endo -93.93 158.54 2.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.336 2.691 . . . . 0.0 111.96 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.45 147.9 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.82 -42.97 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.382 0.611 . . . . 0.0 110.059 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.574 HG23 HD11 ' A' ' 146' ' ' LEU . 98.5 t -125.21 133.69 68.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.209 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 41.4 tp -122.24 105.0 9.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 178' ' ' VAL . 46.8 t -91.25 127.94 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 41.0 p -110.5 -166.24 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.53 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -84.32 -14.5 49.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -92.2 -59.91 1.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.916 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -155.52 170.57 21.66 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.147 0.498 . . . . 0.0 111.957 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 173' ' ' VAL . 97.1 t -83.98 106.69 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.477 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 179' ' ' ARG . 44.3 mtt180 -98.99 93.28 5.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.857 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -72.4 106.66 4.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.6 mt -56.57 -25.55 52.67 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.782 0.676 . . . . 0.0 112.569 -165.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -161.79 130.59 4.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.11 -88.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 174.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.94 -65.28 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.606 -0.33 . . . . 0.0 113.519 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -62.79 103.46 0.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 p -139.4 144.23 38.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.389 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.446 HD23 ' NE2' ' A' ' 189' ' ' HIS . 17.1 tp -103.46 128.31 50.66 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.47 81.38 2.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.431 0.634 . . . . 0.0 109.954 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.446 ' NE2' HD23 ' A' ' 187' ' ' LEU . 21.7 m80 -75.71 -19.94 58.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.03 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 192' ' ' HIS . 16.8 t-80 -140.48 106.24 5.14 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -57.86 -37.33 73.7 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.274 0.359 . . . . 0.0 111.391 -176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' HIS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 190' ' ' HIS . 40.7 m-70 -66.09 106.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.086 0.469 . . . . 0.0 110.08 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -87.38 136.71 32.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.185 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.933 177.084 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.753 0.311 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.83 28.62 0.27 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.18 -25.31 65.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -75.73 -23.25 56.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.246 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 5.4 mm-40 -77.31 -35.02 55.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 10' ' ' VAL . 48.6 tp -77.66 -29.98 51.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.686 ' HG2' HG11 ' A' ' 120' ' ' VAL . 3.8 ttm-85 -53.26 -49.56 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 55.0 pttt -68.93 -31.44 70.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.832 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.21 -43.51 70.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.6 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 6' ' ' LEU . 39.1 t -70.19 -39.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.34 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.649 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -71.87 -38.57 70.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.263 0.554 . . . . 0.0 110.778 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -60.84 -41.96 96.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.868 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.1 pt -90.68 1.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.677 0.275 . . . . 0.0 111.501 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.59 -26.88 31.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.978 0.418 . . . . 0.0 110.804 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.13 143.67 57.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.788 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -85.96 -176.74 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.22 -52.13 65.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.348 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -52.31 -51.37 59.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.797 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.96 -58.23 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.62 0.248 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -57.43 -50.17 73.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.9 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -62.39 -40.6 97.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.972 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -71.05 -44.61 65.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.903 0.382 . . . . 0.0 110.915 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.2 mt -65.01 -42.44 94.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.819 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -63.2 -39.31 94.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.525 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.29 -43.73 92.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.026 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -55.86 -51.34 67.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.731 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 25' ' ' LEU . 52.0 t -62.86 -42.76 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.389 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 56' ' ' ASP . 79.8 mt -62.51 -50.28 80.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.5 t -59.46 -45.18 92.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -63.4 -41.37 98.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.778 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 35.9 tp -63.33 -42.27 98.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.505 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -73.59 -21.1 60.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.7 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -74.35 -27.34 60.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.312 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 33' ' ' LEU . 89.2 mt -57.63 132.49 82.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.778 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.4 -24.04 77.82 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.32 2.014 . . . . 0.0 110.64 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -63.99 -30.05 71.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.862 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.12 -38.32 82.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.012 0.434 . . . . 0.0 110.506 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -70.48 -26.43 63.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 109.759 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -84.34 -13.36 52.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 m -65.47 121.47 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -106.92 -54.87 2.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.862 0.839 . . . . 0.0 109.086 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.663 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 47.8 mmtt -105.06 99.74 9.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.237 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.58 108.82 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.059 0.456 . . . . 0.0 110.679 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -102.28 138.38 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.097 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.11 144.06 47.82 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 24.0 t80 -82.35 -4.16 56.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.9 m 62.1 92.8 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.728 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.4 133.98 27.6 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.339 2.026 . . . . 0.0 111.749 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -121.19 -35.49 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 0.0 110.083 -177.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.43 41.59 1.11 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.524 -177.135 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.41 -90.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 35.3 mt-10 54.85 38.23 29.93 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.845 0.379 . . . . 0.0 111.849 168.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 54' ' ' GLU . 81.7 t 73.17 119.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.35 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 30' ' ' ILE . 11.1 m-20 -69.07 83.25 0.33 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.273 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 99.1 mt -89.83 -4.63 57.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.839 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -61.38 -46.88 94.92 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.074 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.71 -3.37 7.9 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.115 1.876 . . . . 0.0 112.951 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 63' ' ' GLU . 23.0 tp -93.23 -9.84 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.388 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 3.1 m-85 -54.28 -54.04 52.45 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.645 177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.4 Cg_endo -56.19 -39.97 87.85 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.362 2.041 . . . . 0.0 112.374 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.452 ' HG3' HD12 ' A' ' 60' ' ' LEU . 7.7 mm-40 -58.47 -42.39 87.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.065 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.82 -46.86 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.18 -24.55 64.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.877 0.37 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -38.5 78.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.093 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.895 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 7.2 pt-20 -138.27 -46.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.895 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 49.6 mttm -96.6 -173.32 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.995 0.426 . . . . 0.0 111.008 -170.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 39.2 mt-10 -100.14 128.32 46.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.7 tp -100.88 110.83 22.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.4 mt -96.22 119.86 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.292 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.873 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 93.7 mt -122.49 145.6 45.18 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CB ' HD11 ' A' ' 80' ' ' ILE . 72.7 Cg_endo -91.58 127.24 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.045 2.497 . . . . 0.0 113.688 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.788 ' HD3' ' HE2' ' A' ' 83' ' ' TYR . 34.8 tttm -105.98 126.08 51.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.18 128.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.698 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -139.14 100.4 4.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.886 0.374 . . . . 0.0 110.128 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.09 -106.17 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.764 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -124.8 21.3 8.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.426 0.631 . . . . 0.0 109.603 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.75 152.96 35.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.525 HD13 HD22 ' A' ' 139' ' ' LEU . 16.8 tt -128.02 128.0 68.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.422 0.63 . . . . 0.0 110.773 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -104.11 108.61 20.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 139' ' ' LEU . 97.0 mt -85.35 101.1 12.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.788 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 77.2 m-85 -96.17 130.82 43.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.286 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 20.1 ptt180 -92.59 130.17 38.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.15 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.433 -171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -135.17 14.31 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.336 0.588 . . . . 0.0 109.638 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.473 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.0 m -135.09 125.42 17.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.21 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.2 Cg_exo -61.87 -31.56 85.04 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 122.915 2.41 . . . . 0.0 113.423 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.66 -2.25 19.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.72 4.2 51.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.903 0.382 . . . . 0.0 110.663 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.7 mt -104.52 149.06 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.705 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.22 -142.2 6.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 133.06 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -127.27 -98.17 1.0 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.0 114.387 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.32 -2.85 21.82 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -166.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -122.93 -44.56 2.18 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.12 24.82 3.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.879 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.95 173.24 7.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 tpt -69.81 88.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.05 161.63 39.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.295 -172.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.873 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -76.13 125.5 8.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.507 2.138 . . . . 0.0 112.097 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.94 -41.76 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.011 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.99 173.85 11.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.87 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.09 -164.42 25.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.896 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -110.76 122.04 46.82 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.752 -0.264 . . . . 0.0 110.849 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.5 ptm180 -84.31 125.99 32.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 108' ' ' ASN . 3.4 t -122.72 164.28 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' N ' HG12 ' A' ' 107' ' ' VAL . 92.3 m-20 -74.74 153.02 87.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.88 -11.56 24.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.975 2.45 . . . . 0.0 113.314 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -71.03 -20.44 62.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.494 . . . . 0.0 110.455 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.33 -16.44 56.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.459 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.67 124.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.299 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.663 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 19.0 t70 -99.2 -48.41 4.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.508 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.778 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 32.1 t80 -136.9 119.94 16.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -126.15 138.87 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.027 0.442 . . . . 0.0 110.962 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.4 111.4 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.202 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.81 105.8 54.27 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.922 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 48' ' ' TYR . 16.5 Cg_exo -68.59 119.32 6.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.489 2.126 . . . . 0.0 110.941 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.53 153.92 19.67 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.688 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 7' ' ' ARG . 84.1 t -58.77 -49.26 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.188 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.88 36.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.584 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.25 151.84 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 5.0 p-10 -108.36 -163.72 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 97.7 mt -75.69 -19.52 59.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.81 -31.16 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 119.39 35.06 0.96 Allowed Glycine 0 C--O 1.236 0.277 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.529 170.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.96 147.08 35.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.008 0.404 . . . . 0.0 110.16 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.585 ' HB3' ' OD2' ' A' ' 166' ' ' ASP . 25.4 ttp180 -86.78 -12.71 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.083 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.835 ' HB2' HD13 ' A' ' 160' ' ' LEU . 62.0 tp 73.68 -60.21 0.54 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.552 0.741 . . . . 0.0 111.034 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.24 113.14 0.66 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.175 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -73.61 -37.55 65.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.071 0.462 . . . . 0.0 110.262 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -132.51 -144.1 5.21 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -69.15 -72.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 0.0 110.05 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.17 38.04 0.37 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -109.78 171.42 7.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.708 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 70.1 5.3 5.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.049 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.33 -29.81 57.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.46 -25.96 67.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.659 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 82' ' ' LEU . 34.3 tp -78.43 -58.17 3.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.388 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.83 -30.99 69.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.233 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.57 -23.54 53.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.6 -6.06 44.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 139' ' ' LEU . 97.4 t -80.73 104.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.02 7.3 44.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.62 -168.5 44.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.987 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.69 104.01 15.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.502 ' HA ' HG23 ' A' ' 115' ' ' ILE . 9.9 mtmp? -86.24 102.74 14.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.163 0.506 . . . . 0.0 110.22 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.4 116.86 43.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.641 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.99 121.72 5.56 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 29' ' ' VAL . 85.3 t -109.33 120.3 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.87 169.81 21.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 111.597 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' A' ' 155' ' ' GLN . 41.4 m-85 -86.3 168.86 13.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -77.15 -19.84 56.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 109.548 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -69.01 -10.2 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.487 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 152' ' ' TYR . 59.9 mm-40 -111.29 10.26 21.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.625 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.74 131.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.15 -168.73 1.81 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.602 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 34.1 mt-10 -80.02 -59.27 2.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 109.971 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.4 mmt85 -147.2 144.94 29.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.709 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 129' ' ' LEU . 68.6 mt -101.92 137.19 19.45 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 12.0 Cg_exo -70.88 101.92 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.636 2.224 . . . . 0.0 111.075 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 0.5 OUTLIER -130.67 178.33 6.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.211 -174.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -73.45 -67.2 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HA ' HH11 ' A' ' 162' ' ' ARG . . . -151.41 -89.28 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.005 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -116.7 78.12 1.17 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.024 0.44 . . . . 0.0 110.836 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 128' ' ' ARG . 34.9 t70 -70.08 134.66 48.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 62.8 mt -55.97 114.79 8.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 112.057 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.76 175.95 7.38 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.272 2.648 . . . . 0.0 112.851 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.12 160.56 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 14.0 m-20 -87.89 -35.14 17.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.239 0.542 . . . . 0.0 109.924 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.4 t -133.26 143.44 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.483 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 181' ' ' LEU . 56.7 tp -115.64 117.61 30.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.71 116.2 51.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.013 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 70.9 p -109.92 -167.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.747 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 10.4 pt-20 -68.19 -17.42 64.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.199 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 9.8 mtmp? -128.71 -66.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -109.41 152.63 25.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.282 0.563 . . . . 0.0 112.077 -171.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.473 HG21 HD21 ' A' ' 36' ' ' LEU . 61.2 t -118.64 133.87 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.904 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -129.49 146.34 51.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.994 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -89.57 117.06 28.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 172' ' ' LEU . 70.5 mt -106.23 7.3 31.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.175 0.512 . . . . 0.0 110.869 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.14 -177.86 4.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.718 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.579 ' HB3' ' HE ' ' A' ' 185' ' ' ARG . 3.5 m-20 -60.15 105.69 0.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.013 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.57 70.81 2.17 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.579 ' HE ' ' HB3' ' A' ' 183' ' ' ASP . 26.1 mmt180 -87.33 17.77 4.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.9 m -78.23 72.62 4.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.817 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.45 38.09 1.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.341 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -54.64 117.93 3.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.347 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -142.68 80.19 1.68 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.79 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -62.01 134.29 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.931 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -75.58 94.26 3.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.555 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -77.34 172.27 13.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.598 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -92.08 -54.03 4.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 . . . . . 0 C--O 1.248 1.012 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.607 173.477 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.623 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 23.5 mmt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.36 -66.16 0.58 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -76.5 -10.03 59.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 1' ' ' MET . 3.3 p -97.36 -48.33 5.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.181 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 43.7 mt-10 -64.51 -36.36 83.95 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.136 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -53.46 -41.01 65.73 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.386 0.429 . . . . 0.0 111.133 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 7' ' ' ARG . 44.1 ttm180 -65.65 -35.17 80.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.168 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.35 -34.91 17.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -60.17 -52.4 65.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.054 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 98.0 t -62.3 -46.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.482 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 tp -59.77 -42.8 94.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.667 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -61.02 -44.13 97.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.899 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -71.73 -31.18 66.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.241 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 80.0 mtp180 -64.0 -53.6 47.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.715 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 11' ' ' LEU . 26.4 pt -78.44 8.57 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.005 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.98 -9.04 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.478 0.656 . . . . 0.0 109.523 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 54' ' ' GLU . 92.8 mt -68.92 141.06 55.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.504 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -69.4 153.29 43.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 111.251 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 9.4 tp10 -56.64 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.768 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.57 -44.07 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.276 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 7.3 tp10 -61.18 -39.71 91.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 42.0 ttt180 -55.1 -47.96 74.24 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.577 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.3 mmt180 -62.56 -32.23 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.78 -29.78 68.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.382 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 59.0 mt -79.34 -40.43 30.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.263 0.554 . . . . 0.0 110.31 176.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 19.9 m -59.6 -40.02 86.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.906 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.78 -32.07 73.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.439 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 91.0 mttt -60.24 -53.98 51.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.86 -43.1 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.557 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.28 -46.46 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.979 0.419 . . . . 0.0 110.508 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 t -65.38 -42.81 92.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.938 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -70.02 -43.33 71.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.595 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 36' ' ' LEU . 28.0 tp -66.89 -34.67 78.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -86.31 -3.37 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.15 0.5 . . . . 0.0 110.625 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.53 -28.12 31.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 178' ' ' VAL . 70.2 mt -61.45 123.77 77.94 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.141 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.46 -20.5 41.71 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.485 2.123 . . . . 0.0 112.162 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.28 -22.08 55.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.778 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -72.18 -14.99 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.08 -33.5 14.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.249 177.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.71 -38.23 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.624 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 p -61.89 152.0 33.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 42' ' ' SER . 12.8 mptt -132.71 -25.75 1.85 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.848 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 3.3 mptp? -103.9 95.52 6.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 60.9 t -111.4 118.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 111.169 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -106.17 124.34 49.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.204 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.55 123.68 48.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.96 -7.54 49.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.921 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 68.4 m 70.93 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 123.326 0.65 . . . . 0.0 111.964 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 2.9 Cg_exo -75.37 95.48 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.952 2.435 . . . . 0.0 112.132 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 52' ' ' LYS . 27.2 pt -78.39 -40.21 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.097 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 51' ' ' ILE . 94.7 mttt -129.28 103.13 6.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.74 172.6 35.73 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.578 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -93.9 -10.3 34.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.923 0.392 . . . . 0.0 110.29 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG12 ' HG ' ' A' ' 57' ' ' LEU . 57.4 t -75.13 109.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 8.0 m-20 -90.54 84.09 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.512 . . . . 0.0 111.854 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' HG ' HG12 ' A' ' 55' ' ' VAL . 94.0 mt -96.18 -10.7 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.533 0.682 . . . . 0.0 109.248 171.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.475 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 5.6 m -61.17 -49.62 87.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.121 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 58' ' ' THR . 49.2 Cg_endo -69.22 2.27 3.37 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.01 1.807 . . . . 0.0 113.501 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 64' ' ' VAL . 21.2 tp -94.84 -8.17 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.048 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 19.9 m-85 -53.98 -51.53 76.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 12.2 Cg_endo -56.34 -36.17 96.82 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.553 2.168 . . . . 0.0 112.515 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 66' ' ' LYS . 51.8 tp10 -71.58 -41.78 68.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' LEU . 77.0 t -57.97 -43.37 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.53 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.09 -1.52 7.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 63' ' ' GLU . 54.4 mttp -88.93 -26.39 21.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -112.0 -50.66 2.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.112 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 27.6 mtmm -131.83 -174.31 3.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.921 -168.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 36.7 mt-10 -96.84 142.48 28.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.52 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.97 109.4 21.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.24 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 66.9 mt -98.56 118.22 44.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.102 0.477 . . . . 0.0 110.057 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.83 145.81 34.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.063 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' CB ' HD11 ' A' ' 80' ' ' ILE . 87.5 Cg_endo -89.34 120.33 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.183 2.589 . . . . 0.0 113.118 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.831 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 tttt -106.18 117.18 33.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG11 ' HE2' ' A' ' 96' ' ' PHE . 58.7 t -85.36 109.18 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -131.27 98.94 4.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.726 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.81 19.46 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m120 71.15 -36.11 0.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 112.181 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.87 143.52 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.501 HD13 HD22 ' A' ' 139' ' ' LEU . 15.5 tt -98.94 132.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.181 0.515 . . . . 0.0 111.426 -173.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.9 t -120.9 124.19 44.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.377 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 73' ' ' PRO . 77.5 mt -87.13 130.23 34.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.069 0.461 . . . . 0.0 110.85 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.659 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 9.8 m-85 -106.91 126.26 52.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.616 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 71.3 ttt180 -85.45 92.67 8.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.424 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.77 111.59 23.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.537 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.406 ' HD2' ' HG2' ' A' ' 84' ' ' ARG . 4.8 p80 -120.58 20.13 11.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.497 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 p -162.15 122.23 1.49 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.035 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.96 41.57 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.029 2.486 . . . . 0.0 112.97 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.74 -36.53 15.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.767 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.9 m -131.17 102.79 6.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.459 . . . . 0.0 111.428 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.0 mt -140.97 153.4 45.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.852 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.59 160.61 30.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.974 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.59 112.91 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.23 -154.96 6.63 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.357 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.32 -127.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.567 0.347 . . . . 0.0 110.701 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HE2' HG11 ' A' ' 75' ' ' VAL . 88.4 m-85 -85.39 17.64 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.828 0.347 . . . . 0.0 110.812 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 46.8 2.73 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.74 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.0 pt -124.27 170.31 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.823 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.54 93.31 7.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.063 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.831 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 4.3 pt-20 -104.83 109.86 63.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 31.7 Cg_exo -59.63 127.41 23.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.377 2.051 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.43 -56.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.717 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.57 -176.79 4.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.53 -159.84 22.95 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.387 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -96.45 96.85 8.98 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -77.91 120.45 22.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.66 147.72 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.206 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.8 t-20 -58.58 138.91 85.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.463 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' ASN . 53.7 Cg_exo -53.92 -16.22 8.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.573 2.849 . . . . 0.0 114.271 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 42.7 tt0 -61.61 -28.18 69.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.397 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.34 -28.99 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 111.145 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 44' ' ' LYS . 40.5 t -65.41 121.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.33 -20.77 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.603 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 32.6 t80 -135.96 114.34 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 143' ' ' VAL . 16.2 tt -121.28 139.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.15 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.91 106.48 17.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.259 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.35 123.48 34.95 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.773 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -92.84 -163.42 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.01 2.473 . . . . 0.0 112.004 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.73 -176.68 44.14 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.6 -41.46 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 117.046 0.423 . . . . 0.0 110.749 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.68 161.51 38.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.337 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.44 158.59 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.564 0.54 . . . . 0.0 109.781 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 9.3 p30 -120.34 -172.1 2.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.349 . . . . 0.0 110.678 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.5 mt -98.83 7.69 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.465 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -103.38 -30.3 10.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 133.9 -4.09 4.61 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.226 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -88.86 163.38 15.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.24 0.543 . . . . 0.0 111.215 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 128' ' ' ARG . 7.6 mtm-85 -126.15 157.02 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.278 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.75 2.58 19.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.141 0.496 . . . . 0.0 110.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.65 -149.12 51.43 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.979 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -155.39 -62.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.05 179.5 40.17 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -83.93 125.75 32.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 110.565 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 -171.34 15.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -102.81 16.64 25.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.345 0.593 . . . . 0.0 109.876 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -99.65 4.13 45.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.677 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 6.9 p-10 -67.56 -33.34 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -70.27 -8.42 50.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 80' ' ' ILE . 21.2 tp -93.58 -72.27 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.439 ' HA ' HG23 ' A' ' 143' ' ' VAL . 95.5 mt -66.36 -17.7 64.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.313 -171.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.706 ' HG3' ' HB ' ' A' ' 167' ' ' ILE . 83.8 tttt -92.95 -12.1 31.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.671 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -121.33 0.95 10.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.323 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 115' ' ' ILE . 92.8 t -50.35 121.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.0 111.06 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 58.1 mtpt -87.82 -11.38 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.099 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.45 176.82 51.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.208 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.29 110.72 3.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.833 0.349 . . . . 0.0 110.686 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 143' ' ' VAL . 11.6 mmmm -72.47 100.11 2.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.815 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.59 124.92 59.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.359 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -102.08 129.48 9.91 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.19 121.25 66.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.935 0.367 . . . . 0.0 110.84 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.27 165.51 31.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.264 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.579 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 47.8 m-85 -92.2 -178.79 5.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 t -68.47 -22.31 64.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.185 0.516 . . . . 0.0 109.973 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -72.75 -18.04 61.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.164 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.519 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.6 mp0 -95.64 -7.44 37.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.322 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.25 116.61 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.068 0.461 . . . . 0.0 111.701 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.55 174.35 6.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.372 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 26.8 mm-40 -74.26 -60.29 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 110.54 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 34.8 ttt180 -145.97 129.2 16.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 84.7 mt -93.62 160.7 32.31 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.194 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.59 101.64 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.221 . . . . 0.0 111.614 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -80.07 148.26 31.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.204 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -77.1 -60.92 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 169.54 -39.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.137 0.975 . . . . 0.0 109.711 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.467 ' O ' ' HE3' ' A' ' 141' ' ' LYS . 8.3 m-90 -136.13 21.83 3.24 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.06 149.75 18.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.896 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.706 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 6.6 tp -93.79 113.56 60.77 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.227 -175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 167' ' ' ILE . 57.6 Cg_endo -71.53 174.74 10.5 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.463 2.109 . . . . 0.0 112.853 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.78 157.94 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.961 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 182' ' ' ARG . 15.2 t70 -91.91 -42.6 9.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.9 122.21 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.4 tp -106.35 108.0 19.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.056 0.455 . . . . 0.0 109.874 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.16 118.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.064 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 79.7 p -114.36 -178.93 3.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 14.9 pt-20 -71.61 -15.26 62.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.575 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.541 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 99.8 mttt -105.7 -60.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.544 -174.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.17 172.57 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 111.498 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 36' ' ' LEU . 23.6 t -115.09 98.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.545 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -94.49 117.79 30.67 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.561 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.01 111.25 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.155 174.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.458 HD13 ' HA2' ' A' ' 126' ' ' GLY . 64.5 mt -81.64 -45.77 15.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.529 ' HA ' ' OD2' ' A' ' 170' ' ' ASP . 41.7 mtm180 66.12 -178.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.22 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.44 115.31 28.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.225 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -107.41 -164.44 21.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.857 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 185' ' ' ARG . 21.2 ttt180 65.43 28.46 11.63 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.624 0.726 . . . . 0.0 110.0 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.7 t -72.44 -2.65 20.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.781 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.36 -31.43 67.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.537 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -133.62 143.52 48.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.514 0.673 . . . . 0.0 111.278 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 -167.49 2.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -52.28 128.03 23.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.611 0.641 . . . . 0.0 109.911 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -74.78 91.56 2.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -168.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -151.51 77.2 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.036 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -86.79 -11.92 49.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.886 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 C--O 1.244 0.775 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.649 179.816 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.7 tp 65.85 17.04 10.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.3 0.571 . . . . 0.0 111.107 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -69.23 -34.9 75.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.536 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -70.84 -44.48 66.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.4 -36.83 79.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.686 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.62 -50.85 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.297 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HG3' ' HA2' ' A' ' 130' ' ' GLY . 7.8 tmm_? -62.29 -42.24 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.543 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.36 -33.74 75.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.653 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 29.6 ttmt -81.78 -46.03 14.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.312 -176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.22 -35.79 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.302 0.573 . . . . 0.0 110.365 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.7 tp -59.31 -37.13 76.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.938 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -58.6 -41.79 86.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.056 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -74.69 -40.67 61.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.523 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.632 HH11 ' HA ' ' A' ' 120' ' ' VAL . 15.7 ptm180 -70.4 -37.47 74.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.346 -175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 11' ' ' LEU . 33.4 pt -82.83 -0.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.822 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -81.45 -24.88 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.61 137.34 57.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.591 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 t -122.7 -166.59 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.823 -175.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -66.53 -4.59 8.81 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.9 -65.03 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.033 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 10.2 tp10 -76.47 -42.06 45.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.684 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 34.2 ttp85 -66.95 -26.47 66.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 -175.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 54.1 ttt85 -58.97 -49.15 78.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -79.71 -25.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 68.3 mt -63.63 -56.04 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.743 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 50.4 m -67.7 -32.99 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.028 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -58.94 -47.59 84.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 109.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 175' ' ' GLU . 49.6 mtpt -59.44 -39.57 84.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.025 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 175' ' ' GLU . 94.8 t -63.38 -50.31 79.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.716 0.293 . . . . 0.0 110.624 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 74.7 mt -58.86 -49.92 81.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.1 m -64.17 -36.95 85.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.718 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -66.7 -44.94 80.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.125 0.488 . . . . 0.0 109.978 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.5 tp -62.66 -39.43 93.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.746 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 28.0 mtpp -75.94 -14.12 60.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.249 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -84.54 -19.63 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 110.088 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.55 114.3 18.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -56.4 -32.71 89.79 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.291 2.661 . . . . 0.0 113.829 -171.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.45 -23.86 61.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.604 0.24 . . . . 0.0 111.056 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.1 -41.77 94.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.007 0.432 . . . . 0.0 110.552 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -85.67 -10.29 55.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.757 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -9.7 30.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -101.94 -176.77 3.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -136.0 -55.03 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.798 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 30.5 mtpt -89.07 101.99 14.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 111.194 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.89 119.78 62.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.57 131.67 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.392 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.95 138.67 50.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.74 -1.73 36.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.513 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.4 t 73.83 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.387 0 C-N-CA 123.47 0.708 . . . . 0.0 111.587 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.39 49.77 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.097 2.531 . . . . 0.0 112.259 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.792 HG13 ' H ' ' A' ' 52' ' ' LYS . 14.1 pt -56.46 -62.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.895 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.792 ' H ' HG13 ' A' ' 51' ' ' ILE . 94.4 mttt -122.29 9.29 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.719 0.771 . . . . 0.0 110.044 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.26 128.37 9.08 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -84.17 10.55 9.98 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -169.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.671 HG12 ' HG ' ' A' ' 57' ' ' LEU . 92.3 t -63.61 104.43 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.75 77.82 5.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.463 0.649 . . . . 0.0 111.145 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' A' ' 55' ' ' VAL . 96.6 mt -94.03 -2.08 53.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.178 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.496 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -56.65 -44.82 99.91 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.422 -178.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.8 Cg_endo -69.74 1.44 4.42 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.22 1.947 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.01 -18.36 24.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.294 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.83 -44.35 97.93 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 95.2 Cg_exo -45.49 -39.26 16.94 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.328 2.019 . . . . 0.0 113.244 174.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -77.68 -44.76 26.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 68' ' ' LYS . 65.1 t -57.25 -42.84 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.413 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.48 -4.13 17.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 95.5 mttt -98.4 -59.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 6.4 pt-20 -105.45 -17.62 14.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.63 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 45.4 mmtm -111.76 168.51 9.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.455 0.645 . . . . 0.0 111.666 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.798 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.4 mm-40 -102.12 103.16 13.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.984 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.58 100.54 6.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 58.2 mt -91.86 114.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.5 mt -114.79 141.81 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.728 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.6 Cg_exo -80.11 129.19 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.868 2.379 . . . . 0.0 112.071 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 36.3 tttm -105.54 100.39 9.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 80' ' ' ILE . 35.1 t -69.73 98.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -146.92 134.58 21.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.274 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 -92.1 0.47 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.651 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.24 10.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.979 0.419 . . . . 0.0 109.954 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -125.96 154.04 43.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.911 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD13 ' A' ' 139' ' ' LEU . 6.2 pt -96.62 92.46 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 166.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.1 t -80.52 110.85 16.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.846 -170.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.97 121.98 22.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.726 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 97.1 m-85 -121.85 148.94 44.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.006 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -88.45 134.92 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.09 126.86 68.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.848 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -124.05 -1.23 8.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.229 0.538 . . . . 0.0 110.004 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -153.97 151.11 24.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 -174.46 0.84 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.946 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.0 -36.09 0.35 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.193 0.597 . . . . 0.0 111.884 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.94 -3.46 16.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.501 0.667 . . . . 0.0 111.238 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.27 123.68 39.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.28 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.02 135.78 9.56 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.708 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.0 t -82.92 94.37 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.63 -24.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.385 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.19 -156.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 0.0 111.328 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.59 55.98 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.156 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.14 16.48 43.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.037 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 36.2 pt -120.27 165.29 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.85 90.47 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.021 0.438 . . . . 0.0 110.607 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.714 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -88.98 147.54 38.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.514 -177.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 18.3 Cg_endo -61.19 114.46 2.21 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.745 2.297 . . . . 0.0 112.092 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -91.07 -52.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.317 0.58 . . . . 0.0 109.876 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -97.54 87.18 4.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.152 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.54 170.69 35.83 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.198 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.48 137.04 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.764 0.282 . . . . 0.0 110.936 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -77.88 133.54 38.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.753 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.89 135.88 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.737 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -87.02 146.73 41.2 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.593 ' HB3' ' HA ' ' A' ' 143' ' ' VAL . 50.9 Cg_exo -55.39 -25.05 46.16 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.06 2.507 . . . . 0.0 113.371 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 144' ' ' LYS . 43.2 tt0 -72.87 -20.33 61.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.165 0.507 . . . . 0.0 110.962 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -100.23 7.13 44.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.18 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 60.0 t -94.32 111.88 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.06 -54.22 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -124.67 139.34 53.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.603 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 147' ' ' LYS . 4.5 tp -134.22 108.24 10.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.435 0.636 . . . . 0.0 109.561 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.79 112.07 24.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.948 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.11 113.86 51.58 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 150' ' ' VAL . 3.8 Cg_exo -76.52 91.72 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.801 2.334 . . . . 0.0 111.341 175.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.98 158.27 48.03 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.896 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' HH11 ' A' ' 14' ' ' ARG . 57.5 t -74.7 -39.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 110.013 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.539 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -147.76 155.93 42.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.898 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -135.21 153.19 52.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.425 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.605 ' HB3' ' H ' ' A' ' 127' ' ' TYR . 15.3 t70 -78.62 164.72 24.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.268 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.888 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 13.3 mt -55.44 -32.46 62.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 181' ' ' LEU . 46.6 mt-10 -87.53 -64.57 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 172' ' ' LEU . . . 165.11 53.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.85 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.605 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 51.2 m-85 -99.46 161.15 13.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 166' ' ' ASP . 40.3 ptt180 -93.27 155.6 17.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 112.451 -167.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.644 ' HB2' HD13 ' A' ' 160' ' ' LEU . 40.7 tp -160.31 120.29 2.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.381 168.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.599 ' HA2' ' HG3' ' A' ' 7' ' ' ARG . . . 166.97 -111.48 0.45 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.291 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.77 174.57 5.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.91 7.03 13.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.464 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -80.56 64.28 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 109.499 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.3 107.04 1.19 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.974 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 67.31 -176.5 0.2 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.181 0.592 . . . . 0.0 110.522 -175.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 72.24 -47.57 0.67 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.778 0.831 . . . . 0.0 112.182 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.4 -35.99 60.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.045 0.538 . . . . 0.0 111.813 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -60.47 -33.4 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.052 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.675 HD13 HG13 ' A' ' 80' ' ' ILE . 9.1 tt -83.43 -44.26 14.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.43 -18.11 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.775 0.322 . . . . 0.0 111.325 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 141' ' ' LYS . 4.2 ttmp? -89.16 -15.5 33.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.065 0.46 . . . . 0.0 109.883 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.59 -21.82 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 60.7 t -63.58 127.73 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.163 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD2' ' HG3' ' A' ' 110' ' ' GLU . 96.9 mttt -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 112' ' ' VAL . . . -79.63 -170.93 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.123 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.41 110.98 16.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.982 0.42 . . . . 0.0 109.95 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HA ' HG23 ' A' ' 115' ' ' ILE . 95.7 mttt -86.47 109.38 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 63.0 t -106.34 122.25 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.82 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.34 119.66 6.01 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 47.7 t -105.95 117.96 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.69 0.281 . . . . 0.0 110.982 -175.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.35 -178.08 6.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.894 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 35.0 m-85 -106.53 165.63 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -56.48 -30.44 62.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.21 -32.32 72.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.076 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.414 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 12.2 mm100 -90.89 -7.97 50.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.77 117.88 33.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.965 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.63 174.48 5.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.888 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 45.9 mt-10 -69.69 -57.58 4.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 111.267 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.6 ttm105 -144.77 118.58 9.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 -169.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 129' ' ' LEU . 74.8 mt -98.53 141.19 22.51 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.698 0.285 . . . . 0.0 111.452 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.18 113.19 3.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.814 2.343 . . . . 0.0 111.666 174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -98.42 149.37 22.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.62 -75.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.235 -172.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -149.25 -76.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -100.05 69.05 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 109.393 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.4 ' HA ' ' NH2' ' A' ' 128' ' ' ARG . 13.9 t70 -76.04 149.63 37.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.329 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.408 HD11 ' HZ1' ' A' ' 141' ' ' LYS . 65.9 mt -110.87 107.41 57.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.835 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.56 154.59 31.25 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.824 2.349 . . . . 0.0 111.214 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 m -88.39 158.96 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.343 -0.39 . . . . 0.0 109.992 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' A' ' 182' ' ' ARG . 11.6 t70 -88.57 -42.46 12.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.518 0.675 . . . . 0.0 109.502 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 75.7 t -126.35 116.48 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.496 176.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 35.2 tp -99.87 103.65 15.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.911 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.05 125.87 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.128 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 54.0 p -107.83 -166.74 1.17 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.403 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.649 ' HB2' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.54 9.51 36.41 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.697 174.393 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -125.79 -55.21 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.556 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.12 160.03 39.91 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 111.505 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.411 HG12 ' HG3' ' A' ' 180' ' ' ARG . 64.9 t -101.2 113.98 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.96 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -92.49 93.66 8.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.728 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 178' ' ' VAL . 86.1 mtm180 -86.18 121.24 28.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.642 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 125' ' ' GLU . 39.5 mt -109.17 -59.34 1.91 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 182' ' ' ARG . 1.4 tpm_? 68.92 -75.24 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.213 0.605 . . . . 0.0 112.348 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -161.68 162.09 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.79 148.38 46.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.542 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 185' ' ' ARG . 5.7 mpt_? -88.22 13.82 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.656 0.265 . . . . 0.0 111.283 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 50.3 m -63.35 105.35 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.35 176.92 9.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.667 ' HG3' ' H ' ' A' ' 190' ' ' HIS . 8.8 tp10 -77.11 149.63 35.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 190' ' ' HIS . 34.2 t-80 -88.64 -6.99 57.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.667 ' H ' ' HG3' ' A' ' 188' ' ' GLU . 23.7 m80 71.73 117.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.475 0.655 . . . . 0.0 110.724 -174.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -77.45 64.69 2.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.238 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.34 -1.53 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.723 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -176.76 -45.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 . . . . . 0 C--O 1.244 0.788 0 CA-C-O 118.0 -1.0 . . . . 0.0 108.962 170.059 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 4' ' ' SER . 50.0 tp -160.55 141.4 11.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -28.02 66.36 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.565 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.542 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 12.2 m -70.44 -35.72 73.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.115 0.484 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 33.5 tt0 -61.92 -53.73 51.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.859 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 10' ' ' VAL . 65.5 tp -57.66 -45.04 86.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.808 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 120' ' ' VAL . 18.0 ttp180 -55.32 -42.35 73.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.497 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.64 -37.0 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 110.601 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HE2' ' HG2' ' A' ' 5' ' ' GLU . 64.7 mttm -65.03 -37.71 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.413 0.625 . . . . 0.0 110.09 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' LEU . 46.3 t -69.5 -38.93 77.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.637 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.99 -37.43 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.275 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -56.18 -47.75 77.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.059 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 10' ' ' VAL . 62.6 pttt -77.23 -0.17 24.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.585 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 41.6 ttm180 -93.05 -48.86 6.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.672 ' HA ' HH12 ' A' ' 22' ' ' ARG . 31.3 pt -85.54 -11.97 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -89.54 5.16 46.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.124 0.488 . . . . 0.0 110.846 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.97 149.85 42.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.432 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -70.67 146.7 49.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -62.39 -40.35 96.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -52.15 -52.47 51.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.522 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 6.2 pt-20 -81.03 -31.32 34.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.24 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.672 HH12 ' HA ' ' A' ' 15' ' ' ILE . 35.9 ttm-85 -57.04 -49.44 75.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.861 0.362 . . . . 0.0 110.82 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.71 -31.57 70.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -80.22 -34.96 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' VAL . 92.7 mt -65.13 -46.12 82.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 30' ' ' ILE . 20.2 m -64.15 -33.38 75.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.518 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.06 -43.0 99.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.12 -39.63 86.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.355 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' LEU . 64.9 t -65.19 -46.03 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 26' ' ' SER . 76.0 mt -58.98 -46.96 91.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 110.171 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -60.02 -45.66 92.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.48 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.84 -45.08 95.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.427 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.48 -42.46 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.379 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -71.1 -26.18 62.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.014 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 m -73.18 -23.67 60.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.8 mt -60.16 122.08 63.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.306 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 33.8 Cg_exo -60.61 -21.29 68.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.166 2.577 . . . . 0.0 112.913 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -75.49 -39.65 58.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.94 -37.49 76.83 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.387 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -67.3 -37.7 83.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 3.7 tmmm? -78.57 -52.37 8.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.124 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -60.84 131.1 49.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -90.51 -42.49 10.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.91 106.9 18.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.98 0.419 . . . . 0.0 110.322 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.84 108.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.337 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -94.54 117.49 30.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -104.89 122.03 44.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.648 ' HA ' ' HG3' ' A' ' 73' ' ' PRO . 8.9 t80 -76.73 -6.5 52.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.563 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.3 m 69.75 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 121.43 0.633 . . . . 0.0 111.621 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.54 125.74 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.506 2.137 . . . . 0.0 112.923 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.66 145.22 16.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 69.1 -41.4 0.47 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.414 0.686 . . . . 0.0 111.765 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.12 -76.8 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.819 ' HA ' ' HD3' ' A' ' 14' ' ' ARG . 6.3 mm-40 56.69 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.889 0.875 . . . . 0.0 111.305 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 150' ' ' VAL . 95.8 t -153.33 128.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.434 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -82.12 90.15 6.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.204 0.526 . . . . 0.0 110.881 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.583 HD11 HG11 ' A' ' 150' ' ' VAL . 89.1 mt -102.2 6.61 40.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.837 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -61.03 -43.81 92.27 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.065 -175.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 58' ' ' THR . 19.3 Cg_endo -61.2 -7.07 7.5 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.121 1.881 . . . . 0.0 113.886 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.34 -13.93 39.48 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.456 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.1 m-85 -52.48 -49.77 83.82 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.4 Cg_exo -52.36 -36.05 67.32 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.41 2.073 . . . . 0.0 113.225 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mt-10 -74.18 -31.42 62.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.014 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.19 -36.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.429 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -68.04 -5.01 15.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.582 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 43.4 tttp -66.87 -64.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.742 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 11.2 pt-20 -143.92 -4.05 0.85 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 6.3 mptp? -92.92 164.08 13.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.337 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.83 ' HG3' ' HB2' ' A' ' 84' ' ' ARG . 3.0 tp10 -97.3 103.46 15.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.227 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.8 tp -76.78 94.11 3.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 0.0 110.758 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 56.4 mt -88.49 112.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 86.2 mt -110.06 149.59 40.27 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.663 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 48' ' ' TYR . 9.6 Cg_endo -89.23 125.6 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.376 2.717 . . . . 0.0 113.097 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -105.62 105.63 15.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.429 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 80' ' ' ILE . 21.3 t -82.58 95.4 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.345 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.12 5.97 18.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.659 0.742 . . . . 0.0 109.835 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.49 -153.12 18.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -78.36 -6.24 54.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.109 0.48 . . . . 0.0 110.495 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.99 143.46 46.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.145 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 75' ' ' VAL . 49.6 mm -100.47 122.81 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.129 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m -85.84 122.67 30.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.506 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -101.32 133.19 46.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.684 0.278 . . . . 0.0 110.685 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . 93.9 m-85 -128.77 146.02 51.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.83 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 38.3 ptt85 -100.03 134.35 43.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.117 0.484 . . . . 0.0 110.012 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.78 139.38 51.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -124.76 -28.27 3.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.309 171.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.3 m -108.12 131.62 21.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 -10.14 25.35 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.141 2.561 . . . . 0.0 113.441 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.92 60.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.416 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 41.8 m -85.44 8.39 19.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.027 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.6 138.04 39.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.98 0.419 . . . . 0.0 111.5 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.86 176.41 20.68 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.549 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.78 90.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.846 0.355 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.98 -16.26 7.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.591 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.7 -171.05 3.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.303 0.241 . . . . 0.0 110.984 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -53.48 -53.66 48.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.102 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.85 50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.727 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.5 157.42 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.27 147.06 32.42 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.459 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 83' ' ' TYR . 72.9 Cg_endo -80.11 105.98 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.209 1.939 . . . . 0.0 111.458 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.71 -19.43 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.833 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -137.03 -171.97 3.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.916 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.53 -132.63 11.07 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 137.88 32.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -80.54 156.07 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.478 . . . . 0.0 111.68 -175.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.24 142.98 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.407 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -89.94 141.67 28.29 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.721 ' HB3' HG22 ' A' ' 143' ' ' VAL . 87.0 Cg_exo -46.7 -40.41 24.24 Favored 'Trans proline' 0 N--CA 1.476 0.441 0 C-N-CA 123.647 2.898 . . . . 0.0 114.225 -175.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.28 -19.27 64.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.41 -17.82 50.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.22 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 118.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.696 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -76.31 -55.66 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.33 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 148' ' ' VAL . 40.8 t80 -128.35 136.35 50.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.684 -173.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -139.06 139.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.98 113.17 25.82 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.073 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 47.8 t -111.98 124.73 31.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.878 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 4.9 Cg_exo -77.83 131.04 10.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.104 2.536 . . . . 0.0 111.804 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.88 140.18 11.56 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.539 HG11 ' HG2' ' A' ' 7' ' ' ARG . 48.6 t -70.93 -43.55 76.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 117.016 0.408 . . . . 0.0 110.836 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -143.42 130.91 21.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.74 169.29 9.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.01 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 26.4 p30 -132.1 -172.35 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.583 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 88.9 mt -87.29 3.17 47.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.27 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.96 -31.96 10.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.421 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 117.75 29.86 1.95 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.091 169.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.23 156.61 16.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.534 0.667 . . . . 0.0 109.865 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.451 ' CZ ' ' H ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER -101.45 -33.42 9.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -163.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 160' ' ' LEU . 35.6 tp 36.51 70.35 0.17 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.416 0.627 . . . . 0.0 111.908 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.451 ' H ' ' CZ ' ' A' ' 128' ' ' ARG . . . -90.35 -160.07 36.17 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.69 92.69 0.67 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 0.0 110.637 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.18 170.3 45.97 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.474 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.644 ' HE2' ' HA ' ' A' ' 166' ' ' ASP . 46.6 tttm -139.32 169.34 17.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' A' ' 133' ' ' LYS . . . 87.23 -49.01 3.89 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -76.91 154.91 33.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 71.03 0.51 3.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.266 0.626 . . . . 0.0 111.059 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.8 t70 -70.38 161.05 31.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 137' ' ' ASP . 28.4 ttt180 72.93 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 137' ' ' ASP . 30.8 tp -65.46 -65.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.661 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.69 ' HB2' HD13 ' A' ' 167' ' ' ILE . 97.4 mt -71.64 -11.99 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.573 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.61 -23.84 39.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 0.0 110.106 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -96.2 -35.75 11.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.705 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.3 t -73.39 93.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -101.91 26.37 7.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.431 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.95 -175.24 31.86 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.268 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -71.58 98.14 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.119 0.459 . . . . 0.0 109.931 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.518 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.8 mtmm -84.74 102.89 13.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 171' ' ' VAL . 98.6 t -103.49 119.89 52.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.663 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.46 130.85 10.1 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 57' ' ' LEU . 51.0 t -114.61 119.51 61.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -163.71 171.58 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.528 ' HB3' ' OE2' ' A' ' 175' ' ' GLU . 57.1 m-85 -87.21 162.53 17.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 156' ' ' VAL . 5.8 p -77.35 -9.94 59.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 0.0 110.46 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -61.67 -29.64 70.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -105.86 20.43 18.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 111.281 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 153' ' ' SER . 64.0 t -103.42 116.27 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.944 0.402 . . . . 0.0 110.546 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -100.84 -171.57 2.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.262 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.518 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 13.0 mt-10 -92.02 -44.76 8.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -147.59 125.05 11.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.376 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 97.4 mt -84.89 143.97 41.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.643 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 3.7 Cg_exo -74.95 102.26 1.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.812 2.341 . . . . 0.0 110.548 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 28.6 mtt180 -108.87 155.83 20.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 -172.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.58 -55.38 24.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.15 -50.61 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.147 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -129.28 83.74 2.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.853 0.835 . . . . 0.0 111.368 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.644 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.3 t70 -78.01 151.2 33.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 167.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 140' ' ' LEU . 64.6 mt -75.05 113.46 25.2 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.81 0.338 . . . . 0.0 110.676 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -88.88 161.36 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.044 2.496 . . . . 0.0 113.186 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.17 176.45 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.166 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.732 ' HA ' ' HD2' ' A' ' 182' ' ' ARG . 38.6 m-20 -99.28 -45.29 5.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.368 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.9 t -129.04 141.13 47.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.658 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 68.5 tp -117.51 115.56 25.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.98 122.73 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 77.1 p -115.79 -174.38 2.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 111.021 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.859 ' HG3' ' HD2' ' A' ' 176' ' ' LYS . 11.6 pt-20 -70.39 -13.68 62.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.096 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.859 ' HD2' ' HG3' ' A' ' 175' ' ' GLU . 10.1 mptt -121.67 -70.38 0.78 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -110.43 168.92 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.443 -167.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.4 119.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.669 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.751 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 39.0 mmt180 -94.16 102.86 14.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.039 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -79.88 89.62 5.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' CA ' ' A' ' 126' ' ' GLY . 34.2 mt -81.36 -51.38 8.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.718 -173.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.732 ' HD2' ' HA ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -87.75 -88.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.2 t70 58.1 -91.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.226 0.61 . . . . 0.0 112.526 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -104.14 47.63 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.89 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HE ' ' HA ' ' A' ' 185' ' ' ARG . 1.8 tpm_? -83.32 -66.68 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.5 p 46.58 -158.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.825 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 88.6 mt -113.73 137.66 51.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.239 -0.288 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 69.04 -78.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.01 0.819 . . . . 0.0 111.495 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -154.37 164.91 37.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.013 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -129.77 99.95 5.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.666 ' HA ' ' OXT' ' A' ' 194' ' ' HIS . 9.0 t-80 -83.38 64.62 7.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.299 0.571 . . . . 0.0 110.665 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -117.86 -2.75 11.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.494 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -146.58 -45.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' HIS . . . . . 0.666 ' OXT' ' HA ' ' A' ' 191' ' ' HIS . 58.2 t-80 . . . . . 0 C--O 1.249 1.068 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.21 85.45 5.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.937 0.398 . . . . 0.0 110.447 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -75.31 -37.26 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -70.17 -25.27 63.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.56 -38.54 70.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 129' ' ' LEU . 58.1 tp -70.76 -40.06 72.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.756 176.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.605 ' HD3' ' HA3' ' A' ' 130' ' ' GLY . 12.8 ttp180 -60.16 -44.33 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.428 174.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -64.78 -33.03 75.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.94 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -62.71 -47.31 84.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.266 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 121' ' ' ALA . 45.7 t -73.68 -43.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.615 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 14' ' ' ARG . 51.4 tp -57.92 -33.44 68.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.048 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 9.7 t60 -60.44 -43.6 96.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.375 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 44.2 mttp -81.67 -24.66 36.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 0.0 111.033 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 11' ' ' LEU . 41.1 ttt85 -57.77 -51.92 67.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.67 4.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.595 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 8.6 t30 -83.88 -19.21 35.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.35 132.65 52.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.757 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -70.65 153.16 43.11 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.041 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -43.66 79.82 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.334 0.396 . . . . 0.0 111.839 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.0 tp10 -60.95 -56.79 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.792 0.33 . . . . 0.0 111.081 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.46 -44.28 97.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.35 -42.1 98.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.013 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 12.7 tpt180 -62.11 -43.12 99.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.696 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 85.0 mtt180 -60.77 -38.79 86.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 98.4 mt -72.6 -45.22 60.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.882 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -62.67 -35.04 78.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.33 -43.49 79.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -66.36 -39.3 89.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 175' ' ' GLU . 61.5 t -65.06 -47.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.693 0.282 . . . . 0.0 110.776 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.77 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 110.203 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -36.16 83.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.101 0.476 . . . . 0.0 109.971 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -69.32 -44.36 71.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 33' ' ' LEU . 5.2 tt -65.46 -38.55 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.991 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -67.11 -26.53 66.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 111.036 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -83.79 -16.77 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -68.02 112.35 10.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.142 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HD2' HD23 ' A' ' 36' ' ' LEU . 35.1 Cg_endo -64.74 -25.43 61.14 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.611 2.207 . . . . 0.0 112.795 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.35 -24.61 61.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.731 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.26 -42.57 99.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.89 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HA ' ' NZ ' ' A' ' 68' ' ' LYS . 89.3 mttt -83.92 -3.04 57.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.129 0.49 . . . . 0.0 110.808 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.22 -33.8 22.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.492 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.7 p -81.94 152.55 26.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.195 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 24.8 tptp -111.46 -40.33 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 109.732 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 22.2 mmtp -91.99 107.43 19.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.796 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.3 115.01 47.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.278 0.561 . . . . 0.0 111.511 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -104.19 133.07 49.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.39 129.0 51.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.0 0.428 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -88.02 109.88 20.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.0 m -52.68 116.17 8.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.536 0.523 . . . . 0.0 111.621 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.18 69.09 7.24 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.865 2.377 . . . . 0.0 112.44 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 52' ' ' LYS . 26.5 pt -55.0 -43.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.521 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' N ' HG13 ' A' ' 51' ' ' ILE . 64.5 mttm -112.98 30.53 7.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -99.78 149.71 18.89 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.152 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' OE2' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -91.06 -35.62 14.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.32 104.07 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.83 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.85 101.84 7.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.972 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.08 5.9 40.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.781 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.2 m -60.1 -52.92 69.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.427 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 18.6 Cg_exo -68.88 7.28 0.79 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 113.495 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.67 -13.81 38.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.357 . . . . 0.0 110.146 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.6 m-30 -55.75 -49.13 94.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.142 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 75.2 Cg_exo -53.55 -36.06 79.04 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.281 1.987 . . . . 0.0 113.067 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 4.4 tp10 -70.98 -31.33 67.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 110.151 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.52 -40.76 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.396 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 88' ' ' PRO . 95.8 mt -65.65 -11.85 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 41.2 tttp -64.82 -60.5 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.252 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.844 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.8 pt-20 -120.65 -19.82 7.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -172.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.844 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 50.6 mttm -116.38 -172.45 2.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.628 0.251 . . . . 0.0 110.664 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -112.93 143.0 44.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.869 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.9 tp -92.74 124.77 36.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.226 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.55 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 53.5 mt -111.23 126.52 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.997 0.427 . . . . 0.0 110.484 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -123.71 147.93 54.79 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.308 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.72 125.36 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.218 2.612 . . . . 0.0 112.753 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' OE1' ' A' ' 100' ' ' GLU . 85.1 tttt -113.32 139.69 48.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.845 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.71 99.27 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HE2' ' A' ' 74' ' ' LYS . 10.6 mm-40 -81.66 82.57 7.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.734 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.18 -89.74 0.5 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -174.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -123.18 -7.29 8.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.88 0.371 . . . . 0.0 110.37 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.96 98.93 12.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.749 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.9 tt -91.94 127.58 44.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.341 0.591 . . . . 0.0 110.291 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -137.07 167.47 21.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.767 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.6 mt -99.32 138.1 36.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.372 . . . . 0.0 110.456 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -118.87 128.16 54.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -95.99 111.93 23.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.393 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 91' ' ' LEU . 27.0 m -101.94 138.31 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.072 0.463 . . . . 0.0 110.386 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -96.87 -4.81 39.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.347 0.594 . . . . 0.0 109.805 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -167.81 144.7 3.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.893 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD3' HD13 ' A' ' 65' ' ' LEU . 54.3 Cg_endo -72.1 71.27 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.45 2.1 . . . . 0.0 111.818 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.37 -58.05 2.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.812 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 7.7 p -86.43 21.62 2.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.273 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 85' ' ' VAL . 96.5 mt -99.12 108.53 21.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.14 10.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.74 108.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.098 0.449 . . . . 0.0 110.123 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 100' ' ' GLU . . . -150.48 -1.77 0.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.87 -161.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.312 . . . . 0.0 110.338 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.32 -18.75 63.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.257 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.18 -23.36 0.13 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.719 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -83.42 172.91 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.65 -0.275 . . . . 0.0 110.869 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -62.68 138.0 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.098 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.516 ' OE1' ' HG3' ' A' ' 74' ' ' LYS . 3.3 tp10 -108.34 107.19 59.94 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.157 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.58 106.07 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.67 1.58 . . . . 0.0 110.903 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.83 -45.65 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.224 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.67 178.72 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.87 -130.18 4.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.176 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -118.49 118.91 33.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.603 0.239 . . . . 0.0 110.418 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -80.67 97.0 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 111' ' ' ASP . 88.1 t -99.08 119.94 47.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.967 -175.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.17 154.08 86.36 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 143' ' ' VAL . 10.6 Cg_endo -54.1 -19.19 15.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.828 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.5 -41.12 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.937 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.577 ' HB3' HG13 ' A' ' 107' ' ' VAL . 22.1 t70 -87.24 -9.26 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.17 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.1 t -81.25 132.09 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.136 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.574 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 67.4 m-20 -91.7 -49.31 6.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.471 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 148' ' ' VAL . 47.5 t80 -130.31 138.43 50.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.541 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 tt -143.65 140.03 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.94 127.16 54.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -120.69 121.54 28.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.75 -41.26 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.722 2.282 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.25 -145.82 49.42 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.86 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.885 HG23 ' HB2' ' A' ' 131' ' ' PHE . 75.7 t -139.24 -45.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -161.15 157.07 25.28 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.381 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -135.92 166.01 24.32 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.157 0.285 . . . . 0.0 110.85 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -111.06 -171.74 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.892 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 52.9 mt -71.39 -14.38 62.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.63 -21.57 14.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.561 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.19 31.33 3.1 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.941 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -95.63 147.04 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.795 0.331 . . . . 0.0 110.435 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -84.06 150.13 25.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.861 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 6' ' ' LEU . 28.7 tp -94.53 15.37 18.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.515 0.674 . . . . 0.0 109.967 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' A' ' 7' ' ' ARG . . . 135.05 -143.07 14.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.12 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.885 ' HB2' HG23 ' A' ' 120' ' ' VAL . 60.4 t80 73.71 111.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.527 0.731 . . . . 0.0 110.522 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 118.49 61.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.229 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -68.29 131.05 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 110.233 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.04 2.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.555 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -133.81 -95.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 63.81 14.23 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.372 0.606 . . . . 0.0 111.45 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.24 -39.49 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.671 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 37.6 ttm180 -61.8 -17.65 56.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.402 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 45.9 tp -92.9 -70.12 0.71 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.41 . . . . 0.0 111.028 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.775 ' HB2' HD13 ' A' ' 167' ' ' ILE . 7.4 mp -63.49 -32.32 73.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.36 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 141' ' ' LYS . 34.4 ttmt -80.81 -16.59 53.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 138' ' ' ARG . 37.4 mtp180 -101.69 -5.57 24.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.287 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 109' ' ' PRO . 94.0 t -62.04 112.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.124 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -92.16 -7.09 49.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.792 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.34 -173.71 46.66 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.1 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.544 HD11 HG23 ' A' ' 171' ' ' VAL . 32.3 tp -80.21 108.11 13.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.4 mtmm -86.25 106.19 17.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.044 0.45 . . . . 0.0 110.034 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.5 t -102.51 124.36 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.997 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.54 138.82 14.36 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.7 111.45 36.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -151.76 162.85 40.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.65 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 30.8 m-85 -86.16 170.38 12.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.393 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.1 t -72.13 -38.52 69.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.73 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -74.46 -9.07 58.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.486 . . . . 0.0 110.421 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -95.31 -7.7 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.019 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.46 110.29 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.408 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.46 179.99 5.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.242 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.892 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.36 -53.46 6.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.051 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -136.04 140.73 44.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 129' ' ' LEU . 96.7 mt -132.81 158.67 75.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.5 101.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.289 1.993 . . . . 0.0 110.933 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -96.7 128.33 43.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.941 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.926 ' HB3' ' HB2' ' A' ' 166' ' ' ASP . 9.6 t70 -95.11 137.16 34.54 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.59 57.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.81 0.338 . . . . 0.0 111.549 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -119.52 24.01 10.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 0.0 110.552 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.926 ' HB2' ' HB3' ' A' ' 163' ' ' ASP . 12.0 t70 -89.73 -157.61 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.542 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.775 HD13 ' HB2' ' A' ' 140' ' ' LEU . 56.9 mt -125.82 107.27 25.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.841 0.353 . . . . 0.0 111.305 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -93.12 174.49 1.75 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.247 2.632 . . . . 0.0 112.177 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.85 174.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.604 0.24 . . . . 0.0 110.758 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -106.88 -44.24 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.554 . . . . 0.0 109.902 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.544 HG23 HD11 ' A' ' 146' ' ' LEU . 86.5 t -125.96 140.75 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.552 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.62 ' HB2' HD21 ' A' ' 181' ' ' LEU . 53.6 tp -121.0 103.12 8.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.0 110.687 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.95 119.03 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.907 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.7 p -110.34 -175.94 2.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.187 0.518 . . . . 0.0 111.222 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.65 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 9.5 pt-20 -60.12 -27.61 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.658 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 24.9 mtmm -118.45 -56.77 2.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -119.05 174.51 6.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 111.334 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.91 99.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 25.0 ttm-85 -79.05 124.2 28.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.984 -174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 180' ' ' ARG . 4.6 mtp180 -92.22 97.52 10.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.569 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 172' ' ' LEU . 2.9 mm? -64.41 -55.17 22.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.36 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.0 mmm-85 -117.08 30.96 7.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.684 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 180' ' ' ARG . 15.1 t70 67.04 -81.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.751 0.657 . . . . 0.0 110.324 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.22 16.79 69.41 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.697 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -130.64 -2.99 4.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.144 0.472 . . . . 0.0 111.289 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 43.4 m -74.78 129.02 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.9 -157.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.773 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.41 -178.98 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.89 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -110.87 -17.62 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.858 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -74.22 110.56 8.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.53 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -72.71 127.34 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.07 -174.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -121.88 -130.79 0.28 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -61.65 -32.68 72.85 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.046 169.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.987 0.422 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -52.44 -50.38 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.681 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -70.93 -40.08 72.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.8 -37.43 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.115 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.499 HD23 HD22 ' A' ' 129' ' ' LEU . 38.0 tp -67.01 -37.23 83.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.72 -44.96 95.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.245 0.545 . . . . 0.0 109.843 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.38 -50.92 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.121 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -34.8 77.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.57 0.224 . . . . 0.0 111.576 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.12 -40.4 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.366 . . . . 0.0 110.189 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HD3' ' A' ' 14' ' ' ARG . 31.0 tp -62.21 -34.78 77.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -59.65 -43.92 93.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -81.97 -28.78 32.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.096 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.703 ' HD3' HD12 ' A' ' 11' ' ' LEU . 32.1 ttt85 -56.69 -43.96 81.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.293 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 pt -88.41 0.89 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.408 . . . . 0.0 111.115 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -89.57 -20.78 23.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.28 137.56 47.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.44 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.7 t -90.65 145.35 24.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.483 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 40.7 mm-40 -59.8 -25.14 64.71 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.284 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -53.25 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.379 0.609 . . . . 0.0 110.379 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.86 -40.62 65.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 66.9 ttt180 -56.34 -50.67 70.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.686 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -64.15 -33.73 76.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -70.97 -38.83 72.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.3 -37.5 71.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.437 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 55' ' ' VAL . 70.7 m -59.32 -39.98 84.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.704 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.72 -44.19 85.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -62.35 -43.8 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -44.95 99.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.479 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 56' ' ' ASP . 67.1 mt -56.93 -53.87 37.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.0 m -59.28 -44.55 92.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.993 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.432 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 2.7 t-20 -61.1 -52.51 64.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 20.0 tp -60.75 -38.35 84.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.078 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -79.4 -21.19 45.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.315 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -85.83 -18.93 31.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.208 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 32' ' ' ASN . 92.5 mt -55.94 119.61 27.53 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.728 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 39.3 Cg_exo -61.21 -22.76 75.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.015 2.476 . . . . 0.0 112.764 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.95 -23.88 48.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.606 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.53 -23.04 59.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -71.43 -29.12 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.41 -37.35 11.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.272 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m -58.19 122.54 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -90.94 -41.9 10.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.553 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' VAL . 18.7 mmtp -95.23 109.02 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.17 101.45 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -100.64 136.27 40.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.49 151.06 39.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.84 -90.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 35.6 t 176.05 127.23 0.15 Allowed Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.254 0.346 . . . . 0.0 110.344 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.39 112.29 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.169 2.579 . . . . 0.0 110.932 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.6 HG13 ' HG2' ' A' ' 52' ' ' LYS . 10.7 pt -127.98 -47.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HG2' HG13 ' A' ' 51' ' ' ILE . 74.4 mmtt -96.7 -69.24 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -171.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 14' ' ' ARG . . . -149.58 46.79 0.64 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.303 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HG3' HH21 ' A' ' 14' ' ' ARG . 3.9 mp0 -97.87 -156.18 0.53 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 26' ' ' SER . 91.6 t -101.41 138.35 25.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.608 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HD11 ' A' ' 30' ' ' ILE . 27.1 m-20 -72.35 75.18 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.16 0.505 . . . . 0.0 111.08 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 150' ' ' VAL . 93.2 mt -90.72 -5.02 56.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.768 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -47.54 98.85 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.452 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 17.2 Cg_exo -68.3 -7.66 20.72 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.252 1.968 . . . . 0.0 113.205 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 40.9 tp -87.17 -7.08 58.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.794 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.538 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 13.0 m-30 -53.31 -50.65 81.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.943 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.8 Cg_exo -52.17 -42.05 61.74 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.239 1.96 . . . . 0.0 112.977 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -65.41 -43.82 89.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.647 0.261 . . . . 0.0 110.848 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' LEU . 56.0 t -64.66 -48.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.635 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.36 -33.87 66.09 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.435 0.459 . . . . 0.0 111.382 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -64.32 -45.87 86.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.705 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -101.81 -60.55 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -108.55 -171.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.021 0.439 . . . . 0.0 111.272 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HG2' ' HD2' ' A' ' 84' ' ' ARG . 1.8 mp0 -96.35 116.8 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.253 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.79 116.06 18.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.654 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 58.0 mt -111.12 126.02 68.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.896 0.379 . . . . 0.0 110.623 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.3 mt -120.69 150.08 51.78 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 58.8 Cg_endo -73.27 125.7 10.46 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.577 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 8.9 tmtm? -116.63 124.37 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.72 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 80' ' ' ILE . 41.6 t -90.7 105.98 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.13 -24.97 18.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.753 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.44 80.63 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.83 -56.96 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 0.0 111.118 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.96 141.48 34.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 75' ' ' VAL . 67.5 mt -105.08 127.87 59.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -102.89 163.28 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.654 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 66.3 mt -115.8 124.54 50.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.04 0.448 . . . . 0.0 110.855 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -108.36 134.69 50.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.238 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.618 ' HD2' ' HG2' ' A' ' 69' ' ' GLU . 13.7 ptt180 -93.8 140.66 29.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.07 140.99 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.485 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.61 2.71 15.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.796 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 25.4 p -149.86 151.9 33.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.739 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.7 Cg_exo -76.6 44.37 1.39 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.997 2.465 . . . . 0.0 111.742 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 -74.31 0.42 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.848 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.4 t -95.2 92.81 6.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.116 0.484 . . . . 0.0 111.496 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt -138.21 98.82 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.388 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.28 152.65 17.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.218 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.54 107.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.458 . . . . 0.0 110.341 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.78 -40.88 1.39 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 98' ' ' ILE . . . -87.67 -152.48 0.2 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -78.37 58.35 2.11 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.453 0.644 . . . . 0.0 111.405 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.2 -13.67 60.08 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.979 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.407 ' CG1' ' HB3' ' A' ' 95' ' ' ALA . 41.0 pt -90.08 148.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.75 0.31 . . . . 0.0 110.89 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 ptp -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 16.8 pt-20 -138.01 147.52 56.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.79 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 3.7 Cg_exo -81.1 106.66 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.492 2.128 . . . . 0.0 111.418 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.63 -21.16 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.26 127.15 43.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.856 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.59 -143.4 8.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.12 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -106.85 116.79 32.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.966 0.413 . . . . 0.0 110.377 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -79.11 116.52 19.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.333 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 142.04 25.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.855 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.8 p30 -80.2 137.73 52.72 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 82' ' ' LEU . 34.6 Cg_exo -58.88 -24.33 71.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.97 2.447 . . . . 0.0 113.847 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.99 -9.75 59.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.82 -10.86 54.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.349 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 66.7 t -77.21 121.98 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.343 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.485 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 11.5 m-20 -74.7 -52.98 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.468 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 34.6 t80 -124.31 123.99 41.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.253 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 15.2 tt -130.38 139.83 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 110.741 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.61 109.48 20.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.259 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.525 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 11.6 m -119.74 120.05 30.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.289 0.566 . . . . 0.0 111.135 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 1.4 Cg_endo -84.1 163.96 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.025 2.483 . . . . 0.0 111.95 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.41 154.15 25.47 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.6 t -55.97 -47.28 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.982 0.391 . . . . 0.0 110.894 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.5 147.84 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -129.78 167.19 18.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.979 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 1.3 p-10 -127.23 -169.62 2.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.706 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.1 mt -92.3 4.03 54.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 42.7 mt-10 -110.05 -25.82 10.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.649 0.261 . . . . 0.0 110.781 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.518 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 117.86 26.07 2.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 174.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -102.23 158.07 16.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.782 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' OD2' ' A' ' 166' ' ' ASP . 33.0 mtm180 -124.35 -176.97 3.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.499 HD22 HD23 ' A' ' 6' ' ' LEU . 20.6 tp . . . . . 0 C--N 1.319 -0.725 0 CA-C-O 121.28 0.562 . . . . 0.0 109.726 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' LEU . 6.5 p-10 -67.92 -23.85 65.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.008 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.99 -35.99 74.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.902 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.22 -36.76 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 137' ' ' ASP . 79.8 mt -67.66 -26.36 66.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.108 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 34.3 mmtp -76.72 -21.66 54.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 109' ' ' PRO . 27.5 mmt180 -77.52 -53.11 8.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.172 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.84 103.21 4.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.84 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -113.99 24.4 12.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.25 -139.75 5.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.808 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.93 101.36 13.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HE2' HD11 ' A' ' 167' ' ' ILE . 18.9 mttp -88.54 106.67 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 171' ' ' VAL . 67.7 t -101.0 116.98 45.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.801 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -78.94 121.57 5.6 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 57' ' ' LEU . 61.9 t -113.65 115.86 50.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.552 0.215 . . . . 0.0 110.463 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.95 -179.81 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.084 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 156' ' ' VAL . 95.1 m-85 -97.56 156.1 16.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.86 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.3 p -61.23 -25.9 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.589 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.545 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 70.7 m-85 -61.78 -36.4 80.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.545 ' OE1' ' HB2' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -90.62 8.31 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' TYR . 61.5 t -109.66 133.79 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.892 0.377 . . . . 0.0 110.424 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.93 -169.52 1.85 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 48.2 mt-10 -84.74 -50.15 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.281 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.1 ptm180 -141.11 146.65 37.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 176.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 92.5 mt -116.6 149.16 43.35 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.995 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.35 104.57 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.274 1.983 . . . . 0.0 111.007 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -73.55 111.41 8.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.0 110.768 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.71 -78.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.6 -96.26 0.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.781 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -128.54 61.66 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.358 0.599 . . . . 0.0 111.25 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 128' ' ' ARG . 38.7 t70 -74.36 141.82 45.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 ' HE2' ' A' ' 147' ' ' LYS . 14.1 tt -79.11 120.26 80.08 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.941 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.5 Cg_exo -74.15 148.65 39.76 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.023 2.482 . . . . 0.0 111.807 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.94 169.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.011 0.434 . . . . 0.0 111.607 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -93.3 -40.08 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.297 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 148' ' ' VAL . 17.0 t -133.07 155.12 40.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 55.5 tp -135.43 118.31 16.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.97 126.45 73.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 0.0 110.799 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 71.7 p -114.56 -172.49 2.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.266 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 176' ' ' LYS . 2.5 pm0 -85.73 -15.05 43.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.031 0.443 . . . . 0.0 110.125 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 175' ' ' GLU . 29.4 mtpp -112.31 -47.82 3.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.197 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -131.43 163.1 28.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 112.102 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.53 122.56 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.73 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 3.0 mmp_? -108.93 131.73 54.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.993 0.425 . . . . 0.0 110.186 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -121.74 128.39 51.72 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.518 HD13 ' HA3' ' A' ' 126' ' ' GLY . 23.4 mt . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 121.672 0.748 . . . . 0.0 110.247 -172.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -53.21 -57.83 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -60.66 -39.18 87.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.54 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.71 -52.34 21.61 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.091 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -61.88 -35.23 77.72 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.321 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -56.11 -59.42 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.451 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -74.25 -37.54 63.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.764 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.54 -39.79 92.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.494 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.1 t -86.19 -41.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.7 tp -60.34 -37.59 81.14 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.173 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 75.9 t60 -59.69 -31.04 69.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.741 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -82.71 -42.74 17.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.916 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.569 ' NH2' ' HA ' ' A' ' 151' ' ' ALA . 52.2 ttt180 -61.19 -38.75 87.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 0.0 111.103 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.1 pt -88.18 -4.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.368 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 66.1 t30 -98.4 -13.69 20.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.888 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.78 143.83 15.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -61.98 144.59 54.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -59.27 -49.33 78.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.548 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.81 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.786 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.09 -44.61 91.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.409 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -59.13 -42.57 90.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -25.5 66.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.688 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -83.86 -18.48 37.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.903 0.382 . . . . 0.0 110.785 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.7 mt -86.56 -53.52 4.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.094 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 m -57.17 -34.49 68.52 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.09 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -48.27 -50.44 29.83 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.086 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -80.59 -26.59 37.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.323 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 25' ' ' LEU . 58.0 t -65.07 -49.51 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.82 -46.42 96.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.619 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -62.09 -40.94 97.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 178' ' ' VAL . 21.8 t-20 -66.51 -51.14 59.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.008 0.433 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.802 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 36.9 tp -57.64 -38.61 75.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.4 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -72.85 -33.38 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.917 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -75.35 -16.87 60.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.346 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 33' ' ' LEU . 79.7 mt -56.46 126.3 69.03 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.852 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -32.74 96.04 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.571 2.181 . . . . 0.0 111.593 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.27 -35.08 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -62.22 -30.31 71.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.078 0.466 . . . . 0.0 110.433 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -64.52 -40.08 94.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.73 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -80.79 -33.2 35.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.159 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.494 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 46.4 m -55.53 105.81 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.046 0.45 . . . . 0.0 111.1 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 84.4 tttt -98.47 -30.67 12.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.653 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -102.91 98.21 8.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.383 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.16 109.01 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 111.066 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.29 139.64 34.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.551 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.27 145.96 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.888 0.375 . . . . 0.0 110.831 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.29 -4.11 59.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.911 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 70.9 m 65.17 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 123.727 0.642 . . . . 0.0 111.465 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 95.92 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.502 2.135 . . . . 0.0 112.743 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 35.7 pt -90.65 161.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 67.4 mttm 70.91 -55.25 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.725 0.64 . . . . 0.0 110.805 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.22 -83.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 4.4 mm-40 45.53 39.55 4.87 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.801 0.84 . . . . 0.0 112.862 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 53.3 t 68.26 101.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.084 -174.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.07 92.71 1.34 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.826 0.822 . . . . 0.0 111.183 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 150' ' ' VAL . 93.8 mt -88.49 15.19 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.792 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 8.8 p -62.35 -38.47 46.93 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 30.5 Cg_exo -64.38 -11.48 28.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.925 1.75 . . . . 0.0 112.717 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 64' ' ' VAL . 36.9 tp -89.24 -16.2 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.59 0.233 . . . . 0.0 110.741 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 23.9 m-85 -56.51 -50.65 86.54 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 50.4 Cg_exo -55.74 -35.19 92.97 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.13 1.887 . . . . 0.0 112.509 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.46 -43.73 76.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.485 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 60' ' ' LEU . 59.2 t -64.49 -44.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.26 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.51 -18.83 65.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.704 0.288 . . . . 0.0 111.549 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -75.99 -36.52 59.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.393 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -124.11 -46.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 31.1 mmtp -101.93 -175.04 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.017 0.437 . . . . 0.0 111.52 -168.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 38.6 mm-40 -98.3 120.0 37.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.595 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.05 102.44 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.2 mt -91.52 116.89 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.085 0.469 . . . . 0.0 110.494 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.8 mt -117.11 137.09 23.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.205 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.6 119.4 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -105.74 117.45 34.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.08 95.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -96.72 71.29 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 109.71 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.37 -111.18 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.429 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.55 -22.97 14.8 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -77.43 89.05 3.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.719 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.84 119.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -111.85 132.29 54.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.452 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -81.85 103.93 11.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.054 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 3.7 m-85 -95.97 120.19 35.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.197 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 24.2 ptt85 -83.42 131.3 35.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.68 133.19 68.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.998 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.23 12.83 7.69 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.5 m -112.05 109.68 54.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.536 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.2 Cg_exo -74.42 31.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.463 2.775 . . . . 0.0 112.915 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 -28.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 58.2 m -84.75 38.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -172.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.22 152.22 21.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -132.89 176.31 19.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.99 98.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.114 0.457 . . . . 0.0 110.031 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.19 -32.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.058 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -76.18 94.84 3.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.855 0.327 . . . . 0.0 111.072 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 80.1 t80 72.49 -52.13 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.199 0.599 . . . . 0.0 111.809 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.32 33.92 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 95' ' ' ALA . 41.5 pt -122.86 172.72 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 66.1 mtt -94.24 86.94 5.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 2.3 pm0 -87.93 148.36 43.17 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.983 0.421 . . . . 0.0 110.263 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 8.1 Cg_exo -72.17 106.09 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' A' ' 103' ' ' GLU . 31.2 m -76.72 -25.01 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.499 0.666 . . . . 0.0 109.421 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.984 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 59.7 mm-40 -122.28 129.11 51.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.938 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.11 -159.2 28.37 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 34.3 tt0 -138.71 131.16 28.76 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 106' ' ' ARG . 20.7 ttt180 -79.74 113.62 18.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.0 110.514 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.44 154.23 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.138 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -81.99 142.11 47.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.294 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' VAL . 24.2 Cg_endo -61.22 -23.21 76.67 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.299 2.666 . . . . 0.0 113.69 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.82 -19.67 63.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.88 0.371 . . . . 0.0 110.975 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.51 -12.56 53.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.391 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.98 114.22 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 110.847 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 42' ' ' SER . 38.8 t70 -90.47 -51.61 5.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.258 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.802 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 38.3 t80 -130.43 139.39 50.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.471 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 147' ' ' LYS . 15.6 tt -146.29 139.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 110.74 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.64 20.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.463 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 59.4 t -122.33 110.89 32.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.01 165.9 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.922 2.415 . . . . 0.0 112.081 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.78 163.89 30.57 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.01 -38.46 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.571 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.63 159.06 44.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.173 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.28 165.84 25.7 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.524 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 16.1 p30 -126.46 -172.09 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 96.0 mt -88.69 -2.2 58.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.029 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -105.79 -28.7 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.809 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.17 30.64 0.85 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.869 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -108.99 151.83 25.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.318 0.559 . . . . 0.0 110.414 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -122.89 149.6 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.067 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.197 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.442 0.639 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.38 -41.91 99.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.13 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.82 -25.6 65.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.851 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.07 -56.57 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.192 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.2 -12.85 61.69 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.769 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -76.47 -32.52 58.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -94.43 -40.81 9.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.083 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 109' ' ' PRO . 49.7 t -71.82 91.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.268 0.556 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 144' ' ' LYS . 5.6 tmtm? -103.89 68.21 0.91 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.554 0.692 . . . . 0.0 109.837 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.69 -150.29 19.01 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 113' ' ' ASP . 11.0 mp -83.29 89.03 6.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.979 0.889 . . . . 0.0 109.227 171.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HA ' HG23 ' A' ' 115' ' ' ILE . 54.4 mtmt -81.98 102.47 10.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.8 t -98.82 114.72 37.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.622 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -79.03 119.95 5.17 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.539 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 57' ' ' LEU . 47.5 t -98.05 110.73 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.371 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.569 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . . . -154.05 176.5 12.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.248 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.454 ' CZ ' HG22 ' A' ' 55' ' ' VAL . 71.6 m-85 -96.69 151.96 19.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.0 t -62.28 -17.78 59.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.45 0.166 . . . . 0.0 111.071 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -62.73 -33.44 75.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.263 0.554 . . . . 0.0 110.389 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.52 -3.8 58.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.429 -174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 172' ' ' LEU . 38.8 t -91.19 110.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.405 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 35.4 m-85 -105.62 -179.17 3.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.523 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.31 -58.6 4.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.079 0.466 . . . . 0.0 110.039 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -144.77 138.54 27.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.848 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 90.5 mt -93.45 152.65 41.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.87 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 101.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.074 1.849 . . . . 0.0 109.653 167.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -73.63 150.09 41.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.263 0.554 . . . . 0.0 111.114 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -103.85 -172.91 2.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.087 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.58 35.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -96.82 64.19 2.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -74.98 108.36 7.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.863 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.2 103.98 55.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.867 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.49 159.75 10.93 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.839 2.359 . . . . 0.0 112.416 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.35 173.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.02 -52.52 3.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.038 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.2 130.97 68.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.24 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 57.0 tp -104.97 108.63 20.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.033 0.444 . . . . 0.0 110.218 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.01 130.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 175' ' ' GLU . 40.2 p -126.55 -173.89 2.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.275 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -79.34 -9.0 59.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.097 0.475 . . . . 0.0 110.862 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -120.31 -62.01 1.52 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -110.01 151.75 26.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.316 0.579 . . . . 0.0 112.548 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.463 HG22 ' OD1' ' A' ' 32' ' ' ASN . 16.6 t -103.81 99.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.102 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 79.2 mtt85 -94.5 85.23 4.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.292 0.568 . . . . 0.0 110.782 -176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -76.27 99.42 4.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.511 -170.087 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 121.169 0.509 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.644 ' HD2' ' HG ' ' A' ' 129' ' ' LEU . 65.3 pttt -72.72 -11.09 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -60.7 -47.57 85.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.546 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -34.18 71.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.814 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.25 -44.11 80.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.166 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' O ' HG11 ' A' ' 120' ' ' VAL . 4.9 tmt_? -58.39 -43.97 88.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.18 -41.37 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.52 -44.09 89.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 37.2 t -71.78 -46.12 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.322 . . . . 0.0 110.348 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.24 -39.61 83.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.782 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -53.16 -39.38 63.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.072 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -90.75 -1.24 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.653 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 62.6 mtp180 -97.34 -48.74 5.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.127 0.489 . . . . 0.0 111.435 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.59 -21.99 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.687 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -76.82 -16.1 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.35 153.62 26.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.628 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -63.1 144.89 56.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.79 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.66 -48.88 78.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 110.011 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 2.5 mp0 -54.33 -49.14 70.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.963 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.76 -53.04 62.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.631 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 22' ' ' ARG . 33.1 ttp180 -64.49 -38.87 92.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -69.67 -36.13 75.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.863 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -65.98 -30.16 70.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 109.88 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.94 -46.08 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.145 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 t -57.45 -35.31 69.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.289 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.64 -51.32 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.405 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -74.28 -28.11 61.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.974 -174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.17 -47.94 80.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.1 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.454 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 m -62.19 -40.42 95.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.32 -46.05 74.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.403 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 36' ' ' LEU . 46.6 tp -61.49 -41.89 97.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.569 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -64.58 -33.16 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -70.15 -26.17 63.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.739 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 33' ' ' LEU . 92.6 mt -61.91 120.12 54.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.169 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.44 -33.58 78.91 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.241 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -22.08 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 68' ' ' LYS . 50.4 t80 -68.84 -29.94 68.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.83 -31.08 15.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.18 -49.87 74.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 113' ' ' ASP . 70.1 m -86.82 122.1 30.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.37 -21.54 18.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -173.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.58 97.8 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.157 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.98 118.04 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.307 0.575 . . . . 0.0 110.858 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -98.75 137.12 37.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.46 139.28 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.72 0.295 . . . . 0.0 110.262 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -85.57 -6.12 59.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.8 t 67.11 102.08 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.306 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.1 124.41 9.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.429 2.086 . . . . 0.0 112.243 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.4 pp -111.57 152.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.296 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 63.08 20.19 12.13 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.098 0.475 . . . . 0.0 110.982 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.17 -88.19 0.63 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.83 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 70.8 mm-40 64.08 -85.01 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 122.925 0.49 . . . . 0.0 109.769 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 150' ' ' VAL . 88.1 t -148.95 116.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.51 101.41 2.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.78 9.54 24.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.501 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 68.5 p -65.21 -38.81 30.57 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 58' ' ' THR . 68.6 Cg_endo -74.14 4.56 4.19 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.62 1.547 . . . . 0.0 112.543 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.9 tp -99.33 -17.28 18.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.594 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 30.9 m-85 -52.07 -46.25 93.26 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 87.4 Cg_exo -49.86 -45.39 32.47 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.083 1.856 . . . . 0.0 112.589 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.92 -32.96 65.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.692 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 60' ' ' LEU . 76.9 t -61.61 -45.2 99.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.93 -12.71 61.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.427 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 62' ' ' PRO . 31.4 mmmt -92.46 -58.45 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.087 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.24 -38.99 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.372 0.606 . . . . 0.0 110.684 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.614 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 22.6 mttp -125.63 -171.6 2.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.769 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 86' ' ' HIS . 42.8 tt0 -120.17 135.08 55.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.168 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 64' ' ' VAL . 62.3 tp -92.47 132.48 36.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 111.391 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -119.83 127.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 97.4 mt -126.29 144.14 48.24 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.48 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.47 146.45 12.21 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.962 2.442 . . . . 0.0 112.593 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -135.0 135.1 41.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.93 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -99.23 124.51 52.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -119.13 44.21 2.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.03 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.64 -93.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.861 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -109.7 -27.47 9.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -92.75 134.75 34.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 tt -116.82 127.82 74.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.114 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -124.55 178.89 5.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.47 138.77 50.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 27.0 m-85 -121.5 146.68 46.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 0.0 111.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.825 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 21.6 ttm180 -91.2 118.43 30.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.962 -172.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 91' ' ' LEU . 46.4 t -119.04 111.67 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.419 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.1 p-80 -139.06 30.31 2.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.514 0.674 . . . . 0.0 109.222 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.8 p -154.27 143.91 15.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.819 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.6 Cg_exo -73.18 171.77 16.93 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.934 2.422 . . . . 0.0 112.386 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.8 18.83 11.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.793 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 53.4 m -113.93 3.34 15.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 85' ' ' VAL . 91.7 mt -108.3 126.05 52.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.211 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.92 -163.56 9.79 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.8 t -123.04 119.4 57.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.926 0.363 . . . . 0.0 110.09 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.37 -98.61 1.36 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 132.81 46.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.6 t80 72.12 -53.47 0.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.904 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.33 34.26 0.37 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.006 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.9 pt -108.35 172.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 91' ' ' LEU . 48.6 tpp -70.72 102.76 2.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 29.4 tt0 -114.31 134.59 22.23 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -172.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 11.3 Cg_exo -70.27 119.65 6.52 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.357 2.038 . . . . 0.0 109.812 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 103' ' ' GLU . 13.6 t -54.04 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.678 0.611 . . . . 0.0 111.031 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 102' ' ' VAL . 54.4 mm-40 -136.64 145.69 45.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.7 -148.61 13.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.622 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.825 ' HG3' ' HB3' ' A' ' 84' ' ' ARG . 6.3 pt-20 -91.2 151.24 21.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 111.433 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -100.41 162.33 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.751 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 50.5 t -125.57 136.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.073 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -82.77 139.04 43.4 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 143' ' ' VAL . 52.2 Cg_exo -56.42 -23.82 49.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.642 2.228 . . . . 0.0 111.265 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.11 -32.59 71.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.158 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.86 -11.51 36.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.893 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -77.46 126.39 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' SER . 15.0 m-20 -96.0 -51.94 4.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.522 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -123.23 148.35 45.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.895 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.56 138.9 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.012 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.46 112.3 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.09 126.42 28.04 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.503 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.2 -168.05 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.735 2.29 . . . . 0.0 111.768 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.7 150.51 6.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.935 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 7' ' ' ARG . 98.9 t -74.22 -38.69 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 0.0 110.943 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.53 166.08 25.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -140.7 148.7 41.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 111.389 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 159' ' ' ARG . 11.5 t70 -101.97 156.85 17.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.871 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 49.4 mt -71.9 -26.76 62.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 111.226 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -85.81 -7.17 58.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.104 0.478 . . . . 0.0 110.029 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 111.27 -0.88 28.14 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.98 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.501 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 95.1 m-85 -64.47 156.89 28.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.31 0.555 . . . . 0.0 110.689 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 37.0 mtm180 -103.99 -71.98 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 160' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.472 0.632 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.019 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.655 0.74 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.75 -24.54 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.07 -25.42 67.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.176 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 45.1 tp -83.84 -39.93 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.513 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.71 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.538 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.519 ' HG2' ' HB ' ' A' ' 167' ' ' ILE . 22.2 mtmm -86.37 -0.07 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.171 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -100.45 -36.32 9.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.93 0.395 . . . . 0.0 110.477 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.1 t -84.91 91.14 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 110.052 177.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.51 62.28 3.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.748 0.785 . . . . 0.0 110.193 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.81 -152.95 23.17 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 146' ' ' LEU . 3.8 mm? -83.68 94.39 8.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.427 0.614 . . . . 0.0 109.827 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' HE2' ' CD1' ' A' ' 167' ' ' ILE . 9.5 mtmp? -77.49 104.91 8.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 76.3 t -95.12 113.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.484 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -84.75 117.19 4.44 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.441 HG12 HG21 ' A' ' 55' ' ' VAL . 22.6 t -105.8 109.15 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -159.01 -177.83 6.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.109 0.48 . . . . 0.0 111.362 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -100.06 166.92 10.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.176 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.5 m -77.02 -22.09 53.59 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -78.79 2.78 18.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.795 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -101.43 -10.78 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.041 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 t -91.63 115.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.51 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 96.3 m-85 -112.08 178.96 4.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 124' ' ' LEU . 30.0 mt-10 -64.13 -76.72 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 110.837 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.669 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 43.2 mtm180 -141.18 132.91 27.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.774 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 129' ' ' LEU . 52.4 mt -103.5 153.44 38.56 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.577 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.8 101.62 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.131 1.887 . . . . 0.0 111.57 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.845 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -90.57 147.33 23.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.564 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.7 -67.1 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.514 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.69 -85.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.612 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 14.9 m-90 -103.72 66.87 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.894 0.378 . . . . 0.0 111.21 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.05 110.17 18.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 141' ' ' LYS . 19.4 tt -74.06 122.89 88.63 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.472 0.653 . . . . 0.0 111.661 -171.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 21.5 Cg_exo -67.2 154.66 73.56 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.154 2.569 . . . . 0.0 112.851 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -82.75 171.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.975 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -108.82 -46.59 3.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.586 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 46.5 t -123.06 113.51 38.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.686 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.866 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 62.3 tp -100.01 102.65 14.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 110.283 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 33' ' ' LEU . 95.1 t -89.91 112.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.217 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.0 p -105.06 -175.93 2.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 12.4 pt-20 -72.69 -15.6 61.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.385 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.531 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 66.1 mttt -119.31 -48.71 2.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.48 168.82 18.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.625 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 36' ' ' LEU . 23.3 t -91.81 105.03 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 11.7 mmt180 -80.25 86.21 5.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -78.34 103.49 8.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 121.366 0.603 . . . . 0.0 111.164 -173.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.669 0.271 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -61.51 -33.66 74.19 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.61 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -80.45 -31.36 37.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 111.184 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.76 -29.66 32.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.86 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HE2' ' A' ' 9' ' ' LYS . 54.5 tp -58.3 -42.26 86.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 109.563 173.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HB2' HD23 ' A' ' 129' ' ' LEU . 39.6 ttp180 -58.33 -34.96 71.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.624 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -64.68 -49.18 71.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 6' ' ' LEU . 55.6 pttt -72.2 -31.95 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.543 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG11 ' HB2' ' A' ' 121' ' ' ALA . 86.6 t -69.54 -35.19 65.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 15' ' ' ILE . 54.1 tp -64.97 -51.17 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.802 174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 11.6 t-160 -59.47 -32.58 70.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -77.74 -40.0 42.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 15.8 ttm180 -66.1 -38.07 87.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.673 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.616 HG22 ' HA3' ' A' ' 53' ' ' GLY . 36.9 pt -91.41 7.87 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.784 0.325 . . . . 0.0 111.217 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 9.2 t30 -85.47 -18.43 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 109.612 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.434 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.99 144.7 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 48.6 mt-10 -71.42 -38.55 71.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.04 -39.47 93.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.0 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 24' ' ' ARG . 10.7 tp10 -62.47 -40.77 97.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.717 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -60.68 -41.62 95.49 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 17.1 mmt180 -56.7 -41.64 77.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.433 0.635 . . . . 0.0 110.184 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 21' ' ' GLU . 39.2 ttp180 -71.51 -43.34 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.253 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.73 -38.18 83.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.906 0.384 . . . . 0.0 110.756 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 55' ' ' VAL . 68.6 m -58.38 -42.14 86.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.598 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.34 -37.83 73.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mtpt -60.97 -52.59 64.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 110.348 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG11 HG13 ' A' ' 150' ' ' VAL . 48.9 t -61.35 -43.88 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.836 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 81.7 mt -61.11 -45.72 98.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -64.68 -33.46 76.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.61 0.243 . . . . 0.0 110.942 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -66.41 -55.17 17.05 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.291 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.48 -31.53 71.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.069 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 23.3 tttp -68.26 -35.26 77.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.0 p -83.69 -14.56 51.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.275 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.3 tt -58.51 123.34 66.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.847 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -55.63 -44.7 45.56 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.429 2.753 . . . . 0.0 113.452 -172.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 7.6 mp0 -60.95 -25.25 66.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.855 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.74 -36.4 73.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -82.22 -0.54 45.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -106.16 -52.45 2.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -70.08 158.72 35.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.867 -172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -113.31 -34.09 5.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.202 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.03 98.45 11.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.404 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 106.52 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.22 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -97.62 136.76 37.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.49 152.77 42.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.538 ' HB2' HG12 ' A' ' 117' ' ' VAL . 7.1 t80 -80.47 -98.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.189 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 48' ' ' TYR . 49.1 t 177.89 116.46 0.18 Allowed Pre-proline 0 N--CA 1.462 0.154 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 6.6 Cg_endo -88.46 103.12 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.177 2.585 . . . . 0.0 112.058 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.09 140.99 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.361 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 71.85 -51.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.267 0.627 . . . . 0.0 111.483 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 15' ' ' ILE . . . -139.64 -158.68 7.71 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.64 ' OE1' ' HD3' ' A' ' 14' ' ' ARG . 4.2 mm-40 77.34 150.75 0.12 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.974 0.892 . . . . 0.0 112.101 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 26' ' ' SER . 57.1 t -36.85 126.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 112.631 -2.077 . . . . 0.0 112.24 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD11 ' A' ' 30' ' ' ILE . 3.5 m-20 -68.08 76.96 0.23 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.59 -10.3 54.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.838 0.351 . . . . 0.0 110.708 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.473 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -53.87 -49.89 86.91 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 58' ' ' THR . 36.7 Cg_endo -66.0 -8.02 18.72 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.087 1.858 . . . . 0.0 113.526 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.34 -14.09 29.25 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.137 -0.352 . . . . 0.0 110.803 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.524 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.3 m-85 -53.75 -52.35 68.28 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.985 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 53.8 Cg_exo -54.34 -37.11 88.74 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.321 2.014 . . . . 0.0 113.183 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.05 -52.35 36.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.623 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.69 -34.59 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.275 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 88' ' ' PRO . 38.1 tp -66.24 -26.23 67.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.297 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.69 -48.99 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.532 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.39 -45.58 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 111.815 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -123.29 -171.68 2.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.626 -163.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.61 100.93 11.4 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.4 tp -80.52 120.56 24.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.593 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.8 mt -102.42 119.81 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.848 0.356 . . . . 0.0 110.371 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.39 142.59 28.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.536 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.24 121.61 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.203 2.602 . . . . 0.0 113.279 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.808 ' HD2' ' HE2' ' A' ' 83' ' ' TYR . 55.9 tttm -105.97 133.97 49.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 102.4 8.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -86.69 -19.49 29.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.952 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 156.91 80.47 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 7.0 t30 70.44 -50.8 0.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.216 0.607 . . . . 0.0 111.103 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.38 156.53 25.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -104.63 131.94 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.055 0.455 . . . . 0.0 111.513 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -111.0 115.65 29.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 80.6 mt -82.52 141.15 32.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.266 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.808 ' HE2' ' HD2' ' A' ' 74' ' ' LYS . 18.9 m-85 -112.59 141.62 46.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.187 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . 27.0 ttt180 -88.15 91.72 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.118 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.17 114.51 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.368 0.604 . . . . 0.0 111.936 -171.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -140.62 14.44 2.34 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 23.3 t -99.99 104.79 31.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.333 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' HD21 ' A' ' 65' ' ' LEU . 24.4 Cg_exo -63.64 -29.58 69.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.154 2.569 . . . . 0.0 113.524 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.55 -16.12 40.46 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.521 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 47.0 t -89.89 76.01 7.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.357 0.599 . . . . 0.0 110.485 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.9 mt -135.82 117.54 15.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.899 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.59 178.6 25.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.713 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.96 134.46 66.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.87 -74.58 0.93 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.842 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.42 153.74 40.01 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.896 -0.179 . . . . 0.0 111.3 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.4 t80 73.7 -47.55 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.656 0.782 . . . . 0.0 111.995 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.96 11.8 1.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.309 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -93.17 166.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.4 mtp -92.23 120.79 33.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.037 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.7 120.89 28.47 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.971 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.01 124.92 14.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.856 2.37 . . . . 0.0 111.575 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.25 -53.22 42.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.15 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.11 136.93 52.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.461 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.05 175.26 40.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.14 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 84' ' ' ARG . 1.1 pm0 -93.72 141.55 28.37 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 4.1 ptp85 -93.12 139.57 30.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.318 0.58 . . . . 0.0 111.229 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.65 143.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.629 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 31.4 p-10 -92.98 152.92 41.83 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 112' ' ' VAL . 77.3 Cg_exo -52.12 -27.0 27.81 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.224 2.616 . . . . 0.0 113.307 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 43.5 tt0 -60.17 -38.21 82.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.734 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.31 -13.35 57.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 109' ' ' PRO . 88.3 t -60.23 110.84 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.261 0.553 . . . . 0.0 110.773 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -80.0 -53.07 7.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.52 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.66 136.6 48.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.526 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.53 139.12 45.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.36 119.97 24.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 48' ' ' TYR . 35.7 m -125.46 139.56 34.23 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.849 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.618 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 95.3 Cg_endo -80.84 -174.94 2.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 111.506 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.78 -164.32 23.24 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.359 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.95 -50.0 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.574 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -139.72 140.09 36.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' HB3' ' A' ' 128' ' ' ARG . 49.3 m-85 -134.67 168.79 18.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 24.2 p30 -135.27 -170.07 2.51 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.481 HD23 ' NH1' ' A' ' 179' ' ' ARG . 90.0 mt -82.23 -20.69 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.978 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.428 ' CD ' HH12 ' A' ' 162' ' ' ARG . 41.5 mt-10 -92.12 -12.12 33.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.692 0.282 . . . . 0.0 111.353 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.38 12.66 22.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.369 171.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.445 ' HE2' ' H ' ' A' ' 166' ' ' ASP . 48.9 m-85 -88.29 146.8 25.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.052 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.639 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -131.63 132.59 44.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 160' ' ' LEU . 11.1 mp . . . . . 0 C--N 1.318 -0.788 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.346 0.594 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -56.34 -42.89 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.776 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -11.6 59.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.269 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 143' ' ' VAL . 61.8 tp -93.19 -73.17 0.57 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.33 -29.14 69.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -83.52 -14.62 51.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 111.292 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -102.06 -15.54 16.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.111 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.0 t -71.26 123.42 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.44 1.07 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 110.051 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.67 -155.76 10.55 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.754 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.72 120.79 28.4 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.662 -0.316 . . . . 0.0 111.022 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.644 ' HG2' ' OD2' ' A' ' 170' ' ' ASP . 20.3 mmtm -87.04 106.51 17.9 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.44 114.63 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.909 0.385 . . . . 0.0 110.34 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.53 125.35 8.51 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.436 HG13 HG11 ' A' ' 29' ' ' VAL . 39.4 t -102.49 123.43 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.59 155.95 27.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 111.804 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 156' ' ' VAL . 69.0 m-85 -91.27 141.98 28.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.181 174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.3 m -57.3 -26.03 60.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.877 0.736 . . . . 0.0 111.829 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -59.28 -38.7 80.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.434 ' HB2' HH21 ' A' ' 14' ' ' ARG . 10.4 mm100 -108.28 24.03 13.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.601 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 152' ' ' TYR . 50.2 t -116.75 105.92 19.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.322 0.582 . . . . 0.0 109.454 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 82.2 m-85 -92.65 -178.41 4.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.761 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.95 -61.82 2.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 3.1 ptm180 -153.08 135.62 15.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 129' ' ' LEU . 95.9 mt -98.57 155.26 36.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.748 -174.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.9 117.71 4.56 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.819 2.346 . . . . 0.0 111.199 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 162' ' ' ARG . 6.2 ptp180 -126.24 -179.65 4.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.122 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -105.51 -91.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.45 97.55 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.69 0.281 . . . . 0.0 111.576 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 53.16 78.81 0.13 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.599 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.6 t0 -83.84 -169.46 2.58 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.74 102.78 6.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.643 0.259 . . . . 0.0 110.387 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 0.9 OUTLIER -83.07 167.11 14.31 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.194 2.596 . . . . 0.0 112.345 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 147' ' ' LYS . 27.3 m -90.39 166.86 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.794 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.644 ' OD2' ' HG2' ' A' ' 147' ' ' LYS . 24.8 m-20 -100.54 -38.04 8.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 110.388 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.47 112.85 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.871 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 35.6 tp -99.71 110.7 23.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.4 120.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.073 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 52.6 p -109.35 179.62 4.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.036 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.77 9.68 20.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.414 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -133.23 -44.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -128.31 167.87 16.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.057 0.456 . . . . 0.0 111.056 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.35 113.38 41.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 92.6 mtt180 -94.01 99.04 11.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -88.64 108.46 19.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.367 0.603 . . . . 0.0 109.977 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 -174.26 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 93.1 mt . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.87 -30.67 71.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.766 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.449 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 49.0 m -83.14 -30.09 28.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.865 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 tm-20 -70.35 -42.32 72.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.9 tp -61.48 -39.9 92.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.753 174.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -58.78 -38.11 77.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.54 -38.32 89.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -62.96 -43.8 97.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 6' ' ' LEU . 21.3 t -67.54 -48.76 75.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.001 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.11 -47.75 68.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.352 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -58.55 -51.39 70.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.033 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.35 -38.65 88.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.119 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 120' ' ' VAL . 20.0 ttm180 -58.02 -49.74 75.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.931 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 pt -86.94 -0.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.637 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.35 -10.12 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.143 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.17 136.24 56.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -67.09 156.99 34.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.488 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.1 -55.15 31.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.647 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.88 -45.8 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.163 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.82 -45.51 85.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.582 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -62.62 -46.09 89.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.736 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.431 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 21.0 tpt180 -60.06 -36.8 78.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.908 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -38.4 90.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.046 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.58 -51.19 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.799 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -62.54 -34.91 77.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.26 -39.56 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.97 -38.14 87.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.305 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 175' ' ' GLU . 56.2 t -63.75 -47.42 91.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.422 . . . . 0.0 110.487 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.43 -48.13 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.72 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -60.86 -39.11 87.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.09 0.471 . . . . 0.0 110.359 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.19 -53.53 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.03 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.4 -40.61 97.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.87 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -62.61 -32.74 73.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.3 m -83.49 -19.87 35.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.351 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.432 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.0 tt -52.32 115.53 7.07 Favored Pre-proline 0 CA--C 1.533 0.295 0 O-C-N 123.26 0.35 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD2' HD23 ' A' ' 36' ' ' LEU . 50.4 Cg_exo -54.78 -32.56 77.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.223 2.615 . . . . 0.0 113.45 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.54 -26.16 30.36 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.025 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -76.04 -14.82 60.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.149 0.976 . . . . 0.0 109.015 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.47 -22.82 40.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.742 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 54.4 mttp -104.69 -12.37 16.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.451 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -64.29 149.36 48.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 111.76 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -109.84 -65.83 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.731 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HB3' HD11 ' A' ' 71' ' ' ILE . 30.1 mmtp -91.28 95.29 9.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.703 -176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.6 t -102.35 108.28 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.692 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -94.65 119.86 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.433 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.4 129.47 52.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.457 ' HB3' ' HD3' ' A' ' 118' ' ' PRO . 23.2 t80 -77.79 -2.02 34.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.373 -173.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.9 m 66.12 96.58 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.349 0.595 . . . . 0.0 111.548 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.61 128.06 7.57 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.762 2.308 . . . . 0.0 113.084 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 38.7 pt -129.51 158.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.437 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 68.5 -66.02 0.25 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.37 0.668 . . . . 0.0 112.481 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.89 21.15 0.37 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.494 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 51' ' ' ILE . 23.2 mm-40 -82.4 36.36 0.47 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.495 ' HA ' ' OH ' ' A' ' 152' ' ' TYR . 47.2 t 68.85 114.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 122.977 0.511 . . . . 0.0 110.528 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -71.53 80.66 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.957 0.884 . . . . 0.0 111.476 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 150' ' ' VAL . 86.7 mt -86.08 3.82 40.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -53.92 -46.98 98.36 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 58' ' ' THR . 27.0 Cg_endo -62.99 -11.48 24.88 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.104 1.87 . . . . 0.0 113.332 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.6 tp -92.7 -14.28 28.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 14.9 m-85 -56.75 -48.38 97.37 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.878 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.29 -33.58 56.13 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.331 2.021 . . . . 0.0 113.322 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -71.48 -50.75 28.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.405 . . . . 0.0 110.837 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.63 -37.3 79.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.63 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 86' ' ' HIS . 23.7 tp -67.06 -24.39 65.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -93.81 -53.73 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.18 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -50.63 11.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -100.76 -171.78 2.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.183 0.516 . . . . 0.0 111.123 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 39.8 mt-10 -105.21 102.81 12.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.025 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -78.76 114.95 18.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.956 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 61.4 mt -101.39 117.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.059 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 98.0 mt -113.25 139.99 23.8 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.629 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.0 Cg_exo -74.99 120.04 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.873 2.382 . . . . 0.0 112.093 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.606 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 45.0 tttm -116.91 152.78 33.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.13 114.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.493 . . . . 0.0 110.413 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -111.56 107.1 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.147 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.75 39.21 97.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.8 t30 65.91 16.43 10.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.127 0.571 . . . . 0.0 111.114 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.16 136.39 54.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' CD1' ' A' ' 136' ' ' TYR . 20.4 tt -79.08 135.88 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.422 0.63 . . . . 0.0 111.244 -173.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.3 m -139.93 167.49 21.99 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.3 mt -109.89 131.56 54.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.93 0.395 . . . . 0.0 110.951 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.559 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 26.3 m-85 -117.66 124.12 47.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.193 0.521 . . . . 0.0 110.444 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 22.9 ttp180 -93.45 118.54 31.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.861 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.37 154.7 40.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.982 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 65' ' ' LEU . 1.8 p80 -162.44 47.87 0.16 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.986 0.898 . . . . 0.0 109.119 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 43.9 m -156.05 160.41 30.81 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.259 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 87' ' ' SER . 41.7 Cg_endo -67.44 166.78 22.54 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.275 1.983 . . . . 0.0 112.601 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' O ' ' SG ' ' A' ' 90' ' ' CYS . . . 65.14 -155.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.788 0.68 . . . . 0.0 111.065 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 89' ' ' ALA . 15.2 p 60.53 6.33 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.717 1.207 . . . . 0.0 112.828 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.6 mt -97.51 149.34 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.36 -172.41 34.48 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.5 t -134.43 119.53 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.41 -33.28 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.238 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.52 -146.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.223 0.209 . . . . 0.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -39.5 -53.21 2.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.0 0.92 . . . . 0.0 112.971 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.56 47.99 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.17 148.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.2 mtt -72.26 93.43 1.47 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.073 0.463 . . . . 0.0 110.234 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.606 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 11.6 pt-20 -102.06 143.64 27.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.229 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 43.3 Cg_endo -72.27 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.928 1.752 . . . . 0.0 111.171 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.64 -44.19 69.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.11 171.67 7.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.623 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -148.03 19.19 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.909 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 124.32 40.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -75.8 126.8 31.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.178 0.513 . . . . 0.0 111.21 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 91.4 t -122.11 139.24 49.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.58 ' OD1' ' HD2' ' A' ' 109' ' ' PRO . 64.8 t30 -84.42 135.9 40.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HD2' ' OD1' ' A' ' 108' ' ' ASN . 5.1 Cg_endo -47.52 -23.67 3.7 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.744 2.962 . . . . 0.0 113.856 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.67 -34.15 72.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 111.234 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.75 -15.67 53.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.584 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.52 116.15 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -93.85 -25.17 17.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.369 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -134.79 122.68 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.413 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.08 139.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.89 0.376 . . . . 0.0 110.692 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.45 108.74 15.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.466 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 51.6 t -116.24 120.68 34.7 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.493 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 7.0 Cg_exo -74.57 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.917 2.411 . . . . 0.0 111.94 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.64 128.64 1.2 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 39.7 t -58.01 -40.88 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 111.81 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . -132.42 127.76 36.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.774 0.321 . . . . 0.0 111.091 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -121.62 161.72 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.58 174.41 6.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.02 3.84 47.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 37.6 mt-10 -101.31 -33.96 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.584 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 134.31 16.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.179 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.99 158.64 16.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.526 0.663 . . . . 0.0 111.119 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -115.65 157.68 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.693 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 25.2 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 80' ' ' ILE . 69.6 m-85 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.68 -31.19 72.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.527 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -57.94 -23.66 54.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 13.8 tp -93.58 -59.89 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.231 0.539 . . . . 0.0 109.945 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -33.32 72.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.679 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -75.55 -22.58 56.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.748 0.309 . . . . 0.0 111.307 -175.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -102.85 -15.05 16.33 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.696 -0.402 . . . . 0.0 112.053 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' LEU . 62.0 t -67.92 95.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.193 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -86.44 -4.04 59.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.611 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.57 166.75 15.49 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.109 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 46.8 tp -53.0 111.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.095 0.474 . . . . 0.0 110.778 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.499 ' HG3' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -82.88 99.6 9.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.123 -176.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.42 123.99 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -101.25 138.19 13.72 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 57' ' ' LEU . 67.3 t -120.89 124.81 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.081 0.441 . . . . 0.0 110.515 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -164.17 167.47 20.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 156' ' ' VAL . 50.5 m-85 -84.34 149.95 25.7 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.305 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 85.0 p -67.55 -25.03 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.368 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -58.64 -26.53 63.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.025 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 14' ' ' ARG . 21.3 mm-40 -115.42 11.98 16.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.881 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 152' ' ' TYR . 88.1 t -108.46 114.3 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.191 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 91.4 m-85 -94.84 157.09 16.08 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.836 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -54.75 -54.55 40.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -147.22 150.73 35.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.027 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.08 158.54 72.49 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.889 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.47 112.66 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.955 1.77 . . . . 0.0 110.586 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 162' ' ' ARG . 16.6 ttp180 -73.52 131.73 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.642 -170.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.38 -166.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.913 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.97 107.29 15.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.201 0.524 . . . . 0.0 110.857 -174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 79.62 13.07 1.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.076 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.85 123.35 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.0 tt -76.2 116.83 59.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.382 0.611 . . . . 0.0 111.27 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 8.2 Cg_exo -72.15 150.37 53.66 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.996 2.464 . . . . 0.0 112.547 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.499 HG12 ' HG3' ' A' ' 147' ' ' LYS . 34.3 m -86.02 148.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.57 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -87.35 -40.77 14.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.411 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' A' ' 180' ' ' ARG . 61.0 t -120.08 130.44 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.437 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 53.7 tp -111.51 115.92 30.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.054 0.454 . . . . 0.0 110.082 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.1 111.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.352 0.596 . . . . 0.0 109.766 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -109.01 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.264 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' VAL . 9.9 pt-20 -54.9 -34.26 62.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.892 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 47.2 mttm -87.49 -58.64 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.306 -171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -155.53 174.72 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.85 121.59 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.802 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -126.33 119.15 26.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 171' ' ' VAL . 57.1 mtt180 -81.87 139.5 34.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--N 1.318 -0.769 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 10.7 mp . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -70.33 -35.72 73.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.875 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 t -72.63 -29.87 63.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.247 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 2' ' ' LEU . 1.8 mp0 -89.24 -25.33 21.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.823 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.69 -44.95 93.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.62 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' A' ' 129' ' ' LEU . 4.0 ptp180 -66.55 -24.06 66.3 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.865 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HD2' ' HA ' ' A' ' 5' ' ' GLU . 98.6 mttt -73.16 -43.19 61.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.311 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.6 -29.56 70.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG13 ' NE2' ' A' ' 155' ' ' GLN . 77.1 t -75.63 -55.24 12.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.749 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -46.05 91.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.504 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -66.54 -21.23 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.111 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -76.56 -46.71 25.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.47 . . . . 0.0 110.496 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 36.7 mtm180 -73.2 -29.7 63.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.861 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -80.81 3.0 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.929 0.395 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -117.16 -98.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.4 mt 58.38 173.06 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.513 0.673 . . . . 0.0 111.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 m -76.37 123.34 25.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.06 -29.1 60.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.401 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.8 mp0 -63.53 -45.04 92.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.12 -50.13 74.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.445 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -52.55 -44.67 65.98 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.774 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.85 -47.16 69.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 2.6 ptt85 -73.53 -19.72 60.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.449 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 48.8 mt -78.0 -40.67 38.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 172.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -60.91 -35.19 76.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.403 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.66 -41.15 80.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -69.61 -42.65 74.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.0 t -62.33 -45.92 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.08 -44.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.673 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.5 m -60.37 -38.51 84.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -71.19 -47.24 58.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 49.6 tp -62.61 -38.93 92.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.013 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.21 -16.71 54.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.162 0.506 . . . . 0.0 110.513 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.5 t -75.89 -25.76 56.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 178' ' ' VAL . 58.4 mt -55.66 130.78 71.65 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.083 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.6 Cg_exo -64.87 -21.37 64.31 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.63 2.22 . . . . 0.0 111.456 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 2.5 mp0 -69.45 -24.72 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.856 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.411 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 68.3 t80 -68.18 -29.25 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 109.51 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.18 -29.33 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.039 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . 62.4 mttp -63.86 -38.92 92.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.965 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 t -90.78 136.43 33.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.645 0.736 . . . . 0.0 112.038 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -92.31 -17.57 24.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.361 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 71' ' ' ILE . 78.9 mttt -121.2 97.29 5.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.764 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.02 107.51 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -98.41 130.2 45.04 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.996 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.91 130.14 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.06 4.5 14.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.269 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 18.6 t 71.32 125.62 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.29 0.636 . . . . 0.0 111.181 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 4.4 Cg_exo -77.84 45.32 1.75 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.221 2.614 . . . . 0.0 112.929 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.1 pp -61.28 -32.08 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' ILE . 72.5 mmtt -136.33 33.63 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.44 146.71 18.33 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.683 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 7.2 pt-20 -83.71 -15.57 48.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.088 0.47 . . . . 0.0 111.241 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.87 132.23 54.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.735 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.87 86.76 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.98 0.419 . . . . 0.0 110.273 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -88.92 -1.17 57.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.274 0.559 . . . . 0.0 110.25 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -61.08 -47.09 96.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.02 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 58' ' ' THR . 51.0 Cg_endo -69.68 -5.32 15.87 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.592 1.528 . . . . 0.0 113.236 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' HG ' HG23 ' A' ' 64' ' ' VAL . 48.7 tp -88.73 -20.61 24.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.82 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.611 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.0 m-30 -49.73 -52.22 53.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 83.4 Cg_exo -50.28 -40.36 52.37 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.551 2.167 . . . . 0.0 113.362 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 17.0 tt0 -78.27 -37.44 45.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.349 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 70' ' ' LEU . 61.1 t -60.16 -44.83 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.4 -27.02 68.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.988 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 63' ' ' GLU . 31.9 ttpt -74.16 -36.01 64.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.783 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -95.9 -67.32 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.194 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 39' ' ' PHE . 40.4 mttp -124.98 -171.79 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.43 . . . . 0.0 111.981 -165.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.01 118.31 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.153 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 64' ' ' VAL . 58.6 tp -94.36 107.96 19.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 61.8 mt -89.0 116.93 31.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 91.4 mt -115.2 151.31 45.63 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HB3' HG21 ' A' ' 80' ' ' ILE . 5.2 Cg_exo -80.51 127.43 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 112.916 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 101' ' ' PRO . 25.6 tptp -105.8 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -85.61 103.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.876 0.37 . . . . 0.0 110.678 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.83 78.06 1.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.688 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.26 -80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.007 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.479 ' ND2' ' HG3' ' A' ' 79' ' ' GLU . 3.2 p-10 -123.72 -16.26 6.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG3' ' ND2' ' A' ' 78' ' ' ASN . 21.0 mt-10 -126.53 167.42 15.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.493 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 139' ' ' LEU . 65.3 mt -118.43 126.9 75.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 -175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.7 m -96.65 134.46 39.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.289 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 109' ' ' PRO . 98.1 mt -90.43 131.83 35.97 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.57 147.81 44.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.313 0.578 . . . . 0.0 111.939 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 105' ' ' GLU . 39.6 ttt180 -81.6 108.59 15.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.121 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 90' ' ' CYS . 47.3 t -110.07 118.08 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.108 0.48 . . . . 0.0 110.486 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -124.65 -29.19 3.47 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 15.9 m -89.85 126.3 58.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.25 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.1 Cg_exo -61.29 -12.56 24.17 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.196 2.597 . . . . 0.0 113.011 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 4.22 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.853 0.359 . . . . 0.0 111.417 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.525 ' HB3' HG13 ' A' ' 85' ' ' VAL . 49.0 t -88.67 -0.51 57.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 111.073 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.95 113.32 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.021 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.56 158.71 22.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.966 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 61.5 t -79.71 127.99 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 0.0 110.244 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.596 ' HA3' ' OE2' ' A' ' 100' ' ' GLU . . . -81.98 -131.1 1.36 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.655 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.72 2.83 22.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.06 30.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.453 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.28 76.96 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.457 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 24.1 pt -114.1 163.92 10.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.53 119.02 38.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 110.504 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.596 ' OE2' ' HA3' ' A' ' 94' ' ' GLY . 8.5 pt-20 -138.87 155.06 73.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.529 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' HD3' ' A' ' 74' ' ' LYS . 33.5 Cg_endo -64.65 120.45 7.73 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.308 2.672 . . . . 0.0 113.398 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.36 -37.39 7.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 11.6 mm-40 -136.37 109.63 7.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.058 0.456 . . . . 0.0 111.78 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.17 43.68 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 21.1 mp0 -81.49 121.44 26.29 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -70.25 132.52 45.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 109.956 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.87 133.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.624 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.87 132.97 95.05 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . 50.2 Cg_exo -55.2 -33.03 82.96 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.573 2.182 . . . . 0.0 112.674 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -71.75 -19.72 61.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.718 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.95 -17.5 50.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.394 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.463 ' HB ' HG13 ' A' ' 143' ' ' VAL . 93.9 t -60.88 131.76 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.265 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.74 -41.59 7.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.512 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 54.0 t80 -132.9 130.45 39.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.276 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.52 138.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 110.894 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.92 115.95 28.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.82 118.6 36.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.37 90.69 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.301 175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.1 156.54 53.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.004 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.496 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 48.8 t -63.76 -47.72 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -157.44 157.93 34.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.97 156.34 46.36 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.11 0.257 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -109.67 -171.71 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 94.1 mt -79.37 6.03 11.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -119.85 -36.71 3.24 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.63 11.95 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.576 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -95.52 167.18 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.57 -162.49 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.776 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 161' ' ' PRO . 35.8 tp . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.651 0.739 . . . . 0.0 109.748 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.18 -33.73 70.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.985 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -66.3 -30.8 71.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.772 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 80' ' ' ILE . 48.2 tp -67.42 -45.29 76.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.29 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.82 -38.52 75.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.877 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 167' ' ' ILE . 55.7 tttm -81.14 -21.67 39.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.247 0.546 . . . . 0.0 110.465 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HG2' ' HB2' ' A' ' 109' ' ' PRO . 30.0 ttp180 -77.35 -24.61 50.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.951 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.463 HG13 ' HB ' ' A' ' 112' ' ' VAL . 75.6 t -78.66 118.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.724 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -97.16 -2.02 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 110.785 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.58 -179.23 41.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.03 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.37 122.52 17.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.364 . . . . 0.0 110.57 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.72 109.64 21.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 171' ' ' VAL . 80.9 t -107.68 128.95 62.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.562 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -100.54 122.31 7.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.37 114.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.538 0.169 . . . . 0.0 110.629 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.16 164.63 32.75 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.501 0.501 . . . . 0.0 110.13 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.468 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 75.6 m-85 -86.76 158.44 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.511 . . . . 0.0 111.051 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.7 p -61.79 -25.95 67.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.792 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -77.1 -9.23 58.6 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.635 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.593 ' NE2' HG13 ' A' ' 10' ' ' VAL . 8.5 mm100 -108.54 9.4 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.27 116.69 44.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -111.18 179.7 3.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.799 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 30.4 mt-10 -70.8 -68.71 0.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 0.0 111.273 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.75 117.2 13.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.314 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.83 154.05 37.99 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.461 ' HD2' HD13 ' A' ' 129' ' ' LEU . 49.9 Cg_exo -56.14 111.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.259 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -88.31 151.07 22.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.675 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.24 143.15 50.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.18 -15.9 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -110.98 13.12 22.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -89.93 115.3 27.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 141' ' ' LYS . 40.3 mt -74.77 112.09 16.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.666 -172.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.94 163.75 28.16 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.547 2.165 . . . . 0.0 112.209 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 181' ' ' LEU . 28.6 m -103.6 166.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.637 177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.33 -41.02 6.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.258 0.551 . . . . 0.0 110.588 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 148' ' ' VAL . 61.8 t -116.84 120.67 65.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.405 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.8 tp -101.05 114.08 27.68 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 122.36 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.664 ' HB ' ' OE1' ' A' ' 175' ' ' GLU . 46.6 p -111.37 -168.3 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -72.29 -25.17 61.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.113 0.482 . . . . 0.0 110.215 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -115.11 -47.56 2.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.401 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.42 172.99 11.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.309 0.576 . . . . 0.0 112.053 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 98.9 t -126.06 115.03 41.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.632 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -100.03 116.38 31.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -73.71 95.03 2.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.866 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 169' ' ' VAL . 69.6 mt . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 88.6 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -70.86 -52.04 22.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.807 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -66.5 -24.63 66.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.469 . . . . 0.0 110.036 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 42.4 tt0 -58.37 -54.66 44.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.424 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.68 -35.77 75.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.168 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.15 -42.7 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.962 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.13 -42.76 99.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.108 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 26.8 mtpp -63.94 -51.89 62.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.61 -44.78 97.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.99 -35.79 77.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.426 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 24.8 t-80 -67.04 -37.8 84.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.371 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 7.4 mtpm? -66.27 -31.68 72.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 110.44 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 50.8 mtt180 -63.34 -54.45 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.176 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.679 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 27.0 pt -88.03 5.88 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.161 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -84.28 -30.83 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.28 144.99 55.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.863 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.5 m -71.79 151.21 43.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.703 0.287 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 22' ' ' ARG . 5.1 tp10 -59.44 -36.61 76.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.589 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 50.7 mt-10 -55.23 -52.55 63.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.088 0.471 . . . . 0.0 110.623 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.11 -39.81 95.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.379 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.679 ' NH1' ' HA ' ' A' ' 15' ' ' ILE . 23.6 mtm180 -65.76 -39.13 90.74 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.37 -37.5 87.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.0 110.841 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 49.5 mtt85 -69.56 -48.27 60.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -67.79 -43.36 79.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.451 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.6 t -62.03 -43.75 98.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.896 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.75 -35.44 81.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.848 0.356 . . . . 0.0 110.124 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 33.2 ttmt -59.02 -44.5 91.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.441 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 175' ' ' GLU . 42.9 t -67.76 -39.48 82.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 26' ' ' SER . 80.8 mt -61.41 -49.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -64.72 -37.19 86.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.13 -39.44 94.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.242 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.585 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 46.8 tp -65.79 -34.18 77.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.475 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 45.9 mtpt -72.76 -25.52 61.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -78.89 -21.3 47.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.902 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 171' ' ' VAL . 2.4 tt -58.28 121.46 52.01 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.134 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' HD23 ' A' ' 36' ' ' LEU . 69.4 Cg_exo -52.89 -37.71 77.84 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.309 2.672 . . . . 0.0 114.058 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -18.57 58.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.11 -15.65 63.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.967 0.413 . . . . 0.0 111.2 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -76.41 -45.34 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.748 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -74.69 -35.8 62.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.1 p -73.39 95.99 2.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.293 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HE2' ' HG3' ' A' ' 69' ' ' GLU . 79.1 tttt -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 111' ' ' ASP . 40.5 mttm -99.23 101.55 12.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.458 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.95 114.98 48.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -96.66 134.49 39.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.509 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -120.17 136.03 54.76 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 117' ' ' VAL . 26.0 t80 -74.67 -10.67 59.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.019 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' TYR . 41.2 t 67.84 106.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.406 0 CA-C-O 121.3 0.572 . . . . 0.0 110.824 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 76.1 Cg_endo -78.08 151.14 26.89 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.616 2.211 . . . . 0.0 113.437 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -134.85 166.66 27.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.257 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 34.4 mtpt 64.59 8.63 4.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.327 0.392 . . . . 0.0 111.556 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.24 -106.58 2.41 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 70.4 mt-10 61.66 -83.44 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.616 0.767 . . . . 0.0 110.764 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 150' ' ' VAL . 51.2 t -132.8 96.18 2.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 104.71 15.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.691 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 91.6 mt -95.91 3.73 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.671 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.3 m -59.17 -39.5 73.75 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 58' ' ' THR . 50.2 Cg_exo -57.78 -9.71 6.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.175 1.916 . . . . 0.0 114.136 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.8 tp -84.92 -12.93 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.654 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m-30 -54.99 -53.85 56.74 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.644 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 84.4 Cg_exo -52.59 -31.39 49.3 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.73 2.286 . . . . 0.0 113.476 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.0 -43.78 51.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 68' ' ' LYS . 84.0 t -72.98 -42.43 59.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.606 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt -65.93 -5.78 10.38 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' PRO . 63.4 mttp -66.1 -57.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.588 0.233 . . . . 0.0 110.903 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.45 -17.83 1.3 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 64' ' ' VAL . 68.0 mttm -91.69 173.64 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.003 0.43 . . . . 0.0 110.888 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' HE2' ' A' ' 43' ' ' LYS . 42.7 mt-10 -100.93 118.7 37.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.453 175.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.54 111.01 21.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 59.5 mt -97.89 112.37 29.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 98.1 mt -114.78 145.07 33.17 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.199 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.39 132.24 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.009 2.473 . . . . 0.0 112.544 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 5.5 mtpp -105.76 125.89 51.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.985 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.85 89.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.19 17.59 19.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.991 175.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.4 -121.22 2.13 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.78 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -91.14 -10.09 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 0.0 111.185 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -105.18 109.34 21.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.306 0.574 . . . . 0.0 110.285 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.578 HD11 ' HD1' ' A' ' 136' ' ' TYR . 57.1 mt -87.38 110.86 21.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.897 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 19.3 m -82.98 106.8 15.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.879 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 139' ' ' LEU . 94.4 mt -74.65 100.54 3.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 1.2 m-85 -96.11 116.22 28.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.617 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 3.0 ptp180 -83.89 124.29 30.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 101' ' ' PRO . 58.0 t -135.82 133.16 51.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -118.43 -9.98 10.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.5 m -91.4 136.58 26.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.483 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.6 Cg_exo -77.86 165.6 26.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.932 2.422 . . . . 0.0 112.105 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.72 4.76 3.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.1 m -95.94 28.25 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.786 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -113.62 138.39 50.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.03 143.37 15.04 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -91.3 128.15 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.92 -163.12 26.87 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 96' ' ' PHE . . . 47.63 78.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 77.7 t80 72.71 -50.83 0.7 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.879 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.94 36.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.061 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.39 172.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.2 ptm -123.75 99.34 6.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.396 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 5.3 pt-20 -96.67 159.0 32.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.343 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.566 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.14 116.3 4.34 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.48 2.12 . . . . 0.0 111.429 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.23 -22.14 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 110.55 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.38 152.78 51.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.005 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.66 -153.17 25.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -141.44 135.64 30.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.024 0.412 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -77.23 127.16 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.14 160.97 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.322 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.03 145.93 78.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.543 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.01 -17.15 10.41 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.391 2.727 . . . . 0.0 113.456 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.37 -29.73 70.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.061 0.458 . . . . 0.0 110.686 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 21.3 t70 -83.49 -10.35 58.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.83 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.57 95.55 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.401 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.33 -32.41 33.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.093 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.585 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 42.7 t80 -137.51 138.82 40.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.434 HG12 HG13 ' A' ' 117' ' ' VAL . 16.0 tt -146.88 140.54 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.751 0.31 . . . . 0.0 110.401 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.13 112.34 18.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 48' ' ' TYR . 27.3 m -126.33 128.63 24.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.429 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.33 108.81 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.429 2.086 . . . . 0.0 111.485 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.58 157.04 18.28 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.452 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.81 109.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.18 134.52 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.135 0.897 . . . . 0.0 112.512 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.14 146.09 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.886 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -103.27 -172.38 2.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.422 . . . . 0.0 111.219 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 70.5 mt -79.45 -3.97 49.03 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -105.56 -38.11 6.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.853 0.358 . . . . 0.0 110.284 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.6 11.65 1.67 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.682 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.58 168.4 11.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.304 0.552 . . . . 0.0 110.233 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -153.63 135.18 14.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.571 -166.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.956 178.231 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 80' ' ' ILE . 31.9 m-85 . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -22.63 65.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -69.93 -13.77 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 110.583 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 82' ' ' LEU . 48.5 tp -89.81 -42.89 11.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 147' ' ' LYS . 94.2 mt -57.05 -38.68 73.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.667 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -64.72 -26.97 68.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.94 -18.25 29.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.051 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.07 114.72 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -90.45 -6.06 55.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.382 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.72 43.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.39 109.58 11.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.963 0.411 . . . . 0.0 110.261 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 140' ' ' LEU . 32.6 mtmm -82.71 103.12 11.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.829 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.9 t -99.05 122.37 50.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.677 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -94.7 133.32 11.52 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.681 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.488 HG13 HG11 ' A' ' 29' ' ' VAL . 43.5 t -107.64 120.07 58.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.95 154.73 40.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.042 0.449 . . . . 0.0 111.898 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.96 160.9 21.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.836 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 m -55.37 -27.58 48.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.599 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.0 -15.76 63.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.664 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -99.43 -6.22 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.414 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 45.0 t -91.64 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.8 -176.63 2.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.151 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.945 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 33.8 mt-10 -90.79 -66.98 0.88 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 158' ' ' GLU . 10.8 mpt_? -125.4 115.04 19.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.18 143.57 26.86 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.94 101.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.776 1.651 . . . . 0.0 110.165 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -109.74 177.14 4.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.196 -172.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.71 168.3 10.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.454 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.69 64.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -102.39 66.19 0.97 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.571 0.701 . . . . 0.0 109.339 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.66 162.82 12.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.645 HD12 ' HD2' ' A' ' 168' ' ' PRO . 3.9 tp -138.99 111.52 8.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.139 0.495 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.645 ' HD2' HD12 ' A' ' 167' ' ' ILE . 72.5 Cg_endo -77.27 173.56 14.15 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.667 2.245 . . . . 0.0 112.572 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.474 HG23 HD12 ' A' ' 181' ' ' LEU . 21.1 m -112.17 151.98 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.211 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.03 -30.16 34.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.179 0.514 . . . . 0.0 110.083 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 36' ' ' LEU . 49.0 t -142.22 135.03 27.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.648 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 179' ' ' ARG . 61.0 tp -114.33 118.34 33.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 178' ' ' VAL . 63.2 t -109.22 123.22 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.185 0.517 . . . . 0.0 110.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 75.1 p -108.46 -164.86 0.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.601 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.709 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 5.7 pt-20 -73.16 -22.33 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.654 0.264 . . . . 0.0 110.98 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 64.8 mttp -122.26 -61.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.758 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.98 141.03 30.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.216 0.531 . . . . 0.0 112.037 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.538 HG13 HG22 ' A' ' 173' ' ' VAL . 57.6 t -109.47 102.32 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.658 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.783 HH22 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mtp-105 -85.69 99.82 11.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.423 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -76.34 92.39 3.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.474 HD12 HG23 ' A' ' 169' ' ' VAL . 88.0 mt . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.782 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.681 0.277 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -95.42 -45.48 7.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 0.0 109.719 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -58.85 -55.08 39.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.065 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' HD2' ' A' ' 9' ' ' LYS . 37.9 tt0 -59.04 -52.54 65.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.49 -46.31 90.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 8.0 tmm_? -58.67 -45.68 88.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.038 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.01 -45.11 71.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.437 -175.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 13.4 ptmm? -70.36 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.645 HG11 ' HB2' ' A' ' 121' ' ' ALA . 84.0 t -70.14 -35.19 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.004 0.431 . . . . 0.0 110.467 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.74 -46.57 87.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.269 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' HA ' HG12 ' A' ' 15' ' ' ILE . 33.8 t-80 -66.76 -34.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.682 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 68.8 mmtt -51.88 -41.48 61.94 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.455 0.472 . . . . 0.0 111.144 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 54' ' ' GLU . 36.7 ttp180 -72.85 -38.36 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 12' ' ' HIS . 34.0 pt -90.71 -9.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.566 HD22 ' C ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -93.09 -6.51 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.536 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 16' ' ' ASN . 98.7 mt -67.4 161.02 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.602 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.7 m -62.74 127.27 30.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.335 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.9 -42.49 90.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.648 0.261 . . . . 0.0 111.356 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -67.99 -32.18 72.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.954 0.407 . . . . 0.0 110.089 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' CB ' ' HB2' ' A' ' 18' ' ' SER . 9.7 tp10 -63.13 -50.57 69.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.259 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 18' ' ' SER . 72.3 mtp180 -60.41 -37.45 80.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.94 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -56.74 -50.68 71.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.532 . . . . 0.0 110.527 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.95 -33.19 73.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.022 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 97.7 mt -69.58 -47.15 64.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.657 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.6 m -63.34 -31.71 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -56.76 -42.45 79.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.145 0.498 . . . . 0.0 110.255 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.56 -34.3 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 175' ' ' GLU . 66.0 t -62.19 -47.96 90.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.517 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 26' ' ' SER . 72.0 mt -57.48 -46.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.144 0.497 . . . . 0.0 110.097 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -61.76 -38.47 88.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.87 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.33 -43.66 81.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 0.0 110.324 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 36' ' ' LEU . 40.2 tp -61.26 -36.68 80.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.365 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.39 -13.77 59.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.004 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.7 m -82.61 -23.43 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 33' ' ' LEU . 74.3 mt -61.8 118.61 40.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.093 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.21 -23.0 53.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.417 2.078 . . . . 0.0 110.774 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.08 -31.26 70.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.312 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.22 -24.96 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -70.49 -49.62 46.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -72.34 -26.28 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.707 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 114' ' ' PHE . 31.1 m -71.26 98.04 1.66 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 30.9 mtmm -86.35 -25.16 25.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.23 -171.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -110.48 108.58 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 t -109.02 113.05 43.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.5 124.58 40.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.483 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.75 130.99 55.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.25 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' CYS . 48.4 t80 -72.62 -27.57 62.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.8 t 72.24 133.73 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.855 0.722 . . . . 0.0 111.226 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 14.4 Cg_exo -69.36 140.59 44.55 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.677 2.251 . . . . 0.0 111.824 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 pt -124.15 -27.58 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 18.6 tptt -124.38 -35.73 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.628 . . . . 0.0 110.41 -175.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.537 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 138.53 88.13 0.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -121.07 -87.15 0.65 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.552 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -135.09 131.58 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.3 96.57 4.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.294 0.569 . . . . 0.0 110.688 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.57 13.67 20.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.505 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -66.34 -44.8 58.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.536 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 58' ' ' THR . 42.5 Cg_endo -68.81 -0.96 6.84 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.769 1.646 . . . . 0.0 112.773 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 63' ' ' GLU . 60.0 tp -92.07 -17.26 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 30.9 m-85 -50.93 -51.27 68.76 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.8 Cg_endo -56.64 -41.6 74.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.192 1.928 . . . . 0.0 112.471 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' A' ' 60' ' ' LEU . 6.1 mt-10 -66.5 -36.34 82.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.52 -41.79 91.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.434 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 86' ' ' HIS . 65.1 mt -66.3 -14.19 61.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -82.15 -61.9 1.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.99 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -93.04 -29.66 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 27.1 mmtp -124.45 -174.47 3.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.536 0.684 . . . . 0.0 112.234 -166.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.06 128.24 48.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.975 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 112.63 24.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 44' ' ' LYS . 61.5 mt -98.41 117.64 43.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.923 0.392 . . . . 0.0 110.101 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.8 mt -118.96 133.97 23.64 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -84.25 123.17 2.99 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.722 2.281 . . . . 0.0 112.621 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 57.0 tttm -105.42 101.48 11.01 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -82.15 92.72 2.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.313 0.578 . . . . 0.0 109.846 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -101.21 107.15 18.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.236 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.28 -90.97 0.92 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.59 11.61 1.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 109.828 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.22 120.51 40.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.27 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.649 HD11 ' HD1' ' A' ' 136' ' ' TYR . 56.7 mt -85.07 99.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.331 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -95.97 112.11 23.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.68 131.14 35.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.07 144.93 48.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.421 0.629 . . . . 0.0 111.697 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.7 ttt85 -90.65 96.81 10.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.693 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.0 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.466 ' HA ' HD22 ' A' ' 65' ' ' LEU . 1.7 t60 -136.39 16.28 3.18 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -121.31 120.0 29.23 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.023 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.96 -8.62 22.55 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.622 2.215 . . . . 0.0 112.307 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.32 12.46 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.4 t -95.69 -144.93 0.27 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.6 mt 64.57 113.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.799 0.687 . . . . 0.0 112.616 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.95 127.08 4.28 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.18 110.2 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.934 0.367 . . . . 0.0 110.279 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.91 -98.94 0.65 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.014 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . -60.03 127.23 30.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.322 0.249 . . . . 0.0 111.638 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.7 t80 70.47 -38.55 0.42 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.021 0.826 . . . . 0.0 112.061 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 95' ' ' ALA . . . 130.07 10.02 2.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.926 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 pt -91.34 172.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.725 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtm -93.42 100.71 12.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.662 ' HB3' ' HE2' ' A' ' 74' ' ' LYS . 43.2 mt-10 -84.86 132.34 46.38 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.438 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 24.5 Cg_exo -64.15 114.26 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.388 2.059 . . . . 0.0 111.426 174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.79 -17.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.317 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -148.1 150.27 33.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.3 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.06 -158.45 27.74 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.811 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -112.44 161.65 16.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -89.26 126.14 35.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.36 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.58 130.66 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 110.738 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.69 152.23 38.99 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.58 -23.71 41.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.66 -22.07 66.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 44' ' ' LYS . 4.7 t70 -94.7 -3.41 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.229 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.92 112.63 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.239 0.543 . . . . 0.0 111.527 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -60.18 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.187 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 21.3 t80 -134.84 139.61 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.9 139.2 41.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.5 111.65 21.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.497 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 46.1 t -117.89 108.62 42.35 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.18 62.74 8.12 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.206 2.604 . . . . 0.0 111.299 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.06 169.13 22.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.436 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.29 107.35 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . 71.99 133.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.275 0.984 . . . . 0.0 112.335 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.36 165.24 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.244 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.545 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -135.12 -178.72 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.436 HD12 ' HG2' ' A' ' 158' ' ' GLU . 90.6 mt -74.46 -12.72 60.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.51 ' HB2' ' NH1' ' A' ' 159' ' ' ARG . 7.0 tp10 -81.97 -42.16 19.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.08 24.9 2.88 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.192 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -101.31 -176.41 3.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.126 0.489 . . . . 0.0 111.381 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -122.2 -171.84 2.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.556 -173.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 40.6 tp . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.484 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.649 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.1 m-85 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.683 0.754 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.77 -34.73 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.068 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -55.91 -34.42 65.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.116 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 143' ' ' VAL . 56.9 tp -84.75 -54.14 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' A' ' 167' ' ' ILE . 96.9 mt -57.37 -38.55 74.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.8 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.653 ' HD3' HG13 ' A' ' 167' ' ' ILE . 25.9 tptp -74.24 -15.88 60.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 -176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 142' ' ' ARG . 19.7 mtp180 -109.36 -4.5 16.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.417 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.2 t -69.15 104.63 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.078 0.466 . . . . 0.0 109.889 174.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -92.55 12.88 21.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.603 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.29 -174.28 46.25 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 103.1 8.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.428 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 9.8 mtmp? -87.12 102.86 14.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.766 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.7 t -104.97 119.25 53.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -90.87 136.5 13.4 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 174.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.552 HG12 HG21 ' A' ' 55' ' ' VAL . 13.7 t -122.67 124.45 70.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.24 164.13 35.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.529 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.402 ' HE2' HH21 ' A' ' 22' ' ' ARG . 94.3 m-85 -75.61 169.4 18.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.016 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.6 t -69.12 -26.08 64.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.335 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -74.88 -5.68 44.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.055 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -106.47 4.67 28.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.666 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.19 114.9 44.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.615 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -103.0 179.62 4.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.142 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.436 ' HG2' HD12 ' A' ' 124' ' ' LEU . 4.8 tm-20 -89.12 -50.9 5.88 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 125' ' ' GLU . 4.9 tpp180 -149.06 123.62 9.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.335 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.5 mt -101.26 159.09 30.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.162 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.75 103.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.419 2.079 . . . . 0.0 111.223 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 162' ' ' ARG . 39.0 mtm180 -92.6 159.49 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -123.61 179.88 4.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.75 -49.19 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.594 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -93.14 9.27 36.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.341 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.62 159.43 33.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.455 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.665 HG21 ' HB3' ' A' ' 140' ' ' LEU . 3.9 mp -105.12 111.86 65.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.338 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.87 148.79 7.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.79 2.327 . . . . 0.0 112.871 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.64 174.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.172 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 25.1 m-20 -108.62 -49.44 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.93 145.59 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.593 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.1 tp -124.34 103.37 8.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.824 0.345 . . . . 0.0 110.616 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 178' ' ' VAL . 49.1 t -87.05 120.1 35.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 p -105.97 -177.4 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 10.0 pt-20 -71.03 -7.23 44.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.634 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 30.0 mmtp -119.95 -62.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.142 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.86 161.98 30.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.359 . . . . 0.0 111.14 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 173' ' ' VAL . 70.7 t -87.39 101.46 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -88.39 91.91 8.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.671 -175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -74.41 108.71 7.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -174.184 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.732 0.301 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -60.23 -45.75 92.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.453 0.644 . . . . 0.0 110.026 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -71.75 -40.27 69.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.641 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.95 -45.79 76.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.901 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 tp -53.65 -40.82 66.19 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.33 0.394 . . . . 0.0 111.391 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -61.01 -54.74 41.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.264 0.554 . . . . 0.0 110.807 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -25.51 64.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.766 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.48 -55.05 11.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.185 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 155' ' ' GLN . 61.1 t -70.99 -33.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.013 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.593 HD11 ' HG2' ' A' ' 52' ' ' LYS . 54.9 tp -62.19 -29.98 70.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.411 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 10.8 t60 -67.72 -36.7 81.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.992 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -68.32 -32.27 72.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 17.6 mmt180 -52.78 -57.82 8.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.342 0.591 . . . . 0.0 110.602 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.3 9.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.445 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -88.1 -25.63 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.121 -0.362 . . . . 0.0 110.334 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.2 142.73 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.067 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 18.5 t -64.96 148.26 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.45 -42.36 70.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.88 -51.07 64.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.891 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 18' ' ' SER . 1.7 mp0 -60.21 -44.55 95.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.455 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 5.3 tmm_? -57.77 -47.23 83.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.731 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -62.07 -46.22 90.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.097 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -60.11 -47.96 83.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.667 0.27 . . . . 0.0 111.035 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.8 mt -66.69 -37.54 84.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 30' ' ' ILE . 31.1 t -58.96 -49.53 77.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.918 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -59.79 -34.94 73.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -42.02 91.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.579 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 25' ' ' LEU . 45.5 t -62.19 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.073 0.463 . . . . 0.0 109.994 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 26' ' ' SER . 69.8 mt -58.39 -40.12 77.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.505 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.0 m -61.15 -40.28 93.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -42.41 84.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 36' ' ' LEU . 39.9 tp -62.32 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.205 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 39' ' ' PHE . 2.5 mmpt? -66.94 -30.97 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.26 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.1 m -71.58 -24.59 61.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 178' ' ' VAL . 46.4 mt -61.18 116.79 21.04 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.348 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.1 -35.89 84.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.036 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.69 -37.32 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.798 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 69.7 t80 -74.08 -17.15 60.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.207 0.527 . . . . 0.0 110.776 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.88 -41.91 10.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -81.54 -33.23 31.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.761 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 t -84.9 122.04 28.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 92.7 mttt -93.28 -3.93 52.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.714 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 8.7 mmpt? -89.31 86.13 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.61 118.15 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 111.475 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -111.62 138.96 47.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.161 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 57' ' ' LEU . 7.4 mp -120.2 144.17 47.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.787 ' HB2' HG12 ' A' ' 117' ' ' VAL . 37.8 t80 -77.33 -6.63 53.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.152 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.1 t 70.8 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.825 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 2.7 Cg_exo -75.1 98.18 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.864 2.376 . . . . 0.0 112.436 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.837 HG13 ' HD3' ' A' ' 52' ' ' LYS . 40.7 pt -89.4 -5.45 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.227 0.537 . . . . 0.0 110.144 173.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' HG13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -107.19 144.85 33.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.78 72.63 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.708 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HG3' ' H ' ' A' ' 55' ' ' VAL . 5.2 pt-20 -129.52 -79.62 0.56 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.595 0.358 . . . . 0.0 110.203 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.711 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 38.3 t -100.17 123.74 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 22' ' ' ARG . 20.6 m-20 -79.14 71.88 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.898 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 88.2 mt -85.51 -10.46 56.0 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.232 0.539 . . . . 0.0 109.581 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m -62.49 -53.3 58.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.177 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 21.9 Cg_exo -67.31 -6.55 16.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.175 1.917 . . . . 0.0 112.217 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -89.32 -15.25 33.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.389 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.0 m-85 -55.74 -52.38 72.65 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.319 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 61.1 Cg_exo -54.93 -34.37 85.95 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.396 2.064 . . . . 0.0 112.898 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 1.3 tm-20 -65.38 -50.62 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 109.925 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 84.9 t -64.87 -41.51 92.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.586 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' A' ' 88' ' ' PRO . 50.8 tp -67.48 -16.77 64.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.509 . . . . 0.0 111.198 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 13.7 tppt? -71.16 -52.22 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.467 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.4 pt-20 -121.81 -30.01 4.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.074 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.634 ' HE2' ' HA ' ' A' ' 64' ' ' VAL . 30.2 mtmm -103.4 -173.03 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.239 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' A' ' 84' ' ' ARG . 49.2 mt-10 -106.63 119.34 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -89.81 106.06 18.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.047 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 59.3 mt -93.69 123.83 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.2 mt -120.12 141.68 32.08 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.094 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 5.6 Cg_exo -76.81 110.86 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.962 2.441 . . . . 0.0 111.724 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.82 114.82 29.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.26 101.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.418 . . . . 0.0 109.874 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -90.74 85.25 6.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.556 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.74 0.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.16 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -112.13 -9.08 13.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -115.33 109.42 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.669 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.74 135.82 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 m -140.33 149.45 42.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.353 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 3.3 mm? -84.64 114.25 21.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.415 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 10.8 m-85 -95.8 124.67 39.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 17.5 ttm180 -84.31 102.72 12.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 110.21 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 90' ' ' CYS . 55.2 t -89.65 111.81 23.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.253 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -114.85 -4.87 12.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.635 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -117.69 126.65 27.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.609 -178.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.604 ' HA ' HD21 ' A' ' 65' ' ' LEU . 36.3 Cg_exo -60.95 -22.2 73.69 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.812 2.342 . . . . 0.0 113.293 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.15 -5.03 58.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.863 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 87' ' ' SER . 61.3 m -84.44 1.76 43.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 111.495 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.9 129.64 48.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.279 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.5 161.17 29.09 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 t -88.15 86.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.307 0.575 . . . . 0.0 110.374 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.5 -155.91 10.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.58 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.53 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . 55.79 -129.56 1.98 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.564 0.346 . . . . 0.0 110.616 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -97.07 24.05 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.032 0.444 . . . . 0.0 110.783 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.45 51.11 1.0 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.379 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 95' ' ' ALA . 40.1 pt -131.41 163.78 36.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.621 0.248 . . . . 0.0 110.369 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 tpp -81.03 90.97 6.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.79 158.0 36.08 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.991 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 43.9 Cg_endo -72.64 107.92 2.42 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.138 1.892 . . . . 0.0 111.166 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -77.22 -22.97 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.3 0.572 . . . . 0.0 110.224 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.05 -175.52 4.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.527 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.35 -138.38 11.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.418 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -141.69 128.17 20.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 15.4 ptm180 -78.16 101.94 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.538 0.685 . . . . 0.0 110.453 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.42 153.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.741 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 28.5 p-10 -70.93 146.33 92.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.18 -8.45 12.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.238 2.625 . . . . 0.0 112.714 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 42.0 tt0 -69.29 -23.84 63.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.481 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.64 -19.45 57.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.585 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.31 110.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 25.7 t70 -91.06 -36.36 14.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.122 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 31.2 t80 -133.53 127.74 33.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.619 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 147' ' ' LYS . 12.9 tt -135.46 139.74 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.78 118.92 30.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 48' ' ' TYR . 19.9 m -118.25 127.35 26.64 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.131 0.491 . . . . 0.0 111.332 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 6.1 Cg_exo -79.91 84.1 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.983 2.456 . . . . 0.0 111.178 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.33 162.25 19.86 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.886 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 50.8 t -99.08 128.06 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . 67.75 114.72 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.2 0.938 . . . . 0.0 112.684 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -137.6 166.81 23.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.587 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.822 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 16.2 p30 -137.83 -165.14 1.73 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.748 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.93 -5.66 59.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -104.51 -31.48 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.231 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 121.64 17.75 3.8 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.954 172.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 162' ' ' ARG . 22.7 m-30 -69.72 144.43 52.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 117.371 0.585 . . . . 0.0 110.142 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 2.0 tmm_? -122.62 106.04 10.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 110.731 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 28.7 tp . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.145 0.498 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -67.03 -28.19 68.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 109.654 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 138' ' ' ARG . 59.7 mtt85 -76.62 -27.18 55.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.272 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 tp -66.34 -35.56 80.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.74 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.93 -30.71 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' A' ' 167' ' ' ILE . 23.9 ttmm -72.44 -27.24 62.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -78.37 -23.05 47.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.497 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.25 96.2 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.172 0.51 . . . . 0.0 109.81 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -90.09 16.49 8.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.055 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.9 -162.86 34.87 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.33 99.39 9.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.761 0.315 . . . . 0.0 110.169 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 36.9 mtmm -78.87 102.93 8.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.786 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 171' ' ' VAL . 62.1 t -98.41 124.39 51.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.402 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.11 121.43 6.69 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.424 HG12 HG21 ' A' ' 55' ' ' VAL . 43.3 t -102.41 111.95 33.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.831 0.348 . . . . 0.0 110.088 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -145.65 151.76 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.193 0.521 . . . . 0.0 112.094 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.34 151.92 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.124 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -60.38 -23.74 64.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.759 0.314 . . . . 0.0 111.425 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -66.48 -25.06 66.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.67 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 2.8 mp0 -98.37 2.42 47.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.831 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.96 124.82 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.08 -169.4 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.434 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.19 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.822 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 11.2 ttp180 -155.78 141.5 17.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.17 158.94 69.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.768 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.57 107.79 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 111.157 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HD2' ' OH ' ' A' ' 127' ' ' TYR . 25.5 ttt180 -73.67 121.96 21.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.52 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.64 -67.76 0.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.981 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.02 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.499 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -117.61 72.52 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.336 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 33.3 t70 -88.92 145.96 25.21 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.177 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 141' ' ' LYS . 65.2 mt -89.93 107.87 22.03 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.6 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.9 Cg_exo -73.36 157.04 50.13 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.143 2.562 . . . . 0.0 112.317 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 30.6 m -86.61 176.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.593 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 -44.76 7.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.003 0.43 . . . . 0.0 110.95 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.7 t -132.4 134.94 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.484 HD23 HH11 ' A' ' 179' ' ' ARG . 60.5 tp -115.14 112.52 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.885 0.374 . . . . 0.0 110.199 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.4 t -99.21 118.01 45.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 0.0 110.349 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.22 169.76 8.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -84.45 65.7 9.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -175.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 175' ' ' GLU . 10.3 mmtp 179.02 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.262 0.976 . . . . 0.0 110.89 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -144.17 156.92 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 0.0 111.271 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 36' ' ' LEU . 48.0 t -102.54 106.55 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.257 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.484 HH11 HD23 ' A' ' 172' ' ' LEU . 40.8 ttm105 -93.58 95.43 9.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.747 -173.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -78.45 123.89 27.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 169' ' ' VAL . 73.7 mt . . . . . 0 C--N 1.319 -0.754 0 CA-C-O 121.037 0.446 . . . . 0.0 111.109 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 6.4 mp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.21 0.528 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 161' ' ' PRO . 29.2 pttt -68.87 -28.28 66.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.921 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.2 t -78.82 -36.08 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.945 0.402 . . . . 0.0 110.01 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 17.7 tp10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.07 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.67 -48.95 78.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.383 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -56.04 -44.7 79.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.729 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -60.8 -46.91 88.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.923 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HE2' ' HG3' ' A' ' 5' ' ' GLU . 61.7 mttm -58.97 -43.97 91.47 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.189 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG11 ' HG3' ' A' ' 155' ' ' GLN . 43.8 t -67.76 -46.5 82.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.476 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.37 -40.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.121 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.62 -48.11 82.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -78.87 -30.36 45.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.553 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 54' ' ' GLU . 30.5 ttp180 -57.18 -46.91 82.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 52' ' ' LYS . 33.2 pt -90.82 3.27 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.699 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -101.92 2.1 37.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD11 ' CZ ' ' A' ' 154' ' ' PHE . 89.1 mt -67.43 138.12 56.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 p -70.95 155.9 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.59 -58.72 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.562 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.08 -48.93 79.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.582 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.21 -44.24 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -61.62 -46.39 90.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.445 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -69.16 -34.69 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -66.21 -31.03 71.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 0.0 110.923 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.55 -41.77 21.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.253 0.549 . . . . 0.0 110.007 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -61.5 -36.3 80.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.006 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.62 -42.24 82.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.591 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.49 -34.92 75.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 55' ' ' VAL . 42.0 t -66.36 -42.95 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.925 0.393 . . . . 0.0 110.361 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.64 -44.22 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.271 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.8 m -64.52 -32.71 74.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.711 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -63.96 -54.37 35.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.88 -33.33 74.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.703 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -67.83 -30.58 70.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -87.61 -14.25 40.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tt -64.11 113.69 11.17 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 35.5 Cg_exo -59.4 -48.34 13.85 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.869 2.38 . . . . 0.0 112.861 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.79 -20.1 65.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.501 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 77.8 t80 -74.1 -46.7 41.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 57.3 tttm -73.47 -29.75 62.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.719 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 34.1 mmtp -68.76 -37.3 79.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -82.7 148.29 27.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 110.753 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 35.7 mtmt -101.35 -37.04 8.65 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.069 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -89.28 96.52 10.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.14 122.88 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.927 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.02 124.02 44.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.968 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.88 122.27 45.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.741 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.707 ' HD2' ' HD2' ' A' ' 118' ' ' PRO . 6.4 t80 -83.42 98.85 9.72 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 58.6 m -51.9 114.85 5.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.895 0.747 . . . . 0.0 112.673 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 42.2 Cg_endo -68.88 131.67 23.01 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.816 2.344 . . . . 0.0 111.108 174.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.423 HG22 HG21 ' A' ' 98' ' ' ILE . 2.4 pp -120.01 -8.93 10.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 41.0 mttp -145.72 70.37 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.379 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -114.76 3.88 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HG2' ' NH1' ' A' ' 14' ' ' ARG . 29.7 mt-10 61.32 25.48 15.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 169.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 29' ' ' VAL . 98.0 t 69.69 106.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.431 0.634 . . . . 0.0 110.485 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.28 96.52 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.677 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.7 mt -88.12 9.63 22.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.674 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.454 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -62.62 -47.39 88.29 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.3 Cg_endo -70.95 1.13 5.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.694 1.596 . . . . 0.0 112.905 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 tp -88.77 -16.91 30.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.794 0.33 . . . . 0.0 110.599 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.2 m-85 -56.7 -48.02 97.98 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 93.9 Cg_exo -48.1 -31.84 17.32 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 122.53 2.153 . . . . 0.0 113.546 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.59 -48.28 12.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 68' ' ' LYS . 98.9 t -61.89 -39.33 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.512 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 96.2 mt -64.18 -14.77 57.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -88.73 -48.46 7.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.043 0.449 . . . . 0.0 111.34 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 28.3 mt-10 -93.69 -38.0 11.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.45 . . . . 0.0 112.057 -171.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 33.9 mttp -119.66 167.31 12.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -161.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -93.24 121.44 34.6 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.646 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' HG ' ' A' ' 72' ' ' LEU . 58.6 tp -84.02 112.69 20.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.243 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.22 115.87 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.897 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -121.26 136.01 25.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.666 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.5 132.78 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 0.0 111.86 176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 53.2 tttm -105.95 128.81 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.0 104.02 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.48 12.18 30.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.0 -105.02 1.26 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.7 -15.26 22.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.279 0.561 . . . . 0.0 109.805 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -89.52 143.45 26.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.123 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.691 HD11 ' HD1' ' A' ' 136' ' ' TYR . 62.0 mt -113.64 111.64 36.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.212 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 20.1 m -94.95 108.53 20.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.135 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.2 104.13 6.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.98 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.21 140.2 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.853 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.37 151.35 37.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.0 176.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.886 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -139.27 11.05 2.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.365 0.602 . . . . 0.0 109.872 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 p -162.7 150.51 11.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.711 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.8 Cg_exo -76.07 49.76 2.64 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.012 2.475 . . . . 0.0 111.496 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.82 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 38.4 t -124.6 94.41 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.269 0.557 . . . . 0.0 110.834 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 101' ' ' PRO . 95.3 mt -123.07 120.82 34.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.64 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.06 -171.33 27.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.6 t -136.82 116.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.67 -59.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.995 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -107.92 139.1 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.799 -0.236 . . . . 0.0 111.326 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 65.2 10.88 6.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 0.0 111.935 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.66 16.26 67.55 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.782 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 95' ' ' ALA . 39.1 pt -105.58 172.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.833 0.349 . . . . 0.0 110.953 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -73.4 131.26 41.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.281 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -117.04 121.42 32.56 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.237 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 74' ' ' LYS . 24.8 Cg_endo -62.54 118.15 5.04 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.607 2.205 . . . . 0.0 112.398 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 58.5 t -93.18 -55.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.792 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -105.05 154.59 19.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.746 0.308 . . . . 0.0 110.601 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.54 162.77 10.63 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.37 135.8 35.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 106' ' ' ARG . 17.8 ptt85 -87.48 145.28 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.74 153.09 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -82.71 161.88 57.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.53 -14.83 5.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.284 2.656 . . . . 0.0 113.476 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.3 -37.14 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.313 0.578 . . . . 0.0 110.763 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.76 -23.68 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.9 107.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.974 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.87 -49.7 5.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 20.7 t80 -118.75 129.82 55.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.5 tt -139.19 139.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.993 0.425 . . . . 0.0 110.574 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.27 116.05 23.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.066 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 48' ' ' TYR . 33.7 m -124.86 127.35 25.15 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 0.0 111.274 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.707 ' HD2' ' HD2' ' A' ' 48' ' ' TYR . 2.2 Cg_endo -83.35 -164.46 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.001 2.468 . . . . 0.0 111.166 171.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.51 175.55 32.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.782 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -99.98 121.33 50.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 72.58 126.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.32 1.012 . . . . 0.0 112.654 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.502 ' HA ' HD11 ' A' ' 160' ' ' LEU . 63.0 m-85 -138.09 168.41 19.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 45.3 p30 -126.3 -164.55 1.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.268 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.75 -13.8 37.15 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.614 ' O ' HD11 ' A' ' 181' ' ' LEU . 44.7 mt-10 -110.51 -62.49 1.52 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.97 62.32 0.13 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.924 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -82.91 134.03 35.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.2 82.82 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.7 tp . . . . . 0 C--O 1.232 0.16 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.616 175.366 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.691 ' HD1' HD11 ' A' ' 80' ' ' ILE . 95.3 m-85 . . . . . 0 C--O 1.238 0.45 0 CA-C-O 121.786 0.803 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.32 -16.95 63.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.55 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -54.74 -34.52 62.62 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 143' ' ' VAL . 51.6 tp -87.22 -51.22 6.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.142 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.64 -26.93 62.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.11 -28.55 63.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.74 -2.57 15.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.784 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 139' ' ' LEU . 98.4 t -70.19 102.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -97.19 10.98 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.92 -176.42 43.56 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.683 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.0 100.71 1.26 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.986 0.393 . . . . 0.0 110.283 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.43 100.06 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.091 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.582 HG21 ' CZ ' ' A' ' 114' ' ' PHE . 92.3 t -96.29 114.93 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.025 0.441 . . . . 0.0 110.014 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.35 124.26 7.72 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.723 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.27 116.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.23 161.51 40.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.672 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -96.61 156.31 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -62.43 -31.44 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 26.8 p90 -78.18 -6.2 54.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.421 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.525 ' HG3' HG11 ' A' ' 10' ' ' VAL . 28.5 tt0 -100.95 -6.23 24.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 0.0 109.816 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.5 115.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.64 -166.39 1.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 33.6 tt0 -69.69 -67.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.92 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 123' ' ' ASP . 5.1 tpm_? -145.43 132.62 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.462 -173.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 122' ' ' PHE . 80.9 mt -96.52 138.87 21.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.616 0.246 . . . . 0.0 110.75 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 3' ' ' LYS . 3.1 Cg_exo -76.36 101.87 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.789 2.326 . . . . 0.0 111.25 174.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.72 148.66 29.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.102 -177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.1 m-20 -114.81 -135.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.328 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -61.69 -23.79 66.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.42 0.628 . . . . 0.0 110.312 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -87.58 67.68 9.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.278 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.38 -74.18 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.367 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 41.2 mt 41.04 81.38 0.25 Allowed Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 124.285 0.991 . . . . 0.0 113.246 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.04 165.49 5.75 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.44 2.093 . . . . 0.0 111.798 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.58 177.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.75 -43.26 3.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.473 0.654 . . . . 0.0 109.369 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.41 122.33 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 42.5 tp -101.95 109.93 21.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.12 123.68 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.85 3.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.403 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -26.29 28.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.134 0.492 . . . . 0.0 110.479 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.2 -34.2 15.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.34 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.5 171.66 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.946 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 t -113.58 111.49 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 42.0 ttm180 -89.56 96.3 10.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.284 0.564 . . . . 0.0 111.132 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.87 115.26 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.391 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.614 HD11 ' O ' ' A' ' 125' ' ' GLU . 75.6 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 111.042 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.832 0.348 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -48.77 70.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 m -63.88 -35.59 81.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.946 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.99 -53.95 52.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.654 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.54 -48.37 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.512 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.04 -49.45 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -65.08 -43.07 93.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.612 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.51 -46.77 68.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.863 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.17 -37.15 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.0 tp -57.24 -37.49 72.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.285 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.58 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 15.0 t-80 -67.13 -25.93 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.963 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 45.9 mmtt -95.67 -16.22 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 110.968 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.459 HH11 ' HG2' ' A' ' 155' ' ' GLN . 25.0 ttt85 -75.66 -42.98 49.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.3 pt -90.78 6.84 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.256 0.551 . . . . 0.0 110.68 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -77.25 -26.09 52.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.896 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.09 135.35 57.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.639 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -65.3 142.53 58.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.122 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -52.69 -43.15 65.4 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.3 -59.44 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.152 0.501 . . . . 0.0 110.957 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.4 -44.85 81.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.143 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -62.21 -41.83 98.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.967 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -71.07 -35.38 71.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.661 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -65.66 -35.53 81.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.025 0.44 . . . . 0.0 110.469 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.83 -37.49 70.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.444 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 30' ' ' ILE . 38.0 m -65.67 -30.75 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.53 -42.88 79.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.217 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -60.99 -46.52 90.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.127 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 175' ' ' GLU . 37.0 t -61.49 -42.07 92.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.128 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' SER . 80.6 mt -61.18 -50.27 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 110.634 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -60.69 -41.78 95.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.6 -51.25 66.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.79 -36.37 83.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.032 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -76.31 -17.45 59.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.833 0.349 . . . . 0.0 110.706 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -88.52 -18.95 27.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.543 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.459 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.1 tt -55.38 117.3 14.31 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD2' HD23 ' A' ' 36' ' ' LEU . 44.6 Cg_exo -56.48 -42.66 63.23 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.169 2.579 . . . . 0.0 113.273 -176.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.4 -27.81 67.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.84 -34.96 74.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.267 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -64.81 -42.09 95.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.29 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -73.55 -24.0 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.466 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -66.59 124.84 23.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.375 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 61.8 mttm -103.85 -37.1 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.501 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 26.5 mmtp -96.43 108.76 21.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.12 110.51 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.968 0.414 . . . . 0.0 111.152 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -91.64 114.05 26.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 70' ' ' LEU . 89.3 mt -107.35 121.71 45.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.291 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -79.03 105.88 10.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.525 ' HB3' HG22 ' A' ' 98' ' ' ILE . 43.3 t -58.42 115.28 10.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.503 0.502 . . . . 0.0 110.996 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 Cg_exo -73.14 108.23 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.977 2.452 . . . . 0.0 111.899 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.667 HG13 ' HG2' ' A' ' 52' ' ' LYS . 44.7 pt -78.37 -22.55 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.268 -175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.667 ' HG2' HG13 ' A' ' 51' ' ' ILE . 71.7 mmtt -117.31 25.24 10.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 110.884 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.07 -71.42 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 6.1 mm-40 39.74 53.05 2.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.146 0.978 . . . . 0.0 113.029 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t 68.03 100.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.34 0.591 . . . . 0.0 109.778 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.71 111.97 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.203 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.07 14.91 15.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.643 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.525 ' OG1' ' HD3' ' A' ' 59' ' ' PRO . 42.6 p -63.02 -41.37 70.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.525 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 23.4 Cg_exo -66.27 -10.94 29.29 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.879 1.719 . . . . 0.0 112.594 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.97 -21.84 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.291 . . . . 0.0 110.669 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.5 m-85 -57.94 -52.7 72.54 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.015 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.0 Cg_exo -54.52 -34.1 80.85 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.363 2.042 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -66.47 -53.0 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.4 -36.12 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.204 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 70.9 mt -61.11 -26.24 67.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' LYS . 70.9 mmtt -114.17 -7.87 13.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.93 -31.14 9.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.225 0.536 . . . . 0.0 110.702 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 47.7 mttm -142.1 -171.86 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.085 -169.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -105.69 126.48 52.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 54.6 tp -82.58 144.69 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 44' ' ' LYS . 69.6 mt -126.86 114.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 62.8 mt -109.65 138.89 20.75 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.61 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.0 126.54 5.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.846 2.364 . . . . 0.0 112.936 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 9.3 tmtm? -105.5 97.71 7.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 77' ' ' GLY . 11.5 t -92.86 117.81 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.658 -170.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -87.96 5.18 41.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 75' ' ' VAL . . . 106.52 -51.87 0.71 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -104.11 -48.49 3.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.5 -0.35 . . . . 0.0 110.456 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -91.49 149.44 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.051 0.453 . . . . 0.0 111.118 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' HD1' ' A' ' 136' ' ' TYR . 65.1 mt -124.26 101.38 8.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.524 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 15.2 m -85.6 112.67 21.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 90.5 mt -84.47 136.15 33.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 106' ' ' ARG . 88.8 m-85 -128.55 144.1 51.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 0.0 111.248 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 45.2 mtp180 -79.26 106.99 11.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.649 175.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 51.0 t -89.56 111.43 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -107.02 -28.47 10.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.504 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -141.1 158.21 65.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.292 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.86 -155.48 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 74.45 -46.06 0.6 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.561 0.745 . . . . 0.0 112.199 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 5.7 t -81.68 34.96 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.222 0.535 . . . . 0.0 110.903 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -117.25 131.18 56.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.417 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.12 -169.9 12.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.987 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -136.0 123.36 34.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.497 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -132.52 -85.13 0.28 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.502 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.4 155.48 18.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.558 0.218 . . . . 0.0 111.397 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 72.49 -46.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.926 0.891 . . . . 0.0 111.975 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 20.79 5.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.92 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 49' ' ' CYS . 2.1 pp -101.62 172.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.618 0.247 . . . . 0.0 111.205 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.09 105.03 6.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.862 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 2.3 mt-10 -83.6 115.46 59.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.976 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 2.8 Cg_exo -74.39 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 110.56 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.468 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 27.9 t -73.34 -58.74 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.415 -173.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.95 178.62 6.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 111.067 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.66 -139.06 10.12 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.6 138.05 51.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HG2' ' CE1' ' A' ' 83' ' ' TYR . 83.4 mtt180 -83.35 140.75 32.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.948 0.404 . . . . 0.0 110.394 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.555 ' CG2' ' HG3' ' A' ' 84' ' ' ARG . 21.9 t -117.99 137.3 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.577 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -104.69 150.58 38.76 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.33 -35.63 16.12 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.008 3.139 . . . . 0.0 114.998 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.733 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 43.3 tt0 -65.05 -26.98 68.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 14.0 t70 -80.83 -13.69 58.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 0.0 111.148 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.83 131.37 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.618 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 13.0 m-20 -83.94 -52.42 6.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.629 0.728 . . . . 0.0 110.017 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 148' ' ' VAL . 46.2 t80 -129.85 131.03 45.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.528 -170.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.2 tt -125.79 137.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.968 0.413 . . . . 0.0 109.943 173.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' HE1' ' A' ' 114' ' ' PHE . . . -121.23 115.72 23.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.631 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.22 118.95 33.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 37.6 Cg_endo -68.82 110.12 2.28 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.336 2.024 . . . . 0.0 111.258 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 122' ' ' PHE . . . -100.0 131.68 10.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.43 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.73 -30.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 122.476 0.31 . . . . 0.0 111.205 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.91 142.13 19.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.635 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 28.7 m-85 -137.77 168.65 19.26 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.505 0.503 . . . . 0.0 110.254 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.557 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 34.0 p-10 -137.96 -167.82 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.76 -0.29 57.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.274 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 159' ' ' ARG . 34.9 mm-40 -97.32 -36.81 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.411 ' CA ' ' HG ' ' A' ' 181' ' ' LEU . . . 113.98 39.99 1.02 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.734 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -108.29 169.27 8.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.485 . . . . 0.0 111.433 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 157.65 32.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.433 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.672 -179.704 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.725 ' HD1' HD11 ' A' ' 80' ' ' ILE . 18.2 m-85 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.974 0.416 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -70.86 -33.84 71.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.149 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.36 -34.48 77.38 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 143' ' ' VAL . 52.6 tp -70.5 -59.24 2.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.416 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.67 -38.55 78.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.187 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -78.71 -11.16 59.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 111.098 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -107.55 -5.82 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.661 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.9 t -57.62 118.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.733 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 52.8 tttm -87.69 -2.61 58.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 110.509 -175.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -96.2 -161.91 32.96 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.11 131.49 38.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.94 0.37 . . . . 0.0 110.75 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -93.03 110.6 22.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.3 t -109.84 128.16 66.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 0.0 110.973 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.478 ' HA3' ' CZ ' ' A' ' 122' ' ' PHE . . . -98.92 132.95 11.11 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.635 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.63 122.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.661 0.267 . . . . 0.0 110.659 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -158.44 168.29 27.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.876 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 170.91 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.5 p -63.74 -27.3 69.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.242 0.544 . . . . 0.0 110.938 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -68.05 -25.59 65.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.089 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.459 ' HG2' HH11 ' A' ' 14' ' ' ARG . 2.3 mp0 -92.67 4.54 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.531 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.03 113.22 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.402 . . . . 0.0 110.631 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -106.98 178.67 4.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.807 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.47 -54.57 6.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.582 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 71.7 ttp85 -149.28 139.46 22.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.025 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 67.9 mt -98.98 158.39 32.4 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.743 174.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.71 105.79 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.38 2.053 . . . . 0.0 112.539 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.74 100.9 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.96 -77.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.186 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.77 -69.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -80.78 -3.92 52.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -165.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.41 -175.49 5.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.311 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.791 HD12 ' HD2' ' A' ' 168' ' ' PRO . 4.1 tp -135.19 129.38 18.85 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.594 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.791 ' HD2' HD12 ' A' ' 167' ' ' ILE . 56.5 Cg_endo -72.2 159.74 48.98 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.514 2.143 . . . . 0.0 112.701 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.34 -177.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -100.42 -56.08 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.467 ' HB ' HG22 ' A' ' 148' ' ' VAL . 45.8 t -128.13 140.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.62 116.01 30.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.671 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.7 t -106.83 125.28 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 0.0 110.247 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 50.3 p -119.54 -169.67 1.8 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.679 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 9.6 pt-20 -68.75 -27.52 65.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.868 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 56.9 mtpt -125.89 -21.47 4.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.424 HD22 ' C ' ' A' ' 176' ' ' LYS . 0.8 OUTLIER -131.76 143.6 50.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -172.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.403 HG11 ' HG ' ' A' ' 36' ' ' LEU . 63.5 t -111.52 102.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -122.25 112.41 18.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.166 0.507 . . . . 0.0 112.082 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 180' ' ' ARG . 30.6 ttm105 -70.3 152.44 44.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 181' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 122.103 0.954 . . . . 0.0 112.214 -166.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.234 0.269 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 129' ' ' LEU . 15.7 ptpt -66.41 -22.89 66.24 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.94 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.8 t -59.16 -29.5 67.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.184 0.516 . . . . 0.0 110.684 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.32 -45.27 18.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.067 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.17 -35.72 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.628 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -55.38 -45.98 76.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.848 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.37 -39.08 88.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -60.35 -49.69 76.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.6 -42.33 80.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 15' ' ' ILE . 62.1 tp -61.43 -42.51 98.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.667 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 5.0 t60 -58.35 -44.57 88.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.243 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 26.3 mtpp -67.65 -35.48 78.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.314 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 44.2 ttm-85 -60.77 -50.77 72.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.259 0.552 . . . . 0.0 110.652 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 11' ' ' LEU . 18.5 pt -83.67 9.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.0 111.369 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -101.37 -11.62 19.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 152.4 24.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.279 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -75.09 156.53 35.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.544 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 37.8 tt0 -68.28 -39.42 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.261 . . . . 0.0 110.906 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.56 -44.07 97.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 109.742 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.92 -34.47 76.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.401 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 7.5 mmt85 -55.18 -61.49 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.01 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 66.6 ttt180 -62.81 -37.01 85.03 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.035 0.445 . . . . 0.0 110.708 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 52.7 ttt180 -60.56 -44.87 95.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.952 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -86.57 -37.85 17.73 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.267 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.4 t -66.09 -31.86 72.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.528 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 8.7 tt0 -69.77 -26.1 64.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 74.1 mmtt -74.84 -43.94 51.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.901 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.78 -48.26 89.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.742 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 79.0 mt -60.13 -47.35 92.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -61.82 -39.41 91.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.563 HD21 ' HA ' ' A' ' 177' ' ' ASN . 8.3 t-20 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.244 0.545 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.56 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.464 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HE2' ' HG2' ' A' ' 63' ' ' GLU . 2.8 mmmp? -71.43 -31.12 66.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.602 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -84.38 -9.26 58.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.129 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 2.2 tt -71.51 111.45 10.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 36' ' ' LEU . 18.0 Cg_endo -59.67 -33.11 96.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.999 2.466 . . . . 0.0 113.529 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.63 -34.67 77.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.784 0.326 . . . . 0.0 110.334 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.79 -25.3 63.72 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.89 -34.87 74.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.262 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -100.44 -21.64 15.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.084 -171.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -58.93 123.87 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 110.916 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 1.1 mmpp? -74.71 -63.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.644 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 113.48 25.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.149 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' HD12 ' A' ' 70' ' ' LEU . 46.0 t -116.41 115.14 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.34 143.69 29.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -136.93 148.26 46.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.794 0.33 . . . . 0.0 110.551 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 117' ' ' VAL . 64.6 m-85 -97.06 141.6 30.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.898 171.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.546 ' HB2' HG22 ' A' ' 98' ' ' ILE . 67.5 m -73.75 146.8 86.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.569 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 36.5 Cg_exo -58.69 106.52 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.049 2.499 . . . . 0.0 113.042 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.831 HG13 ' H ' ' A' ' 52' ' ' LYS . 8.9 pt -99.96 -85.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.472 174.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.831 ' H ' HG13 ' A' ' 51' ' ' ILE . 45.8 mttp -91.62 -6.82 51.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.24 0.543 . . . . 0.0 109.761 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 14' ' ' ARG . . . -98.07 120.89 6.94 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 174.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.49 7.43 38.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.746 0.308 . . . . 0.0 111.249 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 21.5 t -70.51 100.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD1' ' HD3' ' A' ' 59' ' ' PRO . 6.6 t70 -86.19 102.76 14.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.237 0.541 . . . . 0.0 111.047 -171.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.1 15.77 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.365 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 m -62.71 -50.62 77.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 22.0 Cg_exo -67.07 -0.65 5.05 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -85.87 -19.04 31.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.691 0.282 . . . . 0.0 110.516 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.2 m-85 -59.63 -49.58 91.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 76.1 Cg_exo -53.11 -32.77 60.68 Favored 'Trans proline' 0 C--N 1.359 1.132 0 C-N-CA 122.296 1.997 . . . . 0.0 112.687 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.721 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 18.3 tp10 -71.69 -52.57 17.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.17 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.9 t -57.27 -45.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.221 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -65.17 -12.6 52.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -97.05 -14.22 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.936 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 43.1 mt-10 -110.56 -56.67 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 0.0 110.94 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.67 ' HD2' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -129.43 -171.53 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 -171.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.07 138.29 32.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 41.6 tp -98.94 157.38 16.36 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 67.2 mt -138.52 131.28 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 96.1 mt -129.32 132.6 24.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.37 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.84 2.36 . . . . 0.0 111.77 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 100' ' ' GLU . 2.8 tmtp? -105.89 113.63 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.92 106.71 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.091 0.472 . . . . 0.0 111.1 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -104.45 88.92 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.373 174.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 -98.73 1.04 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -123.18 -4.18 8.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 109.87 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.23 106.71 18.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 ' HD1' ' A' ' 136' ' ' TYR . 55.5 mt -82.72 102.37 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.089 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -84.74 122.72 29.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.495 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.91 100.17 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.541 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 40.8 m-85 -103.21 130.36 50.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.554 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -79.04 153.26 30.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.134 176.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 98.5 t -130.68 124.08 56.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.469 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.416 ' HD2' ' HD3' ' A' ' 84' ' ' ARG . 9.1 p80 -148.85 25.12 0.94 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.2 m -146.37 149.52 37.98 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.741 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.4 Cg_exo -78.23 160.5 29.52 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.742 2.295 . . . . 0.0 111.958 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.27 19.39 11.68 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 85' ' ' VAL . 30.7 p -103.61 5.78 36.75 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.023 -0.423 . . . . 0.0 110.63 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -100.94 129.48 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.43 171.08 25.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.144 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.34 102.06 13.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.967 0.413 . . . . 0.0 110.374 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.31 -34.6 1.92 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -82.24 -163.34 0.66 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.905 0.383 . . . . 0.0 111.209 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -54.85 -43.28 72.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 58.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.628 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 49' ' ' CYS . 43.0 pt -131.3 166.66 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -106.41 96.35 6.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 3.3 pt-20 -105.25 154.38 38.94 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.639 -173.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 11.0 Cg_exo -71.15 112.45 3.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.62 2.213 . . . . 0.0 111.985 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.43 -48.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -121.1 99.08 6.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.842 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.42 -162.42 9.1 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.908 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.45 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 36.9 mt-10 -127.02 142.34 51.57 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -77.27 128.33 34.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.097 0.475 . . . . 0.0 111.613 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 84' ' ' ARG . 84.1 t -124.18 145.13 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.949 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 110' ' ' GLU . 9.5 p30 -97.9 157.46 34.56 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.83 -25.22 42.12 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.503 2.802 . . . . 0.0 114.645 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 108' ' ' ASN . 20.6 tt0 -68.92 -23.59 64.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.846 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -93.42 0.03 56.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.939 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.76 103.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.12 -58.04 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.791 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 23.4 t80 -124.06 144.72 49.69 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.337 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 17.3 tt -149.66 141.01 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.662 0.267 . . . . 0.0 110.494 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.61 120.43 38.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.493 HG12 ' CE1' ' A' ' 48' ' ' TYR . 27.5 m -116.82 120.78 33.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.216 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 4.1 Cg_exo -77.37 104.69 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.787 2.325 . . . . 0.0 111.217 174.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.57 156.5 15.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.852 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 125.65 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.1 106.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.164 0.915 . . . . 0.0 112.491 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -127.84 157.43 40.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.596 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -103.94 -173.98 2.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 46.1 mt -87.06 15.74 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.56 -15.59 6.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.861 0.362 . . . . 0.0 110.571 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.447 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 118.05 5.46 13.39 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.71 169.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -85.92 132.35 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.542 0.671 . . . . 0.0 111.213 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -94.25 128.6 40.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.357 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.554 ' HB2' HD13 ' A' ' 160' ' ' LEU . 30.6 tp . . . . . 0 C--N 1.33 -0.281 0 O-C-N 123.535 0.522 . . . . 0.0 110.56 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.2 m-85 . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.755 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 9.6 p-10 -65.89 -29.37 69.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -49.94 -39.72 41.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.035 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 80' ' ' ILE . 50.5 tp -81.85 -40.64 22.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.148 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.01 -16.64 64.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.454 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.755 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 32.1 mmtp -73.2 -29.22 62.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -95.75 -27.83 15.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.194 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.43 98.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.076 0.465 . . . . 0.0 110.118 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -134.46 56.62 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.096 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.43 9.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 114' ' ' PHE . 23.7 tp -83.39 89.2 7.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 170' ' ' ASP . 25.1 ttpt -91.07 105.38 17.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.688 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 171' ' ' VAL . 45.6 t -104.49 124.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.143 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.2 10.61 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.53 115.99 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.44 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -158.59 175.03 14.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.713 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.623 ' HD1' ' HG3' ' A' ' 175' ' ' GLU . 46.4 m-85 -102.09 153.37 19.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 176' ' ' LYS . 29.6 t -61.08 -13.14 15.01 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.717 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -71.66 -23.55 61.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.585 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 16.4 mp0 -107.58 13.86 26.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.921 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.1 t -117.92 120.92 66.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.181 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.73 -175.16 2.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.391 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.906 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -89.94 -36.74 14.83 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.274 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -138.11 145.34 41.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 129' ' ' LEU . 95.3 mt -132.77 161.84 61.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.95 101.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.572 1.515 . . . . 0.0 110.892 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -104.67 141.0 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 11.3 t70 -128.08 -163.49 1.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.145 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . -81.6 -40.91 22.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 0.0 110.674 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -85.0 43.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.404 0.621 . . . . 0.0 110.241 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.55 110.77 22.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.303 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.98 114.06 53.61 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.579 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.07 160.02 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.172 2.582 . . . . 0.0 113.08 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.419 ' HA ' ' HE3' ' A' ' 147' ' ' LYS . 31.1 m -103.25 -179.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.698 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 8.1 m-20 -107.8 -32.79 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.815 0.34 . . . . 0.0 110.903 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.528 ' HB ' HG22 ' A' ' 148' ' ' VAL . 43.8 t -136.05 153.13 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 181' ' ' LEU . 44.1 tp -128.94 122.15 29.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.631 HG22 HG12 ' A' ' 178' ' ' VAL . 86.2 t -109.14 126.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.166 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.2 p -127.19 -174.6 3.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.322 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.623 ' HG3' ' HD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -85.79 -1.48 57.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 110.113 175.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.444 ' HZ3' ' HB3' ' A' ' 153' ' ' SER . 40.5 mmtm -93.56 -64.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.141 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.563 ' HA ' HD21 ' A' ' 32' ' ' ASN . 8.3 t-20 -155.62 174.87 14.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.022 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 173' ' ' VAL . 4.4 m -108.04 99.6 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.64 . . . . 0.0 110.26 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 179' ' ' ARG . 33.1 ttt180 -103.7 116.57 32.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -74.7 132.74 41.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.521 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 172' ' ' LEU . 61.6 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.184 -171.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -54.18 -40.66 67.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.542 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -62.12 -36.09 80.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.425 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 6.0 mm-40 -77.9 -43.43 30.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.482 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.07 -38.22 85.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -54.54 -53.86 48.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -68.42 -24.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.332 -173.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -74.18 -47.08 38.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 110.394 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.29 -44.63 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.297 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 tp -59.73 -45.57 91.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.558 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 13.7 t-80 -62.05 -43.02 99.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.66 -41.49 99.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.464 HH21 ' N ' ' A' ' 54' ' ' GLU . 10.8 tpt180 -63.95 -53.59 47.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.339 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.2 pt -80.97 4.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 111.599 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 6.5 t30 -78.67 -28.69 45.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.15 142.56 46.86 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.619 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 38.9 p -76.91 160.49 29.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.079 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.16 -30.06 71.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.9 -52.28 64.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.57 -30.78 36.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.386 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 18' ' ' SER . 83.7 mtt180 -56.9 -59.19 5.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.3 -40.35 77.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.38 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.63 -45.8 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.082 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -70.68 -44.65 66.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -61.23 -33.56 73.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.08 -39.28 78.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.427 0.632 . . . . 0.0 110.179 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -74.27 -34.23 63.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 175' ' ' GLU . 44.9 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.415 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.481 HG23 HD13 ' A' ' 60' ' ' LEU . 77.5 mt -58.21 -44.27 87.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.114 0.483 . . . . 0.0 110.325 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.1 m -65.25 -36.56 84.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -67.98 -42.35 80.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.888 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 36' ' ' LEU . 26.3 tp -62.68 -46.61 87.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 39' ' ' PHE . 23.4 mmtp -60.38 -28.94 68.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 176.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -82.97 -17.82 42.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.519 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 33' ' ' LEU . 44.6 mt -61.43 120.52 56.31 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.1 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.03 -35.6 81.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.756 2.304 . . . . 0.0 111.388 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -60.01 -52.67 64.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.651 ' HE2' ' HD3' ' A' ' 34' ' ' LYS . 88.2 t80 -73.34 -30.22 63.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -58.04 -41.39 83.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.04 -23.28 33.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.5 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 39' ' ' PHE . 49.9 m -50.8 123.19 8.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.248 0.546 . . . . 0.0 111.696 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -102.99 -34.57 8.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -113.52 97.96 6.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.075 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.47 122.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.145 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 116' ' ' ALA . 54.1 mt -111.78 136.52 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.065 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -85.64 -0.52 55.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.158 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 45.5 t 65.89 98.76 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.119 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 41.9 Cg_endo -68.35 97.76 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.467 2.111 . . . . 0.0 112.398 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 24.5 pt -87.18 154.82 3.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 tptp 71.63 -15.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.807 0.692 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 133.28 -77.89 0.37 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' HH21 ' A' ' 14' ' ' ARG . 3.3 mm-40 22.93 77.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 113.708 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 HG12 ' A' ' 150' ' ' VAL . 58.4 t 62.56 94.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.402 -174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.76 88.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.793 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 97.5 mt -100.2 9.45 42.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.005 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.485 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -60.09 -44.52 96.72 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 58' ' ' THR . 52.8 Cg_endo -70.19 -5.78 17.26 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.691 1.594 . . . . 0.0 112.488 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 63' ' ' GLU . 60.6 tp -87.81 -18.38 29.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.781 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.551 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 14.2 m-85 -54.31 -54.92 42.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 47.7 Cg_exo -58.84 -34.74 99.19 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.939 1.759 . . . . 0.0 112.278 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.51 ' HB3' HD12 ' A' ' 60' ' ' LEU . 49.6 tp10 -64.91 -45.7 84.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 60' ' ' LEU . 93.2 t -66.85 -41.88 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.92 -27.13 67.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.332 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 30.6 ttpt -74.01 -55.5 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.447 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 66' ' ' LYS . 89.0 mt-10 -81.26 -51.72 8.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.75 -174.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -118.83 -171.92 2.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.353 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 40.5 mt-10 -104.16 130.71 51.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.696 175.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 64' ' ' VAL . 40.1 tp -102.36 121.23 41.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.2 mp -99.14 118.84 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.429 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.68 142.44 28.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.94 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 82' ' ' LEU . 56.3 Cg_endo -71.69 128.82 14.73 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.752 2.301 . . . . 0.0 112.198 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -119.64 117.49 28.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.916 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.07 106.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -92.43 21.7 5.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 81.15 1.46 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.91 -59.05 0.52 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.322 0.649 . . . . 0.0 110.324 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -58.23 118.26 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.995 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.539 HD12 ' HD1' ' A' ' 136' ' ' TYR . 14.4 tt -110.76 136.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 t -130.81 176.75 7.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.4 mt -119.45 122.51 41.87 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m-85 -110.91 127.27 55.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.097 0.475 . . . . 0.0 111.223 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 23.7 ttp85 -86.75 119.55 27.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.482 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -118.66 145.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.638 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -139.23 22.88 2.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 18.5 t -141.06 122.93 9.27 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.805 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 31.5 Cg_exo -59.92 -31.2 93.37 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.155 2.57 . . . . 0.0 113.315 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.73 1.31 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.3 t -109.11 4.14 22.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.255 0.55 . . . . 0.0 110.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.41 136.61 33.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.651 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.91 159.92 30.33 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.986 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.35 113.95 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.758 0.279 . . . . 0.0 110.54 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.18 -58.15 0.41 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.689 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.68 142.55 47.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.882 0.372 . . . . 0.0 111.702 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 73.22 -54.4 0.69 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.021 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.61 44.35 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.916 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.79 168.94 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 72.8 mtm -91.77 100.01 12.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.151 0.501 . . . . 0.0 110.155 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.74 157.34 37.07 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.828 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.18 115.56 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.963 1.776 . . . . 0.0 110.273 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.04 -45.71 70.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.262 0.553 . . . . 0.0 109.545 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -129.82 -157.04 0.79 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.793 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.77 -161.61 14.21 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.358 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' ARG . 35.9 mt-10 -124.03 111.11 15.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 26.2 ptt180 -74.28 148.11 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.908 0.861 . . . . 0.0 112.754 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.32 136.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.473 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.69 142.82 91.78 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HA ' HG23 ' A' ' 112' ' ' VAL . 9.5 Cg_endo -53.73 -18.42 12.18 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.389 2.726 . . . . 0.0 112.879 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' A' ' 144' ' ' LYS . 43.2 tt0 -64.33 -31.12 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -94.06 4.55 53.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.911 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 109' ' ' PRO . 99.9 t -82.74 120.34 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.22 -46.48 6.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.258 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.61 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 35.7 t80 -125.14 129.93 51.16 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.61 139.17 45.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.596 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB3' HD23 ' A' ' 47' ' ' LEU . . . -110.84 113.47 26.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -118.56 113.74 36.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.98 118.66 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.595 2.197 . . . . 0.0 110.579 171.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -121.16 142.24 15.34 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.689 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.5 106.07 14.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.53 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.266 0.979 . . . . 0.0 112.932 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 161.75 25.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -175.87 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 79.3 mt -68.47 -29.45 68.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.47 -39.19 19.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.121 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.404 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 132.5 31.46 0.46 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.468 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -99.93 156.87 16.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.193 0.521 . . . . 0.0 111.057 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -99.63 157.45 16.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.499 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.089 0.471 . . . . 0.0 109.978 175.281 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.539 ' HD1' HD12 ' A' ' 80' ' ' ILE . 2.1 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.657 0.742 . . . . 0.0 109.264 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.01 -51.96 48.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.571 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -57.71 -37.5 73.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.039 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 82' ' ' LEU . 26.5 tp -58.41 -48.23 81.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.949 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.4 mt -59.18 -37.22 76.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.24 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -89.67 0.4 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.977 0.418 . . . . 0.0 110.7 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.601 ' HE ' ' HA ' ' A' ' 142' ' ' ARG . 1.9 tpm_? -95.3 -29.04 14.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.147 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 145' ' ' GLY . 62.0 t -64.96 107.56 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.079 0.466 . . . . 0.0 110.478 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.683 ' HE3' ' HG3' ' A' ' 110' ' ' GLU . 19.7 pttp -85.66 9.32 16.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 143' ' ' VAL . . . -90.19 -154.66 30.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.201 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 171' ' ' VAL . 31.8 tp -93.27 112.23 24.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.359 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -90.24 108.33 19.69 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.251 0.548 . . . . 0.0 110.175 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 114' ' ' PHE . 59.3 t -97.89 111.26 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.48 112.67 3.5 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 55' ' ' VAL . 18.1 t -105.4 116.73 49.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -156.71 -177.27 6.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.675 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.45 ' HE1' ' H ' ' A' ' 55' ' ' VAL . 74.7 m-85 -93.98 161.01 14.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 t -73.38 -28.96 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.801 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.57 -16.29 60.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.017 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 8.6 tt0 -95.1 7.54 45.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.926 0.87 . . . . 0.0 109.483 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 122.45 57.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.288 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.39 179.44 4.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.031 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.766 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 14.6 mt-10 -87.58 -56.4 3.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.377 0.608 . . . . 0.0 109.801 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.63 104.23 5.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.621 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.79 158.34 35.36 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.758 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.38 101.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.785 1.656 . . . . 0.0 110.397 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -90.71 139.7 30.47 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.2 t70 -75.62 -92.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -165.85 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.008 0.433 . . . . 0.0 109.988 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -102.76 50.78 0.81 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.421 0.629 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -81.75 -167.51 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.916 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 64.6 mt -113.54 103.87 55.4 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 153.87 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.304 2.67 . . . . 0.0 112.049 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.53 172.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.798 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.77 -52.55 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.273 0.559 . . . . 0.0 110.266 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.463 HG23 HD11 ' A' ' 146' ' ' LEU . 57.3 t -123.47 140.43 47.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.745 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.94 110.75 18.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.487 HG13 HG22 ' A' ' 178' ' ' VAL . 54.1 t -103.18 121.94 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 80.4 p -108.8 -173.11 2.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.953 0.406 . . . . 0.0 110.745 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 11.1 pt-20 -69.21 -18.8 63.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.302 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 29.7 mmtp -117.06 -65.37 1.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.403 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.59 168.68 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 112.105 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.613 HG21 HD21 ' A' ' 36' ' ' LEU . 61.4 t -114.45 123.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.51 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -102.94 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.642 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 -83.79 89.53 7.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.404 HD13 ' CA ' ' A' ' 126' ' ' GLY . 80.4 mt . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.991 -165.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 7.6 mtpm? -62.3 -49.32 76.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 17.4 p -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.578 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.32 -58.34 9.05 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.749 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.49 -41.96 91.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.63 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -52.45 -51.57 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.553 ' HB2' ' HZ2' ' A' ' 8' ' ' LYS . 9.9 mtmp? -64.49 -44.9 89.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.455 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.77 -45.78 84.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.551 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 120' ' ' VAL . 60.9 t -68.63 -33.06 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.642 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 15' ' ' ILE . 16.3 mt -56.95 -51.65 68.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -59.98 -43.35 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.15 -0.81 15.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.828 ' HD3' ' HG2' ' A' ' 54' ' ' GLU . 21.0 ttm180 -111.73 -41.21 4.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.73 0.3 . . . . 0.0 111.404 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 11' ' ' LEU . 32.2 pt -90.77 -18.16 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.32 -2.01 57.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.049 0.452 . . . . 0.0 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.76 149.31 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.723 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 m -63.3 132.85 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.51 -36.85 85.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.368 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.36 -35.23 79.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.333 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 42.2 tt0 -72.92 -41.22 64.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.36 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -65.64 -37.05 85.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.711 HH21 ' HB2' ' A' ' 56' ' ' ASP . 3.0 tpm_? -58.51 -47.05 85.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.741 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -59.84 -47.96 83.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.12 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -63.32 -43.27 98.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.841 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 30' ' ' ILE . 70.2 m -61.49 -37.64 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.904 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -58.05 -41.71 83.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 109.896 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.53 -40.59 85.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 25' ' ' LEU . 74.8 t -66.51 -41.43 88.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 26' ' ' SER . 74.9 mt -58.14 -45.06 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -69.63 -33.74 73.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.956 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.56 -44.85 81.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 0.0 110.237 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.699 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 24.4 tp -61.58 -42.6 99.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.07 -13.66 60.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.428 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 t -79.84 -26.61 40.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 33' ' ' LEU . 89.7 mt -60.53 122.52 68.42 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.613 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.3 Cg_exo -66.48 -22.23 52.11 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.722 2.282 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.14 -31.67 68.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.365 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.84 -43.8 97.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.875 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -70.95 -18.68 62.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.492 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -79.56 -38.71 33.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 65.9 m -71.82 120.62 17.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.258 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -107.02 -28.23 10.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -89.04 92.53 9.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 57.9 t -112.4 111.21 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.922 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -102.98 134.68 46.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.199 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 7.4 mp -114.83 145.3 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -86.64 1.78 50.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.476 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.01 90.95 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.109 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.54 103.3 1.41 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.906 2.404 . . . . 0.0 112.314 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 1.7 pp -99.28 169.42 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.032 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 65.46 21.15 11.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.29 0.566 . . . . 0.0 110.019 -172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 -86.44 1.56 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.707 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG2' ' HD3' ' A' ' 14' ' ' ARG . 29.9 mt-10 60.88 -84.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.534 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -145.44 133.48 16.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.711 ' HB2' HH21 ' A' ' 23' ' ' ARG . 60.6 m-20 -71.45 79.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.88 0.372 . . . . 0.0 111.297 -178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 150' ' ' VAL . 90.6 mt -98.34 -16.98 19.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 109.777 174.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 6.5 m -63.69 -50.69 70.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.25 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 20.9 Cg_exo -67.97 3.65 1.87 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.339 2.026 . . . . 0.0 112.824 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -93.28 -9.59 38.49 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.522 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 19.5 m-30 -50.83 -49.65 78.59 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.248 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 73.1 Cg_exo -51.96 -35.76 61.84 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.2 1.933 . . . . 0.0 112.791 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.7 -11.91 49.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 68' ' ' LYS . 29.3 t -93.64 -40.52 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.69 -1.94 4.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 94.1 mttt -84.19 -52.67 6.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.647 0.26 . . . . 0.0 111.268 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.967 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 6.8 pt-20 -119.76 -9.72 9.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.967 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 mptp? -116.32 165.06 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.769 0.795 . . . . 0.0 112.185 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 37.1 mt-10 -98.87 114.79 27.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.326 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -78.93 124.16 27.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.467 . . . . 0.0 110.925 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 55.6 mt -114.48 117.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.199 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.0 mt -119.31 147.64 43.59 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.882 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 47' ' ' LEU . 91.6 Cg_endo -81.21 129.66 6.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.895 2.397 . . . . 0.0 113.443 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -127.34 109.56 11.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.13 105.84 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.201 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -81.08 -10.84 59.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.689 -175.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.04 -42.95 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.705 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -137.14 -39.17 0.61 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.015 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.26 141.4 28.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.32 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -80.36 106.89 12.71 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.0 mt -74.31 117.63 16.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.953 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 5.2 m-85 -102.45 133.1 47.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.135 0.493 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.608 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 12.5 ttp180 -99.5 115.18 28.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.853 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -131.42 148.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.97 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -127.21 18.88 7.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.378 0.609 . . . . 0.0 109.518 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.2 m -139.06 141.72 30.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 6.7 Cg_exo -74.5 -174.53 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.931 2.421 . . . . 0.0 111.947 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.61 -30.49 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 112.237 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.4 m -76.37 1.74 15.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 110.681 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.5 mt -104.38 105.65 15.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.102 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -107.18 -163.16 21.93 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.816 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.91 121.9 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.63 -75.61 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.98 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.23 114.9 1.97 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.513 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 65.93 8.29 5.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.275 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.14 82.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.877 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.96 165.86 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 65.4 mtt -71.07 137.27 48.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.085 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.24 141.73 32.85 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.674 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 7.9 Cg_exo -72.26 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.485 2.123 . . . . 0.0 110.426 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.505 HG23 ' HG2' ' A' ' 103' ' ' GLU . 34.9 m -66.29 -22.53 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.505 ' HG2' HG23 ' A' ' 102' ' ' VAL . 9.3 pt-20 -152.91 166.94 30.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.379 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -171.99 21.62 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -109.45 154.56 22.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.922 0.391 . . . . 0.0 111.19 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.94 157.15 23.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 39.1 t -109.8 136.06 46.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.699 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -67.86 132.35 92.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.56 -41.23 45.19 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.912 2.408 . . . . 0.0 113.247 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.9 -4.11 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.361 0.601 . . . . 0.0 110.847 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.96 -19.28 30.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.491 175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.03 122.69 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.995 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.29 -43.43 5.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.699 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 23.8 t80 -126.03 123.97 39.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.443 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.5 tt -128.0 137.5 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.482 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.08 111.36 22.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.266 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 6.2 p -133.99 123.22 16.82 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.718 -178.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.515 ' HB2' ' H ' ' A' ' 119' ' ' GLY . 1.4 Cg_endo -84.49 -122.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.997 2.465 . . . . 0.0 111.322 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 118' ' ' PRO . . . 114.88 -178.07 17.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.935 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 10' ' ' VAL . 98.5 t -100.27 125.64 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.574 -0.313 . . . . 0.0 111.387 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 128' ' ' ARG . . . 69.43 121.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.208 0.943 . . . . 0.0 112.73 171.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -128.91 158.23 39.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.539 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.528 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 38.9 p30 -137.94 -174.19 3.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.32 -6.62 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -89.99 -27.26 19.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 110.044 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.7 21.99 6.9 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.193 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.34 151.51 21.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.08 0.467 . . . . 0.0 110.91 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -151.41 151.95 32.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 121' ' ' ALA . 10.0 mp . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.142 0.496 . . . . 0.0 110.069 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.709 0.29 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.72 -31.68 72.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 110.192 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -67.34 -29.08 68.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.68 -34.29 46.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.44 -24.39 65.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.391 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -96.43 -4.16 42.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -91.87 -28.33 17.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.211 0.529 . . . . 0.0 110.026 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.88 114.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.63 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -92.56 7.25 44.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.73 166.57 54.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.112 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.16 102.58 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.073 0.463 . . . . 0.0 110.104 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 55.9 mtpt -72.19 102.97 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.728 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 65.6 t -97.7 117.65 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.431 . . . . 0.0 110.594 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -88.93 120.32 5.67 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.534 HG12 HG21 ' A' ' 55' ' ' VAL . 19.0 t -99.08 108.2 21.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -139.94 157.68 45.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.329 0.585 . . . . 0.0 112.212 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.38 155.24 17.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.542 ' OG ' ' HG3' ' A' ' 176' ' ' LYS . 3.7 m -52.14 -29.94 24.28 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.363 0.414 . . . . 0.0 111.762 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -68.81 -20.48 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.597 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -99.46 -2.91 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.69 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -104.44 128.44 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.149 0.5 . . . . 0.0 111.514 -173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.65 -165.99 1.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.643 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 43.0 mt-10 -88.67 -62.3 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 3.0 tpm_? -143.7 112.14 6.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.124 -175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.2 mt -102.99 161.52 22.89 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.657 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.69 140.48 74.71 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.35 2.034 . . . . 0.0 111.307 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 162' ' ' ARG . 47.1 mtt180 -76.41 117.72 18.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 165' ' ' TRP . 23.9 t70 -108.94 128.06 54.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 69.1 -14.81 0.29 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.994 0.809 . . . . 0.0 112.237 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.443 ' H ' ' C ' ' A' ' 163' ' ' ASP . 11.3 m-90 58.0 35.17 25.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.96 0.504 . . . . 0.0 111.366 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.536 ' HB3' HH22 ' A' ' 128' ' ' ARG . 14.1 t0 -68.63 153.31 44.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.663 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 13.4 tt -66.55 125.78 91.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.151 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 62.3 Cg_exo -51.54 151.97 13.19 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.302 2.668 . . . . 0.0 112.917 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 HD12 ' A' ' 181' ' ' LEU . 28.7 m -70.52 161.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.168 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -89.88 -43.61 10.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.186 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 81.4 t -131.66 132.91 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.05 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 55.8 tp -114.84 102.3 9.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.825 0.345 . . . . 0.0 110.1 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.59 111.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -113.31 165.7 12.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.6 -177.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -61.77 -30.8 71.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.014 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' OG ' ' A' ' 153' ' ' SER . 95.1 mttt -82.66 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.52 175.28 10.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.884 0.373 . . . . 0.0 110.535 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.56 114.3 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.649 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.796 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 4.9 tpm_? -93.66 98.97 11.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -75.75 120.09 20.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.536 HD12 HG23 ' A' ' 169' ' ' VAL . 95.4 mt . . . . . 0 C--N 1.323 -0.573 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.754 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 161' ' ' PRO . 63.4 pttt -73.64 -13.77 61.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.219 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -64.26 -30.04 71.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.205 0.526 . . . . 0.0 110.357 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.18 -39.86 32.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.29 -38.26 83.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.735 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -57.87 -41.84 83.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.789 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.96 -39.16 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -57.83 -50.46 73.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.22 -42.64 91.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.499 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 tp -60.17 -35.5 75.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.131 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -58.28 -63.65 1.19 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.941 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -67.1 -27.04 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.304 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' HA ' ' A' ' 120' ' ' VAL . 18.4 ttt180 -60.4 -60.75 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.731 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 11' ' ' LEU . 36.2 pt -80.24 9.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.247 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -92.33 -10.64 37.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD12 ' HG2' ' A' ' 54' ' ' GLU . 87.8 mt -58.19 154.54 12.92 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.717 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . 1.2 m -77.74 160.36 28.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -62.57 -66.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.8 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -31.81 73.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.137 0.494 . . . . 0.0 110.098 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 18' ' ' SER . 39.3 tt0 -58.0 -52.5 65.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.78 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.698 HH12 ' HB2' ' A' ' 56' ' ' ASP . 35.7 ptt85 -70.55 -21.82 62.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.598 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -71.11 -41.77 70.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -72.33 -34.35 67.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' VAL . 90.5 mt -64.03 -41.87 97.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.3 m -63.82 -37.9 89.1 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.526 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -64.66 -39.75 94.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.9 t -74.12 -44.64 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.536 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.8 -37.05 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.77 0.319 . . . . 0.0 110.371 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 t -64.91 -36.41 84.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.463 . . . . 0.0 109.914 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.11 -49.94 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.349 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -31.78 71.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.763 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.11 -32.63 67.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.2 p -80.85 -17.01 52.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.144 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.43 HD23 ' HD2' ' A' ' 37' ' ' PRO . 1.1 tt -55.35 113.03 4.85 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.092 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 36' ' ' LEU . 32.6 Cg_exo -60.31 -39.04 71.02 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.624 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -24.51 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.309 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.54 -27.21 62.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 109.531 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -79.64 -24.11 42.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.572 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -78.17 -46.02 21.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 114' ' ' PHE . 43.4 t -59.85 149.06 32.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.565 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 38.1 tttp -138.17 -21.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.976 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 1.001 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 32.5 mmtp -96.7 92.48 6.21 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.456 HG21 ' HD3' ' A' ' 68' ' ' LYS . 29.2 t -108.17 110.78 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 111.343 -172.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.52 119.66 35.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.774 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 70' ' ' LEU . 7.7 mp -104.9 125.86 51.36 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -80.99 3.3 23.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.314 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m 63.16 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.253 0.549 . . . . 0.0 110.754 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 58.9 Cg_endo -73.12 81.98 1.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.456 2.104 . . . . 0.0 113.521 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.0 pp -81.01 127.65 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt 56.8 32.86 22.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.966 0.889 . . . . 0.0 109.556 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -110.04 104.51 1.85 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.638 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 4.5 mp0 -55.51 -30.39 60.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.572 0.349 . . . . 0.0 111.184 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 6.8 t -78.16 96.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.698 ' HB2' HH12 ' A' ' 22' ' ' ARG . 4.9 t70 -82.71 110.13 17.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.52 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 93.6 mt -99.43 7.36 45.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -67.46 -41.04 29.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD3' ' OD1' ' A' ' 56' ' ' ASP . 31.4 Cg_exo -62.08 -6.02 7.31 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.051 1.834 . . . . 0.0 113.393 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HG3' ' A' ' 63' ' ' GLU . 25.7 tp -87.53 -10.09 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.39 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 7.7 m-85 -55.7 -52.87 68.62 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.7 Cg_exo -53.48 -34.94 74.29 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.272 1.982 . . . . 0.0 112.801 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' A' ' 60' ' ' LEU . 11.5 mm-40 -66.23 -48.56 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.46 -40.39 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.285 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 70' ' ' LEU . 97.2 mt -66.95 -11.12 55.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.722 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 26.3 tptp -77.62 -57.42 3.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' OE2' ' HG3' ' A' ' 68' ' ' LYS . 1.7 pp20? -134.67 -9.98 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 43.8 mttp -95.88 179.6 5.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.186 0.517 . . . . 0.0 111.079 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 65.9 mm-40 -107.56 113.89 27.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.575 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' VAL . 49.3 tp -83.86 110.24 18.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.101 0.477 . . . . 0.0 109.999 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 56.4 mt -100.87 112.51 33.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.924 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 88.2 mt -108.62 145.0 30.69 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.689 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 7.8 Cg_endo -87.57 118.52 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.203 2.602 . . . . 0.0 112.457 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 83' ' ' TYR . 36.0 tttp -105.49 121.37 43.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.883 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.67 105.19 7.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -15.87 61.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.988 0.423 . . . . 0.0 111.164 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.88 -44.51 0.28 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.86 -34.43 0.47 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.601 -0.299 . . . . 0.0 110.458 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -105.6 168.04 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.0 mt -107.17 133.89 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.522 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 t -119.03 132.35 56.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 90.5 mt -84.84 142.18 29.93 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 121.333 -0.147 . . . . 0.0 110.748 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.714 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 1.5 m-85 -116.75 138.45 51.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.588 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 72.2 ttt180 -100.96 104.89 16.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.218 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 13.4 t -133.07 154.59 39.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -148.41 46.0 1.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.59 0.709 . . . . 0.0 109.878 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -171.53 148.91 2.36 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.132 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.74 -61.84 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.483 2.122 . . . . 0.0 111.624 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.01 -93.48 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.3 m -125.94 27.5 6.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.438 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -78.25 114.22 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -127.42 -159.8 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.527 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' HA2' ' A' ' 97' ' ' GLY . 59.0 t -117.15 93.4 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.281 0.562 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -96.1 2.42 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.763 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -68.09 122.37 18.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 74.19 -44.6 0.57 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.648 0.779 . . . . 0.0 112.496 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' HA2' HG13 ' A' ' 93' ' ' VAL . . . 131.23 6.69 3.41 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.113 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.4 pt -84.01 173.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.86 99.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.763 ' HG3' ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -110.35 111.89 57.37 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.86 -172.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.26 106.22 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.694 2.262 . . . . 0.0 111.858 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.3 -40.67 89.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -127.1 -177.65 4.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.467 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -177.65 16.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.837 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 1.5 mm-40 -115.88 154.27 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 111.225 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 12.8 mtm180 -86.58 159.32 19.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.784 -167.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 48.6 t -122.73 126.09 73.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.853 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -84.55 151.52 58.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.997 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 112' ' ' VAL . 52.7 Cg_exo -56.13 -20.06 29.44 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.986 2.457 . . . . 0.0 113.065 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -76.62 -9.44 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.088 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -111.11 2.73 18.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.53 . . . . 0.0 110.38 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 109' ' ' PRO . 86.5 t -74.14 106.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.249 0.547 . . . . 0.0 110.905 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 1.001 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 5.1 t0 -86.47 -54.04 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.468 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 148' ' ' VAL . 37.2 t80 -132.19 132.99 43.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.09 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -133.78 138.97 49.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.834 0.349 . . . . 0.0 110.419 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.54 111.56 19.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.302 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.55 117.35 29.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.402 0.62 . . . . 0.0 110.945 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 50' ' ' PRO . 94.2 Cg_endo -86.89 73.94 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.872 2.381 . . . . 0.0 112.359 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.28 159.92 36.53 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.486 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.535 ' HA ' ' NH1' ' A' ' 14' ' ' ARG . 99.3 t -66.87 -50.1 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.494 0.188 . . . . 0.0 111.361 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.86 24.31 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.894 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -132.16 170.33 15.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.68 -177.02 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.536 0.208 . . . . 0.0 110.463 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.587 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.3 mt -83.2 8.72 12.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -109.38 -28.69 8.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 122.11 13.42 4.92 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.843 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -94.12 161.72 14.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.443 0.64 . . . . 0.0 111.999 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.538 ' HD3' ' OD1' ' A' ' 166' ' ' ASP . 2.1 ptm180 -101.96 147.75 26.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.27 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.658 ' HB2' HD13 ' A' ' 160' ' ' LEU . 53.2 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.907 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.241 0.614 0 CA-C-O 121.88 0.848 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 7.1 p-10 -74.92 7.06 3.44 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.677 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.63 -44.18 82.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 165.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 9.9 tt -71.86 -43.77 64.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.974 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 55.7 mt -58.03 -41.06 82.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.835 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 111.384 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 109' ' ' PRO . 77.5 ttt180 -95.46 -12.48 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.941 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' LEU . 94.6 t -62.88 98.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.315 0.579 . . . . 0.0 110.232 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -95.11 14.1 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.69 0.757 . . . . 0.0 109.855 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.51 -166.26 30.93 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.885 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.574 HD11 HG23 ' A' ' 171' ' ' VAL . 35.9 tp -78.69 112.89 16.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 110.947 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.868 ' HD3' HD11 ' A' ' 167' ' ' ILE . 16.0 mttp -93.86 114.24 26.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 171' ' ' VAL . 74.7 t -109.99 115.76 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.205 0.526 . . . . 0.0 110.887 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.53 130.23 10.02 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 55' ' ' VAL . 21.9 t -115.66 109.76 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -161.6 170.86 19.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.694 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 48.0 m-85 -90.26 171.24 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 64.0 m -62.21 -28.74 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.348 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -86.39 10.87 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.104 0.478 . . . . 0.0 111.561 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -105.07 -7.56 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 167.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.34 116.72 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.395 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -105.88 -179.31 3.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.812 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.587 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 54.3 mt-10 -76.48 -46.84 25.04 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.122 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -150.63 144.25 25.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.361 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' A' ' 129' ' ' LEU . 98.1 mt -128.9 147.13 63.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.362 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 31.2 Cg_exo -60.39 114.75 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.663 2.242 . . . . 0.0 111.82 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 80.3 mtt180 -104.14 147.12 27.8 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.77 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.25 -69.15 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.69 -85.45 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.64 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -120.31 74.29 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.432 0.634 . . . . 0.0 109.511 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.538 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 2.5 t70 -89.37 -174.07 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.729 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.868 HD11 ' HD3' ' A' ' 147' ' ' LYS . 4.1 tt -94.77 125.86 49.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 121.075 0.464 . . . . 0.0 111.801 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 98.0 Cg_endo -93.93 158.54 2.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.336 2.691 . . . . 0.0 111.96 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.45 147.9 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.82 -42.97 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.382 0.611 . . . . 0.0 110.059 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.574 HG23 HD11 ' A' ' 146' ' ' LEU . 98.5 t -125.21 133.69 68.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.209 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 41.4 tp -122.24 105.0 9.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 178' ' ' VAL . 46.8 t -91.25 127.94 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 41.0 p -110.5 -166.24 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.53 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -84.32 -14.5 49.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -92.2 -59.91 1.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.916 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -155.52 170.57 21.66 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.147 0.498 . . . . 0.0 111.957 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 173' ' ' VAL . 97.1 t -83.98 106.69 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.477 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 179' ' ' ARG . 44.3 mtt180 -98.99 93.28 5.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.857 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -72.4 106.66 4.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 C--N 1.324 -0.51 0 O-C-N 123.782 0.676 . . . . 0.0 112.569 -165.953 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.18 -25.31 65.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -75.73 -23.25 56.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.246 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 5.4 mm-40 -77.31 -35.02 55.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 10' ' ' VAL . 48.6 tp -77.66 -29.98 51.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.686 ' HG2' HG11 ' A' ' 120' ' ' VAL . 3.8 ttm-85 -53.26 -49.56 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 55.0 pttt -68.93 -31.44 70.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.832 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.21 -43.51 70.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.6 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 6' ' ' LEU . 39.1 t -70.19 -39.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.34 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.649 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -71.87 -38.57 70.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.263 0.554 . . . . 0.0 110.778 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -60.84 -41.96 96.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.868 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.1 pt -90.68 1.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.677 0.275 . . . . 0.0 111.501 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.59 -26.88 31.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.978 0.418 . . . . 0.0 110.804 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.13 143.67 57.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.788 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -85.96 -176.74 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.22 -52.13 65.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.348 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -52.31 -51.37 59.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.797 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.96 -58.23 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.62 0.248 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -57.43 -50.17 73.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.9 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -62.39 -40.6 97.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.972 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -71.05 -44.61 65.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.903 0.382 . . . . 0.0 110.915 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.2 mt -65.01 -42.44 94.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.819 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -63.2 -39.31 94.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.525 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.29 -43.73 92.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.026 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -55.86 -51.34 67.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.731 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 25' ' ' LEU . 52.0 t -62.86 -42.76 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.389 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 56' ' ' ASP . 79.8 mt -62.51 -50.28 80.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.5 t -59.46 -45.18 92.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -63.4 -41.37 98.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.778 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 35.9 tp -63.33 -42.27 98.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.505 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -73.59 -21.1 60.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.7 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -74.35 -27.34 60.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.312 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 33' ' ' LEU . 89.2 mt -57.63 132.49 82.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.778 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.4 -24.04 77.82 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.32 2.014 . . . . 0.0 110.64 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -63.99 -30.05 71.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.862 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.12 -38.32 82.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.012 0.434 . . . . 0.0 110.506 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -70.48 -26.43 63.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 109.759 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -84.34 -13.36 52.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 m -65.47 121.47 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -106.92 -54.87 2.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.862 0.839 . . . . 0.0 109.086 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.663 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 47.8 mmtt -105.06 99.74 9.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.237 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.58 108.82 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.059 0.456 . . . . 0.0 110.679 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -102.28 138.38 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.097 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.11 144.06 47.82 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 24.0 t80 -82.35 -4.16 56.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.9 m 62.1 92.8 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.728 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.4 133.98 27.6 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.339 2.026 . . . . 0.0 111.749 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -121.19 -35.49 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 0.0 110.083 -177.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.43 41.59 1.11 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.524 -177.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.41 -90.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 35.3 mt-10 54.85 38.23 29.93 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.845 0.379 . . . . 0.0 111.849 168.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 54' ' ' GLU . 81.7 t 73.17 119.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.35 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 30' ' ' ILE . 11.1 m-20 -69.07 83.25 0.33 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.273 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 99.1 mt -89.83 -4.63 57.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.839 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -61.38 -46.88 94.92 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.074 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.71 -3.37 7.9 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.115 1.876 . . . . 0.0 112.951 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 63' ' ' GLU . 23.0 tp -93.23 -9.84 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.388 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 3.1 m-85 -54.28 -54.04 52.45 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.645 177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.4 Cg_endo -56.19 -39.97 87.85 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.362 2.041 . . . . 0.0 112.374 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.452 ' HG3' HD12 ' A' ' 60' ' ' LEU . 7.7 mm-40 -58.47 -42.39 87.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.065 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.82 -46.86 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.18 -24.55 64.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.877 0.37 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -38.5 78.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.093 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.895 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 7.2 pt-20 -138.27 -46.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.895 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 49.6 mttm -96.6 -173.32 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.995 0.426 . . . . 0.0 111.008 -170.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.59 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 39.2 mt-10 -100.14 128.32 46.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.7 tp -100.88 110.83 22.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.4 mt -96.22 119.86 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.292 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.873 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 93.7 mt -122.49 145.6 45.18 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CB ' HD11 ' A' ' 80' ' ' ILE . 72.7 Cg_endo -91.58 127.24 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.045 2.497 . . . . 0.0 113.688 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.788 ' HD3' ' HE2' ' A' ' 83' ' ' TYR . 34.8 tttm -105.98 126.08 51.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.18 128.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.698 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -139.14 100.4 4.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.886 0.374 . . . . 0.0 110.128 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.09 -106.17 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.764 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -124.8 21.3 8.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.426 0.631 . . . . 0.0 109.603 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.75 152.96 35.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.525 HD13 HD22 ' A' ' 139' ' ' LEU . 16.8 tt -128.02 128.0 68.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.422 0.63 . . . . 0.0 110.773 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -104.11 108.61 20.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 139' ' ' LEU . 97.0 mt -85.35 101.1 12.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.788 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 77.2 m-85 -96.17 130.82 43.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.286 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 20.1 ptt180 -92.59 130.17 38.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.15 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.433 -171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -135.17 14.31 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.336 0.588 . . . . 0.0 109.638 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.473 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.0 m -135.09 125.42 17.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.21 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.2 Cg_exo -61.87 -31.56 85.04 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 122.915 2.41 . . . . 0.0 113.423 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.66 -2.25 19.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.72 4.2 51.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.903 0.382 . . . . 0.0 110.663 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.7 mt -104.52 149.06 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.705 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.22 -142.2 6.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 133.06 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -127.27 -98.17 1.0 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.0 114.387 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.32 -2.85 21.82 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -166.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -122.93 -44.56 2.18 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.12 24.82 3.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.879 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.95 173.24 7.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 tpt -69.81 88.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.05 161.63 39.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.295 -172.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.873 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -76.13 125.5 8.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.507 2.138 . . . . 0.0 112.097 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.94 -41.76 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.011 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.99 173.85 11.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.87 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.09 -164.42 25.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.896 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -110.76 122.04 46.82 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.752 -0.264 . . . . 0.0 110.849 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.5 ptm180 -84.31 125.99 32.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 108' ' ' ASN . 3.4 t -122.72 164.28 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.4 ' N ' HG12 ' A' ' 107' ' ' VAL . 14.7 m120 -74.74 153.02 87.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.88 -11.56 24.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.975 2.45 . . . . 0.0 113.314 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -71.03 -20.44 62.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.494 . . . . 0.0 110.455 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.33 -16.44 56.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.459 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.67 124.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.299 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.663 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 19.0 t70 -99.2 -48.41 4.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.508 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.778 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 32.1 t80 -136.9 119.94 16.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -126.15 138.87 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.027 0.442 . . . . 0.0 110.962 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.4 111.4 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.202 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.81 105.8 54.27 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.922 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 48' ' ' TYR . 16.5 Cg_exo -68.59 119.32 6.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.489 2.126 . . . . 0.0 110.941 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.53 153.92 19.67 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.688 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 7' ' ' ARG . 84.1 t -58.77 -49.26 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.188 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.88 36.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.584 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.25 151.84 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 5.0 p-10 -108.36 -163.72 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 97.7 mt -75.69 -19.52 59.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.81 -31.16 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 119.39 35.06 0.96 Allowed Glycine 0 C--O 1.236 0.277 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.529 170.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.96 147.08 35.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.008 0.404 . . . . 0.0 110.16 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.585 ' HB3' ' OD2' ' A' ' 166' ' ' ASP . 25.4 ttp180 -86.78 -12.71 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.083 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.835 ' HB2' HD13 ' A' ' 160' ' ' LEU . 62.0 tp . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.552 0.741 . . . . 0.0 111.034 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 120.96 0.41 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.33 -29.81 57.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.46 -25.96 67.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.659 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 82' ' ' LEU . 34.3 tp -78.43 -58.17 3.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.388 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.83 -30.99 69.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.233 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.57 -23.54 53.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.6 -6.06 44.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 139' ' ' LEU . 97.4 t -80.73 104.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.02 7.3 44.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.62 -168.5 44.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.987 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.69 104.01 15.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.502 ' HA ' HG23 ' A' ' 115' ' ' ILE . 9.9 mtmp? -86.24 102.74 14.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.163 0.506 . . . . 0.0 110.22 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.4 116.86 43.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.641 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.99 121.72 5.56 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 29' ' ' VAL . 85.3 t -109.33 120.3 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.87 169.81 21.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 111.597 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' A' ' 155' ' ' GLN . 41.4 m-85 -86.3 168.86 13.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -77.15 -19.84 56.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 109.548 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -69.01 -10.2 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.487 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 152' ' ' TYR . 59.9 mm-40 -111.29 10.26 21.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.625 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.74 131.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.15 -168.73 1.81 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.602 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 34.1 mt-10 -80.02 -59.27 2.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 109.971 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.4 mmt85 -147.2 144.94 29.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.709 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 129' ' ' LEU . 68.6 mt -101.92 137.19 19.45 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 12.0 Cg_exo -70.88 101.92 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.636 2.224 . . . . 0.0 111.075 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 0.5 OUTLIER -130.67 178.33 6.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.211 -174.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -73.45 -67.2 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HA ' HH11 ' A' ' 162' ' ' ARG . . . -151.41 -89.28 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.005 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -116.7 78.12 1.17 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.024 0.44 . . . . 0.0 110.836 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 128' ' ' ARG . 34.9 t70 -70.08 134.66 48.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 62.8 mt -55.97 114.79 8.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 112.057 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.76 175.95 7.38 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.272 2.648 . . . . 0.0 112.851 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.12 160.56 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 14.0 m-20 -87.89 -35.14 17.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.239 0.542 . . . . 0.0 109.924 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.4 t -133.26 143.44 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.483 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 181' ' ' LEU . 56.7 tp -115.64 117.61 30.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.71 116.2 51.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.013 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 70.9 p -109.92 -167.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.747 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 10.4 pt-20 -68.19 -17.42 64.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.199 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 9.8 mtmp? -128.71 -66.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -109.41 152.63 25.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.282 0.563 . . . . 0.0 112.077 -171.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.473 HG21 HD21 ' A' ' 36' ' ' LEU . 61.2 t -118.64 133.87 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.904 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -129.49 146.34 51.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.994 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -89.57 117.06 28.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 172' ' ' LEU . 70.5 mt . . . . . 0 C--N 1.321 -0.673 0 CA-C-O 121.175 0.512 . . . . 0.0 110.869 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -76.5 -10.03 59.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -97.36 -48.33 5.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.181 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.51 -36.36 83.95 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.136 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -53.46 -41.01 65.73 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.386 0.429 . . . . 0.0 111.133 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 7' ' ' ARG . 44.1 ttm180 -65.65 -35.17 80.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.168 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.35 -34.91 17.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -60.17 -52.4 65.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.054 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 98.0 t -62.3 -46.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.482 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 tp -59.77 -42.8 94.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.667 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -61.02 -44.13 97.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.899 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -71.73 -31.18 66.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.241 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 80.0 mtp180 -64.0 -53.6 47.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.715 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 11' ' ' LEU . 26.4 pt -78.44 8.57 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.005 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -94.98 -9.04 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.478 0.656 . . . . 0.0 109.523 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 54' ' ' GLU . 92.8 mt -68.92 141.06 55.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.504 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -69.4 153.29 43.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 111.251 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 9.4 tp10 -56.64 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.768 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.57 -44.07 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.276 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 7.3 tp10 -61.18 -39.71 91.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 42.0 ttt180 -55.1 -47.96 74.24 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.577 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.3 mmt180 -62.56 -32.23 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.78 -29.78 68.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.382 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 59.0 mt -79.34 -40.43 30.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.263 0.554 . . . . 0.0 110.31 176.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 19.9 m -59.6 -40.02 86.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.906 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.78 -32.07 73.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.439 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 91.0 mttt -60.24 -53.98 51.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.86 -43.1 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.557 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.28 -46.46 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.979 0.419 . . . . 0.0 110.508 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 t -65.38 -42.81 92.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.938 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -70.02 -43.33 71.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.595 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 36' ' ' LEU . 28.0 tp -66.89 -34.67 78.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -86.31 -3.37 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.15 0.5 . . . . 0.0 110.625 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.53 -28.12 31.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 178' ' ' VAL . 70.2 mt -61.45 123.77 77.94 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.141 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.46 -20.5 41.71 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.485 2.123 . . . . 0.0 112.162 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.28 -22.08 55.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.778 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -72.18 -14.99 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.08 -33.5 14.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.249 177.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.71 -38.23 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.624 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 p -61.89 152.0 33.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 42' ' ' SER . 12.8 mptt -132.71 -25.75 1.85 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.848 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 3.3 mptp? -103.9 95.52 6.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 60.9 t -111.4 118.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 111.169 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -106.17 124.34 49.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.204 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.55 123.68 48.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.96 -7.54 49.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.921 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 68.4 m 70.93 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 123.326 0.65 . . . . 0.0 111.964 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 2.9 Cg_exo -75.37 95.48 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.952 2.435 . . . . 0.0 112.132 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 52' ' ' LYS . 27.2 pt -78.39 -40.21 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.097 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 51' ' ' ILE . 94.7 mttt -129.28 103.13 6.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.74 172.6 35.73 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.578 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -93.9 -10.3 34.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.923 0.392 . . . . 0.0 110.29 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG12 ' HG ' ' A' ' 57' ' ' LEU . 57.4 t -75.13 109.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 8.0 m-20 -90.54 84.09 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.512 . . . . 0.0 111.854 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.585 ' HG ' HG12 ' A' ' 55' ' ' VAL . 94.0 mt -96.18 -10.7 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.533 0.682 . . . . 0.0 109.248 171.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.475 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 5.6 m -61.17 -49.62 87.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.121 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 58' ' ' THR . 49.2 Cg_endo -69.22 2.27 3.37 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.01 1.807 . . . . 0.0 113.501 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 64' ' ' VAL . 21.2 tp -94.84 -8.17 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.048 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 19.9 m-85 -53.98 -51.53 76.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 12.2 Cg_endo -56.34 -36.17 96.82 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.553 2.168 . . . . 0.0 112.515 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 66' ' ' LYS . 51.8 tp10 -71.58 -41.78 68.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' LEU . 77.0 t -57.97 -43.37 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.53 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.09 -1.52 7.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 63' ' ' GLU . 54.4 mttp -88.93 -26.39 21.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -112.0 -50.66 2.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.112 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 27.6 mtmm -131.83 -174.31 3.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.921 -168.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 36.7 mt-10 -96.84 142.48 28.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.52 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.97 109.4 21.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.24 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 66.9 mt -98.56 118.22 44.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.102 0.477 . . . . 0.0 110.057 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.83 145.81 34.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.063 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' CB ' HD11 ' A' ' 80' ' ' ILE . 87.5 Cg_endo -89.34 120.33 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.183 2.589 . . . . 0.0 113.118 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.831 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 tttt -106.18 117.18 33.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG11 ' HE2' ' A' ' 96' ' ' PHE . 58.7 t -85.36 109.18 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -131.27 98.94 4.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.726 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.81 19.46 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m120 71.15 -36.11 0.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 112.181 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.87 143.52 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.501 HD13 HD22 ' A' ' 139' ' ' LEU . 15.5 tt -98.94 132.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.181 0.515 . . . . 0.0 111.426 -173.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.9 t -120.9 124.19 44.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.377 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 73' ' ' PRO . 77.5 mt -87.13 130.23 34.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.069 0.461 . . . . 0.0 110.85 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.659 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 9.8 m-85 -106.91 126.26 52.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.616 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 71.3 ttt180 -85.45 92.67 8.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.424 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.77 111.59 23.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.537 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.406 ' HD2' ' HG2' ' A' ' 84' ' ' ARG . 4.8 p80 -120.58 20.13 11.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.497 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 p -162.15 122.23 1.49 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.035 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.96 41.57 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.029 2.486 . . . . 0.0 112.97 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.74 -36.53 15.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.767 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.9 m -131.17 102.79 6.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.459 . . . . 0.0 111.428 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.0 mt -140.97 153.4 45.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.852 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.59 160.61 30.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.974 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.59 112.91 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.23 -154.96 6.63 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.357 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.32 -127.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.567 0.347 . . . . 0.0 110.701 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HE2' HG11 ' A' ' 75' ' ' VAL . 88.4 m-85 -85.39 17.64 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.828 0.347 . . . . 0.0 110.812 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 46.8 2.73 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.74 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.0 pt -124.27 170.31 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.823 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.54 93.31 7.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.063 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.831 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 4.3 pt-20 -104.83 109.86 63.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 31.7 Cg_exo -59.63 127.41 23.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.377 2.051 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.43 -56.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.717 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.57 -176.79 4.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.53 -159.84 22.95 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.387 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -96.45 96.85 8.98 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -77.91 120.45 22.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.66 147.72 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.206 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.8 t-20 -58.58 138.91 85.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.463 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' ASN . 53.7 Cg_exo -53.92 -16.22 8.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.573 2.849 . . . . 0.0 114.271 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 42.7 tt0 -61.61 -28.18 69.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.397 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.34 -28.99 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 111.145 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 44' ' ' LYS . 40.5 t -65.41 121.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.33 -20.77 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.603 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 32.6 t80 -135.96 114.34 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 143' ' ' VAL . 16.2 tt -121.28 139.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.15 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.91 106.48 17.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.259 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.35 123.48 34.95 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.773 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -92.84 -163.42 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.01 2.473 . . . . 0.0 112.004 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.73 -176.68 44.14 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.6 -41.46 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 117.046 0.423 . . . . 0.0 110.749 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.68 161.51 38.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.337 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.44 158.59 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.564 0.54 . . . . 0.0 109.781 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 9.3 p30 -120.34 -172.1 2.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.349 . . . . 0.0 110.678 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.5 mt -98.83 7.69 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.465 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -103.38 -30.3 10.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 133.9 -4.09 4.61 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.226 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -88.86 163.38 15.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.24 0.543 . . . . 0.0 111.215 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 128' ' ' ARG . 7.6 mtm-85 -126.15 157.02 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.278 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.141 0.496 . . . . 0.0 110.546 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.869 0.366 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 6.9 p-10 -67.56 -33.34 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -70.27 -8.42 50.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 80' ' ' ILE . 21.2 tp -93.58 -72.27 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.439 ' HA ' HG23 ' A' ' 143' ' ' VAL . 95.5 mt -66.36 -17.7 64.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.313 -171.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.706 ' HG3' ' HB ' ' A' ' 167' ' ' ILE . 83.8 tttt -92.95 -12.1 31.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.671 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -121.33 0.95 10.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.323 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 115' ' ' ILE . 92.8 t -50.35 121.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.0 111.06 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 58.1 mtpt -87.82 -11.38 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.099 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.45 176.82 51.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.208 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.29 110.72 3.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.833 0.349 . . . . 0.0 110.686 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 143' ' ' VAL . 11.6 mmmm -72.47 100.11 2.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.815 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.59 124.92 59.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.359 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -102.08 129.48 9.91 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.19 121.25 66.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.935 0.367 . . . . 0.0 110.84 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.27 165.51 31.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.264 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.579 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 47.8 m-85 -92.2 -178.79 5.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 t -68.47 -22.31 64.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.185 0.516 . . . . 0.0 109.973 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -72.75 -18.04 61.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.164 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.519 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.6 mp0 -95.64 -7.44 37.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.322 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.25 116.61 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.068 0.461 . . . . 0.0 111.701 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.55 174.35 6.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.372 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 26.8 mm-40 -74.26 -60.29 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 110.54 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 34.8 ttt180 -145.97 129.2 16.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 84.7 mt -93.62 160.7 32.31 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.194 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.59 101.64 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.221 . . . . 0.0 111.614 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -80.07 148.26 31.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.204 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -77.1 -60.92 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 169.54 -39.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.137 0.975 . . . . 0.0 109.711 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.467 ' O ' ' HE3' ' A' ' 141' ' ' LYS . 8.3 m-90 -136.13 21.83 3.24 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.06 149.75 18.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.896 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.706 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 6.6 tp -93.79 113.56 60.77 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.227 -175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 167' ' ' ILE . 57.6 Cg_endo -71.53 174.74 10.5 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.463 2.109 . . . . 0.0 112.853 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.78 157.94 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.961 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -91.91 -42.6 9.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.9 122.21 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.4 tp -106.35 108.0 19.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.056 0.455 . . . . 0.0 109.874 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.16 118.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.064 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 79.7 p -114.36 -178.93 3.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 14.9 pt-20 -71.61 -15.26 62.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.575 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.541 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 99.8 mttt -105.7 -60.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.544 -174.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.17 172.57 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 111.498 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 36' ' ' LEU . 23.6 t -115.09 98.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.545 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -94.49 117.79 30.67 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.561 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.01 111.25 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.155 174.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.458 HD13 ' HA2' ' A' ' 126' ' ' GLY . 64.5 mt . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.3 0.571 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -69.23 -34.9 75.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.536 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -70.84 -44.48 66.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.4 -36.83 79.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.686 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.62 -50.85 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.297 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -62.29 -42.24 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.543 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.36 -33.74 75.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.653 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 29.6 ttmt -81.78 -46.03 14.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.312 -176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.22 -35.79 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.302 0.573 . . . . 0.0 110.365 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.7 tp -59.31 -37.13 76.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.938 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -58.6 -41.79 86.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.056 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -74.69 -40.67 61.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.523 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.632 HH11 ' HA ' ' A' ' 120' ' ' VAL . 15.7 ptm180 -70.4 -37.47 74.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.346 -175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 11' ' ' LEU . 33.4 pt -82.83 -0.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.822 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -81.45 -24.88 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.61 137.34 57.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.591 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 t -122.7 -166.59 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.823 -175.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -66.53 -4.59 8.81 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.9 -65.03 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.033 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 10.2 tp10 -76.47 -42.06 45.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.684 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 34.2 ttp85 -66.95 -26.47 66.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 -175.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 54.1 ttt85 -58.97 -49.15 78.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -79.71 -25.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 68.3 mt -63.63 -56.04 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.743 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 50.4 m -67.7 -32.99 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.028 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -58.94 -47.59 84.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 109.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 175' ' ' GLU . 49.6 mtpt -59.44 -39.57 84.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.025 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 175' ' ' GLU . 94.8 t -63.38 -50.31 79.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.716 0.293 . . . . 0.0 110.624 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 74.7 mt -58.86 -49.92 81.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.1 m -64.17 -36.95 85.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.718 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.7 -44.94 80.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.125 0.488 . . . . 0.0 109.978 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.5 tp -62.66 -39.43 93.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.746 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 28.0 mtpp -75.94 -14.12 60.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.249 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -84.54 -19.63 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 110.088 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.55 114.3 18.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -56.4 -32.71 89.79 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.291 2.661 . . . . 0.0 113.829 -171.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.45 -23.86 61.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.604 0.24 . . . . 0.0 111.056 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.1 -41.77 94.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.007 0.432 . . . . 0.0 110.552 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -85.67 -10.29 55.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.757 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -9.7 30.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -101.94 -176.77 3.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -136.0 -55.03 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.798 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 30.5 mtpt -89.07 101.99 14.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 111.194 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.89 119.78 62.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.57 131.67 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.392 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.95 138.67 50.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.74 -1.73 36.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.513 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.4 t 73.83 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.387 0 C-N-CA 123.47 0.708 . . . . 0.0 111.587 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.39 49.77 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.097 2.531 . . . . 0.0 112.259 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.792 HG13 ' H ' ' A' ' 52' ' ' LYS . 14.1 pt -56.46 -62.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.895 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.792 ' H ' HG13 ' A' ' 51' ' ' ILE . 94.4 mttt -122.29 9.29 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.719 0.771 . . . . 0.0 110.044 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.26 128.37 9.08 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -84.17 10.55 9.98 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -169.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.671 HG12 ' HG ' ' A' ' 57' ' ' LEU . 92.3 t -63.61 104.43 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.75 77.82 5.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.463 0.649 . . . . 0.0 111.145 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' A' ' 55' ' ' VAL . 96.6 mt -94.03 -2.08 53.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.178 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.496 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -56.65 -44.82 99.91 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.422 -178.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.8 Cg_endo -69.74 1.44 4.42 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.22 1.947 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.01 -18.36 24.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.294 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.83 -44.35 97.93 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 95.2 Cg_exo -45.49 -39.26 16.94 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.328 2.019 . . . . 0.0 113.244 174.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -77.68 -44.76 26.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 68' ' ' LYS . 65.1 t -57.25 -42.84 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.413 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.48 -4.13 17.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 95.5 mttt -98.4 -59.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 6.4 pt-20 -105.45 -17.62 14.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.63 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 45.4 mmtm -111.76 168.51 9.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.455 0.645 . . . . 0.0 111.666 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.798 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.4 mm-40 -102.12 103.16 13.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.984 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.58 100.54 6.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 58.2 mt -91.86 114.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.5 mt -114.79 141.81 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.728 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.6 Cg_exo -80.11 129.19 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.868 2.379 . . . . 0.0 112.071 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 36.3 tttm -105.54 100.39 9.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 80' ' ' ILE . 35.1 t -69.73 98.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -146.92 134.58 21.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.274 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 -92.1 0.47 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.651 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.24 10.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.979 0.419 . . . . 0.0 109.954 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -125.96 154.04 43.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.911 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD13 ' A' ' 139' ' ' LEU . 6.2 pt -96.62 92.46 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 166.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.1 t -80.52 110.85 16.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.846 -170.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.97 121.98 22.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.726 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 97.1 m-85 -121.85 148.94 44.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.006 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -88.45 134.92 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.09 126.86 68.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.848 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -124.05 -1.23 8.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.229 0.538 . . . . 0.0 110.004 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -153.97 151.11 24.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 -174.46 0.84 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.946 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.0 -36.09 0.35 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.193 0.597 . . . . 0.0 111.884 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.94 -3.46 16.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.501 0.667 . . . . 0.0 111.238 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.27 123.68 39.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.28 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.02 135.78 9.56 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.708 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.0 t -82.92 94.37 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.63 -24.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.385 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.19 -156.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 0.0 111.328 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.59 55.98 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.156 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.14 16.48 43.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.037 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 36.2 pt -120.27 165.29 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.85 90.47 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.021 0.438 . . . . 0.0 110.607 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.714 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -88.98 147.54 38.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.514 -177.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 18.3 Cg_endo -61.19 114.46 2.21 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.745 2.297 . . . . 0.0 112.092 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -91.07 -52.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.317 0.58 . . . . 0.0 109.876 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -97.54 87.18 4.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.152 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.54 170.69 35.83 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.198 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.48 137.04 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.764 0.282 . . . . 0.0 110.936 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -77.88 133.54 38.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.753 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.89 135.88 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.737 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -87.02 146.73 41.2 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.593 ' HB3' ' HA ' ' A' ' 143' ' ' VAL . 50.9 Cg_exo -55.39 -25.05 46.16 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.06 2.507 . . . . 0.0 113.371 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 144' ' ' LYS . 43.2 tt0 -72.87 -20.33 61.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.165 0.507 . . . . 0.0 110.962 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -100.23 7.13 44.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.18 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.445 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 60.0 t -94.32 111.88 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.06 -54.22 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -124.67 139.34 53.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.603 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 147' ' ' LYS . 4.5 tp -134.22 108.24 10.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.435 0.636 . . . . 0.0 109.561 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.79 112.07 24.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.948 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.11 113.86 51.58 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 150' ' ' VAL . 3.8 Cg_exo -76.52 91.72 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.801 2.334 . . . . 0.0 111.341 175.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.98 158.27 48.03 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.896 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' HH11 ' A' ' 14' ' ' ARG . 57.5 t -74.7 -39.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 110.013 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.539 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -147.76 155.93 42.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.898 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -135.21 153.19 52.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.425 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.605 ' HB3' ' H ' ' A' ' 127' ' ' TYR . 15.3 t70 -78.62 164.72 24.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.268 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.888 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 13.3 mt -55.44 -32.46 62.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 181' ' ' LEU . 46.6 mt-10 -87.53 -64.57 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 172' ' ' LEU . . . 165.11 53.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.85 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.605 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 51.2 m-85 -99.46 161.15 13.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 166' ' ' ASP . 40.3 ptt180 -93.27 155.6 17.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 112.451 -167.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.644 ' HB2' HD13 ' A' ' 160' ' ' LEU . 40.7 tp . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.381 168.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.4 -35.99 60.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.045 0.538 . . . . 0.0 111.813 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -60.47 -33.4 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.052 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.675 HD13 HG13 ' A' ' 80' ' ' ILE . 9.1 tt -83.43 -44.26 14.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.43 -18.11 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.775 0.322 . . . . 0.0 111.325 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 141' ' ' LYS . 4.2 ttmp? -89.16 -15.5 33.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.065 0.46 . . . . 0.0 109.883 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.59 -21.82 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 60.7 t -63.58 127.73 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.163 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD2' ' HG3' ' A' ' 110' ' ' GLU . 96.9 mttt -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 112' ' ' VAL . . . -79.63 -170.93 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.123 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.41 110.98 16.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.982 0.42 . . . . 0.0 109.95 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HA ' HG23 ' A' ' 115' ' ' ILE . 95.7 mttt -86.47 109.38 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 63.0 t -106.34 122.25 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.82 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.34 119.66 6.01 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 47.7 t -105.95 117.96 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.69 0.281 . . . . 0.0 110.982 -175.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.35 -178.08 6.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.894 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 35.0 m-85 -106.53 165.63 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -56.48 -30.44 62.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.21 -32.32 72.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.076 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.414 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 12.2 mm100 -90.89 -7.97 50.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.77 117.88 33.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.965 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.63 174.48 5.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.888 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 45.9 mt-10 -69.69 -57.58 4.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 111.267 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.6 ttm105 -144.77 118.58 9.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 -169.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 129' ' ' LEU . 74.8 mt -98.53 141.19 22.51 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.698 0.285 . . . . 0.0 111.452 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.18 113.19 3.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.814 2.343 . . . . 0.0 111.666 174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -98.42 149.37 22.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.62 -75.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.235 -172.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -149.25 -76.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -100.05 69.05 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 109.393 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.4 ' HA ' ' NH2' ' A' ' 128' ' ' ARG . 13.9 t70 -76.04 149.63 37.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.329 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.408 HD11 ' HZ1' ' A' ' 141' ' ' LYS . 65.9 mt -110.87 107.41 57.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.835 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.56 154.59 31.25 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.824 2.349 . . . . 0.0 111.214 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 m -88.39 158.96 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.343 -0.39 . . . . 0.0 109.992 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -88.57 -42.46 12.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.518 0.675 . . . . 0.0 109.502 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 75.7 t -126.35 116.48 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.496 176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 35.2 tp -99.87 103.65 15.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.911 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.05 125.87 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.128 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 54.0 p -107.83 -166.74 1.17 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.403 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.649 ' HB2' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.54 9.51 36.41 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.697 174.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -125.79 -55.21 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.556 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.12 160.03 39.91 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 111.505 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.411 HG12 ' HG3' ' A' ' 180' ' ' ARG . 64.9 t -101.2 113.98 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.96 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -92.49 93.66 8.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.728 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 178' ' ' VAL . 86.1 mtm180 -86.18 121.24 28.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.642 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 125' ' ' GLU . 39.5 mt . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 4' ' ' SER . 50.0 tp . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -28.02 66.36 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.565 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.542 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 12.2 m -70.44 -35.72 73.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.115 0.484 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 33.5 tt0 -61.92 -53.73 51.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.859 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 10' ' ' VAL . 65.5 tp -57.66 -45.04 86.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.808 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 120' ' ' VAL . 18.0 ttp180 -55.32 -42.35 73.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.497 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.64 -37.0 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 110.601 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HE2' ' HG2' ' A' ' 5' ' ' GLU . 64.7 mttm -65.03 -37.71 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.413 0.625 . . . . 0.0 110.09 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' LEU . 46.3 t -69.5 -38.93 77.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.637 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.99 -37.43 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.275 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -56.18 -47.75 77.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.059 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 10' ' ' VAL . 62.6 pttt -77.23 -0.17 24.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.585 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 41.6 ttm180 -93.05 -48.86 6.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.672 ' HA ' HH12 ' A' ' 22' ' ' ARG . 31.3 pt -85.54 -11.97 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -89.54 5.16 46.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.124 0.488 . . . . 0.0 110.846 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.97 149.85 42.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.432 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -70.67 146.7 49.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -62.39 -40.35 96.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -52.15 -52.47 51.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.522 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 6.2 pt-20 -81.03 -31.32 34.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.24 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.672 HH12 ' HA ' ' A' ' 15' ' ' ILE . 35.9 ttm-85 -57.04 -49.44 75.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.861 0.362 . . . . 0.0 110.82 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.71 -31.57 70.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -80.22 -34.96 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' VAL . 92.7 mt -65.13 -46.12 82.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 30' ' ' ILE . 20.2 m -64.15 -33.38 75.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.518 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.06 -43.0 99.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.12 -39.63 86.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.355 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' LEU . 64.9 t -65.19 -46.03 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 26' ' ' SER . 76.0 mt -58.98 -46.96 91.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 110.171 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -60.02 -45.66 92.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.48 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.84 -45.08 95.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.427 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.48 -42.46 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.379 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -71.1 -26.18 62.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.014 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 m -73.18 -23.67 60.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.8 mt -60.16 122.08 63.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.306 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 33.8 Cg_exo -60.61 -21.29 68.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.166 2.577 . . . . 0.0 112.913 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -75.49 -39.65 58.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.94 -37.49 76.83 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.387 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -67.3 -37.7 83.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 3.7 tmmm? -78.57 -52.37 8.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.124 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -60.84 131.1 49.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -90.51 -42.49 10.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.91 106.9 18.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.98 0.419 . . . . 0.0 110.322 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.84 108.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.337 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -94.54 117.49 30.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -104.89 122.03 44.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.648 ' HA ' ' HG3' ' A' ' 73' ' ' PRO . 8.9 t80 -76.73 -6.5 52.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.563 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.3 m 69.75 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 121.43 0.633 . . . . 0.0 111.621 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.54 125.74 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.506 2.137 . . . . 0.0 112.923 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.66 145.22 16.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 69.1 -41.4 0.47 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.414 0.686 . . . . 0.0 111.765 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.12 -76.8 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.819 ' HA ' ' HD3' ' A' ' 14' ' ' ARG . 6.3 mm-40 56.69 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.889 0.875 . . . . 0.0 111.305 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 150' ' ' VAL . 95.8 t -153.33 128.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.434 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -82.12 90.15 6.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.204 0.526 . . . . 0.0 110.881 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.583 HD11 HG11 ' A' ' 150' ' ' VAL . 89.1 mt -102.2 6.61 40.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.837 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -61.03 -43.81 92.27 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.065 -175.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 58' ' ' THR . 19.3 Cg_endo -61.2 -7.07 7.5 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.121 1.881 . . . . 0.0 113.886 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.34 -13.93 39.48 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.456 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.1 m-85 -52.48 -49.77 83.82 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.4 Cg_exo -52.36 -36.05 67.32 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.41 2.073 . . . . 0.0 113.225 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mt-10 -74.18 -31.42 62.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.014 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.19 -36.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.429 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -68.04 -5.01 15.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.582 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 43.4 tttp -66.87 -64.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.742 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 11.2 pt-20 -143.92 -4.05 0.85 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 6.3 mptp? -92.92 164.08 13.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.337 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.83 ' HG3' ' HB2' ' A' ' 84' ' ' ARG . 3.0 tp10 -97.3 103.46 15.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.227 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.8 tp -76.78 94.11 3.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 0.0 110.758 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 56.4 mt -88.49 112.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 86.2 mt -110.06 149.59 40.27 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.663 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 48' ' ' TYR . 9.6 Cg_endo -89.23 125.6 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.376 2.717 . . . . 0.0 113.097 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -105.62 105.63 15.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.429 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 80' ' ' ILE . 21.3 t -82.58 95.4 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.345 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.12 5.97 18.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.659 0.742 . . . . 0.0 109.835 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.49 -153.12 18.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -78.36 -6.24 54.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.109 0.48 . . . . 0.0 110.495 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.99 143.46 46.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.145 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 75' ' ' VAL . 49.6 mm -100.47 122.81 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.129 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m -85.84 122.67 30.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.506 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -101.32 133.19 46.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.684 0.278 . . . . 0.0 110.685 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . 93.9 m-85 -128.77 146.02 51.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.83 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 38.3 ptt85 -100.03 134.35 43.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.117 0.484 . . . . 0.0 110.012 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.78 139.38 51.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -124.76 -28.27 3.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.309 171.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.3 m -108.12 131.62 21.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 -10.14 25.35 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.141 2.561 . . . . 0.0 113.441 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.92 60.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.416 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 41.8 m -85.44 8.39 19.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.027 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.6 138.04 39.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.98 0.419 . . . . 0.0 111.5 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.86 176.41 20.68 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.549 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.78 90.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.846 0.355 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.98 -16.26 7.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.591 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.7 -171.05 3.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.303 0.241 . . . . 0.0 110.984 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -53.48 -53.66 48.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.102 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.85 50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.727 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.5 157.42 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.27 147.06 32.42 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.459 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 83' ' ' TYR . 72.9 Cg_endo -80.11 105.98 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.209 1.939 . . . . 0.0 111.458 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.71 -19.43 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.833 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -137.03 -171.97 3.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.916 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.53 -132.63 11.07 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 137.88 32.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -80.54 156.07 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.478 . . . . 0.0 111.68 -175.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.24 142.98 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.407 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -89.94 141.67 28.29 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.721 ' HB3' HG22 ' A' ' 143' ' ' VAL . 87.0 Cg_exo -46.7 -40.41 24.24 Favored 'Trans proline' 0 N--CA 1.476 0.441 0 C-N-CA 123.647 2.898 . . . . 0.0 114.225 -175.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.28 -19.27 64.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.41 -17.82 50.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.22 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 118.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.696 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -76.31 -55.66 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.33 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 148' ' ' VAL . 40.8 t80 -128.35 136.35 50.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.684 -173.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -139.06 139.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.98 113.17 25.82 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.073 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 47.8 t -111.98 124.73 31.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.878 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 4.9 Cg_exo -77.83 131.04 10.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.104 2.536 . . . . 0.0 111.804 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.88 140.18 11.56 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.539 HG11 ' HG2' ' A' ' 7' ' ' ARG . 48.6 t -70.93 -43.55 76.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 117.016 0.408 . . . . 0.0 110.836 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -143.42 130.91 21.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.74 169.29 9.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.01 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 26.4 p30 -132.1 -172.35 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.583 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 88.9 mt -87.29 3.17 47.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.27 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.96 -31.96 10.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.421 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 117.75 29.86 1.95 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.091 169.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.23 156.61 16.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.534 0.667 . . . . 0.0 109.865 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 167' ' ' ILE . 0.0 OUTLIER -101.45 -33.42 9.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -163.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 160' ' ' LEU . 35.6 tp . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.416 0.627 . . . . 0.0 111.908 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.8 t70 -70.38 161.05 31.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 137' ' ' ASP . 28.4 ttt180 72.93 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 137' ' ' ASP . 30.8 tp -65.46 -65.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.661 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.69 ' HB2' HD13 ' A' ' 167' ' ' ILE . 97.4 mt -71.64 -11.99 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.573 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.61 -23.84 39.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 0.0 110.106 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -96.2 -35.75 11.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.705 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.3 t -73.39 93.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -101.91 26.37 7.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.431 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.95 -175.24 31.86 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.268 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -71.58 98.14 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.119 0.459 . . . . 0.0 109.931 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.518 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.8 mtmm -84.74 102.89 13.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 171' ' ' VAL . 98.6 t -103.49 119.89 52.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.663 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.46 130.85 10.1 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 57' ' ' LEU . 51.0 t -114.61 119.51 61.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -163.71 171.58 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.528 ' HB3' ' OE2' ' A' ' 175' ' ' GLU . 57.1 m-85 -87.21 162.53 17.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 156' ' ' VAL . 5.8 p -77.35 -9.94 59.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 0.0 110.46 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -61.67 -29.64 70.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -105.86 20.43 18.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 111.281 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 153' ' ' SER . 64.0 t -103.42 116.27 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.944 0.402 . . . . 0.0 110.546 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -100.84 -171.57 2.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.262 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.518 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 13.0 mt-10 -92.02 -44.76 8.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -147.59 125.05 11.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.376 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 97.4 mt -84.89 143.97 41.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.643 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 3.7 Cg_exo -74.95 102.26 1.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.812 2.341 . . . . 0.0 110.548 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 28.6 mtt180 -108.87 155.83 20.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 -172.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.58 -55.38 24.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.15 -50.61 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.147 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -129.28 83.74 2.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.853 0.835 . . . . 0.0 111.368 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.01 151.2 33.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 167.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 140' ' ' LEU . 64.6 mt -75.05 113.46 25.2 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.81 0.338 . . . . 0.0 110.676 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -88.88 161.36 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.044 2.496 . . . . 0.0 113.186 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.17 176.45 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.166 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -99.28 -45.29 5.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.368 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.9 t -129.04 141.13 47.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.658 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 68.5 tp -117.51 115.56 25.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.98 122.73 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 77.1 p -115.79 -174.38 2.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 111.021 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.859 ' HG3' ' HD2' ' A' ' 176' ' ' LYS . 11.6 pt-20 -70.39 -13.68 62.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.096 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.859 ' HD2' ' HG3' ' A' ' 175' ' ' GLU . 10.1 mptt -121.67 -70.38 0.78 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -110.43 168.92 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.443 -167.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.4 119.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.669 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.751 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 39.0 mmt180 -94.16 102.86 14.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.039 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -79.88 89.62 5.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' CA ' ' A' ' 126' ' ' GLY . 34.2 mt . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.718 -173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -75.31 -37.26 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -70.17 -25.27 63.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.56 -38.54 70.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 129' ' ' LEU . 58.1 tp -70.76 -40.06 72.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.756 176.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.597 ' HG3' HG11 ' A' ' 120' ' ' VAL . 12.8 ttp180 -60.16 -44.33 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.428 174.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -64.78 -33.03 75.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.94 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -62.71 -47.31 84.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.266 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 121' ' ' ALA . 45.7 t -73.68 -43.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.615 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 14' ' ' ARG . 51.4 tp -57.92 -33.44 68.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.048 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 9.7 t60 -60.44 -43.6 96.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.375 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 44.2 mttp -81.67 -24.66 36.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 0.0 111.033 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 11' ' ' LEU . 41.1 ttt85 -57.77 -51.92 67.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.67 4.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.595 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 8.6 t30 -83.88 -19.21 35.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.35 132.65 52.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.757 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -70.65 153.16 43.11 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.041 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -43.66 79.82 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.334 0.396 . . . . 0.0 111.839 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.0 tp10 -60.95 -56.79 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.792 0.33 . . . . 0.0 111.081 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.46 -44.28 97.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.35 -42.1 98.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.013 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 12.7 tpt180 -62.11 -43.12 99.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.696 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 85.0 mtt180 -60.77 -38.79 86.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 98.4 mt -72.6 -45.22 60.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.882 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -62.67 -35.04 78.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.33 -43.49 79.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -66.36 -39.3 89.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 175' ' ' GLU . 61.5 t -65.06 -47.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.693 0.282 . . . . 0.0 110.776 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.77 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 110.203 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -36.16 83.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.101 0.476 . . . . 0.0 109.971 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -69.32 -44.36 71.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 33' ' ' LEU . 5.2 tt -65.46 -38.55 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.991 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -67.11 -26.53 66.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 111.036 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -83.79 -16.77 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -68.02 112.35 10.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.142 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HD2' HD23 ' A' ' 36' ' ' LEU . 35.1 Cg_endo -64.74 -25.43 61.14 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.611 2.207 . . . . 0.0 112.795 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.35 -24.61 61.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.731 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.26 -42.57 99.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.89 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HA ' ' NZ ' ' A' ' 68' ' ' LYS . 89.3 mttt -83.92 -3.04 57.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.129 0.49 . . . . 0.0 110.808 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.22 -33.8 22.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.492 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.7 p -81.94 152.55 26.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.195 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 24.8 tptp -111.46 -40.33 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 109.732 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 22.2 mmtp -91.99 107.43 19.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.796 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.3 115.01 47.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.278 0.561 . . . . 0.0 111.511 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -104.19 133.07 49.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.39 129.0 51.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.0 0.428 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -88.02 109.88 20.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.0 m -52.68 116.17 8.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.536 0.523 . . . . 0.0 111.621 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.18 69.09 7.24 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.865 2.377 . . . . 0.0 112.44 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 52' ' ' LYS . 26.5 pt -55.0 -43.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.521 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' N ' HG13 ' A' ' 51' ' ' ILE . 64.5 mttm -112.98 30.53 7.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -99.78 149.71 18.89 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.152 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' OE2' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -91.06 -35.62 14.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.32 104.07 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.83 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.85 101.84 7.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.972 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.08 5.9 40.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.781 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.2 m -60.1 -52.92 69.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.427 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 18.6 Cg_exo -68.88 7.28 0.79 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 113.495 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.67 -13.81 38.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.357 . . . . 0.0 110.146 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.6 m-30 -55.75 -49.13 94.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.142 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 75.2 Cg_exo -53.55 -36.06 79.04 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.281 1.987 . . . . 0.0 113.067 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 4.4 tp10 -70.98 -31.33 67.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 110.151 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.52 -40.76 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.396 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 88' ' ' PRO . 95.8 mt -65.65 -11.85 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 41.2 tttp -64.82 -60.5 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.252 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.844 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.8 pt-20 -120.65 -19.82 7.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -172.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.844 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 50.6 mttm -116.38 -172.45 2.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.628 0.251 . . . . 0.0 110.664 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -112.93 143.0 44.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.869 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.9 tp -92.74 124.77 36.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.226 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.55 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 53.5 mt -111.23 126.52 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.997 0.427 . . . . 0.0 110.484 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -123.71 147.93 54.79 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.308 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.72 125.36 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.218 2.612 . . . . 0.0 112.753 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' OE1' ' A' ' 100' ' ' GLU . 85.1 tttt -113.32 139.69 48.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.845 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.71 99.27 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HE2' ' A' ' 74' ' ' LYS . 10.6 mm-40 -81.66 82.57 7.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.734 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.18 -89.74 0.5 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -174.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -123.18 -7.29 8.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.88 0.371 . . . . 0.0 110.37 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.96 98.93 12.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.749 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.9 tt -91.94 127.58 44.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.341 0.591 . . . . 0.0 110.291 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -137.07 167.47 21.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.767 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.6 mt -99.32 138.1 36.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.372 . . . . 0.0 110.456 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -118.87 128.16 54.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -95.99 111.93 23.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.393 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 91' ' ' LEU . 27.0 m -101.94 138.31 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.072 0.463 . . . . 0.0 110.386 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -96.87 -4.81 39.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.347 0.594 . . . . 0.0 109.805 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -167.81 144.7 3.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.893 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD3' HD13 ' A' ' 65' ' ' LEU . 54.3 Cg_endo -72.1 71.27 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.45 2.1 . . . . 0.0 111.818 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.37 -58.05 2.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.812 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 7.7 p -86.43 21.62 2.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.273 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 85' ' ' VAL . 96.5 mt -99.12 108.53 21.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.14 10.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.74 108.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.098 0.449 . . . . 0.0 110.123 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 100' ' ' GLU . . . -150.48 -1.77 0.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.87 -161.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.312 . . . . 0.0 110.338 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.32 -18.75 63.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.257 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.18 -23.36 0.13 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.719 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -83.42 172.91 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.65 -0.275 . . . . 0.0 110.869 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -62.68 138.0 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.098 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.516 ' OE1' ' HG3' ' A' ' 74' ' ' LYS . 3.3 tp10 -108.34 107.19 59.94 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.157 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.58 106.07 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.67 1.58 . . . . 0.0 110.903 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.83 -45.65 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.224 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.67 178.72 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.87 -130.18 4.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.176 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -118.49 118.91 33.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.603 0.239 . . . . 0.0 110.418 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -80.67 97.0 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 111' ' ' ASP . 88.1 t -99.08 119.94 47.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.967 -175.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.17 154.08 86.36 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 143' ' ' VAL . 10.6 Cg_endo -54.1 -19.19 15.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.828 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.5 -41.12 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.937 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.577 ' HB3' HG13 ' A' ' 107' ' ' VAL . 22.1 t70 -87.24 -9.26 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.17 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.1 t -81.25 132.09 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.136 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.574 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 67.4 m-20 -91.7 -49.31 6.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.471 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 148' ' ' VAL . 47.5 t80 -130.31 138.43 50.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.541 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 tt -143.65 140.03 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.94 127.16 54.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -120.69 121.54 28.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.75 -41.26 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.722 2.282 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.25 -145.82 49.42 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.86 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.597 HG11 ' HG3' ' A' ' 7' ' ' ARG . 75.7 t -139.24 -45.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -161.15 157.07 25.28 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.381 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -135.92 166.01 24.32 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.157 0.285 . . . . 0.0 110.85 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -111.06 -171.74 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.892 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 52.9 mt -71.39 -14.38 62.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.63 -21.57 14.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.561 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.19 31.33 3.1 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.941 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -95.63 147.04 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.795 0.331 . . . . 0.0 110.435 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -84.06 150.13 25.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.861 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 6' ' ' LEU . 28.7 tp . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.515 0.674 . . . . 0.0 109.967 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 121.372 0.606 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.24 -39.49 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.671 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 37.6 ttm180 -61.8 -17.65 56.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.402 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 45.9 tp -92.9 -70.12 0.71 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.41 . . . . 0.0 111.028 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.775 ' HB2' HD13 ' A' ' 167' ' ' ILE . 7.4 mp -63.49 -32.32 73.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.36 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 141' ' ' LYS . 34.4 ttmt -80.81 -16.59 53.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 138' ' ' ARG . 37.4 mtp180 -101.69 -5.57 24.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.287 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 109' ' ' PRO . 94.0 t -62.04 112.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.124 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -92.16 -7.09 49.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.792 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.34 -173.71 46.66 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.1 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.544 HD11 HG23 ' A' ' 171' ' ' VAL . 32.3 tp -80.21 108.11 13.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.4 mtmm -86.25 106.19 17.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.044 0.45 . . . . 0.0 110.034 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.5 t -102.51 124.36 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.997 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.54 138.82 14.36 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.7 111.45 36.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -151.76 162.85 40.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.65 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 30.8 m-85 -86.16 170.38 12.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.393 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.1 t -72.13 -38.52 69.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.73 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -74.46 -9.07 58.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.486 . . . . 0.0 110.421 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -95.31 -7.7 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.019 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.46 110.29 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.408 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.46 179.99 5.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.242 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.892 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.36 -53.46 6.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.051 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -136.04 140.73 44.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 129' ' ' LEU . 96.7 mt -132.81 158.67 75.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.5 101.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.289 1.993 . . . . 0.0 110.933 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -96.7 128.33 43.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.941 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.926 ' HB3' ' HB2' ' A' ' 166' ' ' ASP . 9.6 t70 -95.11 137.16 34.54 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.59 57.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.81 0.338 . . . . 0.0 111.549 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -119.52 24.01 10.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 0.0 110.552 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.926 ' HB2' ' HB3' ' A' ' 163' ' ' ASP . 12.0 t70 -89.73 -157.61 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.542 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.775 HD13 ' HB2' ' A' ' 140' ' ' LEU . 56.9 mt -125.82 107.27 25.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.841 0.353 . . . . 0.0 111.305 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -93.12 174.49 1.75 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.247 2.632 . . . . 0.0 112.177 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.85 174.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.604 0.24 . . . . 0.0 110.758 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -106.88 -44.24 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.554 . . . . 0.0 109.902 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.544 HG23 HD11 ' A' ' 146' ' ' LEU . 86.5 t -125.96 140.75 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.552 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.62 ' HB2' HD21 ' A' ' 181' ' ' LEU . 53.6 tp -121.0 103.12 8.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.0 110.687 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.95 119.03 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.907 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.7 p -110.34 -175.94 2.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.187 0.518 . . . . 0.0 111.222 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.65 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 9.5 pt-20 -60.12 -27.61 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.658 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 24.9 mtmm -118.45 -56.77 2.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -119.05 174.51 6.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 111.334 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.91 99.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 25.0 ttm-85 -79.05 124.2 28.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.984 -174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 180' ' ' ARG . 4.6 mtp180 -92.22 97.52 10.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.569 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 172' ' ' LEU . 2.9 mm? . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.36 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.5 mp -91.86 4.86 51.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 110.207 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -52.44 -50.38 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.681 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -70.93 -40.08 72.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -71.8 -37.43 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.115 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.499 HD23 HD22 ' A' ' 129' ' ' LEU . 38.0 tp -67.01 -37.23 83.8 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.72 -44.96 95.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.245 0.545 . . . . 0.0 109.843 173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.38 -50.92 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.121 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -34.8 77.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.57 0.224 . . . . 0.0 111.576 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.12 -40.4 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.366 . . . . 0.0 110.189 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.703 HD12 ' HD3' ' A' ' 14' ' ' ARG . 31.0 tp -62.21 -34.78 77.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.885 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -59.65 -43.92 93.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -81.97 -28.78 32.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.096 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.703 ' HD3' HD12 ' A' ' 11' ' ' LEU . 32.1 ttt85 -56.69 -43.96 81.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.293 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 pt -88.41 0.89 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.408 . . . . 0.0 111.115 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -89.57 -20.78 23.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -55.28 137.56 47.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.44 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.7 t -90.65 145.35 24.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.483 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 40.7 mm-40 -59.8 -25.14 64.71 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.284 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -53.25 -65.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.379 0.609 . . . . 0.0 110.379 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.86 -40.62 65.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.5 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 66.9 ttt180 -56.34 -50.67 70.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.686 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -64.15 -33.73 76.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.859 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -70.97 -38.83 72.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.3 -37.5 71.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.437 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HA ' HG13 ' A' ' 55' ' ' VAL . 70.7 m -59.32 -39.98 84.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.704 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.72 -44.19 85.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -62.35 -43.8 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.159 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.5 -44.95 99.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.479 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 56' ' ' ASP . 67.1 mt -56.93 -53.87 37.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.602 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.0 m -59.28 -44.55 92.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.993 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.432 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 2.7 t-20 -61.1 -52.51 64.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.883 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 20.0 tp -60.75 -38.35 84.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.078 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -79.4 -21.19 45.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.315 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -85.83 -18.93 31.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.208 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 32' ' ' ASN . 92.5 mt -55.94 119.61 27.53 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.728 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 39.3 Cg_exo -61.21 -22.76 75.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.015 2.476 . . . . 0.0 112.764 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.95 -23.88 48.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.606 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -73.53 -23.04 59.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -71.43 -29.12 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.421 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -94.41 -37.35 11.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.272 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m -58.19 122.54 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -90.94 -41.9 10.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.553 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' VAL . 18.7 mmtp -95.23 109.02 21.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.17 101.45 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -100.64 136.27 40.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.49 151.06 39.21 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HD1' ' HA ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -77.84 -90.02 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' TYR . 35.6 t 176.05 127.23 0.15 Allowed Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.254 0.346 . . . . 0.0 110.344 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.39 112.29 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.169 2.579 . . . . 0.0 110.932 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.6 HG13 ' HG2' ' A' ' 52' ' ' LYS . 10.7 pt -127.98 -47.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.6 ' HG2' HG13 ' A' ' 51' ' ' ILE . 74.4 mmtt -96.7 -69.24 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -171.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 14' ' ' ARG . . . -149.58 46.79 0.64 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.303 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HG3' HH21 ' A' ' 14' ' ' ARG . 3.9 mp0 -97.87 -156.18 0.53 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 26' ' ' SER . 91.6 t -101.41 138.35 25.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.608 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HD11 ' A' ' 30' ' ' ILE . 27.1 m-20 -72.35 75.18 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.16 0.505 . . . . 0.0 111.08 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 150' ' ' VAL . 93.2 mt -90.72 -5.02 56.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.768 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -47.54 98.85 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.452 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 17.2 Cg_exo -68.3 -7.66 20.72 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.252 1.968 . . . . 0.0 113.205 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 40.9 tp -87.17 -7.08 58.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 110.794 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.538 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 13.0 m-30 -53.31 -50.65 81.43 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.943 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.8 Cg_exo -52.17 -42.05 61.74 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.239 1.96 . . . . 0.0 112.977 177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -65.41 -43.82 89.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.647 0.261 . . . . 0.0 110.848 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' LEU . 56.0 t -64.66 -48.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.635 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.36 -33.87 66.09 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.435 0.459 . . . . 0.0 111.382 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -64.32 -45.87 86.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.705 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -101.81 -60.55 1.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -108.55 -171.69 1.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.021 0.439 . . . . 0.0 111.272 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.618 ' HG2' ' HD2' ' A' ' 84' ' ' ARG . 1.8 mp0 -96.35 116.8 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.253 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.79 116.06 18.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.654 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 58.0 mt -111.12 126.02 68.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.896 0.379 . . . . 0.0 110.623 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.3 mt -120.69 150.08 51.78 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.265 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 82' ' ' LEU . 58.8 Cg_endo -73.27 125.7 10.46 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.577 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 8.9 tmtm? -116.63 124.37 49.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.72 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 80' ' ' ILE . 41.6 t -90.7 105.98 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -93.13 -24.97 18.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.753 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 170.44 80.63 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.83 -56.96 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.415 0.686 . . . . 0.0 111.118 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.96 141.48 34.43 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 75' ' ' VAL . 67.5 mt -105.08 127.87 59.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.299 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -102.89 163.28 12.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.654 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 66.3 mt -115.8 124.54 50.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.04 0.448 . . . . 0.0 110.855 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -108.36 134.69 50.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.238 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.618 ' HD2' ' HG2' ' A' ' 69' ' ' GLU . 13.7 ptt180 -93.8 140.66 29.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.07 140.99 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.485 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.61 2.71 15.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.796 175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 25.4 p -149.86 151.9 33.34 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.739 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.7 Cg_exo -76.6 44.37 1.39 Allowed 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.997 2.465 . . . . 0.0 111.742 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 -74.31 0.42 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.848 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 49.4 t -95.2 92.81 6.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.116 0.484 . . . . 0.0 111.496 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt -138.21 98.82 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.388 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.28 152.65 17.82 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.218 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.54 107.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.061 0.458 . . . . 0.0 110.341 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.78 -40.88 1.39 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.319 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' HB3' ' CG1' ' A' ' 98' ' ' ILE . . . -87.67 -152.48 0.2 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.661 0.267 . . . . 0.0 111.159 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -78.37 58.35 2.11 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.453 0.644 . . . . 0.0 111.405 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.2 -13.67 60.08 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.979 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.407 ' CG1' ' HB3' ' A' ' 95' ' ' ALA . 41.0 pt -90.08 148.68 4.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.75 0.31 . . . . 0.0 110.89 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 ptp -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 16.8 pt-20 -138.01 147.52 56.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.79 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 3.7 Cg_exo -81.1 106.66 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.492 2.128 . . . . 0.0 111.418 177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.8 m -89.63 -21.16 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.26 127.15 43.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.856 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.59 -143.4 8.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.12 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -106.85 116.79 32.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.966 0.413 . . . . 0.0 110.377 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -79.11 116.52 19.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.333 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 142.04 25.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.855 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 3.8 p30 -80.2 137.73 52.72 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 82' ' ' LEU . 34.6 Cg_exo -58.88 -24.33 71.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.97 2.447 . . . . 0.0 113.847 -172.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.99 -9.75 59.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.82 -10.86 54.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.349 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 44' ' ' LYS . 66.7 t -77.21 121.98 30.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.343 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.485 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 11.5 m-20 -74.7 -52.98 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.468 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.528 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 34.6 t80 -124.31 123.99 41.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.253 -170.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 15.2 tt -130.38 139.83 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 110.741 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.61 109.48 20.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.259 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.525 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 11.6 m -119.74 120.05 30.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.289 0.566 . . . . 0.0 111.135 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 1.4 Cg_endo -84.1 163.96 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.025 2.483 . . . . 0.0 111.95 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 131' ' ' PHE . . . -150.41 154.15 25.47 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.6 t -55.97 -47.28 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.982 0.391 . . . . 0.0 110.894 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.5 147.84 40.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.227 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -129.78 167.19 18.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.979 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 1.3 p-10 -127.23 -169.62 2.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.706 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.1 mt -92.3 4.03 54.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 42.7 mt-10 -110.05 -25.82 10.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.649 0.261 . . . . 0.0 110.781 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.518 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 117.86 26.07 2.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 174.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -102.23 158.07 16.44 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.782 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' OD2' ' A' ' 166' ' ' ASP . 33.0 mtm180 -124.35 -176.97 3.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.499 HD22 HD23 ' A' ' 6' ' ' LEU . 20.6 tp -113.55 0.57 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.28 0.562 . . . . 0.0 109.726 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.6 176.63 33.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.525 -0.762 . . . . 0.0 113.35 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 71.3 m-85 -119.83 -72.1 0.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.88 124.2 1.67 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -88.68 148.43 24.01 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.846 0.355 . . . . 0.0 110.498 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 162.17 -62.08 0.27 Allowed Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.238 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.402 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 28.6 m-85 -133.64 -27.16 1.54 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.912 0.387 . . . . 0.0 111.38 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -75.62 -30.77 59.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' HA ' HD12 ' A' ' 140' ' ' LEU . 6.5 p-10 -67.92 -23.85 65.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.008 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 135' ' ' TYR . 40.0 ttm180 -69.99 -35.99 74.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.902 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.9 tp -65.22 -36.76 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 137' ' ' ASP . 79.8 mt -67.66 -26.36 66.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.108 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 34.3 mmtp -76.72 -21.66 54.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 109' ' ' PRO . 27.5 mmt180 -77.52 -53.11 8.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.172 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -77.84 103.21 4.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.84 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -113.99 24.4 12.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.25 -139.75 5.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.808 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.93 101.36 13.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.629 ' HE2' HD11 ' A' ' 167' ' ' ILE . 18.9 mttp -88.54 106.67 18.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 171' ' ' VAL . 67.7 t -101.0 116.98 45.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.801 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -78.94 121.57 5.6 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 57' ' ' LEU . 61.9 t -113.65 115.86 50.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.552 0.215 . . . . 0.0 110.463 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.95 -179.81 7.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.084 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 156' ' ' VAL . 95.1 m-85 -97.56 156.1 16.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.86 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.3 p -61.23 -25.9 67.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.589 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.545 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 70.7 m-85 -61.78 -36.4 80.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.588 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.545 ' OE1' ' HB2' ' A' ' 154' ' ' PHE . 0.9 OUTLIER -90.62 8.31 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.026 -178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' TYR . 61.5 t -109.66 133.79 53.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.892 0.377 . . . . 0.0 110.424 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.93 -169.52 1.85 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 48.2 mt-10 -84.74 -50.15 7.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.281 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.1 ptm180 -141.11 146.65 37.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 176.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 92.5 mt -116.6 149.16 43.35 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.995 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.35 104.57 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.274 1.983 . . . . 0.0 111.007 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -73.55 111.41 8.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.0 110.768 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.71 -78.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.963 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.6 -96.26 0.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.781 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -128.54 61.66 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.358 0.599 . . . . 0.0 111.25 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 128' ' ' ARG . 38.7 t70 -74.36 141.82 45.13 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 ' HE2' ' A' ' 147' ' ' LYS . 14.1 tt -79.11 120.26 80.08 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.941 -172.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.5 Cg_exo -74.15 148.65 39.76 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.023 2.482 . . . . 0.0 111.807 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.94 169.16 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.011 0.434 . . . . 0.0 111.607 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -93.3 -40.08 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.297 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.533 ' HB ' HG22 ' A' ' 148' ' ' VAL . 17.0 t -133.07 155.12 40.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 55.5 tp -135.43 118.31 16.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 64.6 t -115.97 126.45 73.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.942 0.401 . . . . 0.0 110.799 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 71.7 p -114.56 -172.49 2.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.266 177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 176' ' ' LYS . 2.5 pm0 -85.73 -15.05 43.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.031 0.443 . . . . 0.0 110.125 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 175' ' ' GLU . 29.4 mtpp -112.31 -47.82 3.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.197 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -131.43 163.1 28.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 112.102 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.53 122.56 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.73 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 3.0 mmp_? -108.93 131.73 54.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.993 0.425 . . . . 0.0 110.186 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -121.74 128.39 51.72 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.518 HD13 ' HA3' ' A' ' 126' ' ' GLY . 23.4 mt -110.0 31.11 6.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.672 0.748 . . . . 0.0 110.247 -172.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -129.73 24.87 5.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.086 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.02 140.34 58.86 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.022 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.33 163.91 26.7 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -114.82 -59.4 2.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 117.1 0.45 . . . . 0.0 111.01 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.2 t -153.41 155.37 36.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.6 mt -131.17 132.77 44.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.742 0.306 . . . . 0.0 110.826 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -117.07 150.3 38.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.222 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -108.1 -76.36 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -128.31 76.59 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -113.24 -8.89 13.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.291 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -75.41 73.84 2.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.345 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 28.3 m170 72.02 159.58 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 C--O 1.246 0.913 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.019 179.325 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.22 -14.49 24.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.923 0.392 . . . . 0.0 109.991 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -53.21 -57.83 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.406 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -60.66 -39.18 87.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.54 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.71 -52.34 21.61 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.091 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 tp -61.88 -35.23 77.72 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.725 0.298 . . . . 0.0 110.321 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -56.11 -59.42 4.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.451 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -74.25 -37.54 63.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.764 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.54 -39.79 92.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.494 -173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.1 t -86.19 -41.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.979 0.418 . . . . 0.0 110.339 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.7 tp -60.34 -37.59 81.14 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.173 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 75.9 t60 -59.69 -31.04 69.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.741 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -82.71 -42.74 17.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.916 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' NH2' ' HA ' ' A' ' 151' ' ' ALA . 52.2 ttt180 -61.19 -38.75 87.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 0.0 111.103 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.1 pt -88.18 -4.21 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.368 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 66.1 t30 -98.4 -13.69 20.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.888 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.9 mt -52.78 143.83 15.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -61.98 144.59 54.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.006 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -59.27 -49.33 78.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.549 0.214 . . . . 0.0 111.548 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -62.81 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.786 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.09 -44.61 91.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.409 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -59.13 -42.57 90.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -25.5 66.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.688 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -83.86 -18.48 37.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.903 0.382 . . . . 0.0 110.785 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.7 mt -86.56 -53.52 4.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.094 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 m -57.17 -34.49 68.52 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.09 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -48.27 -50.44 29.83 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.086 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -80.59 -26.59 37.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.323 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 25' ' ' LEU . 58.0 t -65.07 -49.51 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.82 -46.42 96.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.619 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -62.09 -40.94 97.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.156 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 178' ' ' VAL . 21.8 t-20 -66.51 -51.14 59.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.008 0.433 . . . . 0.0 110.282 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.802 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 36.9 tp -57.64 -38.61 75.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.4 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -72.85 -33.38 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.917 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -75.35 -16.87 60.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.346 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD12 HD12 ' A' ' 33' ' ' LEU . 79.7 mt -56.46 126.3 69.03 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.852 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -32.74 96.04 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.571 2.181 . . . . 0.0 111.593 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.27 -35.08 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.78 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -62.22 -30.31 71.01 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.078 0.466 . . . . 0.0 110.433 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -64.52 -40.08 94.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.73 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -80.79 -33.2 35.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.159 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.494 ' HA ' ' OD2' ' A' ' 113' ' ' ASP . 46.4 m -55.53 105.81 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.046 0.45 . . . . 0.0 111.1 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.728 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 84.4 tttt -98.47 -30.67 12.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.653 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -102.91 98.21 8.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.383 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -110.16 109.01 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 111.066 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.29 139.64 34.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.551 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.27 145.96 45.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.888 0.375 . . . . 0.0 110.831 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.29 -4.11 59.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.911 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 70.9 m 65.17 97.04 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 123.727 0.642 . . . . 0.0 111.465 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 95.92 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.502 2.135 . . . . 0.0 112.743 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 35.7 pt -90.65 161.18 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 67.4 mttm 70.91 -55.25 0.65 Allowed 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.725 0.64 . . . . 0.0 110.805 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -177.22 -83.66 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 4.4 mm-40 45.53 39.55 4.87 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.801 0.84 . . . . 0.0 112.862 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 53.3 t 68.26 101.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.084 -174.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.07 92.71 1.34 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.826 0.822 . . . . 0.0 111.183 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 150' ' ' VAL . 93.8 mt -88.49 15.19 8.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.792 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.617 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 8.8 p -62.35 -38.47 46.93 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 30.5 Cg_exo -64.38 -11.48 28.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.925 1.75 . . . . 0.0 112.717 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 64' ' ' VAL . 36.9 tp -89.24 -16.2 31.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.59 0.233 . . . . 0.0 110.741 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 23.9 m-85 -56.51 -50.65 86.54 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 50.4 Cg_exo -55.74 -35.19 92.97 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.13 1.887 . . . . 0.0 112.509 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -68.46 -43.73 76.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.485 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 60' ' ' LEU . 59.2 t -64.49 -44.92 96.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.26 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.51 -18.83 65.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.704 0.288 . . . . 0.0 111.549 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -75.99 -36.52 59.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.393 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -124.11 -46.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 31.1 mmtp -101.93 -175.04 2.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.017 0.437 . . . . 0.0 111.52 -168.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 38.6 mm-40 -98.3 120.0 37.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.595 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.8 tp -86.05 102.44 13.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.306 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.2 mt -91.52 116.89 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.085 0.469 . . . . 0.0 110.494 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.8 mt -117.11 137.09 23.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.205 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.6 119.4 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -105.74 117.45 34.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.08 95.33 4.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.99 0.424 . . . . 0.0 110.642 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -96.72 71.29 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 109.71 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.37 -111.18 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.429 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.55 -22.97 14.8 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -77.43 89.05 3.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.719 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.84 119.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -111.85 132.29 54.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.452 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.1 mt -81.85 103.93 11.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.054 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 3.7 m-85 -95.97 120.19 35.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.197 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 24.2 ptt85 -83.42 131.3 35.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.68 133.19 68.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.998 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.23 12.83 7.69 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.5 m -112.05 109.68 54.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.536 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.2 Cg_exo -74.42 31.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.463 2.775 . . . . 0.0 112.915 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 -28.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 58.2 m -84.75 38.46 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -172.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.22 152.22 21.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.309 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -132.89 176.31 19.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.99 98.32 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.114 0.457 . . . . 0.0 110.031 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.19 -32.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.058 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -76.18 94.84 3.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.855 0.327 . . . . 0.0 111.072 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 80.1 t80 72.49 -52.13 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.199 0.599 . . . . 0.0 111.809 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.32 33.92 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 95' ' ' ALA . 41.5 pt -122.86 172.72 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 66.1 mtt -94.24 86.94 5.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 2.3 pm0 -87.93 148.36 43.17 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.983 0.421 . . . . 0.0 110.263 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 8.1 Cg_exo -72.17 106.09 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.713 2.275 . . . . 0.0 112.31 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' A' ' 103' ' ' GLU . 31.2 m -76.72 -25.01 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.499 0.666 . . . . 0.0 109.421 173.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.984 ' HB2' ' HB3' ' A' ' 90' ' ' CYS . 59.7 mm-40 -122.28 129.11 51.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.938 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.11 -159.2 28.37 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.214 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 34.3 tt0 -138.71 131.16 28.76 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 106' ' ' ARG . 20.7 ttt180 -79.74 113.62 18.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.013 0.435 . . . . 0.0 110.514 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -104.44 154.23 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.138 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -81.99 142.11 47.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.294 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' HB2' HG22 ' A' ' 143' ' ' VAL . 24.2 Cg_endo -61.22 -23.21 76.67 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.299 2.666 . . . . 0.0 113.69 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -69.82 -19.67 63.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.88 0.371 . . . . 0.0 110.975 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.51 -12.56 53.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.391 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.98 114.22 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 110.847 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 42' ' ' SER . 38.8 t70 -90.47 -51.61 5.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.258 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.802 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 38.3 t80 -130.43 139.39 50.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.471 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 147' ' ' LYS . 15.6 tt -146.29 139.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 110.74 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.19 109.64 20.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.463 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 59.4 t -122.33 110.89 32.17 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.01 165.9 27.57 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.922 2.415 . . . . 0.0 112.081 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.78 163.89 30.57 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.01 -38.46 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.571 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.63 159.06 44.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.173 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.28 165.84 25.7 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.524 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 16.1 p30 -126.46 -172.09 2.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.857 0.36 . . . . 0.0 111.122 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 96.0 mt -88.69 -2.2 58.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.029 -174.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -105.79 -28.7 10.5 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.809 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.17 30.64 0.85 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.869 171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -108.99 151.83 25.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 117.318 0.559 . . . . 0.0 110.414 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -122.89 149.6 44.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 111.067 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 59.2 tp -88.45 128.25 35.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -91.31 -153.52 29.6 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.302 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -82.01 0.25 41.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.778 0.323 . . . . 0.0 111.2 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.93 35.06 61.7 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.889 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -155.37 1.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.623 0.249 . . . . 0.0 111.289 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 135' ' ' TYR . . . 78.75 -145.11 28.46 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.73 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 134' ' ' GLY . 32.1 m-85 77.41 123.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.374 0.67 . . . . 0.0 111.46 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 71.09 1.51 3.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.795 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.38 -41.91 99.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.13 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.82 -25.6 65.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.851 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.07 -56.57 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.192 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.2 -12.85 61.69 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.769 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -76.47 -32.52 58.44 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -94.43 -40.81 9.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.083 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 109' ' ' PRO . 49.7 t -71.82 91.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.268 0.556 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 144' ' ' LYS . 5.6 tmtm? -103.89 68.21 0.91 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.554 0.692 . . . . 0.0 109.837 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.69 -150.29 19.01 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 166.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 113' ' ' ASP . 11.0 mp -83.29 89.03 6.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.979 0.889 . . . . 0.0 109.227 171.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HA ' HG23 ' A' ' 115' ' ' ILE . 54.4 mtmt -81.98 102.47 10.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.601 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.8 t -98.82 114.72 37.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.622 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -79.03 119.95 5.17 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.539 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 57' ' ' LEU . 47.5 t -98.05 110.73 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.868 0.366 . . . . 0.0 110.371 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.569 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . . . -154.05 176.5 12.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.248 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.454 ' CZ ' HG22 ' A' ' 55' ' ' VAL . 71.6 m-85 -96.69 151.96 19.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.0 t -62.28 -17.78 59.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.45 0.166 . . . . 0.0 111.071 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -62.73 -33.44 75.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.263 0.554 . . . . 0.0 110.389 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.52 -3.8 58.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.429 -174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 172' ' ' LEU . 38.8 t -91.19 110.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.405 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 35.4 m-85 -105.62 -179.17 3.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.523 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.31 -58.6 4.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.079 0.466 . . . . 0.0 110.039 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -144.77 138.54 27.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.848 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 90.5 mt -93.45 152.65 41.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.87 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 101.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.074 1.849 . . . . 0.0 109.653 167.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -73.63 150.09 41.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.263 0.554 . . . . 0.0 111.114 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -103.85 -172.91 2.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.087 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.41 -26.58 35.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -96.82 64.19 2.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -74.98 108.36 7.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.863 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.2 103.98 55.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.867 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -85.49 159.75 10.93 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.839 2.359 . . . . 0.0 112.416 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.35 173.3 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.02 -52.52 3.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.038 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.2 130.97 68.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.24 -177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 57.0 tp -104.97 108.63 20.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.033 0.444 . . . . 0.0 110.218 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.01 130.64 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.444 ' HB ' ' OE2' ' A' ' 175' ' ' GLU . 40.2 p -126.55 -173.89 2.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.275 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.444 ' OE2' ' HB ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -79.34 -9.0 59.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.097 0.475 . . . . 0.0 110.862 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -120.31 -62.01 1.52 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -110.01 151.75 26.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.316 0.579 . . . . 0.0 112.548 -170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.463 HG22 ' OD1' ' A' ' 32' ' ' ASN . 16.6 t -103.81 99.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.102 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 79.2 mtt85 -94.5 85.23 4.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.292 0.568 . . . . 0.0 110.782 -176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -76.27 99.42 4.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.1 mt -102.71 25.68 8.91 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.511 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -80.44 74.35 7.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.013 0.435 . . . . 0.0 110.16 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -159.76 156.64 27.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.26 -76.94 0.63 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.349 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.553 ' HA ' ' NE ' ' A' ' 185' ' ' ARG . 6.1 tpm_? -169.19 28.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.441 ' HB2' ' OE2' ' A' ' 188' ' ' GLU . 80.9 p -74.33 138.08 43.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.932 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 29.2 tp -144.39 12.05 1.52 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.343 0.592 . . . . 0.0 110.384 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.552 ' H ' ' CD ' ' A' ' 188' ' ' GLU . 1.1 pm0 -81.63 52.32 1.87 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.483 0.658 . . . . 0.0 110.808 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -57.41 -38.23 74.01 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.246 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -156.32 67.2 0.58 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -78.57 -31.2 47.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.7 -173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -83.31 113.8 20.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.173 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -91.23 -177.95 5.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.173 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.36 -179.225 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.77 0.319 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 tp -160.43 -47.08 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.883 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.644 ' HD2' ' HG ' ' A' ' 129' ' ' LEU . 65.3 pttt -72.72 -11.09 60.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -60.7 -47.57 85.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.546 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -34.18 71.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.814 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.25 -44.11 80.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 110.166 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' O ' HG11 ' A' ' 120' ' ' VAL . 4.9 tmt_? -58.39 -43.97 88.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.18 -41.37 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.52 -44.09 89.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 37.2 t -71.78 -46.12 62.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.322 . . . . 0.0 110.348 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.24 -39.61 83.33 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.782 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -53.16 -39.38 63.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.072 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -90.75 -1.24 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.653 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 62.6 mtp180 -97.34 -48.74 5.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.127 0.489 . . . . 0.0 111.435 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.59 -21.99 8.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.687 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -76.82 -16.1 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.35 153.62 26.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.628 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.8 m -63.1 144.89 56.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.79 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.66 -48.88 78.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.986 0.422 . . . . 0.0 110.011 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 2.5 mp0 -54.33 -49.14 70.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.963 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.76 -53.04 62.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.631 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 22' ' ' ARG . 33.1 ttp180 -64.49 -38.87 92.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.16 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -69.67 -36.13 75.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.863 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -65.98 -30.16 70.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.085 0.469 . . . . 0.0 109.88 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.94 -46.08 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.145 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 t -57.45 -35.31 69.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.289 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.64 -51.32 21.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.405 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -74.28 -28.11 61.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.974 -174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.17 -47.94 80.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.1 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.454 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 m -62.19 -40.42 95.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.32 -46.05 74.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.403 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 36' ' ' LEU . 46.6 tp -61.49 -41.89 97.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.569 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -64.58 -33.16 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -70.15 -26.17 63.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.739 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.601 HD12 HD12 ' A' ' 33' ' ' LEU . 92.6 mt -61.91 120.12 54.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.169 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.44 -33.58 78.91 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.241 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -22.08 65.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 68' ' ' LYS . 50.4 t80 -68.84 -29.94 68.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -91.83 -31.08 15.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.18 -49.87 74.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.364 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 113' ' ' ASP . 70.1 m -86.82 122.1 30.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -95.37 -21.54 18.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -173.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -89.58 97.8 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.157 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.98 118.04 57.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.307 0.575 . . . . 0.0 110.858 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -98.75 137.12 37.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.46 139.28 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.72 0.295 . . . . 0.0 110.262 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -85.57 -6.12 59.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.8 t 67.11 102.08 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.306 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.1 124.41 9.54 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.429 2.086 . . . . 0.0 112.243 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.4 pp -111.57 152.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.296 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt 63.08 20.19 12.13 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.098 0.475 . . . . 0.0 110.982 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.17 -88.19 0.63 Allowed Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.83 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 70.8 mm-40 64.08 -85.01 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 122.925 0.49 . . . . 0.0 109.769 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 150' ' ' VAL . 88.1 t -148.95 116.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -71.51 101.41 2.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.78 9.54 24.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.501 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 68.5 p -65.21 -38.81 30.57 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 58' ' ' THR . 68.6 Cg_endo -74.14 4.56 4.19 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 121.62 1.547 . . . . 0.0 112.543 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.9 tp -99.33 -17.28 18.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.594 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 30.9 m-85 -52.07 -46.25 93.26 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 87.4 Cg_exo -49.86 -45.39 32.47 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.083 1.856 . . . . 0.0 112.589 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -72.92 -32.96 65.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.692 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 60' ' ' LEU . 76.9 t -61.61 -45.2 99.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.93 -12.71 61.38 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.427 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 62' ' ' PRO . 31.4 mmmt -92.46 -58.45 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.087 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.24 -38.99 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.372 0.606 . . . . 0.0 110.684 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.614 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . 22.6 mttp -125.63 -171.6 2.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.769 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 86' ' ' HIS . 42.8 tt0 -120.17 135.08 55.09 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.168 170.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 64' ' ' VAL . 62.3 tp -92.47 132.48 36.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 111.391 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 4.2 mp -119.83 127.86 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 97.4 mt -126.29 144.14 48.24 Favored Pre-proline 0 C--N 1.323 -0.55 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.48 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.47 146.45 12.21 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.962 2.442 . . . . 0.0 112.593 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -135.0 135.1 41.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.93 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.8 t -99.23 124.51 52.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -119.13 44.21 2.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.03 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 118.64 -93.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.861 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -109.7 -27.47 9.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -92.75 134.75 34.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 tt -116.82 127.82 74.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.114 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -124.55 178.89 5.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.9 mt -115.47 138.77 50.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 27.0 m-85 -121.5 146.68 46.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 0.0 111.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.825 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 21.6 ttm180 -91.2 118.43 30.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.962 -172.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 HD21 ' A' ' 91' ' ' LEU . 46.4 t -119.04 111.67 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.419 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . 1.1 p-80 -139.06 30.31 2.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.514 0.674 . . . . 0.0 109.222 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.8 p -154.27 143.91 15.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.819 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 7.6 Cg_exo -73.18 171.77 16.93 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.934 2.422 . . . . 0.0 112.386 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.8 18.83 11.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.793 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 53.4 m -113.93 3.34 15.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.043 0.449 . . . . 0.0 110.445 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.529 HD21 HG11 ' A' ' 85' ' ' VAL . 91.7 mt -108.3 126.05 52.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.211 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.92 -163.56 9.79 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.8 t -123.04 119.4 57.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.926 0.363 . . . . 0.0 110.09 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.37 -98.61 1.36 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.562 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 132.81 46.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.318 . . . . 0.0 111.65 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.6 t80 72.12 -53.47 0.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.904 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.33 34.26 0.37 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.006 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.9 pt -108.35 172.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 91' ' ' LEU . 48.6 tpp -70.72 102.76 2.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 29.4 tt0 -114.31 134.59 22.23 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 -172.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 11.3 Cg_exo -70.27 119.65 6.52 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.357 2.038 . . . . 0.0 109.812 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 103' ' ' GLU . 13.6 t -54.04 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.678 0.611 . . . . 0.0 111.031 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 102' ' ' VAL . 54.4 mm-40 -136.64 145.69 45.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.7 -148.61 13.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.622 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.825 ' HG3' ' HB3' ' A' ' 84' ' ' ARG . 6.3 pt-20 -91.2 151.24 21.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 111.433 -175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -100.41 162.33 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.751 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 50.5 t -125.57 136.19 61.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.073 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -82.77 139.04 43.4 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 143' ' ' VAL . 52.2 Cg_exo -56.42 -23.82 49.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.642 2.228 . . . . 0.0 111.265 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.11 -32.59 71.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.158 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.86 -11.51 36.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.893 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -77.46 126.39 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' SER . 15.0 m-20 -96.0 -51.94 4.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.522 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -123.23 148.35 45.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.895 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.7 tt -146.56 138.9 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.012 174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.46 112.3 25.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.511 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.09 126.42 28.04 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.503 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.2 -168.05 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.735 2.29 . . . . 0.0 111.768 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.7 150.51 6.04 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.935 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 7' ' ' ARG . 98.9 t -74.22 -38.69 48.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 0.0 110.943 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.53 166.08 25.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -140.7 148.7 41.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.364 0.602 . . . . 0.0 111.389 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 159' ' ' ARG . 11.5 t70 -101.97 156.85 17.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.871 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 157' ' ' PHE . 49.4 mt -71.9 -26.76 62.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 111.226 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -85.81 -7.17 58.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.104 0.478 . . . . 0.0 110.029 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 111.27 -0.88 28.14 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.98 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.501 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 95.1 m-85 -64.47 156.89 28.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.31 0.555 . . . . 0.0 110.689 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 37.0 mtm180 -103.99 -71.98 0.72 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 160' ' ' LEU . 7.3 tt 71.45 -11.42 0.71 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.019 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -47.17 -51.88 13.78 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.709 0.643 . . . . 0.0 114.709 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -171.63 176.27 3.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.137 0.469 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 150.75 107.59 0.39 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.135 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 133' ' ' LYS . 39.1 mtpt -113.91 -58.2 2.18 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.8 145.01 46.16 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.602 ' HD2' ' HB2' ' A' ' 138' ' ' ARG . 1.7 t80 -81.96 54.58 2.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.167 0.508 . . . . 0.0 110.982 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -80.74 -12.26 59.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.655 0.74 . . . . 0.0 109.724 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.75 -24.54 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.602 ' HB2' ' HD2' ' A' ' 135' ' ' TYR . 79.5 ttt180 -62.07 -25.42 67.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.176 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 45.1 tp -83.84 -39.93 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.513 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.71 -35.46 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.538 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.519 ' HG2' ' HB ' ' A' ' 167' ' ' ILE . 22.2 mtmm -86.37 -0.07 55.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.723 0.297 . . . . 0.0 111.171 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -100.45 -36.32 9.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.93 0.395 . . . . 0.0 110.477 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.1 t -84.91 91.14 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 110.052 177.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.51 62.28 3.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.748 0.785 . . . . 0.0 110.193 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -103.81 -152.95 23.17 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 146' ' ' LEU . 3.8 mm? -83.68 94.39 8.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.427 0.614 . . . . 0.0 109.827 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.419 ' HE2' ' CD1' ' A' ' 167' ' ' ILE . 9.5 mtmp? -77.49 104.91 8.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 76.3 t -95.12 113.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.484 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -84.75 117.19 4.44 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.441 HG12 HG21 ' A' ' 55' ' ' VAL . 22.6 t -105.8 109.15 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -159.01 -177.83 6.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.109 0.48 . . . . 0.0 111.362 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -100.06 166.92 10.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.176 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 52.5 m -77.02 -22.09 53.59 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -78.79 2.78 18.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.795 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -101.43 -10.78 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.041 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 t -91.63 115.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.51 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 96.3 m-85 -112.08 178.96 4.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 124' ' ' LEU . 30.0 mt-10 -64.13 -76.72 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 110.837 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.669 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 43.2 mtm180 -141.18 132.91 27.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.774 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' A' ' 129' ' ' LEU . 52.4 mt -103.5 153.44 38.56 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.577 -175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.8 101.62 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.131 1.887 . . . . 0.0 111.57 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.845 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.2 OUTLIER -90.57 147.33 23.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.564 -178.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.7 -67.1 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.514 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.69 -85.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.612 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 14.9 m-90 -103.72 66.87 0.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.894 0.378 . . . . 0.0 111.21 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -84.05 110.17 18.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 141' ' ' LYS . 19.4 tt -74.06 122.89 88.63 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.472 0.653 . . . . 0.0 111.661 -171.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 21.5 Cg_exo -67.2 154.66 73.56 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.154 2.569 . . . . 0.0 112.851 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -82.75 171.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.975 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -108.82 -46.59 3.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.207 0.527 . . . . 0.0 110.586 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 46.5 t -123.06 113.51 38.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.686 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.866 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 62.3 tp -100.01 102.65 14.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 110.283 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 33' ' ' LEU . 95.1 t -89.91 112.57 24.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.217 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.0 p -105.06 -175.93 2.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.531 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 12.4 pt-20 -72.69 -15.6 61.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.385 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.531 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 66.1 mttt -119.31 -48.71 2.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.48 168.82 18.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.625 -174.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 36' ' ' LEU . 23.3 t -91.81 105.03 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.027 176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 11.7 mmt180 -80.25 86.21 5.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -78.34 103.49 8.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt -82.09 37.78 0.51 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.366 0.603 . . . . 0.0 111.164 -173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 182' ' ' ARG . 3.9 mmp_? -109.87 31.39 5.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.234 175.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.524 ' OD2' ' HB3' ' A' ' 185' ' ' ARG . 27.3 t70 -57.09 -50.81 71.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.116 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.36 -9.04 74.73 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.984 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.524 ' HB3' ' OD2' ' A' ' 183' ' ' ASP . 17.7 ttt180 -85.74 105.62 16.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.479 0.64 . . . . 0.0 110.307 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.9 m -139.41 108.24 5.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.196 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.91 146.89 53.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.378 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 16.5 0.65 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.777 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -63.67 -14.83 55.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.954 0.407 . . . . 0.0 110.903 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -72.18 -6.64 44.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.226 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -61.28 106.04 0.57 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.815 0.817 . . . . 0.0 110.783 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -171.12 29.06 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -98.53 125.09 43.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.542 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.433 178.215 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tmm? . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 121.407 0.622 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 73.3 mt -82.43 -5.24 58.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.127 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -61.51 -33.66 74.19 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.61 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -80.45 -31.36 37.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 111.184 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.76 -29.66 32.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.86 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HE2' ' A' ' 9' ' ' LYS . 54.5 tp -58.3 -42.26 86.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.222 0.534 . . . . 0.0 109.563 173.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' HB2' HD23 ' A' ' 129' ' ' LEU . 39.6 ttp180 -58.33 -34.96 71.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.624 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -64.68 -49.18 71.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.562 ' HE2' HD12 ' A' ' 6' ' ' LEU . 55.6 pttt -72.2 -31.95 66.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.543 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG11 ' HB2' ' A' ' 121' ' ' ALA . 86.6 t -69.54 -35.19 65.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 15' ' ' ILE . 54.1 tp -64.97 -51.17 63.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.802 174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 11.6 t-160 -59.47 -32.58 70.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -77.74 -40.0 42.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' A' ' 54' ' ' GLU . 15.8 ttm180 -66.1 -38.07 87.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.673 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.616 HG22 ' HA3' ' A' ' 53' ' ' GLY . 36.9 pt -91.41 7.87 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.784 0.325 . . . . 0.0 111.217 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 9.2 t30 -85.47 -18.43 33.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.428 0.632 . . . . 0.0 109.612 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.434 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 m -62.99 144.7 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 48.6 mt-10 -71.42 -38.55 71.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.04 -39.47 93.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.0 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 24' ' ' ARG . 10.7 tp10 -62.47 -40.77 97.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.717 173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -60.68 -41.62 95.49 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.536 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 17.1 mmt180 -56.7 -41.64 77.73 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.433 0.635 . . . . 0.0 110.184 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 21' ' ' GLU . 39.2 ttp180 -71.51 -43.34 66.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.253 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.73 -38.18 83.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.906 0.384 . . . . 0.0 110.756 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 55' ' ' VAL . 68.6 m -58.38 -42.14 86.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.598 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.34 -37.83 73.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mtpt -60.97 -52.59 64.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.882 0.372 . . . . 0.0 110.348 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG11 HG13 ' A' ' 150' ' ' VAL . 48.9 t -61.35 -43.88 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.836 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 81.7 mt -61.11 -45.72 98.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.83 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.2 m -64.68 -33.46 76.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.61 0.243 . . . . 0.0 110.942 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -66.41 -55.17 17.05 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.038 0.447 . . . . 0.0 110.291 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.48 -31.53 71.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.069 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 23.3 tttp -68.26 -35.26 77.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.0 p -83.69 -14.56 51.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.275 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.3 tt -58.51 123.34 66.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.847 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 49.3 Cg_exo -55.63 -44.7 45.56 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.429 2.753 . . . . 0.0 113.452 -172.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . 7.6 mp0 -60.95 -25.25 66.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.855 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.74 -36.4 73.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.77 0.319 . . . . 0.0 110.811 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -82.22 -0.54 45.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.995 0.426 . . . . 0.0 110.908 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -106.16 -52.45 2.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -70.08 158.72 35.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.867 -172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -113.31 -34.09 5.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.202 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.03 98.45 11.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.74 0.305 . . . . 0.0 110.404 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 106.52 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.22 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -97.62 136.76 37.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.49 152.77 42.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.538 ' HB2' HG12 ' A' ' 117' ' ' VAL . 7.1 t80 -80.47 -98.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.189 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 48' ' ' TYR . 49.1 t 177.89 116.46 0.18 Allowed Pre-proline 0 N--CA 1.462 0.154 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 6.6 Cg_endo -88.46 103.12 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.177 2.585 . . . . 0.0 112.058 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.09 140.99 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.361 177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt 71.85 -51.15 0.7 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.267 0.627 . . . . 0.0 111.483 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 15' ' ' ILE . . . -139.64 -158.68 7.71 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.64 ' OE1' ' HD3' ' A' ' 14' ' ' ARG . 4.2 mm-40 77.34 150.75 0.12 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.974 0.892 . . . . 0.0 112.101 177.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 26' ' ' SER . 57.1 t -36.85 126.98 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 112.631 -2.077 . . . . 0.0 112.24 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD11 ' A' ' 30' ' ' ILE . 3.5 m-20 -68.08 76.96 0.23 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.4 mt -86.59 -10.3 54.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.838 0.351 . . . . 0.0 110.708 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.473 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -53.87 -49.89 86.91 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 58' ' ' THR . 36.7 Cg_endo -66.0 -8.02 18.72 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.087 1.858 . . . . 0.0 113.526 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.34 -14.09 29.25 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.137 -0.352 . . . . 0.0 110.803 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.3 m-85 -53.75 -52.35 68.28 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.985 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 53.8 Cg_exo -54.34 -37.11 88.74 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.321 2.014 . . . . 0.0 113.183 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.05 -52.35 36.31 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.623 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 47.6 t -62.69 -34.59 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.275 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 88' ' ' PRO . 38.1 tp -66.24 -26.23 67.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.297 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.69 -48.99 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.532 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.39 -45.58 25.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.275 0.559 . . . . 0.0 111.815 -175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -123.29 -171.68 2.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.626 -163.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.61 100.93 11.4 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.4 tp -80.52 120.56 24.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.593 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.8 mt -102.42 119.81 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.848 0.356 . . . . 0.0 110.371 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.39 142.59 28.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.536 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.24 121.61 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.203 2.602 . . . . 0.0 113.279 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.808 ' HD2' ' HE2' ' A' ' 83' ' ' TYR . 55.9 tttm -105.97 133.97 49.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 102.4 8.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -86.69 -19.49 29.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.952 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . 156.91 80.47 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.54 HD21 ' HB2' ' A' ' 135' ' ' TYR . 7.0 t30 70.44 -50.8 0.66 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.216 0.607 . . . . 0.0 111.103 -173.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.38 156.53 25.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -104.63 131.94 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.055 0.455 . . . . 0.0 111.513 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.1 m -111.0 115.65 29.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 80.6 mt -82.52 141.15 32.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.266 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.808 ' HE2' ' HD2' ' A' ' 74' ' ' LYS . 18.9 m-85 -112.59 141.62 46.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.187 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.572 ' HB3' ' HG2' ' A' ' 105' ' ' GLU . 27.0 ttt180 -88.15 91.72 8.88 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.118 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.17 114.51 33.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.368 0.604 . . . . 0.0 111.936 -171.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -140.62 14.44 2.34 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 23.3 t -99.99 104.79 31.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.333 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HA ' HD21 ' A' ' 65' ' ' LEU . 24.4 Cg_exo -63.64 -29.58 69.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.154 2.569 . . . . 0.0 113.524 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.55 -16.12 40.46 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.521 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 47.0 t -89.89 76.01 7.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.357 0.599 . . . . 0.0 110.485 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.9 mt -135.82 117.54 15.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.899 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.59 178.6 25.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.713 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.96 134.46 66.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.87 -74.58 0.93 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.842 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.42 153.74 40.01 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.896 -0.179 . . . . 0.0 111.3 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.4 t80 73.7 -47.55 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.656 0.782 . . . . 0.0 111.995 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.96 11.8 1.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.309 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -93.17 166.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.4 mtp -92.23 120.79 33.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.057 0.456 . . . . 0.0 111.037 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.7 120.89 28.47 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.971 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.01 124.92 14.82 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.856 2.37 . . . . 0.0 111.575 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.25 -53.22 42.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.15 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.11 136.93 52.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.461 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.05 175.26 40.74 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.14 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 84' ' ' ARG . 1.1 pm0 -93.72 141.55 28.37 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 4.1 ptp85 -93.12 139.57 30.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.318 0.58 . . . . 0.0 111.229 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.65 143.94 21.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.629 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 31.4 p-10 -92.98 152.92 41.83 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.436 ' HA ' HG23 ' A' ' 112' ' ' VAL . 77.3 Cg_exo -52.12 -27.0 27.81 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.224 2.616 . . . . 0.0 113.307 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 43.5 tt0 -60.17 -38.21 82.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.734 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.31 -13.35 57.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 109' ' ' PRO . 88.3 t -60.23 110.84 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.261 0.553 . . . . 0.0 110.773 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -80.0 -53.07 7.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.52 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.66 136.6 48.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.526 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.53 139.12 45.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.36 119.97 24.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.53 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 48' ' ' TYR . 35.7 m -125.46 139.56 34.23 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.849 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.618 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 95.3 Cg_endo -80.84 -174.94 2.44 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.823 2.349 . . . . 0.0 111.506 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.78 -164.32 23.24 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.359 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.0 t -117.95 -50.0 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.574 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -139.72 140.09 36.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' HB3' ' A' ' 128' ' ' ARG . 49.3 m-85 -134.67 168.79 18.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 24.2 p30 -135.27 -170.07 2.51 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.481 HD23 ' NH1' ' A' ' 179' ' ' ARG . 90.0 mt -82.23 -20.69 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.978 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.428 ' CD ' HH12 ' A' ' 162' ' ' ARG . 41.5 mt-10 -92.12 -12.12 33.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.692 0.282 . . . . 0.0 111.353 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.38 12.66 22.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.369 171.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.445 ' HE2' ' H ' ' A' ' 166' ' ' ASP . 48.9 m-85 -88.29 146.8 25.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.916 0.389 . . . . 0.0 110.052 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.639 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -131.63 132.59 44.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 160' ' ' LEU . 11.1 mp -104.48 97.59 7.49 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -102.03 -170.39 27.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.881 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -109.53 124.31 50.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 172.07 172.85 38.35 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.961 -0.637 . . . . 0.0 111.749 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -156.09 95.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 0.0 109.972 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 154.44 177.17 27.54 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.54 ' HB2' HD21 ' A' ' 78' ' ' ASN . 96.5 m-85 -94.41 87.71 5.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.421 0.629 . . . . 0.0 110.864 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -87.11 21.44 2.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.078 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -56.34 -42.89 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.776 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -11.6 59.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.269 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 143' ' ' VAL . 61.8 tp -93.19 -73.17 0.57 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.33 -29.14 69.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -83.52 -14.62 51.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 111.292 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -102.06 -15.54 16.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.111 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.0 t -71.26 123.42 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.44 1.07 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 110.051 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.67 -155.76 10.55 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.754 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.72 120.79 28.4 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.662 -0.316 . . . . 0.0 111.022 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.644 ' HG2' ' OD2' ' A' ' 170' ' ' ASP . 20.3 mmtm -87.04 106.51 17.9 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.44 114.63 33.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.909 0.385 . . . . 0.0 110.34 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.53 125.35 8.51 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.436 HG13 HG11 ' A' ' 29' ' ' VAL . 39.4 t -102.49 123.43 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.59 155.95 27.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 111.804 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 156' ' ' VAL . 69.0 m-85 -91.27 141.98 28.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.181 174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.3 m -57.3 -26.03 60.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.877 0.736 . . . . 0.0 111.829 -175.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -59.28 -38.7 80.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.434 ' HB2' HH21 ' A' ' 14' ' ' ARG . 10.4 mm100 -108.28 24.03 13.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.601 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 152' ' ' TYR . 50.2 t -116.75 105.92 19.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.322 0.582 . . . . 0.0 109.454 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 82.2 m-85 -92.65 -178.41 4.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.761 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.95 -61.82 2.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 3.1 ptm180 -153.08 135.62 15.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 129' ' ' LEU . 95.9 mt -98.57 155.26 36.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.748 -174.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.9 117.71 4.56 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.819 2.346 . . . . 0.0 111.199 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 162' ' ' ARG . 6.2 ptp180 -126.24 -179.65 4.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.122 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -105.51 -91.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.45 97.55 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.69 0.281 . . . . 0.0 111.576 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 53.16 78.81 0.13 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.599 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 4.6 t0 -83.84 -169.46 2.58 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.74 102.78 6.53 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.643 0.259 . . . . 0.0 110.387 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 166' ' ' ASP . 0.9 OUTLIER -83.07 167.11 14.31 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.194 2.596 . . . . 0.0 112.345 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 147' ' ' LYS . 27.3 m -90.39 166.86 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.794 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.644 ' OD2' ' HG2' ' A' ' 147' ' ' LYS . 24.8 m-20 -100.54 -38.04 8.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.113 0.482 . . . . 0.0 110.388 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.47 112.85 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.871 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 35.6 tp -99.71 110.7 23.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 61.5 t -95.4 120.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.073 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 52.6 p -109.35 179.62 4.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.036 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.77 9.68 20.88 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.414 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -133.23 -44.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -128.31 167.87 16.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.057 0.456 . . . . 0.0 111.056 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 25.6 t -119.35 113.38 41.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 92.6 mtt180 -94.01 99.04 11.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -88.64 108.46 19.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.367 0.603 . . . . 0.0 109.977 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.7 mt -102.13 14.42 32.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.58 -37.46 83.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.183 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -103.38 -53.31 2.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.32 16.77 79.72 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.951 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -114.66 2.64 14.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.275 0.559 . . . . 0.0 110.007 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.4 m -79.84 -4.7 53.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.324 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -119.15 149.96 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -74.59 145.94 42.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.61 140.6 57.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -76.11 72.57 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.486 0.66 . . . . 0.0 111.094 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -153.21 133.29 13.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.733 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -123.21 128.22 49.71 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -80.22 63.45 4.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.745 0.783 . . . . 0.0 111.571 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.245 0.859 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.435 177.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.845 0.355 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 93.1 mt -93.56 133.58 36.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.73 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -65.87 -30.67 71.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.766 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.449 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 49.0 m -83.14 -30.09 28.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.865 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 tm-20 -70.35 -42.32 72.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 61.9 tp -61.48 -39.9 92.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.753 174.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -58.78 -38.11 77.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.467 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.54 -38.32 89.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -62.96 -43.8 97.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 6' ' ' LEU . 21.3 t -67.54 -48.76 75.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.001 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.11 -47.75 68.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.352 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -58.55 -51.39 70.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.033 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -66.35 -38.65 88.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.119 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 120' ' ' VAL . 20.0 ttm180 -58.02 -49.74 75.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.931 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 pt -86.94 -0.87 7.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.637 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.35 -10.12 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.143 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.17 136.24 56.42 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -67.09 156.99 34.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.488 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.1 -55.15 31.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.647 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.88 -45.8 82.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.163 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.82 -45.51 85.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.582 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -62.62 -46.09 89.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.736 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.431 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 21.0 tpt180 -60.06 -36.8 78.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.908 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -38.4 90.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.046 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.58 -51.19 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.799 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 m -62.54 -34.91 77.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.307 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.26 -39.56 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.97 -38.14 87.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.305 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 175' ' ' GLU . 56.2 t -63.75 -47.42 91.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.422 . . . . 0.0 110.487 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.43 -48.13 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.72 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -60.86 -39.11 87.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.09 0.471 . . . . 0.0 110.359 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.19 -53.53 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.03 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.4 -40.61 97.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.87 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -62.61 -32.74 73.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.3 m -83.49 -19.87 35.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.351 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.432 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.0 tt -52.32 115.53 7.07 Favored Pre-proline 0 CA--C 1.533 0.295 0 O-C-N 123.26 0.35 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HD2' HD23 ' A' ' 36' ' ' LEU . 50.4 Cg_exo -54.78 -32.56 77.25 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.223 2.615 . . . . 0.0 113.45 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.54 -26.16 30.36 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.025 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -76.04 -14.82 60.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.149 0.976 . . . . 0.0 109.015 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.47 -22.82 40.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.742 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 54.4 mttp -104.69 -12.37 16.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.451 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 p -64.29 149.36 48.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 111.76 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -109.84 -65.83 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.731 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HB3' HD11 ' A' ' 71' ' ' ILE . 30.1 mmtp -91.28 95.29 9.95 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.703 -176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.6 t -102.35 108.28 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.692 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -94.65 119.86 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.433 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.4 129.47 52.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.457 ' HB3' ' HD3' ' A' ' 118' ' ' PRO . 23.2 t80 -77.79 -2.02 34.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.373 -173.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.9 m 66.12 96.58 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.349 0.595 . . . . 0.0 111.548 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.61 128.06 7.57 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.762 2.308 . . . . 0.0 113.084 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 38.7 pt -129.51 158.81 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.437 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 68.5 -66.02 0.25 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.37 0.668 . . . . 0.0 112.481 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.89 21.15 0.37 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.494 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 51' ' ' ILE . 23.2 mm-40 -82.4 36.36 0.47 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.495 ' HA ' ' OH ' ' A' ' 152' ' ' TYR . 47.2 t 68.85 114.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 122.977 0.511 . . . . 0.0 110.528 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -71.53 80.66 0.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.957 0.884 . . . . 0.0 111.476 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 150' ' ' VAL . 86.7 mt -86.08 3.82 40.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -53.92 -46.98 98.36 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 58' ' ' THR . 27.0 Cg_endo -62.99 -11.48 24.88 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.104 1.87 . . . . 0.0 113.332 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.6 tp -92.7 -14.28 28.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 58' ' ' THR . 14.9 m-85 -56.75 -48.38 97.37 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.878 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.29 -33.58 56.13 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.331 2.021 . . . . 0.0 113.322 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -71.48 -50.75 28.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.405 . . . . 0.0 110.837 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.63 -37.3 79.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.63 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 86' ' ' HIS . 23.7 tp -67.06 -24.39 65.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.969 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -93.81 -53.73 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.18 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -50.63 11.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -100.76 -171.78 2.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.183 0.516 . . . . 0.0 111.123 -170.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 39.8 mt-10 -105.21 102.81 12.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.025 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.5 tp -78.76 114.95 18.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.956 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 61.4 mt -101.39 117.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.059 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 98.0 mt -113.25 139.99 23.8 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.629 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.0 Cg_exo -74.99 120.04 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.873 2.382 . . . . 0.0 112.093 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.606 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 45.0 tttm -116.91 152.78 33.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.13 114.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.134 0.493 . . . . 0.0 110.413 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -111.56 107.1 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.147 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.75 39.21 97.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.8 t30 65.91 16.43 10.47 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.127 0.571 . . . . 0.0 111.114 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.16 136.39 54.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' CD1' ' A' ' 136' ' ' TYR . 20.4 tt -79.08 135.88 24.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.422 0.63 . . . . 0.0 111.244 -173.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.3 m -139.93 167.49 21.99 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.3 mt -109.89 131.56 54.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.93 0.395 . . . . 0.0 110.951 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.559 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 26.3 m-85 -117.66 124.12 47.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.193 0.521 . . . . 0.0 110.444 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 22.9 ttp180 -93.45 118.54 31.45 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.861 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.37 154.7 40.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.982 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 65' ' ' LEU . 1.8 p80 -162.44 47.87 0.16 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.986 0.898 . . . . 0.0 109.119 175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 43.9 m -156.05 160.41 30.81 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.259 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 87' ' ' SER . 41.7 Cg_endo -67.44 166.78 22.54 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.275 1.983 . . . . 0.0 112.601 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' O ' ' SG ' ' A' ' 90' ' ' CYS . . . 65.14 -155.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.788 0.68 . . . . 0.0 111.065 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 89' ' ' ALA . 15.2 p 60.53 6.33 1.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.717 1.207 . . . . 0.0 112.828 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.6 mt -97.51 149.34 22.29 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.36 -172.41 34.48 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.5 t -134.43 119.53 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.41 -33.28 0.54 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.238 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.52 -146.98 0.1 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.223 0.209 . . . . 0.0 111.22 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -39.5 -53.21 2.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.0 0.92 . . . . 0.0 112.971 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.56 47.99 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.473 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.6 mt -128.17 148.09 32.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.2 mtt -72.26 93.43 1.47 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.073 0.463 . . . . 0.0 110.234 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.606 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 11.6 pt-20 -102.06 143.64 27.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.229 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.641 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 43.3 Cg_endo -72.27 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.928 1.752 . . . . 0.0 111.171 175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.64 -44.19 69.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.287 0.565 . . . . 0.0 110.08 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.11 171.67 7.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.623 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -148.03 19.19 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.909 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 124.32 40.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -75.8 126.8 31.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.178 0.513 . . . . 0.0 111.21 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 91.4 t -122.11 139.24 49.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.58 ' OD1' ' HD2' ' A' ' 109' ' ' PRO . 64.8 t30 -84.42 135.9 40.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HD2' ' OD1' ' A' ' 108' ' ' ASN . 5.1 Cg_endo -47.52 -23.67 3.7 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.744 2.962 . . . . 0.0 113.856 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.67 -34.15 72.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 111.234 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.75 -15.67 53.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.584 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -73.52 116.15 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -93.85 -25.17 17.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.369 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -134.79 122.68 22.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.714 0.292 . . . . 0.0 110.413 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.08 139.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.89 0.376 . . . . 0.0 110.692 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.45 108.74 15.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.466 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 51.6 t -116.24 120.68 34.7 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.493 -177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 7.0 Cg_exo -74.57 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.917 2.411 . . . . 0.0 111.94 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.64 128.64 1.2 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 39.7 t -58.01 -40.88 78.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 111.81 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . -132.42 127.76 36.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.774 0.321 . . . . 0.0 111.091 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -121.62 161.72 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -121.58 174.41 6.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.02 3.84 47.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 37.6 mt-10 -101.31 -33.96 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.584 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 134.31 16.37 1.07 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.179 171.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.99 158.64 16.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.526 0.663 . . . . 0.0 111.119 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -115.65 157.68 23.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.693 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 25.2 tp -97.82 -0.08 45.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.162 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.37 -175.98 45.41 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.969 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -144.11 98.19 3.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.828 0.347 . . . . 0.0 110.207 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.0 -77.3 1.15 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.403 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -121.69 -174.88 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -146.91 95.23 0.17 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.008 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -130.79 -168.51 2.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 80' ' ' ILE . 69.6 m-85 65.11 29.62 11.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.235 0.54 . . . . 0.0 110.988 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.68 -31.19 72.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.527 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -57.94 -23.66 54.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 13.8 tp -93.58 -59.89 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.231 0.539 . . . . 0.0 109.945 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -33.32 72.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.679 -171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -75.55 -22.58 56.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.748 0.309 . . . . 0.0 111.307 -175.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -102.85 -15.05 16.33 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.696 -0.402 . . . . 0.0 112.053 -173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' LEU . 62.0 t -67.92 95.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.193 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -86.44 -4.04 59.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.611 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.57 166.75 15.49 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.109 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 46.8 tp -53.0 111.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.095 0.474 . . . . 0.0 110.778 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.499 ' HG3' HG12 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -82.88 99.6 9.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.123 -176.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.42 123.99 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.746 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -101.25 138.19 13.72 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 57' ' ' LEU . 67.3 t -120.89 124.81 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.081 0.441 . . . . 0.0 110.515 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -164.17 167.47 20.08 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 156' ' ' VAL . 50.5 m-85 -84.34 149.95 25.7 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.305 174.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 85.0 p -67.55 -25.03 65.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.368 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -58.64 -26.53 63.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.025 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 14' ' ' ARG . 21.3 mm-40 -115.42 11.98 16.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.881 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 152' ' ' TYR . 88.1 t -108.46 114.3 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.191 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 123' ' ' ASP . 91.4 m-85 -94.84 157.09 16.08 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.836 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -54.75 -54.55 40.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -147.22 150.73 35.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.027 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.9 mt -129.08 158.54 72.49 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.889 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.47 112.66 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.955 1.77 . . . . 0.0 110.586 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 162' ' ' ARG . 16.6 ttp180 -73.52 131.73 42.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.642 -170.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.38 -166.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.913 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -113.97 107.29 15.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.201 0.524 . . . . 0.0 110.857 -174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 79.62 13.07 1.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.076 171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.85 123.35 19.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.492 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 15.0 tt -76.2 116.83 59.53 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.382 0.611 . . . . 0.0 111.27 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 8.2 Cg_exo -72.15 150.37 53.66 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.996 2.464 . . . . 0.0 112.547 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.499 HG12 ' HG3' ' A' ' 147' ' ' LYS . 34.3 m -86.02 148.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.57 177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' OD2' ' HD2' ' A' ' 182' ' ' ARG . 16.9 t70 -87.35 -40.77 14.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.411 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.712 HG22 ' HG2' ' A' ' 180' ' ' ARG . 61.0 t -120.08 130.44 74.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.437 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 53.7 tp -111.51 115.92 30.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.054 0.454 . . . . 0.0 110.082 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.1 111.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.352 0.596 . . . . 0.0 109.766 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -109.01 174.22 5.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.264 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' VAL . 9.9 pt-20 -54.9 -34.26 62.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.892 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 47.2 mttm -87.49 -58.64 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.306 -171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -155.53 174.72 14.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.809 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.6 t -87.85 121.59 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.802 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -126.33 119.15 26.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 171' ' ' VAL . 57.1 mtt180 -81.87 139.5 34.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.9 mt -104.97 -97.06 0.33 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 170' ' ' ASP . 35.7 ttt85 70.99 -49.18 0.68 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 170.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.01 115.22 5.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.825 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -141.24 103.42 0.34 Allowed Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.761 ' HE ' ' HA ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -90.41 78.93 6.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.352 0.596 . . . . 0.0 110.394 -177.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.6 p -112.52 -28.71 7.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.718 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.4 mt 57.57 31.19 19.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.222 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.76 93.84 0.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.066 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -144.16 105.18 4.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.987 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -65.39 113.53 4.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -132.66 136.91 46.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -135.44 110.26 8.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -54.34 -59.98 3.95 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.2 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.276 176.153 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 10.7 mp 61.87 95.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.685 0.615 . . . . 0.0 110.823 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -70.33 -35.72 73.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.875 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 t -72.63 -29.87 63.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.247 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 2' ' ' LEU . 1.8 mp0 -89.24 -25.33 21.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.823 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 tp -59.69 -44.95 93.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.62 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' A' ' 129' ' ' LEU . 4.0 ptp180 -66.55 -24.06 66.3 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.865 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HD2' ' HA ' ' A' ' 5' ' ' GLU . 98.6 mttt -73.16 -43.19 61.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.311 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.6 -29.56 70.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.644 0.735 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG13 ' NE2' ' A' ' 155' ' ' GLN . 77.1 t -75.63 -55.24 12.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.749 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -46.05 91.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.504 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -66.54 -21.23 66.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.111 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -76.56 -46.71 25.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.088 0.47 . . . . 0.0 110.496 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.66 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 36.7 mtm180 -73.2 -29.7 63.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.861 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 pt -80.81 3.0 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.929 0.395 . . . . 0.0 110.827 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -117.16 -98.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.4 mt 58.38 173.06 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.513 0.673 . . . . 0.0 111.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 m -76.37 123.34 25.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -75.06 -29.1 60.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.401 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.8 mp0 -63.53 -45.04 92.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.12 -50.13 74.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.445 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.1 mtm105 -52.55 -44.67 65.98 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.774 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.85 -47.16 69.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 2.6 ptt85 -73.53 -19.72 60.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.449 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 48.8 mt -78.0 -40.67 38.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 172.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -60.91 -35.19 76.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.403 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.66 -41.15 80.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.316 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -69.61 -42.65 74.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.572 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.0 t -62.33 -45.92 97.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.08 -44.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.673 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.5 m -60.37 -38.51 84.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.681 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -71.19 -47.24 58.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 49.6 tp -62.61 -38.93 92.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.013 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.21 -16.71 54.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.162 0.506 . . . . 0.0 110.513 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 31' ' ' SER . 10.5 t -75.89 -25.76 56.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 178' ' ' VAL . 58.4 mt -55.66 130.78 71.65 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.083 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.6 Cg_exo -64.87 -21.37 64.31 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.63 2.22 . . . . 0.0 111.456 177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 2.5 mp0 -69.45 -24.72 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.856 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.411 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 68.3 t80 -68.18 -29.25 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 109.51 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -88.18 -29.33 20.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.039 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . 62.4 mttp -63.86 -38.92 92.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.965 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 t -90.78 136.43 33.07 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.645 0.736 . . . . 0.0 112.038 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -92.31 -17.57 24.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.361 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 71' ' ' ILE . 78.9 mttt -121.2 97.29 5.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.764 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.02 107.51 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.993 0.425 . . . . 0.0 110.654 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -98.41 130.2 45.04 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.996 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.91 130.14 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -79.06 4.5 14.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.269 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 18.6 t 71.32 125.62 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.29 0.636 . . . . 0.0 111.181 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 4.4 Cg_exo -77.84 45.32 1.75 Allowed 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.221 2.614 . . . . 0.0 112.929 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.1 pp -61.28 -32.08 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.894 0.378 . . . . 0.0 111.411 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' ILE . 72.5 mmtt -136.33 33.63 2.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.44 146.71 18.33 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.683 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 7.2 pt-20 -83.71 -15.57 48.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.088 0.47 . . . . 0.0 111.241 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.87 132.23 54.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.735 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.87 86.76 5.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.98 0.419 . . . . 0.0 110.273 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -88.92 -1.17 57.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.274 0.559 . . . . 0.0 110.25 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -61.08 -47.09 96.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.02 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 58' ' ' THR . 51.0 Cg_endo -69.68 -5.32 15.87 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 121.592 1.528 . . . . 0.0 113.236 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' HG ' HG23 ' A' ' 64' ' ' VAL . 48.7 tp -88.73 -20.61 24.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.82 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.611 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.0 m-30 -49.73 -52.22 53.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 83.4 Cg_exo -50.28 -40.36 52.37 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.551 2.167 . . . . 0.0 113.362 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG3' ' HE2' ' A' ' 66' ' ' LYS . 17.0 tt0 -78.27 -37.44 45.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.349 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 70' ' ' LEU . 61.1 t -60.16 -44.83 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.4 -27.02 68.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.988 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 63' ' ' GLU . 31.9 ttpt -74.16 -36.01 64.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.783 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -95.9 -67.32 0.86 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.194 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 39' ' ' PHE . 40.4 mttp -124.98 -171.79 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.43 . . . . 0.0 111.981 -165.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.01 118.31 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.153 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 64' ' ' VAL . 58.6 tp -94.36 107.96 19.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 61.8 mt -89.0 116.93 31.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 91.4 mt -115.2 151.31 45.63 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HB3' HG21 ' A' ' 80' ' ' ILE . 5.2 Cg_exo -80.51 127.43 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 112.916 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 101' ' ' PRO . 25.6 tptp -105.8 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -85.61 103.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.876 0.37 . . . . 0.0 110.678 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -105.83 78.06 1.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.688 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.26 -80.95 0.96 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.007 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.479 ' ND2' ' HG3' ' A' ' 79' ' ' GLU . 3.2 p-10 -123.72 -16.26 6.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' HG2' ' CB ' ' A' ' 135' ' ' TYR . 21.0 mt-10 -126.53 167.42 15.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.933 0.397 . . . . 0.0 110.493 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 139' ' ' LEU . 65.3 mt -118.43 126.9 75.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 -175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.7 m -96.65 134.46 39.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.289 174.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 109' ' ' PRO . 98.1 mt -90.43 131.83 35.97 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -120.57 147.81 44.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.313 0.578 . . . . 0.0 111.939 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 105' ' ' GLU . 39.6 ttt180 -81.6 108.59 15.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.121 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 90' ' ' CYS . 47.3 t -110.07 118.08 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.108 0.48 . . . . 0.0 110.486 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -124.65 -29.19 3.47 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 15.9 m -89.85 126.3 58.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.25 176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.1 Cg_exo -61.29 -12.56 24.17 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.196 2.597 . . . . 0.0 113.011 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 4.22 28.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.853 0.359 . . . . 0.0 111.417 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.525 ' HB3' HG13 ' A' ' 85' ' ' VAL . 49.0 t -88.67 -0.51 57.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 111.073 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.95 113.32 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.021 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.56 158.71 22.62 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.966 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 61.5 t -79.71 127.99 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.785 0.326 . . . . 0.0 110.244 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.596 ' HA3' ' OE2' ' A' ' 100' ' ' GLU . . . -81.98 -131.1 1.36 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.655 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.72 2.83 22.09 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.06 30.07 1.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.453 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.95 32.28 76.96 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.457 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 24.1 pt -114.1 163.92 10.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 67.1 mtt -104.53 119.02 38.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 110.504 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.596 ' OE2' ' HA3' ' A' ' 94' ' ' GLY . 8.5 pt-20 -138.87 155.06 73.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.529 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' HD3' ' A' ' 74' ' ' LYS . 33.5 Cg_endo -64.65 120.45 7.73 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.308 2.672 . . . . 0.0 113.398 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.36 -37.39 7.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 103' ' ' GLU . 11.6 mm-40 -136.37 109.63 7.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.058 0.456 . . . . 0.0 111.78 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.17 43.68 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 84' ' ' ARG . 21.1 mp0 -81.49 121.44 26.29 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -70.25 132.52 45.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 0.0 109.956 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.87 133.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.624 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.87 132.97 95.05 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' A' ' 142' ' ' ARG . 50.2 Cg_exo -55.2 -33.03 82.96 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.573 2.182 . . . . 0.0 112.674 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -71.75 -19.72 61.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.718 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.95 -17.5 50.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.394 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.463 ' HB ' HG13 ' A' ' 143' ' ' VAL . 93.9 t -60.88 131.76 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.265 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.74 -41.59 7.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.512 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 54.0 t80 -132.9 130.45 39.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.276 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.52 138.51 42.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 110.894 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.92 115.95 28.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.82 118.6 36.36 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.37 90.69 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.69 2.26 . . . . 0.0 111.301 175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.1 156.54 53.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.004 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.496 ' HA ' ' NH2' ' A' ' 14' ' ' ARG . 48.8 t -63.76 -47.72 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -157.44 157.93 34.87 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.97 156.34 46.36 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.11 0.257 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -109.67 -171.71 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 94.1 mt -79.37 6.03 11.11 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -119.85 -36.71 3.24 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.63 11.95 1.24 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.576 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -95.52 167.18 11.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.57 -162.49 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.776 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.461 HD13 ' HD2' ' A' ' 161' ' ' PRO . 35.8 tp -118.04 20.2 13.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.651 0.739 . . . . 0.0 109.748 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.73 -179.62 49.1 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.245 -177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -142.81 -33.53 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.98 0.419 . . . . 0.0 110.313 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.97 174.07 33.36 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -100.33 129.74 46.35 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.7 -134.75 2.32 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.524 ' CB ' ' HG2' ' A' ' 79' ' ' GLU . 88.3 m-85 -128.95 10.81 5.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.23 0.538 . . . . 0.0 110.296 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -70.57 -38.94 74.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.18 -33.73 70.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.985 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -66.3 -30.8 71.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.772 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 80' ' ' ILE . 48.2 tp -67.42 -45.29 76.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.29 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.82 -38.52 75.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.877 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HB2' HD11 ' A' ' 167' ' ' ILE . 55.7 tttm -81.14 -21.67 39.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.247 0.546 . . . . 0.0 110.465 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.545 ' HG2' ' HB2' ' A' ' 109' ' ' PRO . 30.0 ttp180 -77.35 -24.61 50.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.951 177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.463 HG13 ' HB ' ' A' ' 112' ' ' VAL . 75.6 t -78.66 118.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.724 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -97.16 -2.02 43.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.06 0.457 . . . . 0.0 110.785 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.58 -179.23 41.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.03 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.37 122.52 17.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.364 . . . . 0.0 110.57 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.72 109.64 21.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 171' ' ' VAL . 80.9 t -107.68 128.95 62.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.562 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -100.54 122.31 7.54 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.37 114.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.538 0.169 . . . . 0.0 110.629 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.16 164.63 32.75 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.501 0.501 . . . . 0.0 110.13 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.468 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 75.6 m-85 -86.76 158.44 19.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.174 0.511 . . . . 0.0 111.051 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.7 p -61.79 -25.95 67.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.792 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -77.1 -9.23 58.6 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.635 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.593 ' NE2' HG13 ' A' ' 10' ' ' VAL . 8.5 mm100 -108.54 9.4 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.069 0.461 . . . . 0.0 111.228 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.27 116.69 44.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -111.18 179.7 3.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.799 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 30.4 mt-10 -70.8 -68.71 0.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.187 0.518 . . . . 0.0 111.273 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -136.75 117.2 13.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.314 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.83 154.05 37.99 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.461 ' HD2' HD13 ' A' ' 129' ' ' LEU . 49.9 Cg_exo -56.14 111.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.259 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -88.31 151.07 22.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.675 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.24 143.15 50.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.18 -15.9 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -110.98 13.12 22.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -89.93 115.3 27.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 141' ' ' LYS . 40.3 mt -74.77 112.09 16.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.666 -172.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.94 163.75 28.16 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.547 2.165 . . . . 0.0 112.209 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.481 HG23 HD12 ' A' ' 181' ' ' LEU . 28.6 m -103.6 166.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.637 177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.33 -41.02 6.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.258 0.551 . . . . 0.0 110.588 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 148' ' ' VAL . 61.8 t -116.84 120.67 65.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.405 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 49.8 tp -101.05 114.08 27.68 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.9 t -108.08 122.36 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.456 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.664 ' HB ' ' OE1' ' A' ' 175' ' ' GLU . 46.6 p -111.37 -168.3 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -72.29 -25.17 61.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.113 0.482 . . . . 0.0 110.215 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -115.11 -47.56 2.86 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.401 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -133.42 172.99 11.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.309 0.576 . . . . 0.0 112.053 -173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 98.9 t -126.06 115.03 41.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.632 176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -100.03 116.38 31.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -73.71 95.03 2.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.866 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 169' ' ' VAL . 69.6 mt -69.0 -41.78 77.34 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 62.45 99.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.91 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -77.27 -35.69 54.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.077 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.91 90.89 1.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.024 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.89 -176.81 5.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.644 0.259 . . . . 0.0 110.799 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.2 m -62.79 114.17 3.46 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 58.7 tp -88.16 132.96 34.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.676 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 64.66 -83.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.678 0.611 . . . . 0.0 111.318 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 74.85 -29.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.607 0.763 . . . . 0.0 111.701 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -97.08 -51.51 4.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 110.567 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -74.35 105.18 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.493 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -178.5 -61.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.501 0.501 . . . . 0.0 110.403 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -159.09 139.88 12.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.315 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 59.4 m170 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.665 173.537 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.727 0.299 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 88.6 mt -74.66 161.86 29.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -70.86 -52.04 22.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.807 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -66.5 -24.63 66.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.084 0.469 . . . . 0.0 110.036 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 42.4 tt0 -58.37 -54.66 44.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.424 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.68 -35.77 75.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.168 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.15 -42.7 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.962 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.13 -42.76 99.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.108 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 26.8 mtpp -63.94 -51.89 62.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.61 -44.78 97.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -68.99 -35.79 77.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.426 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 24.8 t-80 -67.04 -37.8 84.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.371 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 7.4 mtpm? -66.27 -31.68 72.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 0.0 110.44 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HD3' ' HB3' ' A' ' 54' ' ' GLU . 50.8 mtt180 -63.34 -54.45 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.176 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.679 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 27.0 pt -88.03 5.88 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.161 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -84.28 -30.83 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -67.28 144.99 55.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.863 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.5 m -71.79 151.21 43.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.703 0.287 . . . . 0.0 110.736 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 22' ' ' ARG . 5.1 tp10 -59.44 -36.61 76.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.589 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 50.7 mt-10 -55.23 -52.55 63.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.088 0.471 . . . . 0.0 110.623 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.11 -39.81 95.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.379 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.679 ' NH1' ' HA ' ' A' ' 15' ' ' ILE . 23.6 mtm180 -65.76 -39.13 90.74 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -64.37 -37.5 87.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.939 0.399 . . . . 0.0 110.841 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 49.5 mtt85 -69.56 -48.27 60.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.916 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -67.79 -43.36 79.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.451 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.6 t -62.03 -43.75 98.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.896 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.75 -35.44 81.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.848 0.356 . . . . 0.0 110.124 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 33.2 ttmt -59.02 -44.5 91.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.441 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 175' ' ' GLU . 42.9 t -67.76 -39.48 82.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 26' ' ' SER . 80.8 mt -61.41 -49.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -64.72 -37.19 86.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.075 0.464 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -64.13 -39.44 94.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.242 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.585 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 46.8 tp -65.79 -34.18 77.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.475 178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 45.9 mtpt -72.76 -25.52 61.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -78.89 -21.3 47.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.902 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 171' ' ' VAL . 2.4 tt -58.28 121.46 52.01 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.134 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' HD23 ' A' ' 36' ' ' LEU . 69.4 Cg_exo -52.89 -37.71 77.84 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.309 2.672 . . . . 0.0 114.058 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -18.57 58.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -69.11 -15.65 63.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.967 0.413 . . . . 0.0 111.2 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -76.41 -45.34 32.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.799 0.333 . . . . 0.0 110.748 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp -74.69 -35.8 62.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.1 p -73.39 95.99 2.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.293 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HE2' ' HG3' ' A' ' 69' ' ' GLU . 79.1 tttt -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 111' ' ' ASP . 40.5 mttm -99.23 101.55 12.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.458 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.95 114.98 48.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -96.66 134.49 39.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.509 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -120.17 136.03 54.76 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 117' ' ' VAL . 26.0 t80 -74.67 -10.67 59.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.019 -173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' TYR . 41.2 t 67.84 106.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.406 0 CA-C-O 121.3 0.572 . . . . 0.0 110.824 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 76.1 Cg_endo -78.08 151.14 26.89 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.616 2.211 . . . . 0.0 113.437 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.6 pt -134.85 166.66 27.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.257 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 34.4 mtpt 64.59 8.63 4.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.327 0.392 . . . . 0.0 111.556 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.24 -106.58 2.41 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 70.4 mt-10 61.66 -83.44 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.616 0.767 . . . . 0.0 110.764 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 150' ' ' VAL . 51.2 t -132.8 96.18 2.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 104.71 15.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.894 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.691 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 91.6 mt -95.91 3.73 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.671 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.3 m -59.17 -39.5 73.75 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 58' ' ' THR . 50.2 Cg_exo -57.78 -9.71 6.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.175 1.916 . . . . 0.0 114.136 176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.8 tp -84.92 -12.93 52.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.654 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m-30 -54.99 -53.85 56.74 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.644 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 84.4 Cg_exo -52.59 -31.39 49.3 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.73 2.286 . . . . 0.0 113.476 178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.0 -43.78 51.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.052 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 68' ' ' LYS . 84.0 t -72.98 -42.43 59.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.606 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt -65.93 -5.78 10.38 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 62' ' ' PRO . 63.4 mttp -66.1 -57.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.588 0.233 . . . . 0.0 110.903 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.45 -17.83 1.3 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG13 ' A' ' 64' ' ' VAL . 68.0 mttm -91.69 173.64 7.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.003 0.43 . . . . 0.0 110.888 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HG3' ' HE2' ' A' ' 43' ' ' LYS . 42.7 mt-10 -100.93 118.7 37.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.453 175.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.54 111.01 21.36 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 59.5 mt -97.89 112.37 29.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 98.1 mt -114.78 145.07 33.17 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.199 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 1.1 Cg_endo -83.39 132.24 5.89 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.009 2.473 . . . . 0.0 112.544 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.897 ' HB2' ' HB2' ' A' ' 81' ' ' SER . 5.5 mtpp -105.76 125.89 51.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.985 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.5 t -109.85 89.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.19 17.59 19.58 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.991 175.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.4 -121.22 2.13 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.78 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -91.14 -10.09 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.022 0.439 . . . . 0.0 111.185 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -105.18 109.34 21.3 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.306 0.574 . . . . 0.0 110.285 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.578 HD11 ' HD1' ' A' ' 136' ' ' TYR . 57.1 mt -87.38 110.86 21.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.897 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 19.3 m -82.98 106.8 15.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.879 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 139' ' ' LEU . 94.4 mt -74.65 100.54 3.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 1.2 m-85 -96.11 116.22 28.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.617 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 3.0 ptp180 -83.89 124.29 30.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 101' ' ' PRO . 58.0 t -135.82 133.16 51.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.423 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -118.43 -9.98 10.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 9.5 m -91.4 136.58 26.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.483 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.6 Cg_exo -77.86 165.6 26.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.932 2.422 . . . . 0.0 112.105 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.72 4.76 3.56 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.1 m -95.94 28.25 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.98 0.419 . . . . 0.0 110.786 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -113.62 138.39 50.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.03 143.37 15.04 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.0 t -91.3 128.15 43.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.92 -163.12 26.87 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 96' ' ' PHE . . . 47.63 78.57 0.07 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 95' ' ' ALA . 77.7 t80 72.71 -50.83 0.7 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.879 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.94 36.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.061 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 pt -114.39 172.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.2 ptm -123.75 99.34 6.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.396 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 5.3 pt-20 -96.67 159.0 32.68 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.343 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.566 ' HB3' HG21 ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.14 116.3 4.34 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.48 2.12 . . . . 0.0 111.429 175.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.23 -22.14 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 110.55 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.38 152.78 51.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.005 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.66 -153.17 25.17 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -141.44 135.64 30.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.024 0.412 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -77.23 127.16 32.12 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.14 160.97 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.322 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.03 145.93 78.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.543 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.01 -17.15 10.41 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.391 2.727 . . . . 0.0 113.456 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.37 -29.73 70.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.061 0.458 . . . . 0.0 110.686 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 21.3 t70 -83.49 -10.35 58.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.83 -175.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.57 95.55 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.941 0.401 . . . . 0.0 110.337 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.33 -32.41 33.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.093 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.585 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 42.7 t80 -137.51 138.82 40.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.434 HG12 HG13 ' A' ' 117' ' ' VAL . 16.0 tt -146.88 140.54 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.751 0.31 . . . . 0.0 110.401 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.13 112.34 18.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.185 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 48' ' ' TYR . 27.3 m -126.33 128.63 24.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.429 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.33 108.81 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.429 2.086 . . . . 0.0 111.485 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.58 157.04 18.28 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.452 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.4 t -88.81 109.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.18 134.52 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.135 0.897 . . . . 0.0 112.512 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.14 146.09 42.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.886 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -103.27 -172.38 2.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.985 0.422 . . . . 0.0 111.219 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 70.5 mt -79.45 -3.97 49.03 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -105.56 -38.11 6.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.853 0.358 . . . . 0.0 110.284 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 133.6 11.65 1.67 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.682 174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -90.58 168.4 11.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.304 0.552 . . . . 0.0 110.233 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -153.63 135.18 14.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.571 -166.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.9 tp -58.57 -64.74 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.956 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.99 171.03 22.44 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.321 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.3 -62.22 1.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.619 0.247 . . . . 0.0 110.995 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.51 -51.93 2.6 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.537 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 129' ' ' LEU . 33.7 tptt 73.53 112.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.555 0.742 . . . . 0.0 111.237 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 19.65 55.89 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.963 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.09 -80.26 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.666 -175.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 80' ' ' ILE . 31.9 m-85 -78.08 -23.73 47.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.759 0.79 . . . . 0.0 110.282 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -22.63 65.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.549 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -69.93 -13.77 62.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 110.583 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.435 HD21 HD21 ' A' ' 82' ' ' LEU . 48.5 tp -89.81 -42.89 11.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 172.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 147' ' ' LYS . 94.2 mt -57.05 -38.68 73.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.667 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -64.72 -26.97 68.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -87.94 -18.25 29.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.051 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.07 114.72 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -90.45 -6.06 55.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.382 -171.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.72 43.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.39 109.58 11.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.963 0.411 . . . . 0.0 110.261 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 140' ' ' LEU . 32.6 mtmm -82.71 103.12 11.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.829 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.9 t -99.05 122.37 50.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.677 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -94.7 133.32 11.52 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.681 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.488 HG13 HG11 ' A' ' 29' ' ' VAL . 43.5 t -107.64 120.07 58.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.95 154.73 40.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.042 0.449 . . . . 0.0 111.898 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.96 160.9 21.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.836 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.3 m -55.37 -27.58 48.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.599 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -69.0 -15.76 63.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.664 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -99.43 -6.22 28.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.414 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 45.0 t -91.64 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.8 -176.63 2.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.151 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.945 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 33.8 mt-10 -90.79 -66.98 0.88 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 158' ' ' GLU . 10.8 mpt_? -125.4 115.04 19.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.18 143.57 26.86 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.94 101.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.776 1.651 . . . . 0.0 110.165 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -109.74 177.14 4.82 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.196 -172.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -98.71 168.3 10.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.454 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -73.53 -32.69 64.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -102.39 66.19 0.97 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.571 0.701 . . . . 0.0 109.339 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.66 162.82 12.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.645 HD12 ' HD2' ' A' ' 168' ' ' PRO . 3.9 tp -138.99 111.52 8.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.139 0.495 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.645 ' HD2' HD12 ' A' ' 167' ' ' ILE . 72.5 Cg_endo -77.27 173.56 14.15 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.667 2.245 . . . . 0.0 112.572 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.474 HG23 HD12 ' A' ' 181' ' ' LEU . 21.1 m -112.17 151.98 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.211 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.03 -30.16 34.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.179 0.514 . . . . 0.0 110.083 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 36' ' ' LEU . 49.0 t -142.22 135.03 27.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.648 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 179' ' ' ARG . 61.0 tp -114.33 118.34 33.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 178' ' ' VAL . 63.2 t -109.22 123.22 64.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.185 0.517 . . . . 0.0 110.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 75.1 p -108.46 -164.86 0.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.601 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.709 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 5.7 pt-20 -73.16 -22.33 60.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.654 0.264 . . . . 0.0 110.98 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 64.8 mttp -122.26 -61.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 111.758 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -96.98 141.03 30.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.216 0.531 . . . . 0.0 112.037 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.538 HG13 HG22 ' A' ' 173' ' ' VAL . 57.6 t -109.47 102.32 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.658 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.783 HH22 ' HA ' ' A' ' 124' ' ' LEU . 2.3 mtp-105 -85.69 99.82 11.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.423 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 -76.34 92.39 3.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.474 HD12 HG23 ' A' ' 169' ' ' VAL . 88.0 mt -81.23 6.05 15.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.782 -170.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -71.24 -20.66 62.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.03 80.78 0.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.545 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -130.43 79.69 0.36 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.67 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -148.42 17.81 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.73 0.776 . . . . 0.0 109.874 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.0 p -76.94 -27.42 54.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.812 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.05 -67.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -85.72 85.34 7.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.532 0.682 . . . . 0.0 110.117 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -102.51 108.32 19.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.446 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -85.32 11.5 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.48 -174.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -111.98 161.61 16.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -87.66 -62.25 1.54 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -172.63 176.74 3.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.836 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.148 -0.929 . . . . 0.0 109.57 175.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.867 0.365 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.3 mt -133.68 86.0 2.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.681 0.277 . . . . 0.0 111.34 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -95.42 -45.48 7.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 0.0 109.719 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -58.85 -55.08 39.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.065 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HG2' ' HD2' ' A' ' 9' ' ' LYS . 37.9 tt0 -59.04 -52.54 65.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.49 -46.31 90.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HG3' ' HA ' ' A' ' 131' ' ' PHE . 8.0 tmm_? -58.67 -45.68 88.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.038 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.01 -45.11 71.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.437 -175.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 13.4 ptmm? -70.36 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.369 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.645 HG11 ' HB2' ' A' ' 121' ' ' ALA . 84.0 t -70.14 -35.19 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.004 0.431 . . . . 0.0 110.467 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.74 -46.57 87.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.269 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' HA ' HG12 ' A' ' 15' ' ' ILE . 33.8 t-80 -66.76 -34.66 78.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.682 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 68.8 mmtt -51.88 -41.48 61.94 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.455 0.472 . . . . 0.0 111.144 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 54' ' ' GLU . 36.7 ttp180 -72.85 -38.36 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 12' ' ' HIS . 34.0 pt -90.71 -9.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.566 HD22 ' C ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -93.09 -6.51 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.536 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 16' ' ' ASN . 98.7 mt -67.4 161.02 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.602 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.7 m -62.74 127.27 30.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.335 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.9 -42.49 90.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.648 0.261 . . . . 0.0 111.356 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -67.99 -32.18 72.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.954 0.407 . . . . 0.0 110.089 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' CB ' ' HB2' ' A' ' 18' ' ' SER . 9.7 tp10 -63.13 -50.57 69.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.259 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 18' ' ' SER . 72.3 mtp180 -60.41 -37.45 80.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.94 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -56.74 -50.68 71.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.532 . . . . 0.0 110.527 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -68.95 -33.19 73.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.022 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 97.7 mt -69.58 -47.15 64.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.657 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 30' ' ' ILE . 19.6 m -63.34 -31.71 72.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -56.76 -42.45 79.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.145 0.498 . . . . 0.0 110.255 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.56 -34.3 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 175' ' ' GLU . 66.0 t -62.19 -47.96 90.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.517 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 26' ' ' SER . 72.0 mt -57.48 -46.12 85.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.144 0.497 . . . . 0.0 110.097 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.1 m -61.76 -38.47 88.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.87 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.33 -43.66 81.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 0.0 110.324 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 36' ' ' LEU . 40.2 tp -61.26 -36.68 80.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.365 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -79.39 -13.77 59.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.004 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.7 m -82.61 -23.43 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 33' ' ' LEU . 74.3 mt -61.8 118.61 40.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.093 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.21 -23.0 53.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.417 2.078 . . . . 0.0 110.774 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.08 -31.26 70.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.312 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.22 -24.96 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.732 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -70.49 -49.62 46.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.666 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -72.34 -26.28 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.707 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 114' ' ' PHE . 31.1 m -71.26 98.04 1.66 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 30.9 mtmm -86.35 -25.16 25.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.23 -171.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -110.48 108.58 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 t -109.02 113.05 43.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.5 124.58 40.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.483 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.75 130.99 55.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.25 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' CYS . 48.4 t80 -72.62 -27.57 62.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.967 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.8 t 72.24 133.73 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.855 0.722 . . . . 0.0 111.226 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 14.4 Cg_exo -69.36 140.59 44.55 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.677 2.251 . . . . 0.0 111.824 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.9 pt -124.15 -27.58 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 18.6 tptt -124.38 -35.73 2.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.628 . . . . 0.0 110.41 -175.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.537 ' C ' HH22 ' A' ' 22' ' ' ARG . . . 138.53 88.13 0.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -121.07 -87.15 0.65 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.552 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -135.09 131.58 52.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.3 96.57 4.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.294 0.569 . . . . 0.0 110.688 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.57 13.67 20.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.505 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -66.34 -44.8 58.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.536 -175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 58' ' ' THR . 42.5 Cg_endo -68.81 -0.96 6.84 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.769 1.646 . . . . 0.0 112.773 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 63' ' ' GLU . 60.0 tp -92.07 -17.26 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 30.9 m-85 -50.93 -51.27 68.76 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.8 Cg_endo -56.64 -41.6 74.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.192 1.928 . . . . 0.0 112.471 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' A' ' 60' ' ' LEU . 6.1 mt-10 -66.5 -36.34 82.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.495 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.52 -41.79 91.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.434 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 86' ' ' HIS . 65.1 mt -66.3 -14.19 61.63 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.856 0.36 . . . . 0.0 111.272 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -82.15 -61.9 1.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.99 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -93.04 -29.66 15.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 43' ' ' LYS . 27.1 mmtp -124.45 -174.47 3.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.536 0.684 . . . . 0.0 112.234 -166.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.06 128.24 48.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.975 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 112.63 24.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.821 0.343 . . . . 0.0 110.443 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 44' ' ' LYS . 61.5 mt -98.41 117.64 43.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.923 0.392 . . . . 0.0 110.101 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.8 mt -118.96 133.97 23.64 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.473 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -84.25 123.17 2.99 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.722 2.281 . . . . 0.0 112.621 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 57.0 tttm -105.42 101.48 11.01 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -82.15 92.72 2.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.313 0.578 . . . . 0.0 109.846 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -101.21 107.15 18.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.236 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.28 -90.97 0.92 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.59 11.61 1.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 109.828 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.22 120.51 40.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.27 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.649 HD11 ' HD1' ' A' ' 136' ' ' TYR . 56.7 mt -85.07 99.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.331 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 m -95.97 112.11 23.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -79.68 131.14 35.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.07 144.93 48.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.421 0.629 . . . . 0.0 111.697 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.7 ttt85 -90.65 96.81 10.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.693 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.0 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.466 ' HA ' HD22 ' A' ' 65' ' ' LEU . 1.7 t60 -136.39 16.28 3.18 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -121.31 120.0 29.23 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.023 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.96 -8.62 22.55 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.622 2.215 . . . . 0.0 112.307 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.32 12.46 20.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.4 t -95.69 -144.93 0.27 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.6 mt 64.57 113.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.799 0.687 . . . . 0.0 112.616 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.95 127.08 4.28 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.18 110.2 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.934 0.367 . . . . 0.0 110.279 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -133.91 -98.94 0.65 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.014 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 97' ' ' GLY . . . -60.03 127.23 30.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.322 0.249 . . . . 0.0 111.638 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.7 t80 70.47 -38.55 0.42 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.021 0.826 . . . . 0.0 112.061 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 95' ' ' ALA . . . 130.07 10.02 2.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.926 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 pt -91.34 172.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.716 0.294 . . . . 0.0 110.725 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtm -93.42 100.71 12.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.662 ' HB3' ' HE2' ' A' ' 74' ' ' LYS . 43.2 mt-10 -84.86 132.34 46.38 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.438 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 74' ' ' LYS . 24.5 Cg_exo -64.15 114.26 2.57 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.388 2.059 . . . . 0.0 111.426 174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.79 -17.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.317 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -148.1 150.27 33.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.3 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.06 -158.45 27.74 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.811 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -112.44 161.65 16.47 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -89.26 126.14 35.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.36 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.58 130.66 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 110.738 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.69 152.23 38.99 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.58 -23.71 41.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.66 -22.07 66.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 44' ' ' LYS . 4.7 t70 -94.7 -3.41 49.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.229 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 65.9 t -70.92 112.63 5.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.239 0.543 . . . . 0.0 111.527 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -60.18 1.98 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.187 175.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 21.3 t80 -134.84 139.61 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.9 139.2 41.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.5 111.65 21.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.497 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 46.1 t -117.89 108.62 42.35 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.18 62.74 8.12 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.206 2.604 . . . . 0.0 111.299 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.06 169.13 22.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.436 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.29 107.35 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . 71.99 133.41 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.275 0.984 . . . . 0.0 112.335 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.36 165.24 25.6 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.244 176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.545 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -135.12 -178.72 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.436 HD12 ' HG2' ' A' ' 158' ' ' GLU . 90.6 mt -74.46 -12.72 60.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.51 ' HB2' ' NH1' ' A' ' 159' ' ' ARG . 7.0 tp10 -81.97 -42.16 19.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.08 24.9 2.88 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.192 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -101.31 -176.41 3.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.126 0.489 . . . . 0.0 111.381 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -122.2 -171.84 2.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.556 -173.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 40.6 tp -120.69 143.21 48.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.484 172.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.79 103.99 1.15 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.773 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 87.4 t80 -69.64 -36.81 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 0.0 111.397 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.24 -108.95 2.0 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.686 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -78.27 85.13 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 110.592 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.62 50.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -78.13 83.53 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.167 0.508 . . . . 0.0 111.079 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.649 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.1 m-85 -108.95 19.7 19.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.683 0.754 . . . . 0.0 108.969 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.77 -34.73 71.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.068 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -55.91 -34.42 65.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.116 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.596 ' O ' HG23 ' A' ' 143' ' ' VAL . 56.9 tp -84.75 -54.14 4.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' A' ' 167' ' ' ILE . 96.9 mt -57.37 -38.55 74.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.8 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.653 ' HD3' HG13 ' A' ' 167' ' ' ILE . 25.9 tptp -74.24 -15.88 60.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.84 0.352 . . . . 0.0 111.134 -176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 142' ' ' ARG . 19.7 mtp180 -109.36 -4.5 16.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.417 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.2 t -69.15 104.63 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.078 0.466 . . . . 0.0 109.889 174.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -92.55 12.88 21.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.603 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -89.29 -174.28 46.25 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.34 103.1 8.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.428 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 9.8 mtmp? -87.12 102.86 14.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.307 0.575 . . . . 0.0 110.766 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.7 t -104.97 119.25 53.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.899 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -90.87 136.5 13.4 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 174.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.552 HG12 HG21 ' A' ' 55' ' ' VAL . 13.7 t -122.67 124.45 70.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -159.24 164.13 35.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 0.0 111.529 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.402 ' HE2' HH21 ' A' ' 22' ' ' ARG . 94.3 m-85 -75.61 169.4 18.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.016 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.6 t -69.12 -26.08 64.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.963 0.411 . . . . 0.0 110.335 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -74.88 -5.68 44.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.055 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -106.47 4.67 28.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.666 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.19 114.9 44.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.615 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -103.0 179.62 4.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.142 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.436 ' HG2' HD12 ' A' ' 124' ' ' LEU . 4.8 tm-20 -89.12 -50.9 5.88 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.51 ' NH1' ' HB2' ' A' ' 125' ' ' GLU . 4.9 tpp180 -149.06 123.62 9.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.335 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.5 mt -101.26 159.09 30.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.162 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.75 103.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.419 2.079 . . . . 0.0 111.223 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 162' ' ' ARG . 39.0 mtm180 -92.6 159.49 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.709 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -123.61 179.88 4.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -80.75 -49.19 11.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.594 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -93.14 9.27 36.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.341 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.62 159.43 33.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.455 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.665 HG21 ' HB3' ' A' ' 140' ' ' LEU . 3.9 mp -105.12 111.86 65.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 111.338 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.87 148.79 7.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.79 2.327 . . . . 0.0 112.871 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.64 174.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.172 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 25.1 m-20 -108.62 -49.44 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.085 0.469 . . . . 0.0 110.667 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.93 145.59 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.593 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 64.1 tp -124.34 103.37 8.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.824 0.345 . . . . 0.0 110.616 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 178' ' ' VAL . 49.1 t -87.05 120.1 35.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 p -105.97 -177.4 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 10.0 pt-20 -71.03 -7.23 44.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.634 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 30.0 mmtp -119.95 -62.34 1.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 111.142 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -130.86 161.98 30.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.359 . . . . 0.0 111.14 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.541 HG13 HG22 ' A' ' 173' ' ' VAL . 70.7 t -87.39 101.46 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -88.39 91.91 8.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.671 -175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -74.41 108.71 7.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.14 -43.5 86.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 182' ' ' ARG . 1.5 ppt_? -166.79 156.54 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.832 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.09 -52.93 3.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.525 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 62.96 29.32 73.93 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.657 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -133.96 -48.22 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.311 . . . . 0.0 111.649 -176.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.4 t -98.29 162.65 13.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.244 0.545 . . . . 0.0 111.579 -171.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.18 6.8 47.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.533 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.57 -38.54 69.48 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.62 104.51 16.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -78.55 80.94 4.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.83 -170.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -159.38 111.13 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.392 173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 167.24 12.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -88.48 139.46 30.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.29 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 m170 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.696 174.427 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp 64.57 31.48 12.24 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.28 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -60.23 -45.75 92.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.453 0.644 . . . . 0.0 110.026 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -71.75 -40.27 69.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.641 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.95 -45.79 76.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.901 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.0 tp -53.65 -40.82 66.19 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.33 0.394 . . . . 0.0 111.391 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 1.102 ' HD3' ' HA ' ' A' ' 131' ' ' PHE . 39.2 ttm180 -61.01 -54.74 41.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.264 0.554 . . . . 0.0 110.807 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -69.28 -25.51 64.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.766 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.48 -55.05 11.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.185 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 155' ' ' GLN . 61.1 t -70.99 -33.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.013 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.593 HD11 ' HG2' ' A' ' 52' ' ' LYS . 54.9 tp -62.19 -29.98 70.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.921 0.391 . . . . 0.0 110.411 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 10.8 t60 -67.72 -36.7 81.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.992 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -68.32 -32.27 72.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 11' ' ' LEU . 17.6 mmt180 -52.78 -57.82 8.9 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.342 0.591 . . . . 0.0 110.602 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.3 9.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.445 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -88.1 -25.63 22.92 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.121 -0.362 . . . . 0.0 110.334 -178.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.2 142.73 56.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.067 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 21' ' ' GLU . 18.5 t -64.96 148.26 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.45 -42.36 70.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -169.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.88 -51.07 64.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.891 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 18' ' ' SER . 1.7 mp0 -60.21 -44.55 95.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.455 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 5.3 tmm_? -57.77 -47.23 83.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.731 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -62.07 -46.22 90.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.097 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -60.11 -47.96 83.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.667 0.27 . . . . 0.0 111.035 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.8 mt -66.69 -37.54 84.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.937 0.398 . . . . 0.0 110.402 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 30' ' ' ILE . 31.1 t -58.96 -49.53 77.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.918 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -59.79 -34.94 73.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -65.84 -42.02 91.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.579 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 25' ' ' LEU . 45.5 t -62.19 -46.25 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.073 0.463 . . . . 0.0 109.994 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 26' ' ' SER . 69.8 mt -58.39 -40.12 77.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.505 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.0 m -61.15 -40.28 93.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.015 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -42.41 84.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 36' ' ' LEU . 39.9 tp -62.32 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.205 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 39' ' ' PHE . 2.5 mmpt? -66.94 -30.97 71.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.26 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 63.1 m -71.58 -24.59 61.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 178' ' ' VAL . 46.4 mt -61.18 116.79 21.04 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.348 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.1 -35.89 84.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.036 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.69 -37.32 73.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.798 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' CE2' ' HE3' ' A' ' 34' ' ' LYS . 69.7 t80 -74.08 -17.15 60.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.207 0.527 . . . . 0.0 110.776 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.88 -41.91 10.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.741 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -81.54 -33.23 31.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.761 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.8 t -84.9 122.04 28.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 92.7 mttt -93.28 -3.93 52.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.714 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 8.7 mmpt? -89.31 86.13 6.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.61 118.15 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 111.475 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -111.62 138.96 47.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.161 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 57' ' ' LEU . 7.4 mp -120.2 144.17 47.86 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.787 ' HB2' HG12 ' A' ' 117' ' ' VAL . 37.8 t80 -77.33 -6.63 53.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.152 -176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 49.1 t 70.8 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.825 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 2.7 Cg_exo -75.1 98.18 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.864 2.376 . . . . 0.0 112.436 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.837 HG13 ' HD3' ' A' ' 52' ' ' LYS . 40.7 pt -89.4 -5.45 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.227 0.537 . . . . 0.0 110.144 173.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.837 ' HD3' HG13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -107.19 144.85 33.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.65 177.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.78 72.63 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.708 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.711 ' HG3' ' H ' ' A' ' 55' ' ' VAL . 5.2 pt-20 -129.52 -79.62 0.56 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.595 0.358 . . . . 0.0 110.203 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.711 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 38.3 t -100.17 123.74 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 22' ' ' ARG . 20.6 m-20 -79.14 71.88 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.898 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 88.2 mt -85.51 -10.46 56.0 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.232 0.539 . . . . 0.0 109.581 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.3 m -62.49 -53.3 58.78 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.177 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 21.9 Cg_exo -67.31 -6.55 16.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.175 1.917 . . . . 0.0 112.217 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -89.32 -15.25 33.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.389 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.0 m-85 -55.74 -52.38 72.65 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.319 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 61.1 Cg_exo -54.93 -34.37 85.95 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.396 2.064 . . . . 0.0 112.898 177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 1.3 tm-20 -65.38 -50.62 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 109.925 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 84.9 t -64.87 -41.51 92.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.586 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' A' ' 88' ' ' PRO . 50.8 tp -67.48 -16.77 64.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.168 0.509 . . . . 0.0 111.198 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 13.7 tppt? -71.16 -52.22 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.467 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.4 pt-20 -121.81 -30.01 4.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.074 -172.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.634 ' HE2' ' HA ' ' A' ' 64' ' ' VAL . 30.2 mtmm -103.4 -173.03 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.239 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' A' ' 84' ' ' ARG . 49.2 mt-10 -106.63 119.34 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -89.81 106.06 18.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.047 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 59.3 mt -93.69 123.83 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.2 mt -120.12 141.68 32.08 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.094 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 5.6 Cg_exo -76.81 110.86 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.962 2.441 . . . . 0.0 111.724 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.82 114.82 29.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.26 101.91 7.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.418 . . . . 0.0 109.874 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -90.74 85.25 6.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.556 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.74 0.59 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.16 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -112.13 -9.08 13.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -115.33 109.42 17.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.669 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.74 135.82 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.4 m -140.33 149.45 42.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.353 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 3.3 mm? -84.64 114.25 21.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.415 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 106' ' ' ARG . 10.8 m-85 -95.8 124.67 39.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 17.5 ttm180 -84.31 102.72 12.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 110.21 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 90' ' ' CYS . 55.2 t -89.65 111.81 23.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.253 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -114.85 -4.87 12.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.635 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 0.7 OUTLIER -117.69 126.65 27.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.609 -178.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.604 ' HA ' HD21 ' A' ' 65' ' ' LEU . 36.3 Cg_exo -60.95 -22.2 73.69 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.812 2.342 . . . . 0.0 113.293 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.15 -5.03 58.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.863 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 87' ' ' SER . 61.3 m -84.44 1.76 43.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 111.495 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.9 129.64 48.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.279 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.5 161.17 29.09 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 t -88.15 86.11 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.307 0.575 . . . . 0.0 110.374 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.5 -155.91 10.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.58 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.53 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . 55.79 -129.56 1.98 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.564 0.346 . . . . 0.0 110.616 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -97.07 24.05 6.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.032 0.444 . . . . 0.0 110.783 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.45 51.11 1.0 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.379 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 95' ' ' ALA . 40.1 pt -131.41 163.78 36.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.621 0.248 . . . . 0.0 110.369 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 tpp -81.03 90.97 6.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -109.79 158.0 36.08 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.991 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 43.9 Cg_endo -72.64 107.92 2.42 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.138 1.892 . . . . 0.0 111.166 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.4 m -77.22 -22.97 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.3 0.572 . . . . 0.0 110.224 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.05 -175.52 4.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.527 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.35 -138.38 11.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.789 -0.719 . . . . 0.0 111.418 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -141.69 128.17 20.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.772 0.32 . . . . 0.0 110.334 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 15.4 ptm180 -78.16 101.94 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.538 0.685 . . . . 0.0 110.453 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.42 153.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.741 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 110' ' ' GLU . 28.5 p-10 -70.93 146.33 92.9 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.18 -8.45 12.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.238 2.625 . . . . 0.0 112.714 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 42.0 tt0 -69.29 -23.84 63.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.481 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.64 -19.45 57.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.585 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.6 t -73.31 110.29 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 25.7 t70 -91.06 -36.36 14.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.122 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 31.2 t80 -133.53 127.74 33.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.619 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 147' ' ' LYS . 12.9 tt -135.46 139.74 46.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.78 118.92 30.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.813 0.339 . . . . 0.0 110.841 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 48' ' ' TYR . 19.9 m -118.25 127.35 26.64 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.131 0.491 . . . . 0.0 111.332 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 6.1 Cg_exo -79.91 84.1 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.983 2.456 . . . . 0.0 111.178 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.33 162.25 19.86 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.886 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 50.8 t -99.08 128.06 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 129' ' ' LEU . . . 67.75 114.72 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 124.2 0.938 . . . . 0.0 112.684 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -137.6 166.81 23.0 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.587 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.822 ' HB2' ' HA ' ' A' ' 159' ' ' ARG . 16.2 p30 -137.83 -165.14 1.73 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.748 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.93 -5.66 59.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -104.51 -31.48 9.44 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.231 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 121.64 17.75 3.8 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.954 172.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 162' ' ' ARG . 22.7 m-30 -69.72 144.43 52.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 117.371 0.585 . . . . 0.0 110.142 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 2.0 tmm_? -122.62 106.04 10.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 110.731 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 120' ' ' VAL . 28.7 tp -76.79 -40.01 49.59 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.53 -129.69 49.11 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.922 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 1.102 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 88.9 t80 -162.97 140.93 8.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.61 169.61 30.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.615 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -75.42 -34.73 61.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.036 0.446 . . . . 0.0 110.646 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 162.64 -109.93 0.41 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 65.91 -71.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.304 0.642 . . . . 0.0 111.827 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -94.21 3.08 55.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.008 -171.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -67.03 -28.19 68.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 109.654 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 138' ' ' ARG . 59.7 mtt85 -76.62 -27.18 55.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.272 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 tp -66.34 -35.56 80.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.74 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.93 -30.71 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.217 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' A' ' 167' ' ' ILE . 23.9 ttmm -72.44 -27.24 62.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.042 0.448 . . . . 0.0 110.381 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -78.37 -23.05 47.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.497 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.25 96.2 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.172 0.51 . . . . 0.0 109.81 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -90.09 16.49 8.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.055 -176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -94.9 -162.86 34.87 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.33 99.39 9.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.761 0.315 . . . . 0.0 110.169 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 36.9 mtmm -78.87 102.93 8.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.786 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 171' ' ' VAL . 62.1 t -98.41 124.39 51.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.402 -175.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.11 121.43 6.69 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.424 HG12 HG21 ' A' ' 55' ' ' VAL . 43.3 t -102.41 111.95 33.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.831 0.348 . . . . 0.0 110.088 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -145.65 151.76 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.193 0.521 . . . . 0.0 112.094 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.34 151.92 45.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.124 171.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -60.38 -23.74 64.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.759 0.314 . . . . 0.0 111.425 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -66.48 -25.06 66.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.67 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 2.8 mp0 -98.37 2.42 47.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.831 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.96 124.82 70.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.08 -169.4 1.6 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.434 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.19 -63.99 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.822 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 11.2 ttp180 -155.78 141.5 17.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 172.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.17 158.94 69.05 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.768 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.57 107.79 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 111.157 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' HD2' ' OH ' ' A' ' 127' ' ' TYR . 25.5 ttt180 -73.67 121.96 21.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.52 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.64 -67.76 0.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.981 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.02 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.499 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -117.61 72.52 0.85 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.336 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 33.3 t70 -88.92 145.96 25.21 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.177 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 141' ' ' LYS . 65.2 mt -89.93 107.87 22.03 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.6 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 6.9 Cg_exo -73.36 157.04 50.13 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.143 2.562 . . . . 0.0 112.317 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' LYS . 30.6 m -86.61 176.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.593 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 -44.76 7.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.003 0.43 . . . . 0.0 110.95 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.7 t -132.4 134.94 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.484 HD23 HH11 ' A' ' 179' ' ' ARG . 60.5 tp -115.14 112.52 22.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.885 0.374 . . . . 0.0 110.199 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.4 t -99.21 118.01 45.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 0.0 110.349 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.22 169.76 8.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -84.45 65.7 9.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -175.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 175' ' ' GLU . 10.3 mmtp 179.02 -38.31 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.262 0.976 . . . . 0.0 110.89 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -144.17 156.92 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 0.0 111.271 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 36' ' ' LEU . 48.0 t -102.54 106.55 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.257 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.484 HH11 HD23 ' A' ' 172' ' ' LEU . 40.8 ttm105 -93.58 95.43 9.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.747 -173.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -78.45 123.89 27.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 169' ' ' VAL . 73.7 mt -94.39 27.57 2.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.037 0.446 . . . . 0.0 111.109 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -50.17 -57.76 7.04 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.22 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.549 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.0 5.16 83.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.809 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -99.08 13.7 31.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.805 0.336 . . . . 0.0 110.554 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.2 m -59.22 -30.44 68.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.982 0.42 . . . . 0.0 110.417 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -132.2 26.59 4.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.111 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' OE2' ' HB2' ' A' ' 190' ' ' HIS . 0.1 OUTLIER -142.91 157.54 44.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -177.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.29 9.46 2.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.509 ' HB2' ' OE2' ' A' ' 188' ' ' GLU . 55.5 m80 -77.13 125.98 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.327 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -103.44 -17.28 15.3 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 61.53 -159.26 0.32 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.859 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -147.06 153.98 40.62 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.353 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.508 0.194 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 6.4 mp -86.45 77.21 9.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.21 0.528 . . . . 0.0 109.88 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 161' ' ' PRO . 29.2 pttt -68.87 -28.28 66.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.921 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.2 t -78.82 -36.08 43.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.945 0.402 . . . . 0.0 110.01 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 17.7 tp10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.07 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -57.67 -48.95 78.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.383 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -56.04 -44.7 79.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.729 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -60.8 -46.91 88.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.923 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HE2' ' HG3' ' A' ' 5' ' ' GLU . 61.7 mttm -58.97 -43.97 91.47 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 111.189 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG11 ' HG3' ' A' ' 155' ' ' GLN . 43.8 t -67.76 -46.5 82.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.476 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.37 -40.81 78.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.121 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.62 -48.11 82.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.368 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -78.87 -30.36 45.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.553 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 54' ' ' GLU . 30.5 ttp180 -57.18 -46.91 82.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 52' ' ' LYS . 33.2 pt -90.82 3.27 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.699 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -101.92 2.1 37.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.272 0.558 . . . . 0.0 110.473 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD11 ' CZ ' ' A' ' 154' ' ' PHE . 89.1 mt -67.43 138.12 56.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 p -70.95 155.9 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.59 -58.72 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.562 -173.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.08 -48.93 79.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.582 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.21 -44.24 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -61.62 -46.39 90.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.445 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -69.16 -34.69 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -66.21 -31.03 71.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 0.0 110.923 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.55 -41.77 21.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.253 0.549 . . . . 0.0 110.007 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -61.5 -36.3 80.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.006 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -57.62 -42.24 82.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.411 . . . . 0.0 110.591 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -69.49 -34.92 75.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 55' ' ' VAL . 42.0 t -66.36 -42.95 91.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.925 0.393 . . . . 0.0 110.361 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -62.64 -44.22 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.271 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.8 m -64.52 -32.71 74.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.711 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -63.96 -54.37 35.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.88 -33.33 74.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.703 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -67.83 -30.58 70.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.698 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 m -87.61 -14.25 40.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 tt -64.11 113.69 11.17 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 35.5 Cg_exo -59.4 -48.34 13.85 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.869 2.38 . . . . 0.0 112.861 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -63.79 -20.1 65.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.501 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.405 ' O ' ' HE3' ' A' ' 68' ' ' LYS . 77.8 t80 -74.1 -46.7 41.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 57.3 tttm -73.47 -29.75 62.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.719 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 34.1 mmtp -68.76 -37.3 79.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -82.7 148.29 27.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.064 0.459 . . . . 0.0 110.753 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 35.7 mtmt -101.35 -37.04 8.65 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.069 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -89.28 96.52 10.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -121.14 122.88 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.927 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.02 124.02 44.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.968 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.88 122.27 45.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.741 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.707 ' HD2' ' HD2' ' A' ' 118' ' ' PRO . 6.4 t80 -83.42 98.85 9.72 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 58.6 m -51.9 114.85 5.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 O-C-N 123.895 0.747 . . . . 0.0 112.673 -172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 42.2 Cg_endo -68.88 131.67 23.01 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.816 2.344 . . . . 0.0 111.108 174.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.423 HG22 HG21 ' A' ' 98' ' ' ILE . 2.4 pp -120.01 -8.93 10.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 41.0 mttp -145.72 70.37 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.989 0.423 . . . . 0.0 110.379 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.02 -114.76 3.88 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -174.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HG2' ' NH1' ' A' ' 14' ' ' ARG . 29.7 mt-10 61.32 25.48 15.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 169.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 29' ' ' VAL . 98.0 t 69.69 106.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.431 0.634 . . . . 0.0 110.485 -176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.28 96.52 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.677 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.7 mt -88.12 9.63 22.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.674 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.454 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -62.62 -47.39 88.29 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.3 Cg_endo -70.95 1.13 5.54 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.694 1.596 . . . . 0.0 112.905 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.4 tp -88.77 -16.91 30.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.794 0.33 . . . . 0.0 110.599 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.2 m-85 -56.7 -48.02 97.98 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 93.9 Cg_exo -48.1 -31.84 17.32 Favored 'Trans proline' 0 C--N 1.359 1.113 0 C-N-CA 122.53 2.153 . . . . 0.0 113.546 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.59 -48.28 12.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.979 0.419 . . . . 0.0 110.754 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 68' ' ' LYS . 98.9 t -61.89 -39.33 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.512 -177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 96.2 mt -64.18 -14.77 57.46 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -88.73 -48.46 7.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.043 0.449 . . . . 0.0 111.34 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 28.3 mt-10 -93.69 -38.0 11.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.45 . . . . 0.0 112.057 -171.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 33.9 mttp -119.66 167.31 12.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -161.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -93.24 121.44 34.6 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.646 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' HG ' ' A' ' 72' ' ' LEU . 58.6 tp -84.02 112.69 20.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.243 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.22 115.87 40.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.897 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 92.6 mt -121.26 136.01 25.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.666 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.5 132.78 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.666 2.244 . . . . 0.0 111.86 176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 53.2 tttm -105.95 128.81 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -81.0 104.02 8.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.48 12.18 30.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 117.0 -105.02 1.26 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.7 -15.26 22.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.279 0.561 . . . . 0.0 109.805 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -89.52 143.45 26.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.123 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.691 HD11 ' HD1' ' A' ' 136' ' ' TYR . 62.0 mt -113.64 111.64 36.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.212 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 20.1 m -94.95 108.53 20.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.135 178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -76.2 104.13 6.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.879 0.371 . . . . 0.0 110.98 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.21 140.2 35.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.853 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.37 151.35 37.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.0 176.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.886 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -139.27 11.05 2.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.365 0.602 . . . . 0.0 109.872 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.3 p -162.7 150.51 11.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.711 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 2.8 Cg_exo -76.07 49.76 2.64 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.012 2.475 . . . . 0.0 111.496 177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -71.82 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 38.4 t -124.6 94.41 4.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.269 0.557 . . . . 0.0 110.834 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 101' ' ' PRO . 95.3 mt -123.07 120.82 34.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.64 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -102.06 -171.33 27.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.6 t -136.82 116.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.67 -59.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.995 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 98' ' ' ILE . . . -107.92 139.1 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.799 -0.236 . . . . 0.0 111.326 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 65.2 10.88 6.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.33 0.652 . . . . 0.0 111.935 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.66 16.26 67.55 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.782 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 95' ' ' ALA . 39.1 pt -105.58 172.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.833 0.349 . . . . 0.0 110.953 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -73.4 131.26 41.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.281 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -117.04 121.42 32.56 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.237 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 74' ' ' LYS . 24.8 Cg_endo -62.54 118.15 5.04 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.607 2.205 . . . . 0.0 112.398 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 58.5 t -93.18 -55.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.792 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -105.05 154.59 19.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.746 0.308 . . . . 0.0 110.601 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.54 162.77 10.63 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.37 135.8 35.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 106' ' ' ARG . 17.8 ptt85 -87.48 145.28 26.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.74 153.09 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -82.71 161.88 57.26 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.53 -14.83 5.35 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.284 2.656 . . . . 0.0 113.476 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.3 -37.14 64.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.313 0.578 . . . . 0.0 110.763 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.76 -23.68 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.9 107.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.974 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.87 -49.7 5.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.497 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 20.7 t80 -118.75 129.82 55.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.5 tt -139.19 139.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.993 0.425 . . . . 0.0 110.574 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.27 116.05 23.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.066 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 48' ' ' TYR . 33.7 m -124.86 127.35 25.15 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 0.0 111.274 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.707 ' HD2' ' HD2' ' A' ' 48' ' ' TYR . 2.2 Cg_endo -83.35 -164.46 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.001 2.468 . . . . 0.0 111.166 171.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.51 175.55 32.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.782 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -99.98 121.33 50.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 72.58 126.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 124.32 1.012 . . . . 0.0 112.654 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.502 ' HA ' HD11 ' A' ' 160' ' ' LEU . 63.0 m-85 -138.09 168.41 19.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 45.3 p30 -126.3 -164.55 1.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.268 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.75 -13.8 37.15 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.614 ' O ' HD11 ' A' ' 181' ' ' LEU . 44.7 mt-10 -110.51 -62.49 1.52 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.97 62.32 0.13 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.924 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -82.91 134.03 35.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.2 82.82 7.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -170.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 50.7 tp -59.22 -57.14 14.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.616 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.25 -105.98 2.95 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.468 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -140.29 -65.88 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.661 0.267 . . . . 0.0 111.168 -172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.01 175.19 22.33 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.48 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -94.56 111.29 23.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.425 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.37 75.56 1.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.144 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -144.57 -90.42 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.067 0.46 . . . . 0.0 110.344 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.691 ' HD1' HD11 ' A' ' 80' ' ' ILE . 95.3 m-85 -100.61 6.39 44.11 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.786 0.803 . . . . 0.0 110.567 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.32 -16.95 63.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.55 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -54.74 -34.52 62.62 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 143' ' ' VAL . 51.6 tp -87.22 -51.22 6.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.142 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.64 -26.93 62.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.45 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.11 -28.55 63.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.481 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.74 -2.57 15.26 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.784 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 139' ' ' LEU . 98.4 t -70.19 102.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -97.19 10.98 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -76.92 -176.42 43.56 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.683 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.0 100.71 1.26 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.986 0.393 . . . . 0.0 110.283 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.43 100.06 5.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.091 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.582 HG21 ' CZ ' ' A' ' 114' ' ' PHE . 92.3 t -96.29 114.93 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.025 0.441 . . . . 0.0 110.014 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.35 124.26 7.72 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.723 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.4 t -99.27 116.85 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -147.23 161.51 40.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.672 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -96.61 156.31 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.1 p -62.43 -31.44 72.14 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 26.8 p90 -78.18 -6.2 54.12 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.421 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.525 ' HG3' HG11 ' A' ' 10' ' ' VAL . 28.5 tt0 -100.95 -6.23 24.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 0.0 109.816 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.8 t -100.5 115.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.226 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.64 -166.39 1.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 33.6 tt0 -69.69 -67.91 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.92 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 123' ' ' ASP . 5.1 tpm_? -145.43 132.62 20.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.462 -173.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 122' ' ' PHE . 80.9 mt -96.52 138.87 21.45 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.616 0.246 . . . . 0.0 110.75 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 3' ' ' LYS . 3.1 Cg_exo -76.36 101.87 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.789 2.326 . . . . 0.0 111.25 174.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.72 148.66 29.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.102 -177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.1 m-20 -114.81 -135.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.328 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -61.69 -23.79 66.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.42 0.628 . . . . 0.0 110.312 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -87.58 67.68 9.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.278 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.38 -74.18 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.367 175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 41.2 mt 41.04 81.38 0.25 Allowed Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 124.285 0.991 . . . . 0.0 113.246 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.04 165.49 5.75 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.44 2.093 . . . . 0.0 111.798 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.5 m -89.58 177.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.582 ' OD2' ' HD3' ' A' ' 182' ' ' ARG . 1.0 OUTLIER -111.75 -43.26 3.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.473 0.654 . . . . 0.0 109.369 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.41 122.33 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 42.5 tp -101.95 109.93 21.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.12 123.68 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.85 3.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.403 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.55 -26.29 28.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.134 0.492 . . . . 0.0 110.479 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.2 -34.2 15.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.34 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -155.5 171.66 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.946 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 t -113.58 111.49 36.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 42.0 ttm180 -89.56 96.3 10.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.284 0.564 . . . . 0.0 111.132 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -79.87 115.26 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.391 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.614 HD11 ' O ' ' A' ' 125' ' ' GLU . 75.6 mt -98.03 -46.77 5.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.874 0.368 . . . . 0.0 111.042 -177.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.582 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 15.1 ttt180 -83.87 95.87 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.287 0.565 . . . . 0.0 110.431 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -100.83 -160.42 0.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.197 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.82 45.74 2.77 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.002 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 185' ' ' ARG . 20.1 mtt180 -73.47 97.91 2.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.0 110.655 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.9 m -149.1 141.55 24.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.538 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -125.74 133.59 52.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.331 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 67.79 165.51 0.23 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -92.1 106.67 18.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.321 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -106.88 20.37 19.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.533 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -126.51 73.59 1.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.614 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -94.39 -15.42 24.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.633 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -95.35 -47.32 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.029 0.442 . . . . 0.0 109.878 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.562 -0.733 . . . . 0.0 109.887 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt -87.25 155.22 20.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 0.0 111.682 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -48.77 70.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 m -63.88 -35.59 81.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.946 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.99 -53.95 52.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.654 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.54 -48.37 81.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.512 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.04 -49.45 77.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.485 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -65.08 -43.07 93.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.612 -176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.51 -46.77 68.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.863 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.17 -37.15 77.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' HG12 ' A' ' 15' ' ' ILE . 48.0 tp -57.24 -37.49 72.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.285 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.58 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 15.0 t-80 -67.13 -25.93 66.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.963 -175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 45.9 mmtt -95.67 -16.22 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.966 0.412 . . . . 0.0 110.968 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.459 HH11 ' HG2' ' A' ' 155' ' ' GLN . 25.0 ttt85 -75.66 -42.98 49.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.542 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.3 pt -90.78 6.84 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.256 0.551 . . . . 0.0 110.68 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 5.9 t30 -77.25 -26.09 52.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.896 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.7 mt -63.09 135.35 57.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.639 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -65.3 142.53 58.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.122 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -52.69 -43.15 65.4 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.3 -59.44 4.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.152 0.501 . . . . 0.0 110.957 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.4 -44.85 81.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.143 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -62.21 -41.83 98.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.967 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -71.07 -35.38 71.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.661 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -65.66 -35.53 81.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.025 0.44 . . . . 0.0 110.469 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.83 -37.49 70.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.444 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 30' ' ' ILE . 38.0 m -65.67 -30.75 71.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.389 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -56.53 -42.88 79.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.217 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -60.99 -46.52 90.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.127 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 175' ' ' GLU . 37.0 t -61.49 -42.07 92.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.128 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 26' ' ' SER . 80.6 mt -61.18 -50.27 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.697 0.284 . . . . 0.0 110.634 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -60.69 -41.78 95.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.6 -51.25 66.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.79 -36.37 83.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.032 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -76.31 -17.45 59.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.833 0.349 . . . . 0.0 110.706 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -88.52 -18.95 27.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.543 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.459 HD23 ' HD2' ' A' ' 37' ' ' PRO . 2.1 tt -55.38 117.3 14.31 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD2' HD23 ' A' ' 36' ' ' LEU . 44.6 Cg_exo -56.48 -42.66 63.23 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.169 2.579 . . . . 0.0 113.273 -176.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.4 -27.81 67.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.84 -34.96 74.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.267 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -64.81 -42.09 95.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.29 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -73.55 -24.0 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.466 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -66.59 124.84 23.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.375 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 61.8 mttm -103.85 -37.1 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.501 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 26.5 mmtp -96.43 108.76 21.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.7 t -113.12 110.51 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.968 0.414 . . . . 0.0 111.152 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -91.64 114.05 26.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.064 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 HD12 HD11 ' A' ' 70' ' ' LEU . 89.3 mt -107.35 121.71 45.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.291 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -79.03 105.88 10.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 171.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.525 ' HB3' HG22 ' A' ' 98' ' ' ILE . 43.3 t -58.42 115.28 10.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.503 0.502 . . . . 0.0 110.996 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 Cg_exo -73.14 108.23 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.977 2.452 . . . . 0.0 111.899 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.667 HG13 ' HG2' ' A' ' 52' ' ' LYS . 44.7 pt -78.37 -22.55 13.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.268 -175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.667 ' HG2' HG13 ' A' ' 51' ' ' ILE . 71.7 mmtt -117.31 25.24 10.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.939 0.399 . . . . 0.0 110.884 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.07 -71.42 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 6.1 mm-40 39.74 53.05 2.53 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.146 0.978 . . . . 0.0 113.029 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t 68.03 100.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.34 0.591 . . . . 0.0 109.778 -173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.71 111.97 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.203 -175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.07 14.91 15.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.643 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.525 ' OG1' ' HD3' ' A' ' 59' ' ' PRO . 42.6 p -63.02 -41.37 70.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.525 ' HD3' ' OG1' ' A' ' 58' ' ' THR . 23.4 Cg_exo -66.27 -10.94 29.29 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.879 1.719 . . . . 0.0 112.594 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.97 -21.84 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.712 0.291 . . . . 0.0 110.669 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 17.5 m-85 -57.94 -52.7 72.54 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.015 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.0 Cg_exo -54.52 -34.1 80.85 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.363 2.042 . . . . 0.0 112.45 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -66.47 -53.0 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 91.3 t -60.4 -36.12 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.204 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 61' ' ' PHE . 70.9 mt -61.11 -26.24 67.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' LYS . 70.9 mmtt -114.17 -7.87 13.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.93 -31.14 9.89 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.225 0.536 . . . . 0.0 110.702 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 47.7 mttm -142.1 -171.86 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.085 -169.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -105.69 126.48 52.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 54.6 tp -82.58 144.69 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 44' ' ' LYS . 69.6 mt -126.86 114.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 62.8 mt -109.65 138.89 20.75 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.61 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.0 126.54 5.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.846 2.364 . . . . 0.0 112.936 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 100' ' ' GLU . 9.3 tmtm? -105.5 97.71 7.51 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 77' ' ' GLY . 11.5 t -92.86 117.81 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.658 -170.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -87.96 5.18 41.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.743 ' H ' HG12 ' A' ' 75' ' ' VAL . . . 106.52 -51.87 0.71 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -175.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -104.11 -48.49 3.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.5 -0.35 . . . . 0.0 110.456 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -91.49 149.44 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.051 0.453 . . . . 0.0 111.118 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.725 HD11 ' HD1' ' A' ' 136' ' ' TYR . 65.1 mt -124.26 101.38 8.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.524 175.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 74' ' ' LYS . 15.2 m -85.6 112.67 21.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 90.5 mt -84.47 136.15 33.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 106' ' ' ARG . 88.8 m-85 -128.55 144.1 51.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 0.0 111.248 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 107' ' ' VAL . 45.2 mtp180 -79.26 106.99 11.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.649 175.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 51.0 t -89.56 111.43 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -107.02 -28.47 10.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.504 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -141.1 158.21 65.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.292 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.86 -155.48 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 74.45 -46.06 0.6 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.561 0.745 . . . . 0.0 112.199 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 102' ' ' VAL . 5.7 t -81.68 34.96 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.222 0.535 . . . . 0.0 110.903 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -117.25 131.18 56.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.417 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -131.12 -169.9 12.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.987 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -136.0 123.36 34.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.497 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -132.52 -85.13 0.28 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.502 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.4 155.48 18.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.558 0.218 . . . . 0.0 111.397 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 72.49 -46.37 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.926 0.891 . . . . 0.0 111.975 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.94 20.79 5.89 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.92 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' A' ' 49' ' ' CYS . 2.1 pp -101.62 172.76 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.618 0.247 . . . . 0.0 111.205 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.09 105.03 6.91 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.862 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 74' ' ' LYS . 2.3 mt-10 -83.6 115.46 59.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.976 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 2.8 Cg_exo -74.39 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 110.56 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.468 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 27.9 t -73.34 -58.74 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.415 -173.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -136.95 178.62 6.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.971 0.415 . . . . 0.0 111.067 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.66 -139.06 10.12 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.6 138.05 51.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HG2' ' CE1' ' A' ' 83' ' ' TYR . 83.4 mtt180 -83.35 140.75 32.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.948 0.404 . . . . 0.0 110.394 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.555 ' CG2' ' HG3' ' A' ' 84' ' ' ARG . 21.9 t -117.99 137.3 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.577 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -104.69 150.58 38.76 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -46.33 -35.63 16.12 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.008 3.139 . . . . 0.0 114.998 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.733 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 43.3 tt0 -65.05 -26.98 68.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 14.0 t70 -80.83 -13.69 58.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 0.0 111.148 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.83 131.37 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.618 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 13.0 m-20 -83.94 -52.42 6.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.629 0.728 . . . . 0.0 110.017 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 148' ' ' VAL . 46.2 t80 -129.85 131.03 45.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.528 -170.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.2 tt -125.79 137.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.968 0.413 . . . . 0.0 109.943 173.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' HE1' ' A' ' 114' ' ' PHE . . . -121.23 115.72 23.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.631 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.22 118.95 33.76 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.438 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 37.6 Cg_endo -68.82 110.12 2.28 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.336 2.024 . . . . 0.0 111.258 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.635 ' HA3' ' CE2' ' A' ' 122' ' ' PHE . . . -100.0 131.68 10.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.43 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.73 -30.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 122.476 0.31 . . . . 0.0 111.205 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.91 142.13 19.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.332 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.635 ' CE2' ' HA3' ' A' ' 119' ' ' GLY . 28.7 m-85 -137.77 168.65 19.26 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.505 0.503 . . . . 0.0 110.254 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.557 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 34.0 p-10 -137.96 -167.82 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.76 -0.29 57.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.274 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 159' ' ' ARG . 34.9 mm-40 -97.32 -36.81 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.411 ' CA ' ' HG ' ' A' ' 181' ' ' LEU . . . 113.98 39.99 1.02 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.734 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -108.29 169.27 8.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.117 0.485 . . . . 0.0 111.433 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.66 157.65 32.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.433 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.03 -88.56 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.672 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 148.01 -165.67 28.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.367 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -111.21 -58.65 2.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.564 0.221 . . . . 0.0 110.594 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.19 -175.02 20.48 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.79 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.88 139.02 31.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.017 0.437 . . . . 0.0 111.049 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.63 33.75 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -96.82 28.07 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.33 0.586 . . . . 0.0 110.188 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.725 ' HD1' HD11 ' A' ' 80' ' ' ILE . 18.2 m-85 -68.2 -27.22 66.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.224 -177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -70.86 -33.84 71.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.149 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -67.36 -34.48 77.38 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 143' ' ' VAL . 52.6 tp -70.5 -59.24 2.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.416 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.67 -38.55 78.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.187 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -78.71 -11.16 59.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.655 0.264 . . . . 0.0 111.098 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -107.55 -5.82 17.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.661 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 139' ' ' LEU . 93.9 t -57.62 118.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.733 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 52.8 tttm -87.69 -2.61 58.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 110.509 -175.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -96.2 -161.91 32.96 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mp -93.11 131.49 38.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.94 0.37 . . . . 0.0 110.75 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -93.03 110.6 22.08 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 114' ' ' PHE . 89.3 t -109.84 128.16 66.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 0.0 110.973 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.478 ' HA3' ' CZ ' ' A' ' 122' ' ' PHE . . . -98.92 132.95 11.11 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.635 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.3 t -109.63 122.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.661 0.267 . . . . 0.0 110.659 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -158.44 168.29 27.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.876 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 170.91 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 34.5 p -63.74 -27.3 69.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.242 0.544 . . . . 0.0 110.938 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -68.05 -25.59 65.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.089 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.459 ' HG2' HH11 ' A' ' 14' ' ' ARG . 2.3 mp0 -92.67 4.54 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.531 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.03 113.22 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.943 0.402 . . . . 0.0 110.631 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -106.98 178.67 4.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.807 176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.47 -54.57 6.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.598 0.237 . . . . 0.0 110.582 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 71.7 ttp85 -149.28 139.46 22.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.074 0.464 . . . . 0.0 111.025 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 67.9 mt -98.98 158.39 32.4 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.743 174.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.71 105.79 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.38 2.053 . . . . 0.0 112.539 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.74 100.9 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.96 -77.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.186 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.77 -69.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -80.78 -3.92 52.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -165.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.41 -175.49 5.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.311 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.791 HD12 ' HD2' ' A' ' 168' ' ' PRO . 4.1 tp -135.19 129.38 18.85 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.594 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.791 ' HD2' HD12 ' A' ' 167' ' ' ILE . 56.5 Cg_endo -72.2 159.74 48.98 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.514 2.143 . . . . 0.0 112.701 175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.6 m -92.34 -177.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.317 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -100.42 -56.08 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.467 ' HB ' HG22 ' A' ' 148' ' ' VAL . 45.8 t -128.13 140.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.62 116.01 30.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.671 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.7 t -106.83 125.28 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 0.0 110.247 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 50.3 p -119.54 -169.67 1.8 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.679 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 9.6 pt-20 -68.75 -27.52 65.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.868 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 56.9 mtpt -125.89 -21.47 4.37 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.424 HD22 ' C ' ' A' ' 176' ' ' LYS . 0.8 OUTLIER -131.76 143.6 50.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -172.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.403 HG11 ' HG ' ' A' ' 36' ' ' LEU . 63.5 t -111.52 102.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -122.25 112.41 18.11 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.166 0.507 . . . . 0.0 112.082 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 180' ' ' ARG . 30.6 ttm105 -70.3 152.44 44.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 164.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 181' ' ' LEU . 3.7 mm? -78.42 65.47 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.103 0.954 . . . . 0.0 112.214 -166.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -132.48 124.53 28.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.296 167.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.29 130.47 47.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 110.499 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.91 58.16 4.32 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.357 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -68.53 125.79 27.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.4 m -86.06 90.17 8.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.324 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.3 tt 179.91 -45.58 0.01 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.031 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 192' ' ' HIS . 2.7 tm-20 62.41 -111.83 0.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.243 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.428 ' H ' ' HB3' ' A' ' 188' ' ' GLU . 71.8 m80 -149.3 13.75 0.86 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 67.41 11.66 8.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.667 -175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -99.04 -47.21 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . 0.536 ' HB2' ' HG3' ' A' ' 188' ' ' GLU . 32.3 m80 -104.0 151.27 23.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 166.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -102.64 123.5 46.47 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.369 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 15.3 t60 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.564 -0.731 . . . . 0.0 109.239 175.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.884 0.373 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.08 152.51 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.922 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HB2' HD11 ' A' ' 129' ' ' LEU . 15.7 ptpt -66.41 -22.89 66.24 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.94 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.8 t -59.16 -29.5 67.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.184 0.516 . . . . 0.0 110.684 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.32 -45.27 18.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.067 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.17 -35.72 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.628 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HG3' ' HA ' ' A' ' 131' ' ' PHE . 8.5 tmm_? -55.38 -45.98 76.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.848 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.37 -39.08 88.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -60.35 -49.69 76.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.6 -42.33 80.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 15' ' ' ILE . 62.1 tp -61.43 -42.51 98.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.667 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 5.0 t60 -58.35 -44.57 88.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.243 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 26.3 mtpp -67.65 -35.48 78.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.314 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' HA2' ' A' ' 53' ' ' GLY . 44.2 ttm-85 -60.77 -50.77 72.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.259 0.552 . . . . 0.0 110.652 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 11' ' ' LEU . 18.5 pt -83.67 9.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.988 0.423 . . . . 0.0 111.369 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -101.37 -11.62 19.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 152.4 24.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.279 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -75.09 156.53 35.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.544 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 37.8 tt0 -68.28 -39.42 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.647 0.261 . . . . 0.0 110.906 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.56 -44.07 97.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 109.742 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.92 -34.47 76.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.401 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 7.5 mmt85 -55.18 -61.49 2.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.01 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 66.6 ttt180 -62.81 -37.01 85.03 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.035 0.445 . . . . 0.0 110.708 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 52.7 ttt180 -60.56 -44.87 95.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.952 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.3 mt -86.57 -37.85 17.73 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.267 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 30' ' ' ILE . 8.4 t -66.09 -31.86 72.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.528 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 8.7 tt0 -69.77 -26.1 64.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 74.1 mmtt -74.84 -43.94 51.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.901 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.78 -48.26 89.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.742 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 79.0 mt -60.13 -47.35 92.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 t -61.82 -39.41 91.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.443 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.563 HD21 ' HA ' ' A' ' 177' ' ' ASN . 8.3 t-20 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.244 0.545 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.56 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.464 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HE2' ' HG2' ' A' ' 63' ' ' GLU . 2.8 mmmp? -71.43 -31.12 66.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.602 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -84.38 -9.26 58.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.129 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 2.2 tt -71.51 111.45 10.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 36' ' ' LEU . 18.0 Cg_endo -59.67 -33.11 96.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.999 2.466 . . . . 0.0 113.529 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -67.63 -34.67 77.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.784 0.326 . . . . 0.0 110.334 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -69.79 -25.3 63.72 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.36 0.6 . . . . 0.0 110.584 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -69.89 -34.87 74.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.262 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -100.44 -21.64 15.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.084 -171.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -58.93 123.87 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 110.916 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 1.1 mmpp? -74.71 -63.68 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.644 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 113.48 25.39 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.149 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' O ' HD12 ' A' ' 70' ' ' LEU . 46.0 t -116.41 115.14 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.467 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.34 143.69 29.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.336 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -136.93 148.26 46.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.794 0.33 . . . . 0.0 110.551 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 117' ' ' VAL . 64.6 m-85 -97.06 141.6 30.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.898 171.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.546 ' HB2' HG22 ' A' ' 98' ' ' ILE . 67.5 m -73.75 146.8 86.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.569 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 36.5 Cg_exo -58.69 106.52 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.049 2.499 . . . . 0.0 113.042 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.831 HG13 ' H ' ' A' ' 52' ' ' LYS . 8.9 pt -99.96 -85.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.472 174.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.831 ' H ' HG13 ' A' ' 51' ' ' ILE . 45.8 mttp -91.62 -6.82 51.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.24 0.543 . . . . 0.0 109.761 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' ' 14' ' ' ARG . . . -98.07 120.89 6.94 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 174.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.49 7.43 38.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.746 0.308 . . . . 0.0 111.249 -175.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 21.5 t -70.51 100.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD1' ' HD3' ' A' ' 59' ' ' PRO . 6.6 t70 -86.19 102.76 14.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.237 0.541 . . . . 0.0 111.047 -171.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.1 15.77 28.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.365 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 m -62.71 -50.62 77.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 22.0 Cg_exo -67.07 -0.65 5.05 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.346 2.031 . . . . 0.0 112.958 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -85.87 -19.04 31.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.691 0.282 . . . . 0.0 110.516 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 22.2 m-85 -59.63 -49.58 91.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.543 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 76.1 Cg_exo -53.11 -32.77 60.68 Favored 'Trans proline' 0 C--N 1.359 1.132 0 C-N-CA 122.296 1.997 . . . . 0.0 112.687 176.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.721 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 18.3 tp10 -71.69 -52.57 17.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.17 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 90.9 t -57.27 -45.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.221 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -65.17 -12.6 52.89 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -97.05 -14.22 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.936 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.67 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 43.1 mt-10 -110.56 -56.67 2.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 0.0 110.94 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.67 ' HD2' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -129.43 -171.53 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.388 -171.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -94.07 138.29 32.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.277 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 41.6 tp -98.94 157.38 16.36 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 67.2 mt -138.52 131.28 39.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 96.1 mt -129.32 132.6 24.39 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 8.1 Cg_exo -72.37 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.84 2.36 . . . . 0.0 111.77 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 100' ' ' GLU . 2.8 tmtp? -105.89 113.63 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.92 106.71 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.091 0.472 . . . . 0.0 111.1 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -104.45 88.92 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.373 174.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 -98.73 1.04 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -123.18 -4.18 8.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 109.87 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.23 106.71 18.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.451 HD11 ' HD1' ' A' ' 136' ' ' TYR . 55.5 mt -82.72 102.37 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.089 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -84.74 122.72 29.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.495 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.91 100.17 10.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.541 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 40.8 m-85 -103.21 130.36 50.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.554 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -79.04 153.26 30.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.134 176.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 98.5 t -130.68 124.08 56.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.469 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.416 ' HD2' ' HD3' ' A' ' 84' ' ' ARG . 9.1 p80 -148.85 25.12 0.94 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 49.2 m -146.37 149.52 37.98 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.741 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 4.4 Cg_exo -78.23 160.5 29.52 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.742 2.295 . . . . 0.0 111.958 176.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.27 19.39 11.68 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 85' ' ' VAL . 30.7 p -103.61 5.78 36.75 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.023 -0.423 . . . . 0.0 110.63 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -100.94 129.48 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.577 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.43 171.08 25.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.144 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.34 102.06 13.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.967 0.413 . . . . 0.0 110.374 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.31 -34.6 1.92 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -82.24 -163.34 0.66 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.905 0.383 . . . . 0.0 111.209 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -54.85 -43.28 72.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.21 58.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.628 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 49' ' ' CYS . 43.0 pt -131.3 166.66 28.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -106.41 96.35 6.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 74' ' ' LYS . 3.3 pt-20 -105.25 154.38 38.94 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.639 -173.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 11.0 Cg_exo -71.15 112.45 3.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.62 2.213 . . . . 0.0 111.985 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.43 -48.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -121.1 99.08 6.29 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.842 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.42 -162.42 9.1 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.908 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.45 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 36.9 mt-10 -127.02 142.34 51.57 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -77.27 128.33 34.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.097 0.475 . . . . 0.0 111.613 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 84' ' ' ARG . 84.1 t -124.18 145.13 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.949 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 110' ' ' GLU . 9.5 p30 -97.9 157.46 34.56 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.83 -25.22 42.12 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.503 2.802 . . . . 0.0 114.645 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.479 ' HB3' ' OD1' ' A' ' 108' ' ' ASN . 20.6 tt0 -68.92 -23.59 64.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.0 110.846 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -93.42 0.03 56.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.939 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.76 103.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.12 -58.04 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.791 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 148' ' ' VAL . 23.4 t80 -124.06 144.72 49.69 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.337 -172.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 17.3 tt -149.66 141.01 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.662 0.267 . . . . 0.0 110.494 175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.61 120.43 38.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.887 0.375 . . . . 0.0 110.685 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.493 HG12 ' CE1' ' A' ' 48' ' ' TYR . 27.5 m -116.82 120.78 33.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.216 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 117' ' ' VAL . 4.1 Cg_exo -77.37 104.69 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.787 2.325 . . . . 0.0 111.217 174.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.57 156.5 15.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.852 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 125.65 62.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.1 106.85 0.06 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 124.164 0.915 . . . . 0.0 112.491 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -127.84 157.43 40.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.596 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -103.94 -173.98 2.44 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 46.1 mt -87.06 15.74 5.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.56 -15.59 6.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.861 0.362 . . . . 0.0 110.571 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.447 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 118.05 5.46 13.39 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.71 169.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -85.92 132.35 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.542 0.671 . . . . 0.0 111.213 -176.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -94.25 128.6 40.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.357 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.554 ' HB2' HD13 ' A' ' 160' ' ' LEU . 30.6 tp -55.39 -48.26 74.6 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.535 0.522 . . . . 0.0 110.56 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.14 -178.61 33.27 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.353 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.471 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 84.0 m-85 -110.94 -73.66 0.67 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.087 0.47 . . . . 0.0 110.507 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.524 ' C ' ' HD2' ' A' ' 133' ' ' LYS . . . 142.17 -34.22 1.85 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HD2' ' C ' ' A' ' 132' ' ' GLY . 1.7 mptp? -125.76 148.7 49.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.23 60.87 3.4 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -66.04 -65.16 0.71 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.559 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HD1' HD11 ' A' ' 80' ' ' ILE . 66.2 m-85 61.3 13.85 5.22 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 111.057 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.755 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 9.6 p-10 -65.89 -29.37 69.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -49.94 -39.72 41.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.035 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 80' ' ' ILE . 50.5 tp -81.85 -40.64 22.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.148 178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.01 -16.64 64.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.454 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.755 ' HG2' ' O ' ' A' ' 137' ' ' ASP . 32.1 mmtp -73.2 -29.22 62.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -95.75 -27.83 15.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.194 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.7 t -76.43 98.47 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.076 0.465 . . . . 0.0 110.118 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -134.46 56.62 1.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.096 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.89 -139.43 9.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 114' ' ' PHE . 23.7 tp -83.39 89.2 7.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 170' ' ' ASP . 25.1 ttpt -91.07 105.38 17.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.688 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 171' ' ' VAL . 45.6 t -104.49 124.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.143 -174.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.2 10.61 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.53 115.99 50.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.44 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -158.59 175.03 14.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.713 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.623 ' HD1' ' HG3' ' A' ' 175' ' ' GLU . 46.4 m-85 -102.09 153.37 19.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.444 ' HB3' ' HZ3' ' A' ' 176' ' ' LYS . 29.6 t -61.08 -13.14 15.01 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.717 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -71.66 -23.55 61.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.585 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 16.4 mp0 -107.58 13.86 26.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.921 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.1 t -117.92 120.92 66.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.181 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.73 -175.16 2.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.391 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.906 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -89.94 -36.74 14.83 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.274 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -138.11 145.34 41.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.554 HD13 ' HB2' ' A' ' 129' ' ' LEU . 95.3 mt -132.77 161.84 61.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.95 101.98 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.572 1.515 . . . . 0.0 110.892 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -104.67 141.0 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.838 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 164' ' ' ALA . 11.3 t70 -128.08 -163.49 1.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.145 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 163' ' ' ASP . . . -81.6 -40.91 22.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 0.0 110.674 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -85.0 43.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.404 0.621 . . . . 0.0 110.241 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.55 110.77 22.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.303 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.98 114.06 53.61 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.579 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.07 160.02 1.69 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.172 2.582 . . . . 0.0 113.08 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.419 ' HA ' ' HE3' ' A' ' 147' ' ' LYS . 31.1 m -103.25 -179.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.698 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.485 ' OD1' ' HB3' ' A' ' 147' ' ' LYS . 8.1 m-20 -107.8 -32.79 7.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.815 0.34 . . . . 0.0 110.903 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.528 ' HB ' HG22 ' A' ' 148' ' ' VAL . 43.8 t -136.05 153.13 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 181' ' ' LEU . 44.1 tp -128.94 122.15 29.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.631 HG22 HG12 ' A' ' 178' ' ' VAL . 86.2 t -109.14 126.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.166 177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.2 p -127.19 -174.6 3.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.322 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.623 ' HG3' ' HD1' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -85.79 -1.48 57.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 110.113 175.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.444 ' HZ3' ' HB3' ' A' ' 153' ' ' SER . 40.5 mmtm -93.56 -64.54 1.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.141 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.563 ' HA ' HD21 ' A' ' 32' ' ' ASN . 8.3 t-20 -155.62 174.87 14.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.022 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 HG22 ' A' ' 173' ' ' VAL . 4.4 m -108.04 99.6 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.64 . . . . 0.0 110.26 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 179' ' ' ARG . 33.1 ttt180 -103.7 116.57 32.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -74.7 132.74 41.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.521 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 172' ' ' LEU . 61.6 mt -109.75 15.37 22.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.184 -171.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.762 ' HA ' ' HE ' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -100.21 143.66 30.14 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -68.7 160.05 31.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.497 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -96.11 36.67 3.74 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.34 -176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -149.6 113.29 5.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.103 0.478 . . . . 0.0 110.135 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.7 m -152.08 7.11 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.959 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.07 12.56 26.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 110.557 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -91.76 -3.63 55.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.433 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.425 ' HD2' ' O ' ' A' ' 190' ' ' HIS . 21.5 p-80 -137.11 161.29 36.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.267 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.425 ' O ' ' HD2' ' A' ' 189' ' ' HIS . 13.1 m170 -65.85 161.44 21.06 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.282 0.364 . . . . 0.0 110.858 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -64.28 -79.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.028 -173.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -101.69 -52.36 3.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -161.62 10.69 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.321 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 8.2 t60 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.555 -174.272 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.143 0.497 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.73 8.77 39.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.679 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -54.18 -40.66 67.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.542 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -62.12 -36.09 80.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.425 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 6.0 mm-40 -77.9 -43.43 30.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.482 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.07 -38.22 85.47 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -54.54 -53.86 48.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -68.42 -24.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.332 -173.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -74.18 -47.08 38.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 110.394 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.29 -44.63 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.297 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 34.6 tp -59.73 -45.57 91.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.558 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 13.7 t-80 -62.05 -43.02 99.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.66 -41.49 99.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.077 0.465 . . . . 0.0 110.423 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.464 HH21 ' N ' ' A' ' 54' ' ' GLU . 10.8 tpt180 -63.95 -53.59 47.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.339 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 11' ' ' LEU . 35.2 pt -80.97 4.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 111.599 -175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 12' ' ' HIS . 6.5 t30 -78.67 -28.69 45.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.15 142.56 46.86 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.619 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 38.9 p -76.91 160.49 29.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.079 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -63.16 -30.06 71.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.18 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.9 -52.28 64.64 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.57 -30.78 36.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.386 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 18' ' ' SER . 83.7 mtt180 -56.9 -59.19 5.41 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 174.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -57.3 -40.35 77.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.38 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -63.63 -45.8 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.082 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -70.68 -44.65 66.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -61.23 -33.56 73.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.115 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -58.08 -39.28 78.15 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.427 0.632 . . . . 0.0 110.179 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -74.27 -34.23 63.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.322 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 175' ' ' GLU . 44.9 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.415 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.481 HG23 HD13 ' A' ' 60' ' ' LEU . 77.5 mt -58.21 -44.27 87.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.114 0.483 . . . . 0.0 110.325 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.1 m -65.25 -36.56 84.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -67.98 -42.35 80.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.888 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 36' ' ' LEU . 26.3 tp -62.68 -46.61 87.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.19 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.651 ' HD3' ' HE2' ' A' ' 39' ' ' PHE . 23.4 mmtp -60.38 -28.94 68.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.289 176.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -82.97 -17.82 42.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.519 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.807 HD12 HD12 ' A' ' 33' ' ' LEU . 44.6 mt -61.43 120.52 56.31 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.851 -0.159 . . . . 0.0 111.1 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.03 -35.6 81.7 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.756 2.304 . . . . 0.0 111.388 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -60.01 -52.67 64.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.651 ' HE2' ' HD3' ' A' ' 34' ' ' LYS . 88.2 t80 -73.34 -30.22 63.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -58.04 -41.39 83.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 109.937 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -83.04 -23.28 33.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.5 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 39' ' ' PHE . 49.9 m -50.8 123.19 8.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.248 0.546 . . . . 0.0 111.696 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -102.99 -34.57 8.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -113.52 97.96 6.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.075 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.47 122.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.145 -175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.09 139.19 41.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.767 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 116' ' ' ALA . 54.1 mt -111.78 136.52 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.065 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -85.64 -0.52 55.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.158 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 45.5 t 65.89 98.76 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.119 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HG3' ' HB2' ' A' ' 57' ' ' LEU . 41.9 Cg_endo -68.35 97.76 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.467 2.111 . . . . 0.0 112.398 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 24.5 pt -87.18 154.82 3.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 tptp 71.63 -15.54 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.807 0.692 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ILE . . . 133.28 -77.89 0.37 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' N ' HH21 ' A' ' 14' ' ' ARG . 3.3 mm-40 22.93 77.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 113.708 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG21 HG12 ' A' ' 150' ' ' VAL . 58.4 t 62.56 94.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.402 -174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.76 88.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.793 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 50' ' ' PRO . 97.5 mt -100.2 9.45 42.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.005 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.485 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -60.09 -44.52 96.72 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 58' ' ' THR . 52.8 Cg_endo -70.19 -5.78 17.26 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.691 1.594 . . . . 0.0 112.488 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 63' ' ' GLU . 60.6 tp -87.81 -18.38 29.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.781 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.551 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 14.2 m-85 -54.31 -54.92 42.59 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 47.7 Cg_exo -58.84 -34.74 99.19 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.939 1.759 . . . . 0.0 112.278 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.51 ' HB3' HD12 ' A' ' 60' ' ' LEU . 49.6 tp10 -64.91 -45.7 84.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.707 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' HG ' ' A' ' 60' ' ' LEU . 93.2 t -66.85 -41.88 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.92 -27.13 67.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.332 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 30.6 ttpt -74.01 -55.5 6.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.447 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 66' ' ' LYS . 89.0 mt-10 -81.26 -51.72 8.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.75 -174.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -118.83 -171.92 2.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.353 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 40.5 mt-10 -104.16 130.71 51.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.696 175.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 64' ' ' VAL . 40.1 tp -102.36 121.23 41.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 3.2 mp -99.14 118.84 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.429 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.6 mt -115.68 142.44 28.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.94 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 82' ' ' LEU . 56.3 Cg_endo -71.69 128.82 14.73 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.752 2.301 . . . . 0.0 112.198 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -119.64 117.49 28.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.916 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.07 106.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -92.43 21.7 5.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 81.15 1.46 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 69.91 -59.05 0.52 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.322 0.649 . . . . 0.0 110.324 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -58.23 118.26 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.995 175.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.539 HD12 ' HD1' ' A' ' 136' ' ' TYR . 14.4 tt -110.76 136.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.644 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 t -130.81 176.75 7.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.567 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 95.4 mt -119.45 122.51 41.87 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' ARG . 30.1 m-85 -110.91 127.27 55.41 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.097 0.475 . . . . 0.0 111.223 -177.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 23.7 ttp85 -86.75 119.55 27.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.482 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -118.66 145.42 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.638 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -139.23 22.88 2.57 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 18.5 t -141.06 122.93 9.27 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.805 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 31.5 Cg_exo -59.92 -31.2 93.37 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.155 2.57 . . . . 0.0 113.315 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 13.73 1.31 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 13.3 t -109.11 4.14 22.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.255 0.55 . . . . 0.0 110.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.41 136.61 33.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.651 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -157.91 159.92 30.33 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.986 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t -107.35 113.95 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.758 0.279 . . . . 0.0 110.54 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.18 -58.15 0.41 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.689 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.68 142.55 47.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.882 0.372 . . . . 0.0 111.702 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.8 t80 73.22 -54.4 0.69 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.021 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.61 44.35 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.916 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.8 pt -122.79 168.94 14.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 72.8 mtm -91.77 100.01 12.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.151 0.501 . . . . 0.0 110.155 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -94.74 157.34 37.07 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.828 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.18 115.56 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.963 1.776 . . . . 0.0 110.273 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.04 -45.71 70.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.262 0.553 . . . . 0.0 109.545 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -129.82 -157.04 0.79 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.793 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.77 -161.61 14.21 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.358 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' ARG . 35.9 mt-10 -124.03 111.11 15.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 26.2 ptt180 -74.28 148.11 41.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.908 0.861 . . . . 0.0 112.754 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.32 136.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.473 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -69.69 142.82 91.78 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HA ' HG23 ' A' ' 112' ' ' VAL . 9.5 Cg_endo -53.73 -18.42 12.18 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.389 2.726 . . . . 0.0 112.879 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' A' ' 144' ' ' LYS . 43.2 tt0 -64.33 -31.12 72.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.837 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -94.06 4.55 53.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.911 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 109' ' ' PRO . 99.9 t -82.74 120.34 33.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.22 -46.48 6.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.258 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.61 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 35.7 t80 -125.14 129.93 51.16 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.61 139.17 45.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.929 0.395 . . . . 0.0 110.596 176.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.45 ' HB3' HD23 ' A' ' 47' ' ' LEU . . . -110.84 113.47 26.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.7 t -118.56 113.74 36.41 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.98 118.66 5.74 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.595 2.197 . . . . 0.0 110.579 171.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -121.16 142.24 15.34 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.689 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.5 106.07 14.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 155' ' ' GLN . . . 71.53 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.266 0.979 . . . . 0.0 112.932 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 161.75 25.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.969 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.18 -175.87 2.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 79.3 mt -68.47 -29.45 68.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -84.47 -39.19 19.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.121 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.404 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 132.5 31.46 0.46 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.468 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -99.93 156.87 16.91 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.193 0.521 . . . . 0.0 111.057 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -99.63 157.45 16.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.499 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.77 -36.46 37.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.089 0.471 . . . . 0.0 109.978 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.08 135.28 8.27 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.235 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -146.35 15.62 1.3 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.75 0.31 . . . . 0.0 110.839 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 158.84 154.1 7.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.989 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -146.02 147.2 31.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 166.72 -142.81 7.86 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -72.96 -25.85 61.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.463 . . . . 0.0 110.591 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.539 ' HD1' HD12 ' A' ' 80' ' ' ILE . 2.1 m-85 -69.31 -31.08 69.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.657 0.742 . . . . 0.0 109.264 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.01 -51.96 48.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.571 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -57.71 -37.5 73.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.039 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.528 HD21 HD21 ' A' ' 82' ' ' LEU . 26.5 tp -58.41 -48.23 81.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.949 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.4 mt -59.18 -37.22 76.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.24 -176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -89.67 0.4 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.977 0.418 . . . . 0.0 110.7 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.601 ' HE ' ' HA ' ' A' ' 142' ' ' ARG . 1.9 tpm_? -95.3 -29.04 14.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.147 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 145' ' ' GLY . 62.0 t -64.96 107.56 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.079 0.466 . . . . 0.0 110.478 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.683 ' HE3' ' HG3' ' A' ' 110' ' ' GLU . 19.7 pttp -85.66 9.32 16.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 143' ' ' VAL . . . -90.19 -154.66 30.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.201 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 171' ' ' VAL . 31.8 tp -93.27 112.23 24.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.359 -177.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -90.24 108.33 19.69 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.251 0.548 . . . . 0.0 110.175 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 114' ' ' PHE . 59.3 t -97.89 111.26 27.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.48 112.67 3.5 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 55' ' ' VAL . 18.1 t -105.4 116.73 49.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -156.71 -177.27 6.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.675 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.45 ' HE1' ' H ' ' A' ' 55' ' ' VAL . 74.7 m-85 -93.98 161.01 14.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.7 t -73.38 -28.96 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.801 -171.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -75.57 -16.29 60.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.017 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 8.6 tt0 -95.1 7.54 45.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.926 0.87 . . . . 0.0 109.483 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 122.45 57.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.288 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -107.39 179.44 4.25 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.031 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.766 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 14.6 mt-10 -87.58 -56.4 3.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.377 0.608 . . . . 0.0 109.801 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -136.63 104.23 5.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.621 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.79 158.34 35.36 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.758 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.38 101.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.785 1.656 . . . . 0.0 110.397 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -90.71 139.7 30.47 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 164' ' ' ALA . 2.2 t70 -75.62 -92.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -171.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 163' ' ' ASP . . . -165.85 -76.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.008 0.433 . . . . 0.0 109.988 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -102.76 50.78 0.81 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.421 0.629 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -81.75 -167.51 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.916 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 64.6 mt -113.54 103.87 55.4 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 153.87 13.46 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.304 2.67 . . . . 0.0 112.049 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.53 172.74 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.798 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -101.77 -52.55 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.273 0.559 . . . . 0.0 110.266 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.463 HG23 HD11 ' A' ' 146' ' ' LEU . 57.3 t -123.47 140.43 47.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.745 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.8 tp -117.94 110.75 18.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.661 0.267 . . . . 0.0 110.556 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.487 HG13 HG22 ' A' ' 178' ' ' VAL . 54.1 t -103.18 121.94 55.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 80.4 p -108.8 -173.11 2.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.953 0.406 . . . . 0.0 110.745 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 176' ' ' LYS . 11.1 pt-20 -69.21 -18.8 63.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.302 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 175' ' ' GLU . 29.7 mmtp -117.06 -65.37 1.19 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.403 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.59 168.68 11.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 112.105 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.613 HG21 HD21 ' A' ' 36' ' ' LEU . 61.4 t -114.45 123.46 70.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.51 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -102.94 110.22 22.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.642 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 183' ' ' ASP . 54.5 mtp85 -83.79 89.53 7.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.404 HD13 ' CA ' ' A' ' 126' ' ' GLY . 80.4 mt -64.37 -41.84 96.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.991 -165.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 31.2 ttp-105 -116.45 28.15 8.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.329 0.585 . . . . 0.0 110.515 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 180' ' ' ARG . 21.6 t70 -135.92 113.34 10.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.562 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.97 158.8 8.71 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.123 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 68.51 124.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.541 0.736 . . . . 0.0 112.454 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.9 t -150.57 154.3 37.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.571 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 26.7 tp -154.77 24.67 0.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.622 0.725 . . . . 0.0 109.382 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.85 125.8 47.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.225 -173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -111.32 -148.79 0.43 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 163.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -63.02 118.34 7.7 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -60.03 136.75 58.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.996 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -84.08 26.0 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.732 -173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -154.8 137.48 15.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.05 177.396 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.826 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 17.4 ttt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.826 ' H ' ' HG2' ' A' ' 1' ' ' MET . 60.2 tp -64.09 -26.23 68.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.263 174.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 7.6 mtpm? -62.3 -49.32 76.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 17.4 p -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.578 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.32 -58.34 9.05 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.749 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.49 -41.96 91.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.63 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -52.45 -51.57 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.035 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.553 ' HB2' ' HZ2' ' A' ' 8' ' ' LYS . 9.9 mtmp? -64.49 -44.9 89.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.455 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.77 -45.78 84.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.551 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HB ' HG13 ' A' ' 120' ' ' VAL . 60.9 t -68.63 -33.06 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.642 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 15' ' ' ILE . 16.3 mt -56.95 -51.65 68.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.664 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -59.98 -43.35 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.15 -0.81 15.26 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.828 ' HD3' ' HG2' ' A' ' 54' ' ' GLU . 21.0 ttm180 -111.73 -41.21 4.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.73 0.3 . . . . 0.0 111.404 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 11' ' ' LEU . 32.2 pt -90.77 -18.16 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.32 -2.01 57.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.049 0.452 . . . . 0.0 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.76 149.31 47.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.723 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 m -63.3 132.85 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.51 -36.85 85.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.368 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -66.36 -35.23 79.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.137 0.494 . . . . 0.0 110.333 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 42.2 tt0 -72.92 -41.22 64.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.36 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -65.64 -37.05 85.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.711 HH21 ' HB2' ' A' ' 56' ' ' ASP . 3.0 tpm_? -58.51 -47.05 85.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.741 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -59.84 -47.96 83.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.12 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.6 mt -63.32 -43.27 98.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.841 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 30' ' ' ILE . 70.2 m -61.49 -37.64 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.904 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -58.05 -41.71 83.86 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 109.896 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -67.53 -40.59 85.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 25' ' ' LEU . 74.8 t -66.51 -41.43 88.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 26' ' ' SER . 74.9 mt -58.14 -45.06 88.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.5 p -69.63 -33.74 73.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.956 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.56 -44.85 81.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.172 0.51 . . . . 0.0 110.237 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.699 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 24.4 tp -61.58 -42.6 99.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.671 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -76.07 -13.66 60.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.428 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 t -79.84 -26.61 40.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.45 HD12 HD12 ' A' ' 33' ' ' LEU . 89.7 mt -60.53 122.52 68.42 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.613 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 21.3 Cg_exo -66.48 -22.23 52.11 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.722 2.282 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -71.14 -31.67 68.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.365 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.84 -43.8 97.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.875 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -70.95 -18.68 62.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.492 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -79.56 -38.71 33.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 65.9 m -71.82 120.62 17.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.258 178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -107.02 -28.23 10.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.637 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -89.04 92.53 9.26 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 57.9 t -112.4 111.21 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.161 0.505 . . . . 0.0 110.922 -175.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -102.98 134.68 46.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.199 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 7.4 mp -114.83 145.3 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -86.64 1.78 50.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.476 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.01 90.95 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.109 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.54 103.3 1.41 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.906 2.404 . . . . 0.0 112.314 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 1.7 pp -99.28 169.42 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.032 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 65.46 21.15 11.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.29 0.566 . . . . 0.0 110.019 -172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.41 -86.44 1.56 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.707 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.828 ' HG2' ' HD3' ' A' ' 14' ' ' ARG . 29.9 mt-10 60.88 -84.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 123.45 0.7 . . . . 0.0 110.86 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.534 HG21 HG12 ' A' ' 150' ' ' VAL . 58.6 t -145.44 133.48 16.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.711 ' HB2' HH21 ' A' ' 23' ' ' ARG . 60.6 m-20 -71.45 79.97 0.78 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.88 0.372 . . . . 0.0 111.297 -178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 150' ' ' VAL . 90.6 mt -98.34 -16.98 19.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 109.777 174.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 6.5 m -63.69 -50.69 70.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.25 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 20.9 Cg_exo -67.97 3.65 1.87 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.339 2.026 . . . . 0.0 112.824 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 tp -93.28 -9.59 38.49 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.522 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 19.5 m-30 -50.83 -49.65 78.59 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.248 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 73.1 Cg_exo -51.96 -35.76 61.84 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.2 1.933 . . . . 0.0 112.791 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.7 -11.91 49.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG13 ' HB2' ' A' ' 68' ' ' LYS . 29.3 t -93.64 -40.52 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.69 -1.94 4.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 94.1 mttt -84.19 -52.67 6.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.647 0.26 . . . . 0.0 111.268 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.967 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 6.8 pt-20 -119.76 -9.72 9.68 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.967 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 2.2 mptp? -116.32 165.06 13.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.769 0.795 . . . . 0.0 112.185 178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' OE1' ' HD2' ' A' ' 84' ' ' ARG . 37.1 mt-10 -98.87 114.79 27.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.326 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -78.93 124.16 27.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.467 . . . . 0.0 110.925 -175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 55.6 mt -114.48 117.41 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.199 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.0 mt -119.31 147.64 43.59 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.882 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 47' ' ' LEU . 91.6 Cg_endo -81.21 129.66 6.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.895 2.397 . . . . 0.0 113.443 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -127.34 109.56 11.92 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.13 105.84 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.201 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -81.08 -10.84 59.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.689 -175.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.04 -42.95 0.53 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.705 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -137.14 -39.17 0.61 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.11 0.481 . . . . 0.0 110.015 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.26 141.4 28.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.32 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -80.36 106.89 12.71 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.0 mt -74.31 117.63 16.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.953 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 5.2 m-85 -102.45 133.1 47.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.135 0.493 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.608 ' HD2' ' OE1' ' A' ' 69' ' ' GLU . 12.5 ttp180 -99.5 115.18 28.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.853 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 m -131.42 148.57 32.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.97 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -127.21 18.88 7.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.378 0.609 . . . . 0.0 109.518 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.2 m -139.06 141.72 30.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.769 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 6.7 Cg_exo -74.5 -174.53 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.931 2.421 . . . . 0.0 111.947 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.61 -30.49 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.562 0.745 . . . . 0.0 112.237 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 34.4 m -76.37 1.74 15.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 110.681 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.5 mt -104.38 105.65 15.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.102 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -107.18 -163.16 21.93 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.816 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.91 121.9 45.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.63 -75.61 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.98 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.23 114.9 1.97 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.513 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 65.93 8.29 5.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.275 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.14 82.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.877 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.96 165.86 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 92' ' ' GLY . 65.4 mtt -71.07 137.27 48.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.085 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.24 141.73 32.85 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.674 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 7.9 Cg_exo -72.26 106.15 2.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.485 2.123 . . . . 0.0 110.426 172.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.505 HG23 ' HG2' ' A' ' 103' ' ' GLU . 34.9 m -66.29 -22.53 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.505 ' HG2' HG23 ' A' ' 102' ' ' VAL . 9.3 pt-20 -152.91 166.94 30.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.379 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.18 -171.99 21.62 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -109.45 154.56 22.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.922 0.391 . . . . 0.0 111.19 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.94 157.15 23.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 39.1 t -109.8 136.06 46.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.699 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -67.86 132.35 92.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.56 -41.23 45.19 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.912 2.408 . . . . 0.0 113.247 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.9 -4.11 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.361 0.601 . . . . 0.0 110.847 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.96 -19.28 30.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.491 175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.03 122.69 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.995 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -104.29 -43.43 5.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.699 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 23.8 t80 -126.03 123.97 39.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.443 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.5 tt -128.0 137.5 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.482 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.08 111.36 22.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.266 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.449 ' O ' ' HA2' ' A' ' 149' ' ' GLY . 6.2 p -133.99 123.22 16.82 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.718 -178.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.515 ' HB2' ' H ' ' A' ' 119' ' ' GLY . 1.4 Cg_endo -84.49 -122.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.997 2.465 . . . . 0.0 111.322 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 118' ' ' PRO . . . 114.88 -178.07 17.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.935 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' A' ' 10' ' ' VAL . 98.5 t -100.27 125.64 53.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.574 -0.313 . . . . 0.0 111.387 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 128' ' ' ARG . . . 69.43 121.5 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.208 0.943 . . . . 0.0 112.73 171.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -128.91 158.23 39.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.539 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.528 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 38.9 p30 -137.94 -174.19 3.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -82.32 -6.62 59.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.573 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -89.99 -27.26 19.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.017 0.437 . . . . 0.0 110.044 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.7 21.99 6.9 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.193 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.34 151.51 21.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.08 0.467 . . . . 0.0 110.91 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.536 HH22 ' HB3' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -151.41 151.95 32.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 175.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 121' ' ' ALA . 10.0 mp -83.71 -30.17 26.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.142 0.496 . . . . 0.0 110.069 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.457 ' HA2' ' HA3' ' A' ' 119' ' ' GLY . . . 67.63 -154.66 53.0 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.13 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -83.68 -39.07 20.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.88 0.372 . . . . 0.0 110.261 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 134.76 -130.96 5.68 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.52 ' HD3' ' HE2' ' A' ' 136' ' ' TYR . 98.0 mttt 56.73 77.46 0.26 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.048 0.452 . . . . 0.0 111.516 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.54 51.18 2.97 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.811 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -127.37 -22.19 3.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.342 0.592 . . . . 0.0 109.943 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.52 ' HE2' ' HD3' ' A' ' 133' ' ' LYS . 46.2 m-85 -104.13 9.36 36.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.107 -173.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.72 -31.68 72.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 110.192 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -67.34 -29.08 68.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.68 -34.29 46.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.057 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.44 -24.39 65.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.391 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -96.43 -4.16 42.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -91.87 -28.33 17.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.211 0.529 . . . . 0.0 110.026 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.88 114.35 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.63 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -92.56 7.25 44.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.73 166.57 54.2 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.112 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.16 102.58 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.073 0.463 . . . . 0.0 110.104 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 169' ' ' VAL . 55.9 mtpt -72.19 102.97 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.728 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 65.6 t -97.7 117.65 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.431 . . . . 0.0 110.594 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 117' ' ' VAL . . . -88.93 120.32 5.67 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.534 HG12 HG21 ' A' ' 55' ' ' VAL . 19.0 t -99.08 108.2 21.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -139.94 157.68 45.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.329 0.585 . . . . 0.0 112.212 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.38 155.24 17.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.542 ' OG ' ' HG3' ' A' ' 176' ' ' LYS . 3.7 m -52.14 -29.94 24.28 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.363 0.414 . . . . 0.0 111.762 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -68.81 -20.48 64.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.597 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -99.46 -2.91 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.69 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 64.8 t -104.44 128.44 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.149 0.5 . . . . 0.0 111.514 -173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.65 -165.99 1.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.643 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 43.0 mt-10 -88.67 -62.3 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 159' ' ' ARG . 3.0 tpm_? -143.7 112.14 6.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.124 -175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 85.2 mt -102.99 161.52 22.89 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.657 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.69 140.48 74.71 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.35 2.034 . . . . 0.0 111.307 173.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 162' ' ' ARG . 47.1 mtt180 -76.41 117.72 18.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 165' ' ' TRP . 23.9 t70 -108.94 128.06 54.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 69.1 -14.81 0.29 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.994 0.809 . . . . 0.0 112.237 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.443 ' H ' ' C ' ' A' ' 163' ' ' ASP . 11.3 m-90 58.0 35.17 25.02 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.96 0.504 . . . . 0.0 111.366 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.536 ' HB3' HH22 ' A' ' 128' ' ' ARG . 14.1 t0 -68.63 153.31 44.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.663 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 13.4 tt -66.55 125.78 91.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.151 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 167' ' ' ILE . 62.3 Cg_exo -51.54 151.97 13.19 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.302 2.668 . . . . 0.0 112.917 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 HD12 ' A' ' 181' ' ' LEU . 28.7 m -70.52 161.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.168 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.454 ' OD2' ' HD3' ' A' ' 182' ' ' ARG . 16.9 t70 -89.88 -43.61 10.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.186 -175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 81.4 t -131.66 132.91 62.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.05 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 55.8 tp -114.84 102.3 9.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.825 0.345 . . . . 0.0 110.1 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.59 111.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -113.31 165.7 12.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.6 -177.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -61.77 -30.8 71.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.014 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' OG ' ' A' ' 153' ' ' SER . 95.1 mttt -82.66 -60.78 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.52 175.28 10.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.884 0.373 . . . . 0.0 110.535 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.56 114.3 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.649 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.796 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 4.9 tpm_? -93.66 98.97 11.49 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -75.75 120.09 20.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.536 HD12 HG23 ' A' ' 169' ' ' VAL . 95.4 mt -105.95 -23.69 12.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.754 -176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' HD3' ' OD2' ' A' ' 170' ' ' ASP . 37.8 ttp-105 -78.91 82.24 5.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.164 0.507 . . . . 0.0 109.811 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -163.15 -178.34 5.95 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.001 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.97 23.99 1.77 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 175.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 64.24 -76.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 111.225 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.8 t -178.98 161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.0 103.45 12.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 191' ' ' HIS . 34.4 tt0 -88.17 107.78 18.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.948 -177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -81.57 112.1 18.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.394 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 55.08 82.05 0.1 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.027 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 188' ' ' GLU . 56.5 p-80 -97.55 167.82 10.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.819 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -143.13 156.72 44.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 74.77 -72.36 0.11 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.807 0.692 . . . . 0.0 111.376 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.693 -0.67 . . . . 0.0 109.438 -178.797 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' HG ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' HG ' ' HG2' ' A' ' 1' ' ' MET . 91.9 mt 73.68 149.99 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.846 0.716 . . . . 0.0 110.933 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 161' ' ' PRO . 63.4 pttt -73.64 -13.77 61.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.219 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -64.26 -30.04 71.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.205 0.526 . . . . 0.0 110.357 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.18 -39.86 32.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.052 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 tp -60.29 -38.26 83.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.735 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.619 ' HD2' ' HD1' ' A' ' 131' ' ' PHE . 54.4 ttp180 -57.87 -41.84 83.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.789 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.96 -39.16 76.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -57.83 -50.46 73.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.812 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.22 -42.64 91.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.499 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 tp -60.17 -35.5 75.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.131 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -58.28 -63.65 1.19 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.941 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -67.1 -27.04 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.304 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' HA ' ' A' ' 120' ' ' VAL . 18.4 ttt180 -60.4 -60.75 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.731 176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 11' ' ' LEU . 36.2 pt -80.24 9.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.074 0.464 . . . . 0.0 111.247 -176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -92.33 -10.64 37.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD12 ' HG2' ' A' ' 54' ' ' GLU . 87.8 mt -58.19 154.54 12.92 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.717 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . 1.2 m -77.74 160.36 28.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -62.57 -66.94 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.8 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -31.81 73.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.137 0.494 . . . . 0.0 110.098 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 18' ' ' SER . 39.3 tt0 -58.0 -52.5 65.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.78 177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.698 HH12 ' HB2' ' A' ' 56' ' ' ASP . 35.7 ptt85 -70.55 -21.82 62.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.598 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -71.11 -41.77 70.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -72.33 -34.35 67.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' VAL . 90.5 mt -64.03 -41.87 97.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.3 m -63.82 -37.9 89.1 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.526 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.91 -45.38 78.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -64.66 -39.75 94.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 175' ' ' GLU . 60.9 t -74.12 -44.64 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.536 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.8 -37.05 78.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.77 0.319 . . . . 0.0 110.371 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 t -64.91 -36.41 84.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.071 0.463 . . . . 0.0 109.914 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.11 -49.94 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.349 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.9 tp -61.69 -31.78 71.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.763 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.11 -32.63 67.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.2 p -80.85 -17.01 52.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.144 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.43 HD23 ' HD2' ' A' ' 37' ' ' PRO . 1.1 tt -55.35 113.03 4.85 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.092 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 36' ' ' LEU . 32.6 Cg_exo -60.31 -39.04 71.02 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.624 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -24.51 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.309 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -72.54 -27.21 62.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.329 0.585 . . . . 0.0 109.531 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -79.64 -24.11 42.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.572 176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -78.17 -46.02 21.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.264 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 114' ' ' PHE . 43.4 t -59.85 149.06 32.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.565 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 38.1 tttp -138.17 -21.08 1.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.976 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 1.001 ' HB2' ' HB3' ' A' ' 113' ' ' ASP . 32.5 mmtp -96.7 92.48 6.21 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.456 HG21 ' HD3' ' A' ' 68' ' ' LYS . 29.2 t -108.17 110.78 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 111.343 -172.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -96.52 119.66 35.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.774 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 70' ' ' LEU . 7.7 mp -104.9 125.86 51.36 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -80.99 3.3 23.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.314 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m 63.16 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.253 0.549 . . . . 0.0 110.754 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HG3' ' H ' ' A' ' 57' ' ' LEU . 58.9 Cg_endo -73.12 81.98 1.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.456 2.104 . . . . 0.0 113.521 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 51' ' ' ILE . 2.0 pp -81.01 127.65 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt 56.8 32.86 22.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.966 0.889 . . . . 0.0 109.556 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -110.04 104.51 1.85 Allowed Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.638 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.609 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 4.5 mp0 -55.51 -30.39 60.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.572 0.349 . . . . 0.0 111.184 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' A' ' 152' ' ' TYR . 6.8 t -78.16 96.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.698 ' HB2' HH12 ' A' ' 22' ' ' ARG . 4.9 t70 -82.71 110.13 17.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.557 -174.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.52 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 93.6 mt -99.43 7.36 45.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.404 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -67.46 -41.04 29.71 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD3' ' OD1' ' A' ' 56' ' ' ASP . 31.4 Cg_exo -62.08 -6.02 7.31 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.051 1.834 . . . . 0.0 113.393 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HG3' ' A' ' 63' ' ' GLU . 25.7 tp -87.53 -10.09 52.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 110.39 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 7.7 m-85 -55.7 -52.87 68.62 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 54.7 Cg_exo -53.48 -34.94 74.29 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.272 1.982 . . . . 0.0 112.801 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' A' ' 60' ' ' LEU . 11.5 mm-40 -66.23 -48.56 70.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.46 -40.39 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.285 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 70' ' ' LEU . 97.2 mt -66.95 -11.12 55.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.722 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 66' ' ' LYS . 26.3 tptp -77.62 -57.42 3.82 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' OE2' ' HG3' ' A' ' 68' ' ' LYS . 1.7 pp20? -134.67 -9.98 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 43.8 mttp -95.88 179.6 5.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.186 0.517 . . . . 0.0 111.079 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 65.9 mm-40 -107.56 113.89 27.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.575 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 85' ' ' VAL . 49.3 tp -83.86 110.24 18.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.101 0.477 . . . . 0.0 109.999 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 56.4 mt -100.87 112.51 33.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.924 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 88.2 mt -108.62 145.0 30.69 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.689 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 7.8 Cg_endo -87.57 118.52 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.203 2.602 . . . . 0.0 112.457 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HD2' ' CE2' ' A' ' 83' ' ' TYR . 36.0 tttp -105.49 121.37 43.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.883 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.67 105.19 7.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -15.87 61.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.988 0.423 . . . . 0.0 111.164 -175.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 165.88 -44.51 0.28 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.86 -34.43 0.47 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.601 -0.299 . . . . 0.0 110.458 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -105.6 168.04 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.0 mt -107.17 133.89 50.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 111.522 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 t -119.03 132.35 56.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 90.5 mt -84.84 142.18 29.93 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 121.333 -0.147 . . . . 0.0 110.748 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.714 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 1.5 m-85 -116.75 138.45 51.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.588 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 72.2 ttt180 -100.96 104.89 16.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.218 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 13.4 t -133.07 154.59 39.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -148.41 46.0 1.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.59 0.709 . . . . 0.0 109.878 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -171.53 148.91 2.36 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.132 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.74 -61.84 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.483 2.122 . . . . 0.0 111.624 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.01 -93.48 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 63.3 m -125.94 27.5 6.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.438 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -78.25 114.22 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -127.42 -159.8 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.527 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' HA2' ' A' ' 97' ' ' GLY . 59.0 t -117.15 93.4 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.281 0.562 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.33 -96.1 2.42 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.763 ' H ' ' HG3' ' A' ' 100' ' ' GLU . . . -68.09 122.37 18.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 74.19 -44.6 0.57 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.648 0.779 . . . . 0.0 112.496 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' HA2' HG13 ' A' ' 93' ' ' VAL . . . 131.23 6.69 3.41 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.113 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.4 pt -84.01 173.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.86 99.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.763 ' HG3' ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -110.35 111.89 57.37 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.86 -172.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.26 106.22 1.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.694 2.262 . . . . 0.0 111.858 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.3 -40.67 89.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -127.1 -177.65 4.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.467 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -177.65 16.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.837 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 1.5 mm-40 -115.88 154.27 30.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 111.225 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 12.8 mtm180 -86.58 159.32 19.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.784 -167.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 84' ' ' ARG . 48.6 t -122.73 126.09 73.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.853 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -84.55 151.52 58.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.997 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.542 ' HA ' HG23 ' A' ' 112' ' ' VAL . 52.7 Cg_exo -56.13 -20.06 29.44 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.986 2.457 . . . . 0.0 113.065 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -76.62 -9.44 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.088 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -111.11 2.73 18.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.212 0.53 . . . . 0.0 110.38 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 109' ' ' PRO . 86.5 t -74.14 106.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.249 0.547 . . . . 0.0 110.905 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 1.001 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 5.1 t0 -86.47 -54.04 4.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.468 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 148' ' ' VAL . 37.2 t80 -132.19 132.99 43.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.09 -178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.9 tt -133.78 138.97 49.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.834 0.349 . . . . 0.0 110.419 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.54 111.56 19.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.302 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.55 117.35 29.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.402 0.62 . . . . 0.0 110.945 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.413 ' HG3' ' HB3' ' A' ' 50' ' ' PRO . 94.2 Cg_endo -86.89 73.94 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.872 2.381 . . . . 0.0 112.359 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -63.28 159.92 36.53 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.486 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.535 ' HA ' ' NH1' ' A' ' 14' ' ' ARG . 99.3 t -66.87 -50.1 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.494 0.188 . . . . 0.0 111.361 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.86 24.31 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.894 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -132.16 170.33 15.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.68 -177.02 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.536 0.208 . . . . 0.0 110.463 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.587 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 84.3 mt -83.2 8.72 12.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -109.38 -28.69 8.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 122.11 13.42 4.92 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.843 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -94.12 161.72 14.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.443 0.64 . . . . 0.0 111.999 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.538 ' HD3' ' OD1' ' A' ' 166' ' ' ASP . 2.1 ptm180 -101.96 147.75 26.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.27 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.658 ' HB2' HD13 ' A' ' 160' ' ' LEU . 53.2 tp -67.11 -58.41 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.907 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.52 104.56 0.29 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.619 ' HD1' ' HD2' ' A' ' 7' ' ' ARG . 68.0 t80 -162.26 126.4 3.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 153.44 150.54 5.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.196 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -115.19 143.27 45.49 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.57 4.72 76.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.643 174.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.652 ' HD2' ' HB2' ' A' ' 138' ' ' ARG . 26.2 t80 65.39 57.45 0.9 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.34 0.591 . . . . 0.0 109.935 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -64.04 -22.91 67.13 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.88 0.848 . . . . 0.0 110.364 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.821 ' HA ' ' HB2' ' A' ' 140' ' ' LEU . 7.1 p-10 -74.92 7.06 3.44 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.677 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.652 ' HB2' ' HD2' ' A' ' 135' ' ' TYR . 41.1 ttm180 -66.63 -44.18 82.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 165.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 9.9 tt -71.86 -43.77 64.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.177 -0.919 . . . . 0.0 108.974 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 55.7 mt -58.03 -41.06 82.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.835 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 111.384 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.405 ' HD3' ' HG2' ' A' ' 109' ' ' PRO . 77.5 ttt180 -95.46 -12.48 25.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.941 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' LEU . 94.6 t -62.88 98.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.315 0.579 . . . . 0.0 110.232 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -95.11 14.1 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.69 0.757 . . . . 0.0 109.855 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.51 -166.26 30.93 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.885 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.574 HD11 HG23 ' A' ' 171' ' ' VAL . 35.9 tp -78.69 112.89 16.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 110.947 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.868 ' HD3' HD11 ' A' ' 167' ' ' ILE . 16.0 mttp -93.86 114.24 26.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 171' ' ' VAL . 74.7 t -109.99 115.76 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.205 0.526 . . . . 0.0 110.887 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.53 130.23 10.02 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 55' ' ' VAL . 21.9 t -115.66 109.76 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.676 0.274 . . . . 0.0 110.413 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -161.6 170.86 19.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.671 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.694 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 48.0 m-85 -90.26 171.24 9.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 64.0 m -62.21 -28.74 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.757 -0.201 . . . . 0.0 111.348 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -86.39 10.87 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.104 0.478 . . . . 0.0 111.561 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -105.07 -7.56 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 167.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.34 116.72 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.395 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -105.88 -179.31 3.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.812 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.587 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 54.3 mt-10 -76.48 -46.84 25.04 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.122 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -150.63 144.25 25.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.361 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' A' ' 129' ' ' LEU . 98.1 mt -128.9 147.13 63.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.362 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.546 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 31.2 Cg_exo -60.39 114.75 2.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.663 2.242 . . . . 0.0 111.82 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 80.3 mtt180 -104.14 147.12 27.8 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.77 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.25 -69.15 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.374 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.69 -85.45 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.64 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -120.31 74.29 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.432 0.634 . . . . 0.0 109.511 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.538 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 2.5 t70 -89.37 -174.07 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.729 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.868 HD11 ' HD3' ' A' ' 147' ' ' LYS . 4.1 tt -94.77 125.86 49.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 121.075 0.464 . . . . 0.0 111.801 -174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 98.0 Cg_endo -93.93 158.54 2.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.336 2.691 . . . . 0.0 111.96 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.45 147.9 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.705 0.288 . . . . 0.0 110.729 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.82 -42.97 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.382 0.611 . . . . 0.0 110.059 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.574 HG23 HD11 ' A' ' 146' ' ' LEU . 98.5 t -125.21 133.69 68.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.209 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 41.4 tp -122.24 105.0 9.83 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.551 HG22 HG13 ' A' ' 178' ' ' VAL . 46.8 t -91.25 127.94 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 41.0 p -110.5 -166.24 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.53 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.694 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 0.4 OUTLIER -84.32 -14.5 49.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -92.2 -59.91 1.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.916 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -155.52 170.57 21.66 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.147 0.498 . . . . 0.0 111.957 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 173' ' ' VAL . 97.1 t -83.98 106.69 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.477 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 179' ' ' ARG . 44.3 mtt180 -98.99 93.28 5.92 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.857 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -72.4 106.66 4.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.6 mt -56.57 -25.55 52.67 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.782 0.676 . . . . 0.0 112.569 -165.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -161.79 130.59 4.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 172.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.11 -88.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 174.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.94 -65.28 0.48 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.606 -0.33 . . . . 0.0 113.519 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.9 ttt85 -62.79 103.46 0.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 p -139.4 144.23 38.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.389 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.446 HD23 ' NE2' ' A' ' 189' ' ' HIS . 17.1 tp -103.46 128.31 50.66 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.47 81.38 2.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.431 0.634 . . . . 0.0 109.954 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.446 ' NE2' HD23 ' A' ' 187' ' ' LEU . 21.7 m80 -75.71 -19.94 58.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.03 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 192' ' ' HIS . 16.8 t-80 -140.48 106.24 5.14 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -57.86 -37.33 73.7 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.274 0.359 . . . . 0.0 111.391 -176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 190' ' ' HIS . 40.7 m-70 -66.09 106.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.086 0.469 . . . . 0.0 110.08 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -87.38 136.71 32.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.185 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 . . . . . 0 C--O 1.244 0.777 0 CA-C-O 118.469 -0.777 . . . . 0.0 109.933 177.084 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.753 0.311 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.83 28.62 0.27 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.18 -25.31 65.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.44 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 p -75.73 -23.25 56.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.246 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 5.4 mm-40 -77.31 -35.02 55.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.528 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 10' ' ' VAL . 48.6 tp -77.66 -29.98 51.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.686 ' HG2' HG11 ' A' ' 120' ' ' VAL . 3.8 ttm-85 -53.26 -49.56 66.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.807 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 55.0 pttt -68.93 -31.44 70.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.832 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.21 -43.51 70.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.6 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 6' ' ' LEU . 39.1 t -70.19 -39.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.34 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.27 -32.98 74.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.649 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -71.87 -38.57 70.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.263 0.554 . . . . 0.0 110.778 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.8 ttm105 -60.84 -41.96 96.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.868 -176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.1 pt -90.68 1.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.677 0.275 . . . . 0.0 111.501 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.59 -26.88 31.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.978 0.418 . . . . 0.0 110.804 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -66.13 143.67 57.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.788 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -85.96 -176.74 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.22 -52.13 65.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.348 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -52.31 -51.37 59.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.797 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.96 -58.23 8.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.62 0.248 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -57.43 -50.17 73.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.9 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -62.39 -40.6 97.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.972 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -71.05 -44.61 65.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.903 0.382 . . . . 0.0 110.915 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.2 mt -65.01 -42.44 94.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.819 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -63.2 -39.31 94.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.525 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -59.29 -43.73 92.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 110.026 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -55.86 -51.34 67.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.731 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 25' ' ' LEU . 52.0 t -62.86 -42.76 97.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.389 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 56' ' ' ASP . 79.8 mt -62.51 -50.28 80.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.5 t -59.46 -45.18 92.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.295 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -63.4 -41.37 98.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.778 HD11 ' HZ ' ' A' ' 114' ' ' PHE . 35.9 tp -63.33 -42.27 98.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.505 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -73.59 -21.1 60.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.7 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -74.35 -27.34 60.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.312 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 33' ' ' LEU . 89.2 mt -57.63 132.49 82.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.778 175.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.4 -24.04 77.82 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.32 2.014 . . . . 0.0 110.64 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -63.99 -30.05 71.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.862 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -68.12 -38.32 82.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.012 0.434 . . . . 0.0 110.506 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -70.48 -26.43 63.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.252 0.549 . . . . 0.0 109.759 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -84.34 -13.36 52.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.958 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 m -65.47 121.47 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -106.92 -54.87 2.41 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.862 0.839 . . . . 0.0 109.086 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.663 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 47.8 mmtt -105.06 99.74 9.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.237 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.58 108.82 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.059 0.456 . . . . 0.0 110.679 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -102.28 138.38 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.097 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.11 144.06 47.82 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 24.0 t80 -82.35 -4.16 56.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.9 m 62.1 92.8 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.728 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.4 133.98 27.6 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.339 2.026 . . . . 0.0 111.749 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -121.19 -35.49 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.482 0.658 . . . . 0.0 110.083 -177.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -97.43 41.59 1.11 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.524 -177.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.41 -90.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -171.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 35.3 mt-10 54.85 38.23 29.93 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.845 0.379 . . . . 0.0 111.849 168.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 54' ' ' GLU . 81.7 t 73.17 119.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.35 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 30' ' ' ILE . 11.1 m-20 -69.07 83.25 0.33 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.273 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 99.1 mt -89.83 -4.63 57.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.839 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -61.38 -46.88 94.92 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.074 179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.71 -3.37 7.9 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.115 1.876 . . . . 0.0 112.951 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 63' ' ' GLU . 23.0 tp -93.23 -9.84 37.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.388 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.481 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 3.1 m-85 -54.28 -54.04 52.45 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.645 177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 11.4 Cg_endo -56.19 -39.97 87.85 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.362 2.041 . . . . 0.0 112.374 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.452 ' HG3' HD12 ' A' ' 60' ' ' LEU . 7.7 mm-40 -58.47 -42.39 87.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.065 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -74.82 -46.86 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.18 -24.55 64.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.877 0.37 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -38.5 78.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.093 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.895 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 7.2 pt-20 -138.27 -46.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.895 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 49.6 mttm -96.6 -173.32 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.995 0.426 . . . . 0.0 111.008 -170.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' OE2' ' HD2' ' A' ' 84' ' ' ARG . 39.2 mt-10 -100.14 128.32 46.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.7 tp -100.88 110.83 22.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.418 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 60.4 mt -96.22 119.86 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.292 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.873 ' HB2' ' HG3' ' A' ' 101' ' ' PRO . 93.7 mt -122.49 145.6 45.18 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' CB ' HD11 ' A' ' 80' ' ' ILE . 72.7 Cg_endo -91.58 127.24 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.045 2.497 . . . . 0.0 113.688 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.788 ' HD3' ' HE2' ' A' ' 83' ' ' TYR . 34.8 tttm -105.98 126.08 51.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.544 172.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -95.18 128.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.698 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -139.14 100.4 4.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.886 0.374 . . . . 0.0 110.128 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.09 -106.17 1.58 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.764 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -124.8 21.3 8.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.426 0.631 . . . . 0.0 109.603 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.75 152.96 35.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.525 HD13 HD22 ' A' ' 139' ' ' LEU . 16.8 tt -128.02 128.0 68.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.422 0.63 . . . . 0.0 110.773 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -104.11 108.61 20.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 139' ' ' LEU . 97.0 mt -85.35 101.1 12.29 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 176.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.788 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 77.2 m-85 -96.17 130.82 43.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.286 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HD2' ' OE2' ' A' ' 69' ' ' GLU . 20.1 ptt180 -92.59 130.17 38.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.15 142.27 43.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.433 -171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -135.17 14.31 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.336 0.588 . . . . 0.0 109.638 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.473 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.0 m -135.09 125.42 17.04 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.21 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 87' ' ' SER . 32.2 Cg_exo -61.87 -31.56 85.04 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 122.915 2.41 . . . . 0.0 113.423 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.66 -2.25 19.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.72 4.2 51.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.903 0.382 . . . . 0.0 110.663 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.7 mt -104.52 149.06 25.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.705 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.22 -142.2 6.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.34 133.06 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -127.27 -98.17 1.0 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.162 -1.018 . . . . 0.0 114.387 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.32 -2.85 21.82 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -166.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -122.93 -44.56 2.18 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.12 24.82 3.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.879 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.0 pt -121.95 173.24 7.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 tpt -69.81 88.12 0.54 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -121.05 161.63 39.52 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.295 -172.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.873 ' HG3' ' HB2' ' A' ' 72' ' ' LEU . 4.2 Cg_exo -76.13 125.5 8.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.507 2.138 . . . . 0.0 112.097 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.94 -41.76 32.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.011 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.99 173.85 11.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.87 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.09 -164.42 25.28 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.896 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -110.76 122.04 46.82 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.752 -0.264 . . . . 0.0 110.849 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.5 ptm180 -84.31 125.99 32.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 108' ' ' ASN . 3.4 t -122.72 164.28 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' N ' HG12 ' A' ' 107' ' ' VAL . 14.7 m120 -74.74 153.02 87.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.381 176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.88 -11.56 24.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.975 2.45 . . . . 0.0 113.314 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -71.03 -20.44 62.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.136 0.494 . . . . 0.0 110.455 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.33 -16.44 56.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.459 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.67 124.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.299 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.663 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 19.0 t70 -99.2 -48.41 4.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.508 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.778 ' HZ ' HD11 ' A' ' 33' ' ' LEU . 32.1 t80 -136.9 119.94 16.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -126.15 138.87 53.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.027 0.442 . . . . 0.0 110.962 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.4 111.4 22.93 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.202 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 49.0 t -113.81 105.8 54.27 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.922 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 48' ' ' TYR . 16.5 Cg_exo -68.59 119.32 6.32 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.489 2.126 . . . . 0.0 110.941 171.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -99.53 153.92 19.67 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.688 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.686 HG11 ' HG2' ' A' ' 7' ' ' ARG . 84.1 t -58.77 -49.26 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.188 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.88 36.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.584 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.25 151.84 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 5.0 p-10 -108.36 -163.72 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 97.7 mt -75.69 -19.52 59.06 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.81 -31.16 10.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 181' ' ' LEU . . . 119.39 35.06 0.96 Allowed Glycine 0 C--O 1.236 0.277 0 C-N-CA 119.818 -1.182 . . . . 0.0 114.529 170.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.96 147.08 35.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.008 0.404 . . . . 0.0 110.16 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.585 ' HB3' ' OD2' ' A' ' 166' ' ' ASP . 25.4 ttp180 -86.78 -12.71 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.083 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.835 ' HB2' HD13 ' A' ' 160' ' ' LEU . 62.0 tp 73.68 -60.21 0.54 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.552 0.741 . . . . 0.0 111.034 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.24 113.14 0.66 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.175 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -73.61 -37.55 65.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.071 0.462 . . . . 0.0 110.262 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -132.51 -144.1 5.21 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -69.15 -72.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 0.0 110.05 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.17 38.04 0.37 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -109.78 171.42 7.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.708 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 70.1 5.3 5.23 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.049 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.33 -29.81 57.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -65.46 -25.96 67.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.659 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 82' ' ' LEU . 34.3 tp -78.43 -58.17 3.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.388 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.83 -30.99 69.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.233 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -76.57 -23.54 53.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.931 0.396 . . . . 0.0 110.69 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -94.6 -6.06 44.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 139' ' ' LEU . 97.4 t -80.73 104.11 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.02 7.3 44.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.892 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -86.62 -168.5 44.9 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.987 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.69 104.01 15.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.502 ' HA ' HG23 ' A' ' 115' ' ' ILE . 9.9 mtmp? -86.24 102.74 14.22 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.163 0.506 . . . . 0.0 110.22 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.1 t -99.4 116.86 43.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.641 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.99 121.72 5.56 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.415 HG13 HG11 ' A' ' 29' ' ' VAL . 85.3 t -109.33 120.3 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.87 169.81 21.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.073 0.463 . . . . 0.0 111.597 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' A' ' 155' ' ' GLN . 41.4 m-85 -86.3 168.86 13.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.2 m -77.15 -19.84 56.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 109.548 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -69.01 -10.2 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.487 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 152' ' ' TYR . 59.9 mm-40 -111.29 10.26 21.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.625 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.74 131.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.763 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -123.15 -168.73 1.81 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.083 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.602 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 34.1 mt-10 -80.02 -59.27 2.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.304 0.573 . . . . 0.0 109.971 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 6.4 mmt85 -147.2 144.94 29.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.709 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 129' ' ' LEU . 68.6 mt -101.92 137.19 19.45 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 12.0 Cg_exo -70.88 101.92 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.636 2.224 . . . . 0.0 111.075 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 162' ' ' ARG . 0.5 OUTLIER -130.67 178.33 6.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.211 -174.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -73.45 -67.2 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HA ' HH11 ' A' ' 162' ' ' ARG . . . -151.41 -89.28 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.005 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -116.7 78.12 1.17 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.024 0.44 . . . . 0.0 110.836 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 128' ' ' ARG . 34.9 t70 -70.08 134.66 48.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 167.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 62.8 mt -55.97 114.79 8.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 112.057 -170.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.76 175.95 7.38 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.272 2.648 . . . . 0.0 112.851 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.12 160.56 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.114 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 147' ' ' LYS . 14.0 m-20 -87.89 -35.14 17.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.239 0.542 . . . . 0.0 109.924 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 59.4 t -133.26 143.44 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.483 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 181' ' ' LEU . 56.7 tp -115.64 117.61 30.77 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.71 116.2 51.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.013 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 70.9 p -109.92 -167.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.747 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 176' ' ' LYS . 10.4 pt-20 -68.19 -17.42 64.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.199 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 9.8 mtmp? -128.71 -66.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -109.41 152.63 25.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.282 0.563 . . . . 0.0 112.077 -171.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.473 HG21 HD21 ' A' ' 36' ' ' LEU . 61.2 t -118.64 133.87 64.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.904 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -129.49 146.34 51.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.994 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.4 mtt-85 -89.57 117.06 28.19 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 172' ' ' LEU . 70.5 mt -106.23 7.3 31.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.175 0.512 . . . . 0.0 110.869 -173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.14 -177.86 4.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.718 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.579 ' HB3' ' HE ' ' A' ' 185' ' ' ARG . 3.5 m-20 -60.15 105.69 0.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.013 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.57 70.81 2.17 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.579 ' HE ' ' HB3' ' A' ' 183' ' ' ASP . 26.1 mmt180 -87.33 17.77 4.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.9 m -78.23 72.62 4.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.817 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 87.4 mt -95.45 38.09 1.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.341 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -54.64 117.93 3.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.347 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -142.68 80.19 1.68 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.79 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -62.01 134.29 56.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.931 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -75.58 94.26 3.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.555 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -77.34 172.27 13.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.598 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -92.08 -54.03 4.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 . . . . . 0 C--O 1.248 1.012 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.607 173.477 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.623 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 23.5 mmt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.36 -66.16 0.58 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -76.5 -10.03 59.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 1' ' ' MET . 3.3 p -97.36 -48.33 5.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.181 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 43.7 mt-10 -64.51 -36.36 83.95 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.136 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -53.46 -41.01 65.73 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.386 0.429 . . . . 0.0 111.133 -177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 7' ' ' ARG . 44.1 ttm180 -65.65 -35.17 80.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.168 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.35 -34.91 17.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.932 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -60.17 -52.4 65.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.054 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 98.0 t -62.3 -46.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.482 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 15' ' ' ILE . 35.0 tp -59.77 -42.8 94.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.667 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -61.02 -44.13 97.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.899 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -71.73 -31.18 66.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.241 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 80.0 mtp180 -64.0 -53.6 47.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.715 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 11' ' ' LEU . 26.4 pt -78.44 8.57 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.005 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -94.98 -9.04 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.478 0.656 . . . . 0.0 109.523 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' HG2' ' A' ' 54' ' ' GLU . 92.8 mt -68.92 141.06 55.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.504 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -69.4 153.29 43.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 111.251 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 9.4 tp10 -56.64 -51.93 66.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.768 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -65.57 -44.07 87.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.276 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 7.3 tp10 -61.18 -39.71 91.2 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 42.0 ttt180 -55.1 -47.96 74.24 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.577 174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.3 mmt180 -62.56 -32.23 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.148 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.78 -29.78 68.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.382 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 21' ' ' GLU . 59.0 mt -79.34 -40.43 30.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.263 0.554 . . . . 0.0 110.31 176.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 19.9 m -59.6 -40.02 86.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.906 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.78 -32.07 73.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.439 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 91.0 mttt -60.24 -53.98 51.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.86 -43.1 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.557 -178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.28 -46.46 88.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.979 0.419 . . . . 0.0 110.508 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.4 t -65.38 -42.81 92.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.938 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -70.02 -43.33 71.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.595 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 36' ' ' LEU . 28.0 tp -66.89 -34.67 78.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 110.377 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -86.31 -3.37 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.15 0.5 . . . . 0.0 110.625 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.8 t -82.53 -28.12 31.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 178' ' ' VAL . 70.2 mt -61.45 123.77 77.94 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.141 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.46 -20.5 41.71 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.485 2.123 . . . . 0.0 112.162 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.28 -22.08 55.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.778 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -72.18 -14.99 61.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.08 -33.5 14.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.249 177.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.71 -38.23 33.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 -176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.624 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 11.2 p -61.89 152.0 33.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 175.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HD2' ' O ' ' A' ' 42' ' ' SER . 12.8 mptt -132.71 -25.75 1.85 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.848 -177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 3.3 mptp? -103.9 95.52 6.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 114' ' ' PHE . 60.9 t -111.4 118.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.105 0.478 . . . . 0.0 111.169 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 71' ' ' ILE . . . -106.17 124.34 49.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.204 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.55 123.68 48.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.96 -7.54 49.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.921 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 68.4 m 70.93 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 123.326 0.65 . . . . 0.0 111.964 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 49' ' ' CYS . 2.9 Cg_exo -75.37 95.48 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.952 2.435 . . . . 0.0 112.132 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 52' ' ' LYS . 27.2 pt -78.39 -40.21 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.097 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 51' ' ' ILE . 94.7 mttt -129.28 103.13 6.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.131 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.74 172.6 35.73 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.578 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -93.9 -10.3 34.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.923 0.392 . . . . 0.0 110.29 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG12 ' HG ' ' A' ' 57' ' ' LEU . 57.4 t -75.13 109.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.107 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 8.0 m-20 -90.54 84.09 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.512 . . . . 0.0 111.854 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' HG ' HG12 ' A' ' 55' ' ' VAL . 94.0 mt -96.18 -10.7 27.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.533 0.682 . . . . 0.0 109.248 171.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.475 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 5.6 m -61.17 -49.62 87.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.121 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 58' ' ' THR . 49.2 Cg_endo -69.22 2.27 3.37 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.01 1.807 . . . . 0.0 113.501 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 64' ' ' VAL . 21.2 tp -94.84 -8.17 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.048 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' N ' ' HD2' ' A' ' 62' ' ' PRO . 19.9 m-85 -53.98 -51.53 76.3 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 61' ' ' PHE . 12.2 Cg_endo -56.34 -36.17 96.82 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.553 2.168 . . . . 0.0 112.515 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HA ' ' NZ ' ' A' ' 66' ' ' LYS . 51.8 tp10 -71.58 -41.78 68.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 60' ' ' LEU . 77.0 t -57.97 -43.37 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.53 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.8 mt -69.09 -1.52 7.88 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.605 ' NZ ' ' HA ' ' A' ' 63' ' ' GLU . 54.4 mttp -88.93 -26.39 21.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -112.0 -50.66 2.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.112 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 43' ' ' LYS . 27.6 mtmm -131.83 -174.31 3.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.921 -168.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 84' ' ' ARG . 36.7 mt-10 -96.84 142.48 28.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.52 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.3 tp -99.97 109.4 21.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.24 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' ALA . 66.9 mt -98.56 118.22 44.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.102 0.477 . . . . 0.0 110.057 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.83 145.81 34.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.063 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' CB ' HD11 ' A' ' 80' ' ' ILE . 87.5 Cg_endo -89.34 120.33 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.183 2.589 . . . . 0.0 113.118 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.831 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 78.5 tttt -106.18 117.18 33.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG11 ' HE2' ' A' ' 96' ' ' PHE . 58.7 t -85.36 109.18 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -131.27 98.94 4.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.726 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.39 36.81 19.46 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.5 m120 71.15 -36.11 0.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.731 0.812 . . . . 0.0 112.181 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.87 143.52 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.501 HD13 HD22 ' A' ' 139' ' ' LEU . 15.5 tt -98.94 132.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.181 0.515 . . . . 0.0 111.426 -173.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.9 t -120.9 124.19 44.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.377 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 73' ' ' PRO . 77.5 mt -87.13 130.23 34.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.069 0.461 . . . . 0.0 110.85 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.659 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 9.8 m-85 -106.91 126.26 52.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.616 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 69' ' ' GLU . 71.3 ttt180 -85.45 92.67 8.56 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.424 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.77 111.59 23.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.433 0.635 . . . . 0.0 110.537 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.406 ' HD2' ' HG2' ' A' ' 84' ' ' ARG . 4.8 p80 -120.58 20.13 11.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.653 0.739 . . . . 0.0 109.497 175.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 p -162.15 122.23 1.49 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.035 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.96 41.57 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.029 2.486 . . . . 0.0 112.97 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.74 -36.53 15.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.767 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.9 m -131.17 102.79 6.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.459 . . . . 0.0 111.428 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.0 mt -140.97 153.4 45.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.852 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.59 160.61 30.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.974 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.59 112.91 42.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.23 -154.96 6.63 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.357 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.32 -127.6 1.75 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.567 0.347 . . . . 0.0 110.701 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HE2' HG11 ' A' ' 75' ' ' VAL . 88.4 m-85 -85.39 17.64 3.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.828 0.347 . . . . 0.0 110.812 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 46.8 2.73 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.74 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.0 pt -124.27 170.31 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.823 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.0 mmt -83.54 93.31 7.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.063 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.831 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 4.3 pt-20 -104.83 109.86 63.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.27 0.557 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 31.7 Cg_exo -59.63 127.41 23.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.377 2.051 . . . . 0.0 111.176 176.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -60.43 -56.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.717 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.57 -176.79 4.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.53 -159.84 22.95 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.387 175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -96.45 96.85 8.98 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -77.91 120.45 22.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.66 147.72 27.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.206 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.8 t-20 -58.58 138.91 85.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.463 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 108' ' ' ASN . 53.7 Cg_exo -53.92 -16.22 8.52 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.573 2.849 . . . . 0.0 114.271 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 144' ' ' LYS . 42.7 tt0 -61.61 -28.18 69.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.397 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.34 -28.99 69.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 0.0 111.145 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 44' ' ' LYS . 40.5 t -65.41 121.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -105.33 -20.77 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.603 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.679 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 32.6 t80 -135.96 114.34 11.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.508 HG21 HG11 ' A' ' 143' ' ' VAL . 16.2 tt -121.28 139.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.15 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.91 106.48 17.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.259 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.35 123.48 34.95 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.773 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -92.84 -163.42 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.01 2.473 . . . . 0.0 112.004 175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.73 -176.68 44.14 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.6 -41.46 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 117.046 0.423 . . . . 0.0 110.749 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.68 161.51 38.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.337 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -134.44 158.59 43.49 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.564 0.54 . . . . 0.0 109.781 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 9.3 p30 -120.34 -172.1 2.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.349 . . . . 0.0 110.678 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.5 mt -98.83 7.69 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.465 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -103.38 -30.3 10.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 168' ' ' PRO . . . 133.9 -4.09 4.61 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.226 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -88.86 163.38 15.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.24 0.543 . . . . 0.0 111.215 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.472 HH11 ' HG3' ' A' ' 128' ' ' ARG . 7.6 mtm-85 -126.15 157.02 39.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.278 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.75 2.58 19.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.141 0.496 . . . . 0.0 110.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.65 -149.12 51.43 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.979 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -155.39 -62.3 0.11 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.05 179.5 40.17 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -83.93 125.75 32.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 110.565 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 -171.34 15.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -102.81 16.64 25.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.345 0.593 . . . . 0.0 109.876 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -99.65 4.13 45.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.677 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 6.9 p-10 -67.56 -33.34 74.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -70.27 -8.42 50.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 80' ' ' ILE . 21.2 tp -93.58 -72.27 0.62 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.439 ' HA ' HG23 ' A' ' 143' ' ' VAL . 95.5 mt -66.36 -17.7 64.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.313 -171.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.706 ' HG3' ' HB ' ' A' ' 167' ' ' ILE . 83.8 tttt -92.95 -12.1 31.66 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.671 -177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -121.33 0.95 10.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.323 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.508 HG11 HG21 ' A' ' 115' ' ' ILE . 92.8 t -50.35 121.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.0 111.06 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 110' ' ' GLU . 58.1 mtpt -87.82 -11.38 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.099 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.45 176.82 51.45 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.208 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.29 110.72 3.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.833 0.349 . . . . 0.0 110.686 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 143' ' ' VAL . 11.6 mmmm -72.47 100.11 2.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.815 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.59 124.92 59.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.359 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -102.08 129.48 9.91 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.19 121.25 66.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.935 0.367 . . . . 0.0 110.84 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.27 165.51 31.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.264 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.579 ' HE2' ' HB2' ' A' ' 54' ' ' GLU . 47.8 m-85 -92.2 -178.79 5.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 t -68.47 -22.31 64.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.185 0.516 . . . . 0.0 109.973 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -72.75 -18.04 61.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.164 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.519 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 1.6 mp0 -95.64 -7.44 37.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.322 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.25 116.61 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.068 0.461 . . . . 0.0 111.701 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -115.55 174.35 6.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.372 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 26.8 mm-40 -74.26 -60.29 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 110.54 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 34.8 ttt180 -145.97 129.2 16.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 84.7 mt -93.62 160.7 32.31 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.194 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.59 101.64 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.221 . . . . 0.0 111.614 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -80.07 148.26 31.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.204 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -77.1 -60.92 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 169.54 -39.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.137 0.975 . . . . 0.0 109.711 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.467 ' O ' ' HE3' ' A' ' 141' ' ' LYS . 8.3 m-90 -136.13 21.83 3.24 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.06 149.75 18.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.896 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.706 ' HB ' ' HG3' ' A' ' 141' ' ' LYS . 6.6 tp -93.79 113.56 60.77 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.227 -175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 167' ' ' ILE . 57.6 Cg_endo -71.53 174.74 10.5 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.463 2.109 . . . . 0.0 112.853 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.78 157.94 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.961 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 182' ' ' ARG . 15.2 t70 -91.91 -42.6 9.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.9 122.21 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.43 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 31.4 tp -106.35 108.0 19.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.056 0.455 . . . . 0.0 109.874 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.0 t -95.16 118.64 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.064 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 79.7 p -114.36 -178.93 3.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.672 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 14.9 pt-20 -71.61 -15.26 62.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.575 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.541 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 99.8 mttt -105.7 -60.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.544 -174.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.17 172.57 12.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 111.498 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 36' ' ' LEU . 23.6 t -115.09 98.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.545 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -94.49 117.79 30.67 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.561 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.01 111.25 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.155 174.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.458 HD13 ' HA2' ' A' ' 126' ' ' GLY . 64.5 mt -81.64 -45.77 15.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.529 ' HA ' ' OD2' ' A' ' 170' ' ' ASP . 41.7 mtm180 66.12 -178.36 0.19 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.22 173.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -98.44 115.31 28.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.225 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -107.41 -164.44 21.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.857 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 185' ' ' ARG . 21.2 ttt180 65.43 28.46 11.63 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.624 0.726 . . . . 0.0 110.0 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.7 t -72.44 -2.65 20.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.781 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.36 -31.43 67.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.537 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -133.62 143.52 48.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.514 0.673 . . . . 0.0 111.278 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.71 -167.49 2.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -52.28 128.03 23.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.611 0.641 . . . . 0.0 109.911 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -74.78 91.56 2.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -168.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -151.51 77.2 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.036 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -86.79 -11.92 49.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.886 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 C--O 1.244 0.775 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.649 179.816 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.7 tp 65.85 17.04 10.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.3 0.571 . . . . 0.0 111.107 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -69.23 -34.9 75.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.536 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.0 t -70.84 -44.48 66.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.4 -36.83 79.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.686 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.62 -50.85 72.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.297 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HG3' ' HA2' ' A' ' 130' ' ' GLY . 7.8 tmm_? -62.29 -42.24 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.543 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -62.36 -33.74 75.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.653 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 29.6 ttmt -81.78 -46.03 14.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.312 -176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.22 -35.79 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.302 0.573 . . . . 0.0 110.365 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 15' ' ' ILE . 32.7 tp -59.31 -37.13 76.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.938 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -58.6 -41.79 86.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.056 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -74.69 -40.67 61.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.523 -173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.632 HH11 ' HA ' ' A' ' 120' ' ' VAL . 15.7 ptm180 -70.4 -37.47 74.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.346 -175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 11' ' ' LEU . 33.4 pt -82.83 -0.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.822 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -81.45 -24.88 36.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.61 137.34 57.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.591 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.2 t -122.7 -166.59 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.823 -175.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -66.53 -4.59 8.81 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.9 -65.03 1.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.033 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 10.2 tp10 -76.47 -42.06 45.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.684 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.598 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 34.2 ttp85 -66.95 -26.47 66.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.081 -175.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 54.1 ttt85 -58.97 -49.15 78.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.77 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -79.71 -25.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 68.3 mt -63.63 -56.04 18.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.743 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 30' ' ' ILE . 50.4 m -67.7 -32.99 74.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.028 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -58.94 -47.59 84.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 109.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.649 ' HE2' ' HB2' ' A' ' 175' ' ' GLU . 49.6 mtpt -59.44 -39.57 84.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.025 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 175' ' ' GLU . 94.8 t -63.38 -50.31 79.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.716 0.293 . . . . 0.0 110.624 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 26' ' ' SER . 74.7 mt -58.86 -49.92 81.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.1 m -64.17 -36.95 85.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.718 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.7 -44.94 80.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.125 0.488 . . . . 0.0 109.978 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.5 tp -62.66 -39.43 93.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.746 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 28.0 mtpp -75.94 -14.12 60.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.249 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.8 m -84.54 -19.63 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 110.088 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.55 114.3 18.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -56.4 -32.71 89.79 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.291 2.661 . . . . 0.0 113.829 -171.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.45 -23.86 61.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.604 0.24 . . . . 0.0 111.056 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.1 -41.77 94.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.007 0.432 . . . . 0.0 110.552 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -85.67 -10.29 55.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.757 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -9.7 30.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -101.94 -176.77 3.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -136.0 -55.03 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.798 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 30.5 mtpt -89.07 101.99 14.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 111.194 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.89 119.78 62.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . . . -99.57 131.67 45.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.392 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.95 138.67 50.56 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -78.74 -1.73 36.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.513 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.4 t 73.83 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.387 0 C-N-CA 123.47 0.708 . . . . 0.0 111.587 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.39 49.77 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.097 2.531 . . . . 0.0 112.259 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.792 HG13 ' H ' ' A' ' 52' ' ' LYS . 14.1 pt -56.46 -62.07 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.895 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.792 ' H ' HG13 ' A' ' 51' ' ' ILE . 94.4 mttt -122.29 9.29 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.719 0.771 . . . . 0.0 110.044 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.26 128.37 9.08 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.598 ' HB2' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -84.17 10.55 9.98 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -169.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.671 HG12 ' HG ' ' A' ' 57' ' ' LEU . 92.3 t -63.61 104.43 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.75 77.82 5.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.463 0.649 . . . . 0.0 111.145 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' A' ' 55' ' ' VAL . 96.6 mt -94.03 -2.08 53.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.178 173.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.496 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -56.65 -44.82 99.91 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.422 -178.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 58' ' ' THR . 56.8 Cg_endo -69.74 1.44 4.42 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.22 1.947 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.01 -18.36 24.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.294 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.83 -44.35 97.93 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 95.2 Cg_exo -45.49 -39.26 16.94 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.328 2.019 . . . . 0.0 113.244 174.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -77.68 -44.76 26.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 68' ' ' LYS . 65.1 t -57.25 -42.84 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.413 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.8 mt -69.48 -4.13 17.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 62' ' ' PRO . 95.5 mttt -98.4 -59.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 68' ' ' LYS . 6.4 pt-20 -105.45 -17.62 14.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.63 -170.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' HG3' ' A' ' 67' ' ' GLU . 45.4 mmtm -111.76 168.51 9.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.455 0.645 . . . . 0.0 111.666 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.798 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.4 mm-40 -102.12 103.16 13.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.984 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.58 100.54 6.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.887 0.375 . . . . 0.0 110.386 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 46' ' ' ALA . 58.2 mt -91.86 114.66 29.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 89.5 mt -114.79 141.81 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.728 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' LEU . 3.6 Cg_exo -80.11 129.19 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.868 2.379 . . . . 0.0 112.071 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.714 ' HG3' ' HB2' ' A' ' 100' ' ' GLU . 36.3 tttm -105.54 100.39 9.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 80' ' ' ILE . 35.1 t -69.73 98.52 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -146.92 134.58 21.07 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.274 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 -92.1 0.47 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.651 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.24 10.91 1.01 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.979 0.419 . . . . 0.0 109.954 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -125.96 154.04 43.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.911 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD13 ' A' ' 139' ' ' LEU . 6.2 pt -96.62 92.46 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 166.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.1 t -80.52 110.85 16.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.846 -170.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.97 121.98 22.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.726 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.512 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . 97.1 m-85 -121.85 148.94 44.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.006 175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -88.45 134.92 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.09 126.86 68.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.848 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -124.05 -1.23 8.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.229 0.538 . . . . 0.0 110.004 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -153.97 151.11 24.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 -174.46 0.84 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.946 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.0 -36.09 0.35 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.193 0.597 . . . . 0.0 111.884 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 60.7 m -69.94 -3.46 16.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.501 0.667 . . . . 0.0 111.238 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.8 mt -96.27 123.68 39.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.28 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.02 135.78 9.56 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.708 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.0 t -82.92 94.37 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.63 -24.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.385 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.19 -156.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 0.0 111.328 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.59 55.98 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.156 -171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.14 16.48 43.94 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.037 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 36.2 pt -120.27 165.29 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.85 90.47 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.021 0.438 . . . . 0.0 110.607 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.714 ' HB2' ' HG3' ' A' ' 74' ' ' LYS . 0.5 OUTLIER -88.98 147.54 38.99 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.514 -177.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 18.3 Cg_endo -61.19 114.46 2.21 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.745 2.297 . . . . 0.0 112.092 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -91.07 -52.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.317 0.58 . . . . 0.0 109.876 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -97.54 87.18 4.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.152 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.54 170.69 35.83 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.198 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -90.48 137.04 32.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.764 0.282 . . . . 0.0 110.936 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -77.88 133.54 38.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.753 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -109.89 135.88 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.737 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -87.02 146.73 41.2 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.593 ' HB3' ' HA ' ' A' ' 143' ' ' VAL . 50.9 Cg_exo -55.39 -25.05 46.16 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.06 2.507 . . . . 0.0 113.371 -176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 144' ' ' LYS . 43.2 tt0 -72.87 -20.33 61.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.165 0.507 . . . . 0.0 110.962 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -100.23 7.13 44.68 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.18 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' O ' ' HA3' ' A' ' 145' ' ' GLY . 60.0 t -94.32 111.88 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.06 -54.22 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.176 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -124.67 139.34 53.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.603 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 147' ' ' LYS . 4.5 tp -134.22 108.24 10.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.435 0.636 . . . . 0.0 109.561 172.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.79 112.07 24.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.948 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.11 113.86 51.58 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 150' ' ' VAL . 3.8 Cg_exo -76.52 91.72 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.801 2.334 . . . . 0.0 111.341 175.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.98 158.27 48.03 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.896 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' HH11 ' A' ' 14' ' ' ARG . 57.5 t -74.7 -39.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 110.013 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.539 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -147.76 155.93 42.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.898 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -135.21 153.19 52.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.425 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.605 ' HB3' ' H ' ' A' ' 127' ' ' TYR . 15.3 t70 -78.62 164.72 24.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.268 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.888 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 13.3 mt -55.44 -32.46 62.75 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.508 ' O ' HD11 ' A' ' 181' ' ' LEU . 46.6 mt-10 -87.53 -64.57 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.588 ' HA2' HD22 ' A' ' 172' ' ' LEU . . . 165.11 53.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.85 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.605 ' H ' ' HB3' ' A' ' 123' ' ' ASP . 51.2 m-85 -99.46 161.15 13.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 166' ' ' ASP . 40.3 ptt180 -93.27 155.6 17.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.434 0.635 . . . . 0.0 112.451 -167.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.644 ' HB2' HD13 ' A' ' 160' ' ' LEU . 40.7 tp -160.31 120.29 2.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.381 168.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.599 ' HA2' ' HG3' ' A' ' 7' ' ' ARG . . . 166.97 -111.48 0.45 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.291 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.77 174.57 5.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.91 7.03 13.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.464 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -80.56 64.28 5.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 109.499 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.3 107.04 1.19 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.974 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 67.31 -176.5 0.2 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.181 0.592 . . . . 0.0 110.522 -175.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 72.24 -47.57 0.67 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.778 0.831 . . . . 0.0 112.182 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.4 -35.99 60.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.045 0.538 . . . . 0.0 111.813 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -60.47 -33.4 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.052 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.675 HD13 HG13 ' A' ' 80' ' ' ILE . 9.1 tt -83.43 -44.26 14.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.6 mp -67.43 -18.11 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.775 0.322 . . . . 0.0 111.325 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 141' ' ' LYS . 4.2 ttmp? -89.16 -15.5 33.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.065 0.46 . . . . 0.0 109.883 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -89.59 -21.82 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HA ' ' HB3' ' A' ' 109' ' ' PRO . 60.7 t -63.58 127.73 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.163 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HD2' ' HG3' ' A' ' 110' ' ' GLU . 96.9 mttt -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 112' ' ' VAL . . . -79.63 -170.93 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.123 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.41 110.98 16.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.982 0.42 . . . . 0.0 109.95 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HA ' HG23 ' A' ' 115' ' ' ILE . 95.7 mttt -86.47 109.38 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 171' ' ' VAL . 63.0 t -106.34 122.25 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.82 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.34 119.66 6.01 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 47.7 t -105.95 117.96 52.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.69 0.281 . . . . 0.0 110.982 -175.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -160.35 -178.08 6.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.894 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 25' ' ' LEU . 35.0 m-85 -106.53 165.63 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -56.48 -30.44 62.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.21 -32.32 72.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.076 178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.414 ' HB2' ' HB1' ' A' ' 151' ' ' ALA . 12.2 mm100 -90.89 -7.97 50.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.77 117.88 33.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.965 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -109.63 174.48 5.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.706 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.888 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 45.9 mt-10 -69.69 -57.58 4.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 111.267 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 25.6 ttm105 -144.77 118.58 9.27 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 -169.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 129' ' ' LEU . 74.8 mt -98.53 141.19 22.51 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.698 0.285 . . . . 0.0 111.452 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.18 113.19 3.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.814 2.343 . . . . 0.0 111.666 174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -98.42 149.37 22.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.532 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.62 -75.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.235 -172.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -149.25 -76.32 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -100.05 69.05 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.61 0.719 . . . . 0.0 109.393 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.4 ' HA ' ' NH2' ' A' ' 128' ' ' ARG . 13.9 t70 -76.04 149.63 37.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.329 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.408 HD11 ' HZ1' ' A' ' 141' ' ' LYS . 65.9 mt -110.87 107.41 57.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.835 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -77.56 154.59 31.25 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.824 2.349 . . . . 0.0 111.214 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 m -88.39 158.96 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.343 -0.39 . . . . 0.0 109.992 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' A' ' 182' ' ' ARG . 11.6 t70 -88.57 -42.46 12.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.518 0.675 . . . . 0.0 109.502 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 75.7 t -126.35 116.48 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.496 176.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 179' ' ' ARG . 35.2 tp -99.87 103.65 15.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.911 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.05 125.87 53.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.128 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 54.0 p -107.83 -166.74 1.17 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.403 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.649 ' HB2' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.54 9.51 36.41 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.697 174.393 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -125.79 -55.21 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.556 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -136.12 160.03 39.91 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 111.505 -174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.411 HG12 ' HG3' ' A' ' 180' ' ' ARG . 64.9 t -101.2 113.98 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.96 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.76 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -92.49 93.66 8.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.728 -179.098 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.411 ' HG3' HG12 ' A' ' 178' ' ' VAL . 86.1 mtm180 -86.18 121.24 28.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.642 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 125' ' ' GLU . 39.5 mt -109.17 -59.34 1.91 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.555 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 182' ' ' ARG . 1.4 tpm_? 68.92 -75.24 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.213 0.605 . . . . 0.0 112.348 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -161.68 162.09 29.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.79 148.38 46.46 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.542 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 185' ' ' ARG . 5.7 mpt_? -88.22 13.82 10.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.656 0.265 . . . . 0.0 111.283 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 50.3 m -63.35 105.35 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.35 176.92 9.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.881 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.667 ' HG3' ' H ' ' A' ' 190' ' ' HIS . 8.8 tp10 -77.11 149.63 35.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 190' ' ' HIS . 34.2 t-80 -88.64 -6.99 57.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.667 ' H ' ' HG3' ' A' ' 188' ' ' GLU . 23.7 m80 71.73 117.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.475 0.655 . . . . 0.0 110.724 -174.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -77.45 64.69 2.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.238 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -110.34 -1.53 17.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.723 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -176.76 -45.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 . . . . . 0 C--O 1.244 0.788 0 CA-C-O 118.0 -1.0 . . . . 0.0 108.962 170.059 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.711 0.291 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 4' ' ' SER . 50.0 tp -160.55 141.4 11.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -28.02 66.36 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.565 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.542 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 12.2 m -70.44 -35.72 73.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.115 0.484 . . . . 0.0 109.707 174.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 33.5 tt0 -61.92 -53.73 51.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.859 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 10' ' ' VAL . 65.5 tp -57.66 -45.04 86.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.808 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 120' ' ' VAL . 18.0 ttp180 -55.32 -42.35 73.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.497 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.64 -37.0 83.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 110.601 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' HE2' ' HG2' ' A' ' 5' ' ' GLU . 64.7 mttm -65.03 -37.71 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.413 0.625 . . . . 0.0 110.09 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 6' ' ' LEU . 46.3 t -69.5 -38.93 77.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.637 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.99 -37.43 87.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.275 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -56.18 -47.75 77.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.059 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 10' ' ' VAL . 62.6 pttt -77.23 -0.17 24.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.585 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 41.6 ttm180 -93.05 -48.86 6.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.672 ' HA ' HH12 ' A' ' 22' ' ' ARG . 31.3 pt -85.54 -11.97 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -89.54 5.16 46.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.124 0.488 . . . . 0.0 110.846 -178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.97 149.85 42.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.432 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -70.67 146.7 49.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -62.39 -40.35 96.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -52.15 -52.47 51.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.522 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 6.2 pt-20 -81.03 -31.32 34.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.24 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.672 HH12 ' HA ' ' A' ' 15' ' ' ILE . 35.9 ttm-85 -57.04 -49.44 75.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.861 0.362 . . . . 0.0 110.82 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.71 -31.57 70.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -80.22 -34.96 36.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' VAL . 92.7 mt -65.13 -46.12 82.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 30' ' ' ILE . 20.2 m -64.15 -33.38 75.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.518 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.06 -43.0 99.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.12 -39.63 86.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.355 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' LEU . 64.9 t -65.19 -46.03 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.936 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 26' ' ' SER . 76.0 mt -58.98 -46.96 91.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.078 0.466 . . . . 0.0 110.171 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -60.02 -45.66 92.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.48 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -60.84 -45.08 95.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.427 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -60.48 -42.46 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.379 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -71.1 -26.18 62.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.014 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.0 m -73.18 -23.67 60.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 92.8 mt -60.16 122.08 63.96 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.306 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 36' ' ' LEU . 33.8 Cg_exo -60.61 -21.29 68.45 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.166 2.577 . . . . 0.0 112.913 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -75.49 -39.65 58.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.94 -37.49 76.83 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.387 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -67.3 -37.7 83.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.544 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 3.7 tmmm? -78.57 -52.37 8.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.124 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -60.84 131.1 49.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -90.51 -42.49 10.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.91 106.9 18.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.98 0.419 . . . . 0.0 110.322 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -114.84 108.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.337 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . . . -94.54 117.49 30.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.553 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -104.89 122.03 44.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.648 ' HA ' ' HG3' ' A' ' 73' ' ' PRO . 8.9 t80 -76.73 -6.5 52.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.563 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.3 m 69.75 134.6 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 CA-C-O 121.43 0.633 . . . . 0.0 111.621 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.54 125.74 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.506 2.137 . . . . 0.0 112.923 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.0 pt -109.66 145.22 16.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 69.1 -41.4 0.47 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.414 0.686 . . . . 0.0 111.765 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.12 -76.8 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.819 ' HA ' ' HD3' ' A' ' 14' ' ' ARG . 6.3 mm-40 56.69 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.889 0.875 . . . . 0.0 111.305 -178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 150' ' ' VAL . 95.8 t -153.33 128.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.434 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -82.12 90.15 6.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.204 0.526 . . . . 0.0 110.881 -176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.583 HD11 HG11 ' A' ' 150' ' ' VAL . 89.1 mt -102.2 6.61 40.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.837 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.578 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -61.03 -43.81 92.27 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.065 -175.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 58' ' ' THR . 19.3 Cg_endo -61.2 -7.07 7.5 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.121 1.881 . . . . 0.0 113.886 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.34 -13.93 39.48 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.456 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 4.1 m-85 -52.48 -49.77 83.82 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 74.4 Cg_exo -52.36 -36.05 67.32 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.41 2.073 . . . . 0.0 113.225 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mt-10 -74.18 -31.42 62.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.014 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.19 -36.15 71.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.429 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -68.04 -5.01 15.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.582 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 43.4 tttp -66.87 -64.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.742 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' HG3' ' HD2' ' A' ' 68' ' ' LYS . 11.2 pt-20 -143.92 -4.05 0.85 Allowed 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HG3' ' A' ' 67' ' ' GLU . 6.3 mptp? -92.92 164.08 13.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.337 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.83 ' HG3' ' HB2' ' A' ' 84' ' ' ARG . 3.0 tp10 -97.3 103.46 15.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.227 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.8 tp -76.78 94.11 3.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 0.0 110.758 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 46' ' ' ALA . 56.4 mt -88.49 112.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 86.2 mt -110.06 149.59 40.27 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.663 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 48' ' ' TYR . 9.6 Cg_endo -89.23 125.6 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.376 2.717 . . . . 0.0 113.097 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -105.62 105.63 15.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.429 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 HD12 ' A' ' 80' ' ' ILE . 21.3 t -82.58 95.4 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.345 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -112.12 5.97 18.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.659 0.742 . . . . 0.0 109.835 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.49 -153.12 18.24 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -78.36 -6.24 54.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.109 0.48 . . . . 0.0 110.495 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.99 143.46 46.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.145 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.517 HD12 HG22 ' A' ' 75' ' ' VAL . 49.6 mm -100.47 122.81 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.129 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.5 m -85.84 122.67 30.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.506 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.2 mt -101.32 133.19 46.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.684 0.278 . . . . 0.0 110.685 -177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . 93.9 m-85 -128.77 146.02 51.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.83 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 38.3 ptt85 -100.03 134.35 43.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.117 0.484 . . . . 0.0 110.012 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.78 139.38 51.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -124.76 -28.27 3.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.309 171.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.3 m -108.12 131.62 21.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.67 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.64 -10.14 25.35 Favored 'Trans proline' 0 N--CA 1.474 0.362 0 C-N-CA 123.141 2.561 . . . . 0.0 113.441 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.92 60.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.416 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 41.8 m -85.44 8.39 19.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.027 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.6 138.04 39.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.98 0.419 . . . . 0.0 111.5 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.86 176.41 20.68 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.549 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.78 90.31 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.846 0.355 . . . . 0.0 110.62 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.98 -16.26 7.42 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.591 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.7 -171.05 3.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.303 0.241 . . . . 0.0 110.984 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -53.48 -53.66 48.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.102 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.85 50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.727 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.5 157.42 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.22 103.71 14.43 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.27 147.06 32.42 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.459 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 83' ' ' TYR . 72.9 Cg_endo -80.11 105.98 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.209 1.939 . . . . 0.0 111.458 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 36.0 m -91.71 -19.43 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.833 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -137.03 -171.97 3.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.916 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.53 -132.63 11.07 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 137.88 32.57 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -80.54 156.07 26.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.478 . . . . 0.0 111.68 -175.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.24 142.98 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.407 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -89.94 141.67 28.29 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.721 ' HB3' HG22 ' A' ' 143' ' ' VAL . 87.0 Cg_exo -46.7 -40.41 24.24 Favored 'Trans proline' 0 N--CA 1.476 0.441 0 C-N-CA 123.647 2.898 . . . . 0.0 114.225 -175.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.28 -19.27 64.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.41 -17.82 50.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.22 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 118.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.696 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -76.31 -55.66 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.33 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 148' ' ' VAL . 40.8 t80 -128.35 136.35 50.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.684 -173.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 147' ' ' LYS . 13.2 tt -139.06 139.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.98 113.17 25.82 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.073 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 47.8 t -111.98 124.73 31.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.878 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 48' ' ' TYR . 4.9 Cg_exo -77.83 131.04 10.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.104 2.536 . . . . 0.0 111.804 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.88 140.18 11.56 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.539 HG11 ' HG2' ' A' ' 7' ' ' ARG . 48.6 t -70.93 -43.55 76.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 117.016 0.408 . . . . 0.0 110.836 -175.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 129' ' ' LEU . . . -143.42 130.91 21.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.74 169.29 9.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.01 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . 26.4 p30 -132.1 -172.35 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.583 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 88.9 mt -87.29 3.17 47.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.27 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.96 -31.96 10.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.421 ' CA ' HD13 ' A' ' 181' ' ' LEU . . . 117.75 29.86 1.95 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.091 169.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -94.23 156.61 16.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 117.534 0.667 . . . . 0.0 109.865 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.451 ' CZ ' ' H ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER -101.45 -33.42 9.98 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -163.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 160' ' ' LEU . 35.6 tp 36.51 70.35 0.17 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.416 0.627 . . . . 0.0 111.908 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.451 ' H ' ' CZ ' ' A' ' 128' ' ' ARG . . . -90.35 -160.07 36.17 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -69.69 92.69 0.67 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.018 0.437 . . . . 0.0 110.637 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.18 170.3 45.97 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.474 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.644 ' HE2' ' HA ' ' A' ' 166' ' ' ASP . 46.6 tttm -139.32 169.34 17.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' A' ' 133' ' ' LYS . . . 87.23 -49.01 3.89 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -174.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -76.91 154.91 33.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 71.03 0.51 3.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.266 0.626 . . . . 0.0 111.059 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.8 t70 -70.38 161.05 31.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 137' ' ' ASP . 28.4 ttt180 72.93 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 -174.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' H ' ' C ' ' A' ' 137' ' ' ASP . 30.8 tp -65.46 -65.83 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.661 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.69 ' HB2' HD13 ' A' ' 167' ' ' ILE . 97.4 mt -71.64 -11.99 61.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.573 -175.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.61 -23.84 39.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.215 0.531 . . . . 0.0 110.106 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -96.2 -35.75 11.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.705 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 109' ' ' PRO . 42.3 t -73.39 93.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -101.91 26.37 7.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.431 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.95 -175.24 31.86 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.268 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.6 tp -71.58 98.14 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.119 0.459 . . . . 0.0 109.931 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.518 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.8 mtmm -84.74 102.89 13.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 171' ' ' VAL . 98.6 t -103.49 119.89 52.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.663 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.46 130.85 10.1 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 57' ' ' LEU . 51.0 t -114.61 119.51 61.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -163.71 171.58 15.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.935 0.397 . . . . 0.0 111.16 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.528 ' HB3' ' OE2' ' A' ' 175' ' ' GLU . 57.1 m-85 -87.21 162.53 17.42 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 156' ' ' VAL . 5.8 p -77.35 -9.94 59.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 0.0 110.46 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -61.67 -29.64 70.21 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.419 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -105.86 20.43 18.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 111.281 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 153' ' ' SER . 64.0 t -103.42 116.27 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.944 0.402 . . . . 0.0 110.546 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -100.84 -171.57 2.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.262 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.518 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 13.0 mt-10 -92.02 -44.76 8.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -147.59 125.05 11.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.376 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 123' ' ' ASP . 97.4 mt -84.89 143.97 41.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.643 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 160' ' ' LEU . 3.7 Cg_exo -74.95 102.26 1.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.812 2.341 . . . . 0.0 110.548 171.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 160' ' ' LEU . 28.6 mtt180 -108.87 155.83 20.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.695 -172.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.58 -55.38 24.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -173.15 -50.61 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.147 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -129.28 83.74 2.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.853 0.835 . . . . 0.0 111.368 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.644 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.3 t70 -78.01 151.2 33.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 167.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.69 HD13 ' HB2' ' A' ' 140' ' ' LEU . 64.6 mt -75.05 113.46 25.2 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.81 0.338 . . . . 0.0 110.676 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -88.88 161.36 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.044 2.496 . . . . 0.0 113.186 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.17 176.45 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.166 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.732 ' HA ' ' HD2' ' A' ' 182' ' ' ARG . 38.6 m-20 -99.28 -45.29 5.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.368 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 148' ' ' VAL . 59.9 t -129.04 141.13 47.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.658 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.751 ' HB3' ' HB2' ' A' ' 179' ' ' ARG . 68.5 tp -117.51 115.56 25.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.636 0.255 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.98 122.73 57.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 77.1 p -115.79 -174.38 2.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.139 0.495 . . . . 0.0 111.021 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.859 ' HG3' ' HD2' ' A' ' 176' ' ' LYS . 11.6 pt-20 -70.39 -13.68 62.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.096 178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.859 ' HD2' ' HG3' ' A' ' 175' ' ' GLU . 10.1 mptt -121.67 -70.38 0.78 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -110.43 168.92 9.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.443 -167.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.4 119.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.669 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.751 ' HB2' ' HB3' ' A' ' 172' ' ' LEU . 39.0 mmt180 -94.16 102.86 14.91 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.039 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -79.88 89.62 5.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' CA ' ' A' ' 126' ' ' GLY . 34.2 mt -81.36 -51.38 8.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.718 -173.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.732 ' HD2' ' HA ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -87.75 -88.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.2 t70 58.1 -91.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.226 0.61 . . . . 0.0 112.526 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -104.14 47.63 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.89 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HE ' ' HA ' ' A' ' 185' ' ' ARG . 1.8 tpm_? -83.32 -66.68 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.5 p 46.58 -158.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.825 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 88.6 mt -113.73 137.66 51.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.239 -0.288 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 69.04 -78.62 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.01 0.819 . . . . 0.0 111.495 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -154.37 164.91 37.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.013 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -129.77 99.95 5.31 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.666 ' HA ' ' OXT' ' A' ' 194' ' ' HIS . 9.0 t-80 -83.38 64.62 7.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.299 0.571 . . . . 0.0 110.665 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -117.86 -2.75 11.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.494 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -146.58 -45.56 0.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . 0.666 ' OXT' ' HA ' ' A' ' 191' ' ' HIS . 58.2 t-80 . . . . . 0 C--O 1.249 1.068 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mtm . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.21 85.45 5.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.937 0.398 . . . . 0.0 110.447 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -75.31 -37.26 60.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.252 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.7 m -70.17 -25.27 63.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.56 -38.54 70.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 129' ' ' LEU . 58.1 tp -70.76 -40.06 72.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.756 176.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.605 ' HD3' ' HA3' ' A' ' 130' ' ' GLY . 12.8 ttp180 -60.16 -44.33 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.428 174.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -64.78 -33.03 75.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.94 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -62.71 -47.31 84.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.266 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 121' ' ' ALA . 45.7 t -73.68 -43.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.615 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD12 ' HD3' ' A' ' 14' ' ' ARG . 51.4 tp -57.92 -33.44 68.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.048 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 9.7 t60 -60.44 -43.6 96.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.375 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 44.2 mttp -81.67 -24.66 36.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.757 0.313 . . . . 0.0 111.033 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.538 ' HD3' HD12 ' A' ' 11' ' ' LEU . 41.1 ttt85 -57.77 -51.92 67.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.67 4.15 6.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.595 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 8.6 t30 -83.88 -19.21 35.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.35 132.65 52.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.757 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -70.65 153.16 43.11 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.041 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -43.66 79.82 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.334 0.396 . . . . 0.0 111.839 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.0 tp10 -60.95 -56.79 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.792 0.33 . . . . 0.0 111.081 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.46 -44.28 97.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.174 0.511 . . . . 0.0 110.596 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.35 -42.1 98.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.013 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 12.7 tpt180 -62.11 -43.12 99.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.696 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 85.0 mtt180 -60.77 -38.79 86.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 152' ' ' TYR . 98.4 mt -72.6 -45.22 60.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.882 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -62.67 -35.04 78.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.33 -43.49 79.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -66.36 -39.3 89.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 175' ' ' GLU . 61.5 t -65.06 -47.72 86.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.693 0.282 . . . . 0.0 110.776 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.77 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 110.203 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -36.16 83.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.101 0.476 . . . . 0.0 109.971 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -69.32 -44.36 71.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.356 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 33' ' ' LEU . 5.2 tt -65.46 -38.55 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.991 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -67.11 -26.53 66.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 111.036 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -83.79 -16.77 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.518 HD23 ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -68.02 112.35 10.43 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.142 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HD2' HD23 ' A' ' 36' ' ' LEU . 35.1 Cg_endo -64.74 -25.43 61.14 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.611 2.207 . . . . 0.0 112.795 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.35 -24.61 61.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.731 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -63.26 -42.57 99.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.89 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HA ' ' NZ ' ' A' ' 68' ' ' LYS . 89.3 mttt -83.92 -3.04 57.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.129 0.49 . . . . 0.0 110.808 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.22 -33.8 22.16 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.492 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.7 p -81.94 152.55 26.71 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.195 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 24.8 tptp -111.46 -40.33 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.151 0.5 . . . . 0.0 109.732 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' ' H ' ' A' ' 113' ' ' ASP . 22.2 mmtp -91.99 107.43 19.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.796 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -117.3 115.01 47.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.278 0.561 . . . . 0.0 111.511 -176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 115' ' ' ILE . . . -104.19 133.07 49.72 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.39 129.0 51.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.0 0.428 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -88.02 109.88 20.18 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.0 m -52.68 116.17 8.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.536 0.523 . . . . 0.0 111.621 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.18 69.09 7.24 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.865 2.377 . . . . 0.0 112.44 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 52' ' ' LYS . 26.5 pt -55.0 -43.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.521 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' N ' HG13 ' A' ' 51' ' ' ILE . 64.5 mttm -112.98 30.53 7.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA2' HH21 ' A' ' 14' ' ' ARG . . . -99.78 149.71 18.89 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.152 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' OE2' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -91.06 -35.62 14.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.32 104.07 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.83 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.85 101.84 7.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.972 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.08 5.9 40.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.781 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 59' ' ' PRO . 2.2 m -60.1 -52.92 69.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.427 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 58' ' ' THR . 18.6 Cg_exo -68.88 7.28 0.79 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.54 2.16 . . . . 0.0 113.495 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.67 -13.81 38.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.357 . . . . 0.0 110.146 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' HB2' ' HD3' ' A' ' 62' ' ' PRO . 21.6 m-30 -55.75 -49.13 94.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.142 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 61' ' ' PHE . 75.2 Cg_exo -53.55 -36.06 79.04 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.281 1.987 . . . . 0.0 113.067 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 4.4 tp10 -70.98 -31.33 67.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 110.151 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -75.52 -40.76 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.396 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 88' ' ' PRO . 95.8 mt -65.65 -11.85 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 63' ' ' GLU . 41.2 tttp -64.82 -60.5 3.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.252 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.844 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.8 pt-20 -120.65 -19.82 7.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -172.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.844 ' HG3' ' HG3' ' A' ' 67' ' ' GLU . 50.6 mttm -116.38 -172.45 2.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.628 0.251 . . . . 0.0 110.664 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -112.93 143.0 44.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.869 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.9 tp -92.74 124.77 36.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.226 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.55 ' CG2' ' HB3' ' A' ' 82' ' ' LEU . 53.5 mt -111.23 126.52 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.997 0.427 . . . . 0.0 110.484 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.5 mt -123.71 147.93 54.79 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.308 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.72 125.36 3.74 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.218 2.612 . . . . 0.0 112.753 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' OE1' ' A' ' 100' ' ' GLU . 85.1 tttt -113.32 139.69 48.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.845 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.71 99.27 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.835 0.35 . . . . 0.0 110.869 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HE2' ' A' ' 74' ' ' LYS . 10.6 mm-40 -81.66 82.57 7.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.734 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.18 -89.74 0.5 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -174.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -123.18 -7.29 8.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.88 0.371 . . . . 0.0 110.37 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.96 98.93 12.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.749 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.9 tt -91.94 127.58 44.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.341 0.591 . . . . 0.0 110.291 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.4 m -137.07 167.47 21.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.767 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 71' ' ' ILE . 93.6 mt -99.32 138.1 36.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.372 . . . . 0.0 110.456 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -118.87 128.16 54.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -95.99 111.93 23.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.393 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 91' ' ' LEU . 27.0 m -101.94 138.31 26.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.072 0.463 . . . . 0.0 110.386 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -96.87 -4.81 39.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.347 0.594 . . . . 0.0 109.805 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -167.81 144.7 3.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.893 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HD3' HD13 ' A' ' 65' ' ' LEU . 54.3 Cg_endo -72.1 71.27 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.45 2.1 . . . . 0.0 111.818 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.37 -58.05 2.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.812 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 7.7 p -86.43 21.62 2.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.273 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 85' ' ' VAL . 96.5 mt -99.12 108.53 21.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.14 10.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -131.74 108.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.098 0.449 . . . . 0.0 110.123 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 100' ' ' GLU . . . -150.48 -1.77 0.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.87 -161.43 0.62 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.312 . . . . 0.0 110.338 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.32 -18.75 63.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.257 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 166.18 -23.36 0.13 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.719 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 pt -83.42 172.91 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.65 -0.275 . . . . 0.0 110.869 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -62.68 138.0 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.098 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.516 ' OE1' ' HG3' ' A' ' 74' ' ' LYS . 3.3 tp10 -108.34 107.19 59.94 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.157 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.58 106.07 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.67 1.58 . . . . 0.0 110.903 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.83 -45.65 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.224 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.67 178.72 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.87 -130.18 4.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.176 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -118.49 118.91 33.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.603 0.239 . . . . 0.0 110.418 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -80.67 97.0 7.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 111' ' ' ASP . 88.1 t -99.08 119.94 47.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.967 -175.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.17 154.08 86.36 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 143' ' ' VAL . 10.6 Cg_endo -54.1 -19.19 15.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.828 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.5 -41.12 76.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.937 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.577 ' HB3' HG13 ' A' ' 107' ' ' VAL . 22.1 t70 -87.24 -9.26 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.17 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.1 t -81.25 132.09 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.136 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.574 ' H ' ' HB2' ' A' ' 44' ' ' LYS . 67.4 m-20 -91.7 -49.31 6.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.471 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 148' ' ' VAL . 47.5 t80 -130.31 138.43 50.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.541 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 tt -143.65 140.03 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.94 127.16 54.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.4 t -120.69 121.54 28.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.75 -41.26 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.722 2.282 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 62.25 -145.82 49.42 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.86 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.885 HG23 ' HB2' ' A' ' 131' ' ' PHE . 75.7 t -139.24 -45.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.479 ' HB2' HG11 ' A' ' 10' ' ' VAL . . . -161.15 157.07 25.28 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.381 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -135.92 166.01 24.32 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.157 0.285 . . . . 0.0 110.85 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -111.06 -171.74 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.892 ' HG ' ' HA ' ' A' ' 158' ' ' GLU . 52.9 mt -71.39 -14.38 62.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.63 -21.57 14.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.561 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.19 31.33 3.1 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.941 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -95.63 147.04 24.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.795 0.331 . . . . 0.0 110.435 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -84.06 150.13 25.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.861 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 6' ' ' LEU . 28.7 tp -94.53 15.37 18.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.515 0.674 . . . . 0.0 109.967 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.605 ' HA3' ' HD3' ' A' ' 7' ' ' ARG . . . 135.05 -143.07 14.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.12 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.885 ' HB2' HG23 ' A' ' 120' ' ' VAL . 60.4 t80 73.71 111.66 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.527 0.731 . . . . 0.0 110.522 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 118.49 61.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.229 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -68.29 131.05 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 110.233 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.27 -113.04 2.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.555 -177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -133.81 -95.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 63.81 14.23 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.372 0.606 . . . . 0.0 111.45 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.24 -39.49 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.671 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 37.6 ttm180 -61.8 -17.65 56.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.402 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 45.9 tp -92.9 -70.12 0.71 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.41 . . . . 0.0 111.028 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.775 ' HB2' HD13 ' A' ' 167' ' ' ILE . 7.4 mp -63.49 -32.32 73.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.36 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 141' ' ' LYS . 34.4 ttmt -80.81 -16.59 53.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 138' ' ' ARG . 37.4 mtp180 -101.69 -5.57 24.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.287 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 109' ' ' PRO . 94.0 t -62.04 112.38 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.003 0.43 . . . . 0.0 110.124 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -92.16 -7.09 49.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.792 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.34 -173.71 46.66 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.1 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.544 HD11 HG23 ' A' ' 171' ' ' VAL . 32.3 tp -80.21 108.11 13.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 115' ' ' ILE . 32.4 mtmm -86.25 106.19 17.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.044 0.45 . . . . 0.0 110.034 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 171' ' ' VAL . 84.5 t -102.51 124.36 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.997 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.54 138.82 14.36 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.7 111.45 36.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 174' ' ' THR . . . -151.76 162.85 40.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.65 ' HD1' ' HB3' ' A' ' 175' ' ' GLU . 30.8 m-85 -86.16 170.38 12.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.393 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.1 t -72.13 -38.52 69.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.73 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -74.46 -9.07 58.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.486 . . . . 0.0 110.421 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -95.31 -7.7 37.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.019 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.46 110.29 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.408 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -91.46 179.99 5.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.242 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.892 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.36 -53.46 6.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.051 178.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -136.04 140.73 44.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.214 0.53 . . . . 0.0 110.975 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 129' ' ' LEU . 96.7 mt -132.81 158.67 75.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.5 101.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.289 1.993 . . . . 0.0 110.933 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -96.7 128.33 43.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.941 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.926 ' HB3' ' HB2' ' A' ' 166' ' ' ASP . 9.6 t70 -95.11 137.16 34.54 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.59 57.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.81 0.338 . . . . 0.0 111.549 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -119.52 24.01 10.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 0.0 110.552 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.926 ' HB2' ' HB3' ' A' ' 163' ' ' ASP . 12.0 t70 -89.73 -157.61 0.47 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.542 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.775 HD13 ' HB2' ' A' ' 140' ' ' LEU . 56.9 mt -125.82 107.27 25.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.841 0.353 . . . . 0.0 111.305 -173.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -93.12 174.49 1.75 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.247 2.632 . . . . 0.0 112.177 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.85 174.58 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.604 0.24 . . . . 0.0 110.758 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -106.88 -44.24 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.554 . . . . 0.0 109.902 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.544 HG23 HD11 ' A' ' 146' ' ' LEU . 86.5 t -125.96 140.75 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.552 178.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.62 ' HB2' HD21 ' A' ' 181' ' ' LEU . 53.6 tp -121.0 103.12 8.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.99 0.424 . . . . 0.0 110.687 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -87.95 119.03 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.907 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 81.7 p -110.34 -175.94 2.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.187 0.518 . . . . 0.0 111.222 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.65 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 9.5 pt-20 -60.12 -27.61 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.658 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.518 ' HG3' ' HG3' ' A' ' 175' ' ' GLU . 24.9 mtmm -118.45 -56.77 2.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -119.05 174.51 6.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 111.334 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.91 99.31 8.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HB3' ' HB3' ' A' ' 172' ' ' LEU . 25.0 ttm-85 -79.05 124.2 28.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.276 0.56 . . . . 0.0 110.984 -174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 180' ' ' ARG . 4.6 mtp180 -92.22 97.52 10.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.569 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 172' ' ' LEU . 2.9 mm? -64.41 -55.17 22.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.985 0.421 . . . . 0.0 110.36 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.0 mmm-85 -117.08 30.96 7.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.684 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 180' ' ' ARG . 15.1 t70 67.04 -81.19 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.751 0.657 . . . . 0.0 110.324 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.22 16.79 69.41 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.697 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -130.64 -2.99 4.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.144 0.472 . . . . 0.0 111.289 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 43.4 m -74.78 129.02 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.9 -157.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.773 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.41 -178.98 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.89 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -110.87 -17.62 13.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.858 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -74.22 110.56 8.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.53 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -72.71 127.34 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.07 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -121.88 -130.79 0.28 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -61.65 -32.68 72.85 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 166.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 C--O 1.246 0.917 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.046 169.897 . . . . . . . . 0 0 . 1 stop_ save_